Citrus Sinensis ID: 048724
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.758 | 0.766 | 0.342 | 3e-54 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.677 | 0.291 | 0.324 | 1e-48 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.705 | 0.167 | 0.331 | 7e-47 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.667 | 0.204 | 0.346 | 2e-43 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.664 | 0.280 | 0.367 | 2e-43 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.670 | 0.321 | 0.353 | 6e-43 | |
| Q54RB7 | 527 | Dual specificity protein | no | no | 0.652 | 0.487 | 0.350 | 2e-42 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.654 | 0.158 | 0.353 | 8e-42 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.710 | 0.116 | 0.312 | 1e-41 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.682 | 0.231 | 0.330 | 3e-41 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 212 bits (540), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 112/327 (34%), Positives = 179/327 (54%), Gaps = 28/327 (8%)
Query: 50 DFKSWDIQLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQ 109
+SW + LE W E + EEW +L++L I ++ A G + +YRG Y +
Sbjct: 53 SMESWSMILESENVETW----EASKGEREEWTADLSQLFIGNKFASGAHSRIYRGIYKQR 108
Query: 110 DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQ 169
VAVK++ T A+ + F+ EVA+ +L HPN+ +FI A K P
Sbjct: 109 AVAVKMVRIPTHKEETRAK---LEQQFKSEVALLSRLFHPNIVQFIAAC------KKPP- 158
Query: 170 SATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS 229
C++ EY+ G L+ +L + + L+ + V+++ALD++RG+ YLHS
Sbjct: 159 -------------VYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHS 205
Query: 230 KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN 289
+ ++HRD+K+ N+LL+ +K+ADFG + +E Q R+ G GT +MAPE++ KPY
Sbjct: 206 QGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQC-REAKGNMGTYRWMAPEMIKEKPYT 264
Query: 290 RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD 349
RK DVYSFGI LWE+ +P+ ++ + AV +N RP +P C +LA ++++CW
Sbjct: 265 RKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKRCWS 324
Query: 350 ANPDKRPVMDEVVKLLEAVNTSKGGGM 376
NP KRP +V +LE + G+
Sbjct: 325 ENPSKRPDFSNIVAVLEKYDECVKEGL 351
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (492), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 97/299 (32%), Positives = 168/299 (56%), Gaps = 32/299 (10%)
Query: 74 PRKTEEW----EIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEA 129
P + +++ EI ++L I ++ GT+G VY+G + G VA+K + ED
Sbjct: 645 PSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED------VN 698
Query: 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
+ FR+E+ + +L HPN+ + A NL C + E
Sbjct: 699 NQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNL--------------------CFITE 738
Query: 190 YLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249
YLPGG+L L +K+ K+ ++ ++A+ +A+G++YLH ++HRD+K+ N+LLD +
Sbjct: 739 YLPGGSLYDAL-HSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMN 797
Query: 250 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309
+KI DFG++++++++ +MT G+ +M+PE+L G+ Y K DVY+FGI LWE+ ++
Sbjct: 798 VKICDFGLSKLKSKS-TEMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGEL 856
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
PY L ++ AV ++LRP IP P L+ +++ CW +P KRP E++ LL +
Sbjct: 857 PYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 7e-47, Method: Compositional matrix adjust.
Identities = 103/311 (33%), Positives = 165/311 (53%), Gaps = 33/311 (10%)
Query: 57 QLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKIL 116
Q ++ + + + ER + W I ++ + +I G+YG VYRG + DVA+K
Sbjct: 1369 QAYQYHAAIENNERYLTSAGLCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIK-- 1426
Query: 117 DWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSH 176
+ R+E+A +KL HPN+ +GAS+ N+
Sbjct: 1427 -----KFIKQKIDENHLLGIREEIAFLKKLHHPNIITMVGASLKKPNI------------ 1469
Query: 177 NSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS--KTIVH 234
C+V EY+ G L+ + R KL + I+I +++A+G+SYLHS I+H
Sbjct: 1470 --------CIVTEYMAKGNLRDAM-RTCTPKLEWHQKIKILVNIAKGISYLHSFDPPIIH 1520
Query: 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDV 294
RD+K N+L+D N +KIADFG AR++ +N + GT + APE++ Y+ K DV
Sbjct: 1521 RDIKPSNILIDENWNVKIADFGFARIKEENA--IMTRCGTPCWTAPEIIRNDIYDEKVDV 1578
Query: 295 YSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDK 354
+SFGI +WE+ C P+ +F ++ ++ +++RP IP+ CP A +MRKCW A K
Sbjct: 1579 FSFGIVMWEVLTCKEPFIGANFMKITMDIL-EDVRPKIPQDCPEEFAKLMRKCWHAKSTK 1637
Query: 355 RPVMDEVVKLL 365
RP MD+V+ +L
Sbjct: 1638 RPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 106/306 (34%), Positives = 168/306 (54%), Gaps = 43/306 (14%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
EWE+ L+++ I I RG YG V+RG++ G +VAVK+L + + R+
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKML-------FNDNVNLKLISDLRK 895
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
EV + KL HPN+ F+GA + PS + C+V EYL G+L
Sbjct: 896 EVDLLCKLRHPNIVLFMGAC-------------------TEPS-SPCIVTEYLSRGSLAN 935
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANRTLKIADFG 256
L+ ++ ++ + + +Q+ D ARG++YLHS+ I+HRD+KT+N+L+D + +K+ADFG
Sbjct: 936 ILL-DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFG 994
Query: 257 VARVEAQN-PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
+A V++ + M G T G++APEVL + Y K DVYS+ I LWE+ +PY +
Sbjct: 995 LATVKSHTFAKTMCG---TTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKN 1051
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGG 375
V ++ R P +P CP A++M +CW+ +P RP E++ ++E G
Sbjct: 1052 TMQVVRSIDRGERLP-MPAWCPPKYAALMNRCWETDPTHRPSFPEILPIME--------G 1102
Query: 376 MIPEDQ 381
MI E Q
Sbjct: 1103 MISEFQ 1108
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 108/294 (36%), Positives = 156/294 (53%), Gaps = 32/294 (10%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVK-ILDWAEDGMVTSAEAAAIRASFR 137
E EI L I I G+YG VY + G +VAVK LD G A A FR
Sbjct: 661 ECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSG--------AALAEFR 712
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
EV + ++L HPNV F+GA NL I V E+LP G+L
Sbjct: 713 SEVRIMRRLRHPNVVFFLGAVTRPPNLSI--------------------VTEFLPRGSLY 752
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANRTLKIADF 255
+ L R K + + I++ALD+A G++ LH+ T IVHRD+KT N+L+D N +K+ DF
Sbjct: 753 RILHRPK-SHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDF 811
Query: 256 GVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
G++R++ GT +MAPEVL +P N KCDVYSFG+ LWE+ +P+ ++
Sbjct: 812 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMN 871
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369
V AV QN R +IP+ + I+ +CW +P+ RP ++ ++L+ +N
Sbjct: 872 PMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLN 925
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 104/294 (35%), Positives = 162/294 (55%), Gaps = 30/294 (10%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
++ +I L+I+ +I G++GTV+R + G DVAVKIL M A + F
Sbjct: 542 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKIL------MEQDFHAERVN-EFL 594
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
+EVA+ ++L HPN+ F+GA NL I V EYL G+L
Sbjct: 595 REVAIMKRLRHPNIVLFMGAVTQPPNLSI--------------------VTEYLSRGSLY 634
Query: 198 KFLIRN-KRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANRTLKIAD 254
+ L ++ R++L + + +A D+A+G++YLH++ IVHRD+K+ N+L+D T+K+ D
Sbjct: 635 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCD 694
Query: 255 FGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
FG++R++A GT +MAPEVL +P N K DVYSFG+ LWE+ P+ +L
Sbjct: 695 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 754
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+ V +AV + R +IPR +A+I+ CW P KRP ++ LL +
Sbjct: 755 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 103/294 (35%), Positives = 164/294 (55%), Gaps = 37/294 (12%)
Query: 83 ELAKLDIRHE--IARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
E+++ +I E + G++GTVY+G +DVAVK+ M+ + + FR+EV
Sbjct: 39 EISETEITTESILGDGSFGTVYKGRCRLKDVAVKV-------MLKQVDQKTL-TDFRKEV 90
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
A+ K+ HPN+ F+GA T P + ++ L G L+ L
Sbjct: 91 AIMSKIFHPNIVLFLGACTST------------------PGK--LMICTELMKGNLESLL 130
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSK--TIVHRDVKTENMLLDANRTLKIADFGVA 258
+ + KL +++A D A G+ +LHS +HRD+KT N+L+DAN T+K+ DFG++
Sbjct: 131 L-DPMVKLPLITRMRMAKDAALGVLWLHSSNPVFIHRDLKTSNLLVDANLTVKVCDFGLS 189
Query: 259 RVE--AQNPRD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL- 314
+++ +N +D G GT +MAPEVL G+ +N K DVYSFG+ LW+I+ +P+
Sbjct: 190 QIKQRGENLKDGQDGAKGTPLWMAPEVLQGRLFNEKADVYSFGLVLWQIFTRQELFPEFD 249
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+F +A+ + LRP IP CP SL +++KCWD NP+ RP + +V LE +
Sbjct: 250 NFFKFVAAICEKQLRPSIPDDCPKSLKELIQKCWDPNPEVRPSFEGIVSELEEI 303
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 171 bits (433), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 103/291 (35%), Positives = 148/291 (50%), Gaps = 33/291 (11%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
W I ++ I +I G+YG V+ G + G DVAVK V + FR E
Sbjct: 1357 WIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVK-------KFVKQKLSETQLLEFRAE 1409
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+A +L H N+ FIGA + N+ C+V EY+ G L+
Sbjct: 1410 MAFLSELKHSNIVTFIGACIKKPNI--------------------CIVTEYMRMGNLRDV 1449
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANRTLKIADFGV 257
L +N K+ F +++ A G+ YLHS IVHRD+K N+L+D + +KIADFG
Sbjct: 1450 L-KNPDIKITFANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGF 1508
Query: 258 ARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317
AR++ N MT GT + APEV+ G+ Y K DV+SFG+ +WE+ P+ + +F
Sbjct: 1509 ARIKEDNTT-MT-RCGTPCWTAPEVIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFM 1566
Query: 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
VS ++ RP IP CP A +++KCW A KRP M EVV+ L +
Sbjct: 1567 KVSLDILEGG-RPIIPSDCPHEFAKLIKKCWHAKAHKRPTMTEVVQQLMLI 1616
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 1e-41, Method: Composition-based stats.
Identities = 103/330 (31%), Positives = 167/330 (50%), Gaps = 50/330 (15%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
E+EI+ +L+ I +G +G V RG + DVA+KI+ D T + F+
Sbjct: 2107 EYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKII--YRDQFKTKSSLVM----FQN 2160
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
EV + KL HPNV +F+GA +A + H+ C+V E++ GG+L++
Sbjct: 2161 EVGILSKLRHPNVVQFLGAC-----------TAGGEDHH-------CIVTEWMGGGSLRQ 2202
Query: 199 FLIRN-KRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANR------- 248
FL + + + +++ALD+A+G++YLH T I+HRD+ + N+LLD N
Sbjct: 2203 FLTDHFNLLEQNPHIRLKLALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVV 2262
Query: 249 ------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
KI+DFG++R++ + MT G + YMAPEV G + K DVYS+G+ L+
Sbjct: 2263 SSRQDIKCKISDFGLSRLKMEQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLF 2322
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
E+ D P D+ ++ ++ RP IP S I+ +CWD+NPD RP +++
Sbjct: 2323 ELLTSDEPQQDMKPMKMAHLAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQII 2382
Query: 363 KLLEAVNTSKGGGMIPEDQAHGCLCFIPTR 392
L+ + EDQ +P +
Sbjct: 2383 VHLKEM----------EDQGVSSFASVPVQ 2402
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 104/315 (33%), Positives = 164/315 (52%), Gaps = 46/315 (14%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDW-AEDGMVTSAEAAAIRASFRQE 139
EIE +LDI+ I G + V+RG YDG++VA+KI ED M +R + QE
Sbjct: 136 EIEYNELDIKEVIGSGGFCKVHRGYYDGEEVAIKIAHQTGEDDM------QRMRDNVLQE 189
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
++ L H N+ G + T C+V+EY GG+L +
Sbjct: 190 AKLFWALKHENIAALRGVCLNT---------------------KLCLVMEYARGGSLNRI 228
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSK---TIVHRDVKTENMLL----DAN----R 248
L K+ V++ A+ +ARG++YLH++ +I+HRD+K+ N+L+ + N +
Sbjct: 229 LA----GKIPPDVLVNWAIQIARGMNYLHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQK 284
Query: 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308
TLKI DFG+AR E N + M+ GT +M PEV+ Y++ DV+S+G+ LWE+ +
Sbjct: 285 TLKITDFGLAR-EMYNTQRMSA-AGTYAWMPPEVISVSTYSKFSDVWSYGVLLWELITGE 342
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
PY V+ V L IP+ CP + ++M+ CW +P KRP E++K LE++
Sbjct: 343 TPYKGFDPLSVAYGVAVNTLTLPIPKTCPETWGALMKSCWQTDPHKRPGFKEILKQLESI 402
Query: 369 NTSKGGGMIPEDQAH 383
SK + P++ H
Sbjct: 403 ACSK-FTLTPQESFH 416
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| 255567520 | 444 | protein kinase atmrk1, putative [Ricinus | 0.994 | 0.882 | 0.785 | 0.0 | |
| 224085517 | 387 | predicted protein [Populus trichocarpa] | 0.911 | 0.927 | 0.844 | 1e-180 | |
| 224062367 | 358 | predicted protein [Populus trichocarpa] | 0.906 | 0.997 | 0.845 | 1e-178 | |
| 296085233 | 404 | unnamed protein product [Vitis vinifera] | 1.0 | 0.975 | 0.772 | 1e-177 | |
| 359479665 | 406 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.970 | 0.772 | 1e-177 | |
| 147846115 | 368 | hypothetical protein VITISV_003418 [Viti | 0.918 | 0.983 | 0.834 | 1e-176 | |
| 356497440 | 387 | PREDICTED: serine/threonine-protein kina | 0.944 | 0.961 | 0.764 | 1e-173 | |
| 449458516 | 398 | PREDICTED: serine/threonine-protein kina | 0.906 | 0.896 | 0.793 | 1e-173 | |
| 297835282 | 378 | hypothetical protein ARALYDRAFT_898756 [ | 0.898 | 0.936 | 0.792 | 1e-173 | |
| 255552091 | 393 | protein kinase atmrk1, putative [Ricinus | 0.974 | 0.977 | 0.756 | 1e-173 |
| >gi|255567520|ref|XP_002524739.1| protein kinase atmrk1, putative [Ricinus communis] gi|223535923|gb|EEF37582.1| protein kinase atmrk1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/397 (78%), Positives = 350/397 (88%), Gaps = 5/397 (1%)
Query: 1 MESSSVDGAEGAVK--NEKAD--NNEGDKALLSKVSDMKSPSNKDLFFRADKIDFKSWDI 56
MESS+ A +K NE D +N + +L SKV D S SNK+++FRADKIDFKSWDI
Sbjct: 1 MESSNSKEAGVGLKSANEVVDGTSNAQENSLSSKVKDSGSVSNKEMYFRADKIDFKSWDI 60
Query: 57 QLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKIL 116
QLEKHLS+ WSR EV ++ EEWEI+L+KLD+RH IA+GTYG VYRG YDGQDVAVKIL
Sbjct: 61 QLEKHLSKAWSRNEEVQTKR-EEWEIDLSKLDMRHVIAQGTYGIVYRGNYDGQDVAVKIL 119
Query: 117 DWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSH 176
+W EDG+ T+AE A IRASFRQEVAVW KLDHPNVTKF+GASMGT+NLKIPSQ+ + S+
Sbjct: 120 NWGEDGIATAAEIATIRASFRQEVAVWHKLDHPNVTKFVGASMGTSNLKIPSQNPMNGSY 179
Query: 177 NSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236
+S PSRACCVV+EYLPGGTLKKFLIRN+RKKLAFK+VIQ+ALDL+RGLSYLHSK IVHRD
Sbjct: 180 DSHPSRACCVVLEYLPGGTLKKFLIRNRRKKLAFKIVIQLALDLSRGLSYLHSKKIVHRD 239
Query: 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYS 296
VKTENMLLDA+RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYS
Sbjct: 240 VKTENMLLDAHRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYS 299
Query: 297 FGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
FGICLWEIYCCDMPYPDLSF +VSS VVRQNLRP+IPRCCP+S+ASIMRKCWDANPDKRP
Sbjct: 300 FGICLWEIYCCDMPYPDLSFAEVSSQVVRQNLRPEIPRCCPNSVASIMRKCWDANPDKRP 359
Query: 357 VMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRG 393
MDEVV+LLEA++TSKGGGMIPE Q+ GC CF P RG
Sbjct: 360 EMDEVVRLLEAIDTSKGGGMIPEGQSTGCFCFTPVRG 396
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224085517|ref|XP_002307603.1| predicted protein [Populus trichocarpa] gi|222857052|gb|EEE94599.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1646), Expect = e-180, Method: Compositional matrix adjust.
Identities = 303/359 (84%), Positives = 334/359 (93%)
Query: 36 SPSNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIAR 95
S SNK+L+FRADKIDFKSWDIQLE HLSR WSR+REV P + EEWEI+L KLDIRH I+
Sbjct: 29 SVSNKELYFRADKIDFKSWDIQLENHLSRAWSRDREVQPTRKEEWEIDLGKLDIRHVISY 88
Query: 96 GTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155
GTYGTVYRG YDGQDVAVK+LDW EDG+ T+AE AA+RASF+QEVAVW KLDHPNVTKF+
Sbjct: 89 GTYGTVYRGNYDGQDVAVKVLDWGEDGIATAAETAALRASFKQEVAVWHKLDHPNVTKFV 148
Query: 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQ 215
GASMGT+NLKIPS+S++SDS NS P+RACCVVVEYLPGGTLKKFLIRN+RKKLAFK+VIQ
Sbjct: 149 GASMGTSNLKIPSKSSSSDSVNSPPARACCVVVEYLPGGTLKKFLIRNRRKKLAFKIVIQ 208
Query: 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL 275
+ALDL+RGLSYLHSK IVHRDVKTENMLLDA RTLKIADFGVARVEAQNPRDMTGETGTL
Sbjct: 209 LALDLSRGLSYLHSKKIVHRDVKTENMLLDATRTLKIADFGVARVEAQNPRDMTGETGTL 268
Query: 276 GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRC 335
GYMAPEVLDGKPYNRKCDVYSFGICLWE YCCDMPYPDLSF +VSSAVVRQ+LRP+IPRC
Sbjct: 269 GYMAPEVLDGKPYNRKCDVYSFGICLWETYCCDMPYPDLSFAEVSSAVVRQHLRPEIPRC 328
Query: 336 CPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
CPSSLAS+MRKCWDAN +KRP MDEVV+LLEA++TSKGGGM+PEDQ+ GCLCF P RGP
Sbjct: 329 CPSSLASVMRKCWDANSEKRPEMDEVVRLLEAIDTSKGGGMLPEDQSTGCLCFTPARGP 387
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224062367|ref|XP_002300823.1| predicted protein [Populus trichocarpa] gi|222842549|gb|EEE80096.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1629), Expect = e-178, Method: Compositional matrix adjust.
Identities = 302/357 (84%), Positives = 332/357 (92%)
Query: 38 SNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGT 97
SNK+++FRADKIDFKSWD+QLEKHLSR WSR+ EV + EEWEI+L KLDIRH IA GT
Sbjct: 2 SNKEMYFRADKIDFKSWDVQLEKHLSRAWSRDMEVQSTRKEEWEIDLGKLDIRHVIAYGT 61
Query: 98 YGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157
YG VYRG YDGQDVAVK+LDW EDG+ T+AE AA+RASF+QEVAVW KLDHPNVTKF+GA
Sbjct: 62 YGVVYRGNYDGQDVAVKVLDWGEDGIATAAETAALRASFKQEVAVWHKLDHPNVTKFVGA 121
Query: 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIA 217
SMGT+NLKIPS+S++SDS NS PSRACCVVVEYLPGGTLKKFLIRN RKKLAFK+VIQ+A
Sbjct: 122 SMGTSNLKIPSKSSSSDSVNSPPSRACCVVVEYLPGGTLKKFLIRNTRKKLAFKIVIQLA 181
Query: 218 LDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGY 277
LDL+RGLSYLHSK IVHRDVKTENMLLDA RTLKIADFGVARVEAQNPRDMTGETGTLGY
Sbjct: 182 LDLSRGLSYLHSKKIVHRDVKTENMLLDATRTLKIADFGVARVEAQNPRDMTGETGTLGY 241
Query: 278 MAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCP 337
MAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF +VSSAVVRQ+LRP+IPRCCP
Sbjct: 242 MAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFAEVSSAVVRQHLRPEIPRCCP 301
Query: 338 SSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
SSLAS+MRKCWDANP+KRP MDEVV+LLEA++TSKGGGM+PEDQ+ GCLCF P RGP
Sbjct: 302 SSLASVMRKCWDANPEKRPEMDEVVRLLEAIDTSKGGGMLPEDQSTGCLCFTPARGP 358
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085233|emb|CBI28728.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1618), Expect = e-177, Method: Compositional matrix adjust.
Identities = 312/404 (77%), Positives = 338/404 (83%), Gaps = 10/404 (2%)
Query: 1 MESSSVDGAEGAVKNEKADNNEGDKAL---------LSKVSDMKSPSNKDLFFRADKIDF 51
M+ S D K EK+ EG+ L D + SNKDLF RADKIDF
Sbjct: 1 MDLRSDDEVLVTAKAEKSRTGEGETVSDKSSISSSDLGSKKDGGNTSNKDLFLRADKIDF 60
Query: 52 KSWDIQLEKHLSRVWSREREV-LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD 110
KSWDIQL+KHLSRV SR+REV K E+WEIEL+KLDIR IA GTYGTVYRG YDGQD
Sbjct: 61 KSWDIQLDKHLSRVISRDREVNTNTKKEDWEIELSKLDIRSVIAHGTYGTVYRGVYDGQD 120
Query: 111 VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170
VAVK+LDW EDG+ T+AE AA+R SFRQEVAVW KLDHPNVTKFIGASMGT++L+IPS S
Sbjct: 121 VAVKLLDWGEDGLATAAETAALRTSFRQEVAVWHKLDHPNVTKFIGASMGTSDLRIPSNS 180
Query: 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK 230
+SD N +PSRACCVVVEYLPGGTLKKFLIRN+RKKLAFK+VIQ+ALDL+RGLSYLHSK
Sbjct: 181 ISSDGRNPVPSRACCVVVEYLPGGTLKKFLIRNRRKKLAFKIVIQLALDLSRGLSYLHSK 240
Query: 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNR 290
IVHRDVKTENMLLDA+RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNR
Sbjct: 241 KIVHRDVKTENMLLDAHRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNR 300
Query: 291 KCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
KCDVYSFGICLWE YCCDMPYPDLSF D+SSAVVRQNLRPDIPRCCPSSLASIMRKCWD
Sbjct: 301 KCDVYSFGICLWETYCCDMPYPDLSFADISSAVVRQNLRPDIPRCCPSSLASIMRKCWDG 360
Query: 351 NPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
NPDKRP MDEVV+LLEA++TSKGGGMIPEDQ C F RGP
Sbjct: 361 NPDKRPDMDEVVRLLEAIDTSKGGGMIPEDQVSSCCFFSVARGP 404
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359479665|ref|XP_003632325.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1617), Expect = e-177, Method: Compositional matrix adjust.
Identities = 312/404 (77%), Positives = 338/404 (83%), Gaps = 10/404 (2%)
Query: 1 MESSSVDGAEGAVKNEKADNNEGDKAL---------LSKVSDMKSPSNKDLFFRADKIDF 51
M+ S D K EK+ EG+ L D + SNKDLF RADKIDF
Sbjct: 3 MDLRSDDEVLVTAKAEKSRTGEGETVSDKSSISSSDLGSKKDGGNTSNKDLFLRADKIDF 62
Query: 52 KSWDIQLEKHLSRVWSREREV-LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD 110
KSWDIQL+KHLSRV SR+REV K E+WEIEL+KLDIR IA GTYGTVYRG YDGQD
Sbjct: 63 KSWDIQLDKHLSRVISRDREVNTNTKKEDWEIELSKLDIRSVIAHGTYGTVYRGVYDGQD 122
Query: 111 VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170
VAVK+LDW EDG+ T+AE AA+R SFRQEVAVW KLDHPNVTKFIGASMGT++L+IPS S
Sbjct: 123 VAVKLLDWGEDGLATAAETAALRTSFRQEVAVWHKLDHPNVTKFIGASMGTSDLRIPSNS 182
Query: 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK 230
+SD N +PSRACCVVVEYLPGGTLKKFLIRN+RKKLAFK+VIQ+ALDL+RGLSYLHSK
Sbjct: 183 ISSDGRNPVPSRACCVVVEYLPGGTLKKFLIRNRRKKLAFKIVIQLALDLSRGLSYLHSK 242
Query: 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNR 290
IVHRDVKTENMLLDA+RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNR
Sbjct: 243 KIVHRDVKTENMLLDAHRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNR 302
Query: 291 KCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
KCDVYSFGICLWE YCCDMPYPDLSF D+SSAVVRQNLRPDIPRCCPSSLASIMRKCWD
Sbjct: 303 KCDVYSFGICLWETYCCDMPYPDLSFADISSAVVRQNLRPDIPRCCPSSLASIMRKCWDG 362
Query: 351 NPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
NPDKRP MDEVV+LLEA++TSKGGGMIPEDQ C F RGP
Sbjct: 363 NPDKRPDMDEVVRLLEAIDTSKGGGMIPEDQVSSCCFFSVARGP 406
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147846115|emb|CAN82019.1| hypothetical protein VITISV_003418 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1609), Expect = e-176, Method: Compositional matrix adjust.
Identities = 303/363 (83%), Positives = 326/363 (89%), Gaps = 1/363 (0%)
Query: 33 DMKSPSNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREV-LPRKTEEWEIELAKLDIRH 91
D + SNKDLF RADKIDFKSWDIQL+KHLSRV SR+REV K E+WEIEL+KLDIR
Sbjct: 6 DGGNTSNKDLFLRADKIDFKSWDIQLDKHLSRVISRDREVNTNTKKEDWEIELSKLDIRS 65
Query: 92 EIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151
IA GTYGTVYRG YDGQDVAVK+LDW EDG+ T+AE AA+R SFRQEVAVW KLDHPNV
Sbjct: 66 VIAHGTYGTVYRGVYDGQDVAVKLLDWGEDGLATAAETAALRTSFRQEVAVWHKLDHPNV 125
Query: 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFK 211
TKFIGASMGT++L+IPS S +SD N +PSRACCVVVEYLPGGTLKKFLIRN+RKKLAFK
Sbjct: 126 TKFIGASMGTSDLRIPSNSISSDGRNPVPSRACCVVVEYLPGGTLKKFLIRNRRKKLAFK 185
Query: 212 VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGE 271
+VIQ+ALDL+RGLSYLHSK IVHRDVKTENMLLDA+RTLKIADFGVARVEAQNPRDMTGE
Sbjct: 186 IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDAHRTLKIADFGVARVEAQNPRDMTGE 245
Query: 272 TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPD 331
TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE YCCDMPYPDLSF D+SSAVVRQNLRPD
Sbjct: 246 TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWETYCCDMPYPDLSFADISSAVVRQNLRPD 305
Query: 332 IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPT 391
IPRCCPSSLASIMRKCWD NPDKRP MDEVV+LLEA++TSKGGGMIPEDQ C F
Sbjct: 306 IPRCCPSSLASIMRKCWDGNPDKRPDMDEVVRLLEAIDTSKGGGMIPEDQVSSCCFFSVA 365
Query: 392 RGP 394
RGP
Sbjct: 366 RGP 368
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497440|ref|XP_003517568.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1587), Expect = e-173, Method: Compositional matrix adjust.
Identities = 285/373 (76%), Positives = 327/373 (87%), Gaps = 1/373 (0%)
Query: 22 EGDKALLSKVSDMKSPSNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREVLPRKTEEWE 81
E + AL SK+ + S+KD+ FRADKID KS D QLEKHLSRVWSR E R EEWE
Sbjct: 16 EAEGALNSKMKGAGNVSSKDMIFRADKIDLKSLDAQLEKHLSRVWSRSIET-KRPREEWE 74
Query: 82 IELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA 141
I+LAKLD+R+ +A G YGTVYRG YD QDVAVK+LDW EDG+ T+AE AA+RASFRQEVA
Sbjct: 75 IDLAKLDLRYVVAHGAYGTVYRGTYDTQDVAVKVLDWGEDGVATAAETAALRASFRQEVA 134
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
VWQKLDHPNVTKF+GASMGT+NLKIP ++ + SLPSRACCV+VE++ GGTLK++L
Sbjct: 135 VWQKLDHPNVTKFVGASMGTSNLKIPPKNPMNADEESLPSRACCVIVEFVSGGTLKQYLF 194
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
+++R+KLA+K+VIQ+ALDLARGL+YLHSK IVHRDVKTENMLLD +R LKIADFGVARVE
Sbjct: 195 KSRRRKLAYKIVIQLALDLARGLNYLHSKKIVHRDVKTENMLLDTSRNLKIADFGVARVE 254
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
A NP DMTGETGTLGYMAPEVLDGKPYNR+CDVYSFGICLWEIYCCDMPYPDLSF DVSS
Sbjct: 255 AMNPSDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 314
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQ 381
AVVRQNLRPDIPRCCPS+LA+IMRKCWDANP+KRP M+EVV++LEA++TSKGGGMIPEDQ
Sbjct: 315 AVVRQNLRPDIPRCCPSALANIMRKCWDANPNKRPEMEEVVRMLEALDTSKGGGMIPEDQ 374
Query: 382 AHGCLCFIPTRGP 394
+ GC CF PTRGP
Sbjct: 375 SSGCFCFAPTRGP 387
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458516|ref|XP_004146993.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449518266|ref|XP_004166163.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1586), Expect = e-173, Method: Compositional matrix adjust.
Identities = 285/359 (79%), Positives = 320/359 (89%), Gaps = 2/359 (0%)
Query: 36 SPSNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIAR 95
S SN+D+ FRADKIDFKSWDIQLEKHLSR WSR+REV P K EEWEI+L+KLDIR+ A
Sbjct: 42 SKSNRDMVFRADKIDFKSWDIQLEKHLSRAWSRDREV-PAKKEEWEIDLSKLDIRYVKAH 100
Query: 96 GTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155
GTYGT+YRG YDG DVAVK+LDW EDG+ + AE AA+R SFRQEVAVW KLDHPNV KF
Sbjct: 101 GTYGTIYRGNYDGNDVAVKVLDWGEDGVSSVAEIAALRTSFRQEVAVWHKLDHPNVAKFY 160
Query: 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQ 215
GASMGT+NLKIP +S++ DS+ + PSRACCVVVEYLPGGTLK FLI+N+++KLAFKVVIQ
Sbjct: 161 GASMGTSNLKIPPKSSSFDSNQTFPSRACCVVVEYLPGGTLKSFLIKNRKRKLAFKVVIQ 220
Query: 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL 275
+ALDL+RGLSYLHSK IVHRD+KTEN+LLDA +TLKI DFGVARVEAQNP+DMTGETGTL
Sbjct: 221 LALDLSRGLSYLHSKKIVHRDIKTENVLLDAQKTLKIVDFGVARVEAQNPKDMTGETGTL 280
Query: 276 GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRC 335
GYMAPEVLDGKPYNRKCDVYS GICLWE YCCDMPYPDLSF +VS+AVVRQNLRPDIPRC
Sbjct: 281 GYMAPEVLDGKPYNRKCDVYSLGICLWETYCCDMPYPDLSFAEVSTAVVRQNLRPDIPRC 340
Query: 336 CPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
CPSS A+IM++CWDANP+KRP MDEVVKLLEA++TSKGGGMI EDQ C CF P RGP
Sbjct: 341 CPSSFANIMKRCWDANPEKRPDMDEVVKLLEAIDTSKGGGMITEDQI-SCFCFRPARGP 398
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297835282|ref|XP_002885523.1| hypothetical protein ARALYDRAFT_898756 [Arabidopsis lyrata subsp. lyrata] gi|297331363|gb|EFH61782.1| hypothetical protein ARALYDRAFT_898756 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1586), Expect = e-173, Method: Compositional matrix adjust.
Identities = 283/357 (79%), Positives = 320/357 (89%), Gaps = 3/357 (0%)
Query: 38 SNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGT 97
S KD+ FRADKID K+ DIQLEKHLSRVWSR E P+ EEWEIELAKL++R+ IARG
Sbjct: 25 SKKDMIFRADKIDLKNLDIQLEKHLSRVWSRSIEKHPKPKEEWEIELAKLEMRNVIARGA 84
Query: 98 YGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157
YG VY+G YDGQDVAVK+LDW EDG T+AE +A+RASFRQEVAVW KLDHPNVT+F+GA
Sbjct: 85 YGIVYKGIYDGQDVAVKVLDWGEDGYATTAETSALRASFRQEVAVWHKLDHPNVTRFVGA 144
Query: 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIA 217
SMGTTNLKIPS ++++ NSLP RACCVVVEY+PGGTLK++L RN+RKKLAFKVV+Q+A
Sbjct: 145 SMGTTNLKIPS---SAETENSLPQRACCVVVEYIPGGTLKQYLFRNRRKKLAFKVVVQLA 201
Query: 218 LDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGY 277
LDL+RGLSYLHS+ IVHRDVKTENMLLD R LKIADFGVARVEAQNP+DMTGETGTLGY
Sbjct: 202 LDLSRGLSYLHSERIVHRDVKTENMLLDYQRNLKIADFGVARVEAQNPKDMTGETGTLGY 261
Query: 278 MAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCP 337
MAPEVLDGKPYNR+CDVYSFGICLWEIYCCDMPYPDLSF DVSSAVVRQNLRPDIPRCCP
Sbjct: 262 MAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPDIPRCCP 321
Query: 338 SSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
+SLA+IM++CW+ANP+KRP M+EVV+LLEAV+TSKGGGMIPEDQ C CF+ RGP
Sbjct: 322 TSLATIMKRCWEANPEKRPEMEEVVRLLEAVDTSKGGGMIPEDQRPACFCFVSGRGP 378
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552091|ref|XP_002517090.1| protein kinase atmrk1, putative [Ricinus communis] gi|223543725|gb|EEF45253.1| protein kinase atmrk1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1583), Expect = e-173, Method: Compositional matrix adjust.
Identities = 295/390 (75%), Positives = 336/390 (86%), Gaps = 6/390 (1%)
Query: 7 DGAEGAVKNEKADNNEGDKALLSKVS--DMKSPSNKDLFFRADKIDFKSWDIQLEKHLSR 64
D EG + +K++N +G ++LSKV+ S S+KD+ FRADKID KS DIQLEKHLSR
Sbjct: 8 DDTEGIMAEKKSENTDG--SVLSKVNLRGTGSVSSKDMIFRADKIDLKSLDIQLEKHLSR 65
Query: 65 VWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMV 124
VWSR R EEWEI+L+KLDI+H +A GT+GTVYRG YD QDVAVK+LDW +D
Sbjct: 66 VWSRNINT-QRPKEEWEIDLSKLDIKHAVAHGTFGTVYRGTYDNQDVAVKLLDWGDDSTA 124
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
+A AA+RASFRQEVAVW KLDHPNVT+FIGASMGT+NLKIPS++ + D S PSRAC
Sbjct: 125 ATAGTAALRASFRQEVAVWHKLDHPNVTRFIGASMGTSNLKIPSKNPSED-QTSFPSRAC 183
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
CVVVEYL GGTLK++LIRN+RKKLAFK+VIQ+ALDL+RGLSYLHSK IVHRDVKTENMLL
Sbjct: 184 CVVVEYLAGGTLKQYLIRNRRKKLAFKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 243
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
DA+RTLKIADFGVARVEAQNP DMTGETGTLGYMAPEVLDGKPYNR+CDVYSFGICLWEI
Sbjct: 244 DAHRTLKIADFGVARVEAQNPSDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEI 303
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
YCCDMPYPDLSF DVS+AVVRQNLRP+IPRCCPSSLA+IMRKCWDAN +KRP M EVV++
Sbjct: 304 YCCDMPYPDLSFVDVSTAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMAEVVRM 363
Query: 365 LEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
LEA++TSKGGGMIP+DQA GC CF P RGP
Sbjct: 364 LEAIDTSKGGGMIPDDQATGCFCFAPARGP 393
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.951 | 0.992 | 0.753 | 4.8e-158 | |
| TAIR|locus:2130230 | 364 | AT4G14780 [Arabidopsis thalian | 0.895 | 0.969 | 0.761 | 3e-149 | |
| TAIR|locus:2084193 | 411 | AT3G01490 [Arabidopsis thalian | 0.817 | 0.783 | 0.724 | 5.1e-138 | |
| TAIR|locus:2170106 | 385 | AT5G50000 [Arabidopsis thalian | 0.791 | 0.810 | 0.724 | 1.1e-137 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.906 | 0.913 | 0.684 | 7.4e-137 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.469 | 0.450 | 0.467 | 2.6e-63 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.469 | 0.449 | 0.451 | 1.1e-62 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.520 | 0.390 | 0.407 | 2e-55 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.469 | 0.321 | 0.408 | 6.1e-54 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.494 | 0.342 | 0.386 | 9.9e-54 |
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1540 (547.2 bits), Expect = 4.8e-158, P = 4.8e-158
Identities = 287/381 (75%), Positives = 329/381 (86%)
Query: 14 KNEKADNNEGDKALLSKVSDMKSPSNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREVL 73
+NE + E + L ++ +D + S KD+ FRADKID K+ DIQLEKHLSRVWSR E
Sbjct: 4 RNETKASPENN--LRNRGADGNN-SKKDMIFRADKIDLKNLDIQLEKHLSRVWSRSIEKH 60
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIR 133
P+ EEWEIELAKL++R+ IARG YG VY+G YDGQDVAVK+LDW EDG T+AE +A+R
Sbjct: 61 PKPKEEWEIELAKLEMRNVIARGAYGIVYKGIYDGQDVAVKVLDWGEDGYATTAETSALR 120
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
ASFRQEVAVW KLDHPNVT+F+GASMGT NLKIPS + T NSLP RACCVVVEY+PG
Sbjct: 121 ASFRQEVAVWHKLDHPNVTRFVGASMGTANLKIPSSAETE---NSLPQRACCVVVEYIPG 177
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
GTLK++L RN+RKKLAFKVV+Q+ALDL+RGLSYLHS+ IVHRDVKTENMLLD R LKIA
Sbjct: 178 GTLKQYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLLDYQRNLKIA 237
Query: 254 DFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD 313
DFGVARVEAQNP+DMTGETGTLGYMAPEVLDGKPYNR+CDVYSFGICLWEIYCCDMPYPD
Sbjct: 238 DFGVARVEAQNPKDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPD 297
Query: 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373
LSF DVSSAVVRQNLRPDIPRCCP++LA+IM++CW+ANP+KRP M+EVV LLEAV+T+KG
Sbjct: 298 LSFADVSSAVVRQNLRPDIPRCCPTALATIMKRCWEANPEKRPEMEEVVSLLEAVDTTKG 357
Query: 374 GGMIPEDQAHGCLCFIPTRGP 394
GGMIPEDQ GC CF+ RGP
Sbjct: 358 GGMIPEDQRPGCFCFVSGRGP 378
|
|
| TAIR|locus:2130230 AT4G14780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1457 (517.9 bits), Expect = 3.0e-149, P = 3.0e-149
Identities = 272/357 (76%), Positives = 303/357 (84%)
Query: 38 SNKDLFFRADKIDFKSWDIQLEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGT 97
+ K+ FRADKID KS D QLEKHLSRVWSR EV P+ EEWEI+LAKL+ + IARGT
Sbjct: 12 TTKEKIFRADKIDLKSLDRQLEKHLSRVWSRNLEVNPKAKEEWEIDLAKLETSNVIARGT 71
Query: 98 YGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157
YGTVY+G YDGQDVAVK+LDW +DG T+A+ A RA FRQEV VW KL+HPNVTKF+GA
Sbjct: 72 YGTVYKGIYDGQDVAVKVLDWEDDGNETTAKTATNRALFRQEVTVWHKLNHPNVTKFVGA 131
Query: 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIA 217
SMGTTNL I S +DS SLP +ACCVVVEYLPGGTLK+ LIR+K KKLAFK VI++A
Sbjct: 132 SMGTTNLNIRS----ADSKGSLPQQACCVVVEYLPGGTLKQHLIRHKSKKLAFKAVIKLA 187
Query: 218 LDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGY 277
LDLARGLSYLHS+ IVHRDVKTENMLLDA + LKIADFGVARVEA NP+DMTGETGTLGY
Sbjct: 188 LDLARGLSYLHSEKIVHRDVKTENMLLDAQKNLKIADFGVARVEALNPKDMTGETGTLGY 247
Query: 278 MAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCP 337
MAPEV+DGKPYNR+CDVYSFGICLWEIYCCDMPYPDLSF DVSSAVV NLRP+IPRCCP
Sbjct: 248 MAPEVIDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFVDVSSAVVLHNLRPEIPRCCP 307
Query: 338 SSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRGP 394
++LA IM+ CWD NP KRP M EVVK+LE V+TSKGGGMIPEDQ+ GC CF P RGP
Sbjct: 308 TALAGIMKTCWDGNPQKRPEMKEVVKMLEGVDTSKGGGMIPEDQSRGCFCFAPARGP 364
|
|
| TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.1e-138, Sum P(2) = 5.1e-138
Identities = 237/327 (72%), Positives = 276/327 (84%)
Query: 68 REREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSA 127
R EV + EWEI+ +KL I+ IARGT+GTV+RG YDGQDVAVK+LDW E+G + A
Sbjct: 90 RSTEV-EKSRREWEIDPSKLIIKSVIARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDA 148
Query: 128 EAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
E A++RA+F QEVAVW KLDHPNVTKFIGA+MGT+ + I T + +PS CCVV
Sbjct: 149 EIASLRAAFTQEVAVWHKLDHPNVTKFIGAAMGTSEMSIQ----TENGQMGMPSNVCCVV 204
Query: 188 VEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247
VEY PGG LK FLI+ +R+KLAFKVVIQ++LDLARGLSYLHS+ IVHRDVKTENMLLD +
Sbjct: 205 VEYCPGGALKSFLIKTRRRKLAFKVVIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKS 264
Query: 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307
RTLKIADFGVAR+EA NP DMTGETGTLGYMAPEVL+G PYNRKCDVYSFGICLWEIYCC
Sbjct: 265 RTLKIADFGVARLEASNPNDMTGETGTLGYMAPEVLNGSPYNRKCDVYSFGICLWEIYCC 324
Query: 308 DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
DMPYPDLSF++V+SAVVRQNLRP+IPRCCPSSLA++M++CWDANP+KRP M+EVV +LEA
Sbjct: 325 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPEKRPEMEEVVAMLEA 384
Query: 368 VNTSKGGGMIPEDQAHGCLCFIPTRGP 394
++TSKGGGMIP DQ GC CF RGP
Sbjct: 385 IDTSKGGGMIPPDQQQGCFCFRRHRGP 411
|
|
| TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 1.1e-137, Sum P(2) = 1.1e-137
Identities = 229/316 (72%), Positives = 273/316 (86%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
EWEI+ +KL I+ +ARGT+GTV+RG YDGQDVAVK+LDW E+G + AE ++RA F Q
Sbjct: 74 EWEIDPSKLIIKTVLARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSEAEIVSLRADFAQ 133
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
EVAVW KLDHPNVTKFIGA+MG + L++ ++S ++P+ CCVVVEYLPGG LK
Sbjct: 134 EVAVWHKLDHPNVTKFIGATMGASGLQLQTESGPL----AMPNNICCVVVEYLPGGALKS 189
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
+LI+N+R+KL FK+V+Q+ALDLARGLSYLHS+ IVHRDVKTENMLLD RT+KIADFGVA
Sbjct: 190 YLIKNRRRKLTFKIVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVA 249
Query: 259 RVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318
RVEA NP DMTGETGTLGYMAPEVL+G PYNRKCDVYSFGICLWEIYCCDMPYPDL+F++
Sbjct: 250 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLTFSE 309
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIP 378
V+SAVVRQNLRPDIPRCCPS+LA++M++CWDANPDKRP MDEVV +LE+++T+KGGGMIP
Sbjct: 310 VTSAVVRQNLRPDIPRCCPSALAAVMKRCWDANPDKRPEMDEVVPMLESIDTTKGGGMIP 369
Query: 379 EDQAHGCLCFIPTRGP 394
DQ GCLCF RGP
Sbjct: 370 NDQQQGCLCFRRKRGP 385
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1340 (476.8 bits), Expect = 7.4e-137, P = 7.4e-137
Identities = 247/361 (68%), Positives = 291/361 (80%)
Query: 38 SNKDLFFRADKIDFKSWDIQL-EKHLSRVWSREREV-LPRKT-EEWEIELAKLDIRHEIA 94
+ ++ +FRAD +DF WD+ + + S V + P +EWEI+L+KLD++H +A
Sbjct: 31 AGEERYFRADTLDFSKWDLHMGQTSTSSVLTNSASTSAPAPAMQEWEIDLSKLDMKHVLA 90
Query: 95 RGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154
GTYGTVYRG Y GQ+VAVK+LDW EDG T AE A+RASF QEVAVWQKLDHPNVTKF
Sbjct: 91 HGTYGTVYRGVYAGQEVAVKVLDWGEDGYATPAETTALRASFEQEVAVWQKLDHPNVTKF 150
Query: 155 IGASMGTTNLKIPSQSATSDSHNSL-PSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVV 213
IGASMGT++L+IP T N P+RACCVVVEY+ GGTLKKFLI+ R KL K V
Sbjct: 151 IGASMGTSDLRIPPAGDTGGRGNGAHPARACCVVVEYVAGGTLKKFLIKKYRAKLPIKDV 210
Query: 214 IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETG 273
IQ+ALDLARGLSYLHSK IVHRDVK+ENMLL N+TLKIADFGVARVEAQNP+DMTGETG
Sbjct: 211 IQLALDLARGLSYLHSKAIVHRDVKSENMLLQPNKTLKIADFGVARVEAQNPQDMTGETG 270
Query: 274 TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP 333
TLGYMAPEVL+GKPYNRKCDVYSFG+CLWEIYCCDMPY D SF ++S AVV +NLRP+IP
Sbjct: 271 TLGYMAPEVLEGKPYNRKCDVYSFGVCLWEIYCCDMPYADCSFAEISHAVVHRNLRPEIP 330
Query: 334 RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPTRG 393
+CCP ++A+IM++CWD NPD+RP M+EVVKLLEA++TSKGGGMI DQ GCLCF RG
Sbjct: 331 KCCPHAVANIMKRCWDPNPDRRPEMEEVVKLLEAIDTSKGGGMIAPDQFQGCLCFFKPRG 390
Query: 394 P 394
P
Sbjct: 391 P 391
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 2.6e-63, Sum P(2) = 2.6e-63
Identities = 87/186 (46%), Positives = 132/186 (70%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
C+V EY GG++++FL R + + + K+ ++ ALD+ARG++Y+H + +HRD+K++N+L+
Sbjct: 205 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLI 264
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
A++++KIADFGVAR+E Q MT ETGT +MAPE++ + YN+K DVYSFGI LWE+
Sbjct: 265 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWEL 323
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
+P+ +++ + AVV + +RP +P C L+ IM +CWDANP+ RP EVVKL
Sbjct: 324 ITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKL 383
Query: 365 LEAVNT 370
LEA T
Sbjct: 384 LEAAET 389
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 1.1e-62, Sum P(2) = 1.1e-62
Identities = 84/186 (45%), Positives = 129/186 (69%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
C+V EY GG++++FL + + + + K+ + ALD+ARG++Y+H + +HRD+K++N+L+
Sbjct: 206 CIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLI 265
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
A+R++KIADFGVAR+E Q MT ETGT +MAPE++ +PY +K DVYSFGI LWE+
Sbjct: 266 SADRSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWEL 324
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
+P+ +++ + AVV + +RP +P C L IM +CWDA+P+ RP E+V L
Sbjct: 325 ITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNL 384
Query: 365 LEAVNT 370
LEA T
Sbjct: 385 LEAAET 390
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 451 (163.8 bits), Expect = 2.0e-55, Sum P(2) = 2.0e-55
Identities = 86/211 (40%), Positives = 137/211 (64%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
CV+ +YLP G+L+ FL + + + L K +I+ A+D+ARG+ Y+HS+ I+HRD+K EN+L+
Sbjct: 284 CVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLI 343
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
D LKIADFG+A E + + + GT +MAPE++ KP+ RK DVYSFG+ LWE+
Sbjct: 344 DEEFHLKIADFGIA-CEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKADVYSFGLVLWEM 402
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
+PY D++ + AVV +N+RP IP CP ++ +++ +CW PDKRP ++VK+
Sbjct: 403 VAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKALIEQCWSVAPDKRPEFWQIVKV 462
Query: 365 LE--AVNTSKGGGMIPEDQAHGCLCFIPTRG 393
LE A++ + G + + + +C P +G
Sbjct: 463 LEQFAISLEREGNL---NLSSSKICKDPRKG 490
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 6.1e-54, Sum P(2) = 6.1e-54
Identities = 78/191 (40%), Positives = 127/191 (66%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKV--VIQIALDLARGLSYLHSKTIVHRDVKTENM 242
C+V E++PGG++ +L +K+K + FK+ + ++A+D+ +G+SYLH I+HRD+K N+
Sbjct: 361 CIVTEFMPGGSVYDYL--HKQKGV-FKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANL 417
Query: 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
L+D N +K+ADFGVARV+AQ MT ETGT +MAPEV++ KPY+ K DV+S+GI LW
Sbjct: 418 LMDENEVVKVADFGVARVKAQTGV-MTAETGTYRWMAPEVIEHKPYDHKADVFSYGIVLW 476
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
E+ +PY ++ + VV++ LRP IP+ LA ++ + W+ + +RP E++
Sbjct: 477 ELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDFSEII 536
Query: 363 KLLEAVNTSKG 373
+ L+ + G
Sbjct: 537 EQLQEIAKEVG 547
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 9.9e-54, Sum P(2) = 9.9e-54
Identities = 78/202 (38%), Positives = 130/202 (64%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKV--VIQIALDLARGLSYLHSKTIVHRDVKTENM 242
C+V E++ G++ FL ++K FK+ ++++ALD+++G++YLH I+HRD+KT N+
Sbjct: 363 CIVTEFMTRGSIYDFLHKHKG---VFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANL 419
Query: 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
L+D + +K+ADFGVARV+ ++ MT ETGT +MAPEV++ KPY+ + DV+S+ I LW
Sbjct: 420 LMDEHEVVKVADFGVARVQTESGV-MTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLW 478
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
E+ ++PY L+ + VV++ LRP IP+ L ++ KCW +P RP E++
Sbjct: 479 ELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEII 538
Query: 363 KLLEAVNTSKGGGMIPEDQAHG 384
++L + G +D+ HG
Sbjct: 539 EMLNQLIREVGDDERHKDK-HG 559
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 394 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-72 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-70 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-70 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-52 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-47 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-46 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-44 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-44 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-41 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-41 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-40 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-40 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-39 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-38 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-38 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-38 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-37 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-37 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-37 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-37 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-36 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-36 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-35 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-34 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-34 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-33 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-33 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-33 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-32 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-31 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-31 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-31 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-30 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-30 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-30 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-29 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-29 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-29 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-29 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-28 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-28 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-28 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-28 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-28 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-27 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-27 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-27 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-26 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-25 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-25 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-25 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-24 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-24 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-23 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-23 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-23 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-23 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-22 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-22 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-21 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 1e-72
Identities = 94/288 (32%), Positives = 139/288 (48%), Gaps = 39/288 (13%)
Query: 87 LDIRHEIARGTYGTVYRGAYDG------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
L++ ++ G +G VY+G G VAVK L E R F +E
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK--EGAS------EEEREEFLEEA 52
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
++ +KL HPN+ + +G L +V EY+PGG L FL
Sbjct: 53 SIMKKLSHPNIVRLLGVCTQGEPL--------------------YIVTEYMPGGDLLDFL 92
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
R +KL K ++Q+AL +A+G+ YL SK VHRD+ N L+ N +KI+DFG++R
Sbjct: 93 -RKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD 151
Query: 261 EAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFT 317
++ G L +MAPE L + K DV+SFG+ LWEI+ + PYP +S
Sbjct: 152 IYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
Query: 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
+V + R P CP L +M +CW +P+ RP E+V+ L
Sbjct: 212 EVLEL-LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-70
Identities = 89/290 (30%), Positives = 137/290 (47%), Gaps = 44/290 (15%)
Query: 92 EIARGTYGTVYRGAYDG-----QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
++ G +G VY+G G +VAVK + + R F +E V +KL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVK--------TLKEDASEEERKDFLKEARVMKKL 53
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-- 204
HPNV + +G T + +V+EY+ GG L +L +++
Sbjct: 54 GHPNVVRLLGVC-------------TEEEP-------LYLVLEYMEGGDLLDYLRKSRPV 93
Query: 205 -----RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
+ L+ K ++ A+ +A+G+ YL SK VHRD+ N L+ + +KI+DFG++R
Sbjct: 94 FPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
Query: 260 VEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316
+ G L +MAPE L + K DV+SFG+ LWEI+ PYP LS
Sbjct: 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+V +R+ R P CP L +M CW +P+ RP E+V+ LE
Sbjct: 214 EEVLEY-LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 2e-70
Identities = 92/287 (32%), Positives = 143/287 (49%), Gaps = 37/287 (12%)
Query: 87 LDIRHEIARGTYGTVYRGAYDG------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
L + ++ G +G VY+G G +VAVK L A I F +E
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-------KEDASEQQIEE-FLREA 52
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
+ +KLDHPN+ K +G L +V+EY+PGG L +L
Sbjct: 53 RIMRKLDHPNIVKLLGVCTEEEPL--------------------MIVMEYMPGGDLLDYL 92
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+N+ K+L+ ++ AL +ARG+ YL SK +HRD+ N L+ N +KI+DFG++R
Sbjct: 93 RKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152
Query: 261 EAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTD 318
+ + G + +MAPE L + K DV+SFG+ LWEI+ + PYP +S +
Sbjct: 153 LYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
V +++ R P CP L +M +CW +P+ RP E+V++L
Sbjct: 213 V-LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 5e-70
Identities = 92/285 (32%), Positives = 136/285 (47%), Gaps = 42/285 (14%)
Query: 91 HEIARGTYGTVYRGAYDG------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
++ G +G VY+G G +VAVK L S + F +E + +
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK-----EDASEQQ---IEEFLREARIMR 56
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
KLDHPNV K +G L +V+EY+ GG L +L R
Sbjct: 57 KLDHPNVVKLLGVCTEEEPL--------------------YIVMEYMEGGDLLSYL-RKN 95
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
R KL+ ++ AL +ARG+ YL SK +HRD+ N L+ N +KI+DFG++R
Sbjct: 96 RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLY 153
Query: 265 PRDMTGETGTLG---YMAPEVLDGKPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTDVS 320
D + G +MAPE L + K DV+SFG+ LWEI+ + PYP +S +V
Sbjct: 154 DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV- 212
Query: 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
++ R P CP L +M +CW +P+ RP E+V++L
Sbjct: 213 LEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 7e-69
Identities = 81/281 (28%), Positives = 126/281 (44%), Gaps = 37/281 (13%)
Query: 88 DIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
+I ++ G++G VY A D G+ VA+K++ + R +E+ + +
Sbjct: 2 EILEKLGEGSFGKVYL-ARDKKTGKLVAIKVIKKKKI--------KKDRERILREIKILK 52
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
KL HPN+ + L +V+EY GG L L K
Sbjct: 53 KLKHPNIVRLYDVFEDEDKL--------------------YLVMEYCEGGDLFDLL--KK 90
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
R +L+ + L YLHSK IVHRD+K EN+LLD + +K+ADFG+AR +
Sbjct: 91 RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDP 149
Query: 265 PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324
+T GT YMAPEVL GK Y + D++S G+ L+E+ P+P +
Sbjct: 150 GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
Query: 325 RQNLRPDIPRC--CPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ P P ++RK +P+KR +E ++
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 4e-62
Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 66/277 (23%)
Query: 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G +GTVY G+ VA+KI+ +++++ +E+ + +KL+HPN
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK--------KEDSSSLLEELLREIEILKKLNHPN 52
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ K G +L +V+EY GG+LK ++ KL+
Sbjct: 53 IVKLYGVFEDENHL--------------------YLVMEYCEGGSLKDL-LKENEGKLSE 91
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA-NRTLKIADFGVARVEAQNPRDMT 269
+++I L + GL YLHS I+HRD+K EN+LLD+ N +K+ADFG++++ + +
Sbjct: 92 DEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151
Query: 270 GETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328
GT YMAPEVL GK Y+ K D++S G+ L+E+
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187
Query: 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
L ++RK +P+KRP E+++ L
Sbjct: 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 9e-62
Identities = 88/280 (31%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G++GTVY+ G+ VAVKIL + + R+E+ + ++L HPN
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-------DQTARREIRILRRLSHPN 59
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ + I A +V+EY GG L +L R L+
Sbjct: 60 IVRLIDAFE--------------------DKDHLYLVMEYCEGGDLFDYLSRGGP--LSE 97
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
+IAL + RGL YLHS I+HRD+K EN+LLD N +KIADFG+A+ ++ +T
Sbjct: 98 DEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
Query: 271 ETGTLGYMAPEVL-DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR 329
GT YMAPEVL G Y K DV+S G+ L+E+ P+ + D ++R+ L
Sbjct: 158 FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD-QLQLIRRILG 216
Query: 330 PDIP------RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P + +++KC + +P KRP +E+++
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-52
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 35/279 (12%)
Query: 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ RG++G+VY G+ +AVK + E + E A+ +E+ + L HPN
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALE----REIRILSSLQHPN 60
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ ++ G+ + N+L + +EY+ GG+L L K KL
Sbjct: 61 IVRYYGSE-------------RDEEKNTL-----NIFLEYVSGGSLSSLL--KKFGKLPE 100
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
V+ + + GL+YLHS IVHRD+K N+L+D++ +K+ADFG A+
Sbjct: 101 PVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160
Query: 271 ET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFTDVSSAVVRQN 327
+ GT +MAPEV+ G+ Y R D++S G + E+ P+ +L + +
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG 220
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
P+IP +RKC +P KRP +LL+
Sbjct: 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 91/290 (31%), Positives = 137/290 (47%), Gaps = 39/290 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
W I +L + I +G +G V G Y GQ VAVK L ++ A +A F E
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL---------KDDSTAAQA-FLAE 50
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+V L HPN+ + +G + L I V EY+ G+L +
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYI--------------------VTEYMAKGSLVDY 90
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
L R + + ALD+ G+ YL K VHRD+ N+L+ + K++DFG+A+
Sbjct: 91 LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
Query: 260 VEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MPYPDLSF 316
+Q ++G L + APE L K ++ K DV+SFGI LWEIY +PYP +
Sbjct: 151 EASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
DV V + R + P CP + +M+ CW+ +P KRP ++ + L
Sbjct: 206 KDVVPHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 1e-46
Identities = 91/288 (31%), Positives = 142/288 (49%), Gaps = 37/288 (12%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
W + L KL + I G +G V +G Y GQ VAVK + +A+A F +E
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD-----VTAQA------FLEE 49
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
AV KL H N+ + +G + HN L +V+E + G L F
Sbjct: 50 TAVMTKLHHKNLVRLLGVIL----------------HNGL-----YIVMELMSKGNLVNF 88
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
L R ++ ++Q +LD+A G+ YL SK +VHRD+ N+L+ + K++DFG+AR
Sbjct: 89 LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFTD 318
V + + + APE L K ++ K DV+S+G+ LWE++ PYP +S +
Sbjct: 149 V---GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
V V + R + P CP+ + +M CW+ P KRP ++ + LE
Sbjct: 206 VKEC-VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-46
Identities = 88/279 (31%), Positives = 135/279 (48%), Gaps = 34/279 (12%)
Query: 93 IARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151
I +G +G VY+G G +VAVK S ++ F QE + ++ DHPN+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK--------TCRSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFK 211
K IG + + I V+E +PGG+L FL R K+ +L K
Sbjct: 55 VKLIGVCVQKQPIYI--------------------VMELVPGGSLLTFL-RKKKNRLTVK 93
Query: 212 VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGE 271
++Q++LD A G+ YL SK +HRD+ N L+ N LKI+DFG++R E ++
Sbjct: 94 KLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153
Query: 272 TGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNL 328
+ + APE L+ Y + DV+S+GI LWE + D PYP +S +
Sbjct: 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GY 212
Query: 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
R P+ CP + +M +CW +P+ RP E+ L+
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 7e-45
Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 42/278 (15%)
Query: 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
+I +I +G +G VY+ + G++VA+K++ E+ + E+ +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---------LESKEKKEKIINEIQIL 51
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+K HPN+ K+ G+ + L I V+E+ GG+LK L+++
Sbjct: 52 KKCKHPNIVKYYGSYLKKDELWI--------------------VMEFCSGGSLKD-LLKS 90
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA-RVEA 262
+ L + + +L +GL YLHS I+HRD+K N+LL ++ +K+ DFG++ ++
Sbjct: 91 TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD 150
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
R+ GT +MAPEV++GKPY+ K D++S GI E+ PY +L
Sbjct: 151 TKARNTM--VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LF 207
Query: 323 VVRQNLRPDIPRCCPS----SLASIMRKCWDANPDKRP 356
+ N P + P ++KC NP+KRP
Sbjct: 208 KIATNGPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 3e-44
Identities = 78/289 (26%), Positives = 143/289 (49%), Gaps = 44/289 (15%)
Query: 86 KLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
K +I +I +G++G VY R DG+ +K +D + + E R EV +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---SEKE----REDALNEVKIL 53
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+KL+HPN+ K+ + L C+V+EY GG L + + +
Sbjct: 54 KKLNHPNIIKYYESFEEKGKL--------------------CIVMEYADGGDLSQKIKKQ 93
Query: 204 KRKKLAF------KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
K++ F +Q+ L L YLHS+ I+HRD+K +N+ L +N +K+ DFG+
Sbjct: 94 KKEGKPFPEEQILDWFVQLCL----ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI 149
Query: 258 ARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
++V + D+ +T GT Y++PE+ KPYN K D++S G L+E+ P+ +
Sbjct: 150 SKV-LSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
+++ +++ P IP S L +++ +P++RP + ++++
Sbjct: 208 LLELALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 7e-44
Identities = 86/298 (28%), Positives = 139/298 (46%), Gaps = 49/298 (16%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQD--VAVKILDWAEDGMVTSAEAAAIRASFR 137
WE+E + ++H++ G YG VY G + VAVK L ED M F
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVE--------EFL 50
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
+E AV +++ HPN+ + +G I + E++ G L
Sbjct: 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYI--------------------ITEFMTYGNLL 90
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+L R+++ V++ +A ++ + YL K +HRD+ N L+ N +K+ADFG+
Sbjct: 91 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 150
Query: 258 ARVEAQNPRDMTGETGT--------LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309
+R+ MTG+T T + + APE L ++ K DV++FG+ LWEI M
Sbjct: 151 SRL-------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 203
Query: 310 -PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
PYP + + V ++ + R + P CP + +MR CW NP RP E+ + E
Sbjct: 204 SPYPGIDLSQVYE-LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 92 EIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
E+ G +G V+ G + G+ DVA+K++ E A F +E V KL HPN
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIR----------EGAMSEDDFIEEAKVMMKLSHPN 60
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ + G R +V EY+ G L +L R ++ KL
Sbjct: 61 LVQLYGVC--------------------TKQRPIFIVTEYMANGCLLNYL-RERKGKLGT 99
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
+ ++ + D+ + YL S +HRD+ N L+ + +K++DFG+AR + T
Sbjct: 100 EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTS 157
Query: 271 ETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQ 326
GT + + PEV D ++ K DV+SFG+ +WE++ MPY S ++V + V
Sbjct: 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSA 216
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
R P+ P+ + +IM CW P+ RP +++ L
Sbjct: 217 GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 8e-41
Identities = 75/305 (24%), Positives = 136/305 (44%), Gaps = 60/305 (19%)
Query: 92 EIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ G +G V YD G+ VAVK L+ S E F +E+ + +
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-------HSGEEQHRS-DFEREIEILRT 62
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LDH N+ K+ G SL +++EYLP G+L+ +L R+ R
Sbjct: 63 LDHENIVKYKGV-------------CEKPGGRSL-----RLIMEYLPSGSLRDYLQRH-R 103
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV----- 260
++ K ++ + + +G+ YL S+ +HRD+ N+L+++ +KI+DFG+A+V
Sbjct: 104 DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
Query: 261 ---EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI--YCCDMPYPDLS 315
+ P + + + APE L ++ DV+SFG+ L+E+ Y P
Sbjct: 164 DYYYVKEPGES-----PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218
Query: 316 FTDVSSAVVRQNLRPDI------------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
F + Q + + P CP + +M+ CW+A P RP +++
Sbjct: 219 FLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
Query: 364 LLEAV 368
+++ +
Sbjct: 279 IVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 1e-40
Identities = 90/286 (31%), Positives = 136/286 (47%), Gaps = 39/286 (13%)
Query: 93 IARGTYGTVYRGAY---DGQDV--AVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
I +G +G VY G DGQ + AVK L+ D + E F +E + +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQ------FLKEGIIMKDFS 54
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
HPNV +G + + + VV+ Y+ G L+ F IR++
Sbjct: 55 HPNVLSLLGICLPSEGSPL-------------------VVLPYMKHGDLRNF-IRSETHN 94
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR----VEAQ 263
K +I L +A+G+ YL SK VHRD+ N +LD + T+K+ADFG+AR E
Sbjct: 95 PTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154
Query: 264 NPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSA 322
+ + TG + +MA E L + + K DV+SFG+ LWE+ PYPD+ D++
Sbjct: 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214
Query: 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
++ Q R P CP L +M CW P+ RP E+V +E +
Sbjct: 215 LL-QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 93/311 (29%), Positives = 143/311 (45%), Gaps = 57/311 (18%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAAAI 132
WE+ K+ + E+ +G++G VY G G VA+K ++ E A++
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----------ENASM 50
Query: 133 --RASFRQEVAVWQKLDHPNVTKFIG-ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
R F E +V ++ + +V + +G S G L VV+E
Sbjct: 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL---------------------VVME 89
Query: 190 YLPGGTLKKFLIRNKRKKLAFKVV---------IQIALDLARGLSYLHSKTIVHRDVKTE 240
+ G LK +L R++R + IQ+A ++A G++YL +K VHRD+
Sbjct: 90 LMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAAR 148
Query: 241 NMLLDANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVL-DGKPYNRKCDVYSF 297
N ++ + T+KI DFG+ R E R + +MAPE L DG + K DV+SF
Sbjct: 149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSF 207
Query: 298 GICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
G+ LWE+ + PY LS +V V+ D+P CP L +MR CW NP RP
Sbjct: 208 GVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRP 266
Query: 357 VMDEVVKLLEA 367
E+V L+
Sbjct: 267 TFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 88/278 (31%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 93 IARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151
+ +G +G V++G D VAVK ED ++ F E + ++ DHPN+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK--ED------LPQELKIKFLSEARILKQYDHPNI 54
Query: 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFK 211
K IG + I V+E +PGG FL R K+ +L K
Sbjct: 55 VKLIGVCTQRQPIYI--------------------VMELVPGGDFLSFL-RKKKDELKTK 93
Query: 212 VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG- 270
+++ ALD A G++YL SK +HRD+ N L+ N LKI+DFG++R E +G
Sbjct: 94 QLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153
Query: 271 ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAVVRQNLR 329
+ + + APE L+ Y+ + DV+S+GI LWE + + PYP ++ + V + R
Sbjct: 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-NQQAREQVEKGYR 212
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
P+ CP + +M++CWD P+ RP E+ K L A
Sbjct: 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 87/301 (28%), Positives = 136/301 (45%), Gaps = 55/301 (18%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRG-------AYDGQDVAVKILDWAEDGMVTSAEAAAIR 133
EI L+ + E+ G +G VY+G VA+K L +AE ++
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-------ENAEPK-VQ 52
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
FRQE + L HPN+ +G P+ C++ EYL
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVCT-----------------KEQPT---CMLFEYLAH 92
Query: 194 GTLKKFLIRNK--------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239
G L +FL+RN + L + IA+ +A G+ YL S VHRD+
Sbjct: 93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA 152
Query: 240 ENMLLDANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPE-VLDGKPYNRKCDVYS 296
N L+ T+KI+DFG++R A R + + +M PE +L GK + + D++S
Sbjct: 153 RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWS 211
Query: 297 FGICLWEIYCCDM-PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
FG+ LWEI+ + PY S +V + + L P P CP+ + ++M +CW+ P +R
Sbjct: 212 FGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARR 270
Query: 356 P 356
P
Sbjct: 271 P 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 36/272 (13%)
Query: 95 RGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152
+G+YG+VY+ D Q A+K +D G ++ E R E+ + ++HPN+
Sbjct: 10 KGSYGSVYKVKRLSDNQFYALKEVDL---GSMSQKE----REDAVNEIRILASVNHPNII 62
Query: 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFK- 211
+ A L C+V+EY P G L K + + K+K+
Sbjct: 63 SYKEAF--------------------LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE 102
Query: 212 -VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT- 269
+ +I + L RGL LH + I+HRD+K+ N+LL AN +KI D G+++V +N M
Sbjct: 103 QEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAK 159
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR 329
+ GT YMAPEV G+PY+ K D++S G L+E+ P+ S D+ V R
Sbjct: 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY- 218
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
P IP L + +R P RP D++
Sbjct: 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 86/318 (27%), Positives = 140/318 (44%), Gaps = 58/318 (18%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-------VAVKIL-DWAEDGMVTSAEA 129
EWE+ +L + + G +G V + G D VAVK+L D A + +
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL----- 59
Query: 130 AAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
+ E+ + + + H N+ +G L VVV
Sbjct: 60 ----SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY--------------------VVV 95
Query: 189 EYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLARGLSYLHSKTIVH 234
EY G L+ FL + + L K ++ A +ARG+ +L SK +H
Sbjct: 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIH 155
Query: 235 RDVKTENMLLDANRTLKIADFGVAR-VEAQNPRDMTGETGTLGY--MAPEVLDGKPYNRK 291
RD+ N+L+ + +KIADFG+AR + + T G L MAPE L + Y +
Sbjct: 156 RDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN-GRLPVKWMAPEALFDRVYTHQ 214
Query: 292 CDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
DV+SFG+ LWEI+ PYP + ++ ++++ R + P+ C L +MR CW
Sbjct: 215 SDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKLLKEGYRMEKPQNCTQELYHLMRDCWHE 273
Query: 351 NPDKRPVMDEVVKLLEAV 368
P +RP ++V+ L+ +
Sbjct: 274 VPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 90/298 (30%), Positives = 130/298 (43%), Gaps = 57/298 (19%)
Query: 93 IARGTYGTVYRGAYDGQD-------VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ G +G VY G Y G+D VAVK L + + + F E + K
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--------PESCSEQDESDFLMEALIMSK 65
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+H N+ + IG S LP +++E + GG LK FL N+
Sbjct: 66 FNHQNIVRLIGVSF-----------------ERLPR---FILLELMAGGDLKSFLRENRP 105
Query: 206 K-----KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD---ANRTLKIADFGV 257
+ L K ++ A D+A+G YL +HRD+ N LL R KIADFG+
Sbjct: 106 RPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165
Query: 258 AR------VEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIYCCD-M 309
AR + R M + +M PE LDG + K DV+SFG+ LWEI+ M
Sbjct: 166 ARDIYRASYYRKGGRAML----PIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYM 220
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
PYP + +V V R D P+ CP + IM CW P+ RP +++ ++
Sbjct: 221 PYPGRTNQEVMEFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 83/284 (29%), Positives = 129/284 (45%), Gaps = 41/284 (14%)
Query: 91 HEIARGTYGTVYRGAY---DGQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
E+ G +G+V +G Y G+ +VAVK L AA + F +E +V +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQ 52
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LDHP + + IG G +V+E P G L K+L KR
Sbjct: 53 LDHPCIVRLIGVCKG---------------------EPLMLVMELAPLGPLLKYLK--KR 89
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+++ + ++A +A G++YL SK VHRD+ N+LL KI+DFG++R
Sbjct: 90 REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
Query: 266 RDMTGETG---TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSS 321
T L + APE ++ ++ K DV+S+G+ LWE + PY ++ +V
Sbjct: 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-I 208
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
A++ R P CP + SIM CW P+ RP E+
Sbjct: 209 AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 87/290 (30%), Positives = 140/290 (48%), Gaps = 53/290 (18%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ G + + Y A D G +AVK + + + TS+E + + R+E+ + +L+HP
Sbjct: 8 LGTGAFSSCY-QARDVKTGTLMAVKQVTYVRN---TSSEQEEVVEALRKEIRLMARLNHP 63
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
++ + +GA+ ++ + VE++ GG++ L K A
Sbjct: 64 HIIRMLGATCEDSHFNL--------------------FVEWMAGGSVSHLL----SKYGA 99
Query: 210 FK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN-RTLKIADFGVA-RVEAQNP 265
FK V+I L RGLSYLH I+HRDVK N+L+D+ + L+IADFG A R+ A+
Sbjct: 100 FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159
Query: 266 RDMTGE-----TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD-- 318
GE GT+ +MAPEVL G+ Y R CDV+S G + E+ P+ ++
Sbjct: 160 G--AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217
Query: 319 -----VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++SA P IP L + +C + P+ RP E++K
Sbjct: 218 ALIFKIASA----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 75/281 (26%), Positives = 137/281 (48%), Gaps = 35/281 (12%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I G++G+VY G A G+ +AVK ++ + ++ + +E+A+ ++L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ +++G+S+ +L I +EY+PGG++ L N
Sbjct: 68 IVQYLGSSLDADHLNI--------------------FLEYVPGGSVAALL--NNYGAFEE 105
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
+V + +GL+YLH++ I+HRD+K N+L+D +KI+DFG+++ N
Sbjct: 106 TLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 271 ET------GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324
G++ +MAPEV+ Y RK D++S G + E+ P+PD A+
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIF 222
Query: 325 R--QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ +N P+IP S + K ++ + +KRP E++K
Sbjct: 223 KIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 85/281 (30%), Positives = 131/281 (46%), Gaps = 35/281 (12%)
Query: 92 EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I RG +G V+ G D VAVK ++A F QE + ++ HP
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK--------SCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ + IG + I V+E + GG FL R + +L
Sbjct: 54 NIVRLIGVCTQKQPIYI--------------------VMELVQGGDFLTFL-RTEGPRLK 92
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
K +IQ+ + A G+ YL SK +HRD+ N L+ LKI+DFG++R E T
Sbjct: 93 VKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152
Query: 270 G--ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQ 326
G + + + APE L+ Y+ + DV+SFGI LWE + +PY +LS A + Q
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQ 211
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
+R P CP ++ +M +CW+ +P +RP V + L++
Sbjct: 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 40/284 (14%)
Query: 92 EIARGTYGTVYRGAYDGQ-----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
++ G++G V RG + VAVK L S + + I F +E A+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL--------KSDKLSDIMDDFLKEAAIMHSL 53
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
DH N+ + G + T L + V E P G+L L ++
Sbjct: 54 DHENLIRLYGVVL-THPLMM--------------------VTELAPLGSLLDRLRKDALG 92
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR 266
+ A+ +A G+ YL SK +HRD+ N+LL ++ +KI DFG+ R QN
Sbjct: 93 HFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN-E 151
Query: 267 DMTGETGTL----GYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSS 321
D L + APE L + ++ DV+ FG+ LWE++ + P+ LS + +
Sbjct: 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
+ ++ R + P CP + ++M +CW NP RP + + L
Sbjct: 212 KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-36
Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 39/280 (13%)
Query: 82 IELAKLDIRHEIARGTYGTVYRGAYDGQD-VAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
I ++L + EI G +G V+ G + + VA+K T E A F +E
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIK----------TIREGAMSEEDFIEEA 50
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
V KL HP + + G + + C+V E++ G L +L
Sbjct: 51 QVMMKLSHPKLVQLYGVCTERSPI--------------------CLVFEFMEHGCLSDYL 90
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
R +R K + + ++ + LD+ G++YL S ++HRD+ N L+ N+ +K++DFG+ R
Sbjct: 91 -RAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149
Query: 261 EAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316
+ T TGT + + +PEV Y+ K DV+SFG+ +WE++ PY + S
Sbjct: 150 VLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
++V + R PR S+ +M+ CW P+ RP
Sbjct: 208 SEVVET-INAGFRLYKPRLASQSVYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 79/280 (28%), Positives = 134/280 (47%), Gaps = 48/280 (17%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+I ++I +G++G V++ D + A+K +D + M AI E V K
Sbjct: 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAID-----EARVLAK 55
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LD + ++ + + L +V+EY G L K L +
Sbjct: 56 LDSSYIIRYYESFLDKGKL--------------------NIVMEYAENGDLHKLLKMQRG 95
Query: 206 KKLA----FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
+ L ++ IQI L GL++LHSK I+HRD+K+ N+ LDA +KI D GVA++
Sbjct: 96 RPLPEDQVWRFFIQILL----GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ N GT Y++PE+ + KPYN K DV++ G+ L+E CC +P D ++
Sbjct: 152 SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE--CCTGKHP----FDANN 205
Query: 322 --AVVRQNLR---PDIPRCCPSSLASIMRKCWDANPDKRP 356
A++ + +R P + + LA ++ +C + +RP
Sbjct: 206 QGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 90/293 (30%), Positives = 136/293 (46%), Gaps = 38/293 (12%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WEI L + ++ G +G V+ G ++G VAVK L M S EA F Q
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK--PGTM--SPEA------FLQ 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E + +KL H + + + I V EY+ G+L
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYI--------------------VTEYMSKGSLLD 90
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL + KKL ++ +A +A G++YL S+ +HRD+ N+L+ N KIADFG+A
Sbjct: 91 FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150
Query: 259 RVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314
R+ + + T G + + APE + + K DV+SFGI L EI +PYP +
Sbjct: 151 RLIEDD--EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
+ +V V R R P CP L +M +CWD +P++RP + + LE
Sbjct: 209 TNREVLEQVER-GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 86/292 (29%), Positives = 138/292 (47%), Gaps = 39/292 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
W + + +L + I +G +G V G Y G VAVK + A A A F E
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-------NDATAQA----FLAE 49
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+V +L H N+ + +G + + L +V EY+ G+L +
Sbjct: 50 ASVMTQLRHSNLVQLLGVIV--------------EEKGGL-----YIVTEYMAKGSLVDY 90
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
L R L +++ +LD+ + YL + VHRD+ N+L+ + K++DFG+ +
Sbjct: 91 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
Query: 260 VEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MPYPDLSF 316
EA + +D TG L + APE L K ++ K DV+SFGI LWEIY +PYP +
Sbjct: 151 -EASSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
DV V + + D P CP + +M++CW + RP ++ + LE +
Sbjct: 206 KDVVPR-VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 36/269 (13%)
Query: 92 EIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I RG +G VY+G G VA+K + + + A+ S QE+ + + L HP
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQIS------LEKIKEEAL-KSIMQEIDLLKNLKHP 59
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--KK 207
N+ K+IG+ ++ +SL +++EY G+L++ + + +
Sbjct: 60 NIVKYIGSI---------------ETSDSL-----YIILEYAENGSLRQIIKKFGPFPES 99
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
L V Q+ +GL+YLH + ++HRD+K N+L + +K+ADFGVA +D
Sbjct: 100 LVAVYVYQVL----QGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
GT +MAPEV++ + D++S G + E+ + PY DL+ +V Q+
Sbjct: 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QD 214
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKRP 356
P +P L + +C+ +P+ RP
Sbjct: 215 DHPPLPEGISPELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 83/296 (28%), Positives = 140/296 (47%), Gaps = 40/296 (13%)
Query: 82 IELAKLDI--RHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
E+ + DI I G +G VY+G Y + + +AV + + ++R F
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC------TSPSVREKF 54
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
QE + ++ DHP++ K IG + +++ +V+E P G L
Sbjct: 55 LQEAYIMRQFDHPHIVKLIG---------VITENPV------------WIVMELAPLGEL 93
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ +L NK L +I + L+ L+YL SK VHRD+ N+L+ + +K+ DFG
Sbjct: 94 RSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG 152
Query: 257 VAR-VEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYP 312
++R +E ++ G L +MAPE ++ + + DV+ FG+C+WEI + P+
Sbjct: 153 LSRYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
Query: 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+ DV + R +P CP +L S+M KCW +P KRP E+ L +
Sbjct: 211 GVKNNDVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-35
Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 36/277 (12%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G++G+VY G DG AVK + A+DG T EA QE+A+ KL HPN
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG-QTGQEAVK---QLEQEIALLSKLQHPN 63
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ +++G + + + +E +PGG+L K L +K +F
Sbjct: 64 IVQYLG-------------TEREED-------NLYIFLELVPGGSLAKLL----KKYGSF 99
Query: 211 K--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR-VEAQNPRD 267
V+ + GL YLH + VHRD+K N+L+D N +K+ADFG+A+ V
Sbjct: 100 PEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF--SF 157
Query: 268 MTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
G+ +MAPEV+ + Y D++S G + E+ P+ L + R
Sbjct: 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS 217
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P IP + KC +P RP E+++
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 41/287 (14%)
Query: 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
L+ + +G+ G VY+ + G+ A+K + D ++ E
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE----- 57
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
P V K GA + +V+EY+ GG+L + K
Sbjct: 58 ---SPYVVKCYGA--------FYKEGEI------------SIVLEYMDGGSLAD--LLKK 92
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKT-IVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
K+ V+ IA + +GL YLH+K I+HRD+K N+L+++ +KIADFG+++V
Sbjct: 93 VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152
Query: 264 NPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL---SFTDV 319
D GT+ YM+PE + G+ Y+ D++S G+ L E P+ SF ++
Sbjct: 153 T-LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
A+ + C +P KRP E LL+
Sbjct: 212 MQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE---LLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (328), Expect = 2e-34
Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 50/298 (16%)
Query: 89 IRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
I ++ G++G VY A D + VA+K+L + F +E+ + L+H
Sbjct: 4 ILRKLGEGSFGEVYL-ARDRKLVALKVLA------KKLESKSKEVERFLREIQILASLNH 56
Query: 149 P-NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK- 206
P N+ K +L + V+EY+ GG+L+ L + RK
Sbjct: 57 PPNIVKLYDFFQDEGSLYL--------------------VMEYVDGGSLEDLLKKIGRKG 96
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT-LKIADFGVARV----- 260
L+ + I + L YLHSK I+HRD+K EN+LLD + +K+ DFG+A++
Sbjct: 97 PLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156
Query: 261 -EAQNPRDMTGETGTLGYMAPEVLDGK---PYNRKCDVYSFGICLWEIYCCDMPYPDLS- 315
+ P + GT GYMAPEVL G + D++S GI L+E+ P+
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 316 ----------FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++ + + L P P + + +++K +P R +
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 38/268 (14%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +G++G V R G+ A+K+L + ++ E E + +++HP
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--IIKRKEVEHTLT----ERNILSRINHPF 54
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ K L + L +V+EY PGG L L +K + +
Sbjct: 55 IVK----------LH-----YAFQTEEKL-----YLVLEYAPGGELFSHL--SKEGRFSE 92
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
+ A ++ L YLHS I++RD+K EN+LLDA+ +K+ DFG+A+ +
Sbjct: 93 ERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152
Query: 271 ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL-- 328
GT Y+APEVL GK Y + D +S G+ L+E M F + + +
Sbjct: 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYE-----MLTGKPPFYAEDRKEIYEKILK 207
Query: 329 -RPDIPRCCPSSLASIMRKCWDANPDKR 355
P ++ +P KR
Sbjct: 208 DPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 93 IARGTYGTVYRGAYDGQD-------VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ RG +G V+ G + V VK L +D + S FR+E+ +++K
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--------FRRELDMFRK 64
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L H NV + +G ++ H +++EY G LK+FL K
Sbjct: 65 LSHKNVVRLLG------------LCREAEPH--------YMILEYTDLGDLKQFLRATKS 104
Query: 206 KK-------LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
K L+ K + + +A G+ +L + VHRD+ N L+ + R +K++ ++
Sbjct: 105 KDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164
Query: 259 R-VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 316
+ V + L ++APE + ++ K DV+SFG+ +WE++ ++P+ LS
Sbjct: 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+V + + L +P CPS L +M +CW NP RP E+V L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 34/286 (11%)
Query: 93 IARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+ G +G+V G D VAVK + + T +E F E A + D
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD---IHTYSEIE----EFLSEAACMKDFD 59
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
HPNV K IG + S +P V++ ++ G L FL+ ++
Sbjct: 60 HPNVMKLIGVCF------------EASSLQKIPKPM--VILPFMKHGDLHSFLLYSRLGG 105
Query: 208 LAFKVVIQ----IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
L K+ +Q +D+A G+ YL ++ +HRD+ N +L + T+ +ADFG+++
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 264 NPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVS 320
G + ++A E L + Y K DV++FG+ +WEI PYP + ++
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225
Query: 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+R R P C L +M CW A+P RP ++ ++LE
Sbjct: 226 D-YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 39/292 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WE+ L + ++ G +G V+ G Y+G VA+K L + M A F
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLK--QGSMSPEA--------FLA 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E + ++L HP + + + + ++ EY+ G+L
Sbjct: 51 EANLMKQLQHPRLVRL---------------------YAVVTQEPIYIITEYMENGSLVD 89
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL + KL +I +A +A G++++ K +HRD++ N+L+ KIADFG+A
Sbjct: 90 FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLA 149
Query: 259 RVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MPYPDL 314
R+ N + T G + + APE ++ + K DV+SFGI L EI +PYP +
Sbjct: 150 RLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ +V + R R P CP L +MR CW P++RP + + +LE
Sbjct: 208 TNPEVIQNLER-GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 86/302 (28%), Positives = 132/302 (43%), Gaps = 58/302 (19%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WEI+ + + ++ G +G V+ G ++ VAVK L + G + + F
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKD-------FLA 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC-------VVVEYL 191
E + +KL HP + + A C +V E +
Sbjct: 51 EAQIMKKLRHPKLIQLY---------------------------AVCTLEEPIYIVTELM 83
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
G+L ++L + L +I +A +A G++YL ++ +HRD+ N+L+ N K
Sbjct: 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICK 143
Query: 252 IADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNR---KCDVYSFGICLWEIY 305
+ADFG+ARV ++ G + + APE YNR K DV+SFGI L EI
Sbjct: 144 VADFGLARVIKED--IYEAREGAKFPIKWTAPEAAL---YNRFSIKSDVWSFGILLTEIV 198
Query: 306 C-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
MPYP ++ +V V Q R P CP L IM CW +PD RP + +
Sbjct: 199 TYGRMPYPGMTNAEVLQQ-VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWK 257
Query: 365 LE 366
LE
Sbjct: 258 LE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 87/298 (29%), Positives = 130/298 (43%), Gaps = 54/298 (18%)
Query: 93 IARGTYGTVYRGA-----YDG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
+ G +G VY G G VAVK L G + F +E +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQE-----KKEFLKEAHLMS 54
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
+HPN+ K +G + I ++E + GG L +L R+
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYI--------------------IMELMEGGDLLSYL-RDA 93
Query: 205 RKK------LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL-----DANRTLKIA 253
R + L K ++ I LD+A+G YL +HRD+ N L+ DA+R +KI
Sbjct: 94 RVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153
Query: 254 DFGVARVEAQNPRDMTGETGTLG--YMAPEVL-DGKPYNRKCDVYSFGICLWEIYCC-DM 309
DFG+AR ++ G L +MAPE L DGK + + DV+SFG+ +WEI
Sbjct: 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQ 212
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
PYP L+ +V V R P CP + +M CW +P +RP D + ++L+
Sbjct: 213 PYPALNNQEVL-QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 46/291 (15%)
Query: 89 IRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
I I G +G V RG DVA+K L + G R F E ++
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQ-----RLDFLTEASIM 59
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ DHPN+ + G + + I + EY+ G+L KFL R
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMI--------------------ITEYMENGSLDKFL-RE 98
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
K ++ + +A G+ YL VHRD+ N+L+++N K++DFG++R
Sbjct: 99 NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL-- 156
Query: 264 NPRDMTGETGTLG------YMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 316
D T G + APE + + + DV+SFGI +WE+ + PY D+S
Sbjct: 157 --EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
DV A V R P CPS+L +M CW + ++RP ++V L+
Sbjct: 215 QDVIKA-VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 59/287 (20%)
Query: 92 EIARGTYGTVYRGAYD--GQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
I +G++G VY+ Q VA+K+ L+ AED + +QE+ +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI----------EDIQQEIQFLSQCR 57
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
P +TK+ G+ + + L I ++EY GG+ L K K
Sbjct: 58 SPYITKYYGSFLKGSKLWI--------------------IMEYCGGGSCLDLL---KPGK 94
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR--VEAQNP 265
L + I ++ GL YLH + +HRD+K N+LL +K+ADFGV+ +
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154
Query: 266 RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
R+ GT +MAPEV+ Y+ K D++S GI E+ + P DL V
Sbjct: 155 RNTF--VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL--- 209
Query: 326 QNLRPDIPRCCPSSLASIM---------RKCWDANPDKRPVMDEVVK 363
IP+ P SL C + +P +RP E++K
Sbjct: 210 ------IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 45/285 (15%)
Query: 86 KLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
++ I +G++GTV R DG+ + K +D+ G +T E + + EV +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVS----EVNIL 53
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
++L HPN+ ++ + +N + +V+EY GG L + LI+
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTL------------------YIVMEYCEGGDLAQ-LIQK 94
Query: 204 KRK---KLAFKVVIQIALDLARGLSYLH-----SKTIVHRDVKTENMLLDANRTLKIADF 255
+K + + + +I L L H T++HRD+K N+ LDAN +K+ DF
Sbjct: 95 CKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154
Query: 256 GVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
G+A++ + GT YM+PE L+ Y+ K D++S G ++E+ C + P
Sbjct: 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL--CALSPP--- 209
Query: 316 FTDVSSAVVRQNLR----PDIPRCCPSSLASIMRKCWDANPDKRP 356
FT + + ++ IP S L +++ + +PDKRP
Sbjct: 210 FTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 37/284 (13%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
I +GTYG VY G+ +AVK L G S + ++A R E+ + LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKA-LRSEIETLKDLDH 67
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
N+ +++G L I +EY+PGG++ L +
Sbjct: 68 LNIVQYLGFETTEEYLSI--------------------FLEYVPGGSIGSCL--RTYGRF 105
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ---NP 265
++V + GL+YLHSK I+HRD+K +N+L+DA+ KI+DFG+++ N
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND 165
Query: 266 RDMTGETGTLGYMAPEVLD--GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323
++M+ + G++ +MAPEV+ + Y+ K D++S G + E++ P+ D +
Sbjct: 166 QNMSMQ-GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL 224
Query: 324 VRQNLRPDIPRCCPSSLASI----MRKCWDANPDKRPVMDEVVK 363
+ P IP +L+ + + C+ NPD RP E+++
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 87/313 (27%), Positives = 150/313 (47%), Gaps = 67/313 (21%)
Query: 90 RH-----EIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
RH ++ +G +G+V YD G+ VAVK L + A +R F +
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ--------HSTAEHLR-DFER 54
Query: 139 EVAVWQKLDHPNVTKFIGA--SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
E+ + + L H N+ K+ G S G NL++ V+EYLP G+L
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRL--------------------VMEYLPYGSL 94
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ +L ++ R++L + ++ A + +G+ YL SK VHRD+ T N+L+++ +KI DFG
Sbjct: 95 RDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153
Query: 257 VARVEAQNPRDMT----GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI--YC---- 306
+ +V Q+ GE+ Y APE L ++ DV+SFG+ L+E+ Y
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212
Query: 307 -----------CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
D + + + +++ N R P CP+ + +IM++CW+ +P +R
Sbjct: 213 SPPAEFMRMMGNDKQGQMIVYHLIE--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270
Query: 356 PVMDEVVKLLEAV 368
P E+ +EA+
Sbjct: 271 PSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 81/309 (26%), Positives = 129/309 (41%), Gaps = 51/309 (16%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRG----AYDGQD---VAVKILDWAEDGMVTSAEAAAIR 133
++ + ++ E+ G +G V+ G D VAVK L ++ A R
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL---KETASNDA-----R 52
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F +E + H N+ KF G +V EY+
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVC--------------------TEGDPPIMVFEYMEH 92
Query: 194 GTLKKFLIRN------------KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
G L KFL + +L ++QIA+ +A G+ YL S+ VHRD+ T N
Sbjct: 93 GDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN 152
Query: 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLG--YMAPEVLDGKPYNRKCDVYSFGI 299
L+ + +KI DFG++R G L +M PE + + + + DV+SFG+
Sbjct: 153 CLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212
Query: 300 CLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM 358
LWEI+ P+ LS +V + Q PR CPS + IM CW +P +R +
Sbjct: 213 VLWEIFTYGKQPWYGLSNEEVIE-CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271
Query: 359 DEVVKLLEA 367
++ + L+
Sbjct: 272 KDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WE + + ++ G +G V+ G + + VA+KIL ++ + F++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL---------KSDDLLKQQDFQK 51
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
EV ++L H ++ ++ E + G+L
Sbjct: 52 EVQALKRLRHKHLISLFAVCSV--------------------GEPVYIITELMEKGSLLA 91
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL + + L +I +A +A G++YL + +HRD+ N+L+ + K+ADFG+A
Sbjct: 92 FLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151
Query: 259 RVEAQNPRDMTGETGT-LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316
R+ + ++ + + APE ++ K DV+SFGI L+E++ +PYP ++
Sbjct: 152 RL-IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+V + R P CP + IM +CW A P+ RP
Sbjct: 211 HEVYDQITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 52/283 (18%)
Query: 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
+I G G VY+ G++VA+K + + E+ +
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK----------ELIINEILIM 69
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ HPN+ + DS+ L VV+EY+ GG+L +I
Sbjct: 70 KDCKHPNIVDYY------------------DSY--LVGDELWVVMEYMDGGSLTD-IITQ 108
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA---RV 260
++ + + ++ +GL YLHS+ ++HRD+K++N+LL + ++K+ADFG A
Sbjct: 109 NFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS----- 315
E + GT +MAPEV+ K Y K D++S GI E+ + PY
Sbjct: 169 EKSKRNSV---VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225
Query: 316 FTDVSSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRP 356
F + P + P + KC +P+KRP
Sbjct: 226 FL------ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 70/201 (34%), Positives = 108/201 (53%), Gaps = 20/201 (9%)
Query: 186 VVVEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLSYLHSK 230
V+VEY G L++FL R +R ++L+FK ++ A +ARG+ YL S+
Sbjct: 95 VIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR 153
Query: 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPY 288
+HRD+ N+L+ + +KIADFG+AR G L +MAPE L + Y
Sbjct: 154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213
Query: 289 NRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKC 347
+ DV+SFGI +WEI+ PYP + ++ ++R+ R D P C L +MR+C
Sbjct: 214 THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK-LLREGHRMDKPSNCTHELYMLMREC 272
Query: 348 WDANPDKRPVMDEVVKLLEAV 368
W A P +RP ++V+ L+ V
Sbjct: 273 WHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-32
Identities = 73/219 (33%), Positives = 109/219 (49%), Gaps = 43/219 (19%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVK--ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+ GTYG VY+ A D G+ VA+K LD E+G + S A+R E+++ ++L
Sbjct: 7 LGEGTYGVVYK-ARDKKTGEIVALKKIRLDNEEEG-IPST---ALR-----EISLLKELK 56
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
HPN+ K + D ++ R +V EY LKK+L +
Sbjct: 57 HPNIVKLL------------------DVIHT--ERKLYLVFEYCDM-DLKKYL-DKRPGP 94
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
L+ ++ I L RGL+Y HS I+HRD+K +N+L++ + LK+ADFG+AR R
Sbjct: 95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
T E TL Y APE+L G YS + +W + C
Sbjct: 155 YTHEVVTLWYRAPEILLG------SKHYSTAVDIWSVGC 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 39/276 (14%)
Query: 92 EIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
E+ G +G V G + GQ DVA+K++ ++G ++ E F +E V KL H
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIEEAKVMMKLSHEK 60
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ + G R +V EY+ G L +L R K+
Sbjct: 61 LVQLYGVCT--------------------KQRPIYIVTEYMSNGCLLNYL-REHGKRFQP 99
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
++++ D+ G++YL SK +HRD+ N L+D +K++DFG++R + + T
Sbjct: 100 SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTS 157
Query: 271 ETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQ 326
G+ + + PEVL ++ K DV++FG+ +WE+Y MPY + ++ V Q
Sbjct: 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-Q 216
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
LR P + +IM CW ++RP +++
Sbjct: 217 GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 71/273 (26%), Positives = 133/273 (48%), Gaps = 32/273 (11%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ RG +G V+ R D + V +K + + M AA + E V + L HPN
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAA-----QNECQVLKLLSHPN 60
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ ++ N L +A +V+EY PGGTL +++ + L
Sbjct: 61 IIEYY--------------------ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE 100
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT-LKIADFGVARVEAQNPRDMT 269
++ + + L ++H+K I+HRD+KT+N+LLD ++ +KI DFG++++ + + T
Sbjct: 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR 329
GT Y++PE+ +GKPYN+K D+++ G L+E+ + + + ++
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA 219
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
P R P L ++ + +P KRP + +++
Sbjct: 220 PISDRYSP-DLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 79/282 (28%), Positives = 137/282 (48%), Gaps = 45/282 (15%)
Query: 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-- 148
I RG YG VYRG + G+ VA+KI++ + + I+ +EVA+ +L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQ----REVALLSQLRQSQ 60
Query: 149 -PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
PN+TK+ G+ + L +++EY GG+++ + K
Sbjct: 61 PPNITKYYGSYLKGPRL--------------------WIIMEYAEGGSVRTLM---KAGP 97
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+A K + I ++ L Y+H ++HRD+K N+L+ +K+ DFGVA + QN
Sbjct: 98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157
Query: 268 MTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
+ GT +MAPEV +GK Y+ K D++S GI ++E+ + PY D+ + +
Sbjct: 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS 217
Query: 327 NLRPDIPRCCPSSLASIMRK----CWDANPDKRPVMDEVVKL 364
+P PR + + ++R+ C D P +R +E++K
Sbjct: 218 --KP--PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 38/292 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WEI + + ++ G +G V+ G Y+ VAVK L S +A F +
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQA------FLE 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E + + L H + + + I + EY+ G+L
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYI--------------------ITEYMAKGSLLD 90
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL ++ K+ +I + +A G++Y+ K +HRD++ N+L+ + KIADFG+A
Sbjct: 91 FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150
Query: 259 RVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDL 314
RV N + T G + + APE ++ + K DV+SFGI L+EI +PYP +
Sbjct: 151 RVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
S +DV SA+ R P CP L IM+ CW ++RP D + +L+
Sbjct: 209 SNSDVMSALQRGYRMPR-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 91/304 (29%), Positives = 140/304 (46%), Gaps = 45/304 (14%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMV---TSAEAAAIRA-- 134
WE+ K+ + E+ +G++G VY G A I+ + V T E+A++R
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEG------NARDIIKGEAETRVAVKTVNESASLRERI 54
Query: 135 SFRQEVAVWQKLDHPNVTKFIGA-SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F E +V + +V + +G S G L VV+E +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---------------------VVMELMAH 93
Query: 194 GTLKKFL--IRNK------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
G LK +L +R + R + +IQ+A ++A G++YL++K VHRD+ N ++
Sbjct: 94 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 153
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWE 303
+ T+KI DFG+ R + G G L +MAPE L + D++SFG+ LWE
Sbjct: 154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 213
Query: 304 IYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
I + PY LS V V+ D P CP + +MR CW NP RP E+V
Sbjct: 214 ITSLAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
Query: 363 KLLE 366
LL+
Sbjct: 273 NLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 89/298 (29%), Positives = 140/298 (46%), Gaps = 41/298 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRA--SFR 137
WE+ K+ + E+ +G++G VY G G VK + T EAA++R F
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKG---VVKDEPETRVAIKTVNEAASMRERIEFL 57
Query: 138 QEVAVWQKLDHPNVTKFIGA-SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
E +V ++ + +V + +G S G L V++E + G L
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSQGQPTL---------------------VIMELMTRGDL 96
Query: 197 KKFLIRNKRKKL---------AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247
K +L R+ R ++ + K +IQ+A ++A G++YL++ VHRD+ N ++ +
Sbjct: 97 KSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155
Query: 248 RTLKIADFGVARVEAQNPRDMTGETGTLG--YMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
T+KI DFG+ R + G G L +M+PE L + DV+SFG+ LWEI
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215
Query: 306 C-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
+ PY +S V V+ L D P CP L +MR CW NP RP E++
Sbjct: 216 TLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 60/185 (32%), Positives = 100/185 (54%), Gaps = 5/185 (2%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
V+ EY G L FL R + L + ++ + +A+G+++L SK +HRD+ N+LL
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT 175
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLW 302
+ +KI DFG+AR + N + + + +MAPE + Y + DV+S+GI LW
Sbjct: 176 HGKIVKICDFGLAR-DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 234
Query: 303 EIYCCDM-PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
EI+ PYP + ++++ R P P+ + IM+ CWDA+P KRP ++
Sbjct: 235 EIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
Query: 362 VKLLE 366
V+L+
Sbjct: 295 VQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 83/317 (26%), Positives = 137/317 (43%), Gaps = 63/317 (19%)
Query: 83 ELAKLDIRHE--IARGTYGTVYR----GAYDGQD---VAVKIL-DWAEDGMVTSAEAAAI 132
E + +I + I +G +G V++ G + VAVK+L + A M
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--------- 51
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
+A F++E A+ + DHPN+ K +G + C++ EY+
Sbjct: 52 QADFQREAALMAEFDHPNIVKLLGVCA--------------------VGKPMCLLFEYMA 91
Query: 193 GGTLKKFLIRN--------------------KRKKLAFKVVIQIALDLARGLSYLHSKTI 232
G L +FL L+ + IA +A G++YL +
Sbjct: 92 YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF 151
Query: 233 VHRDVKTENMLLDANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLDGKPYNR 290
VHRD+ T N L+ N +KIADFG++R A + + + +M PE + Y
Sbjct: 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT 211
Query: 291 KCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD 349
+ DV+++G+ LWEI+ M PY ++ +V V N+ P CP L ++MR CW
Sbjct: 212 ESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWS 270
Query: 350 ANPDKRPVMDEVVKLLE 366
P RP + ++L+
Sbjct: 271 KLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 85/292 (29%), Positives = 134/292 (45%), Gaps = 39/292 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WEI L + ++ +G +G V+ G ++G VA+K L EA F Q
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG----TMMPEA------FLQ 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E + +KL H + +P + S+ +V E++ G+L
Sbjct: 51 EAQIMKKLRHDKL--------------VPLYAVVSE-------EPIYIVTEFMGKGSLLD 89
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL K L ++ +A +A G++Y+ +HRD++ N+L+ N KIADFG+A
Sbjct: 90 FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA 149
Query: 259 RVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314
R+ N + T G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 150 RLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+V V R R P+ CP SL +M+ CW +PD+RP + + LE
Sbjct: 208 VNREVLEQVER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-30
Identities = 77/289 (26%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 93 IARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
+ +G +G+V R A Q VAVK+L + + +S++ F +E A ++
Sbjct: 7 LGKGEFGSV-REAQLKSEDGSFQKVAVKML---KADIFSSSDIE----EFLREAACMKEF 58
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
DHPNV K IG S+ S + LP V++ ++ G L FL+ ++
Sbjct: 59 DHPNVIKLIGVSL------------RSRAKGRLPIPM--VILPFMKHGDLHTFLLMSRIG 104
Query: 207 K----LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR--V 260
+ L + +++ +D+A G+ YL SK +HRD+ N +L+ N T+ +ADFG+++
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY 164
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDV 319
R + ++A E L Y DV++FG+ +WEI PY + +++
Sbjct: 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+ +++ N R P C + +M +CW P RP + LE +
Sbjct: 225 YNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 83/285 (29%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 90 RHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
++I GT+G VY G+ +AVK + +D + I+ E+ V + L
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRI-QDN-----DPKTIKE-IADEMKVLELLK 57
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
HPN+ K+ G + H + +EY GGTL++ L + R
Sbjct: 58 HPNLVKYYGVEV----------------HRE----KVYIFMEYCSGGTLEELL-EHGRI- 95
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN--- 264
L V+ L L GL+YLHS IVHRD+K N+ LD N +K+ DFG A N
Sbjct: 96 LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155
Query: 265 -PRDMTGETGTLGYMAPEVLDGKP---YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
++ GT YMAPEV+ G + R D++S G + E+ P+ +L D
Sbjct: 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL---DNE 212
Query: 321 SAV---VRQNLRPDIPRCCPSSLASI--MRKCWDANPDKRPVMDE 360
+ V +P IP S + +C +++P KRP E
Sbjct: 213 FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 73/287 (25%), Positives = 128/287 (44%), Gaps = 35/287 (12%)
Query: 82 IELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
I ++L E+ G +G V+ G + Q VA+K ++ E A F +E
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN----------EGAMSEEDFIEEA 50
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
V KL HP + + G L I V E++ G L +L
Sbjct: 51 KVMMKLSHPKLVQLYGVCTQQKPLYI--------------------VTEFMENGCLLNYL 90
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR- 259
R ++ KL+ +++ + D+ G+ YL + +HRD+ N L+ + +K++DFG+ R
Sbjct: 91 -RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318
V +G + + PEV + Y+ K DV+SFG+ +WE++ MP+ S +
Sbjct: 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
V + R R P+ ++ +M CW P+ RP E+++ +
Sbjct: 210 VVEMISRGF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 84/282 (29%), Positives = 133/282 (47%), Gaps = 36/282 (12%)
Query: 89 IRHEIARGTYGTVY----RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
++ + +G++GTVY + A + + K+L G + E ++A+ QE +
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERL--KVLKEIPVGELNPNET--VQAN--QEAQLLS 57
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNS-LPSRACCVVVEYLPGGTLKKFLIRN 203
KLDHP + KF H S L A C++ EY G L L
Sbjct: 58 KLDHPAIVKF---------------------HASFLERDAFCIITEYCEGRDLDCKLEEL 96
Query: 204 KR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
K K L+ V + + L G+ Y+H + I+HRD+K +N+ L N LKI DFGV+R+
Sbjct: 97 KHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL 155
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ T TGT YM+PE L + Y+ K D++S G L+E+ C + +F V
Sbjct: 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+V + P +P L SIM+ + +P RP E+++
Sbjct: 216 RIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 70/296 (23%), Positives = 111/296 (37%), Gaps = 69/296 (23%)
Query: 92 EIARGTYGTVYRGAYD---GQDVAVKILD----WAEDGMVTSAEAAAIRASFRQEVAVWQ 144
I G++ TV A + ++ A+KILD E + + E V
Sbjct: 8 IIGEGSFSTVVL-AKEKETNKEYAIKILDKRQLIKEKKV----------KYVKIEKEVLT 56
Query: 145 KLD-HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+L+ HP + K NL V+EY P G L +++
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYF--------------------VLEYAPNGELLQYI--R 94
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV--- 260
K L K A ++ L YLHSK I+HRD+K EN+LLD + +KI DFG A+V
Sbjct: 95 KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154
Query: 261 -------------EAQNPRDMTGET----GTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
GT Y++PE+L+ KP + D+++ G +++
Sbjct: 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQ 214
Query: 304 IYCCDMPYPDLSFTDVSSAVVRQNLRP---DIPRCCPSSLASIMRKCWDANPDKRP 356
+ P F + + Q + P P ++ K +P R
Sbjct: 215 MLTGKPP-----FRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 93 IARGTYGTVYRGAYDGQD----VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
+ G +G+V G + D VAVK + A + T +E F E ++ DH
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIA---ICTRSEME----DFLSEAVCMKEFDH 59
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK- 207
PNV + IG + T PS V++ ++ G L FL+ ++
Sbjct: 60 PNVMRLIGVCLQTV------------ESEGYPSPV--VILPFMKHGDLHSFLLYSRLGDC 105
Query: 208 ---LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
L +++++ D+A G+ YL SK+ +HRD+ N +L+ N + +ADFG+++
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
Query: 265 PRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSS 321
G + ++A E L + Y K DV+SFG+ +WEI PYP + +++
Sbjct: 166 DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+RQ R P C L S+M CW NP RP + + LE
Sbjct: 226 -YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 47/299 (15%)
Query: 82 IELAKLDIRHEIARGTYGTVYRG-----AYDGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
I+++ + I I G +G V RG VA+K L S R F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--------KSGYTEKQRRDF 52
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
E ++ + DHPN+ G T SR ++ E++ G L
Sbjct: 53 LSEASIMGQFDHPNIIHLEGV---VTK-----------------SRPVMIITEFMENGAL 92
Query: 197 KKFLIRNKRKKLAFKVVIQIAL--DLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
FL +N + F V+ + + +A G+ YL VHRD+ N+L+++N K++D
Sbjct: 93 DSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 255 FGVARVEAQNPRDMTGETGTLG------YMAPEVLDGKPYNRKCDVYSFGICLWEIYCC- 307
FG++R + D T T +LG + APE + + + DV+S+GI +WE+
Sbjct: 150 FGLSRFLEDDTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 208
Query: 308 DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ PY D+S DV +A + Q+ R P CP++L +M CW + + RP ++V L+
Sbjct: 209 ERPYWDMSNQDVINA-IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 71/293 (24%), Positives = 138/293 (47%), Gaps = 47/293 (16%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRA 134
E EL K+ + + G +GTVY+G + +G+ VA+K+L A +
Sbjct: 6 ETELEKIKV---LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-------EETSPKANKE 55
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
E V +DHP+V + +G + + ++ + +P G
Sbjct: 56 -ILDEAYVMASVDHPHVVRLLGICLSSQ---------------------VQLITQLMPLG 93
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
L ++ RN + + + ++ + +A+G+SYL K +VHRD+ N+L+ + +KI D
Sbjct: 94 CLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITD 152
Query: 255 FGVARVEAQNPRDMTGETGT--LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPY 311
FG+A++ + ++ E G + +MA E + + Y K DV+S+G+ +WE+ PY
Sbjct: 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
Query: 312 PDLSFTDVSSAVVR-QNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
+ ++ + + + L +P I C + ++ KCW + + RP E++
Sbjct: 213 EGIPAVEIPDLLEKGERLPQPPI---CTIDVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 81/292 (27%), Positives = 135/292 (46%), Gaps = 39/292 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WEI L + ++ G +G V+ G ++G VAVK L + G ++ SF +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPE-------SFLE 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E + +KL H + + + +V EY+ G+L
Sbjct: 51 EAQIMKKLRHDKLVQLYAV---------------------VSEEPIYIVTEYMSKGSLLD 89
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL + + L ++ +A +A G++Y+ +HRD+++ N+L+ KIADFG+A
Sbjct: 90 FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149
Query: 259 RVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314
R+ N + T G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 150 RLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ +V V R R P+ CP SL +M +CW +P++RP + + LE
Sbjct: 208 NNREVLEQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-29
Identities = 70/226 (30%), Positives = 103/226 (45%), Gaps = 45/226 (19%)
Query: 91 HEIARGTYGTVYRGA--YDGQDVAVK--ILDWAEDGM-VTSAEAAAIRASFRQEVAVWQK 145
+I GTYG VY+ G+ VA+K ++ ++G +T AIR E+ + QK
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-----AIR-----EIKLLQK 54
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP----GGTLKKFLI 201
L HPN+ + TS S +V EY+ G L+
Sbjct: 55 LRHPNIVRLKEI-------------VTSKGKGS-----IYMVFEYMDHDLTG------LL 90
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR-V 260
+ K + L GL YLHS I+HRD+K N+L++ + LK+ADFG+AR
Sbjct: 91 DSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIY 305
+N D T TL Y PE+L G Y + D++S G L E++
Sbjct: 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-29
Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 33/277 (11%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ +G +G VY YD G+++AVK + + D T E A+ E+ + + L H
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALE----CEIQLLKNLQHE 64
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ ++ G L+ + +EY+PGG++K L L
Sbjct: 65 RIVQYYGC------LRDDET--------------LSIFMEYMPGGSVKDQL--KAYGALT 102
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA-RVEA--QNPR 266
V + + G+ YLHS IVHRD+K N+L D+ +K+ DFG + R++ +
Sbjct: 103 ETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
M TGT +M+PEV+ G+ Y RK DV+S G + E+ P+ + + Q
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P +P + +R+ + N KRP +E+++
Sbjct: 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 70/204 (34%), Positives = 111/204 (54%), Gaps = 22/204 (10%)
Query: 186 VVVEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLSYLHSK 230
V+VEY G L+++L R +R ++L FK ++ A +ARG+ YL S+
Sbjct: 95 VLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ 153
Query: 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKP 287
+HRD+ N+L+ + +KIADFG+AR + N + T + +MAPE L +
Sbjct: 154 KCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212
Query: 288 YNRKCDVYSFGICLWEIYCCD-MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRK 346
Y + DV+SFG+ LWEI+ PYP + ++ ++++ R D P C L IMR+
Sbjct: 213 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTHELYMIMRE 271
Query: 347 CWDANPDKRPVMDEVVKLLEAVNT 370
CW A P +RP ++V+ L+ V T
Sbjct: 272 CWHAVPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 39/292 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WEI L + ++ +G +G V+ G ++G VA+K L S EA F Q
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEA------FLQ 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E V +KL H + + + +V EY+ G+L
Sbjct: 51 EAQVMKKLRHEKLVQLYAV---------------------VSEEPIYIVTEYMSKGSLLD 89
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL K L ++ +A +A G++Y+ VHRD++ N+L+ N K+ADFG+A
Sbjct: 90 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 149
Query: 259 RVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314
R+ N + T G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 150 RLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+V V R R P CP SL +M +CW P++RP + + LE
Sbjct: 208 VNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 39/273 (14%)
Query: 92 EIARGTYGTVYRGAYDGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
E+ G +G V +G Y + DVA+K+L + ++R +E + +LD
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL--------KNENEKSVRDEMMREAEIMHQLD 53
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
+P + + IG + A +V+E GG L KFL K+ +
Sbjct: 54 NPYIVRMIGVC---------------------EAEALMLVMEMASGGPLNKFLS-GKKDE 91
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ V+++ ++ G+ YL K VHRD+ N+LL KI+DFG+++ +
Sbjct: 92 ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151
Query: 268 MTGETG---TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAV 323
+ L + APE ++ + ++ + DV+S+GI +WE + PY + +V S
Sbjct: 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-F 210
Query: 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+ Q R D P CP + ++M+ CW + RP
Sbjct: 211 IEQGKRLDCPAECPPEMYALMKDCWIYKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 82/278 (29%), Positives = 125/278 (44%), Gaps = 63/278 (22%)
Query: 111 VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170
VAVK+L D + R F +EV + +L PN+ + +G
Sbjct: 49 VAVKVL--RPDASDNA------REDFLKEVKILSRLSDPNIARLLGVC------------ 88
Query: 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR---------NKRKKLAFKVVIQIALDLA 221
T D C+++EY+ G L +FL + K L+F ++ +A +A
Sbjct: 89 -TVDPP-------LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140
Query: 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR---------VEAQNPRDMTGET 272
G+ YL S VHRD+ T N L+ N T+KIADFG++R V+ + P
Sbjct: 141 SGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL------ 194
Query: 273 GTLGYMAPE-VLDGKPYNRKCDVYSFGICLWEIY--CCDMPYPDLSFTDV---SSAVVRQ 326
+ +MA E VL GK + K DV++FG+ LWEI C + PY L+ V + R
Sbjct: 195 -PIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD 252
Query: 327 NLRPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEV 361
+ R P CP + +M +CW + + RP E+
Sbjct: 253 DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 82/300 (27%), Positives = 137/300 (45%), Gaps = 50/300 (16%)
Query: 92 EIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ G +G V YD G+ VAVK L E G A+ ++E+ + +
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIAD-------LKKEIEILRN 62
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L H N+ K+ G T D N + +++E+LP G+LK++L RNK
Sbjct: 63 LYHENIVKYKGI-------------CTEDGGNGIK-----LIMEFLPSGSLKEYLPRNK- 103
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
K+ K ++ A+ + +G+ YL S+ VHRD+ N+L+++ +KI DFG+ + +
Sbjct: 104 NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
Query: 266 RDMTGE---TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI--YCCDMPYPDLSFTDVS 320
T + + + APE L + DV+SFG+ L+E+ YC P F +
Sbjct: 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI 223
Query: 321 SA------------VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
V+ + R P CP + +MRKCW+ P KR +++ EA+
Sbjct: 224 GPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 93/322 (28%), Positives = 145/322 (45%), Gaps = 82/322 (25%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAA 130
LP T +E+ +++ I GTYG VY+ GQ VA+KI+D ED E
Sbjct: 1 LPDPTGIFEL----VEV---IGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEE 47
Query: 131 AIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
I+ +E + +K +HPN+ F GA + Q +V+E
Sbjct: 48 EIK----EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ--------------LWLVME 89
Query: 190 YLPGGT----LKKFLIRNKRKK---LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242
GG+ +K + KR K +A+ I + RGL+YLH ++HRD+K +N+
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLRGLAYLHENKVIHRDIKGQNI 144
Query: 243 LLDANRTLKIADFGVAR-VEAQNPRDMTGETGTLGYMAPEVL--DGKP---YNRKCDVYS 296
LL N +K+ DFGV+ +++ R T GT +MAPEV+ D +P Y+ + DV+S
Sbjct: 145 LLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWMAPEVIACDEQPDASYDARSDVWS 203
Query: 297 FGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPD-----IPRCCPSSLAS--------- 342
GI E+ P D + P IPR P +L S
Sbjct: 204 LGITAIELADGKPPLCD--------------MHPMRALFKIPRNPPPTLKSPENWSKKFN 249
Query: 343 -IMRKCWDANPDKRPVMDEVVK 363
+ +C N ++RP M+E+++
Sbjct: 250 DFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 34/275 (12%)
Query: 93 IARGTYG--TVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +G +G T+YR D V W E + +E R E+ + L HPN
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVV-----WKEVNLTRLSEKE--RRDALNEIVILSLLQHPN 60
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ + M L I +EY GGTL ++R K +
Sbjct: 61 IIAYYNHFMDDNTLLIE--------------------MEYANGGTLYDKIVRQKGQLFEE 100
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
++V+ + +SY+H I+HRD+KT N+ L +K+ DFG++++
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMA 158
Query: 271 ET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328
ET GT YM+PE+ G YN K D+++ G L+E+ + + ++ +V+ N
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN- 217
Query: 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ S L S++ +P+KRP DEV+
Sbjct: 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-28
Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 39/273 (14%)
Query: 92 EIARGTYGTVYRGAYD----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
E+ G +GTV +G Y + VAVKIL A++ +E V Q+LD
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILK-------NDNNDPALKDELLREANVMQQLD 54
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
+P + + IG + +V+E G L KFL +NK
Sbjct: 55 NPYIVRMIGICEA---------------------ESWMLVMELAELGPLNKFLQKNKHVT 93
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
K + ++ ++ G+ YL VHRD+ N+LL KI+DFG+++ +
Sbjct: 94 E--KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151
Query: 268 MTGETG---TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAV 323
+T + + APE ++ ++ K DV+SFG+ +WE + PY + +V + +
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-TQM 210
Query: 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+ R + P+ CP + +M+ CW D+RP
Sbjct: 211 IESGERMECPQRCPPEMYDLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 20/201 (9%)
Query: 186 VVVEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLSYLHSK 230
V+VEY G L+++L R +R ++L+FK ++ A +ARG+ YL SK
Sbjct: 101 VIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK 159
Query: 231 TIVHRDVKTENMLLDANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLDGKPY 288
+HRD+ N+L+ + +KIADFG+AR + T + +MAPE L + Y
Sbjct: 160 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219
Query: 289 NRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKC 347
+ DV+SFG+ LWEI+ PYP + ++ ++++ R D P C + L +MR C
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDC 278
Query: 348 WDANPDKRPVMDEVVKLLEAV 368
W A P +RP ++V+ L+ +
Sbjct: 279 WHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-28
Identities = 66/204 (32%), Positives = 109/204 (53%), Gaps = 22/204 (10%)
Query: 186 VVVEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLSYLHSK 230
V+VEY G L+++L R +R +++ FK ++ +ARG+ YL S+
Sbjct: 98 VIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ 156
Query: 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKP 287
+HRD+ N+L+ N +KIADFG+AR + N + T + +MAPE L +
Sbjct: 157 KCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYKKTTNGRLPVKWMAPEALFDRV 215
Query: 288 YNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRK 346
Y + DV+SFG+ +WEI+ PYP + ++ ++++ R D P C + L +MR
Sbjct: 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRD 274
Query: 347 CWDANPDKRPVMDEVVKLLEAVNT 370
CW A P RP ++V+ L+ + T
Sbjct: 275 CWHAIPSHRPTFKQLVEDLDRILT 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 79/317 (24%), Positives = 136/317 (42%), Gaps = 76/317 (23%)
Query: 87 LDIRHEIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
L + G +G V YD G+ VAVK L + +++E+
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--------KRECGQQNTSGWKKEI 57
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC---------VVVEYL 191
+ + L H N+ K+ G CC +++EY+
Sbjct: 58 NILKTLYHENIVKYKG---------------------------CCSEQGGKGLQLIMEYV 90
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
P G+L+ +L ++K L ++ A + G++YLHS+ +HRD+ N+LLD +R +K
Sbjct: 91 PLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVK 147
Query: 252 IADFGVARV-----EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
I DFG+A+ E R+ G++ Y A E L ++ DV+SFG+ L+E+
Sbjct: 148 IGDFGLAKAVPEGHEYYRVRE-DGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLT 205
Query: 307 -CDMPY--PDLSFTDV------SSAVVR------QNLRPDIPRCCPSSLASIMRKCWDAN 351
CD P F ++ VVR + +R P+ CP + +M+ CW+
Sbjct: 206 HCD-SKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE 264
Query: 352 PDKRPVMDEVVKLLEAV 368
RP ++ +L+ +
Sbjct: 265 AKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-28
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 39/211 (18%)
Query: 96 GTYGTVYRGAY--DGQDVAVK---ILDWAE--DGMVTSAEAAAIRASFRQEVAVWQKLDH 148
GTY VY+ G+ VA+K + + E DG+ +A +R E+ + Q+L H
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA----LR-----EIKLLQELKH 61
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
PN+ + +N+ +V E++ L+K +I++K L
Sbjct: 62 PNIIGLLDVFGHKSNI--------------------NLVFEFMET-DLEK-VIKDKSIVL 99
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
+ L RGL YLHS I+HRD+K N+L+ ++ LK+ADFG+AR R M
Sbjct: 100 TPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159
Query: 269 TGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
T + T Y APE+L G + Y D++S G
Sbjct: 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 56/282 (19%)
Query: 111 VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170
VAVK+L +S+E + + F + ++++HP+V K GA
Sbjct: 33 VAVKMLKENA----SSSELRDLLSEFN----LLKQVNHPHVIKLYGA------------- 71
Query: 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK-----------------------K 207
+ D ++VEY G+L+ FL R RK
Sbjct: 72 CSQDG-------PLLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
L +I A ++RG+ YL +VHRD+ N+L+ R +KI+DFG++R +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 268 MTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAVV 324
+ G + +MA E L Y + DV+SFG+ LWEI PYP ++ + + ++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN-LL 242
Query: 325 RQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ R + P C + ++M CW PDKRP ++ K LE
Sbjct: 243 KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 80/292 (27%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 89 IRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ I G VY A + + VA+K +D + TS + R+EV +
Sbjct: 5 LIEVIGVGATAVVYA-AICLPNNEKVAIKRIDL--EKCQTSVD------ELRKEVQAMSQ 55
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC-VVVEYLPGGTLKKFLIRNK 204
+HPNV K+ + S +V+ YL GG+L ++++
Sbjct: 56 CNHPNVVKY---------------------YTSFVVGDELWLVMPYLSGGSLLD-IMKSS 93
Query: 205 RKKLAF-KVVIQIAL-DLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
+ + +I L ++ +GL YLHS +HRD+K N+LL + ++KIADFGV+ A
Sbjct: 94 YPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153
Query: 263 QNPRDMTGET-----GTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
D T + GT +MAPEV++ Y+ K D++SFGI E+ PY
Sbjct: 154 D-GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
Query: 317 TDVSSAVVRQNLRPDIPRC-----CPSSLASIMRKCWDANPDKRPVMDEVVK 363
V + QN P + S ++ C +P KRP +E++K
Sbjct: 213 MKVLMLTL-QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 93 IARGTYGTV--YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +G+YG V R DG+ +K L+ + +A +A+ QE + +L HPN
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLN------LRNASRRERKAA-EQEAQLLSQLKHPN 60
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ + + G L +V+ + GG L L K K L
Sbjct: 61 IVAYRESWEGEDGL-------------------LYIVMGFCEGGDLYHKLKEQKGKLLPE 101
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
V++ + +A L YLH K I+HRD+KT+N+ L +K+ D G+ARV +N DM
Sbjct: 102 NQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMAS 160
Query: 271 E-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR--QN 327
GT YM+PE+ KPYN K DV++ G C++E+ + + D++S V R +
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF---NAKDMNSLVYRIIEG 217
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P +P+ L ++ P+KRP + +++
Sbjct: 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 32/241 (13%)
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
R F E ++ + DHPN+ G S+ +V EY+
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVT--------------------KSKPVMIVTEYME 88
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIA---LDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249
G+L FL RK VIQ+ +A G+ YL VHRD+ N+L+++N
Sbjct: 89 NGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV 144
Query: 250 LKIADFGVARVEAQNPRDMTGETG---TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
K++DFG++RV +P G + + APE + + + DV+S+GI +WE+
Sbjct: 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 307 C-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
+ PY ++S DV A + + R P CP++L +M CW + ++RP +++V +L
Sbjct: 205 YGERPYWEMSNQDVIKA-IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
Query: 366 E 366
+
Sbjct: 264 D 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 53/281 (18%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
DI ++ G+YG+VY+ + GQ VA+K++ ED + +E+++ ++
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEII---------KEISILKQ 54
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
D P + K+ G+ T+L I V+EY G++ +++
Sbjct: 55 CDSPYIVKYYGSYFKNTDLWI--------------------VMEYCGAGSVSD-IMKITN 93
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
K L + + I +GL YLHS +HRD+K N+LL+ K+ADFGV+
Sbjct: 94 KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153
Query: 266 RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
GT +MAPEV+ YN K D++S GI E+ PY D+
Sbjct: 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--- 210
Query: 326 QNLRPDIPRCCPSSLA----------SIMRKCWDANPDKRP 356
IP P +L+ ++KC +P++RP
Sbjct: 211 ------IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 81/292 (27%), Positives = 132/292 (45%), Gaps = 39/292 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
WEI L + ++ G +G V+ Y+ VAVK + M A F
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEA--------FLA 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E V + L H + K H + ++ E++ G+L
Sbjct: 51 EANVMKTLQHDKLVKL---------------------HAVVTKEPIYIITEFMAKGSLLD 89
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
FL ++ K +I + +A G++++ + +HRD++ N+L+ A+ KIADFG+A
Sbjct: 90 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 149
Query: 259 RVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MPYPDL 314
RV N + T G + + APE ++ + K DV+SFGI L EI +PYP +
Sbjct: 150 RVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
S +V A+ R R P CP L +IM +CW P++RP + + +L+
Sbjct: 208 SNPEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 60/269 (22%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 101 VYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160
+Y+G ++ ++V ++ G + E+ +++D N+ K G +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKG------HKVLIDITENEIKNLRRIDSNNILKIYGFII- 88
Query: 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDL 220
D + LP + +++EY G L++ L +K K L+FK + +A+D
Sbjct: 89 -------------DIVDDLPRLS--LILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDC 131
Query: 221 ARGLSYLHSKT-IVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMA 279
+GL L+ T ++++ + + L+ N LKI G+ ++ + P + Y +
Sbjct: 132 CKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKNVNFMVYFS 188
Query: 280 PEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCP 337
++L+ Y K D+YS G+ LWEI+ +P+ +L+ ++ ++ +N +P CP
Sbjct: 189 YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP 248
Query: 338 SSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ I+ C + KRP + E++ L
Sbjct: 249 LEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 36/247 (14%)
Query: 124 VTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRA 183
+T+ ++ +E+ + + P + K+ GA + S S+
Sbjct: 34 ITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD------ESSSSIG---------- 77
Query: 184 CCVVVEYLPGGTL----KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239
+ +EY GG+L KK R R + KV+ +IA + +GLSYLHS+ I+HRD+K
Sbjct: 78 --IAMEYCEGGSLDSIYKKVKKRGGR--IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKP 133
Query: 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
N+LL +K+ DFGV+ E N T TGT YMAPE + GKPY+ DV+S G+
Sbjct: 134 SNILLTRKGQVKLCDFGVSG-ELVNSLAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGL 191
Query: 300 CLWEIYCCDMPYP-----DLSFTDVSSAVVRQ-NLR----PDIPRCCPSSLASIMRKCWD 349
L E+ P+P L ++ S +V N P +++C +
Sbjct: 192 TLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLE 251
Query: 350 ANPDKRP 356
+P +RP
Sbjct: 252 KDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 48/226 (21%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKIL---DWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
I++G YG V+ + G A+K++ D V E + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT---------ERDILSQAQ 51
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL--IRNKR 205
P V K + G NL +V+EYLPGG L L + +
Sbjct: 52 SPYVVKLYYSFQGKKNL--------------------YLVMEYLPGGDLASLLENVGSLD 91
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ +A + +I L L YLHS I+HRD+K +N+L+D+N LK+ DFG+++V
Sbjct: 92 EDVARIYIAEIVL----ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147
Query: 266 RDMTGET--------GTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
+ + GT Y+APEV+ G+ +++ D +S G L+E
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 86/303 (28%), Positives = 137/303 (45%), Gaps = 52/303 (17%)
Query: 89 IRHEIARGTYGTVYRG-AYDGQDVAVKILDWAEDGMVTSAEAA-----AIRASFRQEVAV 142
++ E+ G +G V+ Y+ L +D M+ + +A A R F++E +
Sbjct: 9 LKRELGEGAFGKVFLAECYN--------LSPTKDKMLVAVKALKDPTLAARKDFQREAEL 60
Query: 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL-- 200
L H ++ KF G L +V EY+ G L KFL
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPL--------------------IMVFEYMKHGDLNKFLRA 100
Query: 201 ------------IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
R + +L ++ IA +A G+ YL S+ VHRD+ T N L+ AN
Sbjct: 101 HGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160
Query: 249 TLKIADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
+KI DFG++R V + + + G T + +M PE + + + + DV+SFG+ LWEI+
Sbjct: 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
Query: 307 C-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
P+ LS T+V + Q + PR CP + IM CW P +R + E+ K+L
Sbjct: 221 YGKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
Query: 366 EAV 368
A+
Sbjct: 280 HAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 56/164 (34%), Positives = 89/164 (54%), Gaps = 17/164 (10%)
Query: 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET 272
++ + +A+G+S+L SK +HRD+ N+LL R KI DFG+AR D+ ++
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-------DIRNDS 268
Query: 273 G---------TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSA 322
+ +MAPE + Y + DV+S+GI LWEI+ PYP +
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
++++ R P C PS + IM+ CWDA+P KRP ++V+L+E
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 64/227 (28%), Positives = 94/227 (41%), Gaps = 32/227 (14%)
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
+ E + Q+L+HP F+ NL + D N +VV+ L G
Sbjct: 45 RNVLNERRILQELNHP----FL------VNL----WYSFQDEEN------MYLVVDLLLG 84
Query: 194 GTLKKFLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
G L+ L + + F V ++ L YLHSK I+HRD+K +N+LLD +
Sbjct: 85 GDLRYHLSQKVK----FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVH 140
Query: 252 IADFGVAR-VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP 310
I DF +A V T +GT GYMAPEVL + Y+ D +S G+ +E P
Sbjct: 141 ITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
Query: 311 YP--DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
Y + D A P + + K + +P KR
Sbjct: 199 YRGHSRTIRDQIRAKQETA-DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 34/285 (11%)
Query: 84 LAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA 141
L I +I +G + VY+ DG+ VA+K + E M+ A R +E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE--MM----DAKARQDCLKEID 54
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
+ ++LDHPNV K++ + + L I V+E G L + +I
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNI--------------------VLELADAGDLSR-MI 93
Query: 202 RNKRKK---LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
++ +K+ + + + + + L L ++HSK I+HRD+K N+ + A +K+ D G+
Sbjct: 94 KHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG 153
Query: 259 RVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP-YPD-LSF 316
R + GT YM+PE + YN K D++S G L+E+ P Y D ++
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
+ + + + P L ++ +C + +P+KRP + V
Sbjct: 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 37/223 (16%)
Query: 92 EIARGTYGTVYRG--AYDGQDVAVK----ILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
EI G YGTVY+ G+ VA+K L E+G+ S +R E+A+ ++
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLST----LR-----EIALLKQ 54
Query: 146 LD---HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
L+ HPN+ + L + + L +V E++ L +L +
Sbjct: 55 LESFEHPNIVRL---------LDV---CHGPRTDREL---KLTLVFEHVDQ-DLATYLSK 98
Query: 203 NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
+ L + + + L RG+ +LHS IVHRD+K +N+L+ ++ +KIADFG+AR+ +
Sbjct: 99 CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+T TL Y APEVL Y D++S G E++
Sbjct: 159 FEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 75/305 (24%), Positives = 125/305 (40%), Gaps = 53/305 (17%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRA 134
E+ L+ + E+ +G +Y+G Q VA+K L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--------KDINNPQQWG 52
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
F+QE ++ +L HPN+ +G + C++ EYL G
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVT--------------------QEQPVCMLFEYLNQG 92
Query: 195 TLKKFLIRNK---------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239
L +FLI + L + IA+ +A G+ YL S VH+D+
Sbjct: 93 DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA 152
Query: 240 ENMLLDANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSF 297
N+L+ +KI+D G++R A R + +M PE + ++ D++SF
Sbjct: 153 RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212
Query: 298 GICLWEIYCCDM-PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
G+ LWEI+ + PY S +V V ++ L P CP + S+M +CW P +RP
Sbjct: 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRP 271
Query: 357 VMDEV 361
++
Sbjct: 272 RFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 40/294 (13%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
E+E E + R + +GTYG VY V + I + E +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQ-------PLHE 54
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E+A+ L H N+ +++G+ KI +E +PGG+L
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKI--------------------FMEQVPGGSLSA 94
Query: 199 FLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA-NRTLKIADF 255
L+R+K L +I + GL YLH IVHRD+K +N+L++ + +KI+DF
Sbjct: 95 -LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDF 153
Query: 256 GVA-RVEAQNPRDMTGETGTLGYMAPEVLDGKP--YNRKCDVYSFGICLWEIYCCDMPYP 312
G + R+ NP T TGTL YMAPEV+D P Y D++S G + E+ P+
Sbjct: 154 GTSKRLAGINPCTETF-TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212
Query: 313 DLSFTDVSSAVVRQNL---RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+L + +A+ + + P+IP + + + +C++ +PDKR ++++
Sbjct: 213 ELG--EPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I G +G V+RG ++VAV I + R F E ++ + H
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAI------KTLKPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ + G T K ++ EY+ G L K+L R+ + +
Sbjct: 67 NIIRLEGV---VTKFK-----------------PAMIITEYMENGALDKYL-RDHDGEFS 105
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
++ + +A G+ YL VHRD+ N+L+++N K++DFG++RV +P
Sbjct: 106 SYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165
Query: 270 GETG---TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVR 325
+G + + APE + + + DV+SFGI +WE+ + PY D+S +V A +
Sbjct: 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA-IN 224
Query: 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
R P CPS++ +M +CW + +RP ++V LL+
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 84 LAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDW--AEDGMVTSAEAAAIRASFRQE 139
KL+ I +G++G VY+G + VA+KI+D AED + +QE
Sbjct: 6 FTKLE---RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI----------EDIQQE 52
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+ V + D P +T++ G+ + T L I ++EYL GG+
Sbjct: 53 ITVLSQCDSPYITRYYGSYLKGTKLWI--------------------IMEYLGGGSALDL 92
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
L K L + I ++ +GL YLHS+ +HRD+K N+LL +K+ADFGVA
Sbjct: 93 L---KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
GT +MAPEV+ Y+ K D++S GI E+ + P DL V
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV 209
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++ +N P + + C + +P RP E++K
Sbjct: 210 -LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 3/156 (1%)
Query: 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET 272
+I + +ARG+ +L S+ +HRD+ N+LL N +KI DFG+AR ++P +
Sbjct: 175 LISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 273 GTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAVVRQNLR 329
L +MAPE + K Y + DV+SFG+ LWEI+ PYP + + +++ R
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
P + SIM CW NP+ RP E+V++L
Sbjct: 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 87/304 (28%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 88 DIRHE--IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
DI+ E I G +G V R DG + I M+ + F E+ V
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAI------KMLKEFASENDHRDFAGELEVL 56
Query: 144 QKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
KL HPN+ +GA L I +EY P G L FL +
Sbjct: 57 CKLGHHPNIINLLGACENRGYLYI--------------------AIEYAPYGNLLDFLRK 96
Query: 203 NK--------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
++ L + ++Q A D+A G+ YL K +HRD+ N+L+ N
Sbjct: 97 SRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156
Query: 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC- 307
KIADFG++R E + G + +MA E L+ Y K DV+SFG+ LWEI
Sbjct: 157 ASKIADFGLSRGEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLG 215
Query: 308 DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV----K 363
PY ++ ++ + Q R + PR C + +MR+CW P +RP ++ +
Sbjct: 216 GTPYCGMTCAELYEK-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274
Query: 364 LLEA 367
+LEA
Sbjct: 275 MLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 58/287 (20%)
Query: 88 DIRHEIARGTYGTVY--RGAYDGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVW 143
++ I GTYG VY R G+ VA+K+ L+ +D +QE+++
Sbjct: 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-----------FEIIQQEISML 54
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
++ HPN+ + G+ + L I V+EY GG+L+
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWI--------------------VMEYCGGGSLQDIYQVT 94
Query: 204 KR----KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
+ ++A+ V + L +GL+YLH +HRD+K N+LL + +K+ADFGV+
Sbjct: 95 RGPLSELQIAY--VCRETL---KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS- 148
Query: 260 VEAQNPRDMTGET---GTLGYMAPEVL---DGKPYNRKCDVYSFGICLWEIYCCDMPYPD 313
AQ + GT +MAPEV Y+ KCD+++ GI E+ P D
Sbjct: 149 --AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
Query: 314 LSFTDVSSAVVRQNLRP----DIPRCCPSSLASIMRKCWDANPDKRP 356
L + + N P D + P ++KC +P KRP
Sbjct: 207 LHPMRALFLISKSNFPPPKLKDKEKWSP-VFHDFIKKCLTKDPKKRP 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 49/283 (17%)
Query: 87 LDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
L+ E+ G G V G+ +AVK + AI+ +E+ +
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKT--------IRLEINEAIQKQILRELDILH 54
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
K + P + F GA ++ I +EY+ GG+L K L +
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISI--------------------CMEYMDGGSLDKIL-KEV 93
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ ++ +++ +IA+ + +GL+YLH K I+HRDVK N+L+++ +K+ DFGV+ +
Sbjct: 94 QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-QLV 152
Query: 264 NPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT-----D 318
N T GT YMAPE + G Y+ K D++S G+ L E+ PYP + +
Sbjct: 153 NSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 319 VSSAVVRQNLRPDIPRCCPS-----SLASIMRKCWDANPDKRP 356
+ +V + PR PS + C +P +RP
Sbjct: 212 LLQYIVNE----PPPR-LPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I GTYG VY R G+ VA+K + + A+R E+ + ++L+HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGI--PKTALR-----EIKLLKELNHPN 59
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ K + + +V E++ L K LI+++++ L
Sbjct: 60 IIKLLDV--------FRHKGDLY------------LVFEFMDT-DLYK-LIKDRQRGLPE 97
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
++ L +GL++ HS I+HRD+K EN+L++ LK+ADFG+AR R T
Sbjct: 98 SLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157
Query: 271 ETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIY 305
T Y APE+L G K Y+ D++S G E+
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 75/258 (29%), Positives = 116/258 (44%), Gaps = 51/258 (19%)
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
R F +E+ + +L PN+ + + + + L C++ EY+
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL--------------------CMITEYME 102
Query: 193 GGTLKKFLIRNKRKK---------LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
G L +FL R++ ++ +++ +I +A +A G+ YL S VHRD+ T N L
Sbjct: 103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162
Query: 244 LDANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPE-VLDGKPYNRKCDVYSFGIC 300
+ N T+KIADFG++R R + +M+ E +L GK + DV++FG+
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVT 221
Query: 301 LWEI--YCCDMPYPDLS-----------FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKC 347
LWEI C + PY LS F D RQ P P CP SL +M C
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG----RQVYLPK-PALCPDSLYKLMLSC 276
Query: 348 WDANPDKRPVMDEVVKLL 365
W N +RP E+ L
Sbjct: 277 WRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 68/281 (24%), Positives = 126/281 (44%), Gaps = 31/281 (11%)
Query: 86 KLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
+ +I +I G++G +Y + D + +K +D V EA+ ++EV +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEAS------KKEVILL 53
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
K+ HPN+ F + L I V+EY GG L K + R
Sbjct: 54 AKMKHPNIVTFFASFQENGRLFI--------------------VMEYCDGGDLMKRINRQ 93
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN-RTLKIADFGVARVEA 262
+ + ++ + ++ GL ++H + I+HRD+K++N+ L N K+ DFG+AR
Sbjct: 94 RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
+ GT Y++PE+ +PYN K D++S G L+E+ P+ + +
Sbjct: 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ + P P L S++ + + +P RP + ++K
Sbjct: 214 ICQGYFAPISPN-FSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 38/276 (13%)
Query: 92 EIARGTYGTVYRGAYDGQD--VAVKILDW--AEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+I +G++G V++G + VA+KI+D AED + +QE+ V + D
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI----------EDIQQEITVLSQCD 60
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
P VTK+ G+ + T L I ++EYL GG+ L +
Sbjct: 61 SPYVTKYYGSYLKDTKLWI--------------------IMEYLGGGSALDLLEPGPLDE 100
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+++ ++ +GL YLHS+ +HRD+K N+LL + +K+ADFGVA
Sbjct: 101 TQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
GT +MAPEV+ Y+ K D++S GI E+ + P+ +L V + + N
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN 217
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P + L + C + P RP E++K
Sbjct: 218 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 39/270 (14%)
Query: 92 EIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I++G +G+VY + G A+K+L ++ M+ + ++A + + Q + P
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSD--MIAKNQVTNVKAERA--IMMIQG-ESP 57
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
V K + S + L +V+EYL GG + L
Sbjct: 58 YVAKLY---------------YSFQSKDYL-----YLVMEYLNGGDCASLI--KTLGGLP 95
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
Q ++ G+ LH + I+HRD+K EN+L+D LK+ DFG++R +N +
Sbjct: 96 EDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--- 152
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY----PDLSFTDVSSAVVR 325
GT Y+APE + G ++ D +S G ++E P+ PD F ++ S +
Sbjct: 153 -FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI- 210
Query: 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
N ++ C ++ + +P KR
Sbjct: 211 -NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 78/315 (24%), Positives = 134/315 (42%), Gaps = 62/315 (19%)
Query: 86 KLDIRHEIARGTYGTVY--------------RGAYDGQDVAVKILDWAEDGMVTSAEAAA 131
+L ++ ++ G +G V+ +DGQ V V + M+ +
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAV------KMLRADVTKT 59
Query: 132 IRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
R F +E+ + +L +PN+ + +G + L C++ EY+
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL--------------------CMITEYM 99
Query: 192 PGGTLKKFL----------IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
G L +FL N ++ ++ +A+ +A G+ YL S VHRD+ T N
Sbjct: 100 ENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159
Query: 242 MLLDANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPE-VLDGKPYNRKCDVYSFG 298
L+ + T+KIADFG++R R + +MA E +L GK + DV++FG
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFG 218
Query: 299 ICLWEIY--CCDMPYPDLSFTDV---SSAVVRQNLRP---DIPRCCPSSLASIMRKCWDA 350
+ LWE++ C + PY LS V + R R CPS + +M +CW
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSR 278
Query: 351 NPDKRPVMDEVVKLL 365
+ RP +++ L
Sbjct: 279 DIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 80/293 (27%), Positives = 138/293 (47%), Gaps = 29/293 (9%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKIL-DWAEDGMVTSAEAAAI 132
EI L+ + E+ +G VY+G G Q VA+K L D AE +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---------GPL 51
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK-IPSQSATSDSHNSLPSRACCVVVEYL 191
R F+ E + +L HPN+ +G L I S + SD H L R+ V
Sbjct: 52 REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDV--- 108
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
G T +++ + F + I +A G+ +L S +VH+D+ T N+L+ +K
Sbjct: 109 -GSTDDDKTVKSTLEPADF---VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164
Query: 252 IADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309
I+D G+ R V A + + G + + +M+PE + ++ D++S+G+ LWE++ +
Sbjct: 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 310 -PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
PY S DV + + + P P CP+ + ++M +CW+ P +RP ++
Sbjct: 225 QPYCGYSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-24
Identities = 79/302 (26%), Positives = 132/302 (43%), Gaps = 53/302 (17%)
Query: 89 IRHEIARGTYGTVYRGA-------YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA 141
++ E+ G +G V+ D VAVK L A + + R F++E
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---------SARQDFQREAE 59
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL- 200
+ L H ++ +F G R +V EY+ G L +FL
Sbjct: 60 LLTVLQHQHIVRFYGVCT--------------------EGRPLLMVFEYMRHGDLNRFLR 99
Query: 201 -------IRNKRK-----KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
I + +L ++ IA +A G+ YL S VHRD+ T N L+
Sbjct: 100 SHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159
Query: 249 TLKIADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
+KI DFG++R + + + + G T + +M PE + + + + D++SFG+ LWEI+
Sbjct: 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
Query: 307 C-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
P+ LS T+ + Q + PR CP + +IM+ CW P +R V+ ++ L
Sbjct: 220 YGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
Query: 366 EA 367
+A
Sbjct: 279 QA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 60/177 (33%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 185 CVVVEYLPGGTLKKFLIRN----KRKKL-AFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239
C V+EY GG L + + R A VV+ GL YLH IV+RD+K
Sbjct: 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL--------GLQYLHENKIVYRDLKL 129
Query: 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFG 298
+N+LLD +KIADFG+ + E D T GT ++APEVL Y R D + G
Sbjct: 130 DNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLG 188
Query: 299 ICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ ++E+ + P+P +V ++V N PR SIMR+ NP++R
Sbjct: 189 VLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 8e-24
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 52/290 (17%)
Query: 93 IARGTYGTVYRGAY--DG--QDVAVKIL-DWAEDGMVTSAEAAAIRASFRQEVAVWQKL- 146
I G +G V + DG D A+K + ++A F E+ V KL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD---------HRDFAGELEVLCKLG 53
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-- 204
HPN+ +GA L + +EY P G L FL +++
Sbjct: 54 HHPNIINLLGACEHRGYLYL--------------------AIEYAPHGNLLDFLRKSRVL 93
Query: 205 ------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
L+ + ++ A D+ARG+ YL K +HRD+ N+L+ N KI
Sbjct: 94 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 153
Query: 253 ADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPY 311
ADFG++R + + G + +MA E L+ Y DV+S+G+ LWEI PY
Sbjct: 154 ADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
Query: 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
++ ++ + Q R + P C + +MR+CW P +RP ++
Sbjct: 213 CGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 68/290 (23%), Positives = 136/290 (46%), Gaps = 43/290 (14%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDV----AVKILDWAEDGMVTSAEAAAIRA 134
E EL ++ + + G +GTVY+G + +G+ V A+KIL+ T+ A +
Sbjct: 6 ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN------ETTGPKANVE- 55
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
F E + +DHP++ + +G + T +V + +P G
Sbjct: 56 -FMDEALIMASMDHPHLVRLLGVCLSPT---------------------IQLVTQLMPHG 93
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
L + + + + ++++ + +A+G+ YL + +VHRD+ N+L+ + +KI D
Sbjct: 94 CLLDY-VHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITD 152
Query: 255 FGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPY 311
FG+AR+ + ++ + G + +MA E + + + + DV+S+G+ +WE+ PY
Sbjct: 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
Query: 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
+ ++ + + P P C + +M KCW + D RP E+
Sbjct: 213 DGIPTREIPDLLEKGERLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-23
Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 32/277 (11%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ RG +G VY YD G+++AVK + + D TS E A+ E+ + + L H
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EIQLLKNLRHD 64
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ ++ G L+ P + S + VEY+PGG++K L L
Sbjct: 65 RIVQYYGC------LRDPEEKKLS------------IFVEYMPGGSIKDQL--KAYGALT 104
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA-RVEA--QNPR 266
V + + +G+SYLHS IVHRD+K N+L D+ +K+ DFG + R++ +
Sbjct: 105 ENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
+ TGT +M+PEV+ G+ Y RK DV+S + E+ P+ + + Q
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ 224
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+P +P + +++ + +RP + +++
Sbjct: 225 PTKPMLPDGVSDACRDFLKQIF-VEEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 51/286 (17%)
Query: 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA 141
L++L+ + I G GTVY+ + G+ A+K++ + +R +E+
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--------TVRRQICREIE 124
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
+ + ++HPNV K M N +I V++E++ GG+L+ I
Sbjct: 125 ILRDVNHPNVVKCHD--MFDHNGEIQ------------------VLLEFMDGGSLEGTHI 164
Query: 202 RNKRKKLAFKVVIQIALDLAR----GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+ LA D+AR G++YLH + IVHRD+K N+L+++ + +KIADFGV
Sbjct: 165 -ADEQFLA---------DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214
Query: 258 ARVEAQNPRDMTGETGTLGYMAPEVL-----DGKPYNRKCDVYSFGICLWEIYCCDMPYP 312
+R+ AQ GT+ YM+PE + G D++S G+ + E Y P+
Sbjct: 215 SRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
Query: 313 DLSFTDVSS--AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
D +S + + P+ P + C P KR
Sbjct: 275 VGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRW 320
|
Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 73/291 (25%), Positives = 140/291 (48%), Gaps = 43/291 (14%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQD----VAVKILDWAEDGMVTSAEAAAIRA 134
E E K+ + + G +GTVY+G + +G+ VA+K L A TS +A
Sbjct: 6 ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKA---NK 54
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
E V +D+P+V + +G + +T ++ + +P G
Sbjct: 55 EILDEAYVMASVDNPHVCRLLGICLTST---------------------VQLITQLMPFG 93
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
L + +R + + + ++ + +A+G++YL + +VHRD+ N+L+ + +KI D
Sbjct: 94 CLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITD 152
Query: 255 FGVARVEAQNPRDMTGETGT--LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PY 311
FG+A++ + ++ E G + +MA E + + Y + DV+S+G+ +WE+ PY
Sbjct: 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
Query: 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
+ +++SS ++ + R P C + IM KCW + D RP E++
Sbjct: 213 DGIPASEISS-ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 6/172 (3%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V+EY+ GG L + R+ R A ++ GL +LH + I++RD+K +N+LL
Sbjct: 72 FFVMEYVNGGDLMFHIQRSGRFDEP--RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
D+ +KIADFG+ + E T GT Y+APE+L +PY D ++ G+ L+E
Sbjct: 130 DSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 304 IYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ P+ ++ +++ +R PR SI++ NP+KR
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-23
Identities = 84/299 (28%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 89 IRHEIARGTYGTVYRG-AYD---GQD---VAVKILDWAEDGMVTSAEAAAIRASFRQEVA 141
++ E+ G +G V+ Y+ QD VAVK L A D R F +E
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA---------RKDFHREAE 59
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
+ L H ++ KF G + L +V EY+ G L KFL
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPL--------------------IMVFEYMKHGDLNKFLR 99
Query: 202 R-----------NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250
N+ +L ++ IA +A G+ YL S+ VHRD+ T N L+ N +
Sbjct: 100 AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159
Query: 251 KIADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC- 307
KI DFG++R V + + + G T + +M PE + + + + DV+S G+ LWEI+
Sbjct: 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 219
Query: 308 DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
P+ LS +V + + + PR CP + +M CW P R + E+ LL+
Sbjct: 220 KQPWYQLSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I GTYG VY R G+ VA+K I ED V S AIR E+++ ++L+HP
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPST---AIR-----EISLLKELNHP 58
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ + + L + V E+L LKK++ + L
Sbjct: 59 NIVRLLDVVHSENKLYL--------------------VFEFL-DLDLKKYMDSSPLTGLD 97
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
++ L +G++Y HS ++HRD+K +N+L+D LK+ADFG+AR R T
Sbjct: 98 PPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
E TL Y APE+L G YS + +W I C
Sbjct: 158 HEVVTLWYRAPEILLGSRQ------YSTPVDIWSIGC 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 57/178 (32%), Positives = 93/178 (52%), Gaps = 4/178 (2%)
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
P T + LI N+ L++ ++ + +A G+ +L SK VHRD+ N+L+ + +K
Sbjct: 221 PERTRRDTLI-NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 252 IADFGVARVEAQNPRDMT-GETG-TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-D 308
I DFG+AR ++ ++ G T L +MAPE + Y DV+SFGI LWEI+
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
PYP+L + +++ R P + IM+KCW+ + RP ++V L+
Sbjct: 340 TPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-23
Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 47/286 (16%)
Query: 93 IARGTYGTVYRGAYD-GQDVAVK--ILDWAEDGMVTSAEAAAIRA--SFRQEVAVWQKLD 147
+ +G YGTVY G + GQ +AVK LD TS AA + ++EV + + L
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELD-------TSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
H N+ +++G + + I +E++PGG++ L N+
Sbjct: 61 HVNIVQYLGTCLDDNTISI--------------------FMEFVPGGSISSIL--NRFGP 98
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR------VE 261
L V + + G++YLH+ +VHRD+K N++L N +K+ DFG AR +
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ + GT +MAPEV++ Y RK D++S G ++E+ P L+ D +
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK---PPLASMDRLA 215
Query: 322 AVV----RQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
A+ + L P +P ++ + C + +RP ++++
Sbjct: 216 AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 51/279 (18%)
Query: 87 LDIRHEIARGTYGTV----YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV 142
+ + G++G V ++G+ G+ A+KIL A+ +V + + E +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGS--GKYYALKILSKAK--IVKLKQVEHVLN----EKRI 54
Query: 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
Q + HP + G+ +NL + V+EY+PGG L L +
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYL--------------------VMEYVPGGELFSHLRK 94
Query: 203 NKRKKLAFKV------VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ R F Q+ L L YLHS IV+RD+K EN+LLD++ +KI DFG
Sbjct: 95 SGR----FPEPVARFYAAQVVL----ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG 146
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
A+ R T GT Y+APE++ K Y + D ++ GI ++E+ P+ D +
Sbjct: 147 FAKRVK--GRTYT-LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ ++ +R P ++R + KR
Sbjct: 204 IQIYEKILEGKVR--FPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-23
Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 41/300 (13%)
Query: 84 LAKLDIRHEIARGTYGTVYRGAYD--GQDVAVKILDW--AEDGMVTSAEAAAIRASFRQE 139
KL+ I +G++G V++G + Q VA+KI+D AED + +QE
Sbjct: 6 FTKLE---RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI----------EDIQQE 52
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+ V + D P VTK+ G+ + T L I ++EYL GG+
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWI--------------------IMEYLGGGSALDL 92
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
L + +++ ++ +GL YLHS+ +HRD+K N+LL +K+ADFGVA
Sbjct: 93 LRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
GT +MAPEV+ Y+ K D++S GI E+ + P D+ V
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV 209
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPE 379
+ + N P + + C + +P RP E++K V +K + E
Sbjct: 210 LFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-23
Identities = 82/293 (27%), Positives = 140/293 (47%), Gaps = 46/293 (15%)
Query: 92 EIARGTYGTVYRG-AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
EI G +G V G A+ G A ++ T E + F QEV +++L+HPN
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDE----QLLFLQEVQPYRELNHPN 56
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
V + +G + + +V+E+ P G LK +L R+ R +A
Sbjct: 57 VLQCLGQCIESIPY--------------------LLVLEFCPLGDLKNYL-RSNRGMVAQ 95
Query: 211 ----KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR 266
V+ ++A ++A GL +LH +H D+ N L A+ ++KI D+G+A +
Sbjct: 96 MAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155
Query: 267 DMTGETGT--LGYMAPEVLDG-------KPYNRKCDVYSFGICLWEIY-CCDMPYPDLSF 316
+T + L ++APE+++ K +K +++S G+ +WE++ D PYPDLS
Sbjct: 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215
Query: 317 TDVSSAVVR-QNLRPDIPRC---CPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
V VVR Q+++ P+ +M+ CW +P+ RP +EV +LL
Sbjct: 216 EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-23
Identities = 75/282 (26%), Positives = 123/282 (43%), Gaps = 38/282 (13%)
Query: 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVK---ILDWAEDGMVTSAEAAAIRASFRQ 138
LA I +I RG + VYR DG VA+K I D + A RA +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD---------AKARADCIK 51
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E+ + ++L+HPNV K+ + + L I V+E G L +
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNI--------------------VLELADAGDLSR 91
Query: 199 FL--IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ + +++ + K V + + L L ++HS+ ++HRD+K N+ + A +K+ D G
Sbjct: 92 MIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP-YPDLS 315
+ R + GT YM+PE + YN K D++S G L+E+ P Y D
Sbjct: 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSS-LASIMRKCWDANPDKRP 356
+ Q P +P S L ++ C + +P+KRP
Sbjct: 212 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-23
Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 3/161 (1%)
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
L + +I + +ARG+ +L S+ +HRD+ N+LL N +KI DFG+AR ++P
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 268 MTGETG--TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAVV 324
+ + L +MAPE + K Y + DV+SFG+ LWEI+ PYP + + +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 325 RQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
+ R P + IM CW +P +RP +V++L
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-23
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 40/219 (18%)
Query: 92 EIARGTYGTVY--RGAYDGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+I GTYG VY R G+ VA+K LD +G+ ++A IR E+++ ++L+
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA----IR-----EISLLKELN 57
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
HPN+ K + I ++ N L +V E+L LKKF+ +
Sbjct: 58 HPNIVKLLDV--------IHTE-------NKL-----YLVFEFL-HQDLKKFMDASPLSG 96
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ ++ L +GL++ HS ++HRD+K +N+L++ +K+ADFG+AR R
Sbjct: 97 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
T E TL Y APE+L G C YS + +W + C
Sbjct: 157 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGC 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 8e-23
Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 57/283 (20%)
Query: 111 VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170
VAVKIL A A R F +EV + +L PN+ + +G + L
Sbjct: 49 VAVKILR-------PDANKNA-RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL------ 94
Query: 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK-----------------LAFKVV 213
C++ EY+ G L +FL + +++ +
Sbjct: 95 --------------CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL 140
Query: 214 IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR-VEAQNPRDMTGET 272
+ +AL +A G+ YL S VHRD+ T N L+ N T+KIADFG++R + A + + G
Sbjct: 141 LHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRA 200
Query: 273 G-TLGYMAPE-VLDGKPYNRKCDVYSFGICLWEIY--CCDMPYPDLSFTDV---SSAVVR 325
+ +MA E +L GK + DV++FG+ LWEI C + PY +L+ V + R
Sbjct: 201 VLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFR 259
Query: 326 QNLRPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
R P CP L +M +CW + +RP ++ L
Sbjct: 260 DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 32/277 (11%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ +G +G VY YD G+++AVK + + + TS E A+ E+ + + L H
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLKNLLHE 64
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ ++ G L+ P R + +E++PGG++K L L
Sbjct: 65 RIVQYYGC------LRDP------------MERTLSIFMEHMPGGSIKDQL--KSYGALT 104
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR---VEAQNPR 266
V + + G+SYLHS IVHRD+K N+L D+ +K+ DFG ++ +
Sbjct: 105 ENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT 164
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
M TGT +M+PEV+ G+ Y RK D++S G + E+ P+ + + Q
Sbjct: 165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 224
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P +P +++ + RP DE+++
Sbjct: 225 PTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 77/228 (33%), Positives = 104/228 (45%), Gaps = 39/228 (17%)
Query: 83 ELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKI--LDWAEDGMVTSAEAAAIRASFR 137
E KL + I GTYG VYR A D G+ VA+K +D DG+ S S R
Sbjct: 8 EFEKL---NRIGEGTYGIVYR-ARDTTSGEIVALKKVRMDNERDGIPIS--------SLR 55
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
E+ + L HPN+ LK + +S+ +V+EY
Sbjct: 56 -EITLLLNLRHPNIV----------ELK---EVVVGKHLDSI-----FLVMEYCEQDLAS 96
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
L+ N + V + L L RGL YLH I+HRD+K N+LL LKIADFG+
Sbjct: 97 --LLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGL 154
Query: 258 ARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEI 304
AR + MT + TL Y APE+L G Y D+++ G L E+
Sbjct: 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 46/221 (20%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVK--ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
I G +G V++ A D G+ VA+K L E G+ A +R E+ Q
Sbjct: 8 IGEGAHGIVFK-AKDRETGETVALKKVALRRLEGGIPNQA----LR-----EIKALQACQ 57
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV-EYLPGGTLKKFLIRNKRK 206
HP V K + P + V+V EY+P + ++R++ +
Sbjct: 58 HPYVVKLLDVF---------------------PHGSGFVLVMEYMPSDLSE--VLRDEER 94
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV-EAQNP 265
L V L +G++Y+H+ I+HRD+K N+L+ A+ LKIADFG+AR+ + P
Sbjct: 95 PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154
Query: 266 RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
R + + T Y APE+L G RK Y G+ LW + C
Sbjct: 155 RLYSHQVATRWYRAPELLYGA---RK---YDPGVDLWAVGC 189
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-22
Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 21/220 (9%)
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
R+E + K+ HPN+ F +S +D H +V+EY GG L
Sbjct: 46 RKEAVLLAKMKHPNIVAF-------------KESFEADGH-------LYIVMEYCDGGDL 85
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ + + K ++Q + + G+ ++H K ++HRD+K++N+ L N +K+ DFG
Sbjct: 86 MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFG 145
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
AR+ GT Y+ PE+ + PYN K D++S G L+E+ P+ S+
Sbjct: 146 SARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
++ V + + +P +P L S++++ + NP RP
Sbjct: 206 KNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRP 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 7/209 (3%)
Query: 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARG 223
L+I S SD S R + +K L + + L ++ +ARG
Sbjct: 192 LEIKEASKYSDIQRSNYDRPASY--KGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARG 249
Query: 224 LSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAP 280
+ +L SK VHRD+ N+LL + +KI DFG+AR + + + + T + +MAP
Sbjct: 250 MEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAP 308
Query: 281 EVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSS 339
E + Y DV+S+GI LWEI+ PYP + ++ R P
Sbjct: 309 ESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQE 368
Query: 340 LASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+ IM KCW++ P+KRP + ++E++
Sbjct: 369 VYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 3/164 (1%)
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
+K L + +I + +A+G+ +L S+ +HRD+ N+LL N +KI DFG+AR ++
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 265 PRDMTGETG--TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSS 321
P + L +MAPE + + Y + DV+SFG+ LWEI+ PYP + +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
+++ R P + M CW P +RP E+V+ L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-22
Identities = 91/307 (29%), Positives = 133/307 (43%), Gaps = 53/307 (17%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYR--GAYDGQDVAVKILDWAEDGMVTSAEAA 130
P ++ WEI I +GTYG V++ +G AVKILD D
Sbjct: 13 FPDPSDTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--------- 56
Query: 131 AIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
I E + + L DHPNV KF G + D +V+E
Sbjct: 57 -IDEEIEAEYNILKALSDHPNVVKFYG-------MYYKKDVKNGDQ--------LWLVLE 100
Query: 190 YLPGGTL----KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
GG++ K FL R +R + ++ I + GL +LH +HRDVK N+LL
Sbjct: 101 LCNGGSVTDLVKGFLKRGER--MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT 158
Query: 246 ANRTLKIADFGV-ARVEAQNPRDMTGETGTLGYMAPEV------LDGKPYNRKCDVYSFG 298
+K+ DFGV A++ + R T GT +MAPEV LD Y+ +CDV+S G
Sbjct: 159 TEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAPEVIACEQQLDST-YDARCDVWSLG 216
Query: 299 ICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRP 356
I E+ D P DL + R N P + P + +RKC + +KRP
Sbjct: 217 ITAIELGDGDPPLADLHPMRALFKIPR-NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275
Query: 357 VMDEVVK 363
+ ++++
Sbjct: 276 TVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 70/290 (24%), Positives = 123/290 (42%), Gaps = 43/290 (14%)
Query: 96 GTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
GT+G ++ G ++V VK V + QE + L H
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVK--------TVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR------N 203
N+ + D V+ Y+ G LK FL + N
Sbjct: 69 NILPILHVC-------------IEDGEPPF------VLYPYMNWGNLKLFLQQCRLGEAN 109
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ L+ + ++ +A+ +A G+SYLH + ++H+D+ N ++D +KI D ++R
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 264 NPRDMTG--ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVS 320
G E + +MA E L K Y+ DV+SFG+ LWE+ PY ++ ++
Sbjct: 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM- 228
Query: 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370
+A ++ R P CP L ++M CW +P++RP ++V+ L +
Sbjct: 229 AAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 33/223 (14%)
Query: 86 KLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
K ++ + G YG V R G+ VA+K S + ++ + +EV V
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-------KFKESEDDEDVKKTALREVKVL 54
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
++L H N+ A L + V EY+ L+ L+
Sbjct: 55 RQLRHENIVNLKEAFRRKGRLYL--------------------VFEYVERTLLE--LLEA 92
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR-VEA 262
L V L + ++Y HS I+HRD+K EN+L+ + LK+ DFG AR + A
Sbjct: 93 SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEI 304
+ +T T Y APE+L G Y + DV++ G + E+
Sbjct: 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-22
Identities = 55/234 (23%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC-VVVEYL 191
R R+EVAV + HPN+ ++ S +V++Y
Sbjct: 43 REESRKEVAVLSNMKHPNIVQY---------------------QESFEENGNLYIVMDYC 81
Query: 192 PGGTLKKFLIRNKRKKLAF--KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249
GG L K + N ++ + F ++ + + L ++H + I+HRD+K++N+ L + T
Sbjct: 82 EGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT 139
Query: 250 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309
+K+ DFG+ARV GT Y++PE+ + +PYN K D+++ G L+E+
Sbjct: 140 IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ + ++ ++R + P + L +++ + + NP RP ++ +++
Sbjct: 200 AFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 7e-22
Identities = 77/302 (25%), Positives = 129/302 (42%), Gaps = 59/302 (19%)
Query: 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDV--AVKILDWAEDGMVTSAEAAAIRA 134
+ WEI E+ G +G VY+ + + A KI+ E+
Sbjct: 4 NDIWEII-------GELGDGAFGKVYKAQHKETGLFAAAKIIQ---------IESEEELE 47
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
F E+ + + HPN+ A L I ++E+ GG
Sbjct: 48 DFMVEIDILSECKHPNIVGLYEAYFYENKLWI--------------------LIEFCDGG 87
Query: 195 TLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
L ++ +R + + V + L+ L++LHS ++HRD+K N+LL + +K+
Sbjct: 88 ALDSIMLELERGLTEPQIRYVCRQMLE---ALNFLHSHKVIHRDLKAGNILLTLDGDVKL 144
Query: 253 ADFGVARVEAQNPRDMTGET---GTLGYMAPEVL-----DGKPYNRKCDVYSFGICLWEI 304
ADFGV+ A+N + GT +MAPEV+ PY+ K D++S GI L E+
Sbjct: 145 ADFGVS---AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRP---DIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
+ P+ +L+ V +++ P D P SS ++ C +PD RP E+
Sbjct: 202 AQMEPPHHELNPMRVLLKILKSE--PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
Query: 362 VK 363
+K
Sbjct: 260 LK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 52/163 (31%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR--------VEAQN 264
+++ + +A+G+ +L SK +HRDV N+LL R KI DFG+AR V N
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273
Query: 265 PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAV 323
R + +MAPE + Y + DV+S+GI LWEI+ PYP + +
Sbjct: 274 ARL------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327
Query: 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
V++ + P P + SIM+ CW+ P +RP ++ +L++
Sbjct: 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 34/88 (38%), Positives = 53/88 (60%), Gaps = 1/88 (1%)
Query: 224 LSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL 283
YLH++ I++RD+K EN+LLD+N +K+ DFG A+ + T GT Y+APE++
Sbjct: 106 FEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEII 164
Query: 284 DGKPYNRKCDVYSFGICLWEIYCCDMPY 311
K Y+ D +S GI L+E+ P+
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 73/291 (25%), Positives = 137/291 (47%), Gaps = 43/291 (14%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQD----VAVKILDWAEDGMVTSAEAAAIRA 134
E EL K+ + + G +GTVY+G + DG++ VA+K+L E+ TS +A
Sbjct: 6 ETELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVL--REN---TSPKA---NK 54
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
E V + P V + +G + +T +V + +P G
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGICLTST---------------------VQLVTQLMPYG 93
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
L + +R + ++ + ++ + +A+G+SYL +VHRD+ N+L+ + +KI D
Sbjct: 94 CLLDY-VRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITD 152
Query: 255 FGVARVEAQNPRDMTGETGT--LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PY 311
FG+AR+ + + + G + +MA E + + + + DV+S+G+ +WE+ PY
Sbjct: 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212
Query: 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
+ ++ ++ + R P C + IM KCW + + RP E+V
Sbjct: 213 DGIPAREIPD-LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 82/257 (31%), Positives = 113/257 (43%), Gaps = 48/257 (18%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAE 128
E L T+ WEI I +GTYG VY+ DG AVKILD D
Sbjct: 15 ESLGDPTDTWEI-------IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD------- 60
Query: 129 AAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
+ E + Q L +HPNV KF G + L +V
Sbjct: 61 ---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA---------------DKLVGGQLWLV 102
Query: 188 VEYLPGGT----LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
+E GG+ +K LI +R L ++ I GL +LH+ I+HRDVK N+L
Sbjct: 103 LELCNGGSVTELVKGLLICGQR--LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160
Query: 244 LDANRTLKIADFGV-ARVEAQNPRDMTGETGTLGYMAPEVLDGK-----PYNRKCDVYSF 297
L +K+ DFGV A++ + R T GT +MAPEV+ + Y+ +CDV+S
Sbjct: 161 LTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219
Query: 298 GICLWEIYCCDMPYPDL 314
GI E+ D P D+
Sbjct: 220 GITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 38/213 (17%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVK--ILDWAEDGM-VTSAEAAAIRASFRQEVAVWQKL 146
I GTYG VYR A D G+ VA+K ++ ++G +TS +R E+ + KL
Sbjct: 13 IEEGTYGVVYR-ARDKKTGEIVALKKLKMEKEKEGFPITS-----LR-----EINILLKL 61
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
HPN+ +G+ KI +V+EY+ LK L+ ++
Sbjct: 62 QHPNIVTVKEVVVGSNLDKI------------------YMVMEYVEH-DLKS-LMETMKQ 101
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR 266
V + L L G+++LH I+HRD+KT N+LL+ LKI DFG+AR +
Sbjct: 102 PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161
Query: 267 DMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFG 298
T TL Y APE+L G Y+ D++S G
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 186 VVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLARGLSYLHSKT 231
+ +EY P G L FL +++ L+ + ++ A D+ARG+ YL K
Sbjct: 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144
Query: 232 IVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRK 291
+HRD+ N+L+ N KIADFG++R + + G + +MA E L+ Y
Sbjct: 145 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTN 203
Query: 292 CDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
DV+S+G+ LWEI PY ++ ++ + Q R + P C + +MR+CW
Sbjct: 204 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWRE 262
Query: 351 NPDKRPVMDEVV----KLLEA----VNTS 371
P +RP +++ ++LE VNT+
Sbjct: 263 KPYERPSFAQILVSLNRMLEERKTYVNTT 291
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 60/179 (33%), Positives = 89/179 (49%), Gaps = 24/179 (13%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V+EYL GG L F I++ + A ++ GL +LH K I++RD+K +N+LLD
Sbjct: 74 VMEYLNGGDLM-FHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 247 NRTLKIADFGVARVEAQNPRDMTGET------GTLGYMAPEVLDGKPYNRKCDVYSFGIC 300
+ +KIADFG+ + M GE GT Y+APE+L G+ YN D +SFG+
Sbjct: 132 DGHIKIADFGMCKEN------MNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVL 185
Query: 301 LWEIYCCDMPY----PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
L+E+ P+ D F + N RP PR + K ++ +P KR
Sbjct: 186 LYEMLIGQSPFHGEDEDELFDSI------LNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 4e-21
Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 32/277 (11%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ +G +G VY YD G+++A K + + + TS E +A+ E+ + + L H
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQHE 64
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ ++ G L+ ++ + + +EY+PGG++K L L
Sbjct: 65 RIVQYYGC------LRDRAE------------KTLTIFMEYMPGGSVKDQL--KAYGALT 104
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR---VEAQNPR 266
V + + G+SYLHS IVHRD+K N+L D+ +K+ DFG ++ +
Sbjct: 105 ESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
+ TGT +M+PEV+ G+ Y RK DV+S G + E+ P+ + + Q
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ 224
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P +P + C RP +E+++
Sbjct: 225 PTNPQLPSHISEHARDFLG-CIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-21
Identities = 72/298 (24%), Positives = 123/298 (41%), Gaps = 49/298 (16%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
E++ + I + G +G + RG +++ V I + + + R F
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAI------HTLRAGCSDKQRRGFL 54
Query: 138 QEVAVWQKLDHPNVTKFIGA-SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
E + DH N+ + G + G T + +V EY+ G L
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRGNTMM---------------------IVTEYMSNGAL 93
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
FL R +L ++ + LA G+ YL VH+ + +L++++ KI+ F
Sbjct: 94 DSFL-RKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 257 VARVEAQNPRD--------MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC- 307
+ D M+G++ L + APE + ++ DV+SFGI +WE+
Sbjct: 153 ------RLQEDKSEAIYTTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG 205
Query: 308 DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
+ PY D+S DV A V R PR CP+ L +M CW +RP ++ +L
Sbjct: 206 ERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 40/221 (18%)
Query: 92 EIARGTYGTVYRGAY--DGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+I GTYG VY+G GQ VA+K L+ E+G+ ++A IR E+++ ++L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA----IR-----EISLLKELQ 57
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSH---NSLPSRACCVVVEYLPGGTLKKFLIRNK 204
HPN+ M + L + + + D +SLP +Y+ +K +L
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKG------QYMDAELVKSYLY--- 108
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
QI G+ + HS+ ++HRD+K +N+L+D +K+ADFG+AR
Sbjct: 109 ----------QILQ----GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154
Query: 265 PRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEI 304
R T E TL Y APEVL G P Y+ D++S G E+
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-21
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 41/280 (14%)
Query: 96 GTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIR---ASFRQEVA----VWQKLDH 148
G +G VY+ ++ +L E + A R S V+ + ++L H
Sbjct: 11 GAFGCVYKVRK--KNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
PN+ ++ + L I V++ + G L + K KK
Sbjct: 69 PNIVRYYKTFLENDRLYI--------------------VMDLIEGAPLGEHFNSLKEKKQ 108
Query: 209 AF------KVVIQIALDLARGLSYLH-SKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
F + +Q+ L L YLH K IVHRD+ N++L + + I DFG+A+ +
Sbjct: 109 RFTEERIWNIFVQMVL----ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ +T GT+ Y PE++ +PY K DV++FG L+++ P+ + +++
Sbjct: 165 QPESK-LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT 223
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
+V P + ++ C + + RP + +V
Sbjct: 224 KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 32/279 (11%)
Query: 84 LAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA 141
LA I +I RG + VYR D + VA+K + E + A+A R +E+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE---MMDAKA---RQDCVKEID 54
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
+ ++L+HPNV K++ + + L I V+E G L + +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNI--------------------VLELADAGDLSQMIK 94
Query: 202 RNKRKK--LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
K++K + + V + + L + ++HS+ ++HRD+K N+ + A +K+ D G+ R
Sbjct: 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
+ GT YM+PE + YN K D++S G L+E+ P+
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214
Query: 320 S-SAVVRQNLRPDIPRCCPSS-LASIMRKCWDANPDKRP 356
S + Q P +P S L ++ C +PD+RP
Sbjct: 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 92 EIARGTYGTVYRGA--YDGQDVAVK--ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+I GTYGTV++ + VA+K LD ++G+ +SA R E+ + ++L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--------LR-EICLLKELK 57
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
H N+ + L + V EY LKK+ +
Sbjct: 58 HKNIVRLYDVLHSDKKLTL--------------------VFEYC-DQDLKKYF-DSCNGD 95
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ ++V L +GL++ HS ++HRD+K +N+L++ N LK+ADFG+AR R
Sbjct: 96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155
Query: 268 MTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEI 304
+ E TL Y P+VL G K Y+ D++S G E+
Sbjct: 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 4/171 (2%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
C V+EY+ GG L F ++ + + ++ L YLHS IV+RD+K EN++L
Sbjct: 71 CFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
D + +KI DFG+ + + M GT Y+APEVL+ Y R D + G+ ++E+
Sbjct: 129 DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
C +P+ + + ++ ++++ PR + S++ +P+KR
Sbjct: 189 MCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 38/268 (14%)
Query: 93 IARGTYGTV--YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +GT+G V R G+ A+KIL ++ ++ E A R V Q HP
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESR----VLQNTRHP- 55
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---RKK 207
F+ T LK Q+ H+ L C V+EY GG L L R + ++
Sbjct: 56 ---FL------TALKYAFQT-----HDRL-----CFVMEYANGGELFFHLSRERVFTEER 96
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
F ++ L YLHS+ +V+RD+K EN++LD + +KI DFG+ + +
Sbjct: 97 ARF-----YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
M GT Y+APEVL+ Y R D + G+ ++E+ C +P+ + + ++ +
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKR 355
+R PR S++ +P +R
Sbjct: 212 IR--FPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 53/290 (18%)
Query: 87 LDIRHE--IARGTYGTVYRGAY--DGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEV 140
DI+++ + G GTVY+ + + +AVK+ LD +T ++ E+
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD------IT----VELQKQIMSEL 50
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
+ K D P + F GA + I C E++ GG+L +
Sbjct: 51 EILYKCDSPYIIGFYGAFFVENRISI------------------CT--EFMDGGSLDVY- 89
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+K+ V+ +IA+ + +GL+YL S I+HRDVK NML++ +K+ DFGV+
Sbjct: 90 -----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST- 143
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
+ N T GT YMAPE + G+ Y DV+S GI E+ PYP + +
Sbjct: 144 QLVNSIAKT-YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI-QKNQG 201
Query: 321 SAVVRQNLRPDIPRCCP--------SSLASIMRKCWDANPDKRPVMDEVV 362
S + Q L+ + P + +C P +RP + ++
Sbjct: 202 SLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 96 GTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153
G GTV + DG+ AVK++D +GM +EA RA EV D ++
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVDM--EGM---SEADKNRAQ--AEVCCLLNCDFFSI-- 93
Query: 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFK-- 211
+K A D N +V++Y G L++ + + F+
Sbjct: 94 ----------VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143
Query: 212 ----VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ IQ+ L + ++HSK ++HRD+K+ N+LL +N +K+ DFG +++ A D
Sbjct: 144 EAGLLFIQVLL----AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 268 MTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
G T GT Y+APE+ KPY++K D++S G+ L+E+ P+ + +V +
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259
Query: 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
P P P + I+ ++P +RP
Sbjct: 260 GRYDPLPPSISP-EMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 44/285 (15%)
Query: 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-P 149
+ GTYG VY+G + GQ A+K++D VT E I+ QE+ + +K H
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD------VTGDEEEEIK----QEINMLKKYSHHR 63
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ + GA + + Q +V+E+ G++ + K L
Sbjct: 64 NIATYYGAFIKKNPPGMDDQ--------------LWLVMEFCGAGSVTDLIKNTKGNTLK 109
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
+ + I ++ RGLS+LH ++HRD+K +N+LL N +K+ DFGV+ +
Sbjct: 110 EEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169
Query: 270 GETGTLGYMAPEVL--DGKP---YNRKCDVYSFGICLWEIY-----CCDMPYPDLSFTDV 319
GT +MAPEV+ D P Y+ K D++S GI E+ CDM +P +
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALF-- 226
Query: 320 SSAVVRQNLRPDI-PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++ +N P + + S + C N +RP ++++K
Sbjct: 227 ---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 70/226 (30%), Positives = 105/226 (46%), Gaps = 40/226 (17%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +GT+G V R G+ A+KIL ++ ++ E A R V Q HP
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILK--KEVIIAKDEVAHTLTESR----VLQNTRHP- 55
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-----R 205
F+ T LK Q+ H+ L C V+EY GG L L R + R
Sbjct: 56 ---FL------TALKYSFQT-----HDRL-----CFVMEYANGGELFFHLSRERVFSEDR 96
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ + I AL YLHS +V+RD+K EN++LD + +KI DFG+ + +
Sbjct: 97 ARF-YGAEIVSALG------YLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149
Query: 266 RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
M GT Y+APEVL+ Y R D + G+ ++E+ C +P+
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 54/165 (32%), Positives = 78/165 (47%), Gaps = 21/165 (12%)
Query: 196 LKKFLIRNKRK---KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
L +L + R A + QI GL YLH++ I+HRDVKTEN+ ++ + I
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQIL----EGLRYLHAQRIIHRDVKTENIFINDVDQVCI 198
Query: 253 ADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYP 312
D G A+ P + G GT+ APEVL YN K D++S GI L+E+ + YP
Sbjct: 199 GDLGAAQFPVVAPAFL-GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM----LAYP 253
Query: 313 DLSFTDVSSAVVRQNLRPDIP-RCCPSSLASIMRKCWDANPDKRP 356
F D S P+ + C S L I+ +P++ P
Sbjct: 254 STIFEDPPST-------PEEYVKSCHSHLLKIISTL-KVHPEEFP 290
|
Length = 357 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 45/129 (34%), Positives = 75/129 (58%), Gaps = 1/129 (0%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
C+V+ + GG LK + + L + VI + + G+ +LHS IV+RD+K EN+LL
Sbjct: 69 CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL 128
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
D +++D G+A VE ++ + +T GT GYMAPE+L +PY+ D ++ G ++E+
Sbjct: 129 DDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
Query: 305 YCCDMPYPD 313
P+ D
Sbjct: 188 VAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-19
Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 52/303 (17%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKI--LDWAEDGMVTSAE 128
L R+ + + EL + I GTYG VY R G+ A+K+ L+ ED V
Sbjct: 2 LSRRNPQEDFELIQ-----RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV--- 53
Query: 129 AAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
+QE+ + + H N+ + G+ + L I +
Sbjct: 54 --------QQEIIMMKDCKHSNIVAYFGSYLRRDKLWI--------------------CM 85
Query: 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
E+ GG+L+ I + L+ + ++ + +GL YLHSK +HRD+K N+LL N
Sbjct: 86 EFCGGGSLQD--IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG 143
Query: 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV--LDGK-PYNRKCDVYSFGICLWEIY 305
+K+ADFGV+ GT +MAPEV ++ K YN+ CD+++ GI E+
Sbjct: 144 HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203
Query: 306 CCDMPYPDLSFTDVSSAVVRQNLRPDIPRC-----CPSSLASIMRKCWDANPDKRPVMDE 360
P DL + + N +P P+ +S ++ NP KRP ++
Sbjct: 204 ELQPPMFDLHPMRALFLMTKSNFQP--PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK 261
Query: 361 VVK 363
+++
Sbjct: 262 LLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 63/298 (21%)
Query: 88 DIRHEIARGTYGTVYRGAYD--GQDVAVKILDWA-----EDGMVTSAEAAAIRASFRQEV 140
+I E+ G +G VY+ G A K+++ ED MV E+
Sbjct: 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV--------------EI 60
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
+ +HP + K +GA L I ++E+ PGG + +
Sbjct: 61 EILATCNHPYIVKLLGAFYWDGKLWI--------------------MIEFCPGGAVDAIM 100
Query: 201 IRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
+ R + +V+ + L+ L YLHS I+HRD+K N+LL + +K+ADFGV+
Sbjct: 101 LELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
Query: 259 RVEAQNPRDMTGETGTLGYMAPEV-----LDGKPYNRKCDVYSFGICLWEIYCCDMPYPD 313
+ + GT +MAPEV + PY+ K D++S GI L E+ + P+ +
Sbjct: 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217
Query: 314 LSFTDVSSAVVRQNLRPDIPRC-CPSSLA----SIMRKCWDANPDKRPVMDEVVKLLE 366
L+ V + + + P PS + ++ D +P+ RP +LLE
Sbjct: 218 LNPMRVLLKIAKS----EPPTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 39/217 (17%)
Query: 96 GTYGTVYRG--AYDGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151
GTY TVY+G G+ VA+K LD AE+G + AIR E+++ ++L H N+
Sbjct: 11 GTYATVYKGRNRTTGEIVALKEIHLD-AEEG----TPSTAIR-----EISLMKELKHENI 60
Query: 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV-EYLPGGTLKKFL-IRNKRKKLA 209
+ H+ + + ++V EY+ LKK++ R L
Sbjct: 61 VRL---------------------HDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALD 98
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
V L +G+++ H ++HRD+K +N+L++ LK+ADFG+AR +
Sbjct: 99 PNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158
Query: 270 GETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIY 305
E TL Y AP+VL G + Y+ D++S G + E+
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 40/277 (14%)
Query: 88 DIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+I E+ G +G VY+ Q+ +L A+ V ++ + E+ + D
Sbjct: 8 EIIGELGDGAFGKVYKA----QNKETGVLAAAK---VIDTKSEEELEDYMVEIDILASCD 60
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-- 205
HPN+ K + A NL I ++E+ GG + ++ +R
Sbjct: 61 HPNIVKLLDAFYYENNLWI--------------------LIEFCAGGAVDAVMLELERPL 100
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ +VV + L+ L+YLH I+HRD+K N+L + +K+ADFGV+ +
Sbjct: 101 TEPQIRVVCKQTLE---ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157
Query: 266 RDMTGETGTLGYMAPEVL-----DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
+ GT +MAPEV+ +PY+ K DV+S GI L E+ + P+ +L+ V
Sbjct: 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL 217
Query: 321 SAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKR 355
+ + P + P S ++KC + N D R
Sbjct: 218 LKIAKSE-PPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 7e-19
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 89 IRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ I G YG V A D G+ VA+K + V A R R E+ + +
Sbjct: 4 LLKPIGSGAYGVVCS-AVDKRTGRKVAIKKI-----SNVFDDLIDAKRI-LR-EIKLLRH 55
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT-LKKFLIRNK 204
L H N+ + ++ P + N + +V E + T L K +I++
Sbjct: 56 LRHENIIGLL-------DILRPPSP---EDFNDV-----YIVTELME--TDLHK-VIKSP 97
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV---E 261
+ L + + RGL YLHS ++HRD+K N+L+++N LKI DFG+AR +
Sbjct: 98 QP-LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 262 AQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFG 298
+T T Y APE+ L Y + D++S G
Sbjct: 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 66/236 (27%), Positives = 110/236 (46%), Gaps = 48/236 (20%)
Query: 85 AKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQE-- 139
+ LD +I G+ G V A D G+ VAVK +D +R R+E
Sbjct: 19 SYLDNFVKIGEGSTGIVCI-ATDKSTGRQVAVKKMD--------------LRKQQRRELL 63
Query: 140 ---VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
V + + HPN+ + S+ L VV+E+L GG L
Sbjct: 64 FNEVVIMRDYQHPNIVEMY------------------SSY--LVGDELWVVMEFLEGGAL 103
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ + + V L + LS+LH++ ++HRD+K++++LL ++ +K++DFG
Sbjct: 104 TDIVTHTRMNEEQIATVCLAVL---KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFG 160
Query: 257 -VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
A+V + PR + GT +MAPEV+ PY + D++S GI + E+ + PY
Sbjct: 161 FCAQVSKEVPRRKS-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 8e-19
Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 92 EIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+I +G GTVY GQ+VA+K ++ + + E+ V ++ HP
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---------KELIINEILVMRENKHP 76
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ ++ DS+ L VV+EYL GG+L + +
Sbjct: 77 NIVNYL------------------DSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
V + L + L +LHS ++HRD+K++N+LL + ++K+ DFG +
Sbjct: 117 IAAVCRECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA-VVRQNL 328
GT +MAPEV+ K Y K D++S GI E+ + PY L+ + + ++ N
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNG 231
Query: 329 RPDIPRCCPSSLASIMR----KCWDANPDKRPVMDEVVK 363
P++ P L++I R +C + + +KR E+++
Sbjct: 232 TPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 69/290 (23%), Positives = 131/290 (45%), Gaps = 43/290 (14%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
E EL KL + + G +GTV++G + +G + + + + + + + R +F Q
Sbjct: 6 ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKIPV-------AIKTIQDRSGRQTF-Q 54
Query: 139 EVA----VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
E+ LDH + + +G P + +V + P G
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC---------------------PGASLQLVTQLSPLG 93
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
+L +R R L + ++ + +A+G+ YL +VHR++ N+LL ++ ++IAD
Sbjct: 94 SLLDH-VRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 255 FGVAR-VEAQNPRDMTGETGT-LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PY 311
FGVA + + + E T + +MA E + Y + DV+S+G+ +WE+ PY
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
Query: 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
+ +V ++ + R P+ C + +M KCW + + RP E+
Sbjct: 213 AGMRPHEVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 55/172 (31%), Positives = 91/172 (52%), Gaps = 10/172 (5%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V+EY+ GG L + I+ K FK + A ++A GL +LHSK I++RD+K +N++L
Sbjct: 79 VMEYVNGGDLM-YHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
DA +KIADFG+ + E T GT Y+APE++ +PY + D ++FG+ L+E
Sbjct: 135 DAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
Query: 304 IYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ P+ ++ +++ N P+ SI + +P KR
Sbjct: 194 MLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 59/175 (33%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V+EYL GG L F I++ K A ++ GL +LHSK IV+RD+K +N+LLD
Sbjct: 74 VMEYLNGGDLM-FHIQSCHK-FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 247 NRTLKIADFGVARVEAQNPRDMTGET------GTLGYMAPEVLDGKPYNRKCDVYSFGIC 300
+ +KIADFG+ + +M G+ GT Y+APE+L G+ YN D +SFG+
Sbjct: 132 DGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVL 185
Query: 301 LWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
L+E+ P+ ++ ++ N P PR I+ K + P++R
Sbjct: 186 LYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 68/231 (29%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 96 GTYGTVYRGAY--DGQDVAVK--ILDWAEDGM-VTSAEAAAIRASFRQEVAVWQKLDHPN 150
GT+G VY+ G+ VA+K ++ +DG +T A+R E+ + +KL HPN
Sbjct: 19 GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT-----ALR-----EIKILKKLKHPN 68
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY----LPGGTLKKFLIRNKRK 206
V I ++ + + S+ +V Y L G L+ N
Sbjct: 69 VVPLI-------DMAVERPDKSKRKRGSV-----YMVTPYMDHDLSG------LLENPSV 110
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV---EAQ 263
KL + L L G++YLH I+HRD+K N+L+D LKIADFG+AR
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 264 NP--------RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIY 305
NP R T T Y PE+L G + Y D++ G E++
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 52/296 (17%)
Query: 92 EIARGTYGTVYRG----AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
EI G +G V G Y V VK L + + + F +E ++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKEL--------RVSASVQEQMKFLEEAQPYRSLQ 53
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
H N+ + +G T +V+E+ P G LK +L R+ RK
Sbjct: 54 HSNLLQCLGQCTEVTPY--------------------LLVMEFCPLGDLKGYL-RSCRKA 92
Query: 208 LAF----KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ ++A ++A GL +LH +H D+ N LL A+ T+KI D+G++ + +
Sbjct: 93 ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152
Query: 264 NPRDMTGETG--TLGYMAPEVLDGKPYN-------RKCDVYSFGICLWEIY-CCDMPYPD 313
+T + L ++APE++D N ++ +V+S G+ +WE++ PY
Sbjct: 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
Query: 314 LSFTDVSSAVVR-QNLRPDIPRC-CPSS--LASIMRKCWDANPDKRPVMDEVVKLL 365
LS V + VR Q L+ PR P S +M+ CW P++RP +EV LL
Sbjct: 213 LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 40/226 (17%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I +GT+G V+ R Q VA+K +L M E I A +E+ + Q L H
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITA--LREIKILQLLKHE 71
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV----EY-LPGGTLKKFLIRNK 204
NV I +I AT + + +V E+ L G L+ NK
Sbjct: 72 NVVNLI---------EICRTKATPYNRY----KGSFYLVFEFCEHDLAG------LLSNK 112
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV---- 260
K + ++ L GL Y+H I+HRD+K N+L+ + LK+ADFG+AR
Sbjct: 113 NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIY 305
+ P T TL Y PE+L G + Y D++ G + E++
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 39/79 (49%), Positives = 51/79 (64%), Gaps = 2/79 (2%)
Query: 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAP 280
RGL YLHS I+HRD+K N+L+++N LKI DFG+ARVE + + MT E T Y AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 281 EVLDGKP-YNRKCDVYSFG 298
E+L G Y D++S G
Sbjct: 174 EILMGSRHYTSAVDIWSVG 192
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 39/269 (14%)
Query: 93 IARGTYGTV--YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +GT+G V + G+ A+KIL ++ +V E A R V Q HP
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENR----VLQNSRHPF 56
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---RKK 207
+T LK Q+ H+ L C V+EY GG L L R + +
Sbjct: 57 LT----------ALKYSFQT-----HDRL-----CFVMEYANGGELFFHLSRERVFSEDR 96
Query: 208 LAFKVVIQIALDLARGLSYLHS-KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR 266
F ++ L YLHS K +V+RD+K EN++LD + +KI DFG+ + ++
Sbjct: 97 ARF-----YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
M GT Y+APEVL+ Y R D + G+ ++E+ C +P+ + + ++ +
Sbjct: 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+R PR S++ +P +R
Sbjct: 212 EIR--FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 4/169 (2%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V+E+L GG L F I++K + ++ A ++ GL +LHSK I++RD+K +N++LD
Sbjct: 74 VMEFLNGGDLM-FHIQDKGRFDLYRATF-YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
+ +KIADFG+ + + GT Y+APE+L G Y D +SFG+ L+E+
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 307 CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
P+ ++ + +R + P PR I+ K ++ +P +R
Sbjct: 192 GQSPFHGDDEDELFES-IRVD-TPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-P 149
+ GTYG VY+G + GQ A+K++D VT E I+ E+ + +K H
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD------VTEDEEEEIK----LEINMLKKYSHHR 73
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ + GA I D L V+E+ G++ + K L
Sbjct: 74 NIATYYGAF-------IKKSPPGHDDQLWL-------VMEFCGAGSVTDLVKNTKGNALK 119
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
+ I ++ RGL++LH+ ++HRD+K +N+LL N +K+ DFGV+ AQ R +
Sbjct: 120 EDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVG 176
Query: 270 GET---GTLGYMAPEVL--DGKP---YNRKCDVYSFGICLWEIY-----CCDM 309
GT +MAPEV+ D P Y+ + D++S GI E+ CDM
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 39/150 (26%)
Query: 187 VVEYLPGGTLKKFLIRNK--RKKLA-FKVV-IQIALDLARGLSYLHSKTIVHRDVKTENM 242
V+EY+PGG L LIR ++ A F + + +ALD +H +HRD+K +N+
Sbjct: 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD------SVHKLGFIHRDIKPDNI 132
Query: 243 LLDANRTLKIADFGVA------------RVEAQNPRDMTGET-----------------G 273
L+DA+ +K+ADFG+ ++ N G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192
Query: 274 TLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
T Y+APEVL G PY +CD +S G+ L+E
Sbjct: 193 TPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 43/243 (17%)
Query: 77 TEEWEIELAKLDIRHEIARGTYGTV----YRGAYDGQDVAVKILDWAEDGMVTSAEAAAI 132
T W+ L+ ++ + G++G V ++G G+ A+K L E + + A
Sbjct: 12 TSSWK--LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVA- 66
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
QE ++ +L HP + + + + ++E++
Sbjct: 67 -----QEKSILMELSHPFIVNMMCSFQDENRVYF--------------------LLEFVV 101
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
GG L F K + V +L YLHSK I++RD+K EN+LLD +K+
Sbjct: 102 GGEL--FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKV 159
Query: 253 ADFGVA-RVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP 310
DFG A +V D T GT Y+APEV+ K + + D ++ G+ L+E P
Sbjct: 160 TDFGFAKKV-----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
Query: 311 YPD 313
+ D
Sbjct: 215 FFD 217
|
Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 75 RKTEEWEIELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAI 132
R+ + + EL + + GTYG VY R + G+ AVKI+ E
Sbjct: 4 RRNPQHDYELIQ-----RVGSGTYGDVYKARNLHTGELAAVKII---------KLEPGDD 49
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
+ +QE+ + ++ H N+ + G+ + L I +EY
Sbjct: 50 FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI--------------------CMEYCG 89
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
GG+L+ I + L+ + + + +GL+YLHSK +HRD+K N+LL N +K+
Sbjct: 90 GGSLQD--IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKL 147
Query: 253 ADFGVARVEAQNPRDMTGETGTLGYMAPEVL---DGKPYNRKCDVYSFGICLWEIYCCDM 309
ADFGVA GT +MAPEV YN+ CD+++ GI E+
Sbjct: 148 ADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRC-----CPSSLASIMRKCWDANPDKRPVMDEVV 362
P DL + + N +P P+ S+ + ++ NP KRP + ++
Sbjct: 208 PMFDLHPMRALFLMSKSNFQP--PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 36/213 (16%)
Query: 92 EIARGTYGTVYRGA--YDGQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
+I GTYG VY+ + +A+K I ED V S AIR E+++ +++ H
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPST---AIR-----EISLLKEMQH 60
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC-VVVEYLPGGTLKKFLIRNKRKK 207
N+ + + + S +V EYL LKK + +
Sbjct: 61 GNIVRL---------------------QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFA 98
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR-TLKIADFGVARVEAQNPR 266
+++ + RG++Y HS ++HRD+K +N+L+D LK+ADFG+AR R
Sbjct: 99 KNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158
Query: 267 DMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
T E TL Y APE+L G + Y+ D++S G
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191
|
Length = 294 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 52/179 (29%), Positives = 97/179 (54%), Gaps = 15/179 (8%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V+EY+ GG L + R ++KL + + +++ L+YLH + I++RD+K +N+LLD+
Sbjct: 74 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 247 NRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+K+ D+G+ + E P D T GT Y+APE+L G+ Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 306 CCDMPY--------PDLSFTD-VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
P+ PD + D + ++ + +R IPR AS+++ + +P +R
Sbjct: 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 53/232 (22%)
Query: 85 AKLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV-- 140
L+ + GT+G V+ R A+K++ E IR Q V
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE----------VIRLKQEQHVHN 50
Query: 141 --AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
V +++ HP + + L + ++EY+PGG L
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYM--------------------LMEYVPGGELFS 90
Query: 199 FLIRNKRK-----KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
+L RN + L + I AL+ YLHSK IV+RD+K EN+LLD +K+
Sbjct: 91 YL-RNSGRFSNSTGLFYASEIVCALE------YLHSKEIVYRDLKPENILLDKEGHIKLT 143
Query: 254 DFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
DFG A+ RD T GT Y+APEV+ K +N+ D ++ GI ++E+
Sbjct: 144 DFGFAK----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 46/129 (35%), Positives = 71/129 (55%), Gaps = 1/129 (0%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
C+V+ + GG LK + I A + GL +LH + IV+RD+K EN+LL
Sbjct: 69 CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
D + ++I+D G+A VE + + + G GT GYMAPEVL G+ Y+ D ++ G L+E+
Sbjct: 129 DDHGNVRISDLGLA-VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
Query: 305 YCCDMPYPD 313
P+
Sbjct: 188 IAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 51/178 (28%), Positives = 98/178 (55%), Gaps = 13/178 (7%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+V+EY+ GG L + R ++KL + A ++ L++LH + I++RD+K +N+LLD
Sbjct: 73 LVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
A+ +K+ D+G+ + E P D T GT Y+APE+L G+ Y D ++ G+ ++E+
Sbjct: 131 ADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 305 YCCDMPY------PDLSFTD-VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
P+ PD++ D + ++ + +R IPR + +++ + +P +R
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--IPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 55/186 (29%), Positives = 101/186 (54%), Gaps = 18/186 (9%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
VV+E+L GG L + + + + + + L + R LSYLH++ ++HRD+K++++LL
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 246 ANRTLKIADFG-VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
++ +K++DFG A+V + P+ + GT +MAPEV+ PY + D++S GI + E+
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 305 YCCDMPY---PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD----ANPDKRPV 357
+ PY P L + +R NL P + ++S++R D P +R
Sbjct: 212 IDGEPPYFNEPPLQ----AMRRIRDNLPPRVKDS--HKVSSVLRGFLDLMLVREPSQRAT 265
Query: 358 MDEVVK 363
E+++
Sbjct: 266 AQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 82/298 (27%), Positives = 129/298 (43%), Gaps = 62/298 (20%)
Query: 92 EIARGTYGTVY--RGAYDGQDVAVKIL--DWAEDGMVTSAEAAAIRASFRQEVAVWQKL- 146
EI G YGTVY R + G VA+K + EDG+ S +EVA+ ++L
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV---------REVALLKRLE 57
Query: 147 --DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
DHPN+ + + ++ +D + +V E++ L+ +L +
Sbjct: 58 AFDHPNIVRLMDVC----------ATSRTDRETKV-----TLVFEHV-DQDLRTYLDKVP 101
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
L + + + RGL +LH+ IVHRD+K EN+L+ + +K+ADFG+AR+ +
Sbjct: 102 PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161
Query: 265 PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE------IYCCD---------- 308
+T TL Y APEVL Y D++S G E ++C +
Sbjct: 162 -MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220
Query: 309 ----MPYPDLSFTDVSSAVVRQNLRPDIPR----CCP---SSLASIMRKCWDANPDKR 355
+P D DV+ + R P PR P S A ++ + NP KR
Sbjct: 221 DLIGLPPEDDWPRDVT--LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 50/169 (29%), Positives = 89/169 (52%), Gaps = 4/169 (2%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V+EY+ GG L + + R K V A ++A GL +LHSK I++RD+K +N++LD+
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136
Query: 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
+KIADFG+ + + GT Y+APE++ +PY + D ++FG+ L+E+
Sbjct: 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 307 CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
P+ ++ +++ N+ P+ +I + +P KR
Sbjct: 197 GQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 59/235 (25%)
Query: 93 IARGTYGTVYRGAYD---GQDVA---VKILDWAED--------GMVTSAEAAAIRASFRQ 138
+ GTYG V + AYD G+ VA VKI++ + D GM I + +
Sbjct: 17 LGEGTYGKVEK-AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC------GIHFTTLR 69
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E+ + ++ H N+ MG ++ + +V++ + LKK
Sbjct: 70 ELKIMNEIKHENI-------MGLVDVYVEGD-------------FINLVMDIM-ASDLKK 108
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
+ +++ +L V I L + GL+ LH +HRD+ N+ +++ KIADFG+A
Sbjct: 109 VV--DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166
Query: 259 RVEAQNP--------------RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
R P +MT + TL Y APE+L G + Y+ D++S G
Sbjct: 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 76/282 (26%), Positives = 121/282 (42%), Gaps = 43/282 (15%)
Query: 91 HEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
EI G++G VY R + VA+K + + + ++ +EV Q+L H
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSY------SGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
PN ++ G L +V+EY G ++ +K L
Sbjct: 75 PNTIEYKGCY--------------------LREHTAWLVMEYCLGSASD--ILEVHKKPL 112
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
+ I +GL+YLHS +HRD+K N+LL T+K+ADFG A + +P +
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL--VSPANS 170
Query: 269 TGETGTLGYMAPEV---LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV-- 323
GT +MAPEV +D Y+ K DV+S GI E+ P ++ + SA+
Sbjct: 171 F--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYH 225
Query: 324 VRQNLRPDIPRCCPS-SLASIMRKCWDANPDKRPVMDEVVKL 364
+ QN P + S + + C P RP +E++K
Sbjct: 226 IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV---EAQNPRDMTGETGTLGYM 278
RGL Y+HS ++HRD+K N+LL+ N LKI DFG+AR+ E + +T T Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 279 APEV-LDGKPYNRKCDVYSFGICLWEIYCC 307
APE+ L+ K Y + D++S G L E+
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVK--ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
I GTYG VY+ A D G+ VA+K L+ E+G+ +A +E+++ Q L
Sbjct: 9 IGEGTYGKVYK-ARDKNTGKLVALKKTRLEMDEEGIPPTA---------LREISLLQMLS 58
Query: 148 H-PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
+ + + + +V EYL LKKF+ N R
Sbjct: 59 ESIYIVRLL---------------DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRG 102
Query: 207 ---KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR-TLKIADFGVARVEA 262
L K + L +G+++ H ++HRD+K +N+L+D + LKIAD G+ R +
Sbjct: 103 PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
Query: 263 QNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
+ T E TL Y APEVL G Y+ D++S G
Sbjct: 163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 38/223 (17%)
Query: 86 KLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
KLD ++ GTY TV++G VA+K + + A AIR EV++
Sbjct: 9 KLD---KLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIR-----EVSLL 57
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV-EYLPGGTLKKFLIR 202
+ L H N+ H+ + + C +V EYL LK++L
Sbjct: 58 KNLKHANIVTL---------------------HDIIHTERCLTLVFEYLDS-DLKQYL-D 94
Query: 203 NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
N ++ V L RGLSY H + I+HRD+K +N+L++ LK+ADFG+AR ++
Sbjct: 95 NCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEI 304
+ + E TL Y P+VL G Y+ D++ G L+E+
Sbjct: 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 37/87 (42%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 220 LARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMA 279
L RGL Y+HS ++HRD+K N+LL+AN LKI DFG+AR ++ MT T Y A
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176
Query: 280 PEVLDGKPYNRKCDVYSFGICLWEIYC 306
PE+L C Y+ I +W + C
Sbjct: 177 PELL------LNCSEYTTAIDVWSVGC 197
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 1e-16
Identities = 77/284 (27%), Positives = 135/284 (47%), Gaps = 48/284 (16%)
Query: 90 RHE-IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
R+E I +G GTV+ A D GQ+VA+K ++ + + E+ V ++
Sbjct: 23 RYEKIGQGASGTVFT-AIDVATGQEVAIKQIN---------LQKQPKKELIINEILVMKE 72
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L +PN+ F+ DS L VV+EYL GG+L +
Sbjct: 73 LKNPNIVNFL------------------DSF--LVGDELFVVMEYLAGGSLTDVVTETCM 112
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG-VARVEAQN 264
+ V + L + L +LH+ ++HRD+K++N+LL + ++K+ DFG A++ +
Sbjct: 113 DEAQIAAVCRECL---QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169
Query: 265 PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA-V 323
+ T GT +MAPEV+ K Y K D++S GI E+ + PY L+ + + +
Sbjct: 170 SKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYL 226
Query: 324 VRQNLRPDIPRCCPSSLASIMR----KCWDANPDKRPVMDEVVK 363
+ N P++ P L+ I R +C + + +KR E+++
Sbjct: 227 IATNGTPELQN--PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 54/185 (29%), Positives = 101/185 (54%), Gaps = 16/185 (8%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
VV+E+L GG L + + + + + + L + + LS LH++ ++HRD+K++++LL
Sbjct: 94 VVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT 150
Query: 246 ANRTLKIADFG-VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
+ +K++DFG A+V + PR + GT +MAPE++ PY + D++S GI + E+
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 305 YCCDMPY---PDLSFTDVSSAVVRQNLRP---DIPRCCPSSLASIMRKCWDANPDKRPVM 358
+ PY P L + ++R NL P ++ + P SL + + +P +R
Sbjct: 210 VDGEPPYFNEPPLK----AMKMIRDNLPPKLKNLHKVSP-SLKGFLDRLLVRDPAQRATA 264
Query: 359 DEVVK 363
E++K
Sbjct: 265 AELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 16/191 (8%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENML 243
C+ +E++ G+L + I K + +++ +IA+ + GL+YL++ I+HRD+K N+L
Sbjct: 79 CMCMEFMDCGSLDR--IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
+++ +K+ DFGV+ E N T GT YM+PE + G Y K DV+S GI + E
Sbjct: 137 VNSRGQIKLCDFGVSG-ELINSIADTF-VGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 304 IYCCDMPY---PDLSFTDVSSA----VVRQNLRPDIPRCCPSSLASIMR----KCWDANP 352
+ P+ +++Q ++ PR S +R C +P
Sbjct: 195 LALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDP 254
Query: 353 DKRPVMDEVVK 363
+RP ++
Sbjct: 255 TERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 92 EIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+I +G GTVY GQ+VA++ ++ + + E+ V ++ +P
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNP 77
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ ++ DS+ L VV+EYL GG+L + +
Sbjct: 78 NIVNYL------------------DSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 117
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
V + L + L +LHS ++HRD+K++N+LL + ++K+ DFG +
Sbjct: 118 IAAVCRECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA-VVRQNL 328
GT +MAPEV+ K Y K D++S GI E+ + PY L+ + + ++ N
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNG 232
Query: 329 RPDIPRCCPSSLASIMR----KCWDANPDKRPVMDEVVK 363
P++ P L++I R +C D + +KR E+++
Sbjct: 233 TPELQN--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 220 LARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD----MTGETGTL 275
L RGL Y+HS ++HRD+K N+L++ + L+I DFG+AR + +P + MT T
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 276 GYMAPEVLDGKP-YNRKCDVYSFGICLWE 303
Y APE+L P Y D++S G E
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 38/84 (45%), Positives = 55/84 (65%), Gaps = 4/84 (4%)
Query: 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 281
RGL Y+HS +VHRD+K N+L++ N LKI DFG+AR+ Q+P+ MTG T Y APE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQ-MTGYVSTRYYRAPE 175
Query: 282 V-LDGKPYNRKCDVYSFGICLWEI 304
+ L + Y+ + D++S G E+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 74/307 (24%), Positives = 118/307 (38%), Gaps = 82/307 (26%)
Query: 92 EIARGTYGTVYRGAY--DGQDVAVKIL-----DWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
++ GT+G+VY G+ VA+K + W E +R EV +
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--------CMNLR-----EVKSLR 52
Query: 145 KL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
KL +HPN+ K L V EY+ G L + +
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYF--------------------VFEYMEG-NLYQLMKDR 91
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR-VEA 262
K K + V+ I + +GL+++H HRD+K EN+L+ +KIADFG+AR + +
Sbjct: 92 KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIY---------------- 305
+ P T T Y APE+L Y+ D+++ G + E+Y
Sbjct: 152 RPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209
Query: 306 --CCDMPYPDLSFTDVSSAVVRQ-NLRPDIPRCCPSSLASI-----------MRKC--WD 349
C + P + + R P+ P+SL + ++ WD
Sbjct: 210 KICSVLGTPTKQDWPEGYKLASKLGFR--FPQFAPTSLHQLIPNASPEAIDLIKDMLRWD 267
Query: 350 ANPDKRP 356
P KRP
Sbjct: 268 --PKKRP 272
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 44/286 (15%)
Query: 92 EIARGTYGTVYRGAYD--GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV-AVWQKLDH 148
EI RG +GTV + + G +AVK + T E R ++ V + D
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIR------STVDEKEQKR--LLMDLDVVMRSSDC 62
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR---NKR 205
P + KF GA L C + L +L KF +
Sbjct: 63 PYIVKFYGA---------------------LFREGDCWICMELMDISLDKFYKYVYEVLK 101
Query: 206 KKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
+ +++ +IA+ + L+YL + I+HRDVK N+LLD N +K+ DFG++ + +
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVD 160
Query: 265 PRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFTDVS 320
T + G YMAPE +D Y+ + DV+S GI L+E+ PYP S D
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 321 SAVVRQN---LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ VV+ + L R S + + C + KRP E+++
Sbjct: 221 TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 74/281 (26%), Positives = 134/281 (47%), Gaps = 47/281 (16%)
Query: 92 EIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
+I +G GTVY A D GQ+VA+K ++ + + E+ V ++ +
Sbjct: 26 KIGQGASGTVYT-AIDIATGQEVAIKQMNLQQQ---------PKKELIINEILVMRENKN 75
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
PN+ ++ DS+ L VV+EYL GG+L + +
Sbjct: 76 PNIVNYL------------------DSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEG 115
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG-VARVEAQNPRD 267
V + L + L +LHS ++HRD+K++N+LL + ++K+ DFG A++ + +
Sbjct: 116 QIAAVCRECL---QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA-VVRQ 326
T GT +MAPEV+ K Y K D++S GI E+ + PY L+ + + ++
Sbjct: 173 ST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIAT 229
Query: 327 NLRPDIPRCCPSSLASIMR----KCWDANPDKRPVMDEVVK 363
N P++ P L+++ R +C + + D+R E+++
Sbjct: 230 NGTPELQN--PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 44/130 (33%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENML 243
+ +E++ GG+L + L + R + ++ +I++ + RGL+YL K I+HRDVK N+L
Sbjct: 75 SICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNIL 132
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
+++ +K+ DFGV+ Q M GT YM+PE L G Y + D++S G+ L
Sbjct: 133 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 303 EIYCCDMPYP 312
E+ P P
Sbjct: 190 EMAIGRYPIP 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 52/172 (30%), Positives = 85/172 (49%), Gaps = 5/172 (2%)
Query: 144 QKLDHPNVTKFIGASMGTTNL----KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+KL+ + K G SM K+ S+ S ++ A C+V+ + GG LK
Sbjct: 31 KKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 90
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
+ + A ++ GL LH + IV+RD+K EN+LLD + ++I+D G+A
Sbjct: 91 IYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA- 149
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
V + + G GT+GYMAPEV+ + Y D ++ G L+E+ P+
Sbjct: 150 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 5/165 (3%)
Query: 144 QKLDHPNVTKFIGASMGTTNL----KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+KL+ + K G +M K+ S+ S ++ A C+V+ + GG LK
Sbjct: 31 KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 90
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
+ + + A ++ GL LH + IV+RD+K EN+LLD ++I+D G+A
Sbjct: 91 IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA- 149
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
VE + G GT+GYMAPEV+ + Y D + G ++E+
Sbjct: 150 VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 44/284 (15%)
Query: 88 DIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D+R EI G++G VY R + VA+K + + + ++ +EV Q+
Sbjct: 29 DLR-EIGHGSFGAVYFARDVRTNEVVAIKKMSY------SGKQSNEKWQDIIKEVKFLQR 81
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+ HPN ++ G L +V+EY G L+ +
Sbjct: 82 IKHPNSIEYKGCY--------------------LREHTAWLVMEYCLGSASD--LLEVHK 119
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
K L + I +GL+YLHS ++HRD+K N+LL +K+ADFG A + +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177
Query: 266 RDMTGETGTLGYMAPEV---LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
GT +MAPEV +D Y+ K DV+S GI E+ P L + SA
Sbjct: 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPPLFNMNAMSA 232
Query: 323 V--VRQNLRPDIPRCCPSS-LASIMRKCWDANPDKRPVMDEVVK 363
+ + QN P + S + + C P RP +E++K
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 40/137 (29%), Positives = 76/137 (55%), Gaps = 2/137 (1%)
Query: 219 DLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYM 278
+LA L +LHS I++RD+K EN+LLD +K+ DFG+++ + + GT+ YM
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 165
Query: 279 APEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPS 338
APEV++ + + + D +SFG+ ++E+ +P+ + + +++ L +P+
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSP 223
Query: 339 SLASIMRKCWDANPDKR 355
S++R + NP R
Sbjct: 224 EAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 77/324 (23%), Positives = 133/324 (41%), Gaps = 93/324 (28%)
Query: 84 LAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQE 139
L K +I ++ +G YG V++ A D + VA+K I D + T A+ R +FR E
Sbjct: 6 LRKYEILQKLGKGAYGIVWK-AIDRRTKEVVALKKIFDAFRN--ATDAQ----R-TFR-E 56
Query: 140 VAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG---GT 195
+ Q+L DHPN+ K + + + + +V EY+
Sbjct: 57 IMFLQELGDHPNIVKLL------------------NVIKAENDKDIYLVFEYMETDLHAV 98
Query: 196 LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADF 255
++ ++ + K+ I L + L Y+HS ++HRD+K N+LL+++ +K+ADF
Sbjct: 99 IRANILEDVHKRY-------IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADF 151
Query: 256 GVARV------EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC--- 306
G+AR +NP +T T Y APE+L G Y+ G+ +W + C
Sbjct: 152 GLARSLSELEENPENP-VLTDYVATRWYRAPEILLGSTR------YTKGVDMWSVGCILG 204
Query: 307 ------------------------CDMPYP-DL---------SFTDVSSAVVRQNLRPDI 332
P D+ + D + R+ L +
Sbjct: 205 EMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL 264
Query: 333 PRCCPSSLASIMRKCWDANPDKRP 356
P+ +L +++K NP+KR
Sbjct: 265 PKASDDAL-DLLKKLLVFNPNKRL 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 5/172 (2%)
Query: 144 QKLDHPNVTKFIGASMGTTNL----KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
++L+ + K G SM K+ SQ + ++ A C+V+ + GG LK
Sbjct: 31 KRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFH 90
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
+ + + A ++ GL LH + V+RD+K EN+LLD ++I+D G+A
Sbjct: 91 IYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA- 149
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
V+ + G GT+GYMAPEVL+ + Y D + G ++E+ P+
Sbjct: 150 VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 50/179 (27%), Positives = 97/179 (54%), Gaps = 15/179 (8%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V+E++ GG L + R ++KL + + +++ L++LH + I++RD+K +N+LLDA
Sbjct: 74 VIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 247 NRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+K+ D+G+ + E P D T GT Y+APE+L G+ Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 306 CCDMPY--------PDLSFTD-VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
P+ PD + D + ++ + +R IPR +S+++ + +P +R
Sbjct: 191 AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 36/90 (40%), Positives = 60/90 (66%), Gaps = 2/90 (2%)
Query: 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT-GETGTLGYMAPE 281
GL +LH + I++RD+K EN+LLD + ++I+D G+A VE ++ + T G GT G+MAPE
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPE 167
Query: 282 VLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
+L G+ Y+ D ++ G+ L+E+ P+
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 187 VVEYLPGGTLKKFLIRNKR---KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
V++Y+ GG L L R + + F A ++A L YLHS I++RD+K EN+L
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEPRARF-----YAAEIASALGYLHSLNIIYRDLKPENIL 128
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
LD+ + + DFG+ + E T GT Y+APEVL +PY+R D + G L+
Sbjct: 129 LDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQ--NLRPDIPRCCPSSLASIMRK 346
E+ P+ ++ ++ + L+P+I L +++K
Sbjct: 188 EMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 34/228 (14%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASF 136
WE+ ++ + G YG V A+D G+ VA+K L SA A + ++
Sbjct: 11 WEVPDRYQNLSP-VGSGAYGQVCS-AFDTKTGRKVAIKKLSRP----FQSAIHA--KRTY 62
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
R E+ + + +DH NV IG L + + +++ + + +V +L G L
Sbjct: 63 R-ELRLLKHMDHENV---IGL------LDVFTPASSLEDFQDV------YLVTHLMGADL 106
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ K +KL+ + + + RGL Y+HS I+HRD+K N+ ++ + LKI DFG
Sbjct: 107 NNIV---KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWE 303
+AR +MTG T Y APE+ L+ YN+ D++S G + E
Sbjct: 164 LAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 48/172 (27%), Positives = 90/172 (52%), Gaps = 10/172 (5%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V+EY+ GG L + + + K V A +++ GL +LH + I++RD+K +N++LD+
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 247 NRTLKIADFGVAR---VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
+KIADFG+ + V+ R GT Y+APE++ +PY + D +++G+ L+E
Sbjct: 137 EGHIKIADFGMCKEHMVDGVTTRTF---CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYE 193
Query: 304 IYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ P+ ++ +++ N+ P+ SI + +P KR
Sbjct: 194 MLAGQPPFDGEDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 187 VVEYLPGGTLKKFLIRNKR---KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
V++Y+ GG L L R + + F A ++A + YLHS I++RD+K EN+L
Sbjct: 74 VLDYVNGGELFFHLQRERCFLEPRARF-----YAAEVASAIGYLHSLNIIYRDLKPENIL 128
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
LD+ + + DFG+ + E P + T GT Y+APEVL +PY+R D + G L+
Sbjct: 129 LDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLY 187
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMR 345
E+ P+ + + ++ + L+ +P + ++
Sbjct: 188 EMLYGLPPFYSRDVSQMYDNILHKPLQ--LPGGKTVAACDLLV 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 79/281 (28%), Positives = 121/281 (43%), Gaps = 43/281 (15%)
Query: 91 HEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
HEI G++G VY ++ + VAVK + ++ G T+ + I +EV Q+L H
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYS--GKQTNEKWQDII----KEVKFLQQLKH 80
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
PN ++ G L +V+EY G L+ +K L
Sbjct: 81 PNTIEYKGCY--------------------LKEHTAWLVMEYCLGSASD--LLEVHKKPL 118
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
+ I +GL+YLHS ++HRD+K N+LL +K+ADFG A +
Sbjct: 119 QEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----A 174
Query: 269 TGETGTLGYMAPEV---LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV-- 323
GT +MAPEV +D Y+ K DV+S GI E+ P L + SA+
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPPLFNMNAMSALYH 231
Query: 324 VRQNLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ QN P + S + C P +RP E+++
Sbjct: 232 IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 86 KLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
K +I I RGTYG VY+ A DG++ A+K + T +A R E+
Sbjct: 1 KYEIEGCIGRGTYGRVYK-AKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACR-----EI 53
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY----LPGGTL 196
A+ ++L H NV + + + + ++ +Y L +
Sbjct: 54 ALLRELKHENVVSLVEVFLEHADKSV------------------YLLFDYAEHDL--WQI 93
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKI 252
KF + KR + +V + + G+ YLHS ++HRD+K N+L+ +KI
Sbjct: 94 IKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153
Query: 253 ADFGVARVEAQNPRDMTGETG---TLGYMAPEVLDG-KPYNRKCDVYSFG 298
D G+AR+ + + T+ Y APE+L G + Y + D+++ G
Sbjct: 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 27/184 (14%)
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
AIR +E+ V + + P + F GA SD S + +E+
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFY-------------SDGEIS-------ICMEH 84
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRT 249
+ GG+L + L KR + +++ ++++ + RGL+YL K I+HRDVK N+L+++
Sbjct: 85 MDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE 142
Query: 250 LKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308
+K+ DFGV+ Q M GT YM+PE L G Y+ + D++S G+ L E+
Sbjct: 143 IKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
Query: 309 MPYP 312
P P
Sbjct: 200 YPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 38/104 (36%), Positives = 60/104 (57%), Gaps = 10/104 (9%)
Query: 215 QIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM--TGE 271
+IA+ + + L YLHSK +++HRDVK N+L++ N +K+ DFG++ + T +
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAKTID 163
Query: 272 TGTLGYMAPEVLDG----KPYNRKCDVYSFGICLWEIYCCDMPY 311
G YMAPE ++ K Y+ K DV+S GI + E+ PY
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 92 EIARGTYGTV--YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+I G+ G V R + G+ VAVK++D + R EV + + H
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---------RELLFNEVVIMRDYQHQ 78
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
NV + + + L V++E+L GG L + + + +
Sbjct: 79 NVVEMYKSYLVGEEL--------------------WVLMEFLQGGALTDIVSQTRLNEEQ 118
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
V + L + L YLHS+ ++HRD+K++++LL + +K++DFG AQ +D+
Sbjct: 119 IATVCESVL---QALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVP 172
Query: 270 GE---TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
GT +MAPEV+ PY + D++S GI + E+ + PY
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 33/230 (14%)
Query: 93 IARGTYGTVYRGAYDG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ G YG+V AYD Q VAVK L ++ + R ++R E+ + + + H
Sbjct: 23 VGSGAYGSVC-SAYDTRLRQKVAVKKLSRPFQSLIHA------RRTYR-ELRLLKHMKHE 74
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
NV +G ++ P+ S + + L V L G L + K +KL+
Sbjct: 75 NV-------IGLLDVFTPATSIENFNEVYL--------VTNLMGADLNNIV---KCQKLS 116
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
+ V + L RGL Y+HS I+HRD+K N+ ++ + L+I DFG+AR Q +MT
Sbjct: 117 DEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT 173
Query: 270 GETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318
G T Y APE+ L+ YN+ D++S G + E+ +P + D
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 39/107 (36%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
LI+ +++ L K V L + L ++H I HRD+K EN+L+ + LK+ADFG R
Sbjct: 89 LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
Query: 260 VEAQNPRDMTGETGTLGYMAPEVL--DGKPYNRKCDVYSFGICLWEI 304
P T T Y APE L DG Y K D+++ G +EI
Sbjct: 148 GIYSKP-PYTEYISTRWYRAPECLLTDGY-YGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 73/234 (31%), Positives = 109/234 (46%), Gaps = 39/234 (16%)
Query: 84 LAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQE 139
+ K DI +I GTYG VY R G+ VA+K LD ++G +A IR E
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA----IR-----E 56
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLK---IPSQSATSDSHNSLPSRACCVVVEYLPG--- 193
+ + ++L+H N+ NLK Q A + A +V EY+
Sbjct: 57 IKILRQLNHRNIV----------NLKEIVTDKQDALDFKKDK---GAFYLVFEYMDHDLM 103
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
G L+ L+ + L GL+Y H K +HRD+K N+LL+ +K+A
Sbjct: 104 GLLESGLVHFSEDHIK-----SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158
Query: 254 DFGVARV-EAQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIY 305
DFG+AR+ ++ R T + TL Y PE+L G+ Y DV+S G L E++
Sbjct: 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 187 VVEYLPGGTLKKFLIRNK---RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
V++Y+ GG L L R + + F A ++A L YLHS IV+RD+K EN+L
Sbjct: 74 VLDYINGGELFYHLQRERCFLEPRARF-----YAAEIASALGYLHSLNIVYRDLKPENIL 128
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
LD+ + + DFG+ + ++ + GT Y+APEVL +PY+R D + G L+E
Sbjct: 129 LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 188
Query: 304 IYCCDMPYPDLSFTDVSSAVVRQ--NLRPDIPRCCPSSLASIMRK 346
+ P+ + ++ ++ + L+P+I L +++K
Sbjct: 189 MLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 44/284 (15%)
Query: 88 DIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D+R EI G++G VY R + + VA+K + ++ G ++ + I +EV QK
Sbjct: 19 DLR-EIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDII----KEVRFLQK 71
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L HPN ++ G L +V+EY G L+ +
Sbjct: 72 LRHPNTIQYRGCY--------------------LREHTAWLVMEYCLGSASD--LLEVHK 109
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
K L + + +GL+YLHS ++HRDVK N+LL +K+ DFG A + A
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167
Query: 266 RDMTGETGTLGYMAPEV---LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
GT +MAPEV +D Y+ K DV+S GI E+ P L + SA
Sbjct: 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPPLFNMNAMSA 222
Query: 323 V--VRQNLRPDIPRCCPS-SLASIMRKCWDANPDKRPVMDEVVK 363
+ + QN P + S + + C P RP + ++K
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 52/141 (36%), Positives = 75/141 (53%), Gaps = 18/141 (12%)
Query: 186 VVVEYLPGGTLKKFL----IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
+V+EY+PGG L + I K + V+ +ALD +HS +HRDVK +N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVV-LALDA------IHSMGFIHRDVKPDN 172
Query: 242 MLLDANRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVL-----DGKPYNRKCDVY 295
MLLD + LK+ADFG +++A GT Y++PEVL DG Y R+CD +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY-YGRECDWW 231
Query: 296 SFGICLWEIYCCDMPYPDLSF 316
S G+ L+E+ D P+ S
Sbjct: 232 SVGVFLYEMLVGDTPFYADSL 252
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 51/172 (29%), Positives = 84/172 (48%), Gaps = 5/172 (2%)
Query: 144 QKLDHPNVTKFIGASMGTTNL----KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+KL+ + K G +M K+ S+ S ++ A C+V+ + GG LK
Sbjct: 31 KKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFH 90
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
+ + I A +L GL L + IV+RD+K EN+LLD ++I+D G+A
Sbjct: 91 IYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA- 149
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
V+ + G GT+GYMAPEV++ + Y D + G ++E+ P+
Sbjct: 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFK------VVIQIALDLARGLSYLHSKTIVHRDVKT 239
+++EY GG L K + + ++ L F+ + QI L L +HS+ ++HRD+K+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL----ALDEVHSRKMMHRDLKS 197
Query: 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSF 297
N+ L +K+ DFG ++ + + + GT Y+APE+ + K Y++K D++S
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257
Query: 298 GICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV 357
G+ L+E+ P+ S ++ V+ P P S + +++ NP RP
Sbjct: 258 GVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPT 316
Query: 358 MDEVV 362
+++
Sbjct: 317 TQQLL 321
|
Length = 478 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 27/184 (14%)
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
AIR +E+ V + + P + F GA SD S + +E+
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFY-------------SDGEIS-------ICMEH 84
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRT 249
+ GG+L + L K ++ +++ ++++ + +GL+YL K I+HRDVK N+L+++
Sbjct: 85 MDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 142
Query: 250 LKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308
+K+ DFGV+ Q M GT YM+PE L G Y+ + D++S G+ L E+
Sbjct: 143 IKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
Query: 309 MPYP 312
P P
Sbjct: 200 YPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 22/172 (12%)
Query: 166 IPS-QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIAL-DLARG 223
IP Q A D N +V+EY PGG L L N+ + + + Q L +L
Sbjct: 63 IPQLQYAFQDKDNLY------LVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA 114
Query: 224 LSYLHSKTIVHRDVKTENMLLDANRTLKIADFG-VARVEAQNPRDMTGETGTLGYMAPEV 282
+ +H VHRD+K EN+L+D +K+ADFG AR+ A + GT Y+APEV
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 283 L---DGKP---YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328
L +G Y +CD +S G+ +E+ P F + +SA N+
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-----FHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 79/306 (25%), Positives = 124/306 (40%), Gaps = 72/306 (23%)
Query: 88 DIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
DI I +G G VY AYD + VA+K + ED +E ++ F +E +
Sbjct: 5 DIIRLIGKGGMGEVYL-AYDPVCSRRVALKKI--RED----LSENPLLKKRFLREAKIAA 57
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDS---HNSLPSRACCVVVEYLPGGTLKKFLI 201
L HP + +P S SD + ++P Y+ G TLK L+
Sbjct: 58 DLIHPGI--------------VPVYSICSDGDPVYYTMP---------YIEGYTLKS-LL 93
Query: 202 RNKRK----------KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
++ + K + + I + + Y+HSK ++HRD+K +N+LL +
Sbjct: 94 KSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV 153
Query: 252 IADFGVARVEAQNPRD---------------MT--GE-TGTLGYMAPEVLDGKPYNRKCD 293
I D+G A + D MT G+ GT YMAPE L G P + D
Sbjct: 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTD 213
Query: 294 VYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP----RCCPSSLASIMRKCWD 349
+Y+ G+ L+++ PY +S R + I R P L+ I K
Sbjct: 214 IYALGVILYQMLTLSFPYRRKKGRKIS---YRDVILSPIEVAPYREIPPFLSQIAMKALA 270
Query: 350 ANPDKR 355
+P +R
Sbjct: 271 VDPAER 276
|
Length = 932 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 40/224 (17%)
Query: 86 KLDIRHEIARGTYGTVYRGAYDGQD--VAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAV 142
KLD ++ GTY TVY+G D VA+K I E+G A AIR EV++
Sbjct: 10 KLD---KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIR-----EVSL 57
Query: 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPS-RACCVVVEYLPGGTLKKFLI 201
+ L H N+ H+ + + ++ +V EYL LK++L
Sbjct: 58 LKDLKHANIVTL---------------------HDIIHTEKSLTLVFEYL-DKDLKQYL- 94
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
+ + V L RGL+Y H + ++HRD+K +N+L++ LK+ADFG+AR +
Sbjct: 95 DDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEI 304
+ + + E TL Y P++L G Y+ + D++ G +E+
Sbjct: 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 65/298 (21%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKI-LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ G+YG V + GQ VA+K L+ +D MV + A+R E+ + ++L H
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV---KKIAMR-----EIRMLKQLRHE 60
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ I L + + + L E P G L ++ +K
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---------EKYPNG-----LDESRVRKYL 106
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
F+++ RG+ + HS I+HRD+K EN+L+ + +K+ DFG AR A T
Sbjct: 107 FQIL--------RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
Query: 270 GETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR--- 325
T Y APE+L G Y R D+++ G + E+ + +P S D +++
Sbjct: 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218
Query: 326 ---------------------------QNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+ L P+ L + ++C +PD RP
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 44/124 (35%), Positives = 64/124 (51%), Gaps = 11/124 (8%)
Query: 213 VIQIALDLAR----------GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
VIQ+ LD R G+ +LHS I+HRD+K N+++ ++ TLKI DFG+AR A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 176
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
MT T Y APEV+ G Y D++S G + E+ + +P D +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 323 VVRQ 326
V+ Q
Sbjct: 237 VIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 9e-15
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 92 EIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
++ G+Y TVY+G +G+ VA+K++ E+ AIR E ++ + L H
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIR-----EASLLKGLKHA 63
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG----TLKKFLIRNKR 205
N+ L + + +D C ++ PGG +K FL +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTD---------LCQYMDKHPGGLHPENVKLFLFQ--- 111
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
L RGLSY+H + I+HRD+K +N+L+ LK+ADFG+AR ++
Sbjct: 112 --------------LLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157
Query: 266 RDMTGETGTLGYMAPEVLDGKPYNRKC-DVYSFGICLWEI 304
+ E TL Y P+VL G C D++ G E+
Sbjct: 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-15
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 92 EIARGTYGTVYRGA--YDGQDVAVKILDW-AEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
++ G+Y TVY+G +GQ VA+K++ E+G+ +A IR E ++ + L H
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA----IR-----EASLLKGLKH 62
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSR-ACCVVVEYLPGGTLKKFLIRNKRKK 207
N+ H+ + ++ V EY+ L +++I++
Sbjct: 63 ANIVLL---------------------HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGL 100
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ V + L RGL+Y+H + I+HRD+K +N+L+ LK+ADFG+AR ++ +
Sbjct: 101 HPYNVRL-FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159
Query: 268 MTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIY 305
+ E TL Y P+VL G Y+ D++ G E+
Sbjct: 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 36/89 (40%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR----VEAQNPRDMTGETGTLGY 277
GL Y+HS ++HRD+K N+L++A+ LKI DFG+AR +N MT T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 278 MAPEV-LDGKPYNRKCDVYSFGICLWEIY 305
APE+ L + Y + DV+S G L E+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
+F + ++ +L H ++ K G + N+ +V EY+ G
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRDENI---------------------MVEEYVKFG 85
Query: 195 TLKKFLIRNKRK-KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRT- 249
L FL R K L +K + +A LA L YL K +VH +V +N+L+ N
Sbjct: 86 PLDVFLHREKNNVSLHWK--LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGY 143
Query: 250 ---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEI 304
+K++D G+ R+ E + ++APE + D +SFG L EI
Sbjct: 144 VPFIKLSDPGIPI--TVLSREERVE--RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
Query: 305 YC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+ P LS ++ Q+ P +P C LA+++ +CW +P KRP
Sbjct: 200 CSNGEEPLSTLSSSEKERFYQDQHRLP-MPDCAE--LANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 36/223 (16%)
Query: 92 EIARGTYGTVYRGAYD----GQDVAVKIL--DWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
EI G YG V++ A D G+ VA+K + E+GM S IR EVAV +
Sbjct: 8 EIGEGAYGKVFK-ARDLKNGGRFVALKRVRVQTGEEGMPLST----IR-----EVAVLRH 57
Query: 146 LD---HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
L+ HPNV + + +D L +V E++ L +L +
Sbjct: 58 LETFEHPNVVRLFDVCT----------VSRTDRETKL-----TLVFEHV-DQDLTTYLDK 101
Query: 203 NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
+ + + + L RGL +LHS +VHRD+K +N+L+ ++ +K+ADFG+AR+ +
Sbjct: 102 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+T TL Y APEVL Y D++S G E++
Sbjct: 162 FQMA-LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 13/129 (10%)
Query: 187 VVEYLPGGTLKKF-LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+++Y+ G L F L++ + K L+ V +I L L+ LH I+H D+K EN+L D
Sbjct: 87 IMDYIKDGDL--FDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
Query: 246 ANRT-LKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
+ + + D+G+ ++ P D GTL Y +PE + G Y+ D ++ G+ +
Sbjct: 144 RAKDRIYLCDYGLCKIIGT-PSCYD-----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTY 197
Query: 303 EIYCCDMPY 311
E+ P+
Sbjct: 198 ELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 55/303 (18%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRAS 135
+++ +L L+ EI GT G VY+ + G +AVK M + +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVK-------QMRRTGNKEENKRI 60
Query: 136 FRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195
V + D P + K G + +++ I + L
Sbjct: 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME---------------------LMSTC 99
Query: 196 LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRTLKIAD 254
L K L R + + ++ ++ + + + L YL K ++HRDVK N+LLDA+ +K+ D
Sbjct: 100 LDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD 158
Query: 255 FGVA--RVEAQNPRDMTGETGTLGYMAPEVLDGKP----YNRKCDVYSFGICLWEIYCCD 308
FG++ V++ + T G YMAPE +D Y+ + DV+S GI L E+
Sbjct: 159 FGISGRLVDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
Query: 309 MPYP--DLSFTDVSSAVVRQNLRPDIPRCCPSS------LASIMRKCWDANPDKRPVMDE 360
PY F +V + ++++ P P + S + C + KRP E
Sbjct: 216 FPYKNCKTEF-EVLTKILQEE-----PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269
Query: 361 VVK 363
+++
Sbjct: 270 LLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 67/295 (22%), Positives = 125/295 (42%), Gaps = 49/295 (16%)
Query: 91 HEIARGTYGTVYRGA-YDGQDVAVKILDWAEDGMVTSAEAAAI---RASFRQEVAVWQKL 146
EI G +G V Y VA + V +A A + F Q+ ++ L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVV--------VKELKANASSKEQNEFLQQGDPYRIL 52
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--K 204
HPN+ + +G + IP +V EY G LK +L +
Sbjct: 53 QHPNILQCLGQCVEA----IPY----------------LLVFEYCELGDLKSYLSQEQWH 92
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
R+ ++ ++A ++A G++++H +H D+ N L ++ T+K+ D+G+ +
Sbjct: 93 RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152
Query: 265 PRDMTGET--GTLGYMAPEV-------LDGKPYNRKCDVYSFGICLWEIY-CCDMPYPDL 314
T + L ++APE+ L + +V++ G+ LWE++ PY L
Sbjct: 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212
Query: 315 SFTDVSSAVVRQN----LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
S +V + V++ +P + +++ CW +P+KR +EV +LL
Sbjct: 213 SDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 11/96 (11%)
Query: 213 VIQIALDLAR----------GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
VIQ+ LD R G+ +LHS I+HRD+K N+++ ++ TLKI DFG+AR A
Sbjct: 110 VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 168
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFG 298
MT T Y APEV+ G Y D++S G
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 49/137 (35%), Positives = 72/137 (52%), Gaps = 20/137 (14%)
Query: 186 VVVEYLPGGTLKKFLIR-NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+V+EY+PGG L + + +K A ++ L L +HS ++HRDVK +NMLL
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL----ALDAIHSMGLIHRDVKPDNMLL 175
Query: 245 DANRTLKIADFGVARVEAQNPRDMTG------ETGTLGYMAPEVLDGKP----YNRKCDV 294
D + LK+ADFG D TG GT Y++PEVL + Y R+CD
Sbjct: 176 DKHGHLKLADFGTCM-----KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 295 YSFGICLWEIYCCDMPY 311
+S G+ L+E+ D P+
Sbjct: 231 WSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 9/130 (6%)
Query: 186 VVVEYLPGGTLKKFLIRNKR---KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242
+V +Y+ GG L L + R + F + +L L +LH IV+RD+K EN+
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-----ELVLALEHLHKYDIVYRDLKPENI 127
Query: 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICL 301
LLDA + + DFG+++ + + GT Y+APEV LD K Y + D +S G+ +
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187
Query: 302 WEIYCCDMPY 311
+E+ C P+
Sbjct: 188 FEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 4/162 (2%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
V++++ GG L F ++ +R + A ++A L YLHS IV+RD+K EN+LLD+
Sbjct: 74 VLDFVNGGELF-FHLQRERSFPEPRARFYAA-EIASALGYLHSINIVYRDLKPENILLDS 131
Query: 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
+ + DFG+ + T GT Y+APEV+ +PY+ D + G L+E+
Sbjct: 132 QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191
Query: 307 CDMPYPDLSFTDVSSAVVRQ--NLRPDIPRCCPSSLASIMRK 346
P+ ++ ++ + LRP S L ++ K
Sbjct: 192 GLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 46/132 (34%), Positives = 71/132 (53%), Gaps = 10/132 (7%)
Query: 186 VVVEYLPGGTLKKFLIR-NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+V+EY+PGG L + + +K A ++ L L +HS +HRDVK +NMLL
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL----ALDAIHSMGFIHRDVKPDNMLL 175
Query: 245 DANRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLDGKP----YNRKCDVYSFGI 299
D + LK+ADFG ++ + GT Y++PEVL + Y R+CD +S G+
Sbjct: 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 300 CLWEIYCCDMPY 311
L+E+ D P+
Sbjct: 236 FLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 45/225 (20%)
Query: 86 KLDIRHEIARGTYGTVYRG--AYDGQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAV 142
KLD E G+Y TVY+G GQ VA+K I E+G A AIR E ++
Sbjct: 9 KLDKLGE---GSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIR-----EASL 56
Query: 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPS-RACCVVVEYLPGGTLKKFLI 201
+ L H N+ H+ + + + +V EYL LK+++
Sbjct: 57 LKDLKHANIVTL---------------------HDIIHTKKTLTLVFEYLDT-DLKQYMD 94
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
V + L RGL+Y H + ++HRD+K +N+L+ LK+ADFG+AR +
Sbjct: 95 DCGGGLSMHNVRL-FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK 153
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
+ + + E TL Y P+VL G YS + +W + C
Sbjct: 154 SVPSKTYSNEVVTLWYRPPDVLLGS------TEYSTSLDMWGVGC 192
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 15/123 (12%)
Query: 189 EYLPGGTLKKFLIRN---KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
EY+PGG + L F + + LH +HRD+K EN L+D
Sbjct: 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-----AVDALHELGYIHRDLKPENFLID 135
Query: 246 ANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
A+ +K+ DFG+++ V N G+ YMAPEVL GK Y+ D +S G L+E
Sbjct: 136 ASGHIKLTDFGLSKGIVTYAN-----SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYE 190
Query: 304 IYC 306
C
Sbjct: 191 FLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 46/175 (26%), Positives = 90/175 (51%), Gaps = 7/175 (4%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
++++Y+ GG L L + + + +V + IA ++ L +LH I++RD+K EN+LLD
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQLGIIYRDIKLENILLD 139
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKP--YNRKCDVYSFGICLW 302
+ + + DFG+++ + GT+ YMAPEV+ G +++ D +S G+ +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKR 355
E+ P+ + S + R+ L+ P P+ + ++K + +P KR
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 18/149 (12%)
Query: 175 SHNSLPSRACCV--------VVEYLPGGTLKKFLIRNKRK----KLAFKVVIQIALDLAR 222
+H L CC V+E++ GG L F I+ R+ + F A ++
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARF-----YAAEITS 107
Query: 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV 282
L +LH K I++RD+K +N+LLD K+ADFG+ + N + + GT Y+APE+
Sbjct: 108 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 283 LDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
L Y D ++ G+ L+E+ C P+
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 47/263 (17%)
Query: 108 GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167
G +VA+K+L + E RA FR+E A+ +L HPN+ +
Sbjct: 3 GHEVAIKLL------RTDAPEEEHQRARFRRETALCARLYHPNIVALL------------ 44
Query: 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYL 227
DS + P V EY+PG TL++ L L ++ L + L+
Sbjct: 45 ------DSGEAPPGLLF-AVFEYVPGRTLREVL--AADGALPAGETGRLMLQVLDALACA 95
Query: 228 HSKTIVHRDVKTENMLL---DANRTLKIADFGVAR----VEAQNPRDMTGETGTLG---Y 277
H++ IVHRD+K +N+++ K+ DFG+ V + +T T LG Y
Sbjct: 96 HNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTY 155
Query: 278 MAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCP 337
APE L G+P D+Y++G+ E C + V+ ++ Q L P P
Sbjct: 156 CAPEQLRGEPVTPNSDLYAWGLIFLE---CLTGQRVVQGASVAE-ILYQQLSPV-DVSLP 210
Query: 338 SSLAS-----IMRKCWDANPDKR 355
+A ++RK + +P +R
Sbjct: 211 PWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 37/218 (16%)
Query: 92 EIARGTYGTVYRGAYDGQD--VAVKILDWA-EDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
++ GTY TV++G + VA+K + E+G A AIR EV++ + L H
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIR-----EVSLLKDLKH 63
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPS-RACCVVVEYLPGGTLKKFLIRNKRKK 207
N+ H+ + + ++ +V EYL LK+++ +
Sbjct: 64 ANIVTL---------------------HDIVHTDKSLTLVFEYL-DKDLKQYM-DDCGNI 100
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
++ V + RGL+Y H + ++HRD+K +N+L++ LK+ADFG+AR ++ +
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160
Query: 268 MTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEI 304
+ E TL Y P+VL G Y+ + D++ G +E+
Sbjct: 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 55/291 (18%)
Query: 83 ELAKLDIRHEIARGTYGTVYRGAYDGQDV--AVKILDWAEDGMVTSAEAAAIRASFRQ-- 138
E+ LD E+ +G YG+VY+ + V A+K + D + F Q
Sbjct: 2 EIEVLD---ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-----------ESKFNQII 47
Query: 139 -EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
E+ + K P + F GA I A + +EY+ G+L
Sbjct: 48 MELDILHKAVSPYIVDFYGA------FFIEG--------------AVYMCMEYMDAGSLD 87
Query: 198 KFLI-RNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRTLKIADF 255
K + + V+ +I + +GL +L + I+HRDVK N+L++ N +K+ DF
Sbjct: 88 KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDF 147
Query: 256 GVA-RVEAQNPRDMTGETGTLGYMAPEVLDGK------PYNRKCDVYSFGICLWEIYCCD 308
GV+ + A + G YMAPE + Y + DV+S G+ + E+
Sbjct: 148 GVSGNLVASLAKT---NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
Query: 309 MPYPDLSFTDVS---SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
PYP ++ ++ SA+V + P +P + KC + P++RP
Sbjct: 205 YPYPPETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 70/240 (29%), Positives = 104/240 (43%), Gaps = 51/240 (21%)
Query: 88 DIRHEIARGTYG--TVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+I I RG +G V + GQ A+KIL+ E M+ AE A FR+E V
Sbjct: 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--MLKRAETAC----FREERDVLVN 57
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
D +T A NL + V++Y GG L L
Sbjct: 58 GDRRWITNLHYAFQDENNLYL--------------------VMDYYVGGDLLTLLS---- 93
Query: 206 KKLAFKVVIQIALDLAR--------GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
K ++ D+AR + +H VHRD+K +N+LLD N +++ADFG
Sbjct: 94 -----KFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGS 148
Query: 258 A-RVEAQNPRDMTGETGTLGYMAPEVL----DGK-PYNRKCDVYSFGICLWEIYCCDMPY 311
R+ A GT Y++PE+L DGK Y +CD +S G+C++E+ + P+
Sbjct: 149 CLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 171 ATSDSHNSLPSRACCV--------VVEYLPGGTLKKFLIRNKRK----KLAFKVVIQIAL 218
A + H L + CC V+EY+ GG L F I+ RK + F A
Sbjct: 50 ALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLM-FQIQRSRKFDEPRSRF-----YAA 103
Query: 219 DLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYM 278
++ L +LH +++RD+K +N+LLDA K+ADFG+ + N T GT Y+
Sbjct: 104 EVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYI 163
Query: 279 APEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPS 338
APE+L Y D ++ G+ ++E+ P+ + D+ +++ ++ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--YPVWLSK 221
Query: 339 SLASIMRKCWDANPDKR 355
SI++ NP+KR
Sbjct: 222 EAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 39/100 (39%), Positives = 54/100 (54%), Gaps = 4/100 (4%)
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA---RVEAQN 264
L + I I L L+YLH + I+HRDVKTEN+ LD + DFG A
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 265 PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
P+ G +GTL +PE+L PY K D++S G+ L+E+
Sbjct: 242 PQCY-GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 33/237 (13%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
+ G YG+V A+D G VAVK L ++ + + ++R E+ + + + H
Sbjct: 25 VGSGAYGSVC-AAFDTKTGLRVAVKKLSRPFQSIIHA------KRTYR-ELRLLKHMKHE 76
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
NV +G ++ P++S + N + +V +L G L + K +KL
Sbjct: 77 NV-------IGLLDVFTPARSL--EEFNDV------YLVTHLMGADLNNIV---KCQKLT 118
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
V + + RGL Y+HS I+HRD+K N+ ++ + LKI DFG+AR +MT
Sbjct: 119 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMT 175
Query: 270 GETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
G T Y APE+ L+ YN+ D++S G + E+ +P D ++R
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 36/191 (18%)
Query: 126 SAEAAAIRASFRQ----EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPS 181
+ E I+A R E + + ++HP++ + GT ++N
Sbjct: 116 TCEHVVIKAGQRGGTATEAHILRAINHPSIIQL----KGTF------------TYNKF-- 157
Query: 182 RACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
C++ LP + ++ +A ++ I + R + YLH I+HRD+K EN
Sbjct: 158 --TCLI---LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212
Query: 242 MLLDANRTLKIADFGVARVEAQNPRDMT-----GETGTLGYMAPEVLDGKPYNRKCDVYS 296
+ ++ + + DFG A P D+ G GT+ APE+L PY D++S
Sbjct: 213 IFINHPGDVCLGDFGAACF----PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWS 268
Query: 297 FGICLWEIYCC 307
GI L+E+ C
Sbjct: 269 AGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 33/86 (38%), Positives = 49/86 (56%), Gaps = 1/86 (1%)
Query: 220 LARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR-VEAQNPRDMTGETGTLGYM 278
L + + + H IVHRD+K EN+L+ N LK+ DFG AR + + + T T Y
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 279 APEVLDGKPYNRKCDVYSFGICLWEI 304
+PE+L G PY + D++S G L E+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 47/141 (33%), Positives = 70/141 (49%), Gaps = 16/141 (11%)
Query: 213 VIQIALDLAR----------GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
VIQ+ LD R G+ +LHS I+HRD+K N+++ ++ TLKI DFG+AR A
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 169
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
MT T Y APEV+ G Y D++S G + E+ + +P + D +
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 323 VVRQNLRPDIPRCCPSSLASI 343
V+ Q P CP + +
Sbjct: 230 VIEQLGTP-----CPEFMKKL 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 20/191 (10%)
Query: 186 VVVEYLPGGTLKKFLIRNKRK-KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+V EY+ G+L +L +NK +++K +++A LA L +L K + H +V +N+LL
Sbjct: 76 MVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDKGLTHGNVCAKNVLL 133
Query: 245 ---DANRT-----LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-DGKPYNRKCDVY 295
+ +T +K++D G++ P+++ E + ++ PE + + + + D +
Sbjct: 134 IREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLE--RIPWVPPECIENPQNLSLAADKW 189
Query: 296 SFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDK 354
SFG LWEI+ D P LS D + R +P + LA+++ +C D PD
Sbjct: 190 SFGTTLWEIFSGGDKP---LSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDF 246
Query: 355 RPVMDEVVKLL 365
RP +++ L
Sbjct: 247 RPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 42/202 (20%)
Query: 182 RACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR--------GLSYLHSKTIV 233
R C+V+EY+ GG L K + + +D+AR L YLH+ IV
Sbjct: 74 RHLCMVMEYVEGGDCATLL----------KNIGALPVDMARMYFAETVLALEYLHNYGIV 123
Query: 234 HRDVKTENMLLDANRTLKIADFGVARV----------EAQNPRDMTGE------TGTLGY 277
HRD+K +N+L+ + +K+ DFG++++ E +D T E GT Y
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-TREFLDKQVCGTPEY 182
Query: 278 MAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY----PDLSFTDVSSAVVRQNLRPDIP 333
+APEV+ + Y + D ++ GI L+E +P+ P+ F V S + P+
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---EWPEGD 239
Query: 334 RCCPSSLASIMRKCWDANPDKR 355
P+ ++ + NP +R
Sbjct: 240 EALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 43/119 (36%), Positives = 64/119 (53%), Gaps = 5/119 (4%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+V+E++ GG FL RNKR V A + YL S IV+RD+K EN+LLD
Sbjct: 108 LVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
+ +K+ DFG A+V + GT Y+APE+L + + D ++ GI ++EI
Sbjct: 166 KDGFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 4/103 (3%)
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
K +KL+ + + + +GL Y+H+ I+HRD+K N+ ++ + LKI DFG+AR Q
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---Q 167
Query: 264 NPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIY 305
+MTG T Y APEV L+ Y + D++S G + E+
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 54/217 (24%)
Query: 187 VVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V++Y+PGG + LIR + LA IA +L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVHKMGFIHRDIKPDNILI 134
Query: 245 DANRTLKIADFGV------------------ARVEAQNPRDMTGE--------------- 271
D + +K+ DFG+ R ++ P + E
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194
Query: 272 ----------TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
GT Y+APEVL Y + CD +S G+ L+E+ P+ + +
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL 254
Query: 322 AVVRQNLRPDIPRC---CPSSLASIMRKCWDANPDKR 355
V+ IP + I+R C + R
Sbjct: 255 KVINWETTLHIPSQAKLSREASDLILRLC--CGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 35/246 (14%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I G+YG V+ R GQ VA+K V S + I+ +E+ + ++L HPN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK-------KFVESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ I L + V EY T+ L +N R +
Sbjct: 62 LVNLIEVFRRKRKLHL--------------------VFEYC-DHTVLNELEKNPRG-VPE 99
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
++ +I + +++ H +HRDVK EN+L+ +K+ DFG AR+ D T
Sbjct: 100 HLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 271 ETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA-VVRQNL 328
T Y APE+L G Y DV++ G E+ +P S DV ++R+ L
Sbjct: 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS--DVDQLYLIRKTL 217
Query: 329 RPDIPR 334
IPR
Sbjct: 218 GDLIPR 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 47/178 (26%), Positives = 94/178 (52%), Gaps = 13/178 (7%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
++++Y+ GG L L + +R K +V I ++ L +LH I++RD+K EN+LLD
Sbjct: 82 LILDYINGGELFTHLSQRERFK-EQEVQIYSG-EIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 246 ANRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLDGKP--YNRKCDVYSFGICL 301
+N + + DFG+++ E + R + GT+ YMAP+++ G +++ D +S G+ +
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198
Query: 302 WEIYCCDMPYP----DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+E+ P+ S ++S +++ P P+ + I+++ +P KR
Sbjct: 199 YELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 72/260 (27%), Positives = 110/260 (42%), Gaps = 45/260 (17%)
Query: 87 LDIRHEIARGTYGTVYRGAYDGQD--VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
+I I RG +G V D A+KIL+ E M+ AE A FR+E V
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETAC----FREERDVLV 56
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL----KKFL 200
D+ +T A NL + V++Y GG L KF
Sbjct: 57 NGDNQWITTLHYAFQDENNLYL--------------------VMDYYVGGDLLTLLSKFE 96
Query: 201 IRNKRKKLAFKVV-IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA- 258
R F + + IA+D L Y VHRD+K +N+L+D N +++ADFG
Sbjct: 97 DRLPEDMARFYLAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCL 150
Query: 259 RVEAQNPRDMTGETGTLGYMAPEVL----DGK-PYNRKCDVYSFGICLWEIYCCDMPYPD 313
++ + GT Y++PE+L DGK Y +CD +S G+C++E+ + P+
Sbjct: 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 314 LSFTDVSSAVVRQNLRPDIP 333
S + ++ R P
Sbjct: 211 ESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 6/174 (3%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
++++Y+ GG + L +R + V + ++ L +LH IV+RD+K EN+LLD
Sbjct: 82 LILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWE 303
+ + + DFG+++ ++ T GT+ YMAPE++ GK + + D +S GI ++E
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199
Query: 304 IYCCDMPYPDLSFTDVSSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKR 355
+ P+ + S V R+ L+ P P ++ K +P KR
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 39/121 (32%), Positives = 65/121 (53%), Gaps = 6/121 (4%)
Query: 186 VVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
+++EYL GG L L R + A + +I+L L +LH + I++RD+K EN+L
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISL----ALEHLHQQGIIYRDLKPENIL 132
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
LDA +K+ DFG+ + GT+ YMAPE+L + + D +S G +++
Sbjct: 133 LDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYD 192
Query: 304 I 304
+
Sbjct: 193 M 193
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 213 VIQIALDLAR----------GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
VI + LD R G+ +LHS I+HRD+K N+++ ++ TLKI DFG+AR
Sbjct: 115 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
N MT T Y APEV+ G Y D++S G + E+
Sbjct: 175 TNFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 43/147 (29%), Positives = 76/147 (51%), Gaps = 3/147 (2%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+V+ ++ GG L L R R L+ L A L LH +++RD+K EN+LLD
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHKFNVIYRDLKPENILLD 127
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+ + DFG+ ++ ++ GT Y+APE+L G Y + D ++ G+ L+E+
Sbjct: 128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
Query: 306 CCDMPYPDLSFTDVSSAVVRQNLR-PD 331
P+ D + ++ ++++ LR PD
Sbjct: 188 TGLPPFYDENVNEMYRKILQEPLRFPD 214
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 49/144 (34%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 186 VVVEYLPGGTLK--KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
VV+E++P K K RN L +V + L R L+Y+HSK I HRD+K +N+L
Sbjct: 144 VVMEFIPQTVHKYMKHYARNN-HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202
Query: 244 LDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICL 301
+D N TLK+ DFG A+ R ++ Y APE++ G Y D++S G +
Sbjct: 203 IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCII 261
Query: 302 WEIYCCDMPYPDLSFTDVSSAVVR 325
E+ + YP S +VR
Sbjct: 262 AEMI---LGYPIFSGQSSVDQLVR 282
|
Length = 440 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 62/252 (24%), Positives = 106/252 (42%), Gaps = 36/252 (14%)
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPS-RACCVVVEYLPGGTL 196
+E+ + ++LDH N+ K +G PS S ++ SL + +V EY+ L
Sbjct: 51 REIKIIRRLDHDNIVKVYEV-LG------PSGSDLTEDVGSLTELNSVYIVQEYMET-DL 102
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR-TLKIADF 255
L + L+ + L RGL Y+HS ++HRD+K N+ ++ LKI DF
Sbjct: 103 ANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159
Query: 256 GVARV---EAQNPRDMTGETGTLGYMAPE-VLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
G+AR+ + ++ T Y +P +L Y + D+++ G E+ +
Sbjct: 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
Query: 312 P---DLSFTDV---SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-------VM 358
+L + S VVR+ R + + S +R D +RP V
Sbjct: 220 AGAHELEQMQLILESVPVVREEDR----NELLNVIPSFVRN--DGGEPRRPLRDLLPGVN 273
Query: 359 DEVVKLLEAVNT 370
E + LE + T
Sbjct: 274 PEALDFLEQILT 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 41/132 (31%), Positives = 71/132 (53%), Gaps = 13/132 (9%)
Query: 185 CVVVEYLPGGTLKKFLIRN---KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
C +++ + GG L L ++ K++ F A ++ GL ++H++ +V+RD+K N
Sbjct: 73 CFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHNRFVVYRDLKPAN 127
Query: 242 MLLDANRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGI 299
+LLD + ++I+D G+A + P GT GYMAPEVL G Y+ D +S G
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184
Query: 300 CLWEIYCCDMPY 311
L+++ P+
Sbjct: 185 MLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 44/228 (19%)
Query: 134 ASFRQEVAVWQKLDHPNVTKFIG--ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
AS E + ++L HP V + G T L +P SD + L +R
Sbjct: 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR--SDLYTYLGARL-------- 254
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
+ L V +A L + Y+H + I+HRD+KTEN+L++ +
Sbjct: 255 --------------RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 252 IADFGVARVEAQNPRDMT---GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308
+ DFG A A+ G GT+ APEVL G PY D++S G+ ++E
Sbjct: 301 LGDFGAA-CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE----- 354
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
V +A + R D R + + I+R+ + D+ P
Sbjct: 355 --------AAVHTASLFSASRGDERRPYDAQILRIIRQA-QVHVDEFP 393
|
Length = 461 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 35/84 (41%), Positives = 50/84 (59%), Gaps = 4/84 (4%)
Query: 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 281
GL Y+HS I+HRD+K N+ ++ + LKI DFG+AR +MTG T Y APE
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPE 184
Query: 282 V-LDGKPYNRKCDVYSFGICLWEI 304
V L+ YN+ D++S G + E+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 7/122 (5%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+++ + GG L L ++ + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 73 SFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 245 DANRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVL-DGKPYNRKCDVYSFGICLW 302
D + ++I+D G+A + P GT GYMAPEVL G Y+ D +S G L+
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 187
Query: 303 EI 304
++
Sbjct: 188 KL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 65/246 (26%), Positives = 104/246 (42%), Gaps = 61/246 (24%)
Query: 92 EIARGTYGTVY----RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+ +G G V+ +G G+ A+K+LD E M+ + R QE+ LD
Sbjct: 8 LLGKGDVGRVFLVRLKGT--GKLFALKVLDKKE--MIKRNKVK--RVLTEQEIL--ATLD 59
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
HP F+ P+ A+ + C+V++Y PGG L + L R K
Sbjct: 60 HP----FL-----------PTLYASFQT-----ETYLCLVMDYCPGGELFRLLQRQPGKC 99
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADF---------GVA 258
L+ +V A ++ L YLH IV+RD+K EN+LL + + ++DF
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
Query: 259 RVEA-------QNPRDMTGET-------------GTLGYMAPEVLDGKPYNRKCDVYSFG 298
+A + + ET GT Y+APEV+ G + D ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219
Query: 299 ICLWEI 304
I L+E+
Sbjct: 220 ILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+V++Y GG L L + + + IA ++ + +H VHRD+K +N+LLD
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 246 ANRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVL----DGK-PYNRKCDVYSFGI 299
N +++ADFG ++ + GT Y++PE+L DG Y +CD +S G+
Sbjct: 137 MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 196
Query: 300 CLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP 333
C++E+ + P+ S + ++ R P
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 27/192 (14%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL- 244
+V E++ G L F+ R K L ++A LA LSYL K +VH +V T+N+LL
Sbjct: 81 MVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 245 ------DANRTLKIADFGV-----ARVEAQNPRDMTGETGTLGYMAPE-VLDGKPYNRKC 292
+ +K++D G+ +R E + ++APE V D K +
Sbjct: 140 REGIDGECGPFIKLSDPGIPITVLSRQEC---------VERIPWIAPECVEDSKNLSIAA 190
Query: 293 DVYSFGICLWEI-YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDAN 351
D +SFG LWEI Y ++P D + + P C LA +M C + +
Sbjct: 191 DKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCMLVTPSC--KELADLMTHCMNYD 247
Query: 352 PDKRPVMDEVVK 363
P++RP +++
Sbjct: 248 PNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 8/90 (8%)
Query: 220 LARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE-AQNPRDM--TGETGTLG 276
L R L Y+H+ + HRD+K +N+L +A+ LKI DFG+ARV P + T T
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 277 YMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
Y APE L G +++ Y+ I +W I C
Sbjct: 172 YRAPE-LCGSFFSK----YTPAIDIWSIGC 196
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 71/261 (27%)
Query: 93 IARGTYGTV--YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I RG +G V + G A+KIL A+ M+ + A IRA E + + D
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKAD--MLEKEQVAHIRA----ERDILVEADGAW 62
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
V K + NL + ++E+LPGG + L+ K+ L+
Sbjct: 63 VVKMFYSFQDKRNLYL--------------------IMEFLPGGDMMTLLM--KKDTLSE 100
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV------------- 257
+ + + +H +HRD+K +N+LLDA +K++DFG+
Sbjct: 101 EATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 258 ---------------------ARVEAQNPRDMTGET-GTLGYMAPEVLDGKPYNRKCDVY 295
A +N R + T GT Y+APEV YN+ CD +
Sbjct: 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 296 SFGICLWEI------YCCDMP 310
S G+ ++E+ +C + P
Sbjct: 221 SLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 46/168 (27%)
Query: 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
++EYLPGG + L+ K+ + + + +H +HRD+K +N+LLDA
Sbjct: 79 IMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136
Query: 247 NRTLKIADFGV-----------------------ARVEAQNPRDMTGET----------- 272
+K++DFG+ P +
Sbjct: 137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA 196
Query: 273 ----GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI------YCCDMP 310
GT Y+APEV YN++CD +S G+ ++E+ +C D P
Sbjct: 197 YSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 43/166 (25%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+++E+LPGG + L+ K+ L + + + +H +HRD+K +N+LLD
Sbjct: 78 LIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135
Query: 246 ANRTLKIADFGV----------------------------------ARVEAQNPRDMTGE 271
+ +K++DFG+ A +N R +
Sbjct: 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFS 195
Query: 272 T-GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI------YCCDMP 310
T GT Y+APEV YN+ CD +S G+ ++E+ +C + P
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 41/228 (17%)
Query: 92 EIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
++ RGTYG VY+ DG+D D + E I S +E+A+ ++L HPN
Sbjct: 8 KVGRGTYGHVYKAKRKDGKD--------DRDYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 151 VTKFIGASMGTTNLKI--PSQSATSDSHNSL----PSRACCVVVEYLPGGTLKKFLIRNK 204
V + + K+ A D + + S+A V+ LP G +K L +
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQ-- 116
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFGVARV 260
+ G+ YLH+ ++HRD+K N+L+ +KIAD G AR+
Sbjct: 117 ---------------ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
Query: 261 --EAQNP-RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEI 304
P D+ T Y APE+L G + Y + D+++ G E+
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 56/217 (25%)
Query: 187 VVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V++Y+PGG + LIR + + LA + ++ L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL----AIESVHKMGFIHRDIKPDNILI 134
Query: 245 DANRTLKIADFGVA------------------RVEAQNPRD--------------MTGE- 271
D + +K+ DFG+ R ++ P D T E
Sbjct: 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ 194
Query: 272 --------------TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317
GT Y+APEVL K Y + CD +S G+ L+E+ P+ + T
Sbjct: 195 RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT 254
Query: 318 DVSSAVVRQNLRPDIP---RCCPSSLASIMRKCWDAN 351
+ V+ IP + P ++ I + C A
Sbjct: 255 ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT--GETG 273
I L + Y+H K ++HRD+K EN+ L+ + + + DFG A + + R+ G G
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKEREAFDYGWVG 330
Query: 274 TLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
T+ +PE+L G Y D++S G+ L ++
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 92 EIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
++ RGTYG VY+ DG+D ++ + E I S +E+A+ ++L HPN
Sbjct: 8 KVGRGTYGHVYKAKRKDGKD--------EKEYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 151 VTKFIGASMGTTNLKI--PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
V + ++ K+ A D + ++++ K K +L
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEHDLWH---------IIKFHRASKANK-----KPMQL 105
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFGVARV--EA 262
+V + + G+ YLH+ ++HRD+K N+L+ +KIAD G AR+
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 263 QNP-RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEI 304
P D+ T Y APE+L G + Y + D+++ G E+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 34/172 (19%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I+RG +G VY R + + AVK++ A+ M+ ++A R +A+ +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKAD--MINKNMVHQVQAE-RDALALSK------ 62
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL--IRNKRKKL 208
+ FI +L QSA + +V+EYL GG +K L +++
Sbjct: 63 -SPFI------VHLYYSLQSANN----------VYLVMEYLIGGDVKSLLHIYGYFDEEM 105
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
A K + ++AL L YLH I+HRD+K +NML+ +K+ DFG+++V
Sbjct: 106 AVKYISEVAL----ALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 52/240 (21%), Positives = 88/240 (36%), Gaps = 54/240 (22%)
Query: 96 GTYGTVYRGAYDGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153
+ + VAVK LD + +QE+ ++L HPN+
Sbjct: 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKL---------LQQEIITSRQLQHPNILP 63
Query: 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVV 213
++ S DS VV + G+ + L + + L +
Sbjct: 64 YV-------------TSFIVDSE-------LYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103
Query: 214 IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV---EAQNPRDM-- 268
I D+ L Y+HSK +HR VK ++LL + + ++ + + R +
Sbjct: 104 AFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 269 --TGETGTLGYMAPEVLD----GKPYNRKCDVYSFGICLWEIYCCDM-----PYPDLSFT 317
L +++PEVL G YN K D+YS GI C++ P+ D+ T
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGIT-----ACELANGHVPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 37/190 (19%)
Query: 186 VVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+V E++ G L L + K R +A+K+ + A LA LSYL K +VH +V +N+LL
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITV--AQQLASALSYLEDKNLVHGNVCAKNILL 150
Query: 245 DANRTL--------KIADFGVA--------RVEAQNPRDMTGETGTLGYMAPEVL-DGKP 287
A L K++D GV+ RVE + ++APE + G
Sbjct: 151 -ARLGLAEGTSPFIKLSDPGVSFTALSREERVE------------RIPWIAPECVPGGNS 197
Query: 288 YNRKCDVYSFGICLWEI-YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRK 346
+ D +SFG L EI + ++P + + ++ +++ P+ P C LA+++ +
Sbjct: 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPE-PSC--KELATLISQ 254
Query: 347 CWDANPDKRP 356
C P +RP
Sbjct: 255 CLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 58/221 (26%)
Query: 187 VVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V++Y+PGG + LIR + LA + + L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAE----LTCAVESVHKMGFIHRDIKPDNILI 134
Query: 245 DANRTLKIADFGVA---------------------------------------------- 258
D + +K+ DFG+
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLER 194
Query: 259 RVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317
R Q+ R + GT Y+APEVL Y + CD +S G+ L+E+ P+ +
Sbjct: 195 RAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL 254
Query: 318 DVSSAVVRQNLRPDIP---RCCPSSLASIMRKCWDANPDKR 355
+ V+ IP + P + I++ C P+ R
Sbjct: 255 ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC--RGPEDR 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 17/115 (14%)
Query: 196 LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADF 255
K+ +NK K++ I D+ L Y+H I H D+K EN+++D N I D+
Sbjct: 117 FKRIKCKNK------KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170
Query: 256 GVA--------RVE-AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301
G+A +E ++ +D+ GTL Y + +G R+ D+ S G C+
Sbjct: 171 GIASHFIIHGKHIEYSKEQKDL--HRGTLYYAGLDAHNGACVTRRGDLESLGYCM 223
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 60/248 (24%), Positives = 101/248 (40%), Gaps = 50/248 (20%)
Query: 88 DIRHEIARG--TYGTVY--RGAYDGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVA 141
+++ EI RG +VY R G V V+I L+ + + + + + + F +
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR--- 57
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
HPN+ + L + S S NSL + Y P G + + LI
Sbjct: 58 ------HPNIMTSWTVFTTGSWLWVISPFMAYGSANSL-------LKTYFPEG-MSEALI 103
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG----- 256
N I RGL+YLH +HR++K ++L+ + + ++
Sbjct: 104 GN------------ILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSL 151
Query: 257 -----VARVEAQNPRDMTGETGTLGYMAPEVL--DGKPYNRKCDVYSFGICLWEIYCCDM 309
A+V P+ T L +++PE+L D YN K D+YS GI E+ +
Sbjct: 152 VRNGQKAKVVYDFPQ---FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208
Query: 310 PYPDLSFT 317
P+ D+ T
Sbjct: 209 PFQDMLRT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 49/168 (29%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+++E+LPGG L LI K + V + + +H +HRD+K +N+L+D
Sbjct: 78 LIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID 135
Query: 246 ANRTLKIADFGVA-----------------RVEAQNP----------------------- 265
+K++DFG++ +N
Sbjct: 136 RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIA 195
Query: 266 ------RDMTGET-GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
R M T GT Y+APE+ + Y ++CD +S G ++E
Sbjct: 196 TWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 63/278 (22%), Positives = 96/278 (34%), Gaps = 99/278 (35%)
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV-EYLPGGTLK 197
E+A KL HPN+ K IG S ++ EY+ G L
Sbjct: 733 EIADMGKLQHPNIVKLIGLCR---------------------SEKGAYLIHEYIEGKNLS 771
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLH---SKTIVHRDVKTENMLLDANRTLKIAD 254
+ L + L+++ +IA+ +A+ L +LH S +V ++ E +++D
Sbjct: 772 EVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK------- 819
Query: 255 FGVARVEAQNPRDMTGETGTL----------GYMAPEVLDGKPYNRKCDVYSFGICL--- 301
P G L Y+APE + K K D+Y FG+ L
Sbjct: 820 --------DEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871
Query: 302 -------------------WEIYC---C--DMPYPDLSFTDVSSAVVRQNLRPDIPRCCP 337
W YC C DM DVS V QN
Sbjct: 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS---VNQN---------- 918
Query: 338 SSLASIMR---KCWDANPDKRPVMDEVVKLLEAVNTSK 372
+ +M C +P RP ++V+K LE+ + S
Sbjct: 919 -EIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 7/72 (9%)
Query: 194 GTLKKFLIRNKR-------KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
G L++F++ K+ K V+ + + GL LH IVHRD+K EN+L+
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344
Query: 247 NRTLKIADFGVA 258
+ +KI DFG A
Sbjct: 345 DGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 19/48 (39%), Positives = 27/48 (56%), Gaps = 2/48 (4%)
Query: 213 VIQIALD-LARGLSYLHSKTIVHRDVKTENMLLD-ANRTLKIADFGVA 258
+IQ + + L LHS IVHRDVK +N++ + + KI D G A
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 38/171 (22%), Positives = 70/171 (40%), Gaps = 13/171 (7%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+V+++ GG L + +K + + V + A ++ L LH + IV RD+ N+LLD
Sbjct: 62 LVLQHAEGGKLWSHI--SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 246 ANRTLKIADFGVAR-VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
+++ F VE + Y APEV CD +S G L+E+
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFEL 175
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ + + + + +IP S++++ NP +R
Sbjct: 176 LT------GKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 63/230 (27%)
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
EV V ++L H N+ ++I + N K+ +++E+ G L
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKL------------------YILMEFCDAGDLS- 102
Query: 199 FLIRNKRK------KLAFKVVIQIALDLARGLSYLHS-------KTIVHRDVKTENMLLD 245
RN +K K+ ++ I L L+Y H+ + ++HRD+K +N+ L
Sbjct: 103 ---RNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159
Query: 246 ------------ANR-----TLKIADFGVAR---VEAQNPRDMTGETGTLGYMAPEVL-- 283
AN KI DFG+++ +E+ GT Y +PE+L
Sbjct: 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLH 215
Query: 284 DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP 333
+ K Y+ K D+++ G ++E+ C P + S + PD+P
Sbjct: 216 ETKSYDDKSDMWALGCIIYEL--CSGKTPFHKANNFSQLISELKRGPDLP 263
|
Length = 1021 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 36/152 (23%), Positives = 51/152 (33%), Gaps = 27/152 (17%)
Query: 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL 275
+ L L LH + + T + LL G A + +
Sbjct: 22 VCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DGSV---AFKTPEQSRPDPYF 70
Query: 276 GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD-----------LSFTDVSSAVV 324
MAPEV+ G+ Y K D+YS GI L+E ++PY + L+
Sbjct: 71 --MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD 128
Query: 325 RQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
R NL S MR C P +R
Sbjct: 129 RSNLEGVSAAR---SFEDFMRLCASRLPQRRE 157
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 24/75 (32%), Positives = 33/75 (44%), Gaps = 10/75 (13%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+V+EY+ G LK L R L +V + LH IVH D+ T N++L
Sbjct: 76 IVMEYIEGELLKDALEEA-RPDLLREVGRLVGK--------LHKAGIVHGDLTTSNIILS 126
Query: 246 ANRTLKIADFGVARV 260
R I DFG+
Sbjct: 127 GGRIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 3e-04
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 15/83 (18%)
Query: 187 VVEYLPGGTLKKFL--IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V+EY+ G LK + + +L+ ++ + LHS I+H D+ T NM+L
Sbjct: 77 VMEYIEGEPLKDLINSNGMEELELSREIGRLVGK--------LHSAGIIHGDLTTSNMIL 128
Query: 245 DANRTLKIADFGVA----RVEAQ 263
+ + + DFG+A +E +
Sbjct: 129 -SGGKIYLIDFGLAEFSKDLEDR 150
|
Length = 211 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 15/146 (10%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
VV ++ G+ K + + ++ + I + + L Y+H VHR VK ++L+
Sbjct: 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135
Query: 246 AN---------RTLKIADFGV-ARVEAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCD 293
+ L + + G RV P+ L +++PEVL + Y+ K D
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY---SVKVLPWLSPEVLQQNLQGYDAKSD 192
Query: 294 VYSFGICLWEIYCCDMPYPDLSFTDV 319
+YS GI E+ +P+ D+ T +
Sbjct: 193 IYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 33/87 (37%), Positives = 42/87 (48%), Gaps = 12/87 (13%)
Query: 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307
RT K G A VE R + GT Y+APE+L GKP+ D ++ G+CL+E
Sbjct: 523 RTPKSVRRGAAPVE--GERIL----GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTG 576
Query: 308 DMPYPDLSFTDVSSAVVRQN-LRPDIP 333
P F D + V QN L DIP
Sbjct: 577 IPP-----FNDETPQQVFQNILNRDIP 598
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 12/74 (16%)
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS---KTIVHRDVKTENM 242
+++E++ G TL + K IA LA L+ LH + H D+ N+
Sbjct: 70 LLMEWIEGETLDEVSEEEK---------EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNI 120
Query: 243 LLDANRTLKIADFG 256
L+D + L I D+
Sbjct: 121 LVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.08 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.5 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.02 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.87 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.86 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.52 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.44 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.27 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.98 | |
| PLN02236 | 344 | choline kinase | 96.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.68 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.61 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.55 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.4 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.14 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.09 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.82 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.61 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.45 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.97 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.81 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.5 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 93.96 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-56 Score=425.39 Aligned_cols=273 Identities=44% Similarity=0.811 Sum_probs=244.7
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEECCee-EEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
...+|.+...++.+...||+|+||+||+|.|.|+. ||||++........ ..+.|.+|+.+|++++|||||+|
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~-------~~~~f~~E~~il~~l~HpNIV~f 104 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE-------SRKAFRREASLLSRLRHPNIVQF 104 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH-------HHHHHHHHHHHHHhCCCCCeeeE
Confidence 34678899999999999999999999999999998 99999975432211 16789999999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-Cc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT-IV 233 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-ii 233 (394)
+|+|..... .++|||||+++|+|.+++.......+++..++.|+.||++||.|||+++ ||
T Consensus 105 ~G~~~~~~~-------------------~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iI 165 (362)
T KOG0192|consen 105 YGACTSPPG-------------------SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPII 165 (362)
T ss_pred EEEEcCCCC-------------------ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCee
Confidence 999986552 2399999999999999998755578999999999999999999999999 99
Q ss_pred ccCCCCCceeeCCCC-cEEEeeccccccccCCCCCccCCCCCCCcCCccccC--CCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 234 HRDVKTENMLLDANR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD--GKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 234 H~Dlkp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
||||||+|||++.++ ++||+|||+++.........+...||+.|||||+++ ...|+.++||||||+++|||+||+.|
T Consensus 166 HrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 166 HRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred ecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 999999999999997 999999999986554434455579999999999999 66999999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
|.+.....+...++..+.++.++..|++.+..+|..||+.||++||++.+++..|+.+...-..
T Consensus 246 f~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 246 FEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 9999998889999999999999999999999999999999999999999999999999875443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-55 Score=397.74 Aligned_cols=253 Identities=29% Similarity=0.526 Sum_probs=221.9
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..+...+++.++.||+|+.|+||++.+ +++.+|+|++... ....+++++.+|+++++.++|||||++||+
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--------~~~~~~~Qi~rEl~il~~~~spyIV~~yga 145 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--------IDPALQKQILRELEILRSCQSPYIVGFYGA 145 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence 346677899999999999999999988 6899999999522 234456888999999999999999999999
Q ss_pred ecCCCc-cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCccc
Q 048724 158 SMGTTN-LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHR 235 (394)
Q Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~ 235 (394)
|+.... + +|+||||++|+|++++... +.+++..+.+|+.+|++||.|||+ .+||||
T Consensus 146 F~~~~~~i--------------------sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHR 203 (364)
T KOG0581|consen 146 FYSNGEEI--------------------SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHR 203 (364)
T ss_pred EEeCCceE--------------------EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeec
Confidence 997764 4 8999999999999999654 569999999999999999999995 999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL- 314 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~- 314 (394)
||||+|||++..|.|||||||.++...+. ...+..||..|||||.+.+..|+.++||||||++++|+++|+.||+..
T Consensus 204 DIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~ 281 (364)
T KOG0581|consen 204 DIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN 281 (364)
T ss_pred cCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC
Confidence 99999999999999999999999876544 334579999999999999999999999999999999999999999874
Q ss_pred ----ChhhHHHHHHhccCCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 315 ----SFTDVSSAVVRQNLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 315 ----~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
...+....++. +..+.+|.. +|+++++|+..||++||.+|||+++++.+-
T Consensus 282 ~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 282 PPYLDIFELLCAIVD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCCCHHHHHHHHhc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 45566656644 446677775 999999999999999999999999999843
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-55 Score=413.91 Aligned_cols=266 Identities=31% Similarity=0.637 Sum_probs=239.2
Q ss_pred CcccccccccccceeeeccCCceEEEEEEECCe-eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
...|+++.+.+.+.+.||+|.||.||.|.++++ .||+|.++..... .+.|.+|+.+|++|+|+|||+++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----------~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----------PEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----------hhHHHHHHHHHHhCcccCeEEEE
Confidence 568999999999999999999999999999876 9999999854321 26788999999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
|+|.....+ ||||||++.|+|.+||+...+..++..+.+.++.||++||+||+++++|||
T Consensus 268 gV~~~~~pi--------------------yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHR 327 (468)
T KOG0197|consen 268 GVCTKQEPI--------------------YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHR 327 (468)
T ss_pred EEEecCCce--------------------EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccch
Confidence 999876655 999999999999999988667789999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
||...|||++++..+||+|||+|+...++.. ......-+..|.|||.+....++.++|||||||+||||+| |+.||+.
T Consensus 328 DLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 328 DLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred hhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 9999999999999999999999995433322 2233445789999999999999999999999999999998 8999999
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
.++.++...+ ..+.+.+-|..||+++.++|..||+.+|++|||++.+...|+++.+...
T Consensus 408 msn~ev~~~l-e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 408 MSNEEVLELL-ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCHHHHHHHH-hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 9999999766 7788999999999999999999999999999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=414.82 Aligned_cols=272 Identities=26% Similarity=0.446 Sum_probs=238.9
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|...+.||+|||+.||.+++ +|+.||+|++.+.. ......++.+.+|++|.++|+|||||+++++|++.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~------l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL------LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH------hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 5699999999999999999987 89999999997532 223344678889999999999999999999999988
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
++ |||.|+|..++|..+++ .+++++|.+++.+++||+.||.|||+++|+|||||..|+
T Consensus 92 nV--------------------YivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl 149 (592)
T KOG0575|consen 92 NV--------------------YIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL 149 (592)
T ss_pred ce--------------------EEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence 87 89999999999999985 567899999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++++.+|||+|||+|+....+..+..+.||||.|+|||++....++..+||||+||+||.|++|++||...+..+.+..
T Consensus 150 fL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 150 FLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK 229 (592)
T ss_pred eecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH
Confidence 99999999999999999887776667778999999999999999999999999999999999999999999999999988
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCceeEeccC
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLCFIPT 391 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (394)
+....+ .+|..++.+.++||.++|++||.+|||+++|+..=.= ..+..|......|+-.+|-
T Consensus 230 Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff-----~~g~~p~~lp~~~l~~~p~ 291 (592)
T KOG0575|consen 230 IKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF-----KSGFTPARLPSSCLTMVPR 291 (592)
T ss_pred HHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh-----hCCCcCCCCCccccccCCc
Confidence 876644 4667899999999999999999999999999974221 3344455555555555554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-54 Score=393.59 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=218.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|.+.+.||+|+||.|-+|.. +|+.||||+++.......... ..-.....+|++||++|+|||||+++++|..+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~--~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA--IAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc--ccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 46788999999999999999987 899999999986654332221 11123457899999999999999999999987
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.. ||||||++||+|.+++..+ +.+.+..-..+++|++.|+.|||++||+||||||+|
T Consensus 249 ds~--------------------YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeN 306 (475)
T KOG0615|consen 249 DSS--------------------YMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPEN 306 (475)
T ss_pred Cce--------------------EEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcce
Confidence 776 8999999999999999765 458888889999999999999999999999999999
Q ss_pred eeeCCC---CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 242 MLLDAN---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP---YNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 242 Ill~~~---~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||++.+ ..+||+|||+|+... ....+.+.||||.|.|||++.++. +..++|+||+||+||-+++|.+||.+..
T Consensus 307 ILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 307 ILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred EEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999765 789999999999765 456677799999999999998764 3347899999999999999999998876
Q ss_pred hhh-HHHHHHhccCC--CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 316 FTD-VSSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 316 ~~~-~~~~~~~~~~~--~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
... ...++..+.+. +.....++.+..+||.+||..||++|||+.++|..-+
T Consensus 386 ~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 386 TDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred CCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 666 66667666543 3445678999999999999999999999999998543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-54 Score=375.55 Aligned_cols=258 Identities=27% Similarity=0.492 Sum_probs=220.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
.+.+|++.++||+|+||+||++.. +|..||.|-+++.. ..+..++....|+.+|++|+|||||+++++-..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-------md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-------MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-------ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 467899999999999999999977 89999999987543 223335778899999999999999999985433
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHh--CC--Ccc
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLHS--KT--IVH 234 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~--~~--iiH 234 (394)
.+.- .++||||||.+|+|...++. ..+..++++.+|+++.|++.||.++|+ .. |+|
T Consensus 90 ~~~e------------------vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH 151 (375)
T KOG0591|consen 90 EDNE------------------VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH 151 (375)
T ss_pred ccch------------------hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence 3322 23899999999999999874 345679999999999999999999998 44 999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||||.||+|+.+|.|||+|||+++............+|||.||+||.+.+.+|+.++||||+||++|||+...+||.+.
T Consensus 152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 152 RDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred ccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 99999999999999999999999998776665566689999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHHhccCCCCCC-CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIP-RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
+..+....+....+ ++.| ..+|.++..||..|+..||+.||+...++..++
T Consensus 232 n~~~L~~KI~qgd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 232 NLLSLCKKIEQGDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred cHHHHHHHHHcCCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 88888887765544 3455 678999999999999999999998555544444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=381.35 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=218.9
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+..++|+++++||+|+||+||.++. +++.+|+|++++..-. .....+....|..||..++||.||+++-.|
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv------~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV------EKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh------hhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 35678999999999999999999876 7899999999854421 112246677899999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
++...+ |+|+||+.||.|...|.+ .+.+++..+..++.+|+.||.|||++||||||||
T Consensus 95 Qt~~kL--------------------ylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlK 152 (357)
T KOG0598|consen 95 QTEEKL--------------------YLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLK 152 (357)
T ss_pred ccCCeE--------------------EEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 988777 899999999999998854 4569999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+|||++.+|+++|+|||+++..........+.+||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+...
T Consensus 153 PENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 153 PENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred HHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 99999999999999999999865555555566899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp 356 (394)
+...+.... ....+...+.+.+++++++|++||++|.
T Consensus 233 ~~~~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 233 MYDKILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 998887765 2445566899999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=377.04 Aligned_cols=249 Identities=27% Similarity=0.481 Sum_probs=214.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|.+.+.||+|+||+||+|++ ++..||||.+...+. .....+.+..|+.+|+.++|||||.+++++...
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 57899999999999999999988 678999999864321 233456677899999999999999999999887
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+|||||.||+|.+||+++ +.+++..+..++.||+.||++||+++||||||||.|
T Consensus 82 ~~i--------------------~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQN 139 (429)
T KOG0595|consen 82 DFI--------------------YLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQN 139 (429)
T ss_pred CeE--------------------EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcce
Confidence 766 9999999999999999664 469999999999999999999999999999999999
Q ss_pred eeeCCC------CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 242 MLLDAN------RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 242 Ill~~~------~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||+.. -.+||+|||+|+..... .-..+.+|++-|||||++....|+.|+|+||+|+++|++++|+.||...+
T Consensus 140 iLLs~~~~~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 140 ILLSTTARNDTSPVLKIADFGFARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred EEeccCCCCCCCceEEecccchhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999764 46899999999976533 33445799999999999999999999999999999999999999999999
Q ss_pred hhhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 316 FTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 316 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
..+....+..... .+.++..++..+.+++...|..+|.+|.++.+-.
T Consensus 219 ~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 219 PKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 9998886655443 3445566777888999999999999997776544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=358.65 Aligned_cols=241 Identities=27% Similarity=0.455 Sum_probs=218.6
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
..+++|++++.||.|+||.|.+++. +|..+|+|++++.. ...-...+...+|..+|+.+.||+++++++.|.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~------vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK------VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH------HHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 5689999999999999999999987 78899999997543 222333567778999999999999999999999
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+.+.+ |+||||++||.|..++++. +++++..++.++.||+.||+|||+++|++|||||
T Consensus 115 d~~~l--------------------ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKP 172 (355)
T KOG0616|consen 115 DNSNL--------------------YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKP 172 (355)
T ss_pred cCCeE--------------------EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCCh
Confidence 88887 8999999999999999654 4699999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+|||+|.+|.+||+|||+|+..... ..+.||||.|+|||++.+++|+.++|+|+||+++|||+.|.+||...+...+
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 9999999999999999999865433 4457999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~R 355 (394)
...++...+. +|..++.++++||+++|+.|-.+|
T Consensus 250 Y~KI~~~~v~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKVK--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCccc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 9999888654 778899999999999999999999
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-50 Score=385.32 Aligned_cols=305 Identities=31% Similarity=0.558 Sum_probs=261.7
Q ss_pred ceEEecCCCCCChHHHHHHHhhhhhhh---h-hccCCCCCcccccccccccceeeeccCCceEEEEEEE--C-C--ee-E
Q 048724 42 LFFRADKIDFKSWDIQLEKHLSRVWSR---E-REVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--D-G--QD-V 111 (394)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~-g--~~-v 111 (394)
.++......|.+...++..|....... . ....|...+.|++..++..+.++||+|+||.||+|+. . + .. |
T Consensus 110 ~~~~~~~~~F~si~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~V 189 (474)
T KOG0194|consen 110 LFFFEGLRKFPTISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPV 189 (474)
T ss_pred eeEEeccccCCcHHHHHHHHHhcccceeccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeee
Confidence 566667788999998888776544321 1 2445777889999999999999999999999999987 2 2 23 8
Q ss_pred EEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecC
Q 048724 112 AVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191 (394)
Q Consensus 112 avK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~ 191 (394)
|||..+.. ..........|.+|+++|++++|||||++||++....++ +||||+|
T Consensus 190 AvK~~k~~------~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl--------------------~ivmEl~ 243 (474)
T KOG0194|consen 190 AVKTTKGS------SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL--------------------MLVMELC 243 (474)
T ss_pred EEEeeccc------ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc--------------------EEEEEec
Confidence 99988731 122344568899999999999999999999999987777 8999999
Q ss_pred CCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCC
Q 048724 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGE 271 (394)
Q Consensus 192 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 271 (394)
+||+|.++|+++.. .++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+++............
T Consensus 244 ~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~ 322 (474)
T KOG0194|consen 244 NGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLK 322 (474)
T ss_pred CCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccc
Confidence 99999999977543 69999999999999999999999999999999999999999999999999998654222222123
Q ss_pred CCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchh
Q 048724 272 TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350 (394)
Q Consensus 272 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~ 350 (394)
.-+..|+|||.+....|+.++|||||||++||+++ |..||++....++...+...+++...+...|.++..++.+||..
T Consensus 323 klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~ 402 (474)
T KOG0194|consen 323 KLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKK 402 (474)
T ss_pred cCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccC
Confidence 46789999999999999999999999999999998 78899999999999999899999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhccC
Q 048724 351 NPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 351 dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
+|++||+|.++.+.|+.+.....
T Consensus 403 ~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 403 DPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ChhhccCHHHHHHHHHHHHhccc
Confidence 99999999999999999976544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=357.07 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=213.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+.|+.+.++|+|+||+||++++ +|+.||||.+... ++...+.+...+|+++|++++|+|+|.++.+|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 5788899999999999999987 8999999998643 344556677789999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ ++|+|||+.--|.+ |.+. ...++...+.++++|++.|+.|+|++++|||||||+||
T Consensus 75 kl--------------------hLVFE~~dhTvL~e-Le~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI 132 (396)
T KOG0593|consen 75 KL--------------------HLVFEYCDHTVLHE-LERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI 132 (396)
T ss_pred ee--------------------EEEeeecchHHHHH-HHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence 65 89999998755554 4443 34588999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||+.+|.+||||||+|+....+...++..+.|..|.|||.+.+ -.|..++|||++||++.||++|.+-|++.+..+...
T Consensus 133 Lit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 133 LITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred EEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 9999999999999999988777777888899999999999987 679999999999999999999999999998887776
Q ss_pred HHHhc-------------------cCCCCCC----------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQ-------------------NLRPDIP----------RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~-------------------~~~~~~~----------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+... +.+.+-+ ...+.-+.+|+++||+.||++|++.++++.
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 66432 1111111 124567889999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=376.58 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=221.9
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGAS 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 158 (394)
-...+|.+++.||+|+|++|++|+. +++.||||++.+.- ...+.-.+....|-.+|.+| +||.|++|+-.|
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~------Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY------IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH------HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 3468999999999999999999987 78999999986432 12222245667899999999 899999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
+|...+ |+|+||+++|+|.++|++. +.|++.-.+.++.+|+.||+|||++||||||||
T Consensus 144 QD~~sL--------------------YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlK 201 (604)
T KOG0592|consen 144 QDEESL--------------------YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLK 201 (604)
T ss_pred ecccce--------------------EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCC
Confidence 988887 8899999999999999664 569999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC-----------CC--ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHH
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP-----------RD--MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~-----------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 305 (394)
|+|||++.++++||+|||.|+...... .. ....+||..|.+||++.....++.+|+|+|||+||.|+
T Consensus 202 PENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQml 281 (604)
T KOG0592|consen 202 PENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQML 281 (604)
T ss_pred hhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHh
Confidence 999999999999999999998643211 11 13478999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 306 CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 306 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.|.+||.+.+.-.+.+.++.. ..++|..+++...+|++++|..||++|+|.++|.++
T Consensus 282 aG~PPFra~NeyliFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 282 AGQPPFRAANEYLIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cCCCCCccccHHHHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 999999999988888888664 556888899999999999999999999999988763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=361.47 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=224.3
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
....+|-++.++|++..+||.|..++||+|+. ++..||||++...+ .......+.+|+..|+.++||||+
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk--------c~~~ld~l~kE~~~msl~~HPNIv 87 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK--------CNNDLDALRKEVQTMSLIDHPNIV 87 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh--------hhhhHHHHHHHHHHhhhcCCCCcc
Confidence 34457888999999999999999999999988 78999999997332 222257788999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
+++..|.....+ |+||.||.+|++.+.++......+++..+..|++++++||.|||++|.
T Consensus 88 ~~~~sFvv~~~L--------------------WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~ 147 (516)
T KOG0582|consen 88 TYHCSFVVDSEL--------------------WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH 147 (516)
T ss_pred eEEEEEEeccee--------------------EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence 999999987776 999999999999999988777789999999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCCC----ccCCCCCCCcCCccccC--CCCCCccchHHHHHHHHHHHHh
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLD--GKPYNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~ellt 306 (394)
||||||+.||||+.+|.|||+|||.+........+ ..+..||++|||||++. ...|+.|+||||||++..||.+
T Consensus 148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 99999999999999999999999987643332221 14568999999999964 3579999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHhccCC--------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 307 CDMPYPDLSFTDVSSAVVRQNLR--------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 307 g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
|..||......++....+..... .+..+.++..+++++..||.+||.+|||++++++
T Consensus 228 G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 228 GHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 99999999998888665544321 1122446788999999999999999999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=363.95 Aligned_cols=258 Identities=30% Similarity=0.553 Sum_probs=215.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..++...+.||+|+||+||++.. +|...|||.+...... . .+.+.+|+.+|++++|||||+++|.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-----~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-----T----SESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch-----h----HHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 45677788999999999999988 4799999998743110 0 35678999999999999999999964332
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.. ..+++.|||+++|+|.+++.+... .+++..+..+..||++||.|||++|+||+||||+|
T Consensus 87 ~~------------------~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N 147 (313)
T KOG0198|consen 87 EN------------------DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN 147 (313)
T ss_pred cC------------------eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence 21 235899999999999999987654 79999999999999999999999999999999999
Q ss_pred eeeCC-CCcEEEeeccccccccC---CCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCC-CC
Q 048724 242 MLLDA-NRTLKIADFGVARVEAQ---NPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPD-LS 315 (394)
Q Consensus 242 Ill~~-~~~vkl~DFG~a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~-~~ 315 (394)
||++. ++.+||+|||+++.... .........||+.|||||++... ...+++|||||||++.||+||..||.. ..
T Consensus 148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~ 227 (313)
T KOG0198|consen 148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE 227 (313)
T ss_pred EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence 99999 79999999999986542 11223346899999999999953 344599999999999999999999987 44
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.......+......+.+|..+|.+.++||.+|+..||++|||++++|+......
T Consensus 228 ~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 228 EAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred hHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 444445555566667899999999999999999999999999999999776544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=381.07 Aligned_cols=255 Identities=28% Similarity=0.613 Sum_probs=229.3
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
...+-|+|.++...-++-||.|+.|-||+|+..++.||||.++. .-..+++-|++|+||||+.|
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e----------------lkETdIKHLRkLkH~NII~F 177 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE----------------LKETDIKHLRKLKHPNIITF 177 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh----------------hhhhhHHHHHhccCcceeeE
Confidence 34567999999999999999999999999999999999998752 22357889999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
.|+|.....+ |||||||..|.|.+.|+. ..+++......|.++|+.||.|||.+.|||
T Consensus 178 kGVCtqsPcy--------------------CIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIH 235 (904)
T KOG4721|consen 178 KGVCTQSPCY--------------------CIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIH 235 (904)
T ss_pred eeeecCCcee--------------------EEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhh
Confidence 9999866554 999999999999999955 456888999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||||.-||||+.+..|||+|||-++..... ..+..++||..|||||+++..+.+.++|||||||+||||+||..||.+.
T Consensus 236 RDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 236 RDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 999999999999999999999999865444 3444589999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
+...++..+-...+..+.|..||+.|+-||++||+..|..||+|++++..|+-.
T Consensus 315 dssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 315 DSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 888777777666788889999999999999999999999999999999998743
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=373.17 Aligned_cols=260 Identities=27% Similarity=0.518 Sum_probs=222.9
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGAS 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~ 158 (394)
...+.|.+.+.||+|+||+|++|.+ +|..||+|+++...... .. ....+.+.+|+.+++.++ ||||++++.++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~---~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS---KS-QKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc---cc-cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 4468999999999999999999987 78999999876542110 11 122355668999999998 99999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.....+ |+||||+.||+|.+++.+ .+++.+..+..++.|++.|++|||++||+|||||
T Consensus 90 ~t~~~~--------------------~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK 147 (370)
T KOG0583|consen 90 ATPTKI--------------------YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK 147 (370)
T ss_pred ecCCeE--------------------EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 876665 899999999999999976 4679999999999999999999999999999999
Q ss_pred CCceeeCCC-CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 239 TENMLLDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP-YN-RKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 239 p~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|+|||++.+ +++||+|||++...........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||.+.+
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 999999999 9999999999987633344566789999999999999987 86 79999999999999999999999988
Q ss_pred hhhHHHHHHhccCCCCCCCCC-cHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 316 FTDVSSAVVRQNLRPDIPRCC-PSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
...+...+... ...+|..+ +.+++.|+.+||..||.+|+|+.+++ .-..+..
T Consensus 228 ~~~l~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 228 VPNLYRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 77777776554 44577777 99999999999999999999999999 4444543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=380.45 Aligned_cols=265 Identities=34% Similarity=0.664 Sum_probs=228.0
Q ss_pred CcccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.++|+|..+++.+...||+|.||+||+|.|.| .||||+++.... + .+..+.|+.|+.++++-+|.||+=|.|
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p---t----~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP---T----PEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCC---C----HHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 47899999999999999999999999999988 599999985432 2 124688999999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|..+.. .||.-+|+|.+|+.+|+... ..|...+.+.|+.||++||.|||.++|||||
T Consensus 456 ~~~~p~~---------------------AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrD 513 (678)
T KOG0193|consen 456 ACMNPPL---------------------AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRD 513 (678)
T ss_pred hhcCCce---------------------eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhh
Confidence 9986544 68999999999999998654 5699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
||..|||+.+++.|||+|||++.....- ........|...|||||+++. .+|++.+||||||+++|||+||..||
T Consensus 514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 9999999999999999999999753221 112223567889999999974 57999999999999999999999999
Q ss_pred CCCChhhHHHHHHhccCCCCCC---CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIP---RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
.....+.++..+-++.+.++.. ..|+.++++|+..||..++++||.+.+|+..|+.+..+
T Consensus 594 si~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred CCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 9777777777666665554443 56899999999999999999999999999998888763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=370.74 Aligned_cols=264 Identities=29% Similarity=0.566 Sum_probs=217.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcc
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNV 151 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nI 151 (394)
|++..++|++.+.||+|+||+||+|.+ +++.||||+++.... ......+.+|+.+++.+ +||||
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~ni 73 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--------ASEHKALMSELKILIHIGNHLNV 73 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--------hHHHHHHHHHHHHHHHhccCcce
Confidence 788889999999999999999999974 245799999863221 11235678899999999 89999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---------------------------
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------------------- 204 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------------------- 204 (394)
++++++|..... .+++||||+++|+|.+++....
T Consensus 74 v~~~~~~~~~~~-------------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (338)
T cd05102 74 VNLLGACTKPNG-------------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134 (338)
T ss_pred eeEEeEecCCCC-------------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccc
Confidence 999998864332 2489999999999999997532
Q ss_pred ---------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEE
Q 048724 205 ---------------------------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251 (394)
Q Consensus 205 ---------------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vk 251 (394)
..++++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~k 214 (338)
T cd05102 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK 214 (338)
T ss_pred cccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEE
Confidence 13478889999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccC
Q 048724 252 IADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 252 l~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||+.....+........+.
T Consensus 215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 999999975432211 1122345688999999999999999999999999999997 9999987665444444444454
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
....+..+++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 295 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 555677789999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=391.69 Aligned_cols=267 Identities=31% Similarity=0.562 Sum_probs=232.2
Q ss_pred ccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
..++...+..+.+.||+|+||+||+|... ...||||.++... ....+++|++|++++..++||||
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--------~~~~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--------ENQARQDFRREAELLAELQHPNI 551 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--------cHHHHHHHHHHHHHHHhccCCCe
Confidence 45677788899999999999999999762 3579999997432 22347899999999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc------------cCCCCHHHHHHHHHH
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK------------RKKLAFKVVIQIALD 219 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~q 219 (394)
|+|+|+|...+.+ |+|+|||..|+|.+||+... +.+++..+.+.||.|
T Consensus 552 VrLlGVC~~~~P~--------------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~Q 611 (774)
T KOG1026|consen 552 VRLLGVCREGDPL--------------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQ 611 (774)
T ss_pred EEEEEEEccCCee--------------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHH
Confidence 9999999988777 99999999999999997532 234899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeecccccccc-CCCCCcc-CCCCCCCcCCccccCCCCCCccchHHHH
Q 048724 220 LARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA-QNPRDMT-GETGTLGYMAPEVLDGKPYNRKCDVYSF 297 (394)
Q Consensus 220 i~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~-~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 297 (394)
|+.||.||-++.+|||||..+|+||.++..|||+|||+++-.- .+..+.. ...-+.+||+||.+..++|+.++|||||
T Consensus 612 IAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 612 IAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred HHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 9999999999999999999999999999999999999998432 2221111 2345789999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 298 GICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 298 G~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
||+|||+++ |+.||.+.++.+++..+..++. .+-|..||.++.+||..||+.+|.+||++.+|-..|+........
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999999997 8999999999999988866665 788999999999999999999999999999999999998755443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=371.99 Aligned_cols=249 Identities=27% Similarity=0.481 Sum_probs=217.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
...|+...+||+|+.|.||.|.. +++.||||.+....... ++-+.+|+.+|+..+|+|||.+++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---------keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---------KELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---------hhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 35677888999999999999987 77899999987544221 35677899999999999999999998876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+||||++||+|.|.+... .+++.++..|+++++.||+|||.+||+|||||.+|
T Consensus 343 deL--------------------WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDn 399 (550)
T KOG0578|consen 343 DEL--------------------WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDN 399 (550)
T ss_pred cee--------------------EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccce
Confidence 665 9999999999999998543 49999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.+|.+||+|||++............-+|||.|||||++..+.|+.++||||||++++||+-|++||-..+...-.+
T Consensus 400 ILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 400 ILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred eEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence 99999999999999999877666656667899999999999999999999999999999999999999998766666555
Q ss_pred HHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+...+ .+...+..+|+.+++||.+||+.||++|+++.++|+.
T Consensus 480 LIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 480 LIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 553332 3344567899999999999999999999999999973
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=356.81 Aligned_cols=261 Identities=22% Similarity=0.428 Sum_probs=220.2
Q ss_pred cccccccce--eeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIR--HEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~--~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+..++++.. ..||+|++|.||+|.++|+.||||+++.... ......+.|.+|+.+|++++||||++++|++.
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHK------GHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccc------ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 334444444 5799999999999999999999999874321 12233467889999999999999999999987
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVK 238 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlk 238 (394)
+... ....+++||||+++|+|.+++... ..+++...+.++.|++.||.|||+ .+++|||||
T Consensus 89 ~~~~----------------~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlk 150 (283)
T PHA02988 89 DIVD----------------DLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150 (283)
T ss_pred eccc----------------CCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCC
Confidence 5111 012348999999999999999653 468999999999999999999998 599999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+|||++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 151 p~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 151 SVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred hhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999999754332 123568899999999976 6799999999999999999999999998888
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.+....+...+.++..+..++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 88877777676777777779999999999999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=364.87 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=218.0
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+..++|+++++||+|+||.||+|+- +|..+|+|++++... .........+.|-.+|...++|+||+++-.|
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M------~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM------LKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH------HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 57889999999999999999999976 899999999986542 2223346677899999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
++.+++ ||||||++||++..+|.+. ..|++..+..++.+++.|+.-||+.|+||||||
T Consensus 211 QD~~~L--------------------YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIK 268 (550)
T KOG0605|consen 211 QDKEYL--------------------YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIK 268 (550)
T ss_pred cCCCee--------------------EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCC
Confidence 998887 9999999999999999654 579999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccC-----------------------CCC-----Cc-------------------cCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQ-----------------------NPR-----DM-------------------TGE 271 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~-----------------------~~~-----~~-------------------~~~ 271 (394)
|+|+|||..|++||+|||++.-... ... .. ...
T Consensus 269 PdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~St 348 (550)
T KOG0605|consen 269 PDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYST 348 (550)
T ss_pred hhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcc
Confidence 9999999999999999999852100 000 00 124
Q ss_pred CCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhch
Q 048724 272 TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWD 349 (394)
Q Consensus 272 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~ 349 (394)
+|||.|||||++.+..|+..+|+|||||++|||+.|.+||...+..+...+++.......+| ..++++.++||.+||.
T Consensus 349 VGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 349 VGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred cCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc
Confidence 69999999999999999999999999999999999999999999999999987665333333 4578999999999999
Q ss_pred hCCCCCC---CHHHHHH
Q 048724 350 ANPDKRP---VMDEVVK 363 (394)
Q Consensus 350 ~dP~~Rp---t~~~ll~ 363 (394)
||++|. .++||.+
T Consensus 429 -d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKK 444 (550)
T ss_pred -CHHHhcCcccHHHHhc
Confidence 999997 4666655
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=373.35 Aligned_cols=248 Identities=26% Similarity=0.436 Sum_probs=218.3
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 156 (394)
..+.+++|.++++||+|+||+|+++.. +++.+|||++++..- ....+ .+....|..|+... +||.++.++.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I--l~~d~----Ve~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI--LQRDE----VESLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce--ecccc----HHHHHHHHHHHHHhccCCeEeeccc
Confidence 357789999999999999999999988 678999999986542 22222 24556788888887 5999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|+..+++ |+||||+.||++..+ .....+++..+..++..|+.||+|||++||||||
T Consensus 437 ~fQT~~~l--------------------~fvmey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRD 493 (694)
T KOG0694|consen 437 CFQTKEHL--------------------FFVMEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRD 493 (694)
T ss_pred ccccCCeE--------------------EEEEEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHhcCceeee
Confidence 99988887 889999999995433 3346799999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||.+|||+|.+|++||+|||+++-.........+.||||.|||||++.+..|+.++|+|+|||+||||+.|..||++.+.
T Consensus 494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 494 LKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred cchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999999999998655455567779999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
+++...++.. ++.+|..+|.+..++|+++|.+||++|..+
T Consensus 574 ee~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 EEVFDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 9999998765 556788899999999999999999999754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=361.09 Aligned_cols=269 Identities=26% Similarity=0.392 Sum_probs=220.7
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHH-HH----HHHHHHHHHHHHhCCCCccee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAA-AI----RASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~-~~----~~~~~~E~~il~~l~h~nIv~ 153 (394)
...+++|++.+.||+|.||.|-+|.. +++.||||++.+............ .. .+...+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 35578999999999999999999988 789999999976543211111111 11 257789999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK-LAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
|+.+..+... ..+|||+|||..|.+... ...++ +++.++++|+.+++.||.|||.+||
T Consensus 173 LiEvLDDP~s------------------~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgi 231 (576)
T KOG0585|consen 173 LIEVLDDPES------------------DKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGI 231 (576)
T ss_pred EEEeecCccc------------------CceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 9998765444 455999999999988532 23344 9999999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeecccccccc-----CCCCCccCCCCCCCcCCccccCCCC----CCccchHHHHHHHHHH
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEA-----QNPRDMTGETGTLGYMAPEVLDGKP----YNRKCDVYSFGICLWE 303 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~e 303 (394)
|||||||+|+||+++|+|||+|||.+.... ..........|||.|+|||.+.+.. .+.+.||||+||+||.
T Consensus 232 iHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYC 311 (576)
T KOG0585|consen 232 IHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYC 311 (576)
T ss_pred eccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHH
Confidence 999999999999999999999999987442 1122233468999999999987632 3468899999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 304 IYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 304 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
|+.|+.||.+....+....++...+..+....+...+++||.+||.+||++|.+..+|....+....
T Consensus 312 llfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 312 LLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999999999999999999988776655555578999999999999999999999999988776543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=331.04 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=228.6
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
..+++|++++.||+|-||.||+|+. ++-.||+|++.+. ..........+.+|++|-+.|+||||+++|++|.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs------qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS------QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH------HHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 3468999999999999999999988 5678999998632 2445556788999999999999999999999999
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+.... |+++||.++|+|...|.......+++...+.++.|++.|+.|+|.+++|||||||
T Consensus 93 d~~ri--------------------yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp 152 (281)
T KOG0580|consen 93 DSKRI--------------------YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP 152 (281)
T ss_pred cccee--------------------EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCH
Confidence 87776 9999999999999999877777899999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+|+|++..+.+||+|||-+.... .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.
T Consensus 153 enlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et 230 (281)
T KOG0580|consen 153 ENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET 230 (281)
T ss_pred HHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH
Confidence 99999999999999999997544 3344457999999999999999999999999999999999999999999998888
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
+..+... +..+|..++.+.+++|.+||..+|.+|.+..+++..-+
T Consensus 231 YkrI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 231 YKRIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 8887655 44567889999999999999999999999999987644
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=360.96 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=212.1
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeec
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASM 159 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~ 159 (394)
..++|.++++||.|+||.||+|+. +|..||||.++..-. ..++. -=.+|+..|++|+ |||||++.+++.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~---s~ee~-----~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY---SWEEC-----MNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc---cHHHH-----HHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 357899999999999999999987 788999999874321 22222 2247999999998 999999999998
Q ss_pred CCC-ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 160 GTT-NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 160 ~~~-~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
+.+ .+ |+||||| ..+|.++++.+ +..+++..+..|+.||++||+|+|.+|+.|||+|
T Consensus 80 d~~~~L--------------------~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlK 137 (538)
T KOG0661|consen 80 DNDRIL--------------------YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLK 137 (538)
T ss_pred ccCceE--------------------eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence 877 44 8999999 56999999876 6789999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|+|||+.....+||+|||+|+-.... .-++..+.|..|.|||++. ..-|+.+.|+|++||+++|+++-++-|++.+..
T Consensus 138 PENiLi~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~ 216 (538)
T KOG0661|consen 138 PENILISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI 216 (538)
T ss_pred hhheEecccceeEecccccccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH
Confidence 99999998899999999999965433 3455678999999999874 567999999999999999999999999999988
Q ss_pred hHHHHHHhc-------------------cCCCCC---------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQ-------------------NLRPDI---------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~-------------------~~~~~~---------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+.+..+..- +++.+. -..++.++.++|.+||..||++|||++++++.
T Consensus 217 Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 217 DQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 877776431 111110 12367899999999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=364.31 Aligned_cols=248 Identities=32% Similarity=0.538 Sum_probs=220.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|.+.+.||+|+||+||+|+. +.+.||+|.+.+.... +...+.+.+|++|++.++|||||.++++|....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-------~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-------EKELKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-------hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 6788999999999999999977 6789999998754321 112356788999999999999999999999777
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
++ |+|.||+.| +|..+|... +.++++.+..|+++++.||.|||+.+|+|||+||.||
T Consensus 75 ~~--------------------~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqni 131 (808)
T KOG0597|consen 75 HL--------------------WVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNI 131 (808)
T ss_pred eE--------------------EEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCccee
Confidence 76 999999976 999999654 5699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|+..++.+|+||||+|+.........+...|||-|||||.+.+.+|+..+|.||+||++||+++|++||...+..+....
T Consensus 132 Ll~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~ 211 (808)
T KOG0597|consen 132 LLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS 211 (808)
T ss_pred eecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence 99999999999999999777666666778999999999999999999999999999999999999999999888888887
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+.... ..+|...+..+.+|+..+|.+||.+|.|..+++..
T Consensus 212 I~~d~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 212 ILKDP--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HhcCC--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 76654 34556789999999999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=368.71 Aligned_cols=254 Identities=29% Similarity=0.525 Sum_probs=224.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|++++.||.|+-|.|-+|++ +|+.+|||++..... ........+.+|+-||+.+.||||+++|+++.+.
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~------~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~ 84 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE------LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK 84 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccc------cccccccchhhhhHHHHHhcCCCeeeeeeeeccC
Confidence 56788899999999999999998 999999999975431 1122235677899999999999999999999987
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.++ |+|.||++||.|++++.++ +++++.++.+++.||+.|+.|+|..+|+||||||+|
T Consensus 85 ~~l--------------------ylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpEN 142 (786)
T KOG0588|consen 85 QHL--------------------YLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPEN 142 (786)
T ss_pred ceE--------------------EEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchh
Confidence 776 8999999999999999654 679999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
+|++..+++||+|||+|.+.. +..-..+.||.|.|.|||++.|.+|+ .++||||.||+||.|+||+.||.+.+...++
T Consensus 143 lLLd~~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL 221 (786)
T KOG0588|consen 143 LLLDVKNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL 221 (786)
T ss_pred hhhhcccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH
Confidence 999999999999999998643 33445567999999999999999886 6999999999999999999999988888888
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..+.++.+ ++|..+|.+.++||++||..||++|.|+++|++.-.-.
T Consensus 222 lKV~~G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 222 LKVQRGVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred HHHHcCcc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 88766644 57788999999999999999999999999999976543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=359.96 Aligned_cols=248 Identities=31% Similarity=0.491 Sum_probs=216.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|.....||+|+||.||+|.+ +++.||+|++.-.. .+.....+.+|+.+|.+++++||.++||.+....
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--------~~deIediqqei~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--------cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence 4566668899999999999988 78899999997332 2233467789999999999999999999999877
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ +++||||.||++.+.+... ..+.+..+..|+++++.|+.|||.++.+|||||+.||
T Consensus 85 ~L--------------------wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaani 142 (467)
T KOG0201|consen 85 KL--------------------WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANI 142 (467)
T ss_pred cH--------------------HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccce
Confidence 77 7899999999999999543 3458888999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|+..+|.+||+|||++...........+.+||+.|||||++.+..|+.++||||||++.+||.+|.+||....+..+...
T Consensus 143 l~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl 222 (467)
T KOG0201|consen 143 LLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL 222 (467)
T ss_pred eEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe
Confidence 99999999999999998766665555778999999999999998999999999999999999999999998887665544
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+ -....|.+...+++.+++||..||++||+.||++.++++
T Consensus 223 I-pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 223 I-PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c-cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4 334455566789999999999999999999999999886
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=351.13 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=211.9
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|.+ +|+.||+|+++... .........+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE------VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH------HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence 4688999999999999999988 58899999986321 111223466788999999999999999998887665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI 132 (291)
T cd05612 75 FL--------------------YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132 (291)
T ss_pred eE--------------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 54 8999999999999999653 4689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++.++.+||+|||+++..... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 133 li~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~ 209 (291)
T cd05612 133 LLDKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209 (291)
T ss_pred EECCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999999754322 2235789999999999999999999999999999999999999998887777766
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
+.... ..++..++..+++||++||+.||.+||+ ++++++.
T Consensus 210 i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 ILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 65543 4566778999999999999999999995 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.35 Aligned_cols=244 Identities=27% Similarity=0.432 Sum_probs=207.5
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 168 (394)
+.||+|+||.||+|+. +|+.||||+++... .........+.+|+.++++++||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~---- 70 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV------IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL---- 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE----
Confidence 3699999999999987 68899999997422 11122235677899999999999999999998876655
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~ 248 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 71 ----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~ 132 (323)
T cd05571 71 ----------------CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132 (323)
T ss_pred ----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC
Confidence 8999999999999998653 4689999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccC
Q 048724 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 249 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|||++|..||...+.......+...
T Consensus 133 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-- 210 (323)
T cd05571 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-- 210 (323)
T ss_pred CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--
Confidence 999999999875333333344467999999999999999999999999999999999999999887777666655444
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
...++..+++++.++|.+||+.||++|| ++.++++.
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3456677899999999999999999999 79998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=362.15 Aligned_cols=264 Identities=31% Similarity=0.567 Sum_probs=218.6
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 148 (394)
..+|.+..++|++.+.||+|+||+||+|++ ++..||||+++.... ....+.+.+|+.+++.+ +|
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~Ei~il~~l~~H 98 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYLGNH 98 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--------cHHHHHHHHHHHHHHHhcCC
Confidence 346888889999999999999999999974 345899999863321 11135678899999999 89
Q ss_pred CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc------------------------
Q 048724 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK------------------------ 204 (394)
Q Consensus 149 ~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~------------------------ 204 (394)
|||++++++|.+.... ++||||+++|+|.+++....
T Consensus 99 pnIv~l~~~~~~~~~~--------------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (375)
T cd05104 99 INIVNLLGACTVGGPT--------------------LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQR 158 (375)
T ss_pred cceeeeeeeeccCCcc--------------------eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhh
Confidence 9999999999876655 89999999999999996532
Q ss_pred -------------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 205 -------------------------------------------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 205 -------------------------------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
...+++..++.++.||+.||.|||++|++||
T Consensus 159 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 238 (375)
T cd05104 159 EMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHR 238 (375)
T ss_pred cccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 1247888999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCC--ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 239 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 239 DLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred CCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999754322211 112335678999999999999999999999999999998 899998
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..............+.+...+...+.++.+|+.+||+.||++|||+.++++.|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 319 GMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 77655555555566556666677899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=343.59 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=224.7
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC--CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD--GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
..-.+.+++|++++.||+|.-|+||++... +..+|+|++.+.. ........+...|.+||+.++||.++.+|
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~------l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES------LASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH------HhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 445678899999999999999999999984 4799999997433 22233345667799999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+.|...... |++||||+||+|..+.+++..+.+++..++.++.+|+-||+|||-.|||+|
T Consensus 144 a~fet~~~~--------------------cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYR 203 (459)
T KOG0610|consen 144 ASFETDKYS--------------------CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYR 203 (459)
T ss_pred heeecccee--------------------EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeec
Confidence 999876665 999999999999999998888899999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccC---------------------------------C-C----------------
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQ---------------------------------N-P---------------- 265 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~---------------------------------~-~---------------- 265 (394)
||||+||||-++|+|.|+||.++..... . .
T Consensus 204 DLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~ 283 (459)
T KOG0610|consen 204 DLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPEL 283 (459)
T ss_pred cCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhh
Confidence 9999999999999999999987642100 0 0
Q ss_pred ------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHH
Q 048724 266 ------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSS 339 (394)
Q Consensus 266 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (394)
......+||-.|+|||+++|...+.++|+|+|||++|||+.|..||.+.+..+...+++.+....+-...++..
T Consensus 284 ~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~ 363 (459)
T KOG0610|consen 284 VAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSA 363 (459)
T ss_pred hcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhH
Confidence 01112468999999999999999999999999999999999999999999999999999887766555578899
Q ss_pred HHHHHHHhchhCCCCCCC----HHHHHH
Q 048724 340 LASIMRKCWDANPDKRPV----MDEVVK 363 (394)
Q Consensus 340 l~~li~~cL~~dP~~Rpt----~~~ll~ 363 (394)
+++||+++|.+||.+|.. +.||-+
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhhc
Confidence 999999999999999997 777765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=356.46 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=213.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||+||+|++ +++.||+|+++... .........+.+|+.++++++||||+++++++.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE------ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 458999999999999999999988 67899999987422 1112234668899999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+
T Consensus 90 ~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~ 147 (329)
T PTZ00263 90 ENRV--------------------YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE 147 (329)
T ss_pred CCEE--------------------EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 6655 8999999999999999653 46899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|||++.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.....
T Consensus 148 NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 224 (329)
T PTZ00263 148 NLLLDNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224 (329)
T ss_pred HEEECCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH
Confidence 999999999999999999754322 22357899999999999999999999999999999999999999888777766
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
..+... ...++..++..+++||.+||+.||.+||+ +++++..
T Consensus 225 ~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 EKILAG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhcC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 666544 34566778999999999999999999986 6888754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=384.69 Aligned_cols=264 Identities=35% Similarity=0.663 Sum_probs=228.2
Q ss_pred cccccccceeeeccCCceEEEEEEE---CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY---DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~---~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+.....++.+.||+|+||.||.|.. .|. .||||.++... .......|.+|+.+|+.++|||||++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--------~~~~~~~Fl~Ea~~m~~f~HpNiv~l 760 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--------SEQEVSDFLKEALLMSKFDHPNIVSL 760 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--------CHHHHHHHHHHHHHHhcCCCcceeeE
Confidence 4467788899999999999999987 333 49999887432 22335789999999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-----RKKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
+|+|.+.... +|++|||+||+|..||++.+ ...++...++.++.||++|+.||++
T Consensus 761 iGv~l~~~~~--------------------~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~ 820 (1025)
T KOG1095|consen 761 IGVCLDSGPP--------------------LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES 820 (1025)
T ss_pred EEeecCCCCc--------------------EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh
Confidence 9999886555 89999999999999998752 3468899999999999999999999
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc-cccCCCCCccCC-CCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR-VEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC- 306 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~-~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt- 306 (394)
+++|||||..+|+|++....|||+|||+|+ +...+....... .-+..|||||.+....++.++|||||||+|||++|
T Consensus 821 ~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifsl 900 (1025)
T KOG1095|consen 821 KHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSL 900 (1025)
T ss_pred CCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhC
Confidence 999999999999999999999999999999 322222222222 44579999999999999999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 307 CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 307 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
|..||++.++.++...+..++ +.+.|..||..+.++|.+||+.+|++||++..|++.+..+.....+
T Consensus 901 G~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 901 GATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred CCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 799999999999998888887 8899999999999999999999999999999999999988765443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=361.33 Aligned_cols=265 Identities=29% Similarity=0.524 Sum_probs=220.0
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE--C-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY--D-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 148 (394)
...|.+..++|++.+.||+|+||.||+|++ . +..||||+++..... .....+.+|+.+++.+ +|
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~~h 101 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--------DEREALMSELKILSHLGQH 101 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--------HHHHHHHHHHHHHHhhccC
Confidence 456888899999999999999999999875 2 247999998643211 1135678899999999 89
Q ss_pred CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc------------------------
Q 048724 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK------------------------ 204 (394)
Q Consensus 149 ~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~------------------------ 204 (394)
+|||+++++|...... |+||||+++|+|.+++....
T Consensus 102 ~nIv~~~~~~~~~~~~--------------------~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (374)
T cd05106 102 KNIVNLLGACTHGGPV--------------------LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161 (374)
T ss_pred CceeeEeeEecCCCCe--------------------EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccc
Confidence 9999999999876554 89999999999999986432
Q ss_pred --------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 205 --------------------------------------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 205 --------------------------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
..++++..+++++.||+.||.|||++|++||||||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 241 (374)
T cd05106 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAAR 241 (374)
T ss_pred hhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchh
Confidence 124788899999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCC--ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFT 317 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~ 317 (394)
|||++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||......
T Consensus 242 Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred eEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 999999999999999998754322111 112235678999999998899999999999999999997 99999887665
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
...............+..+++++.+++.+||+.||++|||+.++++.|+++.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 322 SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 5555555555666667778999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=339.79 Aligned_cols=258 Identities=30% Similarity=0.621 Sum_probs=220.2
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
|++...+|.+.+.||+|+||.||+|.+ +++.||+|+++.... ....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQLLGV 70 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----------HHHHHHHHHHHHHhCCCCChhheEEE
Confidence 678888999999999999999999988 578999999863211 12467789999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.....+ +++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||
T Consensus 71 ~~~~~~~--------------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 130 (263)
T cd05052 71 CTREPPF--------------------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130 (263)
T ss_pred EcCCCCc--------------------EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 8766554 89999999999999997655567899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCC-ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
||+||+++.++.+||+|||++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||+...
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999999998754332111 111234568999999998899999999999999999998 999998877
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..+....+ ........+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 211 LSQVYELL-EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 76665544 44556677788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=351.59 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=211.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|+.+++||+|+||.||+|++ +|+.||+|.++........ .....+|+.||++|+||||+++.+...+.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-------~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-------PITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-------hHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 47899999999999999999988 7899999999876532221 24456899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.. ..+|+|+|||+. +|.-++.. ..-.|++.++.-+++||+.||.|||.+||+|||||.+|
T Consensus 189 ~~------------------~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SN 248 (560)
T KOG0600|consen 189 LS------------------GSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSN 248 (560)
T ss_pred CC------------------ceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccc
Confidence 22 234999999976 88877743 34579999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|||+.+|.+||+|||+|+...... ..++..+.|+.|.|||.+.|. .|+.++|+||.||||.||++|++.|++.+..+.
T Consensus 249 iLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ 328 (560)
T KOG0600|consen 249 ILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ 328 (560)
T ss_pred eEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence 999999999999999999655443 347778899999999999875 699999999999999999999999999887777
Q ss_pred HHHHHhc------------c------CCCCC---------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQ------------N------LRPDI---------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~------------~------~~~~~---------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+... . +++.. ...++....+|+..+|..||.+|.|+.++|.
T Consensus 329 l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 329 LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 6665421 0 01100 1235788899999999999999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=344.54 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=206.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|++.+.||+|+||+||+|.+ +|+.||+|.+..... ........+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~ 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI------KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh------hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence 367889999999999999987 688999999864321 111223457789999999999999999999886655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+||||+++|+|.+++.......+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 75 ~--------------------~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil 134 (285)
T cd05631 75 L--------------------CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134 (285)
T ss_pred E--------------------EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence 4 89999999999998886554556999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||++...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05631 135 LDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213 (285)
T ss_pred ECCCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 999999999999999754322 2223457899999999999999999999999999999999999999876543222211
Q ss_pred Hh--ccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 324 VR--QNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 324 ~~--~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
.. ......++..++.++.+|+++||+.||++||+ ++++++.
T Consensus 214 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11 12233456678999999999999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=345.29 Aligned_cols=251 Identities=25% Similarity=0.480 Sum_probs=220.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||+|+||.|-+|.. .|+.||||.+++.+- ..+...-.+++|++||+.|+||||+.+|.+|...
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI------kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk 125 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI------KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK 125 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc------ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence 36799999999999999999976 799999999985442 2233356788999999999999999999999988
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ .|||||..+|.|+||+.+. +.|++.++..+++||+.|+.|+|.++++|||||.+|
T Consensus 126 dKI--------------------vivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLEN 183 (668)
T KOG0611|consen 126 DKI--------------------VIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLEN 183 (668)
T ss_pred ceE--------------------EEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhh
Confidence 777 8899999999999999654 569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||+|.++++||+|||++..... ....+++||+|-|.+||++++.+|. +.+|.||||++||.|+.|.+||.+.+...+.
T Consensus 184 ILLD~N~NiKIADFGLSNly~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv 262 (668)
T KOG0611|consen 184 ILLDQNNNIKIADFGLSNLYAD-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV 262 (668)
T ss_pred eeecCCCCeeeeccchhhhhcc-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH
Confidence 9999999999999999986543 3445678999999999999999875 7899999999999999999999999999888
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
.++.++.++.+ .-|....-||++||..||++|.|+.+|...-+
T Consensus 263 rQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 263 RQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 88877665432 23567789999999999999999999988654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=357.40 Aligned_cols=254 Identities=25% Similarity=0.482 Sum_probs=227.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|..++++|+|+||.+++.++ +++.+++|.+...... ...++...+|+.++++++|||||.+.+.|+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-------~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-------EPERRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-------chhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 57899999999999999998766 6779999999755422 12234667899999999999999999999887
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ .||||+||+||+|.+.+.+.+...++++.+..|+.|++.|+.|||++.|+|||||+.|
T Consensus 76 ~~~-------------------l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~N 136 (426)
T KOG0589|consen 76 GQL-------------------LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCAN 136 (426)
T ss_pred Cce-------------------EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhh
Confidence 762 3999999999999999998877889999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.|+|+|||+|+.............||+.||+||.+.+.+|+.++|||||||++|||++-+++|...+......
T Consensus 137 ifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ 216 (426)
T KOG0589|consen 137 IFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL 216 (426)
T ss_pred hhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH
Confidence 99999999999999999987665545556799999999999999999999999999999999999999999999988888
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.... -.++|...+.+++.+|+.||..+|..||++.++|..
T Consensus 217 ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 KINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 887665 456788899999999999999999999999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=338.94 Aligned_cols=258 Identities=30% Similarity=0.581 Sum_probs=219.1
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|.+..++|++.++||+|+||.||+|.. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----------SVQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----------hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 788899999999999999999999987 567899998763221 135678899999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.... ++++||+++++|.+++.......+++..++.++.|++.||+|||+.+++|||||
T Consensus 71 ~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~ 130 (261)
T cd05072 71 TKEEPI--------------------YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR 130 (261)
T ss_pred cCCCCc--------------------EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 765554 899999999999999977656678999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 131 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred hhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 9999999999999999999975433211 1122345678999999998889999999999999999998 9999988777
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
......+. ...+.+....++.++.+++.+||+.+|++||+++++++.|+++
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 211 SDVMSALQ-RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 66665553 3344445567899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.32 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=210.3
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|++ +++.||||+++... .........+..|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL------LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence 4689999999999999999988 57899999997432 111223456788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+||||++||+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 132 (333)
T cd05600 75 YL--------------------YLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132 (333)
T ss_pred EE--------------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 55 8999999999999999643 4689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++.++.+||+|||++..... ......||+.|+|||.+.+..++.++|||||||++|||++|..||...+..+....
T Consensus 133 l~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 133 LIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred EECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence 999999999999999975432 22345799999999999999999999999999999999999999998877776655
Q ss_pred HHhccCCCCCC------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPDIP------RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+.........+ ..++.++.++|.+||..+|.+||++.++++.
T Consensus 210 i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 54322111111 1468999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=322.03 Aligned_cols=269 Identities=28% Similarity=0.407 Sum_probs=220.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
.+|...++||+|+||+||+|++ +|+.||||.++..+... .+.....+|++.|+.++|+||+.++++|...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-------Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-------GINRTALREIKLLQELKHPNIIELIDVFPHKS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-------CccHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence 4678888999999999999998 78999999998654321 12244568999999999999999999999887
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ .+|+||++ .+|+..++.+ ...++...+..++.++++||+|||++.|+||||||.|+
T Consensus 75 ~l--------------------~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL 132 (318)
T KOG0659|consen 75 NL--------------------SLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL 132 (318)
T ss_pred ce--------------------EEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence 77 78999995 5999888654 46799999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||+++|.+||+|||+|+.........+..+.|..|.|||.+-| +.|+..+|+||.||++.||+-+.+-|++.+..+...
T Consensus 133 Lis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 133 LISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred EEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 9999999999999999988777666666789999999999876 579999999999999999999999999888777666
Q ss_pred HHHhccCC---------------------CC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHHHhccC
Q 048724 322 AVVRQNLR---------------------PD-----IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAVNTSKG 373 (394)
Q Consensus 322 ~~~~~~~~---------------------~~-----~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~~~~~~ 373 (394)
.+.+.--. +. +-..++.+..+|+.+||..||.+|+|++|++++ +...-.-..
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 65432100 00 112356778999999999999999999999985 222222334
Q ss_pred CCCCCCCCC
Q 048724 374 GGMIPEDQA 382 (394)
Q Consensus 374 ~~~~~~~~~ 382 (394)
.+.+|...+
T Consensus 293 ~~~lp~p~~ 301 (318)
T KOG0659|consen 293 PSKLPIPST 301 (318)
T ss_pred hhhCcCCcc
Confidence 444444443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=350.68 Aligned_cols=241 Identities=21% Similarity=0.359 Sum_probs=204.1
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||+|+||+||+|.+ +++.||+|+++... .........+..|+.++++++||||+++++++.+.+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH------IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL------ 68 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE------
Confidence 79999999999988 57899999987322 11122345677899999999999999999998765554
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus 69 --------------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~ 132 (312)
T cd05585 69 --------------YLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHI 132 (312)
T ss_pred --------------EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcE
Confidence 8999999999999999653 468999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCC
Q 048724 251 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRP 330 (394)
Q Consensus 251 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 330 (394)
+|+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ..
T Consensus 133 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~ 210 (312)
T cd05585 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PL 210 (312)
T ss_pred EEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CC
Confidence 9999999975433333334457999999999999999999999999999999999999999988877777666544 34
Q ss_pred CCCCCCcHHHHHHHHHhchhCCCCCCC---HHHHHH
Q 048724 331 DIPRCCPSSLASIMRKCWDANPDKRPV---MDEVVK 363 (394)
Q Consensus 331 ~~~~~~~~~l~~li~~cL~~dP~~Rpt---~~~ll~ 363 (394)
.++..+++++.++|.+||+.||++||+ +.+++.
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 566778999999999999999999975 566655
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=339.48 Aligned_cols=257 Identities=25% Similarity=0.499 Sum_probs=214.8
Q ss_pred cccccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
++..+|++.+.||+|+||.||+|.+ .+..||+|+++.... ......|.+|+.++++++||||+++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 73 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--------DKQRRGFLAEALTLGQFDHSNIVRLEG 73 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--------HHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 4567899999999999999999976 246899999874321 112356889999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++...... ++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|++|||
T Consensus 74 ~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~d 132 (266)
T cd05064 74 VITRGNTM--------------------MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKG 132 (266)
T ss_pred EEecCCCc--------------------EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 98765554 8999999999999999754 34689999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~ 314 (394)
|||+||+++.++.++++|||.+....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||...
T Consensus 133 ikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999999999876432211 11112345678999999999999999999999999999775 99999888
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
+..+....+ ..+...+.+..++..+.+++.+||+.+|++||++++|++.|.++
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 213 SGQDVIKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 777766555 34445566778999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.40 Aligned_cols=264 Identities=33% Similarity=0.578 Sum_probs=208.3
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
+.....++|.-...||+|+||+||+|.. +|+.||||.+....... ..+|..|+.++.+++|||+|+++|+
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---------~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---------EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---------hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4445567888888999999999999999 45899999876433210 2459999999999999999999999
Q ss_pred ecCCCc-cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CCc
Q 048724 158 SMGTTN-LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK---TIV 233 (394)
Q Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---~ii 233 (394)
|.+.+. . ++|+||+++|+|.++|......+++|.++.+|+.++|+||+|||.. .||
T Consensus 140 C~e~~~~~--------------------~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~ii 199 (361)
T KOG1187|consen 140 CLEGGEHR--------------------LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPII 199 (361)
T ss_pred EecCCceE--------------------EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEe
Confidence 997763 4 8999999999999999765432899999999999999999999974 499
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCC-CCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||||||+|||+|+++++||+|||+|+............ .||.+|++||.+.....+.++||||||++|.|++||+.|..
T Consensus 200 HrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 200 HRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred cCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 99999999999999999999999997544311111112 89999999999999999999999999999999999998775
Q ss_pred CCC------hhhHHHHHHhc-----cCCCCCC-CCCc-----HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 313 DLS------FTDVSSAVVRQ-----NLRPDIP-RCCP-----SSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 313 ~~~------~~~~~~~~~~~-----~~~~~~~-~~~~-----~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
... ..+.....+.. -.++.+. ...+ ..+..+...|++.+|.+||+|.+|+++|+.+...
T Consensus 280 ~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 280 QSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 432 12211122222 1233333 2233 2356777899999999999999999999766543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=334.00 Aligned_cols=274 Identities=25% Similarity=0.390 Sum_probs=232.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.++||+|.|++|+++.+ +|+.+|+|+++..+... ...+.+.+|+.|.+.|+|||||++...+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-------~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------RDFQKLEREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-------ccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence 46788999999999999999876 89999999986443211 1346788999999999999999999877655
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+|+++|++|..-|..+ ..+++..+-.++.||+++|.|+|.+||||||+||+|
T Consensus 83 ~~~--------------------ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~n 140 (355)
T KOG0033|consen 83 SFH--------------------YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPEN 140 (355)
T ss_pred cee--------------------EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 544 8999999999997655443 568999999999999999999999999999999999
Q ss_pred eeeC---CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLD---ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~---~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+|+- ..--+||+|||+|.... .........|||.|||||+++..+|+..+|||+-|++||-|+.|.+||.+.+.+.
T Consensus 141 llLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 141 LLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred eeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 9994 34468999999998665 4555667899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCceeE
Q 048724 319 VSSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGCLC 387 (394)
Q Consensus 319 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~ 387 (394)
++..+..+.++.+- ...++++.++|+++||..||.+|.|+.|+|+.-+-.....-.+++..+.+..|..
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lr 290 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLK 290 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHH
Confidence 99999888766443 4678999999999999999999999999998776666555566666555555543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=350.21 Aligned_cols=244 Identities=28% Similarity=0.438 Sum_probs=206.4
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 168 (394)
+.||+|+||.||++.. +|+.||+|+++.... ........+.+|+.+++.++||||++++++|...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~---- 70 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL---- 70 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE----
Confidence 3699999999999987 688999999874221 1122245667899999999999999999999866554
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~ 248 (394)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++
T Consensus 71 ----------------~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 132 (323)
T cd05595 71 ----------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132 (323)
T ss_pred ----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC
Confidence 8999999999999888553 4689999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccC
Q 048724 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 249 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
.+||+|||++..............||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 133 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~- 211 (323)
T cd05595 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE- 211 (323)
T ss_pred CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-
Confidence 9999999998743332233334579999999999999999999999999999999999999998887777666655443
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
..++..+++++.++|.+||+.||++|| ++.++++.
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 346677899999999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.96 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=216.0
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC---CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
..+.+..++|++.+.||+|+||.||+|++. +..||+|++.... .........+.+|+.+++.++||||+++
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK------IIKQKQVDHVFSERKILNYINHPFCVNL 96 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH------hhhhhhHHHHHHHHHHHHhCCCCCCcce
Confidence 346678899999999999999999999862 3589999986332 1112234567889999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++.+...+ |+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++|
T Consensus 97 ~~~~~~~~~~--------------------~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 154 (340)
T PTZ00426 97 YGSFKDESYL--------------------YLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154 (340)
T ss_pred EEEEEeCCEE--------------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence 9999876554 8999999999999999654 46899999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||||+|||++.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus 155 rDLkp~NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 155 RDLKPENLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred cCCCHHHEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 999999999999999999999999754322 23457999999999999988999999999999999999999999988
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
+.......+.... ..++..+++.+.++|++||+.||++|+ +++++++.
T Consensus 232 ~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 232 EPLLIYQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 7776666665443 345677899999999999999999995 89998875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=350.52 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=206.5
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 168 (394)
+.||+|+||.||++.. +|+.||+|+++.... ........+.+|+.+++.++||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~---- 70 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI------IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL---- 70 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE----
Confidence 3699999999999987 688999999974321 1122245677899999999999999999998876655
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~ 248 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 71 ----------------~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 132 (328)
T cd05593 71 ----------------CFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132 (328)
T ss_pred ----------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC
Confidence 8999999999999888553 4689999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccC
Q 048724 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 249 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 133 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-- 210 (328)
T cd05593 133 HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-- 210 (328)
T ss_pred cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--
Confidence 999999999875333223334457999999999999999999999999999999999999999887776666555433
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
...++..++.++.++|.+||+.||++|| ++.++++.
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3456777899999999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=338.12 Aligned_cols=259 Identities=27% Similarity=0.550 Sum_probs=221.1
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|+....+|++.+.||.|+||.||+|.+ .+..+|+|+++.... .....+..|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 71 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---------LKQQDFQKEVQALKRLRHKHLISLFAVC 71 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---------hhHHHHHHHHHHHhcCCCcchhheeeeE
Confidence 455667899999999999999999998 568899999863321 1134677899999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.... ++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+
T Consensus 72 ~~~~~~--------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~ 131 (261)
T cd05148 72 SVGEPV--------------------YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLA 131 (261)
T ss_pred ecCCCe--------------------EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC
Confidence 765554 899999999999999977655678999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFT 317 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~ 317 (394)
|+||+++.++.++|+|||.+..............++..|++||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 132 ~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 132 ARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred cceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999999765433222233456778999999998889999999999999999998 89999888777
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
+....+. ...+...+..++.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 212 EVYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 7666554 4455566778999999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=341.17 Aligned_cols=257 Identities=31% Similarity=0.600 Sum_probs=215.6
Q ss_pred cccccccceeeeccCCceEEEEEEECC-------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+..++|++.+.||+|+||.||+|...+ ..||+|.++... .......|.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--------~~~~~~~~~~ei~~l~~l~h~~i~~~ 73 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--------EPKVQQEFRQEAELMSDLQHPNIVCL 73 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--------CHHHHHHHHHHHHHHHhcCCcccceE
Confidence 456789999999999999999998732 469999886322 12234678899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--------------CCCCHHHHHHHHHHH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------------KKLAFKVVIQIALDL 220 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi 220 (394)
++++.+.... |++|||+++++|.+++..... ..+++..++.++.|+
T Consensus 74 ~~~~~~~~~~--------------------~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 133 (283)
T cd05048 74 LGVCTKEQPT--------------------CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133 (283)
T ss_pred EEEEcCCCce--------------------EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHH
Confidence 9998765554 899999999999999975421 458889999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHH
Q 048724 221 ARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFG 298 (394)
Q Consensus 221 ~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 298 (394)
+.||.|||++|++|+||||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++||||||
T Consensus 134 ~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG 213 (283)
T cd05048 134 AAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFG 213 (283)
T ss_pred HHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHH
Confidence 999999999999999999999999999999999999987432211 112234567889999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 299 ICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 299 ~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
|++|||++ |..||.+....+....+. .......+..+|+++.+|+.+||+.||++||++++|++.|+.
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 214 VVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 99999998 999998888777766554 444455677899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=355.28 Aligned_cols=267 Identities=28% Similarity=0.512 Sum_probs=221.2
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 147 (394)
+....|++..++|++.+.||+|+||+||+|++. +..||||+++.... ....+.+.+|+.++++++
T Consensus 27 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~Ei~~l~~l~ 98 (400)
T cd05105 27 PYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--------SSEKQALMSELKIMTHLG 98 (400)
T ss_pred CCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcC
Confidence 334578899999999999999999999999862 23699999864321 112367889999999995
Q ss_pred -CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----------------------
Q 048724 148 -HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---------------------- 204 (394)
Q Consensus 148 -h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---------------------- 204 (394)
||||++++++|.+...+ |+|||||++|+|.+++..+.
T Consensus 99 ~HpnIv~l~~~~~~~~~~--------------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (400)
T cd05105 99 PHLNIVNLLGACTKSGPI--------------------YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINP 158 (400)
T ss_pred CCCCeeeEEEEEccCCce--------------------EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCc
Confidence 99999999999866554 99999999999999986532
Q ss_pred ------------------------------------------------------------------------cCCCCHHH
Q 048724 205 ------------------------------------------------------------------------RKKLAFKV 212 (394)
Q Consensus 205 ------------------------------------------------------------------------~~~l~~~~ 212 (394)
...+++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~ 238 (400)
T cd05105 159 ADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLD 238 (400)
T ss_pred ccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHH
Confidence 12477888
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCc
Q 048724 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNR 290 (394)
Q Consensus 213 ~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 290 (394)
++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.
T Consensus 239 ~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 318 (400)
T cd05105 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318 (400)
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence 999999999999999999999999999999999999999999999975432211 122235678899999999888999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 291 KCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 291 ~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
++|||||||++|+|++ |..||+................+...+..++..+.+++.+||+.+|++|||+.++.+.|+++.
T Consensus 319 ~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 9999999999999997 999998765555444455555566667788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=333.22 Aligned_cols=255 Identities=30% Similarity=0.636 Sum_probs=217.4
Q ss_pred cccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
|-++..+|++.+.||+|+||.||++...|..||+|.++... ..+.+.+|+.++++++|+|++++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----------hHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 66788899999999999999999999999999999986321 1256788999999999999999999765
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
.... ..++++||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||
T Consensus 70 ~~~~-------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 130 (256)
T cd05082 70 EEKG-------------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130 (256)
T ss_pred cCCC-------------------ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccch
Confidence 3322 238999999999999999776555689999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~ 318 (394)
+||+++.++.+||+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+
T Consensus 131 ~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05082 131 RNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred heEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999987432221 22345678999999998889999999999999999997 999998877766
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
....+ ........+..+++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 208 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 208 VVPRV-EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHH-hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 65554 34455566778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=333.89 Aligned_cols=257 Identities=30% Similarity=0.589 Sum_probs=217.9
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|++..++|++.++||+|+||.||+|.. +++.||+|.++..... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----------PEAFLAEANLMKQLQHPRLVRLYAVV 70 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----------HHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence 678889999999999999999999988 6789999998633211 24678899999999999999999886
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. .. .+++|||+++++|.+++.......+++.++..++.|++.||+|||+.|++|+|||
T Consensus 71 ~~-~~--------------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~ 129 (260)
T cd05067 71 TQ-EP--------------------IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLR 129 (260)
T ss_pred cc-CC--------------------cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence 42 22 3899999999999999977666679999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|++++ |+.||...+.
T Consensus 130 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 130 AANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred HHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 999999999999999999987543221 11222345678999999998889999999999999999998 9999988776
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.+....+ ......+.+..++.++.+++.+||+.+|++||++++++..|+.+
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 210 PEVIQNL-ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 6665544 34455566777899999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=342.44 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=205.8
Q ss_pred ccccccceeeeccCCceEEEEEEE------------------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHH
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY------------------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~------------------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~ 144 (394)
..++|.+.+.||+|+||.||+|.+ ++..||+|+++.... ...+..|.+|+.++.
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~ 74 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--------KNARNDFLKEVKILS 74 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--------HHHHHHHHHHHHHHh
Confidence 357889999999999999999975 123699999864321 122467889999999
Q ss_pred hCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-----------------cCC
Q 048724 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-----------------RKK 207 (394)
Q Consensus 145 ~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-----------------~~~ 207 (394)
+++||||+++++++.+.+.. |+||||+++|+|.+++.... ...
T Consensus 75 ~l~h~niv~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPL--------------------CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPA 134 (304)
T ss_pred hcCCCCeeEEEEEEecCCce--------------------EEEEecCCCCcHHHHHHhcccccccccccccccccccccc
Confidence 99999999999999865554 89999999999999986532 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCC
Q 048724 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDG 285 (394)
Q Consensus 208 l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 285 (394)
+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++...... .......++..|+|||.+.+
T Consensus 135 ~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (304)
T cd05096 135 ISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM 214 (304)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc
Confidence 6788999999999999999999999999999999999999999999999987432221 11122345788999999988
Q ss_pred CCCCccchHHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHh---c---cCCCCCCCCCcHHHHHHHHHhchhCCCCCCC
Q 048724 286 KPYNRKCDVYSFGICLWEIYC--CDMPYPDLSFTDVSSAVVR---Q---NLRPDIPRCCPSSLASIMRKCWDANPDKRPV 357 (394)
Q Consensus 286 ~~~~~~~DvwslG~~l~ellt--g~~Pf~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt 357 (394)
..++.++||||||+++|+|++ +..||...+..+....... . ......+..++..+.+|+.+||+.+|++|||
T Consensus 215 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 889999999999999999986 5678887766555443321 1 1112234568999999999999999999999
Q ss_pred HHHHHHHHH
Q 048724 358 MDEVVKLLE 366 (394)
Q Consensus 358 ~~~ll~~l~ 366 (394)
+.+|...|+
T Consensus 295 ~~~i~~~l~ 303 (304)
T cd05096 295 FSDIHAFLT 303 (304)
T ss_pred HHHHHHHHh
Confidence 999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=332.95 Aligned_cols=258 Identities=31% Similarity=0.565 Sum_probs=217.6
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|++..++|++.+.||+|+||.||+|.+ +++.||+|.++.... . .+.+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~-------~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---D-------PKDFLAEAQIMKKLRHPKLIQLYAVC 70 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---c-------HHHHHHHHHHHHHCCCCCccceeEEE
Confidence 678889999999999999999999988 567899999864321 1 24577899999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...... |++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|||||
T Consensus 71 ~~~~~~--------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 130 (261)
T cd05068 71 TLEEPI--------------------YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130 (261)
T ss_pred ecCCCe--------------------eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 765554 899999999999999976544568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCC-ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||+++.++.++|+|||+++........ ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 131 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred cceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999999764422111 111223467999999998889999999999999999999 9999988777
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
......+ ........+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 211 AEVLQQV-DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 6666555 33344455667899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.29 Aligned_cols=264 Identities=29% Similarity=0.612 Sum_probs=235.1
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEECC--eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG--QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
...+|+++..+.....+||-|.||.||.|.|+. -.||||.++.... -...|..|+.+|+.++|||+|+
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----------eveEFLkEAAvMKeikHpNLVq 327 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQ 327 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----------hHHHHHHHHHHHHhhcCccHHH
Confidence 447899999999999999999999999999953 5899999973321 1378999999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
++|+|.....+ |||.|||..|+|.+||++.++..++.-.++.++.||..||.||..+++|
T Consensus 328 LLGVCT~EpPF--------------------YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFI 387 (1157)
T KOG4278|consen 328 LLGVCTHEPPF--------------------YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFI 387 (1157)
T ss_pred HhhhhccCCCe--------------------EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhh
Confidence 99999876665 9999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCCC-ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPY 311 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf 311 (394)
||||...|+|+.++..||++|||++++...+... .....-++.|.|||.+.-..++.++|||+||++|||+.| |..||
T Consensus 388 HRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY 467 (1157)
T KOG4278|consen 388 HRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 467 (1157)
T ss_pred hhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999999975443221 122234678999999999999999999999999999987 67899
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
++.+..+++. ++..+++++-|..||+.+.+||+.||+.+|.+||++.++-..++.+..
T Consensus 468 PGidlSqVY~-LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 468 PGIDLSQVYG-LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCccHHHHHH-HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 9999988885 558889999999999999999999999999999999999999998764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=345.99 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=205.4
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHH---HhCCCCcceeeeeeecCC
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW---QKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il---~~l~h~nIv~l~~~~~~~ 161 (394)
|++.+.||+|+||.||+|.+ +|+.||||+++.... ........+..|..++ +.++||||+++++++...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI------IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence 67789999999999999987 678999999974321 1111234555666554 566899999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||+++|+|..++.. ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 75 ~~~--------------------~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~N 131 (324)
T cd05589 75 DHV--------------------CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131 (324)
T ss_pred CEE--------------------EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHH
Confidence 554 999999999999988743 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.+||+|||+++.............|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 132 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~ 211 (324)
T cd05589 132 LLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211 (324)
T ss_pred eEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999998743333333344679999999999999999999999999999999999999999888777776
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
.+.... ...+..++..+.++|.+||+.||++|| ++.++++.
T Consensus 212 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 665543 346677899999999999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=341.74 Aligned_cols=249 Identities=35% Similarity=0.708 Sum_probs=206.0
Q ss_pred cceeeeccCCceEEEEEEEC------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 88 DIRHEIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.+.||.|.||.||+|.+. +..|+||+++.... ......|.+|+..+++++||||++++|++...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~ 73 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS--------EEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN 73 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS--------HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc--------cccceeeeeccccccccccccccccccccccc
Confidence 35678999999999999986 57899999953211 11247788899999999999999999999855
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++|+||+++|+|.++|.......+++..++.|+.||+.||.|||+++++|+||+++|
T Consensus 74 ~~~--------------------~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~n 133 (259)
T PF07714_consen 74 EPL--------------------FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSN 133 (259)
T ss_dssp SSE--------------------EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred ccc--------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 544 899999999999999988755679999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~ 318 (394)
||++.++.+||+|||++....... ...........|+|||.+.+..++.++||||||+++|||++ |+.||...+..+
T Consensus 134 ill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 134 ILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp EEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999997652111 11223456788999999988889999999999999999999 689999988888
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
....+ ..+.+...+..++..+.++|.+||+.+|++|||++++++.|
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 214 IIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 77776 55556667788999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.94 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=211.9
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|.+ +|+.||||+++.... ........+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM------IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH------hhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence 4688999999999999999998 588999999974321 11123467888999999999999999999987665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI 132 (350)
T cd05573 75 HL--------------------YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132 (350)
T ss_pred eE--------------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 54 8999999999999999654 5699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC-----------------------------CCccCCCCCCCcCCccccCCCCCCccch
Q 048724 243 LLDANRTLKIADFGVARVEAQNP-----------------------------RDMTGETGTLGYMAPEVLDGKPYNRKCD 293 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 293 (394)
|++.++.+||+|||++....... .......||+.|+|||.+.+..++.++|
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 212 (350)
T cd05573 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD 212 (350)
T ss_pred EECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCcee
Confidence 99999999999999987543322 1223357899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHh--ccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-HHHHHHH
Q 048724 294 VYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR--QNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-MDEVVKL 364 (394)
Q Consensus 294 vwslG~~l~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-~~~ll~~ 364 (394)
||||||++|+|++|+.||...........+.. .....+....+++++.++|.+||. +|.+||+ +.++++.
T Consensus 213 iwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 213 WWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred eEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99999999999999999998887776666655 222322233469999999999997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=352.65 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=214.5
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.+.+..++|++.+.||+|+||+||++++ +++.||+|+++... .........+.+|+.+++.++||||+++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE------MIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4567789999999999999999999988 67899999986321 111122355778999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.+...+ |+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+|||
T Consensus 111 ~~~~~~~~--------------------~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 167 (370)
T cd05596 111 AFQDDKYL--------------------YMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRD 167 (370)
T ss_pred EEecCCEE--------------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 98866554 899999999999999854 3488999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCC----CCCccchHHHHHHHHHHHHhCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGK----PYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
|||+|||++.++.+||+|||++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||
T Consensus 168 Lkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred CCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 99999999999999999999997543221 122345799999999998653 4788999999999999999999999
Q ss_pred CCCChhhHHHHHHhccCCCCCCC--CCcHHHHHHHHHhchhCCCC--CCCHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPR--CCPSSLASIMRKCWDANPDK--RPVMDEVVKL 364 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~ 364 (394)
...+.......+........++. .++.++.++|.+||+.+|.+ |+++.+++..
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 248 YADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 98887777777665443344443 57999999999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.85 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=203.3
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||.|+||+||+|.. +++.||+|+++...... ....+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--------APCTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--------cchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 357899999999999999999987 67899999986432211 12356689999999999999999999876
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... ++||||+++ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 75 ~~~~--------------------~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~ 132 (288)
T cd07871 75 ERCL--------------------TLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQ 132 (288)
T ss_pred CCeE--------------------EEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 5544 899999975 999888653 345889999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|||++.++.+||+|||+++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus 133 Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 133 NLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred HEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999754333333344578999999999865 5689999999999999999999999988776554
Q ss_pred HHHHHhccC--------------------CC--------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNL--------------------RP--------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~--------------------~~--------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+..... .+ .....++.++.+||.+||+.||.+|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 443321100 00 001246788999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=346.96 Aligned_cols=265 Identities=30% Similarity=0.581 Sum_probs=217.1
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCc
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPN 150 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~n 150 (394)
.|++..++|++.+.||+|+||.||+|.+ +++.||+|+++.... . .....+.+|+.+++++ +|+|
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~----~----~~~~~~~~E~~~~~~l~~h~n 72 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT----A----SEYKALMTELKILIHIGHHLN 72 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC----H----HHHHHHHHHHHHHHhhccCcc
Confidence 3888889999999999999999999964 236899999863221 1 1124567899999999 8999
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-------------------------
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR------------------------- 205 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~------------------------- 205 (394)
|++++++|...+. .+++++||+++++|.+++.....
T Consensus 73 iv~~~~~~~~~~~-------------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (337)
T cd05054 73 VVNLLGACTKPGG-------------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133 (337)
T ss_pred hhheeeeEecCCC-------------------CEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence 9999998864332 24889999999999999864321
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEE
Q 048724 206 ----------------------------------KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251 (394)
Q Consensus 206 ----------------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vk 251 (394)
..+++..+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vk 213 (337)
T cd05054 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK 213 (337)
T ss_pred ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEE
Confidence 2688999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccC
Q 048724 252 IADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 252 l~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+..........
T Consensus 214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 293 (337)
T cd05054 214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293 (337)
T ss_pred EeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC
Confidence 999999975432211 1222345678999999999999999999999999999998 9999987655444444445555
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
....+..+++++.+++.+||+.+|++||++.++++.|+++..
T Consensus 294 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 555667789999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=345.11 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=206.1
Q ss_pred eeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 91 HEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
+.||+|+||.||+++. +++.||||+++.... .........+..|+.+++.++||||++++++|.....+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~- 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-----VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL- 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-----HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE-
Confidence 5799999999999875 467899999874321 11122235677899999999999999999998766554
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
|+||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 76 -------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 134 (323)
T cd05584 76 -------------------YLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134 (323)
T ss_pred -------------------EEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 8999999999999998653 4688999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHh
Q 048724 246 ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~ 325 (394)
.++.+||+|||+++.............|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+..
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 135 AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999999987433322333345799999999999998899999999999999999999999998877776666654
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 326 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
. ...++..+++.+.++|.+||+.+|++|| ++++++..
T Consensus 215 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 215 G--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 4 3456677899999999999999999999 88888773
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=351.58 Aligned_cols=267 Identities=28% Similarity=0.527 Sum_probs=222.7
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 147 (394)
+....|++..++|.+.+.||+|+||.||+|++. +..||||+++.... ....+.+.+|+.+|.++.
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~E~~~l~~l~ 98 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--------SSEKQALMSELKIMSHLG 98 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--------hhHHHHHHHHHHHHHhcC
Confidence 445569999999999999999999999999863 35799999974321 111346788999999997
Q ss_pred -CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc---------------------
Q 048724 148 -HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------------------- 205 (394)
Q Consensus 148 -h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------------------- 205 (394)
|||||+++++|.....+ ++|+||+++|+|.++++.+..
T Consensus 99 ~H~niv~~~~~~~~~~~~--------------------~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (401)
T cd05107 99 PHLNIVNLLGACTKGGPI--------------------YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGS 158 (401)
T ss_pred CCCCeEEEEEEEccCCCc--------------------EEEEeccCCCcHHHHHHhccccchhhhccccccccccccccc
Confidence 99999999999865554 899999999999999975321
Q ss_pred ---------------------------------------------------------------------------CCCCH
Q 048724 206 ---------------------------------------------------------------------------KKLAF 210 (394)
Q Consensus 206 ---------------------------------------------------------------------------~~l~~ 210 (394)
..+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (401)
T cd05107 159 TPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSY 238 (401)
T ss_pred ccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCH
Confidence 23677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCC
Q 048724 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPY 288 (394)
Q Consensus 211 ~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 288 (394)
..++.++.||+.||.|||+++++||||||+|||++.++.++|+|||+++...... .......+++.|+|||.+.+..+
T Consensus 239 ~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 239 MDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred HHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 7889999999999999999999999999999999999999999999997533221 11222456788999999998889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 289 NRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 289 ~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
+.++||||||+++|||++ |..||......+........+.++..+..++.++.+|+.+||+.+|++||++++|+..|++
T Consensus 319 ~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 319 TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 999999999999999998 8999987766665555556666666777889999999999999999999999999999998
Q ss_pred HH
Q 048724 368 VN 369 (394)
Q Consensus 368 ~~ 369 (394)
+.
T Consensus 399 ~~ 400 (401)
T cd05107 399 LL 400 (401)
T ss_pred Hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.29 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=207.3
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|.. +++.||||+++... .........+..|+.++.+++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD------MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4789999999999999999987 67899999997321 112233467788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 75 ~~--------------------~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 75 NL--------------------YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred eE--------------------EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 55 8999999999999999653 4699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC-----------------------------------CccCCCCCCCcCCccccCCCC
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR-----------------------------------DMTGETGTLGYMAPEVLDGKP 287 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~ 287 (394)
|++.++.+||+|||+++....... .....+||+.|+|||.+.+..
T Consensus 133 Li~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 212 (363)
T cd05628 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 212 (363)
T ss_pred EECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC
Confidence 999999999999999864321100 012347999999999999999
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCC--CCcHHHHHHHHHhchhCCC---CCCCHHHHH
Q 048724 288 YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPR--CCPSSLASIMRKCWDANPD---KRPVMDEVV 362 (394)
Q Consensus 288 ~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cL~~dP~---~Rpt~~~ll 362 (394)
++.++|||||||++|||++|..||...+..+....+........++. .++++++++|.+|+. +|. .||++++++
T Consensus 213 ~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 99999999999999999999999998887777776655333333332 468899999998665 444 568999999
Q ss_pred HH
Q 048724 363 KL 364 (394)
Q Consensus 363 ~~ 364 (394)
+.
T Consensus 292 ~h 293 (363)
T cd05628 292 TN 293 (363)
T ss_pred CC
Confidence 86
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=331.34 Aligned_cols=256 Identities=30% Similarity=0.565 Sum_probs=216.2
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|++..++|++.+.||+|+||.||+|.+ .+..||+|.++..... ...+.+|+.++++++|+|++++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----------PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----------HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 678889999999999999999999987 5678999998743211 24578899999999999999999887
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. .. .|++|||+++++|.+++.......+++..++.++.|++.||.|||++|++|||||
T Consensus 71 ~~-~~--------------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 129 (260)
T cd05070 71 SE-EP--------------------IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129 (260)
T ss_pred CC-CC--------------------cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 43 22 2899999999999999976555568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 130 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred cceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999975433211 1122345668999999988889999999999999999999 8999988777
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
.+....+ ......+.+..++..+.+++.+||..+|++|||+.++.++|++
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 210 REVLEQV-ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6666554 3344556677789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=351.67 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=208.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|++ +|+.||||+++... .........+.+|+.+++.++||||++++++|.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE------MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 4789999999999999999988 68899999997422 111233466788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI 132 (364)
T cd05599 75 YL--------------------YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132 (364)
T ss_pred eE--------------------EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 65 8999999999999998653 4699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC--------------------------------------CccCCCCCCCcCCccccC
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR--------------------------------------DMTGETGTLGYMAPEVLD 284 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~ 284 (394)
|++.++.++|+|||++........ .....+||+.|+|||++.
T Consensus 133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (364)
T cd05599 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212 (364)
T ss_pred EECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc
Confidence 999999999999999864321100 011236899999999999
Q ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCC---HH
Q 048724 285 GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPV---MD 359 (394)
Q Consensus 285 ~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt---~~ 359 (394)
+..++.++|||||||++|||++|..||...+..+....+.........+ ..+++++.++|.+||. +|.+|++ +.
T Consensus 213 ~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 213 QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9999999999999999999999999999888777666655433333333 2468999999999997 9999997 99
Q ss_pred HHHHH
Q 048724 360 EVVKL 364 (394)
Q Consensus 360 ~ll~~ 364 (394)
+++..
T Consensus 292 ~ll~h 296 (364)
T cd05599 292 EIKSH 296 (364)
T ss_pred HHhcC
Confidence 98874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=343.82 Aligned_cols=253 Identities=25% Similarity=0.450 Sum_probs=208.1
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+..++|++.+.||+|+||.||++++ ++..||+|+++... .......+.+|+.++++++||||+++++++.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 4568999999999999999999998 57899999986421 1223467889999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVK 238 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiH~Dlk 238 (394)
..+.+ ++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +++|||||
T Consensus 74 ~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlk 131 (331)
T cd06649 74 SDGEI--------------------SICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVK 131 (331)
T ss_pred ECCEE--------------------EEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCC
Confidence 66554 8999999999999999653 4589999999999999999999986 69999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+|||++.++.++|+|||++...... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......+
T Consensus 132 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 132 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred hhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999998754322 2233578999999999999999999999999999999999999997655444
Q ss_pred HHHHHH---------------------------------------------hccCCCCCC-CCCcHHHHHHHHHhchhCC
Q 048724 319 VSSAVV---------------------------------------------RQNLRPDIP-RCCPSSLASIMRKCWDANP 352 (394)
Q Consensus 319 ~~~~~~---------------------------------------------~~~~~~~~~-~~~~~~l~~li~~cL~~dP 352 (394)
....+. .....+..+ ..+++++.+||.+||+.||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCc
Confidence 322111 001111111 2468899999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 048724 353 DKRPVMDEVVKLLE 366 (394)
Q Consensus 353 ~~Rpt~~~ll~~l~ 366 (394)
++|||++++++.-.
T Consensus 290 ~~Rpt~~ell~h~~ 303 (331)
T cd06649 290 AERADLKMLMNHTF 303 (331)
T ss_pred ccCCCHHHHhcChH
Confidence 99999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=344.53 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=206.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC-CcceeeeeeecCCC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-PNVTKFIGASMGTT 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~ 162 (394)
+|++.+.||+|+||.||+|++ +++.||||+++.... ........+..|..++..++| ++|+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence 588899999999999999988 567899999874321 111223567789999999966 46888988887665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 75 ~~--------------------~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 132 (324)
T cd05587 75 RL--------------------YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (324)
T ss_pred EE--------------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 54 8999999999999998553 4589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++.++.+||+|||++..............||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred EEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999986432222233345799999999999999999999999999999999999999998887777766
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH-----HHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM-----DEVVK 363 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~-----~~ll~ 363 (394)
+... ...++..++.++.+++.+||+.||.+|++. +++++
T Consensus 213 i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 213 IMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 6543 345677789999999999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=329.29 Aligned_cols=255 Identities=34% Similarity=0.677 Sum_probs=219.4
Q ss_pred cccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
|.+..++|++.+.||.|+||.||+|...|+.||+|.++.... ..+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 70 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----------AAQAFLAEASVMTTLRHPNLVQLLGVVL 70 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----------HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence 567788999999999999999999999999999999863321 2467888999999999999999999987
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+.... |+||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||
T Consensus 71 ~~~~~--------------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p 130 (256)
T cd05039 71 QGNPL--------------------YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAA 130 (256)
T ss_pred CCCCe--------------------EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhccc
Confidence 64443 8999999999999999766555799999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~ 318 (394)
+||+++.++.++|+|||.++...... .....+..|+|||.+.+..++.++||||||+++|++++ |..||...+..+
T Consensus 131 ~Nili~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 131 RNVLVSEDLVAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred ceEEEeCCCCEEEccccccccccccc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999997543221 12345678999999988889999999999999999997 999998887666
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
....+ ........+..+++.+.+++.+||..+|++|||+.+++++|+.+
T Consensus 208 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 VVPHV-EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHH-hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 65544 33445556677899999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=331.14 Aligned_cols=258 Identities=31% Similarity=0.543 Sum_probs=215.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|.+..++|++.+.||+|+||+||+|++ ....||+|+++.... . ...+.+|+.+++.++||||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~-------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---S-------PEAFLQEAQVMKKLRHEKLVQLYAVV 70 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---C-------HHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 677888999999999999999999988 445799999874221 1 24678899999999999999999876
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. .. .|+||||+++|+|.+++.......+++..+..++.|++.||.|||+.+++|+|||
T Consensus 71 ~~-~~--------------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (262)
T cd05071 71 SE-EP--------------------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129 (262)
T ss_pred CC-CC--------------------cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 43 12 2899999999999999976555568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||+++.++.++|+|||.++....... ......++..|+|||...+..++.++||||||+++|+|++ |..||.....
T Consensus 130 p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred cccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 9999999999999999999975432221 1112345678999999988889999999999999999999 8899988776
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.+....+. .......+..++..+.+++.+||+.+|++||++.+++++|+++.
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 210 REVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 66655543 33334445668999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=328.90 Aligned_cols=275 Identities=29% Similarity=0.377 Sum_probs=223.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|+.+..|++|+||.||+|++ +++.||+|.++.......-. -...+|+.+|.+++|||||.+-.+....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-------ItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-------ITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-------chhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 57899999999999999999998 68899999998765432221 2335799999999999999999988765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.- .+|||||||+. +|..++..-. .++...++.-++.|+++|++|||.+.|+||||||+|
T Consensus 148 ~~d------------------~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SN 207 (419)
T KOG0663|consen 148 NMD------------------KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSN 207 (419)
T ss_pred ccc------------------eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhh
Confidence 442 35999999965 9998886543 679999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
+|+++.|.+||+|||+|+....+...++..+.|..|.|||.+.+ ..|+.+.|+||+||++.||+++++-|++.+..+..
T Consensus 208 LLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 208 LLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred eeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 99999999999999999988888778888899999999999976 56999999999999999999999999998877766
Q ss_pred HHHHhc-----------------------------cCCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 048724 321 SAVVRQ-----------------------------NLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAV 368 (394)
Q Consensus 321 ~~~~~~-----------------------------~~~~~~~~~-~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~ 368 (394)
..+... .++..++.. .+..-.+|+..+|..||.+|.|+++.|+. +.+.
T Consensus 288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 665421 011111111 45778899999999999999999999974 3332
Q ss_pred HhccCCCCCCCCCCCce
Q 048724 369 NTSKGGGMIPEDQAHGC 385 (394)
Q Consensus 369 ~~~~~~~~~~~~~~~~~ 385 (394)
-....-++.|..+++.-
T Consensus 368 P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 368 PLPIDPSMFPTWPAKSE 384 (419)
T ss_pred CCCCChhhcCCCccccc
Confidence 23334445555555443
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=329.90 Aligned_cols=251 Identities=26% Similarity=0.563 Sum_probs=210.3
Q ss_pred ccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+.++|++.+.||+|+||.||++.+ ++..+|+|.++.... . ...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---S-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---c-------HHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence 456789999999999999999988 456899998763321 1 24677899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+|
T Consensus 72 ~~~--------------------~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05114 72 KPL--------------------YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130 (256)
T ss_pred CCE--------------------EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcce
Confidence 544 89999999999999986533 468999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~ 319 (394)
|+++.++.++|+|||.++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.
T Consensus 131 i~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05114 131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV 210 (256)
T ss_pred EEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999999875432211 1122345668999999998889999999999999999999 8999988877776
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
...+.. +.+...+...+..+.+++.+||+.+|++||++.+++..|
T Consensus 211 ~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 211 VEMISR-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 666543 334445666789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=337.99 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=201.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|++ +++.||+|+++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-------EEVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-------ccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 4689999999999999999998 5789999998743221 122356778999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||++++.|..+.. ....+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 74 ~~--------------------~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 131 (287)
T cd07848 74 KL--------------------YLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL 131 (287)
T ss_pred EE--------------------EEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 54 89999999877765442 234689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
+++.++.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++|++||+..+..+...
T Consensus 132 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 132 LISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred EEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999997543221 12233568999999999998889999999999999999999999998776544333
Q ss_pred HHHhcc-------------------CCC-----------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQN-------------------LRP-----------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~-------------------~~~-----------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+.... ... .....+|.++.+||.+||+.||++|||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 212 TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 221100 000 011236788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=344.51 Aligned_cols=243 Identities=24% Similarity=0.393 Sum_probs=203.6
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|++ +++.||||+++... .........+..|..+++.+ +||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~--- 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV------ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL--- 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH------HhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE---
Confidence 3699999999999988 57899999987422 11112235566788888877 799999999999866555
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 72 -----------------~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~ 132 (320)
T cd05590 72 -----------------FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE 132 (320)
T ss_pred -----------------EEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 8999999999999988654 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~- 211 (320)
T cd05590 133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND- 211 (320)
T ss_pred CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-
Confidence 9999999999875332333334467999999999999999999999999999999999999999988887777666543
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCH------HHHHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVM------DEVVK 363 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~------~~ll~ 363 (394)
....+..++.++.++|.+||+.||++||++ ++++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 212 -EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred -CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 334566789999999999999999999998 56655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.95 Aligned_cols=258 Identities=30% Similarity=0.549 Sum_probs=212.9
Q ss_pred cccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
|.+..++|++.+.||+|+||+||+|.+. +..||+|+++.... ......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv 72 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--------MRERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCee
Confidence 7788899999999999999999998763 35799998753211 11235678899999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHH
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------RKKLAFKVVIQIALDLARGL 224 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l 224 (394)
++++++...... ++||||+++|+|.+++.... ...+++..+..++.|++.||
T Consensus 73 ~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 73 RLLGVVSQGQPT--------------------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred eEEEEEcCCCCe--------------------EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH
Confidence 999998765544 89999999999999996532 12467888999999999999
Q ss_pred HHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 225 SYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 225 ~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
.|||+.|++|+||||+||+++.++.++|+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|
T Consensus 133 ~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 212 (277)
T cd05062 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212 (277)
T ss_pred HHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHH
Confidence 999999999999999999999999999999999874322111 111234577899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 303 EIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 303 ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
||++ |..||...........+... .....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 213 EIATLAEQPYQGMSNEQVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 9999 78999888776666555433 334566778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=347.60 Aligned_cols=244 Identities=28% Similarity=0.438 Sum_probs=205.6
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 168 (394)
+.||+|+||+||++.+ +|+.||+|+++.... ........+..|+.+++.++||||+++++++.....+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~---- 70 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL---- 70 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE----
Confidence 3699999999999987 688999999974321 1122235667899999999999999999998866554
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceeeCCC
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+ +|++||||||+|||++.+
T Consensus 71 ----------------~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~ 132 (325)
T cd05594 71 ----------------CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132 (325)
T ss_pred ----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC
Confidence 8999999999999988553 468999999999999999999997 799999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~- 211 (325)
T cd05594 133 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME- 211 (325)
T ss_pred CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-
Confidence 9999999999874332223333457999999999999999999999999999999999999999887776666655433
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
...++..+++++.++|.+||+.||++|+ ++.++++.
T Consensus 212 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 -EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3446677899999999999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=350.99 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=205.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|++++.||+|+||+||+|++ +++.||||+++... .........+.+|+.++++++||||+++++++.+.+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD------VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence 688999999999999999988 67899999987322 1122334678899999999999999999999987665
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+||||++||+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 76 ~--------------------~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil 133 (381)
T cd05626 76 L--------------------YFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133 (381)
T ss_pred E--------------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE
Confidence 5 8999999999999998654 45899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCC-----------------------------------------------CCccCCCCCCC
Q 048724 244 LDANRTLKIADFGVARVEAQNP-----------------------------------------------RDMTGETGTLG 276 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~-----------------------------------------------~~~~~~~gt~~ 276 (394)
++.++.+||+|||+++...... .......||+.
T Consensus 134 i~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (381)
T cd05626 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN 213 (381)
T ss_pred ECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcc
Confidence 9999999999999875321000 00112469999
Q ss_pred cCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhc--hhCC
Q 048724 277 YMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCW--DANP 352 (394)
Q Consensus 277 y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL--~~dP 352 (394)
|+|||.+.+..++.++|||||||++|||++|..||...+..+....+........++ ..+++++.+||.+|+ ..+|
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999899999999999999999999999998877666555554332222333 357899999999955 5556
Q ss_pred CCCCCHHHHHHH
Q 048724 353 DKRPVMDEVVKL 364 (394)
Q Consensus 353 ~~Rpt~~~ll~~ 364 (394)
..||++.+++..
T Consensus 294 ~~R~~~~~~l~h 305 (381)
T cd05626 294 LGRNGADDIKAH 305 (381)
T ss_pred cCCCCHHHHhcC
Confidence 669999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=338.88 Aligned_cols=270 Identities=30% Similarity=0.572 Sum_probs=222.4
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL- 146 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 146 (394)
.+.|++..++|.+.+.||+|+||.||+|.+. ...+|+|.++.... ......+..|+.+++.+
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~ 81 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--------EKDLSDLISEMEMMKMIG 81 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--------hHHHHHHHHHHHHHHHhc
Confidence 4468888999999999999999999999762 24699999863211 11135677899999999
Q ss_pred CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--------------CCCCHHH
Q 048724 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------------KKLAFKV 212 (394)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------------~~l~~~~ 212 (394)
+||||+++++++...... |+||||+++|+|.+++..... ..+++.+
T Consensus 82 ~h~~i~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 141 (307)
T cd05098 82 KHKNIINLLGACTQDGPL--------------------YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141 (307)
T ss_pred CCCCEeeEEEEEecCCce--------------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHH
Confidence 899999999998766554 899999999999999976421 2488999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCc
Q 048724 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNR 290 (394)
Q Consensus 213 ~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 290 (394)
++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.++...... .......+++.|+|||.+.+..++.
T Consensus 142 ~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (307)
T cd05098 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221 (307)
T ss_pred HHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence 99999999999999999999999999999999999999999999987443211 1111223457899999999888999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 291 KCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 291 ~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
++|||||||++|+|++ |..||...+..+....+ ......+.+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus 222 ~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 222 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 9999999999999998 88999877766655544 444455667778999999999999999999999999999999998
Q ss_pred hccCCC
Q 048724 370 TSKGGG 375 (394)
Q Consensus 370 ~~~~~~ 375 (394)
....+.
T Consensus 301 ~~~~~~ 306 (307)
T cd05098 301 ALTSNQ 306 (307)
T ss_pred HHhhcC
Confidence 765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=342.10 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=200.2
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|++ +++.||||+++.... ........+..|..++..+ +||||+++++++.....+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~--- 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV------LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL--- 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence 3699999999999988 577899999974321 1111123445566666654 899999999998765554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 72 -----------------~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~ 132 (316)
T cd05592 72 -----------------FFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD 132 (316)
T ss_pred -----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC
Confidence 8999999999999988653 468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 133 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-- 210 (316)
T cd05592 133 GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-- 210 (316)
T ss_pred CCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--
Confidence 999999999997543322333446799999999999999999999999999999999999999998887776666543
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH-HHHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMD-EVVK 363 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~-~ll~ 363 (394)
..+.++..++.++.++|.+||+.||++||++. ++++
T Consensus 211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 34556777899999999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=343.00 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=207.2
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTT 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 162 (394)
+|++.+.||+|+||+||+|.+ +++.||||+++.... ........+..|..++..+ +|++|+++++++.+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV------IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence 578899999999999999988 567999999874321 1112234556678888777 6899999999987665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Ni 132 (323)
T cd05616 75 RL--------------------YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (323)
T ss_pred EE--------------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHe
Confidence 54 8999999999999988553 4589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++.++.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......
T Consensus 133 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 133 MLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212 (323)
T ss_pred EECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999987533223333446799999999999999999999999999999999999999998888777776
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH-----HHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM-----DEVVK 363 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~-----~~ll~ 363 (394)
+.... ..++..++.++.+++.+||+.+|++|++. .++++
T Consensus 213 i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 213 IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 66543 34567789999999999999999999974 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.59 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=205.1
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|++ +++.||||+++.... ........+..|..++..+ +||||+++++++.....+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~--- 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL--- 71 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE---
Confidence 3699999999999988 567999999874221 1122235566788888876 899999999999866554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|..++... ..+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 72 -----------------~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~ 132 (321)
T cd05591 72 -----------------FFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132 (321)
T ss_pred -----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 9999999999999988653 458999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||++..............||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred CCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998753333333344578999999999999999999999999999999999999999888877777665543
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCC-------CHHHHHHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRP-------VMDEVVKL 364 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-------t~~~ll~~ 364 (394)
...+..++.++.++|.+||+.||++|| +++++++.
T Consensus 213 --~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 --VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 345566899999999999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=331.54 Aligned_cols=259 Identities=25% Similarity=0.452 Sum_probs=211.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|++ +++.||||.++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM------DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC------CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 6789999999999999999987 7889999987642211 1122466788999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.. ++++||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+
T Consensus 76 ~~--------------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ 135 (267)
T cd08228 76 EL--------------------NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPA 135 (267)
T ss_pred eE--------------------EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHH
Confidence 44 8999999999999988642 2345889999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--hh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--TD 318 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~--~~ 318 (394)
||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 136 nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~ 215 (267)
T cd08228 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215 (267)
T ss_pred HEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH
Confidence 9999999999999999987544332222335688899999999988899999999999999999999999865432 33
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
....+......+..+..++..+.+++.+||+.+|++||++.++++.++.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 216 LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 333332222223333457889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=339.58 Aligned_cols=260 Identities=25% Similarity=0.552 Sum_probs=215.0
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+...+|++.+.||+|+||+||+|++ ++. .||+|+++.... ....+.+.+|+.+++.++||||++++
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3457899999999999999999987 444 489999863211 11235678899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
|++.... .++++||+++|+|.+++..+. ..+++..++.++.||+.||+|||++|++||
T Consensus 76 g~~~~~~---------------------~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~ 133 (316)
T cd05108 76 GICLTST---------------------VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHR 133 (316)
T ss_pred EEEcCCC---------------------ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9987532 278999999999999997643 458899999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCc--cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 134 dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred ccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998644322211 12334678999999999999999999999999999997 999998
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
+....+.. .+.........+..++.++.+++.+||..+|++||++.+++..+.++....
T Consensus 214 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 214 GIPASEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCHHHHH-HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 87766654 344555555666778999999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.64 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=206.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||++.. +++.||||++.... .........+.+|+.++++++||||++++++|.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE------MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 4788999999999999999987 78899999986321 112233467788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 75 ~~--------------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI 132 (377)
T cd05629 75 YL--------------------YLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132 (377)
T ss_pred ee--------------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 55 9999999999999998653 4689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC-------------C----------------------------------CccCCCCCC
Q 048724 243 LLDANRTLKIADFGVARVEAQNP-------------R----------------------------------DMTGETGTL 275 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~-------------~----------------------------------~~~~~~gt~ 275 (394)
|++.++.+||+|||+++...... . ......||+
T Consensus 133 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (377)
T cd05629 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP 212 (377)
T ss_pred EECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCc
Confidence 99999999999999985211100 0 001246899
Q ss_pred CcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCC--CCcHHHHHHHHHhchhCCC
Q 048724 276 GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPR--CCPSSLASIMRKCWDANPD 353 (394)
Q Consensus 276 ~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cL~~dP~ 353 (394)
.|+|||.+.+..++.++|||||||++|||++|..||...+..+....+........++. .++.++.++|.+||. +|.
T Consensus 213 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 213 DYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred cccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 99999999999999999999999999999999999988777666666554333333343 478999999999998 777
Q ss_pred CC---CCHHHHHHH
Q 048724 354 KR---PVMDEVVKL 364 (394)
Q Consensus 354 ~R---pt~~~ll~~ 364 (394)
+| +++.+++..
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=329.47 Aligned_cols=256 Identities=30% Similarity=0.585 Sum_probs=214.5
Q ss_pred ccccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..++|++.+.||+|+||+||+|.+. ...||||+++.... ......|..|+.++++++||||+++++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--------DKQRLDFLTEASIMGQFDHPNIIRLEGV 73 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--------hHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence 3578999999999999999999872 34799998864321 1224567889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...... +++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++++|+||
T Consensus 74 ~~~~~~~--------------------~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di 132 (266)
T cd05033 74 VTKSRPV--------------------MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132 (266)
T ss_pred EecCCce--------------------EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 8765544 89999999999999997643 46899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~ 314 (394)
||+||+++.++.++|+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred CcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 99999999999999999999986532111 1112345678999999998899999999999999999998 99999887
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
...+....+. .....+.+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 213 SNQDVIKAVE-DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7776665553 3344455667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=332.80 Aligned_cols=258 Identities=32% Similarity=0.584 Sum_probs=216.4
Q ss_pred cccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
|++..++|++.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~ 72 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--------SMRERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--------CHHHHHHHHHHHHHHHhCCCCcee
Confidence 6788899999999999999999999873 2679999975321 111235677899999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHH
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------RKKLAFKVVIQIALDLARGL 224 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l 224 (394)
++++++...... ++||||+++|+|.+++.... ...+++..++.++.|++.||
T Consensus 73 ~~~~~~~~~~~~--------------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 73 RLLGVVSTGQPT--------------------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred EEEEEEcCCCCc--------------------EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 999998866554 89999999999999996532 22478889999999999999
Q ss_pred HHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 225 SYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 225 ~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
.|||+.+++||||||+||+++.++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|
T Consensus 133 ~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred HHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 99999999999999999999999999999999987533221 1122345678999999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 303 EIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 303 ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
|+++ |..||...+..+....+. .......+..++.++.+++.+||+.+|++|||+.+++..|+
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 9998 999998887777666554 44455667778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=336.66 Aligned_cols=263 Identities=29% Similarity=0.555 Sum_probs=219.8
Q ss_pred cccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCC
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHP 149 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~ 149 (394)
.+|.+..++|.+.+.||+|+||.||+|.+ .+..||||+++.... ....+.+.+|+.+++++ +||
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~ 99 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--------SSEREALMSELKIMSHLGNHE 99 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--------hHHHHHHHHHHHHHHhccCCC
Confidence 35778889999999999999999999975 234799998864321 11235788999999999 899
Q ss_pred cceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 150 nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
||+++++++...+.. |++|||+++|+|.+++.......+++.++..++.|++.||.|||+
T Consensus 100 ~iv~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 159 (302)
T cd05055 100 NIVNLLGACTIGGPI--------------------LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159 (302)
T ss_pred CcceEEEEEecCCce--------------------EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999998765554 899999999999999976554558999999999999999999999
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC- 306 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt- 306 (394)
++++|+||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 160 ~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~ 239 (302)
T cd05055 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239 (302)
T ss_pred CCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999875432211 1112345778999999999889999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 307 CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 307 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
|..||......+..............+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 240 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 240 GSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 99999877765555555555555556667899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=328.10 Aligned_cols=256 Identities=30% Similarity=0.572 Sum_probs=214.2
Q ss_pred cccccccccceeeeccCCceEEEEEEEC-CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYD-GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|++..++|.+.+.||+|+||.||+|.+. +..+|+|.+..... ....+.+|+.+++.++|+|++++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----------MPEAFLQEAQIMKKLRHDKLVPLYAVV 70 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----------cHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 6777889999999999999999999884 45799998763221 125677899999999999999999887
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. .. .+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+
T Consensus 71 ~~-~~--------------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~ 129 (260)
T cd05069 71 SE-EP--------------------IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129 (260)
T ss_pred cC-CC--------------------cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC
Confidence 43 22 2899999999999999976555568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||++++++.++|+|||.+....... .......++..|+|||...+..++.++||||||+++|+|++ |..||.+...
T Consensus 130 ~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred cceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997543221 11122345678999999998889999999999999999999 8999988776
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
.+....+ ........+...+..+.+++.+||+.||++||++++++++|++
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 210 REVLEQV-ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHH-HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6655544 3344555566789999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=335.83 Aligned_cols=268 Identities=30% Similarity=0.580 Sum_probs=222.5
Q ss_pred cccccccccccceeeeccCCceEEEEEEE---------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-C
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY---------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-D 147 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 147 (394)
+.|++...+|++.+.||+|+||.||+|++ ++..||+|.++... .......+.+|+.+++.+ +
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--------chHHHHHHHHHHHHHHhhcc
Confidence 45888999999999999999999999974 23479999886321 111235678899999999 8
Q ss_pred CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHH
Q 048724 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVV 213 (394)
Q Consensus 148 h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~ 213 (394)
||||+++++++...... |+||||+++|+|.+++.... ...+++..+
T Consensus 80 h~~i~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (304)
T cd05101 80 HKNIINLLGACTQDGPL--------------------YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139 (304)
T ss_pred CCCchheeEEEecCCce--------------------EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHH
Confidence 99999999998765544 89999999999999997642 135788899
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCcc
Q 048724 214 IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRK 291 (394)
Q Consensus 214 ~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 291 (394)
..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....... ......+++.|+|||.+.+..++.+
T Consensus 140 ~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 219 (304)
T cd05101 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 219 (304)
T ss_pred HHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch
Confidence 99999999999999999999999999999999999999999999975432211 1222345678999999998889999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 292 CDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 292 ~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+||||||+++|+|++ |..||...+..+....+ ....+...+..++.++.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 220 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 220 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 999999999999998 78999888877776655 3444455667789999999999999999999999999999999987
Q ss_pred ccCC
Q 048724 371 SKGG 374 (394)
Q Consensus 371 ~~~~ 374 (394)
...+
T Consensus 299 ~~~~ 302 (304)
T cd05101 299 LTTN 302 (304)
T ss_pred hhhc
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=334.21 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=207.5
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|++.+.||+|+||+||++.+ +++.||+|++.... .........+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR------IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh------hhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence 478889999999999999987 68899999986322 1112224567789999999999999999999876655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+||||+++|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 75 ~--------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (285)
T cd05605 75 L--------------------CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134 (285)
T ss_pred E--------------------EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEE
Confidence 4 99999999999999887655557999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
+++++.++|+|||++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.........+
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 135 LDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred ECCCCCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 999999999999998754322 2223457899999999999888999999999999999999999999876543332222
Q ss_pred Hh--ccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 324 VR--QNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 324 ~~--~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
.. ......++..++..+.+|+.+||+.||++|| ++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11 1223345566899999999999999999999 88898764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=341.50 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=204.8
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|.+ +++.||||+++.... ........+..|..+++.+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~--- 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL--- 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence 3699999999999988 577999999974321 1112235566788898888 799999999998866554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 72 -----------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 132 (318)
T cd05570 72 -----------------FFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE 132 (318)
T ss_pred -----------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC
Confidence 9999999999999988654 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.++|+|||+++.............|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~- 211 (318)
T cd05570 133 GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED- 211 (318)
T ss_pred CcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999999864322223333457899999999999999999999999999999999999999888877776665443
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCH-----HHHHHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVM-----DEVVKL 364 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~-----~~ll~~ 364 (394)
...++..++..+.+||.+||+.||++||++ .++++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 334567789999999999999999999999 888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=334.12 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=201.8
Q ss_pred ccccceeeeccCCceEEEEEEE---CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC---CCCcceeeeeee
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGAS 158 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~ 158 (394)
++|++.+.||+|+||+||+|++ .++.||+|+++........ ...+.+|+.+++.+ +||||++++++|
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~hpniv~~~~~~ 73 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDVC 73 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-------hHHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence 3688999999999999999987 3678999998754321111 13344577666665 699999999988
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.....- .....++||||++ ++|.+++.......+++..++.++.|++.||.|||++|++|||||
T Consensus 74 ~~~~~~---------------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 74 TVSRTD---------------RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred ecccCC---------------CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 532211 1234589999996 699999976655678999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+|||++.++.+||+|||+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||.+....+
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~ 216 (290)
T cd07862 138 PQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216 (290)
T ss_pred HHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 99999999999999999999754332 22334578999999999998889999999999999999999999998877666
Q ss_pred HHHHHHhccCCC-------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 319 VSSAVVRQNLRP-------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 319 ~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
....+......+ .+...++..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 555543211000 011246788899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=337.10 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=198.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.. +++.||||+++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--------TPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--------cchhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 46899999999999999999988 68899999987433211 113456799999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+. ++|.+++..+ ...+++..+..++.|++.||.|||++|++||||||+|
T Consensus 76 ~~~--------------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~N 133 (303)
T cd07869 76 ETL--------------------TLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133 (303)
T ss_pred CeE--------------------EEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 554 89999995 6888887653 3568999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChh-hH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT-DV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~-~~ 319 (394)
||++.++.+||+|||+++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... +.
T Consensus 134 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 134 LLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred EEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 99999999999999998754333333344678999999999865 45888999999999999999999999875432 22
Q ss_pred HHHHHhc--c--------------CCCC-----CC---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQ--N--------------LRPD-----IP---------RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~--~--------------~~~~-----~~---------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+... . ..+. .+ ...++.+.+|+.+||+.||++|||++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 2111110 0 0000 00 013567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=327.72 Aligned_cols=257 Identities=32% Similarity=0.596 Sum_probs=217.6
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|++..++|++.+.||+|+||+||+|.+ ++..||||.++..... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----------PEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----------HHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 678889999999999999999999987 4578999998743211 24678899999999999999999988
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...... ++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+
T Consensus 71 ~~~~~~--------------------~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~ 130 (261)
T cd05034 71 SEEEPI--------------------YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA 130 (261)
T ss_pred ecCCce--------------------EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 754443 899999999999999977555579999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||+++.++.++|+|||++....... ........+..|+|||.+.+..++.++||||||+++|++++ |+.||.....
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987543211 11112334578999999998889999999999999999998 9999988777
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
......+. .......+..++.++.+++.+||+.+|.+||++.++++.|+.
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 211 REVLEQVE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 66665553 344555566679999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=318.62 Aligned_cols=271 Identities=25% Similarity=0.424 Sum_probs=232.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.+.|.-.+.||.|..++|-++.+ +|+.+|+|++........ ......+++.-.+|+.||+++ .||+|+++.++|..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~-~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTES-GETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccC-CccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 45677778899999999999877 788999999875544332 233667788888999999999 89999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
+..+ ++|+|.|+.|.|.|+|.. ...++++...+|++|+++|+.|||.++||||||||+
T Consensus 95 ~sF~--------------------FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpE 152 (411)
T KOG0599|consen 95 DAFV--------------------FLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPE 152 (411)
T ss_pred cchh--------------------hhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChh
Confidence 6665 889999999999999955 356999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD------GKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||++++.++||+|||+++... ...+....||||+|+|||.+. ...|+..+|.|+.|+++|.|+.|-+||...
T Consensus 153 NILlddn~~i~isDFGFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 153 NILLDDNMNIKISDFGFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred heeeccccceEEeccceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 9999999999999999998654 455667789999999999984 357899999999999999999999999888
Q ss_pred ChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHHhccCCCCCC
Q 048724 315 SFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAVNTSKGGGMIP 378 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~~~~~~~~~~~ 378 (394)
...-+.+.+..+++...-| ..++...++||.+||+.||.+|.|++++|. ++..+.....-.|.|
T Consensus 232 kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 8888888888888765444 457889999999999999999999999997 455555555556666
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.32 Aligned_cols=260 Identities=30% Similarity=0.535 Sum_probs=216.6
Q ss_pred cccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
|+..+|.+.+.||+|+||+||++.. ++..+|+|.++... ......+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIVKF 72 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---------HHHHHHHHHHHHHHHhCCCCCcceE
Confidence 4567899999999999999999974 23568999886321 1224568889999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-----------cCCCCHHHHHHHHHHHHHH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-----------RKKLAFKVVIQIALDLARG 223 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~ 223 (394)
++++...... ++|+||+++++|.+++.... ...+++..++.++.|++.|
T Consensus 73 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~a 132 (288)
T cd05093 73 YGVCVEGDPL--------------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132 (288)
T ss_pred EEEEecCCcc--------------------EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence 9999866554 89999999999999996532 2358999999999999999
Q ss_pred HHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHH
Q 048724 224 LSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301 (394)
Q Consensus 224 l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l 301 (394)
|+|||++|++||||||+||+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++
T Consensus 133 L~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred HHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 999999999999999999999999999999999987443221 111223457789999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 302 WEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 302 ~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|+|++ |..||......+....+... .....+..++.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 213 ~~l~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNEVIECITQG-RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 99998 89999888777766665443 33445667899999999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.25 Aligned_cols=261 Identities=29% Similarity=0.578 Sum_probs=231.9
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CC---eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+|+.....|.++||.|.||.|++|+. .| ..||||.++-+. .+..+.+|..|+.||-+++||||++|.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--------tekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--------TEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--------cHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 56777888999999999999999987 23 479999998443 344578999999999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
|+......+ +||.|||++|+|+.||+.+. +.++..++..++++|+.||.||-+.++|||
T Consensus 697 GVVTks~Pv--------------------MIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHR 755 (996)
T KOG0196|consen 697 GVVTKSKPV--------------------MIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHR 755 (996)
T ss_pred EEEecCcee--------------------EEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhh
Confidence 998866555 89999999999999998866 569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCccCC---CCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGE---TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPY 311 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf 311 (394)
||..+|||++.+-..|++|||+++...++....... .-+.+|.|||.+..++++.++||||||++|||.++ |..||
T Consensus 756 DLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 756 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 999999999999999999999999776555332222 23579999999999999999999999999999775 89999
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
.++++.+++..+ .++++.+.|..||..+.+||..||++|-++||++.+|+..|+++..+
T Consensus 836 WdmSNQdVIkaI-e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 836 WDMSNQDVIKAI-EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cccchHHHHHHH-HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999877 67788888999999999999999999999999999999999999754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=327.82 Aligned_cols=252 Identities=28% Similarity=0.566 Sum_probs=210.3
Q ss_pred ccccccceeeeccCCceEEEEEEECC-eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAYDG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+.++|++.+.||+|+||+||+|.+.+ ..||+|.++.... . ...+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---S-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---c-------HHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45688999999999999999998854 4699998863221 1 24578899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+|
T Consensus 72 ~~~--------------------~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05113 72 RPI--------------------YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130 (256)
T ss_pred CCc--------------------EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcce
Confidence 544 89999999999999997643 368999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~ 319 (394)
|+++.++.+||+|||.++....... ......++..|++||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 131 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05113 131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210 (256)
T ss_pred EEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 9999999999999999875432211 1112345678999999998889999999999999999998 9999988777666
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
...+. ...+...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 211 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 211 VEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 65553 33444556667899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=347.39 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=211.9
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..+..++|++.+.||+|+||.||++++ +++.||+|+++.... ........+.+|+.+++.++||||++++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM------IKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 455678999999999999999999988 578999999863221 111223567789999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+...+ |+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||
T Consensus 112 ~~~~~~~--------------------~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDL 168 (370)
T cd05621 112 FQDDKYL--------------------YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168 (370)
T ss_pred EEcCCEE--------------------EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 9876555 8999999999999998543 4899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCC----CCccchHHHHHHHHHHHHhCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKP----YNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||+|||++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.
T Consensus 169 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred CHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 99999999999999999999975432221 223457999999999997543 7889999999999999999999999
Q ss_pred CCChhhHHHHHHhccCCCCCCC--CCcHHHHHHHHHhchhCCCC--CCCHHHHHHH
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPR--CCPSSLASIMRKCWDANPDK--RPVMDEVVKL 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~ 364 (394)
..+.......+........++. .++..+++++.+||..++.+ |+++.++++.
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 249 ADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 8887777777765544444443 46899999999999855544 8899999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.13 Aligned_cols=251 Identities=28% Similarity=0.487 Sum_probs=213.2
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|.+.+.||+|+||.||+|++ +++.|++|.+...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-------RREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence 477889999999999999988 6789999998643211 1224678889999999999999999999876654
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+|+||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus 74 ~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nil 133 (256)
T cd08529 74 L--------------------NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133 (256)
T ss_pred E--------------------EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 4 89999999999999998765567999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||+++.............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+
T Consensus 134 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 134 LDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred EeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999875544333333456889999999999988999999999999999999999999887766655554
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.. ...+.++..++.++.+++.+||+.+|++||++.++++.
T Consensus 214 ~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 214 IR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred Hc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 33 33445566789999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=350.27 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=206.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++++.||+|+||+||+|+. +++.||||++.... .........+.+|+.++++++||||+++++.|.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD------VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH------HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 4789999999999999999987 67899999986321 112223466788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 ~~--------------------~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 132 (376)
T cd05598 75 NL--------------------YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132 (376)
T ss_pred EE--------------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence 55 8999999999999999653 4689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCC-------------------------------------------CCCccCCCCCCCcCC
Q 048724 243 LLDANRTLKIADFGVARVEAQN-------------------------------------------PRDMTGETGTLGYMA 279 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~-------------------------------------------~~~~~~~~gt~~y~a 279 (394)
|++.++.+||+|||++...... ........||+.|+|
T Consensus 133 ll~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 212 (376)
T cd05598 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA 212 (376)
T ss_pred EECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC
Confidence 9999999999999997421100 000112468999999
Q ss_pred ccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCC-
Q 048724 280 PEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRP- 356 (394)
Q Consensus 280 PE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rp- 356 (394)
||++.+..++.++|||||||++|||++|+.||......+....+......... ...+++++.++|.+|+ .+|.+|+
T Consensus 213 PE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 213 PEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred HHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 99999999999999999999999999999999888776665555433222222 2357899999999977 5999999
Q ss_pred --CHHHHHHH
Q 048724 357 --VMDEVVKL 364 (394)
Q Consensus 357 --t~~~ll~~ 364 (394)
++.+++..
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=326.58 Aligned_cols=251 Identities=29% Similarity=0.591 Sum_probs=209.8
Q ss_pred ccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
...+|++.+.||+|+||.||+|.+ .+..+|+|+++.... . ...+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---S-------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---C-------HHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 346788999999999999999988 456899999863321 1 24577899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++..+. ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 72 ~~~--------------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05059 72 RPI--------------------FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130 (256)
T ss_pred Cce--------------------EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhh
Confidence 544 89999999999999997543 368999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~ 319 (394)
|+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 131 i~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred EEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 9999999999999999875432211 1111234467999999998889999999999999999999 8999987776666
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
...+ ....+...+..++.++.+++.+||+.+|++|||+.++++.|
T Consensus 211 ~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 211 VESV-SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHH-HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 6544 34455666777899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=342.13 Aligned_cols=266 Identities=28% Similarity=0.550 Sum_probs=215.9
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCc
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPN 150 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~n 150 (394)
.|.+..++|++.+.||+|+||+||+|.+ +++.||||+++.... ......+.+|+.++.++ +|||
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~n 72 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGHHLN 72 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--------hHHHHHHHHHHHHHHhccCCcc
Confidence 3788889999999999999999999974 467899999863221 11135677899999999 7899
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------------------
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-------------------------- 204 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-------------------------- 204 (394)
|+++++++..... ..+++|||+++|+|.+++....
T Consensus 73 iv~~~~~~~~~~~-------------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (343)
T cd05103 73 VVNLLGACTKPGG-------------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133 (343)
T ss_pred HhhhcceeecCCC-------------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhh
Confidence 9999998864332 2389999999999999986532
Q ss_pred ---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 205 ---------------------------------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 205 ---------------------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
...+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 213 (343)
T cd05103 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 213 (343)
T ss_pred hhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc
Confidence 12467888999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 048724 246 ANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSA 322 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~ 322 (394)
.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 214 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 293 (343)
T cd05103 214 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293 (343)
T ss_pred CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH
Confidence 999999999999875322211 1112345678999999998899999999999999999997 9999987654444444
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
....+.....+..+++++.+++..||+.+|++|||+.++++.|+.+...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4445555566667889999999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=356.33 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=216.5
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
+...++|++.+.||+|+||+||+|++ +|+.||||+++.... . ......+.+|+.++..++|+||++++..+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~----~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---S----EADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---C----HHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 44568999999999999999999987 789999999864321 1 11235677899999999999999998877
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
....... ......+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++||+|||
T Consensus 101 ~~~~~~~------------~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrD 168 (496)
T PTZ00283 101 AKKDPRN------------PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168 (496)
T ss_pred ecccccC------------cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 5432210 001123589999999999999986532 34689999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||+|||++.++.+||+|||+++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 169 LKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred CCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999754322 11223457999999999999999999999999999999999999999988
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+..+....+.... ...++..+++++.+++.+||+.||.+||++.+++..
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 249 NMEEVMHKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 8777776665443 334667789999999999999999999999999874
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=341.62 Aligned_cols=243 Identities=23% Similarity=0.408 Sum_probs=199.0
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||.||+|.+ +++.||+|+++.... ........+..|..++..+ +||||++++++|.+...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~--- 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV------NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL--- 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE---
Confidence 3699999999999988 678999999974321 1122345677899999998 799999999999876655
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 72 -----------------~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~ 132 (329)
T cd05588 72 -----------------FFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE 132 (329)
T ss_pred -----------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 8999999999999888543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--------hhh-
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS--------FTD- 318 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~--------~~~- 318 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05588 133 GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212 (329)
T ss_pred CCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH
Confidence 99999999998743222233334679999999999999999999999999999999999999996321 111
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC------HHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV------MDEVVK 363 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt------~~~ll~ 363 (394)
....+... ...+|..++..+.++|.+||+.||.+||+ ++++++
T Consensus 213 ~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 213 LFQVILEK--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 22222222 34466778999999999999999999997 677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=356.18 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=211.1
Q ss_pred cccccceeeeccCCceEEEEEEE--C-CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--D-GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
...|.+.+.||+|+||.||+|.. + +..||+|.+.... ......+..|+.+++.++|||||+++++|..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---------ERQAAYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 34599999999999999999977 3 6789999764221 1123466789999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.+ |+||||++||+|.+++... ...++++..+..++.||+.||.|||++||+|||||
T Consensus 137 ~~~~--------------------~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk 196 (478)
T PTZ00267 137 DDKL--------------------LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196 (478)
T ss_pred CCEE--------------------EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcC
Confidence 6655 8999999999999988642 34568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+|||++.++.+||+|||+++...... ......+||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.
T Consensus 197 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999998543321 112345799999999999999999999999999999999999999998887
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.++...+..... ...+..++.++.++|.+||+.||++||++.+++.
T Consensus 277 ~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 REIMQQVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 777766655443 3456678999999999999999999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=332.30 Aligned_cols=256 Identities=30% Similarity=0.549 Sum_probs=213.2
Q ss_pred cccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+..++|.+.+.||+|+||.||+|.+. +..||||+++.... ......+.+|+++++.++|+||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~ 73 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--------NDARKDFEREAELLTNFQHENIVKF 73 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--------HHHHHHHHHHHHHHHhcCCCCchhe
Confidence 34578999999999999999999762 36899999864321 1124678899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc------------cCCCCHHHHHHHHHHHHH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK------------RKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~ 222 (394)
++++...... ++||||+++++|.+++.... ...+++..+..++.|++.
T Consensus 74 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 133 (280)
T cd05049 74 YGVCTEGDPP--------------------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIAS 133 (280)
T ss_pred eeEEecCCCe--------------------EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHH
Confidence 9998866544 89999999999999997542 245788999999999999
Q ss_pred HHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHH
Q 048724 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGIC 300 (394)
Q Consensus 223 ~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 300 (394)
||.|||++|++||||||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++||||||++
T Consensus 134 ~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05049 134 GMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213 (280)
T ss_pred HHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHH
Confidence 9999999999999999999999999999999999987432211 11123345788999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 301 LWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 301 l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
+|+|++ |..||......+....+. .+.....+..++..+.+++.+||+.||++||++.++++.|+
T Consensus 214 l~e~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 214 LWEIFTYGKQPWYGLSNEEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 999998 999998877777665554 33334455678999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=331.00 Aligned_cols=263 Identities=31% Similarity=0.547 Sum_probs=215.8
Q ss_pred cccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
|++..++|++.+.||+|+||.||+|..+ +..||+|.++.... ......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~ 72 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--------LRERIEFLNEASVMKGFTCHHVV 72 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--------HHHHHHHHHHHHHHHhCCCCCee
Confidence 7888999999999999999999998652 34799998753221 11124577899999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHH
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------RKKLAFKVVIQIALDLARGL 224 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l 224 (394)
++++++.+.... |+||||+++|+|.+++.... ...++...+..++.|++.||
T Consensus 73 ~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 73 RLLGVVSKGQPT--------------------LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred eEEEEEcCCCCc--------------------EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 999998765544 89999999999999997532 23456788999999999999
Q ss_pred HHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 225 SYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 225 ~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
.|||+++++||||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|
T Consensus 133 ~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~ 212 (288)
T cd05061 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212 (288)
T ss_pred HHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHH
Confidence 999999999999999999999999999999999874332211 112234567899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 303 EIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 303 ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
||++ |..||......+....+... .....+..+++.+.+++.+||+.+|++|||+.++++.|++....
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 213 EITSLAEQPYQGLSNEQVLKFVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 9998 78999888777766555433 33445667889999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=331.93 Aligned_cols=257 Identities=28% Similarity=0.563 Sum_probs=211.9
Q ss_pred cccccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+.+.+|++.+.||+|+||+||+|.+ .+..||+|.++.... ......+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~ 73 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--------PQQWGEFQQEASLMAELHHPNIVCLL 73 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--------HHHHHHHHHHHHHHhhCCCCCeeeEE
Confidence 4567899999999999999999975 346899999863221 11235678899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---------------cCCCCHHHHHHHHHHH
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---------------RKKLAFKVVIQIALDL 220 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qi 220 (394)
+++...... |+||||+++++|.+++.... ...+++..+..++.|+
T Consensus 74 ~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 133 (283)
T cd05090 74 GVVTQEQPV--------------------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133 (283)
T ss_pred EEEecCCce--------------------EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHH
Confidence 998765554 89999999999999986432 2347889999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHH
Q 048724 221 ARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFG 298 (394)
Q Consensus 221 ~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 298 (394)
+.||.|||++|++||||||+||+++.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||
T Consensus 134 ~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05090 134 AAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFG 213 (283)
T ss_pred HHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHH
Confidence 999999999999999999999999999999999999997532211 112233456789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 299 ICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 299 ~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
+++|||++ |..||.+.........+ ........+..++..+.+++.+||+.||.+||++.++++.|..
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 214 VVLWEIFSFGLQPYYGFSNQEVIEMV-RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 99999998 99999877766555544 3333445667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=338.88 Aligned_cols=243 Identities=28% Similarity=0.425 Sum_probs=200.6
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|.+ +++.||||+++.... ........+..|..+++.+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~--- 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV------LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL--- 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE---
Confidence 3699999999999988 567899999974321 0111124455677777765 999999999999876554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 72 -----------------~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~ 132 (316)
T cd05619 72 -----------------FFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132 (316)
T ss_pred -----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC
Confidence 8999999999999998653 458999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~- 211 (316)
T cd05619 133 GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD- 211 (316)
T ss_pred CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999999874322222333457899999999999999999999999999999999999999888777766665433
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH-HHHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMD-EVVK 363 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~-~ll~ 363 (394)
.+.++..++.++.+++.+||+.||++||++. +++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 -NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2345666899999999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=333.65 Aligned_cols=264 Identities=31% Similarity=0.587 Sum_probs=220.4
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 148 (394)
...|++..++|++.+.||+|+||.||++.+. ...+|+|+++.... ......+.+|+.+++++ +|
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~~h 75 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--------EKDLSDLVSEMEMMKMIGKH 75 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--------HHHHHHHHHHHHHHHhhcCC
Confidence 3568899999999999999999999999862 25799999863221 11235578899999999 89
Q ss_pred CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--------------ccCCCCHHHHH
Q 048724 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--------------KRKKLAFKVVI 214 (394)
Q Consensus 149 ~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--------------~~~~l~~~~~~ 214 (394)
+||+++++++.....+ +++|||+++|+|.+++... ....+++..++
T Consensus 76 ~~i~~~~~~~~~~~~~--------------------~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 135 (293)
T cd05053 76 KNIINLLGVCTQEGPL--------------------YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135 (293)
T ss_pred CCeeeEEEEEcCCCCe--------------------EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence 9999999998765544 8999999999999999652 23468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccc
Q 048724 215 QIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKC 292 (394)
Q Consensus 215 ~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~ 292 (394)
.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++...... .......++..|+|||.+.+..++.++
T Consensus 136 ~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 215 (293)
T cd05053 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS 215 (293)
T ss_pred HHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccc
Confidence 999999999999999999999999999999999999999999997543221 111223456789999999988899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 293 DVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 293 DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
|||||||++|+|++ |..||......+....+ ........+..++..+.+|+.+||..||++|||+.++++.|+++.
T Consensus 216 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 216 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99999999999997 99999888777766554 344455667778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=328.57 Aligned_cols=259 Identities=26% Similarity=0.471 Sum_probs=212.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.+ ++..||||.+.... .........+.+|+.+++.++|+||+++++++....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD------LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh------hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 5788999999999999999986 78899999876322 112223467889999999999999999999988655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.. +++|||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||+|+
T Consensus 76 ~~--------------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ 135 (267)
T cd08229 76 EL--------------------NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA 135 (267)
T ss_pred eE--------------------EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 54 8999999999999998642 2346899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--hh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--TD 318 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~--~~ 318 (394)
||+++.++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||..... ..
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08229 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred HEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH
Confidence 9999999999999999987544333323345788999999999988899999999999999999999999965433 22
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
....+......+..+..++..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 216 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 223332222222233457899999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=348.12 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=205.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|++++.||+|+||+||+|+. +++.||+|++.... .........+.+|+.++++++||||+++++.|.+...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD------VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH------hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence 588999999999999999988 67899999986321 1122334678889999999999999999999987665
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 76 ~--------------------~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL 133 (382)
T cd05625 76 L--------------------YFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133 (382)
T ss_pred E--------------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 5 8999999999999998653 46899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCC-----------------------------------------------CCccCCCCCCC
Q 048724 244 LDANRTLKIADFGVARVEAQNP-----------------------------------------------RDMTGETGTLG 276 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~-----------------------------------------------~~~~~~~gt~~ 276 (394)
++.++.+||+|||+++...... .......||+.
T Consensus 134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (382)
T cd05625 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213 (382)
T ss_pred ECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence 9999999999999975211000 00112468999
Q ss_pred cCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCC
Q 048724 277 YMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDK 354 (394)
Q Consensus 277 y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~ 354 (394)
|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.........+ ..+++++.++|.+|+ .+|.+
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred cCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999999999999999999999999999998877766665554433333333 457899999999976 59999
Q ss_pred CCC---HHHHHH
Q 048724 355 RPV---MDEVVK 363 (394)
Q Consensus 355 Rpt---~~~ll~ 363 (394)
|++ +.+++.
T Consensus 293 R~~~~~~~ei~~ 304 (382)
T cd05625 293 RLGKNGADEIKA 304 (382)
T ss_pred cCCCCCHHHHhc
Confidence 987 888776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=341.15 Aligned_cols=239 Identities=25% Similarity=0.384 Sum_probs=197.7
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHH-HHHHhCCCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV-AVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|++ +|+.||+|++..... ........+..|. .+++.++||||+++++.+.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~--- 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI------LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL--- 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE---
Confidence 3699999999999988 688999999864321 1111123334444 456789999999999998766554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 72 -----------------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~ 132 (323)
T cd05575 72 -----------------YFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ 132 (323)
T ss_pred -----------------EEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 8999999999999988653 468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||++..............||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 133 GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred CcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998743332333344579999999999999999999999999999999999999999888777776665443
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMD 359 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~ 359 (394)
...+..++..+.++|.+||+.||.+||++.
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 334556799999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=340.95 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=222.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 160 (394)
...|++.+.||+|.||+||+++. +|+.+|+|++++....... ....+.+|+.+|+++. |||||.++++|.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~------~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE------DREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc------cHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 46788899999999999999988 6899999999865432111 2467789999999997 9999999999998
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
...+ ++|||+|.||.|.+.+... .+++..+..++.|++.+++|||+.|++||||||+
T Consensus 108 ~~~~--------------------~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE 164 (382)
T KOG0032|consen 108 PDSV--------------------YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE 164 (382)
T ss_pred CCeE--------------------EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH
Confidence 7766 8999999999999999766 3999999999999999999999999999999999
Q ss_pred ceeeCC----CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 241 NMLLDA----NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 241 NIll~~----~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+|+.. ++.+|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.
T Consensus 165 N~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 165 NLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred HeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 999953 35799999999987655 5566778999999999999999999999999999999999999999999998
Q ss_pred hhHHHHHHhccCCC--CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRP--DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 317 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
......+....+.. +....++..++++++.||..||.+|+|+.++|+.-+
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 88888888776643 333567999999999999999999999999999633
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=338.47 Aligned_cols=243 Identities=24% Similarity=0.380 Sum_probs=203.2
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCCC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTT 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~ 162 (394)
+|++.+.||+|+||+||+|.+ +|+.||+|+++.... ........+..|..+++.+. |++|+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV------IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 477889999999999999987 678999999874221 11122345667888888885 577888998887665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||++||+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Ni 132 (323)
T cd05615 75 RL--------------------YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132 (323)
T ss_pred EE--------------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 54 8999999999999998553 4599999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++.++.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||...+.......
T Consensus 133 ll~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 133 MLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred EECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999987533222223345689999999999999999999999999999999999999998887777776
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
+.... ..++..++.++.+++.+||+.+|.+|++.
T Consensus 213 i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 65543 34667789999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.94 Aligned_cols=252 Identities=34% Similarity=0.682 Sum_probs=215.3
Q ss_pred cccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
|-+...+|++.+.||+|+||.||++..+++.||+|.++... ....+.+|+.+++.++|||++++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----------TAQAFLEETAVMTKLHHKNLVRLLGVIL 69 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----------hHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 55677899999999999999999999999999999986321 1256788999999999999999999875
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
... .+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||
T Consensus 70 ~~~---------------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p 128 (254)
T cd05083 70 HNG---------------------LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128 (254)
T ss_pred CCC---------------------cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCc
Confidence 422 28999999999999999766555689999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~ 318 (394)
+||+++.++.++|+|||++...... ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 129 ~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 129 RNILVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ceEEEcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 9999999999999999998753221 122344678999999998889999999999999999997 999998887776
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
....+ ..+.++..+..++..+.+++.+||+.+|++||++.+++..|++
T Consensus 206 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 VKECV-EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHH-hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 66554 3445555667789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.53 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=209.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||++.. +|+.||+|+++... .........+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV------LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 4688999999999999999987 68899999997432 112233567888999999999999999999987665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 75 NL--------------------YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred eE--------------------EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 54 8999999999999999764 24699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLD------GKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|++.++.+||+|||++........ ......||+.|+|||.+. ...++.++|||||||++|+|++|..||...+
T Consensus 134 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred EECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 999999999999999975433221 222347899999999986 4567889999999999999999999998887
Q ss_pred hhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.......+........++ ..++.++.+||.+||+ +|.+|||+++++..
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 777666665433222233 3578999999999998 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=324.63 Aligned_cols=254 Identities=27% Similarity=0.488 Sum_probs=213.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.. +++.||+|.++..... .........+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS----PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 4688899999999999999987 6889999998744321 111222456888999999999999999999998765
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ ++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 78 ~~--------------------~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 78 TL--------------------SIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred eE--------------------EEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 44 8999999999999998653 4589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 136 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 136 LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred EEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 9999999999999998753321111 1234678899999999998899999999999999999999999987766665
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
............++..++..+.++|.+||..+|++|||+.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 555555555666777899999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=345.28 Aligned_cols=251 Identities=26% Similarity=0.461 Sum_probs=203.4
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.....+|++.+.||+|+||+||+|++ +++.||||++.... .......+.+|+.+++.++|+||+++++++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 141 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--------EDTVRRQICREIEILRDVNHPNVVKCHDMF 141 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--------cHHHHHHHHHHHHHHHhCCCCCcceeeeEe
Confidence 44567899999999999999999988 58899999986322 122346788999999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.....+ |+||||+++|+|.+. ...++..+..++.||+.||.|||++|++|||||
T Consensus 142 ~~~~~~--------------------~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 195 (353)
T PLN00034 142 DHNGEI--------------------QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIK 195 (353)
T ss_pred ccCCeE--------------------EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 766554 899999999998643 235678889999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
|+|||++.++.+||+|||+++.............||..|+|||.+.. ...+.++|||||||++|||++|+.||..
T Consensus 196 p~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred HHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865433333344679999999998853 2345689999999999999999999974
Q ss_pred CChhhHHHHH--HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 314 LSFTDVSSAV--VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 314 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
....+..... .........+..++.++.+||.+||+.||++|||+.++++.-
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred CCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 4332222111 122334455667899999999999999999999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=338.45 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=200.4
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||.||+|.+ +|+.||+|+++.... ........+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~--- 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV------LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL--- 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE---
Confidence 3699999999999988 678999999974321 0111124456677777765 899999999999876655
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++..+ ..+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 72 -----------------~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~ 132 (316)
T cd05620 72 -----------------FFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132 (316)
T ss_pred -----------------EEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 8999999999999998653 468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.++|+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~- 211 (316)
T cd05620 133 GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD- 211 (316)
T ss_pred CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999999874322222334467899999999999999999999999999999999999999888777666555432
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH-HHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMD-EVV 362 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~-~ll 362 (394)
.+.++..++.+++++|.+||+.||++||++. +++
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 -TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3456667899999999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.92 Aligned_cols=249 Identities=24% Similarity=0.459 Sum_probs=219.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+-|++.+.||+|.|++|-+|++ +|..||||++.+.+.+.. ....+.+|+..|+.++|||||++|.+.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-------st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-------STGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-------hhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 5688889999999999999976 999999999986654322 2366778999999999999999999877655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+|+|.-++|+|.|||-++. ..+.+..+.+++.||+.|+.|+|+..+|||||||+||
T Consensus 91 Kl--------------------yLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENV 149 (864)
T KOG4717|consen 91 KL--------------------YLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENV 149 (864)
T ss_pred eE--------------------EEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCccee
Confidence 55 99999999999999998765 4599999999999999999999999999999999998
Q ss_pred eeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 243 LLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 243 ll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
++. .-|-|||+|||++... .+.....+.||.+.|-|||++.+..|+ +++||||||++||.|++|++||+..+..+..
T Consensus 150 VFFEKlGlVKLTDFGFSNkf-~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL 228 (864)
T KOG4717|consen 150 VFFEKLGLVKLTDFGFSNKF-QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL 228 (864)
T ss_pred EEeeecCceEeeeccccccC-CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence 875 5689999999999754 345667778999999999999999887 5889999999999999999999999988888
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..++.-. ...|..++.++++||..||..||.+|.+.++|...
T Consensus 229 TmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 229 TMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 8877654 45788899999999999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.38 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=198.6
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||+|+||+||++.+ +++.||+|.+.... .........+..|+.+++.++|+||+++.+++.....+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~------ 68 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR------LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL------ 68 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH------HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE------
Confidence 79999999999987 68899999986322 11112235667899999999999999999988765554
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~ 248 (394)
|+||||+++|+|.+++... ....+++..++.++.||+.||.|||++|++||||||+||+++.++
T Consensus 69 --------------~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 134 (280)
T cd05608 69 --------------CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG 134 (280)
T ss_pred --------------EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 8999999999999887542 234689999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhc--
Q 048724 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ-- 326 (394)
Q Consensus 249 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~-- 326 (394)
.++|+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|+.||...............
T Consensus 135 ~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 214 (280)
T cd05608 135 NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214 (280)
T ss_pred CEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc
Confidence 999999999875433333333457899999999999999999999999999999999999999765432211111111
Q ss_pred cCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 327 ~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
.....++..++..+.+++.+||+.||++|| +++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 112344566899999999999999999999 77788764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.54 Aligned_cols=246 Identities=30% Similarity=0.563 Sum_probs=206.0
Q ss_pred eeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccC
Q 048724 92 EIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+||+|+||.||+|.+ ++..||+|+++.... .......+..|+.+++.++||||+++++++... .
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~---- 69 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-------DPALKDELLREANVMQQLDNPYIVRMIGICEAE-S---- 69 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-------cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C----
Confidence 699999999999975 467899999863321 123356788899999999999999999987532 2
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||.||+++.+
T Consensus 70 ----------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~ 131 (257)
T cd05116 70 ----------------WMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131 (257)
T ss_pred ----------------cEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC
Confidence 38999999999999999643 468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 048724 248 RTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~ 323 (394)
+.++|+|||++......... .....++..|+|||.+....++.++||||||+++|||++ |..||......+....+
T Consensus 132 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i 211 (257)
T cd05116 132 HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211 (257)
T ss_pred CeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999754332211 122344678999999988889999999999999999998 99999887776666554
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..+..++.+..++.++.++|.+||+.||++||++.+|.+.|+.+
T Consensus 212 -~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 212 -ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 44445667778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=342.03 Aligned_cols=239 Identities=26% Similarity=0.421 Sum_probs=201.7
Q ss_pred eeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 91 HEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
+.||+|+||.||++.. +|+.||+|+++.... .......+..|+.++++++||||+++++++.+...+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL- 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEE-
Confidence 5799999999998864 578999999974321 111234567899999999999999999999866554
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+|||++
T Consensus 74 -------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 132 (318)
T cd05582 74 -------------------YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD 132 (318)
T ss_pred -------------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC
Confidence 8999999999999998543 4689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHh
Q 048724 246 ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~ 325 (394)
.++.+||+|||+++.............|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+..
T Consensus 133 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~ 212 (318)
T cd05582 133 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212 (318)
T ss_pred CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 99999999999987543332333446789999999999998899999999999999999999999998877776666654
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 326 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
.. ..++..+++.+.++|.+||+.||++||++.+
T Consensus 213 ~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 43 3466778999999999999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=344.68 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=212.0
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
++.+..++|++.+.||+|+||.||++.+ +++.||+|+++... .........+.+|..+++.++||||+++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE------MIKRSDSAFFWEERDIMAFANSPWVVQLFY 110 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH------hhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4566779999999999999999999988 67899999986321 111222456778999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.+...+ |+||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||
T Consensus 111 ~~~~~~~~--------------------~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 167 (371)
T cd05622 111 AFQDDRYL--------------------YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRD 167 (371)
T ss_pred EEEcCCEE--------------------EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 99866554 8999999999999998543 489999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCC----CCCccchHHHHHHHHHHHHhCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGK----PYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
|||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||
T Consensus 168 Lkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 99999999999999999999997543222 122345799999999998754 3788999999999999999999999
Q ss_pred CCCChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCC--CCCHHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDK--RPVMDEVVKLL 365 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~l 365 (394)
...+.......+........++ ..++..++++|.+||..++.+ |+++.++++..
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 248 YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 9888777777766544333333 458999999999999844433 78999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=325.53 Aligned_cols=250 Identities=24% Similarity=0.455 Sum_probs=212.6
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||++.+ +++.||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 578899999999999999987 678999999863321 1123567789999999999999999999986665
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+++||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 73 ~--------------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nil 132 (255)
T cd08219 73 L--------------------YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132 (255)
T ss_pred E--------------------EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 5 89999999999999987655567899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 133 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 212 (255)
T cd08219 133 LTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212 (255)
T ss_pred ECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence 99999999999999875543333333456889999999999888999999999999999999999999887766666555
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.. +.....+..++..+.+++.+||+.||++|||+.+++..
T Consensus 213 ~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 CQ-GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hc-CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 43 33344666789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.58 Aligned_cols=259 Identities=32% Similarity=0.565 Sum_probs=215.4
Q ss_pred ccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
...+|.+.+.||+|+||.||+|++ ++..+++|.++... ......+.+|+.++++++|+||++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---------LAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---------HHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 456788999999999999999975 23468899875321 12235678899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHHHHHHHHHH
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLA 221 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~ 221 (394)
+++...... ++||||+++++|.+++..+. ...+++..++.++.||+
T Consensus 74 ~~~~~~~~~--------------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 133 (291)
T cd05094 74 GVCGDGDPL--------------------IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 133 (291)
T ss_pred EEEccCCce--------------------EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHH
Confidence 998765554 89999999999999997542 23488999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 299 (394)
.||.|||++|++||||||+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+
T Consensus 134 ~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 213 (291)
T cd05094 134 SGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213 (291)
T ss_pred HHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHH
Confidence 99999999999999999999999999999999999987533221 1122345678899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 300 CLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 300 ~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
++|+|++ |..||...+..+....+ ........+..+|..+.+++.+||+.+|++|||+++++++|+++...
T Consensus 214 il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 214 ILWEIFTYGKQPWFQLSNTEVIECI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 9999998 99999887777666554 33344445667899999999999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=340.99 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=203.5
Q ss_pred cccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 86 KLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
+|++.+.||+|+||+||+++. +++.||+|+++.... .........+..|+.+++.+ +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence 478899999999999999875 578999999864221 11223345677899999999 5999999999987
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
....+ |+||||+++|+|.+++..+ ..+++..+..++.||+.||.|||++|++||||||
T Consensus 76 ~~~~~--------------------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp 133 (332)
T cd05614 76 TEAKL--------------------HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKL 133 (332)
T ss_pred cCCEE--------------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH
Confidence 65554 8999999999999998653 4689999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCC-CCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh-
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSF- 316 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~- 316 (394)
+|||++.++.+||+|||+++..... ........||+.|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus 134 ~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred HHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 9999999999999999998753222 2222345799999999999865 478899999999999999999999964322
Q ss_pred ---hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 317 ---TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 317 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
......+. ...+.++..+++.+.+++.+||+.||++|| +++++++.
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 214 NTQSEVSRRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 22222222 234566777899999999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.81 Aligned_cols=251 Identities=25% Similarity=0.472 Sum_probs=204.5
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+..++|++.+.||+|+||.||++.+ ++..+|+|+++... .......+.+|++++++++||||++++++|.
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 4568999999999999999999988 57899999886421 1122466889999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVK 238 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiH~Dlk 238 (394)
+...+ |+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +++|||||
T Consensus 74 ~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlk 131 (333)
T cd06650 74 SDGEI--------------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 131 (333)
T ss_pred ECCEE--------------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence 76554 8999999999999999653 4589999999999999999999975 79999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+|||++.++.+||+|||++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+
T Consensus 132 p~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 132 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred hhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 99999999999999999998754322 1223578999999999999889999999999999999999999997654433
Q ss_pred HHHHH-------------------------------------------HhccCCCCCC-CCCcHHHHHHHHHhchhCCCC
Q 048724 319 VSSAV-------------------------------------------VRQNLRPDIP-RCCPSSLASIMRKCWDANPDK 354 (394)
Q Consensus 319 ~~~~~-------------------------------------------~~~~~~~~~~-~~~~~~l~~li~~cL~~dP~~ 354 (394)
..... ......+..+ ..++.++++||.+||+.||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCccc
Confidence 22111 0011111111 235788999999999999999
Q ss_pred CCCHHHHHHH
Q 048724 355 RPVMDEVVKL 364 (394)
Q Consensus 355 Rpt~~~ll~~ 364 (394)
|||+.+++..
T Consensus 290 Rpt~~ell~h 299 (333)
T cd06650 290 RADLKQLMVH 299 (333)
T ss_pred CcCHHHHhhC
Confidence 9999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=334.28 Aligned_cols=269 Identities=31% Similarity=0.580 Sum_probs=221.2
Q ss_pred cccccccccccceeeeccCCceEEEEEEE---------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-C
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY---------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-D 147 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 147 (394)
.+|.+..++|.+.+.||+|+||.||+|+. ....||+|.++.... ......+..|+.+++++ +
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~~ 76 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--------DKDLADLISEMELMKLIGK 76 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhccC
Confidence 45888889999999999999999999975 234799998863221 11135677899999999 6
Q ss_pred CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHH
Q 048724 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVV 213 (394)
Q Consensus 148 h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~ 213 (394)
||||+++++++.+.... |++|||+++|+|.+++.... ...+++..+
T Consensus 77 h~~iv~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (314)
T cd05099 77 HKNIINLLGVCTQEGPL--------------------YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136 (314)
T ss_pred CCCeeeEEEEEccCCce--------------------EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHH
Confidence 99999999998765444 89999999999999997532 135889999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCcc
Q 048724 214 IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRK 291 (394)
Q Consensus 214 ~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 291 (394)
..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.+
T Consensus 137 ~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 216 (314)
T cd05099 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216 (314)
T ss_pred HHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc
Confidence 99999999999999999999999999999999999999999999975432111 1122234568999999998889999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 292 CDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 292 ~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+||||||+++|+|++ |..||...+..+....+. .......+..++.++.+++.+||+.+|++|||+.++++.|+++..
T Consensus 217 ~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 217 SDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred chhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 999999999999999 899998887776665553 334455667789999999999999999999999999999999986
Q ss_pred ccCCC
Q 048724 371 SKGGG 375 (394)
Q Consensus 371 ~~~~~ 375 (394)
...+.
T Consensus 296 ~~~~~ 300 (314)
T cd05099 296 AVSEE 300 (314)
T ss_pred HhcCC
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=324.30 Aligned_cols=257 Identities=30% Similarity=0.578 Sum_probs=216.2
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
|++..++|++.+.||+|+||.||++.+ .+..+|+|.++... . ....+.+|+.+++.++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~------~----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------M----SVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh------h----HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 788899999999999999999999987 56689999876321 1 135678899999999999999999987
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. .. .+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+
T Consensus 71 ~~-~~--------------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (260)
T cd05073 71 TK-EP--------------------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129 (260)
T ss_pred cC-CC--------------------eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence 65 22 3899999999999999976555668899999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+.
T Consensus 130 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred cceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999987543221 11122345678999999998889999999999999999998 8999988776
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
......+ ......+.+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 210 PEVIRAL-ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHH-hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 6665544 34444555667899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=340.29 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=198.1
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 168 (394)
+.||+|+||+||+|++ +++.||+|++..... .........+.++..+++.++||||+++++++...+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~---- 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI-----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL---- 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE----
Confidence 3699999999999988 567899999873221 01111122233344467888999999999998866555
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~ 248 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 72 ----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~ 133 (325)
T cd05602 72 ----------------YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG 133 (325)
T ss_pred ----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC
Confidence 8999999999999998653 4588999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccC
Q 048724 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 249 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 134 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~- 212 (325)
T cd05602 134 HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP- 212 (325)
T ss_pred CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-
Confidence 9999999998743333333344679999999999999999999999999999999999999999888777766665443
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
...+..++..+.+++.+||+.+|.+||++.+.+
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 213 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 234456899999999999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.98 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=198.6
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||+|++ +|+.||||+++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 588899999999999999987 6789999998632211 1112457789999999999999999998864332
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. .....|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 74 ~---------------~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 135 (338)
T cd07859 74 R---------------EFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNIL 135 (338)
T ss_pred C---------------CCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 1 112359999999 56999988643 45999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 244 LDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
++.++.+||+|||+++...... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|++||...+...
T Consensus 136 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 136 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred ECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 9999999999999997532211 11234578999999999876 678999999999999999999999997765433
Q ss_pred HHHHHHh--------------------------ccCCCCC---CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVR--------------------------QNLRPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~--------------------------~~~~~~~---~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+.. ....... ...+++.+.+++.+||+.||++|||++++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 2211100 0000000 12367889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=327.25 Aligned_cols=259 Identities=25% Similarity=0.531 Sum_probs=213.3
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+...+|++.+.||+|+||+||+|++ +++ .||+|+++.... ......+.+|+.+++.++||||++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--------PKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--------HHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 3467899999999999999999987 444 489999864321 11235677899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.... .++++||+++|+|.+++..+ ...+++..++.++.|++.||.|||+++++||
T Consensus 76 ~~~~~~~---------------------~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~ 133 (279)
T cd05109 76 GICLTST---------------------VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133 (279)
T ss_pred EEEcCCC---------------------cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 9886422 27899999999999998654 3468999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCC--ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 134 dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999754322211 112345678999999998889999999999999999998 899998
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
.......... .......+.+..++.++.+++.+||+.||++||++.++++.|..+...
T Consensus 214 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 214 GIPAREIPDL-LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCHHHHHHH-HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 7766665543 344445555667899999999999999999999999999999888644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=333.08 Aligned_cols=261 Identities=30% Similarity=0.555 Sum_probs=212.8
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCe--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIG 156 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 156 (394)
+..++|++.+.||+|+||+||+|.+ ++. .+|+|.++... .......+.+|+.++.++ +|+||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~ 75 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLG 75 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--------CHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence 4578999999999999999999987 444 45777654211 112246778899999999 8999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHHHHHHHHHHH
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~ 222 (394)
++...... |+|+||+++++|.+++.... ...+++..++.++.|++.
T Consensus 76 ~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 135 (303)
T cd05088 76 ACEHRGYL--------------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 135 (303)
T ss_pred EECCCCCc--------------------eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHH
Confidence 98766554 89999999999999997542 135789999999999999
Q ss_pred HHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 223 ~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
||+|||++|++||||||+|||++.++.++|+|||++...... ........+..|+|||.+.+..++.++||||||+++|
T Consensus 136 al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 136 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 999999999999999999999999999999999998632211 1111233467899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 303 EIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 303 ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
+|++ |..||...+..+..... ........+..++.++.+|+.+||+.+|++||++.+++..|.++...+
T Consensus 215 ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 215 EIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHhcCCCCcccCChHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9998 99999877766655444 334444556668899999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=324.08 Aligned_cols=258 Identities=26% Similarity=0.495 Sum_probs=212.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.. +|+.||+|.++..... .......+.+|+.++++++|+|++++++.+...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM------DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc------chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 5789999999999999999988 6889999988642211 1122467888999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.. ++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++||||+|+
T Consensus 76 ~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ 135 (267)
T cd08224 76 EL--------------------NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135 (267)
T ss_pred eE--------------------EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChh
Confidence 44 8999999999999998653 2345899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--hhh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS--FTD 318 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~--~~~ 318 (394)
||+++.++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+
T Consensus 136 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08224 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred hEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH
Confidence 999999999999999998754433222333568889999999998889999999999999999999999996543 223
Q ss_pred HHHHHHhccCCCCCCC-CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPR-CCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
....+ ..+..++.+. .++..+.++|.+||..+|++|||+.+|++.|+.+.
T Consensus 216 ~~~~~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 LCKKI-EKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHhhh-hcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 33332 2223333443 67889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=322.60 Aligned_cols=245 Identities=33% Similarity=0.624 Sum_probs=203.3
Q ss_pred eeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCC
Q 048724 92 EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQ 169 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 169 (394)
.||+|+||+||+|++ +++.||+|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----- 68 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI----- 68 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe-----
Confidence 699999999999987 78899999875321 112236688899999999999999999998765544
Q ss_pred CCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCc
Q 048724 170 SATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249 (394)
Q Consensus 170 ~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~ 249 (394)
|+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 69 ---------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~ 132 (252)
T cd05084 69 ---------------YIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV 132 (252)
T ss_pred ---------------EEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc
Confidence 8999999999999998653 346899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCCc--cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhc
Q 048724 250 LKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQ 326 (394)
Q Consensus 250 vkl~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~ 326 (394)
+||+|||++.......... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+ ..
T Consensus 133 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-~~ 211 (252)
T cd05084 133 LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQ 211 (252)
T ss_pred EEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-Hc
Confidence 9999999987433211111 11123457999999998889999999999999999997 89999877766555444 34
Q ss_pred cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 327 ~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4455667778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=326.58 Aligned_cols=260 Identities=23% Similarity=0.472 Sum_probs=212.0
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+...+|++.+.||+|+||+||+|++ +++ .|++|.+.... .......+..|+.++++++||||++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~~~~~l~~l~h~~iv~~~ 75 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--------GRQTFQEITDHMLAMGSLDHAYIVRLL 75 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--------chHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 3457888999999999999999988 454 47777764211 112235677888899999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++... . .++++||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++||
T Consensus 76 ~~~~~~-~--------------------~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 133 (279)
T cd05111 76 GICPGA-S--------------------LQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHR 133 (279)
T ss_pred EEECCC-c--------------------cEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence 987532 1 278999999999999996543 468999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++||+++ |..||.
T Consensus 134 dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred ccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999975432211 1223456778999999998889999999999999999998 999998
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
+........ +...+.....+..++.++.+++.+||..+|++|||+.++++.|..+....
T Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 214 GMRPHEVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCCHHHHHH-HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 776655443 34555555666778999999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.53 Aligned_cols=257 Identities=26% Similarity=0.517 Sum_probs=213.6
Q ss_pred cccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
++..+|.+.+.||+|+||+||+|.+. +..||||+++.... ......+.+|+.+++.++||||+++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~ 73 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--------GPLREEFKHEAMMRSRLQHPNIVCL 73 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--------HHHHHHHHHHHHHHhcCCCCCcCeE
Confidence 55678999999999999999999862 36899999873321 1234678889999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--------------ccCCCCHHHHHHHHHHH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--------------KRKKLAFKVVIQIALDL 220 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qi 220 (394)
++++...... ++++||+++++|.+++... .+..+++..++.++.|+
T Consensus 74 ~~~~~~~~~~--------------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql 133 (283)
T cd05091 74 LGVVTKEQPL--------------------SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQI 133 (283)
T ss_pred EEEEcCCCce--------------------EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence 9999866654 8899999999999998532 12358888999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHH
Q 048724 221 ARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFG 298 (394)
Q Consensus 221 ~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 298 (394)
+.||.|||++|++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||
T Consensus 134 ~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05091 134 AAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213 (283)
T ss_pred HHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHH
Confidence 999999999999999999999999999999999999987532211 112233457899999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 299 ICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 299 ~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
|++|||++ |..||.+....+....+.... ....+..++..+.+++.+||+.+|++||++++|+..|+.
T Consensus 214 ~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 214 VVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 99999998 888998887777766654433 344567799999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.24 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=196.7
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||+|+||+||++.. +|+.||+|.+..... ........+..|++++++++||||+++++++......
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~------ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL------KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL------ 68 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh------hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE------
Confidence 79999999999987 689999999863221 1111123455699999999999999999998765554
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
|+||||++|++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 69 --------------~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~ 134 (277)
T cd05607 69 --------------CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNC 134 (277)
T ss_pred --------------EEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCE
Confidence 899999999999998876655678999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh----hHHHHHHhc
Q 048724 251 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT----DVSSAVVRQ 326 (394)
Q Consensus 251 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~----~~~~~~~~~ 326 (394)
+|+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ++.......
T Consensus 135 ~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 213 (277)
T cd05607 135 RLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED 213 (277)
T ss_pred EEeeceeeeecCCC-ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc
Confidence 99999998754332 2223357899999999999888999999999999999999999999764332 222222222
Q ss_pred cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 327 ~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.... ....++.++.+++.+||+.||++||+++++++.+
T Consensus 214 ~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 214 EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 2111 1235789999999999999999999997765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=328.85 Aligned_cols=256 Identities=30% Similarity=0.546 Sum_probs=212.2
Q ss_pred cccceeeeccCCceEEEEEEECC-------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 86 KLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~~g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
+|++.+.||+|+||+||+|.... ..+++|.+..... . .....+.+|+.+++.++||||+++++.+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS----S----SELRDLLSEFNLLKQVNHPHVIKLYGAC 72 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC----H----HHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 47788999999999999998632 4699998763221 1 1135678899999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----------------------cCCCCHHHHHHH
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----------------------RKKLAFKVVIQI 216 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i 216 (394)
...... ++++||+.+++|.+++.... ...+++..++.+
T Consensus 73 ~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 132 (290)
T cd05045 73 SQDGPL--------------------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132 (290)
T ss_pred ecCCCc--------------------EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHH
Confidence 765554 89999999999999986421 135789999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchH
Q 048724 217 ALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDV 294 (394)
Q Consensus 217 ~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 294 (394)
+.|++.||.|||+++++||||||+|||+++++.++|+|||+++....... ......++..|+|||.+.+..++.++||
T Consensus 133 ~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 212 (290)
T cd05045 133 AWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212 (290)
T ss_pred HHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHH
Confidence 99999999999999999999999999999999999999999875332211 1222355678999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 295 YSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 295 wslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
||||+++|+|++ |..||++.....+.... ........+..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 213 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 213 WSFGVLLWEIVTLGGNPYPGIAPERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 999999999998 99999887766665443 4445666677889999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=335.03 Aligned_cols=267 Identities=31% Similarity=0.576 Sum_probs=221.1
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL- 146 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 146 (394)
.++|++...+|++.+.||+|+||.||+|.+. +..||+|+++.... ......+.+|+.+++++
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~ 75 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--------DKDLSDLVSEMEMMKMIG 75 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--------HHHHHHHHHHHHHHHhhc
Confidence 3679999999999999999999999999751 23689998763211 11235678899999999
Q ss_pred CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHH
Q 048724 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKV 212 (394)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~ 212 (394)
+||||++++++|.....+ ++++||+++|+|.+++.... ...+++.+
T Consensus 76 ~h~~iv~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 135 (334)
T cd05100 76 KHKNIINLLGACTQDGPL--------------------YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135 (334)
T ss_pred CCCCeeeeeEEEccCCce--------------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHH
Confidence 899999999998765544 89999999999999997532 23478899
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCc
Q 048724 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNR 290 (394)
Q Consensus 213 ~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 290 (394)
+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.
T Consensus 136 ~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 999999999999999999999999999999999999999999999875432211 112233456799999999999999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 291 KCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 291 ~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
++||||||+++|||++ |..||...+..+....+. .....+.+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 9999999999999998 899998887777665553 34455566778999999999999999999999999999999998
Q ss_pred hcc
Q 048724 370 TSK 372 (394)
Q Consensus 370 ~~~ 372 (394)
+..
T Consensus 295 ~~~ 297 (334)
T cd05100 295 TVT 297 (334)
T ss_pred hhc
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.41 Aligned_cols=244 Identities=23% Similarity=0.404 Sum_probs=197.4
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|.+ +++.||+|+++.... ........+..|..++.++ +||||+++++++.....+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~--- 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL--- 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh------cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE---
Confidence 3699999999999987 678999999974321 1112235567888888877 899999999998876555
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|..++... ..+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus 72 -----------------~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~ 132 (329)
T cd05618 72 -----------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132 (329)
T ss_pred -----------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 8999999999999888543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--------hhh-
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS--------FTD- 318 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~--------~~~- 318 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ...
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05618 133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212 (329)
T ss_pred CCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH
Confidence 99999999998743322233344678999999999999999999999999999999999999995311 111
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC------HHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV------MDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt------~~~ll~~ 364 (394)
....+.. ....+|..++..+.++|.+||+.||++||+ +.++++.
T Consensus 213 ~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 213 LFQVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2222222 234567788999999999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=343.32 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=206.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||++.. +++.||||+++... .........+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD------MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4688999999999999999987 67899999997321 112233467788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 75 ~~--------------------~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI 132 (360)
T cd05627 75 NL--------------------YLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132 (360)
T ss_pred EE--------------------EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 55 8999999999999998653 4689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC-----------------------------------CCccCCCCCCCcCCccccCCCC
Q 048724 243 LLDANRTLKIADFGVARVEAQNP-----------------------------------RDMTGETGTLGYMAPEVLDGKP 287 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~ 287 (394)
|++.++.++|+|||+++...... .......||+.|+|||++.+..
T Consensus 133 li~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 212 (360)
T cd05627 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 212 (360)
T ss_pred EECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC
Confidence 99999999999999986432110 0011347999999999999999
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCC--CCcHHHHHHHHHhchhCCCCCCC---HHHHH
Q 048724 288 YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPR--CCPSSLASIMRKCWDANPDKRPV---MDEVV 362 (394)
Q Consensus 288 ~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cL~~dP~~Rpt---~~~ll 362 (394)
++.++|||||||++|||++|+.||...+.......+........++. .++.+++++|.+|+. ||.+|++ +++++
T Consensus 213 ~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 99999999999999999999999998887777666654332333332 368899999999874 9999984 67777
Q ss_pred HH
Q 048724 363 KL 364 (394)
Q Consensus 363 ~~ 364 (394)
..
T Consensus 292 ~h 293 (360)
T cd05627 292 SH 293 (360)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=324.94 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=208.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.+.|++.+.||+|+||.||+|.+ +++.||+|+++..... ...+.+|+.+++++ +|+||++++++|..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYYGAFIK 74 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence 46788889999999999999987 6789999998643211 24567899999998 79999999999875
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... .....+|++|||+++++|.+++.......+++..+..++.|++.||+|||+++++|+||+|+
T Consensus 75 ~~~~--------------~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ 140 (272)
T cd06637 75 KNPP--------------GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140 (272)
T ss_pred cCCC--------------CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 4321 11234689999999999999997655567899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||+++.++.++|+|||++..............|++.|+|||.+. +..++.++|||||||++|+|++|+.||....
T Consensus 141 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred HEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 99999999999999999875433323334457899999999986 3458889999999999999999999997766
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.................+..++.++.+|+.+||..+|.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 221 PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 555444443333333334568899999999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=339.53 Aligned_cols=240 Identities=25% Similarity=0.372 Sum_probs=198.2
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHH-HHHhCCCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA-VWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|++ +|+.||+|++..... ........+..|.. +++.++||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~--- 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV------LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL--- 71 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE---
Confidence 3699999999999987 688999999864321 11112234444544 56778999999999998876655
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 72 -----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~ 132 (325)
T cd05604 72 -----------------YFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ 132 (325)
T ss_pred -----------------EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC
Confidence 899999999999988854 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 133 GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred CCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998743332333344679999999999999999999999999999999999999999888777776665543
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
...+...+..+.++|.+||+.+|.+||++.+
T Consensus 213 --~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 213 --LVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2344458899999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=328.82 Aligned_cols=260 Identities=32% Similarity=0.557 Sum_probs=213.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCe--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
++|++.+.||+|+||.||+|.. ++. .+++|.++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--------ENDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--------HHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 5789999999999999999987 333 478888763211 11235678899999999 7999999999987
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHHHHHHHHHHHHHH
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLARGLS 225 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~ 225 (394)
....+ |+++||+++++|.+++.... ...+++..++.++.|++.||+
T Consensus 74 ~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~ 133 (297)
T cd05089 74 NRGYL--------------------YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQ 133 (297)
T ss_pred cCCcc--------------------eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHH
Confidence 65544 89999999999999996532 135889999999999999999
Q ss_pred HHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHH
Q 048724 226 YLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305 (394)
Q Consensus 226 yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 305 (394)
|||++|++||||||+|||++.++.+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|+
T Consensus 134 ~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 134 YLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred HHHHCCcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999986322111 111223356799999999888999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 306 C-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 306 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
+ |..||......+....+. .......+..++.++.+|+.+||+.+|.+|||+.++++.|..+......
T Consensus 213 t~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 7 999998887777665553 3445566777999999999999999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=337.09 Aligned_cols=239 Identities=24% Similarity=0.382 Sum_probs=196.8
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHH-HHHHhCCCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV-AVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|++ +++.||+|++.... .........+..|. .+++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~--- 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT------ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL--- 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE---
Confidence 3699999999999988 67899999986322 11111223344444 467889999999999998766554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus 72 -----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 132 (321)
T cd05603 72 -----------------YFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ 132 (321)
T ss_pred -----------------EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 899999999999988854 3468899999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|||++|..||...+.......+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~- 211 (321)
T cd05603 133 GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK- 211 (321)
T ss_pred CCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-
Confidence 9999999999874322222333457899999999999999999999999999999999999999888777766665543
Q ss_pred CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 048724 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMD 359 (394)
Q Consensus 328 ~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~ 359 (394)
...++...+..+.+++.+||+.+|.+||++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 -PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3445667889999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=326.83 Aligned_cols=255 Identities=30% Similarity=0.554 Sum_probs=211.3
Q ss_pred cccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
++..+|++.++||+|+||.||++.. ++..+|+|.++... ......+.+|+.+++.++|+||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTVLQHQHIVRF 72 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---------HHHHHHHHHHHHHHhcCCCCCCceE
Confidence 3457888999999999999999864 35689999876321 1224678899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-------------CCCCHHHHHHHHHHHH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-------------KKLAFKVVIQIALDLA 221 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~ 221 (394)
++++.+.... ++++||+++++|.+++..... ..+++..++.++.|++
T Consensus 73 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 132 (280)
T cd05092 73 YGVCTEGRPL--------------------LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132 (280)
T ss_pred EEEEecCCce--------------------EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHH
Confidence 9998765554 899999999999999975431 3588999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 299 (394)
.||+|||++|++||||||+|||+++++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||
T Consensus 133 ~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred HHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 99999999999999999999999999999999999987432211 1112234567899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 300 CLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 300 ~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
++|+|++ |.+||......+...... .......+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus 213 il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 9999998 899998777666665543 33344566778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.28 Aligned_cols=255 Identities=28% Similarity=0.538 Sum_probs=212.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|.+...||+|+||.||+|.+ +++.||+|.+...................+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366788999999999999987 678999998875443322233344456788899999999999999999999886655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++++||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 81 ~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil 138 (267)
T cd06628 81 L--------------------NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138 (267)
T ss_pred c--------------------EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEE
Confidence 4 8999999999999999654 46899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCC------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 244 LDANRTLKIADFGVARVEAQNPR------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred EcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 99999999999999875432111 111235788999999999888999999999999999999999999877655
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.....+. ....+..+..++..+.++|.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 QAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 5444332 24455667778999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=348.86 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=202.6
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
...+|++.+.||+|+||+||+|.+ +++.||||.+.... ....+|+.+++.++|||||++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 346899999999999999999987 67899999885321 223469999999999999999988754
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.... .......+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++||+|||||
T Consensus 131 ~~~~------------~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLK 197 (440)
T PTZ00036 131 ECFK------------KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK 197 (440)
T ss_pred cccc------------cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcC
Confidence 2211 00111235799999974 78777753 234569999999999999999999999999999999
Q ss_pred CCceeeCCC-CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 239 TENMLLDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+|||++.+ +.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|.+||.+.+.
T Consensus 198 p~NILl~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 198 PQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred HHHEEEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999865 47999999999854332 22234578999999999865 4689999999999999999999999988765
Q ss_pred hhHHHHHHhcc---------------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHH
Q 048724 317 TDVSSAVVRQN---------------------------LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEA 367 (394)
Q Consensus 317 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~ 367 (394)
.+....+.... +...+|...++++.+||.+||..||.+|||+.+++. +++.
T Consensus 277 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 277 VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 55444332210 011133457889999999999999999999999996 5556
Q ss_pred HHh
Q 048724 368 VNT 370 (394)
Q Consensus 368 ~~~ 370 (394)
+..
T Consensus 357 ~~~ 359 (440)
T PTZ00036 357 LRD 359 (440)
T ss_pred hhc
Confidence 554
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=341.80 Aligned_cols=245 Identities=23% Similarity=0.403 Sum_probs=195.2
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+...+|++.+.||+|+||.||+|.+ +++.||+|... ...+.+|+.++++++|||||+++++|.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------------~~~~~~E~~il~~l~HpnIv~~~~~~~ 153 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------------RGGTATEAHILRAINHPSIIQLKGTFT 153 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------------hhhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence 4557899999999999999999988 67899999753 134568999999999999999999987
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..... |+|+|++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 154 ~~~~~--------------------~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP 210 (391)
T PHA03212 154 YNKFT--------------------CLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKA 210 (391)
T ss_pred ECCee--------------------EEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 65544 8999999 57898888553 4589999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCC-CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF-- 316 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~-- 316 (394)
+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 211 ~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 211 ENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred HhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 9999999999999999999643221 1223345799999999999999999999999999999999999987643210
Q ss_pred -----hhHHHHHH--------------------------hccCCCC--CC-----CCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 317 -----TDVSSAVV--------------------------RQNLRPD--IP-----RCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 317 -----~~~~~~~~--------------------------~~~~~~~--~~-----~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
......+. ....... .+ ..++.++.+||.+||+.||++|||+
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence 01111110 0000000 00 1246789999999999999999999
Q ss_pred HHHHHH
Q 048724 359 DEVVKL 364 (394)
Q Consensus 359 ~~ll~~ 364 (394)
+++++.
T Consensus 371 ~elL~h 376 (391)
T PHA03212 371 EALLDF 376 (391)
T ss_pred HHHhcC
Confidence 999963
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=325.57 Aligned_cols=254 Identities=26% Similarity=0.516 Sum_probs=203.0
Q ss_pred ccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 87 LDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
|++.+.||+|+||+||++.+ ++..||+|+++.... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--------QQNTSGWKKEINILKTLYHENIVKYKGCCSE 77 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 38889999999999988653 467899999864321 1123567789999999999999999998764
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... ..++++|||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+
T Consensus 78 ~~~------------------~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~ 136 (283)
T cd05080 78 QGG------------------KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAAR 136 (283)
T ss_pred CCC------------------ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChh
Confidence 332 2248999999999999998653 4999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 137 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 216 (283)
T cd05080 137 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216 (283)
T ss_pred eEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch
Confidence 999999999999999998754322111 11234567799999998888999999999999999999999998543211
Q ss_pred --h------------HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 318 --D------------VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 318 --~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
+ ............+.+..++.++.+++.+||+.+|++|||+++++..|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 011112223334456678999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=321.13 Aligned_cols=246 Identities=28% Similarity=0.585 Sum_probs=204.7
Q ss_pred eeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccC
Q 048724 92 EIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
.||+|+||.||+|.+ ++..||+|+++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-~---- 68 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-A---- 68 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-C----
Confidence 489999999999976 24569999986332 122346788999999999999999999987532 2
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 69 ----------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~ 131 (257)
T cd05115 69 ----------------LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ 131 (257)
T ss_pred ----------------eEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC
Confidence 38999999999999998643 3568999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 048724 248 RTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~ 323 (394)
+.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+
T Consensus 132 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05115 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211 (257)
T ss_pred CcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 9999999999874332211 1122234578999999988889999999999999999996 99999888777666544
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..+.+...+..+++++.+++.+||..+|++||++.++.+.|+.+
T Consensus 212 -~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 212 -EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 44456667778899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.83 Aligned_cols=260 Identities=28% Similarity=0.515 Sum_probs=207.7
Q ss_pred ccceeeeccCCceEEEEEEEC--Ce--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 87 LDIRHEIARGTYGTVYRGAYD--GQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~--g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
|.+.+.||+|+||.||+|.+. +. .||+|.++.... .......+..|+.+++.++|+||+++++++....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 356788999999999999873 32 699998864321 1122467788999999999999999999875432
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN----KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. ......++++||+++|+|.+++... ....+++..+..++.|++.||.|||+++++|||||
T Consensus 74 ~~--------------~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 139 (272)
T cd05075 74 ES--------------EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLA 139 (272)
T ss_pred cc--------------cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 21 0112348999999999999988532 23458999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
|+|||++.++.++|+|||+++....... ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||+...
T Consensus 140 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 140 ARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred hhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999975432211 1122345678999999999999999999999999999999 899998877
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..+....+.. +.....+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 220 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 220 NSEIYDYLRQ-GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7666655433 333445567899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=325.33 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=203.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||+|+||.||+|++ +++.||+|+++..... ....+.+|+.++++++||||+++++.+...
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---------DFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---------hHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 46899999999999999999987 6789999998633210 124567899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+|
T Consensus 79 ~~~--------------------~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~n 136 (267)
T cd06646 79 EKL--------------------WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGAN 136 (267)
T ss_pred CEE--------------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 544 8999999999999998643 468999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+++.++.++|+|||++..............++..|+|||.+. ...++.++||||||+++|+|++|+.||......+
T Consensus 137 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 137 ILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred EEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 9999999999999999975433322233456889999999884 3457889999999999999999999996654433
Q ss_pred HHHHHHhccCCCCC---CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 319 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
....+......+.. ...++..+.+++.+||+.+|++|||++++++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 217 ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred hheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 32222222222221 234688999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.90 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=206.1
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|+..+.||+|+||+||+|.+ +++.||+|.+.... .........+.+|+.+++.++|+||+++.+.+...+..
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR------IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL 75 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh------hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence 66778999999999999988 68899999986322 11122235567899999999999999999998766554
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
|++|||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 76 --------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili 135 (285)
T cd05632 76 --------------------CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL 135 (285)
T ss_pred --------------------EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE
Confidence 899999999999998876555579999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~ 324 (394)
+.++.++|+|||++...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~ 214 (285)
T cd05632 136 DDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214 (285)
T ss_pred CCCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999998654322 22234578999999999998899999999999999999999999998766543333332
Q ss_pred hc--cCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 325 RQ--NLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 325 ~~--~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
.. .....++..++.++.+|+.+||+.||++||+ +.+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 215 RRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 21 1123455668899999999999999999999 7777774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.82 Aligned_cols=260 Identities=28% Similarity=0.542 Sum_probs=211.7
Q ss_pred ccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 87 LDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
|++.+.||+|+||.||+|... +..||+|.++.... . ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---T----YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---C----HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence 567889999999999999862 36799999864221 1 11235678899999999999999999988654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
... ......++++||+++|+|..++.... ...+++..++.++.|++.||.|||+++++||||
T Consensus 74 ~~~--------------~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 139 (273)
T cd05035 74 SSL--------------QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDL 139 (273)
T ss_pred Ccc--------------ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 431 11233489999999999999986432 246899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~ 314 (394)
||+||++++++.+||+|||+++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 140 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 140 AARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred chheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999975432211 1112345678999999988889999999999999999999 89999888
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
...+....+. .......+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus 220 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 220 ENHEIYDYLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CHHHHHHHHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7777665553 3345556778999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=323.33 Aligned_cols=256 Identities=29% Similarity=0.592 Sum_probs=212.1
Q ss_pred ccccccceeeeccCCceEEEEEEE--CC---eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..++|++.+.||+|+||.||+|.+ ++ ..+|+|.++.... ......+..|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--------EKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 356889999999999999999986 22 3799998863221 1124678889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...+.. |+||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||
T Consensus 74 ~~~~~~~--------------------~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dl 132 (267)
T cd05066 74 VTKSKPV--------------------MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 132 (267)
T ss_pred EecCCcc--------------------EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhh
Confidence 8765544 89999999999999997543 46899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
||+||+++.++.++|+|||++......... .....++..|++||.+.+..++.++||||||+++|++++ |..||..
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred chhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 999999999999999999999754332211 111233568999999998889999999999999999886 9999988
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
....+....+. ...+.+.+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 213 MSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 77666655543 3345555667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=318.44 Aligned_cols=252 Identities=27% Similarity=0.482 Sum_probs=210.7
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|++.+.||+|++|.||++++ +++.||+|.+..... .....+.+.+|+.++++++|+|++++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC
Confidence 488999999999999999987 578899999863221 11224567889999999999999999987753322
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
..|+++||+++++|.+++.......+++.+++.++.|++.|+.|||++|++||||+|+||+
T Consensus 74 -------------------~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil 134 (257)
T cd08223 74 -------------------LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134 (257)
T ss_pred -------------------EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEE
Confidence 2389999999999999997755567999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+
T Consensus 135 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 214 (257)
T cd08223 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214 (257)
T ss_pred EecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999976543333333456889999999999999999999999999999999999999877766655554
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
... ..+..+..+++++.+++.+||+.+|++|||+.++++.
T Consensus 215 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 215 IEG-KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred Hhc-CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 433 3344566789999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.63 Aligned_cols=262 Identities=31% Similarity=0.616 Sum_probs=227.0
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC----Ce--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD----GQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
..+++..+..+..+.||.|.||.||+|+++ |. .||||.-+..-. ....+.|.+|+-+|++++||||
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--------~d~tekflqEa~iMrnfdHphI 453 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--------PDDTEKFLQEASIMRNFDHPHI 453 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--------hhhHHHHHHHHHHHHhCCCcch
Confidence 457788888888999999999999999883 33 589998774321 1115789999999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
|+++|+|.+ .++|||||.++-|.|..||..++ ..++...+..+++||+.||.|||++.
T Consensus 454 ikLIGv~~e---------------------~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr 511 (974)
T KOG4257|consen 454 IKLIGVCVE---------------------QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR 511 (974)
T ss_pred hheeeeeec---------------------cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc
Confidence 999999975 34599999999999999997654 56999999999999999999999999
Q ss_pred CcccCCCCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 232 IVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
+|||||..+|||+.....|||+|||+++...+... ..+...-+..|||||.++-+.++.++|||.||+++||++. |..
T Consensus 512 fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvk 591 (974)
T KOG4257|consen 512 FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVK 591 (974)
T ss_pred hhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999997655432 2223455789999999999999999999999999999875 899
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
||.+..+.+++..+ ..+.+.+.|..||+.+..|+.+||+.+|.+||++.++...|.++..
T Consensus 592 PfqgvkNsDVI~~i-EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 592 PFQGVKNSDVIGHI-ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ccccccccceEEEe-cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999988888554 6777899999999999999999999999999999999998887764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=334.04 Aligned_cols=244 Identities=24% Similarity=0.394 Sum_probs=198.3
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|.. +++.||+|+++... .........+..|+.++.++ +||||+++++++.+...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~--- 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL------VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL--- 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE---
Confidence 3699999999999987 67899999997432 11222345677899999888 799999999998866555
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.+
T Consensus 72 -----------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~ 132 (327)
T cd05617 72 -----------------FLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD 132 (327)
T ss_pred -----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC
Confidence 8999999999999888543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC------ChhhHHH
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL------SFTDVSS 321 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~------~~~~~~~ 321 (394)
+.+||+|||+++.............||+.|+|||.+.+..++.++|||||||++|+|++|..||... ...+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 212 (327)
T cd05617 133 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212 (327)
T ss_pred CCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH
Confidence 9999999999874332223334467999999999999999999999999999999999999999532 1222222
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH------HHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM------DEVVK 363 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~------~~ll~ 363 (394)
..... ....+|..++..+.+++.+||+.||++|+++ +++++
T Consensus 213 ~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 213 QVILE-KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred HHHHh-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 22222 2344677789999999999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.15 Aligned_cols=265 Identities=23% Similarity=0.415 Sum_probs=215.0
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CC-eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~ 156 (394)
.++...++++.+.|.+|||+.||+|.+ .+ ..||+|++-.. .+.......+|+.+|++|. |+|||.+++
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---------de~~L~~v~~EI~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---------DEEALNAVKREIDIMKLLSGHKNIVSYID 102 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---------CHHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence 567778889999999999999999998 34 89999987532 1222466789999999995 999999998
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--Ccc
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVH 234 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiH 234 (394)
.......- ....-.++|+||||.||.|-|++..+-...|++.++++|+.++++|+.+||... |||
T Consensus 103 ss~~~~~~-------------~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIH 169 (738)
T KOG1989|consen 103 SSAINRSS-------------NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIH 169 (738)
T ss_pred cccccccC-------------CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccch
Confidence 43211100 011235689999999999999998766667999999999999999999999887 999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCc---------cCCCCCCCcCCcccc---CCCCCCccchHHHHHHHHH
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDM---------TGETGTLGYMAPEVL---DGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~ 302 (394)
||||-+||||+.+|..||||||.++......... .....|+.|.|||++ .+.+.+.|+|||+|||+||
T Consensus 170 RDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 170 RDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY 249 (738)
T ss_pred hhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence 9999999999999999999999987432222110 112468999999998 5778999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 303 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
-|++...||+..... .|+..++..+....++..+.+||+.||+.||++||++-+++..+.++..
T Consensus 250 kLCy~t~PFe~sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 250 KLCYFTTPFEESGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HHHHhCCCcCcCcce----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 999999999865332 3445556555556789999999999999999999999999999999974
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=320.20 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=210.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|...+.||+|+||.|..|.+ +|+.||||.+...- ......++..+|+++|+.++|+||+.+.+++..+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-------~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-------hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 4455578999999999999988 78999999886222 22233466778999999999999999999987522
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.- .-..+|+|+|+| +.+|...++.+ ..++...+..+++|+++||.|+|+.+++||||||.|+
T Consensus 95 ~~---------------~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNl 156 (359)
T KOG0660|consen 95 RD---------------KFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNL 156 (359)
T ss_pred cc---------------ccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhhe
Confidence 11 124569999999 67999998543 3499999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccC--CCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|++.++.+||+|||+|+.... ....++..+.|..|.|||.+. ...|+.+.||||.||++.||++|++-|++.+..+.
T Consensus 157 l~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q 236 (359)
T KOG0660|consen 157 LLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ 236 (359)
T ss_pred eeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH
Confidence 999999999999999997543 234456778899999999874 57899999999999999999999999988775554
Q ss_pred HHHHHhc------------------------cCCCCCC-----CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 048724 320 SSAVVRQ------------------------NLRPDIP-----RCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAV 368 (394)
Q Consensus 320 ~~~~~~~------------------------~~~~~~~-----~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~ 368 (394)
...+... ...+..+ ...++...+|+.+||..||.+|+|++|+|.. |..+
T Consensus 237 l~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 237 LQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 4443211 1111111 3568899999999999999999999999984 5555
Q ss_pred Hhcc
Q 048724 369 NTSK 372 (394)
Q Consensus 369 ~~~~ 372 (394)
....
T Consensus 317 hdp~ 320 (359)
T KOG0660|consen 317 HDPE 320 (359)
T ss_pred cCCc
Confidence 4433
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.93 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=202.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|.+.+.||+|+||+||+|++ +++.||+|.++....... ...+.+|+.++++++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--------chhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 47899999999999999999987 678899999874432111 23456799999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.. |+||||+++ +|.+++... ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 77 ~~~--------------------~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~N 134 (309)
T cd07872 77 KSL--------------------TLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQN 134 (309)
T ss_pred CeE--------------------EEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 554 899999965 888887653 3458899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.+||+|||+++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+..
T Consensus 135 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 135 LLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred EEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999754333333334578899999998865 56889999999999999999999999887665544
Q ss_pred HHHHhcc---------------------CCC-------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 321 SAVVRQN---------------------LRP-------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 321 ~~~~~~~---------------------~~~-------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+.... ... .....++.++.++|.+||+.||.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 3332110 000 011246889999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=332.41 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=206.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+++. +++.||+|+++... .........+.+|..+++.++|+||++++++|.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE------MLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 4789999999999999999987 67899999986321 112223466888999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||++||+|.+++.+. ...+++..+..++.||+.||+|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (331)
T cd05597 75 NL--------------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133 (331)
T ss_pred eE--------------------EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHE
Confidence 55 9999999999999999653 34689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|++.++.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 134 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred EECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 999999999999999865432221 2223468999999999863 4578899999999999999999999988877
Q ss_pred hhHHHHHHhccCCCCCC---CCCcHHHHHHHHHhchhCCCC--CCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIP---RCCPSSLASIMRKCWDANPDK--RPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~ 364 (394)
.+....+........++ ..++..++++|.+||..++++ |++++++++.
T Consensus 214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 77666665433222222 347899999999988754443 7899999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.77 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=213.3
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|+||.||.++. +++.+++|.+...... ......+.+|+.++++++|+||+++++++.+...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-------EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence 588899999999999988876 6889999988643211 1223567789999999999999999999987655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ +++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 74 ~--------------------~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~ 133 (256)
T cd08221 74 L--------------------LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF 133 (256)
T ss_pred E--------------------EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEE
Confidence 4 89999999999999997765567899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.+||+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+
T Consensus 134 ~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 134 LTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred EeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999999976544332333456899999999999888899999999999999999999999887776666666
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
...... ..+..++..+.+++.+||+.+|++||++.++++.+
T Consensus 214 ~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 214 VQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 544433 34466899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=323.41 Aligned_cols=256 Identities=31% Similarity=0.572 Sum_probs=209.5
Q ss_pred cccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+..++|++.+.||+|+||.||+|.+. +..||+|.++.... ......|..|+.+++.++|+||+++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--------EQDESDFLMEALIMSKFNHQNIVRL 74 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 34578999999999999999999883 35789998753221 1113567889999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-----KKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
++++.+.... ++||||++|++|.+++..... ..+++..++.++.||+.||.|||+
T Consensus 75 ~~~~~~~~~~--------------------~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 134 (277)
T cd05036 75 IGVSFERLPR--------------------FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE 134 (277)
T ss_pred EEEEccCCCc--------------------EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9998765554 899999999999999976432 258999999999999999999999
Q ss_pred CCCcccCCCCCceeeCCCC---cEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHH
Q 048724 230 KTIVHRDVKTENMLLDANR---TLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~---~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el 304 (394)
++++||||||+||+++.++ .+||+|||+++....... .......+..|+|||.+.+..++.++|||||||++|+|
T Consensus 135 ~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (277)
T cd05036 135 NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214 (277)
T ss_pred CCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHH
Confidence 9999999999999998654 699999999975422111 11122345689999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 305 YC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 305 lt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
++ |..||...+..+....+ ....+...+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 215 ~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 215 FSLGYMPYPGRTNQEVMEFV-TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 97 99999887776666544 334455667778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=320.09 Aligned_cols=257 Identities=28% Similarity=0.571 Sum_probs=212.7
Q ss_pred cccccccceeeeccCCceEEEEEEE--CC---eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
|..++|+..+.||+|+||.||+|+. ++ ..+|+|.++.... ....+.+..|+.++++++|+||+++.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--------EKQRQDFLSEASIMGQFSHHNIIRLEG 73 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--------HHHHHHHHHHHHHHhcCCCCCeeEEEE
Confidence 4567889999999999999999987 33 3799998863221 112356788999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.+.+.. |+||||+++++|.+++..+. ..+++.++..++.|++.||+|||+.|++|+|
T Consensus 74 ~~~~~~~~--------------------~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 132 (268)
T cd05063 74 VVTKFKPA--------------------MIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRD 132 (268)
T ss_pred EEccCCCc--------------------EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 99766554 89999999999999986543 5689999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCc---cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDM---TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
|||+||+++.++.++|+|||++.......... .....+..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 133 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999987543221111 11223457999999998889999999999999999997 999998
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..+..+....+.. ....+.+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 213 ~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 213 DMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred cCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 8777666665543 344445566899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=325.57 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=204.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|++.+.||+|+||+||++.+ +++.||+|.+...... .......+.+|+.++++++|+||+++++.+.+.+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc------chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence 367788999999999999988 6789999988643211 11123456789999999999999999999876655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+||||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 75 ~--------------------~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil 134 (285)
T cd05630 75 L--------------------CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134 (285)
T ss_pred E--------------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence 4 89999999999999987655556999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh---hHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT---DVS 320 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~---~~~ 320 (394)
++.++.++|+|||++...... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~ 213 (285)
T cd05630 135 LDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213 (285)
T ss_pred ECCCCCEEEeeccceeecCCC-ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 999999999999998754322 2223357899999999999989999999999999999999999999765422 111
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVK 363 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~ 363 (394)
.... .......+..+++++.+|+.+||+.||++||| ++++++
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 214 ERLV-KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred Hhhh-hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1111 12233455678999999999999999999999 889988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.26 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=200.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||++.+ +|..||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 57899999999999999999987 688999999864321 111235567899999999999999999998754
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+. .....|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 93 ~~~~--------------~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 153 (359)
T cd07876 93 KSLE--------------EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153 (359)
T ss_pred CCcc--------------ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 4321 12345899999965 6766663 248899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||+++..... .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 154 Il~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 154 IVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred EEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999753322 22234578999999999999999999999999999999999999998765433222
Q ss_pred HHHh----------------------ccCC------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 322 AVVR----------------------QNLR------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 322 ~~~~----------------------~~~~------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
.+.. .... .......++.+++||.+||+.||++|||+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 1111 0000 00112246789999999999999999999999
Q ss_pred HHHH
Q 048724 362 VKLL 365 (394)
Q Consensus 362 l~~l 365 (394)
+..-
T Consensus 313 l~hp 316 (359)
T cd07876 313 LRHP 316 (359)
T ss_pred hcCc
Confidence 9854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=323.65 Aligned_cols=254 Identities=28% Similarity=0.382 Sum_probs=198.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC---CCCcceeeeeeecC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGASMG 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~ 160 (394)
+|++.+.||+|+||+||+|.+ +++.||+|.++........ ...+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-------PLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-------chHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 478899999999999999988 6889999998743221111 12334566666554 79999999998864
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... .....++++||++ ++|.+++.......+++..+..++.|++.||.|||++|++||||||+
T Consensus 74 ~~~~---------------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~ 137 (288)
T cd07863 74 SRTD---------------RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 137 (288)
T ss_pred ccCC---------------CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 3221 1234589999997 58999887655556999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||+++.++.+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|+|++|.+||......+..
T Consensus 138 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~ 216 (288)
T cd07863 138 NILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216 (288)
T ss_pred HEEECCCCCEEECccCccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH
Confidence 999999999999999999754322 2223356889999999999888999999999999999999999999877655544
Q ss_pred HHHHhcc------------------CCC-------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 321 SAVVRQN------------------LRP-------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 321 ~~~~~~~------------------~~~-------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+.... +.. .....++..+.+++.+||+.||++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 217 GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 4332210 000 011246788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=319.21 Aligned_cols=259 Identities=31% Similarity=0.597 Sum_probs=213.9
Q ss_pred ccccccccceeeeccCCceEEEEEEECC-----eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYDG-----QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
++...+|++.+.||+|+||.||+|.+.. ..||||....... ....+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~ 73 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--------PSVREKFLQEAYIMRQFDHPHIVKLI 73 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCchhcee
Confidence 4556789999999999999999998722 3689998763321 12246788899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.+.. .|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.|++|+
T Consensus 74 ~~~~~~~---------------------~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~ 131 (270)
T cd05056 74 GVITENP---------------------VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHR 131 (270)
T ss_pred EEEcCCC---------------------cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 9876422 289999999999999996543 358999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
||||+||+++.++.++|+|||+++....... ......++..|+|||.+....++.++||||||+++|++++ |..||..
T Consensus 132 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999875433211 1122344568999999988889999999999999999986 9999988
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
....+....+ ....+...+..++..+.+++.+||..+|++|||+.++++.|+++..
T Consensus 212 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 212 VKNNDVIGRI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 8776655444 3444555677889999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=317.16 Aligned_cols=247 Identities=36% Similarity=0.693 Sum_probs=210.8
Q ss_pred eeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 91 HEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
+.||+|+||.||+|.+. +..|++|+++...... ....+.+|+.+++.++|+||+++++++......
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~- 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL- 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--------HHHHHHHHHHHHhhcCCCChheeeeeecCCCce-
Confidence 36999999999999884 7799999987443211 346788999999999999999999998764443
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+
T Consensus 72 -------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 132 (262)
T cd00192 72 -------------------YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132 (262)
T ss_pred -------------------EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccC
Confidence 89999999999999997642 3579999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 133 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 133 ARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred cceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999998644322 22334567889999999988889999999999999999999 699999888
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
..+....+.. ......+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 213 NEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 7777666543 4556677788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.49 Aligned_cols=247 Identities=32% Similarity=0.586 Sum_probs=204.9
Q ss_pred eeeccCCceEEEEEEE--CC---eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 91 HEIARGTYGTVYRGAY--DG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
++||+|+||.||+|++ ++ ..||+|.++..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 68 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---- 68 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC----
Confidence 3699999999999987 22 57999998643211 2346788899999999999999999987532
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||.++++|+||||+||+++
T Consensus 69 -----------------~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~ 129 (257)
T cd05060 69 -----------------PLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129 (257)
T ss_pred -----------------ceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc
Confidence 2389999999999999996543 689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCc---cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 048724 246 ANRTLKIADFGVARVEAQNPRDM---TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSS 321 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~ 321 (394)
.++.++|+|||.++......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus 130 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~ 209 (257)
T cd05060 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209 (257)
T ss_pred CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 99999999999987543322111 11233568999999998899999999999999999998 999998877766655
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.+ ........+..++..+++++.+||+.+|++||++.++++.|+++.
T Consensus 210 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 210 ML-ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HH-HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 44 344455667778999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=320.33 Aligned_cols=256 Identities=29% Similarity=0.579 Sum_probs=211.4
Q ss_pred ccccccceeeeccCCceEEEEEEE--CC---eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
...+|++.+.||+|+||.||+|.+ ++ ..||||+++... .......|..|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 73 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--------TEKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 356788999999999999999987 23 369999986321 12224678899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+.... ++||||+++++|.+++... ...+++.+++.++.|++.||.|||++|++|+||
T Consensus 74 ~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl 132 (269)
T cd05065 74 VTKSRPV--------------------MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDL 132 (269)
T ss_pred ECCCCce--------------------EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 8765554 8999999999999998654 356899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCC--ccCCC---CCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRD--MTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPY 311 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf 311 (394)
||+||+++.++.++|+|||++......... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||
T Consensus 133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred ChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 999999999999999999998754322111 11111 2457999999998899999999999999999886 99999
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
...+..+....+ ......+.+..++..+.+++.+||+.+|++||++++++..|+++
T Consensus 213 ~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 213 WDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCHHHHHHHH-HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 887777666555 34445555667899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.81 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=207.9
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||++++ +++.||+|++.... .........+.+|..++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE------MLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH------HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788999999999999999988 56789999986321 112223456788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Ni 133 (332)
T cd05623 75 NL--------------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133 (332)
T ss_pred EE--------------------EEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 55 8999999999999999653 34689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 243 LLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|++.++.+||+|||++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.
T Consensus 134 li~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred EECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999986433222 1223357999999999986 34688899999999999999999999998887
Q ss_pred hhHHHHHHhccCCCCCC---CCCcHHHHHHHHHhchhCCCC--CCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIP---RCCPSSLASIMRKCWDANPDK--RPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~ 364 (394)
.+....+.....+..++ ..++.++.+|+++||..++++ |+++.++++.
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 77777766554333333 357999999999999765554 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.10 Aligned_cols=257 Identities=30% Similarity=0.566 Sum_probs=211.6
Q ss_pred cccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
++.++|++.+.||+|+||.||+|.+ ++..||+|+++.... ......+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~iv~~ 73 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDHPNIVKL 73 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--------HHHHHHHHHHHHHHHhcCCCchheE
Confidence 4567899999999999999999976 356899999863221 1223568889999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------------cCCCCHHHHH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------------RKKLAFKVVI 214 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------------~~~l~~~~~~ 214 (394)
++++.+.... |+++||+++|+|.+++.... ...+++..++
T Consensus 74 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 133 (288)
T cd05050 74 LGVCAVGKPM--------------------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133 (288)
T ss_pred EEEEcCCCcc--------------------EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHH
Confidence 9998866554 89999999999999996432 1247888999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccc
Q 048724 215 QIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKC 292 (394)
Q Consensus 215 ~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~ 292 (394)
.++.|++.||.|||+++++||||||+||+++.++.++|+|||++....... ........+..|+|||.+.+..++.++
T Consensus 134 ~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (288)
T cd05050 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES 213 (288)
T ss_pred HHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchh
Confidence 999999999999999999999999999999999999999999987432211 111223456779999999988999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 293 DVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 293 DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
|||||||++|+|++ |..||.+....+....+.... ....+..++.++.+++.+||+.+|.+|||+.++++.|++
T Consensus 214 Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 99999999999997 888998877777666554333 334456789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.64 Aligned_cols=258 Identities=20% Similarity=0.361 Sum_probs=205.6
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
..+...++|++++.||+|+||+||+|.+ ++..||+|++..... .......|..|+.++++++|||||++++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-------~e~~~~~~~~EI~IL~~L~HPNIVrl~d 79 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-------KEREKSQLVIEVNVMRELKHKNIVRYID 79 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-------CHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 3456678999999999999999999988 677899999874321 1122466788999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSK---- 230 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~---- 230 (394)
+|.+... ..+||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.
T Consensus 80 ~f~de~~------------------~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~ 141 (1021)
T PTZ00266 80 RFLNKAN------------------QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGP 141 (1021)
T ss_pred EEEecCC------------------CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhccccc
Confidence 9865433 23499999999999999997532 34699999999999999999999984
Q ss_pred ---CCcccCCCCCceeeCC-----------------CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC--CCC
Q 048724 231 ---TIVHRDVKTENMLLDA-----------------NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--KPY 288 (394)
Q Consensus 231 ---~iiH~Dlkp~NIll~~-----------------~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 288 (394)
+||||||||+||||+. .+.+||+|||++....... ......||+.|+|||++.+ ..+
T Consensus 142 ~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~ 220 (1021)
T PTZ00266 142 NGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSY 220 (1021)
T ss_pred ccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCC
Confidence 5999999999999964 2358999999997543222 2233578999999999854 458
Q ss_pred CccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 289 NRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 289 ~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+.++|||||||+||+|++|..||............+........ ...+.++.+||..||+.+|.+||++.+++.
T Consensus 221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 89999999999999999999999766544433333333222222 346899999999999999999999999995
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.84 Aligned_cols=258 Identities=28% Similarity=0.523 Sum_probs=223.9
Q ss_pred ccccccccceeeeccCCceEEEEEEEC---Ce--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYD---GQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~---g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
-|..++..+.++||+|.||+|++|.|+ |+ .||||.++...... ...+|.+|+.+|.+|+|+|++++|
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--------~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--------IMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--------hHHHHHHHHHHHHhccCcceeEEe
Confidence 455677888999999999999999993 43 69999997443221 468899999999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
|+..+ ..+ .+|+|.++.|+|.+.|++..+..|-...+..++.||+.||.||.++++|||
T Consensus 178 GvVl~-qp~--------------------mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHR 236 (1039)
T KOG0199|consen 178 GVVLD-QPA--------------------MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHR 236 (1039)
T ss_pred eeecc-chh--------------------hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 99876 332 689999999999999988667788899999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCc--cC-CCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDM--TG-ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPY 311 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~--~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf 311 (394)
||...|+|+-....|||+|||+.+.+......+ .. ...+..|+|||.++...++.++|||+|||++|||++ |..||
T Consensus 237 DLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 237 DLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred hhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 999999999999999999999999765443322 11 235678999999999999999999999999999998 68999
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.+....++...+- .+.+.+.|+.|+..+.++++.||..+|.+||||..|.+.+-..
T Consensus 317 ~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 317 VGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 9999999998875 7778888999999999999999999999999999998554433
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.52 Aligned_cols=261 Identities=25% Similarity=0.478 Sum_probs=214.8
Q ss_pred cccccccceeeeccCCceEEEEEEEC------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+..++|++.+.||+|+||.||+|.+. +..|++|+++... .......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~~~~ 74 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--------SEIQVTLLLQESCLLYGLSHQNILPIL 74 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45688999999999999999999873 4789999886321 112246678899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR------KKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
+++..... ..+++++|+++++|.+++..... ..+++..++.++.|++.||+|||+
T Consensus 75 ~~~~~~~~-------------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 135 (280)
T cd05043 75 HVCIEDGE-------------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135 (280)
T ss_pred EEEecCCC-------------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 98765322 23899999999999999976432 458999999999999999999999
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC- 306 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt- 306 (394)
++++||||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|++++
T Consensus 136 ~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 9999999999999999999999999999975322111 1112345678999999998889999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 307 CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 307 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
|+.||......+....+ ........+..+++++.+++.+||..+|++|||+.+++..|+++..
T Consensus 216 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 216 GQTPYVEIDPFEMAAYL-KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCcCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999887766655433 3444545556689999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.13 Aligned_cols=256 Identities=31% Similarity=0.553 Sum_probs=208.4
Q ss_pred ccccccceeeeccCCceEEEEEEECC------------------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHH
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAYDG------------------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~~g------------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~ 144 (394)
..++|++.+.||+|+||.||+|.+.+ ..||+|.+..... ......+.+|+.+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~ 74 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--------DNAREDFLKEVKILS 74 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--------HHHHHHHHHHHHHHH
Confidence 35789999999999999999987622 4589998864321 123467889999999
Q ss_pred hCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---------cCCCCHHHHHH
Q 048724 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---------RKKLAFKVVIQ 215 (394)
Q Consensus 145 ~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---------~~~l~~~~~~~ 215 (394)
+++||||+++++++...... ++++||+++++|.+++.... ...+++..++.
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPL--------------------CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLY 134 (296)
T ss_pred hcCCCCEeEEEEEEecCCCc--------------------EEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHH
Confidence 99999999999998766544 89999999999999997643 12689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccch
Q 048724 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCD 293 (394)
Q Consensus 216 i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D 293 (394)
++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++|
T Consensus 135 ~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 214 (296)
T cd05051 135 MATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214 (296)
T ss_pred HHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccch
Confidence 99999999999999999999999999999999999999999987532221 1112235677899999998888999999
Q ss_pred HHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHhc------cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 294 VYSFGICLWEIYC--CDMPYPDLSFTDVSSAVVRQ------NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 294 vwslG~~l~ellt--g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
|||||+++|+|++ +..||...+..+........ ......+..++.++.+++.+||+.||++|||+.++++.|
T Consensus 215 v~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 215 VWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred hhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 9999999999998 67899877666655544322 111223455789999999999999999999999999988
Q ss_pred H
Q 048724 366 E 366 (394)
Q Consensus 366 ~ 366 (394)
+
T Consensus 295 ~ 295 (296)
T cd05051 295 Q 295 (296)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.04 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=206.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||++++ +++.||+|+++... .........+.+|..++..++|+||+++++++.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE------MLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH------HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4789999999999999999987 67889999986321 112223456788999999999999999999998765
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+||||++||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus 75 ~~--------------------~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni 133 (331)
T cd05624 75 YL--------------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133 (331)
T ss_pred EE--------------------EEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence 55 8999999999999999653 34689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|++.++.+||+|||++........ ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 134 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred EEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 999999999999999875433221 1223579999999999875 4678899999999999999999999988877
Q ss_pred hhHHHHHHhccCCCCCCC---CCcHHHHHHHHHhchhCCCC--CCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPR---CCPSSLASIMRKCWDANPDK--RPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~ 364 (394)
.+....+.....+..++. .++.++++++.+||..++++ |++++++++.
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 776666655443333433 36899999999999876554 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=316.01 Aligned_cols=252 Identities=28% Similarity=0.607 Sum_probs=210.0
Q ss_pred ccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
...+|++.+.||+|+||.||+|.+ ++..+|+|.++.... . ...|.+|++++++++|||++++++++...
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---S-------EEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---C-------HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 356888999999999999999988 478899998863321 1 24577899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+|
T Consensus 72 ~~~--------------------~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~n 130 (256)
T cd05112 72 SPI--------------------CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130 (256)
T ss_pred Cce--------------------EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccce
Confidence 544 89999999999999986543 468899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~ 319 (394)
|+++.++.++|+|||.++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 131 i~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred EEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 9999999999999999875432211 1112345678999999998889999999999999999998 9999988776666
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
...+ ..+.+...+...+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus 211 ~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 211 VETI-NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHH-hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 6554 333444456667999999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=321.56 Aligned_cols=257 Identities=30% Similarity=0.563 Sum_probs=204.0
Q ss_pred cccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..+|++.+.||+|+||+||++.. ++..||+|.++... ....+.+.+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 73 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---------AEHLRDFEREIEILKSLQHDNIVKYKGV 73 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 35788999999999999999874 46789999986332 1223567889999999999999999998
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...+. ...++|+||+++++|.+++... +..+++..++.++.|++.||.|||++|++||||
T Consensus 74 ~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dl 134 (284)
T cd05081 74 CYSAGR------------------RNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDL 134 (284)
T ss_pred EccCCC------------------CceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 754322 2248999999999999998653 346899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+||+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 135 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 135 ATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred CHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 999999999999999999999854332211 11122345699999999888999999999999999999987665332
Q ss_pred Chhh---------------HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 SFTD---------------VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.... ............+.+..++.++.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2110 01112233334445567899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=317.42 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=216.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc-ceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN-VTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~ 160 (394)
...|+..++||+|+||+||+|+. +|+.||+|.++-.... +..-....+|+.+|+.++|+| ||.+++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-------EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-------EGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-------cCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 56788888999999999999987 8899999999855431 111133457999999999999 9999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.. .....+++|+||+ .-+|.+++..... ..++...+..++.||+.||+|||+++|+|||||
T Consensus 83 ~~~~--------------~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLK 147 (323)
T KOG0594|consen 83 SNNH--------------RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLK 147 (323)
T ss_pred cccc--------------cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Confidence 6531 1234568999999 5699999987553 357889999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|.||||+++|.+||+|||+|+....+....+...+|..|.|||++.+. .|+...||||+||+++||+++++-|++.+..
T Consensus 148 PQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~ 227 (323)
T KOG0594|consen 148 PQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI 227 (323)
T ss_pred cceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH
Confidence 999999999999999999999777677778888999999999999876 7999999999999999999999999998887
Q ss_pred hHHHHHHhcc----------------CCCCCC------------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHH
Q 048724 318 DVSSAVVRQN----------------LRPDIP------------RCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEA 367 (394)
Q Consensus 318 ~~~~~~~~~~----------------~~~~~~------------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~ 367 (394)
+....+.+.- +...++ ...+++..+++.+||+.+|.+|.|+..++.+ +..
T Consensus 228 ~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 228 DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 7666654321 111111 1123478899999999999999999999986 544
Q ss_pred H
Q 048724 368 V 368 (394)
Q Consensus 368 ~ 368 (394)
+
T Consensus 308 ~ 308 (323)
T KOG0594|consen 308 L 308 (323)
T ss_pred c
Confidence 4
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=316.89 Aligned_cols=253 Identities=26% Similarity=0.491 Sum_probs=208.8
Q ss_pred cccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
+|++.+.||+|+||+||+|.. +++.+|+|.++..... ..........+.+|+.++++++|+||+++++++.+....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN---VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc---hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence 477888999999999999987 7889999998743221 112223346788999999999999999999999866544
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
|+++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+++|+||+|+||++
T Consensus 78 --------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 135 (265)
T cd06631 78 --------------------SIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML 135 (265)
T ss_pred --------------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE
Confidence 8999999999999999653 458899999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCC------CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 245 DANRTLKIADFGVARVEAQN------PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+.++.++|+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+...
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 136 MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 99999999999998743211 111223468899999999999889999999999999999999999998766554
Q ss_pred HHHHHHhc-cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 319 VSSAVVRQ-NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 319 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
....+... ...+..+..++.++.+++.+||+.+|++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44333322 3345567778999999999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=320.70 Aligned_cols=256 Identities=28% Similarity=0.533 Sum_probs=212.7
Q ss_pred ccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
..++|++...||+|+||+||+|+.. .+.|++|.+.... .......+.+|+.++++++|+||++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--------DENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--------chHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 3578899999999999999999862 3579999875322 122346788899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHH
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-------KKLAFKVVIQIALDLARGLSYLH 228 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~l~yLH 228 (394)
+++.+.... |+||||+++|+|.+++..... ..+++..+..++.|++.||+|||
T Consensus 75 ~~~~~~~~~--------------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 75 GLCREAEPH--------------------YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred EEECCCCcc--------------------eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 998765544 899999999999999975441 25899999999999999999999
Q ss_pred hCCCcccCCCCCceeeCCCCcEEEeeccccccccCC-CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-
Q 048724 229 SKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC- 306 (394)
Q Consensus 229 ~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt- 306 (394)
+++++||||||+||+++.++.++|+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 135 ~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~ 214 (275)
T cd05046 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ 214 (275)
T ss_pred hcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999998643221 112233456778999999988888999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 307 CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 307 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
|..||.....................+..++..+.+++.+||+.+|++|||+.+++..|.
T Consensus 215 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 215 GELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 788998777766666655444444556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=335.05 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=195.7
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC---CCCcceeeeeeecCCCccccC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~~~ 167 (394)
||+|+||+||+|++ +++.||||++..... ........+..|..++..+ +||||+++++++.+...+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~--- 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL--- 71 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE---
Confidence 79999999999987 688999999863211 1111123344566666655 799999999999876655
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 72 -----------------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~ 132 (330)
T cd05586 72 -----------------YLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT 132 (330)
T ss_pred -----------------EEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 8999999999999988653 468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~ 326 (394)
+.++|+|||++..............||+.|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 133 GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence 999999999987533322333446799999999998754 5889999999999999999999999888777776666544
Q ss_pred cCCCCCCCCCcHHHHHHHHHhchhCCCCCC----CHHHHHH
Q 048724 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRP----VMDEVVK 363 (394)
Q Consensus 327 ~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp----t~~~ll~ 363 (394)
..+.. ...+++++.+++.+||+.||.+|| ++.++++
T Consensus 213 ~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 33322 234789999999999999999998 5677766
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=316.38 Aligned_cols=247 Identities=30% Similarity=0.573 Sum_probs=208.1
Q ss_pred eeeccCCceEEEEEEEC---C--eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 91 HEIARGTYGTVYRGAYD---G--QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~---g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
+.||+|++|+||+|.+. + ..||||.++..... ...+.+.+|+.++++++||||+++++.+.+ ..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~-- 69 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP-- 69 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce--
Confidence 36899999999999872 2 26999998643211 445788899999999999999999999876 33
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
.++|+||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++
T Consensus 70 ------------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~ 131 (257)
T cd05040 70 ------------------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA 131 (257)
T ss_pred ------------------EEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe
Confidence 38999999999999999765435689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 048724 246 ANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSS 321 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~ 321 (394)
.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus 132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 211 (257)
T cd05040 132 SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211 (257)
T ss_pred cCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999975433211 1112456788999999999899999999999999999998 999998888777776
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
.+.........+..+|..+.+++.+||+.+|++||++.+++..|.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 212 KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 665544455556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.99 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=206.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
..+.|++.+.||.|+||.||+|.+ +++.||+|++.... .....+..|+.+++++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----------DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----------HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 347888999999999999999988 67899999986321 1124567899999998 7999999999986
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..... ......|++|||+++|+|.+++.......+++..+..++.||+.||.|||+.|++|+||+|
T Consensus 84 ~~~~~--------------~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~ 149 (282)
T cd06636 84 KKSPP--------------GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKG 149 (282)
T ss_pred ccccc--------------CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 43211 1234569999999999999999776556789999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
+||+++.++.++|+|||++..............+++.|+|||.+. +..++.++|||||||++|+|++|..||...
T Consensus 150 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 150 QNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred HHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 999999999999999999875433222333457889999999985 346788999999999999999999999776
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.....................++.++.++|.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 5544443332222222233457899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=355.99 Aligned_cols=261 Identities=26% Similarity=0.352 Sum_probs=208.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.++||+|+||+||+|.+ +|+.||||+++.... ........+.+|+.++++++||||+++++++.+.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~------~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS------ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc------cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 6899999999999999999988 688999999863221 12234567889999999999999999999987665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---------RKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
.. |++|||++||+|.+++.... ...+++..++.++.||+.||+|||++|++
T Consensus 76 ~l--------------------yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII 135 (932)
T PRK13184 76 PV--------------------YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL 135 (932)
T ss_pred EE--------------------EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 54 89999999999999986421 12356678899999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCC------------------CCccCCCCCCCcCCccccCCCCCCccchHH
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNP------------------RDMTGETGTLGYMAPEVLDGKPYNRKCDVY 295 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 295 (394)
||||||+||+++.++.++|+|||+++...... .......||+.|+|||.+.+..++.++|||
T Consensus 136 HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIW 215 (932)
T PRK13184 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIY 215 (932)
T ss_pred ccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHH
Confidence 99999999999999999999999997541110 011124689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHhc-cCCCCCCCCCcHHHHHHHHHhchhCCCCCC-CHHHHHHHHHHHHhc
Q 048724 296 SFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ-NLRPDIPRCCPSSLASIMRKCWDANPDKRP-VMDEVVKLLEAVNTS 371 (394)
Q Consensus 296 slG~~l~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-t~~~ll~~l~~~~~~ 371 (394)
||||++|||++|..||............... .........+|+.+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 216 SLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 216 ALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999775544333221111 011111235789999999999999999995 778888888887654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=306.68 Aligned_cols=266 Identities=20% Similarity=0.319 Sum_probs=213.2
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.-|+-++|.+.+.||+|||+-||+++. +++.+|+|.+..... ...+...+|++..++++|||+++++++
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---------~~~e~~~rEid~~rkf~s~~vl~l~dh 86 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---------EDIEEALREIDNHRKFNSPNVLRLVDH 86 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---------HHHHHHHHHHHHHHhhCCcchHHHHHH
Confidence 457788999999999999999999875 889999999875431 113556789999999999999999998
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKT--IV 233 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~--ii 233 (394)
......= .....||+++|...|+|.+.+.... ...+++.+++.|+.+|++||.+||+.. ++
T Consensus 87 ~l~~~~D---------------~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yA 151 (302)
T KOG2345|consen 87 QLREEKD---------------GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYA 151 (302)
T ss_pred HHHhhcc---------------CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCccc
Confidence 8643331 2345699999999999999997543 346999999999999999999999988 99
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCC---------CCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHH
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQN---------PRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICL 301 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~---------~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l 301 (394)
||||||.|||+++++.++|.|||.++...-. ...+.....|..|.|||.+. +...+.++|||||||++
T Consensus 152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 9999999999999999999999998742211 12334457899999999996 45678899999999999
Q ss_pred HHHHhCCCCCCCCChh--hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 302 WEIYCCDMPYPDLSFT--DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 302 ~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
|+|+.|..||...-.. .+...+...++..+-...+|..+.++|++||+.||.+||++.+++..++++.
T Consensus 232 Ya~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 9999999999642211 1111122223333333458999999999999999999999999999998874
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.91 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=201.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||++.+ +++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-------ChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 57899999999999999999987 688999999864321 111235667899999999999999999998654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ......|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 89 ~~~--------------~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 149 (355)
T cd07874 89 KSL--------------EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_pred ccc--------------cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 332 112345899999965 67776632 48899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||+++..... .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 150 ill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 150 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred EEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999754322 22234578999999999999999999999999999999999999998766544332
Q ss_pred HHHhcc----------------------C------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 322 AVVRQN----------------------L------------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 322 ~~~~~~----------------------~------------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
...... . ....+...+.++++||.+||+.||++|||+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 221100 0 000112235678999999999999999999999
Q ss_pred HHH
Q 048724 362 VKL 364 (394)
Q Consensus 362 l~~ 364 (394)
++.
T Consensus 309 l~h 311 (355)
T cd07874 309 LQH 311 (355)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=322.17 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=207.5
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
|-...+.|++.+.||.|+||.||+|.+ +++.|++|++.... ......+.+|+.+++.++||||+++++.
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---------EEELEDYMVEIEILATCNHPYIVKLLGA 77 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCcEeeeEEE
Confidence 444557899999999999999999988 57899999986321 1224667889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...... |+||||+++++|..++.+.. ..+++..++.++.|++.||.|||++|++||||
T Consensus 78 ~~~~~~~--------------------~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 136 (292)
T cd06644 78 FYWDGKL--------------------WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136 (292)
T ss_pred EEeCCeE--------------------EEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCC
Confidence 8765544 99999999999988875533 46899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||+||+++.++.++|+|||++..............+++.|+|||.+. ...++.++|||||||++|+|++|..||.
T Consensus 137 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred CcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 99999999999999999999875433323333456888999999984 3457889999999999999999999998
Q ss_pred CCChhhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 313 DLSFTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+............. ....+..++.++.+++.+||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 217 ELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 7665554444322211 12234567889999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=322.80 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=206.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||+|+||.||+|.+ +++.||+|.+...... ....+.+|+.+++.++|+||+++++.|...
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 36889999999999999999987 6789999988643211 125677899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+|
T Consensus 90 ~~~--------------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~N 146 (296)
T cd06654 90 DEL--------------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146 (296)
T ss_pred CEE--------------------EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 544 999999999999999854 358999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++..............+++.|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 147 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred EEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 99999999999999998754333222334578899999999998889999999999999999999999998766544333
Q ss_pred HHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....... ....+..++..+.+++.+||..+|++||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 3322221 122345678899999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=320.39 Aligned_cols=250 Identities=27% Similarity=0.450 Sum_probs=203.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|.+.+.||+|+||.||+|.+ +++.||+|+++.... .....+.+|+.+++.++||||+++++.+...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 46889999999999999999988 678999999864321 1124567899999999999999999998766
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||+++++|.+++... +.+++.+++.++.|++.||.|||+.|++|+||||+|
T Consensus 79 ~~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n 136 (267)
T cd06645 79 DKL--------------------WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGAN 136 (267)
T ss_pred CEE--------------------EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 554 8999999999999998653 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+++.++.++|+|||++..............|+..|+|||.+. ...++.++|||||||++|+|++|..||.......
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~ 216 (267)
T cd06645 137 ILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred EEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh
Confidence 9999999999999999875443333333457899999999874 4568889999999999999999999987655443
Q ss_pred HHHHHHhccCCCCC---CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...........+.. ...++..+.+++.+||+.+|++|||++++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 217 ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 33333222222221 12467899999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=315.01 Aligned_cols=251 Identities=24% Similarity=0.466 Sum_probs=212.1
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||+++. +|+.||+|.+...... ......+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-------PKEREESRKEVAVLSNMKHPNIVQYQESFEENGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence 578899999999999999987 6789999998643211 1123567889999999999999999999876555
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+|+||+++++|.+++.......+++.+++.++.|++.||.|||++|++|+||+|+||+
T Consensus 74 ~--------------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil 133 (256)
T cd08218 74 L--------------------YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 133 (256)
T ss_pred E--------------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 4 89999999999999987654456899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+
T Consensus 134 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 134 LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred EcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 99999999999999975443322222346788999999999888999999999999999999999999887777666655
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
... ..+..+..++.++.++|.+||+.+|++||++.++++.
T Consensus 214 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 214 IRG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred hcC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 443 3445566789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=323.80 Aligned_cols=257 Identities=28% Similarity=0.533 Sum_probs=205.8
Q ss_pred cccccccceeeeccCCceEEEEEEECC----------------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYDG----------------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~g----------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 145 (394)
+...+|++.+.||+|+||.||++...+ ..||+|.++.... ......|.+|++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~ei~~l~~ 73 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--------KTARNDFLKEIKIMSR 73 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--------HHHHHHHHHHHHHHHh
Confidence 345689999999999999999987522 2589999863211 1124568899999999
Q ss_pred CCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----------cCCCCHHHHHH
Q 048724 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----------RKKLAFKVVIQ 215 (394)
Q Consensus 146 l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----------~~~l~~~~~~~ 215 (394)
++|+|++++++++...... ++||||+++++|.+++.... ...+++..++.
T Consensus 74 l~h~~i~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (295)
T cd05097 74 LKNPNIIRLLGVCVSDDPL--------------------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLY 133 (295)
T ss_pred CCCCCcCeEEEEEcCCCcc--------------------EEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHH
Confidence 9999999999999766554 89999999999999986532 12368889999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccch
Q 048724 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCD 293 (394)
Q Consensus 216 i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D 293 (394)
++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.+..++.++|
T Consensus 134 i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 134 MAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred HHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhh
Confidence 99999999999999999999999999999999999999999987432211 1112234567899999999888999999
Q ss_pred HHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHh------ccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 294 VYSFGICLWEIYC--CDMPYPDLSFTDVSSAVVR------QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 294 vwslG~~l~ellt--g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
|||||+++|+|++ +..||...+..+....... .......+..+++.+.+|+.+||+.+|++|||+.+|++.|
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999988 6788887766665544321 1111223455789999999999999999999999999988
Q ss_pred H
Q 048724 366 E 366 (394)
Q Consensus 366 ~ 366 (394)
+
T Consensus 294 ~ 294 (295)
T cd05097 294 R 294 (295)
T ss_pred h
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=321.26 Aligned_cols=248 Identities=35% Similarity=0.637 Sum_probs=201.7
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|++.+.||+|+||+||+++. +++.||+|++..... .........+|+.++++++||||+++++++.+....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-------EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-------HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-------cccccchhhhhhhccccccccccccccccccccccc
Confidence 67889999999999999999 567899999974431 112223344599999999999999999999875554
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
++||||+++++|.+++. ....+++..++.++.|+++||.+||++|++|+||||+||++
T Consensus 74 --------------------~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~ 131 (260)
T PF00069_consen 74 --------------------YIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL 131 (260)
T ss_dssp --------------------EEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE
T ss_pred --------------------ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc
Confidence 89999999999999997 34568999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH---
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS--- 320 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~--- 320 (394)
+.++.++|+|||.+..............++..|+|||.+. +..++.++||||||+++|+|++|..||......+..
T Consensus 132 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~ 211 (260)
T PF00069_consen 132 DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII 211 (260)
T ss_dssp STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 9999999999999875333334445567899999999998 888999999999999999999999999887322222
Q ss_pred HHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 321 SAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 321 ~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
........... .....+..+.++|.+||+.||++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 212 EKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22221111111 11123489999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.96 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=201.1
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||+||++.+ +|+.||||.+...... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-------LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-------hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 478889999999999999987 6889999988532111 1113567789999999999999999999875442
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ....+|+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 74 ~---------------~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (372)
T cd07853 74 D---------------PFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL 135 (372)
T ss_pred c---------------ccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEE
Confidence 1 1124599999995 688888744 346999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
++.++.+||+|||+++...... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+...
T Consensus 136 i~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 215 (372)
T cd07853 136 VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215 (372)
T ss_pred ECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999999999999997543221 223335678999999998774 57899999999999999999999998776554433
Q ss_pred HHHh-----------------------ccCCC-------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVR-----------------------QNLRP-------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~-----------------------~~~~~-------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.. ....+ ......++++.+||.+||+.||++|||+.+++..
T Consensus 216 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 216 LITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 3221 11111 1223468899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=319.88 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=200.4
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||+|+. +++.||+|.++..... ......+.+|+.++++++||||+++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-------EGVPSTAIREISLLKELQHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-------CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence 478889999999999999987 6889999998643211 1112456789999999999999999999986555
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. |+||||++ ++|.+++..... ..+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 74 ~--------------------~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni 132 (285)
T cd07861 74 L--------------------YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNL 132 (285)
T ss_pred E--------------------EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 4 89999997 689888865332 5689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
+++.++.++|+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+...
T Consensus 133 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~ 212 (285)
T cd07861 133 LIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212 (285)
T ss_pred EEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999999998754333333334567899999998865 457889999999999999999999998665433322
Q ss_pred HHHhcc---------------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQN---------------------------LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...... ........+++++.++|.+||+.||++|||+.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 213 RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 211100 0001123478899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=322.81 Aligned_cols=255 Identities=29% Similarity=0.532 Sum_probs=205.0
Q ss_pred cccccceeeeccCCceEEEEEEEC------------------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYD------------------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~------------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 145 (394)
.++|++.+.||+|+||+||++.+. +..||+|+++... .......+.+|+.+++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--------NKNARNDFLKEIKIMSR 75 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--------CHHHHHHHHHHHHHHHh
Confidence 467999999999999999998542 3368999886322 11224678899999999
Q ss_pred CCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc---------CCCCHHHHHHH
Q 048724 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR---------KKLAFKVVIQI 216 (394)
Q Consensus 146 l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~---------~~l~~~~~~~i 216 (394)
++|+||+++++++...+.. |+||||+++++|.+++..... ..+++.+++.+
T Consensus 76 l~~~~i~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (296)
T cd05095 76 LKDPNIIRLLAVCITSDPL--------------------CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFM 135 (296)
T ss_pred CCCCCcceEEEEEecCCcc--------------------EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHH
Confidence 9999999999998766554 899999999999999976431 24778899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC-C-ccCCCCCCCcCCccccCCCCCCccchH
Q 048724 217 ALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR-D-MTGETGTLGYMAPEVLDGKPYNRKCDV 294 (394)
Q Consensus 217 ~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv 294 (394)
+.|++.||+|||++|++|+||||+|||++.++.++|+|||+++....... . .....+++.|++||...+..++.++||
T Consensus 136 ~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 215 (296)
T cd05095 136 ATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV 215 (296)
T ss_pred HHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhh
Confidence 99999999999999999999999999999999999999999874322211 1 112234678999999888889999999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCChhhHHHHHHh------ccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 295 YSFGICLWEIYC--CDMPYPDLSFTDVSSAVVR------QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 295 wslG~~l~ellt--g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
|||||++|||++ |..||...+..+....... .....+.+..++..+.+|+.+||+.||++||++.+|++.|+
T Consensus 216 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 216 WAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 999999999998 7789987766555433211 11122344568899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.16 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=208.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||.|+||+||++.+ ++..||+|+++... ......+..|+.++++++||||+++++.+...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---------EEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---------HHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 46799999999999999999988 57899999986322 11235678899999999999999999998865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 75 ~~~--------------------~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n 133 (280)
T cd06611 75 NKL--------------------WILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN 133 (280)
T ss_pred CeE--------------------EEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence 544 89999999999999986533 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+++.++.++|+|||++..............+++.|+|||.+. ...++.++||||||+++|+|++|+.||.....
T Consensus 134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 134 ILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred EEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 9999999999999999875443333333456889999999974 34577899999999999999999999988776
Q ss_pred hhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
......+..... ....+..++.++.+++.+||+.+|.+||++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 665544433221 122345688999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=320.27 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=204.9
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|++.+.||+|+||.||+|.+ ++..+++|.+.... ......+.+|+.+++.++||||+++++.+.....
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---------EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 367888999999999999988 56788999885321 1123567789999999999999999999876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+|+||+++++|..++.+. ..++++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 77 ~--------------------~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nil 135 (282)
T cd06643 77 L--------------------WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNIL 135 (282)
T ss_pred E--------------------EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEE
Confidence 4 8999999999999887653 356999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
++.++.++|+|||++..............+++.|+|||.+. +..++.++|||||||++|+|++|++||...+..+
T Consensus 136 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 136 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred EccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 99999999999999875433323333457899999999983 4557889999999999999999999998877655
Q ss_pred HHHHHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 319 VSSAVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 319 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
......... .....+..++.++.++|.+||+.+|++||++.++++.-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 216 VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 554443322 12234556889999999999999999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=312.63 Aligned_cols=245 Identities=33% Similarity=0.648 Sum_probs=204.2
Q ss_pred eeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 92 EIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
.||+|+||.||+|.. +++.||+|.++.... ......+.+|+.+++.++||||+++++++......
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 67 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI------ 67 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc------
Confidence 699999999999987 677899998863221 11234678899999999999999999998765544
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+
T Consensus 68 --------------~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~ 132 (250)
T cd05085 68 --------------YIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL 132 (250)
T ss_pred --------------EEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeE
Confidence 89999999999999986543 458999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCC-ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccC
Q 048724 251 KIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 251 kl~DFG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
+|+|||++......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||...........+ ....
T Consensus 133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-~~~~ 211 (250)
T cd05085 133 KISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EKGY 211 (250)
T ss_pred EECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCC
Confidence 99999998643222111 112244678999999998889999999999999999998 99999887766665544 3445
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
+...+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 55566778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=318.93 Aligned_cols=248 Identities=28% Similarity=0.471 Sum_probs=209.1
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||.|+||.||+|.+ +++.||+|++..... ......+.+|+.+++.++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence 3688889999999999999988 678999999864321 111355778999999999999999999987665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+|+||+++++|.+++... ++++..++.++.|++.||.|||+++++|+||+|+||
T Consensus 73 ~~--------------------~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 129 (274)
T cd06609 73 KL--------------------WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129 (274)
T ss_pred eE--------------------EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 44 8999999999999998643 689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+++.++.++|+|||+++.............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 130 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~ 209 (274)
T cd06609 130 LLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209 (274)
T ss_pred EECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 99999999999999998655443333445788899999999988899999999999999999999999987765555444
Q ss_pred HHhccCCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~-~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+. ....+..+.. ++..+.+++.+||..+|++|||++++++.
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 210 IP-KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hh-hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 33 3334444444 88999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.91 Aligned_cols=257 Identities=25% Similarity=0.563 Sum_probs=213.9
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
...+|++.+.||+|+||+||+|.+ +|. .||+|.++.... ......+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--------PKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 457889999999999999999986 333 589998764321 223466788999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.. .. .++|+||+++|+|.+++..+. ..+++..++.++.|++.||+|||++|++|+|
T Consensus 77 ~~~~-~~--------------------~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~d 134 (279)
T cd05057 77 ICLS-SQ--------------------VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134 (279)
T ss_pred EEec-Cc--------------------eEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecc
Confidence 9875 22 289999999999999997643 4589999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCc--cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
|||+||+++.++.++|+|||+++......... ....++..|+|||.+....++.++||||||+++||+++ |..||..
T Consensus 135 i~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999997543222111 11234568999999988889999999999999999998 9999998
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
....++...+. .+.....+..++..+.+++.+||..+|++||++.++++.|.++..
T Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 215 IPAVEIPDLLE-KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 88777665554 344455566789999999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=316.09 Aligned_cols=249 Identities=28% Similarity=0.491 Sum_probs=207.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||.|+||.||+|.+ +++.+++|++...... ....+.+|+.++++++||||+++++.+.+..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---------DFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---------hHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 6788999999999999999987 5788999998743211 2467788999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |++|||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 74 ~~--------------------~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 132 (262)
T cd06613 74 KL--------------------WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANI 132 (262)
T ss_pred EE--------------------EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhE
Confidence 54 8999999999999988654 24699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC---CCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||++..............++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+....
T Consensus 133 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~ 212 (262)
T cd06613 133 LLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212 (262)
T ss_pred EECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999987544332233345788899999999776 889999999999999999999999988776555
Q ss_pred HHHHHhccCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNLRPD---IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
............ .+...+.++.+++.+||..+|.+|||+.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 213 LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 544443322221 22345788999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=331.72 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=201.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||.||++.+ +++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-------chhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 57899999999999999999987 6789999998643211 11235567899999999999999999988654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ......|+||||++ ++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 96 ~~~--------------~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 156 (364)
T cd07875 96 KSL--------------EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156 (364)
T ss_pred ccc--------------cccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 332 11234599999996 477777632 48899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||+++..... .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 157 Ill~~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 157 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred EEECCCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999754322 22234578999999999999999999999999999999999999998776655444
Q ss_pred HHHhccC--------------------CC--------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 322 AVVRQNL--------------------RP--------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 322 ~~~~~~~--------------------~~--------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
.+..... ++ ......+..+++||.+||+.||++|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 4322100 00 0011235678999999999999999999999
Q ss_pred HHH
Q 048724 362 VKL 364 (394)
Q Consensus 362 l~~ 364 (394)
++.
T Consensus 316 L~h 318 (364)
T cd07875 316 LQH 318 (364)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.36 Aligned_cols=249 Identities=25% Similarity=0.445 Sum_probs=208.2
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||.|+||+||+|.+ +++.||+|.+...... ....+.+|+.+++.++||||+++++.+...
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---------KKELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---------hHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 35799999999999999999986 7889999988643211 125677899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||+++++|.+++.. ..+++.++..++.|++.||.|||++|++|+||+|+|
T Consensus 89 ~~~--------------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~N 145 (296)
T cd06655 89 DEL--------------------FVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDN 145 (296)
T ss_pred ceE--------------------EEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 554 899999999999998854 358999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++..............++..|+|||.+.+..++.++|||||||++|+|++|+.||...+......
T Consensus 146 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~ 225 (296)
T cd06655 146 VLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (296)
T ss_pred EEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999998754333222333568899999999999889999999999999999999999998876655444
Q ss_pred HHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+..... ....+..+++.+.++|.+||..+|++||++.+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 226 LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 4332221 223455688999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=319.83 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=204.9
Q ss_pred cccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
...|++.+.||+|+||.||++.+ ++..||+|.++.... ......+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEIEILRNLYHENIVKYKGI 74 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--------HHHHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 34678899999999999999874 467899999863321 1123568899999999999999999998
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...... ..++||||++|++|.+++.... ..+++..++.++.|++.||+|||++|++||||
T Consensus 75 ~~~~~~~------------------~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dl 135 (284)
T cd05079 75 CTEDGGN------------------GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDL 135 (284)
T ss_pred EecCCCC------------------ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 8754221 2389999999999999986543 35899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|+++..|+...
T Consensus 136 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~ 215 (284)
T cd05079 136 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSP 215 (284)
T ss_pred chheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccc
Confidence 99999999999999999999875432211 112345677899999998888999999999999999999987654221
Q ss_pred C--------------hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 S--------------FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
. ...............+.+..++..+.+|+.+||+.+|++|||+.++++.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 216 MTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 00111112233334445667899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=320.73 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=205.3
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|.-.+++|.|+||+||+|+. +++.||||..-.... .-.+|+.+|+.++|||||++.-+|.....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------------~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------------YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------------cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 456678899999999999988 678999998753321 12369999999999999999988864332
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
- ..-...+||||+|. +|.++++.. .+..++.-.+.-+.+||++||.|||+.||+||||||.|
T Consensus 92 ~---------------d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqN 155 (364)
T KOG0658|consen 92 S---------------DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQN 155 (364)
T ss_pred C---------------chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChhe
Confidence 1 11233789999976 999988742 24568888899999999999999999999999999999
Q ss_pred eeeCCC-CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+|+|.+ |.+||||||.|+........ .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|++.+..+.
T Consensus 156 lLvD~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ 234 (364)
T KOG0658|consen 156 LLVDPDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ 234 (364)
T ss_pred EEEcCCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH
Confidence 999975 99999999999976544333 34567889999999876 5799999999999999999999999999877666
Q ss_pred HHHHHhc------------c----------CC-----CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHHh
Q 048724 320 SSAVVRQ------------N----------LR-----PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAVNT 370 (394)
Q Consensus 320 ~~~~~~~------------~----------~~-----~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~~~ 370 (394)
...+.+- + +. .-+....+++..+|+.++|..+|++|.++.+++. +++.++.
T Consensus 235 L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 235 LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 6555321 0 00 0133457899999999999999999999999996 6777765
Q ss_pred c
Q 048724 371 S 371 (394)
Q Consensus 371 ~ 371 (394)
.
T Consensus 315 ~ 315 (364)
T KOG0658|consen 315 P 315 (364)
T ss_pred c
Confidence 4
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=324.03 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=209.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|.. +++.||+|.+..... ........+..|+.+++.++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM------IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc------chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence 3688899999999999999988 578999999874321 11123467888999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 75 ~~--------------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 134 (316)
T cd05574 75 YL--------------------CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134 (316)
T ss_pred EE--------------------EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHe
Confidence 54 8999999999999999765556799999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC-----------------------------CccCCCCCCCcCCccccCCCCCCccch
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR-----------------------------DMTGETGTLGYMAPEVLDGKPYNRKCD 293 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 293 (394)
+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 214 (316)
T cd05574 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214 (316)
T ss_pred EEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHH
Confidence 999999999999999864321110 011235788999999999988999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC----HHHHHH
Q 048724 294 VYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV----MDEVVK 363 (394)
Q Consensus 294 vwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt----~~~ll~ 363 (394)
|||||+++|+|++|..||...+.......+.............+..+.+++.+||+.+|++||| +.+++.
T Consensus 215 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9999999999999999998887766666555444333333336899999999999999999999 777777
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=327.67 Aligned_cols=249 Identities=21% Similarity=0.366 Sum_probs=196.2
Q ss_pred ceeeeccC--CceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 89 IRHEIARG--TYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 89 ~~~~lG~G--~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
+.++||+| +||+||++.. +|+.||+|+++.... .......+.+|+.+++.++||||++++++|...+..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence 56789999 7899999987 788999999864321 112245677899999999999999999999866554
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
|+|+||+++|+|.+++..+....+++..++.++.|++.||.|||++|++||||||+|||+
T Consensus 75 --------------------~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~ 134 (327)
T cd08227 75 --------------------WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134 (327)
T ss_pred --------------------EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE
Confidence 899999999999999976555568999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCC-------CccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 245 DANRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
+.++.++++||+.+........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 135 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999999999986543211110 0112356778999999976 468899999999999999999999997655
Q ss_pred hhhHHHHHHhccCC--------------------------------------------CCCCCCCcHHHHHHHHHhchhC
Q 048724 316 FTDVSSAVVRQNLR--------------------------------------------PDIPRCCPSSLASIMRKCWDAN 351 (394)
Q Consensus 316 ~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~l~~li~~cL~~d 351 (394)
.............. .+....+++.+.+|+.+||+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 294 (327)
T cd08227 215 ATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN 294 (327)
T ss_pred hhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhC
Confidence 44333222111000 0011235678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 048724 352 PDKRPVMDEVVKL 364 (394)
Q Consensus 352 P~~Rpt~~~ll~~ 364 (394)
|++|||++++++.
T Consensus 295 P~~Rpt~~ell~~ 307 (327)
T cd08227 295 PDARPSASTLLNH 307 (327)
T ss_pred chhcCCHHHHhcC
Confidence 9999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.19 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=209.9
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||++.+ +++.||+|+++... .........+.+|++++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK------IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence 4688999999999999999988 67899999986322 112223467888999999999999999999988665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|.||
T Consensus 75 ~~--------------------~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni 132 (290)
T cd05580 75 NL--------------------YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132 (290)
T ss_pred eE--------------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 55 8999999999999998654 5689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+++.++.+||+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 133 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 209 (290)
T cd05580 133 LLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK 209 (290)
T ss_pred EECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999998754332 2335788999999999888889999999999999999999999988776655555
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
+... ...++..++..+++++.+||..||.+|+ ++++++..
T Consensus 210 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 ILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 5432 3456677899999999999999999999 77777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=315.32 Aligned_cols=254 Identities=25% Similarity=0.466 Sum_probs=207.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
.+|++.+.||+|+||.||+|.. ++..||+|.++...... ........+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP----ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc----hhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 3688899999999999999987 68899999987443211 12223456888999999999999999999876432
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. ...++++||+++++|.+++... ..+++..++.++.|++.||.|||+++++||||+|+||
T Consensus 78 ~------------------~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ni 137 (266)
T cd06651 78 E------------------KTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI 137 (266)
T ss_pred C------------------CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 2 2238999999999999999653 3589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 99999999999999987432211 111224578899999999988899999999999999999999999987765555
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..........+.++..++..+++++ +||..+|++||+++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 5554444445666777889999999 688889999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=317.23 Aligned_cols=246 Identities=28% Similarity=0.479 Sum_probs=215.9
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+..++|+++++||+|.||.|.+++. +++.+|+|++++.. .....+ ...-..|-.+|+..+||.+..+.-.|
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev--iiakdE----VAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV--IIAKDE----VAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh--eeehHH----hhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 46678999999999999999999987 78999999998432 222222 34556789999999999999988777
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
+..+.+ |+||||..||.|.-.|.+ ...+++.....+...|+.||.|||+++||+||||
T Consensus 238 Qt~drl--------------------CFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK 295 (516)
T KOG0690|consen 238 QTQDRL--------------------CFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK 295 (516)
T ss_pred ccCceE--------------------EEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence 766555 999999999999877754 4569999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
.+|+|++.+|++||+|||+++-.-.....+.+.||||.|+|||++....|+.++|+|.+|+++|||+||+.||...+...
T Consensus 296 LENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k 375 (516)
T KOG0690|consen 296 LENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK 375 (516)
T ss_pred hhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH
Confidence 99999999999999999999865556677788999999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp 356 (394)
....++-..+ .+|..++++.+.|+.-+|.+||.+|.
T Consensus 376 LFeLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 376 LFELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 8887776644 47888999999999999999999995
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=321.45 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=202.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||.|+||.||+|.+ +++.||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--------APCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--------chhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 57899999999999999999987 67899999987443211 123456799999999999999999999765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||++ ++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 77 ~~~--------------------~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~N 134 (301)
T cd07873 77 KSL--------------------TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134 (301)
T ss_pred CeE--------------------EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHH
Confidence 554 89999996 5898888654 3468999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.++|+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+..
T Consensus 135 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 135 LLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred EEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999754333333334567899999999865 45788999999999999999999999877655443
Q ss_pred HHHHhcc----------------C-CCC-----------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 321 SAVVRQN----------------L-RPD-----------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 321 ~~~~~~~----------------~-~~~-----------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+.... . ... ....+++.+++||.+||+.||.+|||+.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 215 HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 3222100 0 000 11246889999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.57 Aligned_cols=253 Identities=28% Similarity=0.523 Sum_probs=211.1
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|+||.||++.+ +++.||+|+++.... . ......+..|+.+++.++|+||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---T----EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---C----HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 478889999999999999987 678999999864321 1 1123567789999999999999999998764332
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH-----hCCCcccC
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLH-----SKTIVHRD 236 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH-----~~~iiH~D 236 (394)
...|+++||+++++|.+++... ...++++..++.++.||+.||.||| +.+++|+|
T Consensus 74 ------------------~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 74 ------------------QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred ------------------CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 2348999999999999999653 2357899999999999999999999 89999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+|+||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 136 l~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 215 (265)
T cd08217 136 LKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ 215 (265)
T ss_pred CCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH
Confidence 99999999999999999999998654433223345789999999999988899999999999999999999999988776
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
......+ .......++..++..+.+++.+||+.+|++||++.+|++.
T Consensus 216 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 LQLASKI-KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHH-hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 6555444 3334445677789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.79 Aligned_cols=248 Identities=31% Similarity=0.564 Sum_probs=202.8
Q ss_pred eeccCCceEEEEEEE--CCe--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCcccc
Q 048724 92 EIARGTYGTVYRGAY--DGQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~ 166 (394)
.||+|+||.||+|.+ ++. .+++|.++.... ......+..|+.+++++ +||||+++++++.....+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~-- 71 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL-- 71 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--------HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCc--
Confidence 699999999999987 333 578888763211 11235678899999999 899999999999765544
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
|++|||+++|+|.+++..+. ...+++.++..++.|++.||+|||++|+
T Consensus 72 ------------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i 133 (270)
T cd05047 72 ------------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 133 (270)
T ss_pred ------------------eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 89999999999999997532 1247899999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPY 311 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf 311 (394)
+||||||+||+++.++.+||+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 134 ~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 134 IHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred eecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999986322111 1112234667999999988889999999999999999997 99999
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
...+..+....+ ......+.+..++.++.+++.+||+.+|.+|||+.+++..|+++.
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 213 CGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cccCHHHHHHHH-hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 877766655544 334455566678899999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.81 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=207.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
.+|++.+.||+|+||.||+|.+ ++..||||.+....... ........+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP----ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc----ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 4788899999999999999987 67899999886432111 11123467888999999999999999999876543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ..++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++|+||+|+||
T Consensus 78 ~~------------------~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 137 (265)
T cd06652 78 ER------------------TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI 137 (265)
T ss_pred Cc------------------eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 21 238999999999999998653 4588999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCC---CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQN---PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 9999999999999998743221 1122234688899999999888899999999999999999999999987765555
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..........+..+...+..+.+++.+||. +|++||+++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 544444444555666778899999999995 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=319.70 Aligned_cols=248 Identities=30% Similarity=0.501 Sum_probs=207.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+.|+..+.||+|+||.||+|.+ ++..||+|.++.... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--------hHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 3567778899999999999987 678999998863221 122467889999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 76 ~~--------------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni 132 (277)
T cd06642 76 KL--------------------WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANV 132 (277)
T ss_pred ce--------------------EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheE
Confidence 54 899999999999998843 4589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+++.++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06642 133 LLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL 212 (277)
T ss_pred EEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh
Confidence 99999999999999987544332222334678899999999998899999999999999999999999976655554433
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+ .....+..+..++.++.+++.+||+.+|++||++.+++..
T Consensus 213 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 213 I-PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred h-hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3 3333444556688999999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=331.68 Aligned_cols=261 Identities=29% Similarity=0.553 Sum_probs=220.6
Q ss_pred ccccccccceeeeccCCceEEEEEEECC-eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYDG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
++..+.+.+.++||+|.||.|.++...+ ..||||+++... ....+..|..|+++|.+|+|||||.++|+|.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--------TKNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc--------chhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 4556778899999999999999999866 899999997432 3334689999999999999999999999999
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
.++.+ |+|+||+++|+|..|+..+....+......+|+.||+.||+||.+.++|||||.+
T Consensus 606 ~DePi--------------------cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~ 665 (807)
T KOG1094|consen 606 QDDPL--------------------CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLAT 665 (807)
T ss_pred cCCch--------------------HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccc
Confidence 87776 9999999999999999887544456677788999999999999999999999999
Q ss_pred CceeeCCCCcEEEeecccccccc-CCCCC-ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHH--hCCCCCCCCC
Q 048724 240 ENMLLDANRTLKIADFGVARVEA-QNPRD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY--CCDMPYPDLS 315 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~-~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell--tg~~Pf~~~~ 315 (394)
.|+|++.++++||+|||+++-.- .+... .....-+.+|||||.+..++++.++|||+||+++||++ +...||...+
T Consensus 666 rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 666 RNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred cceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 99999999999999999998432 22111 11234578999999999999999999999999999986 4689999998
Q ss_pred hhhHHHHHHhc---c---CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 316 FTDVSSAVVRQ---N---LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 316 ~~~~~~~~~~~---~---~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.+++..+...- . .-+..|..||..+.++|..||..+-++||+++++...|++..
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 88877665321 1 123456789999999999999999999999999999998753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.33 Aligned_cols=251 Identities=33% Similarity=0.601 Sum_probs=201.4
Q ss_pred eeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 91 HEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
+.||+|+||.||+|.+ .+..||+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG-- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--------HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC--
Confidence 3689999999999986 235799998753211 1123567789999999999999999997753322
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
..++++||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+|||++
T Consensus 71 -----------------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~ 132 (262)
T cd05058 71 -----------------SPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD 132 (262)
T ss_pred -----------------CcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc
Confidence 1389999999999999996543 3467888899999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHH
Q 048724 246 ANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVS 320 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~ 320 (394)
.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+..
T Consensus 133 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 212 (262)
T cd05058 133 ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212 (262)
T ss_pred CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999987432211 11122345678999999988889999999999999999999 56778776666655
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
..+ .....+..+..++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 213 ~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 213 VYL-LQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHH-hcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 444 3333445566789999999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.69 Aligned_cols=259 Identities=25% Similarity=0.582 Sum_probs=210.8
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+..++|+..+.||+|+||.||+|++ +|. .||+|.+..... ......+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--------PKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 3457888899999999999999987 444 478888753221 11124578899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.... .++++||+++|+|.+++..+. ..+++..++.++.|++.||.|||++|++|+
T Consensus 76 ~~~~~~~---------------------~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~ 133 (303)
T cd05110 76 GVCLSPT---------------------IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133 (303)
T ss_pred EEEcCCC---------------------ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 9886432 168999999999999986543 358899999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999975432221 1122345678999999998899999999999999999997 899998
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
+........ +...+.....+..++..+.+++.+||..+|++||++.++++.|.++...
T Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 214 GIPTREIPD-LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 776555443 3344445555667889999999999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.28 Aligned_cols=244 Identities=27% Similarity=0.498 Sum_probs=198.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.+ +++.||+|++..... ......+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--------VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence 3678889999999999999987 778999999864311 112356888999999999999999999998765
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++|+||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 73 ~~--------------------~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 126 (279)
T cd06619 73 RI--------------------SICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126 (279)
T ss_pred EE--------------------EEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence 54 8999999999997542 478889999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh-----
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT----- 317 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~----- 317 (394)
+++.++.++|+|||++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 127 ll~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 204 (279)
T cd06619 127 LVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204 (279)
T ss_pred EECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence 9999999999999998754322 223357899999999999988999999999999999999999999653221
Q ss_pred --hHHHHHHhccCCCCC-CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 318 --DVSSAVVRQNLRPDI-PRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 318 --~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.....+. ....... ....++++.+++.+||+.+|++||+++++++.-
T Consensus 205 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 205 PLQLLQCIV-DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred hHHHHHHHh-ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1111111 1112222 234688999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.95 Aligned_cols=249 Identities=30% Similarity=0.488 Sum_probs=208.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|+..+.||.|+||.||+|++ ++..||+|+++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 4577888999999999999987 578999999863221 122367888999999999999999999998765
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+||||+++++|.+++.. .++++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 76 ~~--------------------~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Ni 132 (277)
T cd06640 76 KL--------------------WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred EE--------------------EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhE
Confidence 54 999999999999999854 3589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 133 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06640 133 LLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 212 (277)
T ss_pred EEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence 99999999999999997544332222334678899999999988899999999999999999999999987765554443
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
+ .....+..+..++..+.+++.+||+.+|++||++.+++..-
T Consensus 213 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 213 I-PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred h-hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 3 33334455566889999999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.11 Aligned_cols=261 Identities=29% Similarity=0.459 Sum_probs=205.7
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 156 (394)
+....++|++.+.||+|+||+||++.+ +++.+|+|+++.... ....+..|+.+++.+ +||||+++++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----------IDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----------hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 344568899999999999999999987 678999998753211 124567799999999 7999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++...... .....++||||+++++|.+++... ....+++..++.++.|++.||.|||+++++|
T Consensus 83 ~~~~~~~~---------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 147 (286)
T cd06638 83 MYYKKDVK---------------NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH 147 (286)
T ss_pred eeeecccC---------------CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 88532211 123459999999999999988642 2356889999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHHhCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~ 309 (394)
|||||+||+++.++.++|+|||+++.............|++.|+|||.+.. ..++.++|||||||++|+|++|+.
T Consensus 148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred cCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 999999999999999999999998754333223334578999999999853 457889999999999999999999
Q ss_pred CCCCCChhhHHHHHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 310 PYPDLSFTDVSSAVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
||................ .....+..++..+.+++.+||+.||++|||+.++++..
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 228 PLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 998765444332221111 11123445688999999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=310.86 Aligned_cols=250 Identities=26% Similarity=0.475 Sum_probs=209.2
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||++.. +++.+|+|.+...... ......+.+|+.++++++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence 578899999999999999887 6789999998643211 1124678889999999999999999998875554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++|+||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 74 ~--------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 133 (256)
T cd08220 74 L--------------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133 (256)
T ss_pred E--------------------EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 4 89999999999999997755556899999999999999999999999999999999999
Q ss_pred eCCC-CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++.+ +.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 212 (256)
T cd08220 134 LDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212 (256)
T ss_pred EcCCCCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 9854 468999999997544322 22234678899999999988899999999999999999999999988776665555
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+... ....++..++..+.+++.+||+.+|++|||+.+++..
T Consensus 213 ~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 213 IMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 5433 2344566789999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=310.39 Aligned_cols=250 Identities=36% Similarity=0.704 Sum_probs=209.0
Q ss_pred ccceeeeccCCceEEEEEEECC------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 87 LDIRHEIARGTYGTVYRGAYDG------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~g------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
+++.+.||.|+||.||++.+.. ..||+|+++..... .....+.+|+.+++.++|+||+++++++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--------QQIEEFLREARIMRKLDHPNIVKLLGVCTE 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--------HHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 4567899999999999998843 78999998643211 124678889999999999999999999886
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... +++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus 73 ~~~~--------------------~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~ 132 (258)
T smart00219 73 EEPL--------------------MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAAR 132 (258)
T ss_pred CCee--------------------EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccc
Confidence 6544 89999999999999997654333899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCcc-CCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMT-GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~ 318 (394)
||+++.++.++|+|||+++.......... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+...
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 133 NCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred eEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999975443211111 2346789999999988889999999999999999998 789998877777
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
....+.. ......+..++.++.+++.+||..+|++|||+.++++.|
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 VLEYLKK-GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHhc-CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 6665543 344555666899999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=313.24 Aligned_cols=255 Identities=28% Similarity=0.486 Sum_probs=204.7
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.+.+.+++.....||+|+||+||+|.+ ++..||+|.+..... ...+.+.+|+.++++++|+||++++++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 73 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHRNIVQYLGS 73 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---------HHHHHHHHHHHHHHhcCCCCeeeeeee
Confidence 455667777778999999999999987 567899998763221 123567889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCC--CHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL--AFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+...+.. ++|+||+++++|.+++.... ..+ ++..+..++.||+.||.|||++|++||
T Consensus 74 ~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~ 132 (268)
T cd06624 74 DSENGFF--------------------KIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132 (268)
T ss_pred eccCCEE--------------------EEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 8765554 89999999999999997542 334 888899999999999999999999999
Q ss_pred CCCCCceeeCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 236 DVKTENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK--PYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||||+||+++. ++.++|+|||.+..............+++.|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus 133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred CCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999976 6789999999987543322223334688999999998654 37889999999999999999999997
Q ss_pred CCChhhH-HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 313 DLSFTDV-SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 313 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....... ..........+.++..+++++.+++.+||+.+|++|||+.+++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 213 ELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 6543222 112212233455677789999999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=327.04 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=201.7
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
|++ .++|++.+.||+|+||+||+|.+ +++.||||+++.... .......+.+|+.++++++||||++++++
T Consensus 11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07878 11 WEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-------SLIHARRTYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred hhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-------hhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence 444 37899999999999999999987 678999999863321 11123456789999999999999999998
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+....... .....|++++++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||
T Consensus 83 ~~~~~~~~--------------~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdi 144 (343)
T cd07878 83 FTPATSIE--------------NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDL 144 (343)
T ss_pred hccccccc--------------ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 86433210 123458999988 8899888743 45999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||+||+++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 145 kp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 145 KPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred ChhhEEECCCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999999975432 2234578999999999876 5688999999999999999999999987665
Q ss_pred hhHHHHHHhccC---------------------CCCC--------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNL---------------------RPDI--------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~---------------------~~~~--------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....+..... .+.. ....++.+.+||.+||+.||++|||+.+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 443333221100 0000 12356678999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.47 Aligned_cols=248 Identities=25% Similarity=0.447 Sum_probs=205.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||+|+||.||+|.. +++.||+|.+...... ....+.+|+.+++.++|+||++++++|...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 37889999999999999999987 6889999998643211 125577899999999999999999999865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+|
T Consensus 89 ~~~--------------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~N 145 (297)
T cd06656 89 DEL--------------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDN 145 (297)
T ss_pred CEE--------------------EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 554 899999999999999854 358999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|++++|..||...+......
T Consensus 146 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred EEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 99999999999999998754333222333568889999999999889999999999999999999999997655433322
Q ss_pred HHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...... .....+..++..+.+++.+||..+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred eeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222211 122234567889999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=320.92 Aligned_cols=251 Identities=26% Similarity=0.468 Sum_probs=203.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||++.+ ++..+|+|.++... .......+.+|++++++++||||++++++|.+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3688999999999999999988 67889999886321 1123456788999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCc
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVKTEN 241 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlkp~N 241 (394)
.+ |+|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+|
T Consensus 73 ~~--------------------~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 73 EI--------------------SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred EE--------------------EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence 55 8999999999999999654 568999999999999999999997 699999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.++|+|||++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+......
T Consensus 131 il~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 208 (308)
T cd06615 131 ILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208 (308)
T ss_pred EEEecCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence 99999999999999998643222 1223578899999999988889999999999999999999999997554333222
Q ss_pred HHHh-----------------------------------ccCCCCCC-CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 322 AVVR-----------------------------------QNLRPDIP-RCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 322 ~~~~-----------------------------------~~~~~~~~-~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.... ....+..+ ..++.++++++.+||..+|++|||+.+++...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1110 00111111 13678899999999999999999999999875
Q ss_pred HH
Q 048724 366 EA 367 (394)
Q Consensus 366 ~~ 367 (394)
.-
T Consensus 289 ~~ 290 (308)
T cd06615 289 FI 290 (308)
T ss_pred hh
Confidence 43
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.28 Aligned_cols=247 Identities=28% Similarity=0.480 Sum_probs=193.6
Q ss_pred eeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 91 HEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
+.||+|+||.||+|.+ ++..+|+|.++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 70 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY-- 70 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc--
Confidence 3699999999999986 235799998763321 11124678899999999999999999998765544
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++++|+||||+||+
T Consensus 71 ------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil 132 (269)
T cd05087 71 ------------------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCL 132 (269)
T ss_pred ------------------EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 89999999999999997532 234677888899999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCC-------CCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 244 LDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGK-------PYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
++.++.++|+|||+++....... ......++..|+|||.+.+. .++.++||||||+++|||++ |+.||+.
T Consensus 133 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 133 LTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred EcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999864322211 11224567889999998642 35789999999999999996 9999987
Q ss_pred CChhhHHHHHHhcc-CC---CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 314 LSFTDVSSAVVRQN-LR---PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 314 ~~~~~~~~~~~~~~-~~---~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
....+......... .+ +.....+++.+.+++..|| .+|++|||+++|+..|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 213 LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 76665544333221 11 2222346889999999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=309.49 Aligned_cols=251 Identities=30% Similarity=0.524 Sum_probs=208.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|+..+.||+|+||+||+|.. +++.|++|.+........ .....+.+.+|+.+++.++|+||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT----GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc----chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 366778899999999999988 688999999875432211 12224668889999999999999999999876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+++||+++++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus 77 ~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~ 134 (258)
T cd06632 77 L--------------------YIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134 (258)
T ss_pred E--------------------EEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 4 8999999999999999654 45899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++.++.+||+|||.+....... ......++..|++||.+.... ++.++|+||||+++|+|++|+.||......+....
T Consensus 135 ~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~ 213 (258)
T cd06632 135 VDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213 (258)
T ss_pred ECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence 9999999999999987543322 223456889999999987766 89999999999999999999999987765555544
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+......+.++..++..+.+++.+||+.+|++||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 44434445566778999999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=310.38 Aligned_cols=247 Identities=28% Similarity=0.495 Sum_probs=206.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||.|+||.||+|.+ +++.|++|.++... . ...+.+|+.++++++|+||+++++.+.+..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------D----LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------H----HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 6789999999999999999988 47899999986321 1 467889999999999999999999988655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+++||+++++|.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 72 ~~--------------------~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 130 (256)
T cd06612 72 DL--------------------WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNI 130 (256)
T ss_pred cE--------------------EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 44 8999999999999998653 35689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+++.++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|+.||...........
T Consensus 131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~ 210 (256)
T cd06612 131 LLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210 (256)
T ss_pred EECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence 99999999999999987654433233334578899999999998999999999999999999999999987665544433
Q ss_pred HHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 323 VVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 323 ~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+.... .....+..++..+.+++.+||+.||++|||+.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 22111 111233457789999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=317.85 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=208.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||++.+ +++.||+|.++... .........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN------LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence 3688999999999999999988 57899999886332 111223457778999999999999999999987665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ ++||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 75 ~~--------------------~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI 132 (305)
T cd05609 75 HL--------------------CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132 (305)
T ss_pred EE--------------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence 54 8999999999999999654 4689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC---------------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR---------------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg 307 (394)
+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 133 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g 212 (305)
T cd05609 133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212 (305)
T ss_pred EECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999863211000 01123577899999999888899999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHhccCC-CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 308 DMPYPDLSFTDVSSAVVRQNLR-PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 308 ~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
..||.+....+........... +.....++.++.++|.+||+.+|++||++..+++.|+.
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 213 CVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 9999888777767666554332 22223578999999999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.22 Aligned_cols=258 Identities=27% Similarity=0.587 Sum_probs=209.0
Q ss_pred cccccceeeeccCCceEEEEEEEC------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..+|++.+.||+|+||.||+|+++ +..||||+++..... .....|.+|+.+++.++|+||++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~ei~~l~~l~~~~i~~~~~~ 74 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--------QHRSDFEREIEILRTLDHENIVKYKGV 74 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--------HHHHHHHHHHHHHHhCCCCChheEEee
Confidence 357888899999999999999862 678999998743321 234678899999999999999999998
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+..... ...+++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||
T Consensus 75 ~~~~~~------------------~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl 135 (284)
T cd05038 75 CEKPGG------------------RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDL 135 (284)
T ss_pred eecCCC------------------CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 865332 12389999999999999996543 35999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+||+++.++.++|+|||.+......... .....++..|++||.+.+..++.++||||||+++|||++|..|+...
T Consensus 136 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 136 AARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 999999999999999999999765422111 11234556799999998888999999999999999999999988543
Q ss_pred Chhh--------------HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 SFTD--------------VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.... ..........+...+..++.++.+++.+||+.+|++|||+.+++++|+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2211 11222334444455667889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=319.53 Aligned_cols=247 Identities=27% Similarity=0.453 Sum_probs=214.1
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+-|+++++||+|+||.||+|.+ +|+.||||.+....+ .+.+..|+.|+++++.|++|++||.+....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----------LQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----------LQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----------HHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 4588999999999999999987 899999998863321 366778999999999999999999988766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |||||||..|++.+.++. +++++++.++..++...+.||+|||...-||||||..||
T Consensus 102 DL--------------------WIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNI 160 (502)
T KOG0574|consen 102 DL--------------------WIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNI 160 (502)
T ss_pred ce--------------------EeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccE
Confidence 66 999999999999999865 457899999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++.+|..||+|||.|..+.+......+..|||.|||||++..-.|+.++||||||++..||..|++||.+.....-...
T Consensus 161 LLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 161 LLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred EEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 99999999999999998776666666678999999999999999999999999999999999999999988765544433
Q ss_pred HHhccCCC--CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRP--DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+- .+..+ ..|...++++.+++++||-++|++|.|+-++++.
T Consensus 241 IP-T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 241 IP-TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred cc-CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 31 22222 2345678999999999999999999999988764
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=314.80 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=201.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|++ +|+.||+|++....... ...+.+.+|+.++++++|+|++++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-------VIKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-------cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 4688999999999999999988 58899999986432211 12355778999999999999999999988665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++||||+++++|..++.. ...+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 74 ~~--------------------~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni 131 (286)
T cd07847 74 KL--------------------HLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131 (286)
T ss_pred EE--------------------EEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence 54 899999999888877643 34589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
+++.++.++|+|||++..............++..|+|||.+.+ ..++.++||||||+++|+|++|++||.+....+...
T Consensus 132 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~ 211 (286)
T cd07847 132 LITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211 (286)
T ss_pred EEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999999865443323334567889999999876 557889999999999999999999998776554433
Q ss_pred HHHhcc-------------------CCCCC----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQN-------------------LRPDI----------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~-------------------~~~~~----------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+.... ...+. ....+..+.+|+.+||+.+|++||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 322100 00000 1235788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=312.63 Aligned_cols=246 Identities=31% Similarity=0.558 Sum_probs=193.6
Q ss_pred eeccCCceEEEEEEE-C---CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccC
Q 048724 92 EIARGTYGTVYRGAY-D---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+||+|+||+||+|.. + ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+......
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~--- 70 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY--- 70 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCce---
Confidence 699999999999975 2 3468888765221 111235678899999999999999999998765554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR---KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
|+||||+++|+|.+++..... ...++..+..++.||+.||+|||++|++||||||+|||+
T Consensus 71 -----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill 133 (269)
T cd05042 71 -----------------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133 (269)
T ss_pred -----------------EEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe
Confidence 899999999999999976432 235678889999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 048724 245 DANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDG-------KPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-g~~Pf~~~ 314 (394)
+.++.+||+|||++....... .......+++.|+|||.+.. ..++.++|||||||++|||++ |..||...
T Consensus 134 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 134 TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 999999999999986422211 11122345678999998743 356789999999999999999 78999887
Q ss_pred ChhhHHHHHHhccC----CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNL----RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 315 ~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
...+.......... .+..+..++..+.+++..|| .||++|||+++|++.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 76665555443321 12234467899999999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.03 Aligned_cols=260 Identities=22% Similarity=0.472 Sum_probs=210.9
Q ss_pred cccceeeeccCCceEEEEEEEC---CeeEEEEEeecccccccc-hHHHHHHHHHHHHHHHHHHh-CCCCcceeeeeeecC
Q 048724 86 KLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVT-SAEAAAIRASFRQEVAVWQK-LDHPNVTKFIGASMG 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~~---g~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~ 160 (394)
.|++.+.||+|+||.||+|.+. ++.+|+|.+......... ..........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999983 578999988644322111 01122234556778888875 699999999999886
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDV 237 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dl 237 (394)
.... +++|||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+++|+||
T Consensus 81 ~~~~--------------------~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl 140 (269)
T cd08528 81 NDRL--------------------YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDL 140 (269)
T ss_pred CCeE--------------------EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCC
Confidence 6554 899999999999998854 234568999999999999999999996 78999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 141 TPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred CHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 9999999999999999999997544332 334457889999999999888999999999999999999999999877766
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
.....+......+.....++..+.+++.+||+.||++||++.++..++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 6665554444443333467899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=307.99 Aligned_cols=246 Identities=34% Similarity=0.675 Sum_probs=204.6
Q ss_pred eeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCC
Q 048724 91 HEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQ 169 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 169 (394)
++||+|+||.||++.+ .++.||+|.++..... .....+.+|+.++++++|+||+++++++.+....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----- 67 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI----- 67 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe-----
Confidence 3699999999999988 4889999988643211 2246788899999999999999999998766554
Q ss_pred CCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCc
Q 048724 170 SATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249 (394)
Q Consensus 170 ~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~ 249 (394)
++|+||+++++|.+++.... ..+++..+..++.+++.||.|||+++++||||+|+||+++.++.
T Consensus 68 ---------------~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~ 131 (251)
T cd05041 68 ---------------YIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV 131 (251)
T ss_pred ---------------EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc
Confidence 89999999999999986543 46889999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCCc--cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhc
Q 048724 250 LKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQ 326 (394)
Q Consensus 250 vkl~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~ 326 (394)
++|+|||++.......... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+ ..
T Consensus 132 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~ 210 (251)
T cd05041 132 LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ES 210 (251)
T ss_pred EEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hc
Confidence 9999999987543211111 11234567999999988889999999999999999999 89999887766555444 33
Q ss_pred cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 327 ~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
......+..++.++.+++.+||..+|.+|||+.++++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3455566778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=313.18 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=206.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||.||+|.+ +++.|++|+++.... ....+.+|+.+++++ +|+||+++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----------EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 47899999999999999999998 567899999864321 135678999999999 79999999999976
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.... ......|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+
T Consensus 75 ~~~~--------------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~ 140 (275)
T cd06608 75 KNPP--------------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140 (275)
T ss_pred cCCC--------------CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 4431 11234589999999999999986533 4578999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
|+||+++.++.++|+|||++..............++..|+|||.+.. ..++.++||||||+++|+|++|+.||..
T Consensus 141 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred HHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 99999999999999999998754433333334568899999998753 3467899999999999999999999986
Q ss_pred CChhhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 314 LSFTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.........+..... ....+..++..+.+++.+||..||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 221 MHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 655444444433221 11122346789999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=313.28 Aligned_cols=237 Identities=24% Similarity=0.415 Sum_probs=189.9
Q ss_pred eeccCCceEEEEEEEC--------------------------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh
Q 048724 92 EIARGTYGTVYRGAYD--------------------------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~~--------------------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 145 (394)
.||+|+||.||+|.+. ...||+|+++.. .......|.+|+.+++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~~~~ 72 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---------HRDIALAFFETASLMSQ 72 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---------HHHHHHHHHHHHHHHhc
Confidence 6999999999998741 135889987521 12234668889999999
Q ss_pred CCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Q 048724 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLS 225 (394)
Q Consensus 146 l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~ 225 (394)
++||||+++++++...... ++||||+++|+|..++... ...+++..+..++.||+.||+
T Consensus 73 l~h~niv~~~~~~~~~~~~--------------------~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ 131 (274)
T cd05076 73 VSHIHLAFVHGVCVRGSEN--------------------IMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALS 131 (274)
T ss_pred CCCCCeeeEEEEEEeCCce--------------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Confidence 9999999999999866554 8999999999999988653 356899999999999999999
Q ss_pred HHHhCCCcccCCCCCceeeCCCC-------cEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHH
Q 048724 226 YLHSKTIVHRDVKTENMLLDANR-------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSF 297 (394)
Q Consensus 226 yLH~~~iiH~Dlkp~NIll~~~~-------~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvwsl 297 (394)
|||++|++||||||+|||++..+ .++++|||++...... ....++..|+|||.+.+ ..++.++|||||
T Consensus 132 ~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 132 YLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred HHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 99999999999999999997543 4899999988543211 22457788999998865 568999999999
Q ss_pred HHHHHHHH-hCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 298 GICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 298 G~~l~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
|+++||++ +|..||......+..... .. ....+...++.+.++|.+||+.+|++|||+.++++.|
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKERFY-EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHHH-Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99999985 689999876655443322 22 2223444567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.83 Aligned_cols=246 Identities=30% Similarity=0.594 Sum_probs=201.7
Q ss_pred eeccCCceEEEEEEECC--------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 92 EIARGTYGTVYRGAYDG--------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.||+|+||.||+|++.. ..+|+|.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc--------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 69999999999998632 5799998753211 1123567889999999999999999999876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-----RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
. ++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++++|+||+
T Consensus 74 ~--------------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 133 (269)
T cd05044 74 Q--------------------YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133 (269)
T ss_pred e--------------------EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4 89999999999999997532 2347889999999999999999999999999999
Q ss_pred CCceeeCCCC-----cEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCC
Q 048724 239 TENMLLDANR-----TLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMP 310 (394)
Q Consensus 239 p~NIll~~~~-----~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~P 310 (394)
|+||+++.++ .++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 134 p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred hheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 9999998877 89999999987432211 11122345688999999998899999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
|......+....+ ........+..+|..+.+++.+||..+|.+||++.++++.|+
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 214 YPALNNQEVLQHV-TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CcccCHHHHHHHH-hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9877766655444 333445566778999999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=335.57 Aligned_cols=250 Identities=25% Similarity=0.465 Sum_probs=212.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+.|+|++.||.|+||.||+|+. ++-..|-|++... ......+|.-|++||..++||+||++++.|+..+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---------seEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 4567899999999999999987 4556778887522 1222467888999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ ||+.|||.||.++..+..-. ..|++.++..+++|++.||.|||+++|||||||..||
T Consensus 103 kL--------------------wiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNi 161 (1187)
T KOG0579|consen 103 KL--------------------WILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNI 161 (1187)
T ss_pred ce--------------------EEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccce
Confidence 66 89999999999998887654 4699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCcccc-----CCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-----DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|++-+|.++|+|||.+............+.|||.|||||+. ...+|+.++||||||++|.||..+.+|....+..
T Consensus 162 L~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 162 LLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred EEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 99999999999999987654444445567999999999987 3568999999999999999999999999999988
Q ss_pred hHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.++..+..... ..-.|..++.+|.+|+++||.+||..||++.++++.
T Consensus 242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 88877654322 122357789999999999999999999999999863
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=313.30 Aligned_cols=257 Identities=30% Similarity=0.435 Sum_probs=205.5
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
..++|++.+.||+|+||.||++.. +++.+|+|++..... ....+.+|+.+++++ +|||++++++++.
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----------VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----------HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 368899999999999999999988 678999999863211 124566789999999 8999999999987
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
..+.. .....|+|+||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||
T Consensus 90 ~~~~~---------------~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl 154 (291)
T cd06639 90 KADKL---------------VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDV 154 (291)
T ss_pred ecccc---------------CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 54322 123458999999999999988642 2356899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-----CCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-----PYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||+||+++.++.++|+|||++..............++..|+|||.+... .++.++|||||||++|+|++|+.||.
T Consensus 155 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 155 KGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred CHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999987544332223345688999999998643 36789999999999999999999998
Q ss_pred CCChhhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 313 DLSFTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..........+..... ....+...+..+.++|.+||+.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 235 DMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 7765544443322211 112234567889999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=310.40 Aligned_cols=237 Identities=25% Similarity=0.438 Sum_probs=189.7
Q ss_pred eeccCCceEEEEEEEC--------------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 92 EIARGTYGTVYRGAYD--------------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~~--------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.||+|+||.||+|++. ...|++|++... .......|.+|+.+++.++||||++++++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---------HRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---------hhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 6899999999999752 225888887532 12234578889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...... ++||||+++|+|..++... ...+++..++.++.||+.||+|||+++++||||
T Consensus 73 ~~~~~~~--------------------~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 131 (262)
T cd05077 73 CVRDVEN--------------------IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNV 131 (262)
T ss_pred EecCCCC--------------------EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCC
Confidence 8765544 8999999999999887643 346899999999999999999999999999999
Q ss_pred CCCceeeCCCCc-------EEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHH-hCC
Q 048724 238 KTENMLLDANRT-------LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIY-CCD 308 (394)
Q Consensus 238 kp~NIll~~~~~-------vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-tg~ 308 (394)
||+|||++.++. ++++|||++..... .....++..|+|||.+. +..++.++||||||+++|+|+ +|.
T Consensus 132 kp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~ 207 (262)
T cd05077 132 CTKNILLAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207 (262)
T ss_pred CcccEEEecCCccCCCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 999999986654 89999999864322 12245788999999886 567899999999999999997 588
Q ss_pred CCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 309 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.||......+.... ..... ......+.++.+||.+||+.||++||++.+|++.|
T Consensus 208 ~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 208 IPLKDKTLAEKERF-YEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCcchhHHHHH-HhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 89877654443322 12221 22333568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.69 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=193.2
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC------Cccee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH------PNVTK 153 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h------~nIv~ 153 (394)
+..++|++.+.||+|+||+||+|.+ +++.||||+++... .....+..|+.+++.++| .++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----------KYTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----------hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 4457899999999999999999987 67899999986321 012334456677666654 45888
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTI 232 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~i 232 (394)
++++|..... .+|+|||++ |++|.+++.+. ..+++..+..|+.||+.||.|||+ .||
T Consensus 196 i~~~~~~~~~-------------------~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gI 253 (467)
T PTZ00284 196 IQRYFQNETG-------------------HMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHL 253 (467)
T ss_pred eEEEEEcCCc-------------------eEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCe
Confidence 8888764322 348999998 78999988654 469999999999999999999997 599
Q ss_pred cccCCCCCceeeCCCC----------------cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHH
Q 048724 233 VHRDVKTENMLLDANR----------------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYS 296 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~----------------~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 296 (394)
|||||||+|||++.++ .+||+|||.+.... .......||+.|+|||++.+..|+.++||||
T Consensus 254 iHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred ecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 9999999999998665 49999999875322 2233468999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHhcc-------------------------CCCCC---------------CCCC
Q 048724 297 FGICLWEIYCCDMPYPDLSFTDVSSAVVRQN-------------------------LRPDI---------------PRCC 336 (394)
Q Consensus 297 lG~~l~elltg~~Pf~~~~~~~~~~~~~~~~-------------------------~~~~~---------------~~~~ 336 (394)
|||++|||++|+.||...+..+....+.... +++.. ....
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 9999999999999998766544333221110 00000 0012
Q ss_pred cHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 048724 337 PSSLASIMRKCWDANPDKRPVMDEVVK--LLEAV 368 (394)
Q Consensus 337 ~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~ 368 (394)
++.+.+||.+||+.||++|||++|+++ ++...
T Consensus 411 ~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 456789999999999999999999998 44443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=315.36 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=197.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||+|++ +|+.||+|.++..... ......+.+|+.++++++||||+++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-------ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence 478889999999999999988 6889999998743211 1112456679999999999999999999876555
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+|+||++ ++|.+++... ...+++..++.++.||++||.|||++|++||||||+||+
T Consensus 74 ~--------------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil 131 (284)
T cd07839 74 L--------------------TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLL 131 (284)
T ss_pred e--------------------EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 4 89999996 5888887653 356999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCC-CCCChhhHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPY-PDLSFTDVSS 321 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf-~~~~~~~~~~ 321 (394)
++.++.++|+|||+++.............+++.|+|||.+.+. .++.++|||||||++|+|++|..|| +..+..+...
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 132 INKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred EcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 9999999999999997544333333445678999999998764 4789999999999999999998885 4433333222
Q ss_pred HHHhcc------------------CCC---------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQN------------------LRP---------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~------------------~~~---------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.... ... .....+++++.++|.+||+.||.+|||++++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 221100 000 0112467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=313.31 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=201.9
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|+||.||+|++ +|+.||||.++..... ......+.+|++++++++||||+++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-------cccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 478899999999999999988 6889999988643211 1123567789999999999999999999876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++||||+. ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+
T Consensus 74 ~--------------------~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nil 132 (284)
T cd07860 74 L--------------------YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 132 (284)
T ss_pred E--------------------EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 4 89999995 68999987665667999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++.++.++|+|||++..............+++.|+|||.+.+. .++.++||||||+++|+|+||+.||...+..+....
T Consensus 133 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 133 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred ECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999999987544333333445678899999988764 468899999999999999999999987665443333
Q ss_pred HHhccCCC---------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRP---------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.......+ .....++.+++++|.+||+.||++|||+++++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 22110000 0112467889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.90 Aligned_cols=250 Identities=25% Similarity=0.496 Sum_probs=204.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||++.+ +++.||+|.++.... ......+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--------ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC
Confidence 4688999999999999999988 588999998863211 112356778999999999999999999887655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVKTE 240 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlkp~ 240 (394)
.+ |+|+||+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||||+
T Consensus 73 ~~--------------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ 132 (286)
T cd06622 73 AV--------------------YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT 132 (286)
T ss_pred eE--------------------EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHH
Confidence 44 89999999999999886531 2368999999999999999999996 59999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC------CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK------PYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+++.++.++|+|||++...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 133 NVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred HEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 999999999999999998754322 22234678899999998654 3578999999999999999999999766
Q ss_pred ChhhHHHHH--HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 315 SFTDVSSAV--VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 315 ~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
......... ......+..+..++.++.++|.+||+.+|++||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 211 TYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred chhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 544433322 12233445666689999999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.09 Aligned_cols=249 Identities=31% Similarity=0.545 Sum_probs=203.9
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||+|.. +++.|++|+++..... ......+..|+.+++.++|+||+++++.+...+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence 478889999999999999987 6789999998744321 2335778899999999999999999998876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 74 ~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil 131 (264)
T cd06626 74 V--------------------YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131 (264)
T ss_pred E--------------------EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 4 8999999999999998653 35889999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCc----cCCCCCCCcCCccccCCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDM----TGETGTLGYMAPEVLDGKP---YNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
++.++.+||+|||.+.......... ....++..|+|||.+.+.. ++.++||||||+++|++++|+.||.....
T Consensus 132 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred ECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 9999999999999987543322211 1246788999999998766 88999999999999999999999976643
Q ss_pred hhHHHHHHhccCCCCCCCC--CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRC--CPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.............+.++.. ++..+.+++.+||+.+|.+|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 212 EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 3322222222334444443 4899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=310.25 Aligned_cols=253 Identities=30% Similarity=0.574 Sum_probs=206.5
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|+..+.||+|+||.||++.. +++.||+|+++..... ..........+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT---SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC---chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence 467788999999999999987 7889999998743321 12233345788899999999999999999999886665
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++|+||+++++|.+++.+. .++++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus 78 ~--------------------~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil 135 (268)
T cd06630 78 F--------------------NLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLL 135 (268)
T ss_pred E--------------------EEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 5 8999999999999999653 46899999999999999999999999999999999999
Q ss_pred eCCCC-cEEEeeccccccccCCCCC----ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 244 LDANR-TLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 244 l~~~~-~vkl~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
++.++ .++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 136 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 136 IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred EcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 98765 5999999998754332111 112357889999999988889999999999999999999999997554332
Q ss_pred HHH---HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 319 VSS---AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 319 ~~~---~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
... ........+..+..+++++.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 222 222233445566678899999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=307.82 Aligned_cols=251 Identities=25% Similarity=0.487 Sum_probs=208.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|.+.+.||+|+||.||++.. +|..||+|.+...... ......+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-------VKEKEASKKEVILLAKMKHPNIVTFFASFQENGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-------chhhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence 478889999999999999988 6789999998643211 0113567789999999999999999999876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+|+||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 74 ~--------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil 133 (257)
T cd08225 74 L--------------------FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133 (257)
T ss_pred E--------------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence 4 89999999999999997655556899999999999999999999999999999999999
Q ss_pred eCCCC-cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDANR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++.++ .++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 134 LSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred EcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 98875 46999999987654333222334688999999999888899999999999999999999999987776666555
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..... ....+..++.++.+++.+||..+|++|||+.++++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 214 ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 44332 334455678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=316.31 Aligned_cols=255 Identities=24% Similarity=0.498 Sum_probs=207.6
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
++.++|++.+.||+|+||+||++.+ +++.||+|++.... .......+.+|+.+++.++||||+++++.+.
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--------KSSVRKQILRELQIMHECRSPYIVSFYGAFL 73 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--------cchHHHHHHHHHHHHHHcCCCCcceEeeeEe
Confidence 4567899999999999999999988 58899999886322 1122467889999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVK 238 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlk 238 (394)
....+ |+|+||+++++|.+++... +.+++..+..++.+++.||.|||+ .+++||||+
T Consensus 74 ~~~~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~ 131 (284)
T cd06620 74 NENNI--------------------CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIK 131 (284)
T ss_pred cCCEE--------------------EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCC
Confidence 76554 8999999999999988653 468999999999999999999997 699999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh-
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT- 317 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~- 317 (394)
|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|++++|..||......
T Consensus 132 p~nil~~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 209 (284)
T cd06620 132 PSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209 (284)
T ss_pred HHHEEECCCCcEEEccCCcccchhhhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhh
Confidence 999999999999999999986432211 12357899999999998888999999999999999999999999765432
Q ss_pred ----------hHHHHHHhccCCCCCCC-CCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 318 ----------DVSSAVVRQNLRPDIPR-CCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 318 ----------~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
+....+.... .+.++. .++..+.+|+.+||+.||++|||+.+++++..-+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 210 DGQDDPMGILDLLQQIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhhHHHHHHHHHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1222222211 222222 37889999999999999999999999998755443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.24 Aligned_cols=257 Identities=28% Similarity=0.497 Sum_probs=205.1
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeeccccccc-chHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMV-TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+|.+.+.||.|+||.||+|.. +|+.||+|.++....... .........+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999976 688999998864321111 11122234567888999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++|+||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||+|+||
T Consensus 82 ~~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni 139 (272)
T cd06629 82 YL--------------------SIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL 139 (272)
T ss_pred ce--------------------EEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence 54 8999999999999999654 5689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 243 LLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+++.++.++|+|||+++...... .......++..|+|||.+.... ++.++|+||||+++|++++|..||.......
T Consensus 140 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 219 (272)
T cd06629 140 LVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219 (272)
T ss_pred EEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH
Confidence 99999999999999987533211 1122346888999999987654 7889999999999999999999997665544
Q ss_pred HHHHHHhccCCCCCC----CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIP----RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.............++ ..++.++.+++.+||+.+|++|||+.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 220 AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 443333232222222 3468999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.49 Aligned_cols=246 Identities=25% Similarity=0.423 Sum_probs=205.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-C-----Ccceeeeee
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-H-----PNVTKFIGA 157 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----~nIv~l~~~ 157 (394)
+|.+.+.||+|+||.|.+|.+ +++.||||+++.... ...+-..|+.+|..|+ | -|+|+++++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 788999999999999999988 789999999984432 1234456899999996 4 389999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
|+..+++ |||+|.+ +.+|.++|+.++...++...++.|+.||+.||.+||+.||||+||
T Consensus 257 F~fr~Hl--------------------ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDL 315 (586)
T KOG0667|consen 257 FYFRNHL--------------------CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDL 315 (586)
T ss_pred cccccce--------------------eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9988877 9999999 679999999988888999999999999999999999999999999
Q ss_pred CCCceeeCCC--CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 238 KTENMLLDAN--RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 238 kp~NIll~~~--~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||+||||... ..|||+|||.|+....... ...-+..|.|||++.|.+|+.+.|+|||||+++||++|.+-|++.+
T Consensus 316 KPENILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 316 KPENILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ChhheeeccCCcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 9999999643 4799999999986544322 4567789999999999999999999999999999999999999988
Q ss_pred hhhHHHHHHhc----------------------c----------------------------CCCCCC-----------C
Q 048724 316 FTDVSSAVVRQ----------------------N----------------------------LRPDIP-----------R 334 (394)
Q Consensus 316 ~~~~~~~~~~~----------------------~----------------------------~~~~~~-----------~ 334 (394)
..+....++.. . .....| .
T Consensus 393 e~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~ 472 (586)
T KOG0667|consen 393 EYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPK 472 (586)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhccc
Confidence 87777665421 0 000011 0
Q ss_pred CCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 335 CCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 335 ~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.-...+.++|++||..||.+|+|..++++.-
T Consensus 473 ~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 473 ADDKLFIDFLKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred ccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence 1134689999999999999999999999853
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=317.49 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=185.2
Q ss_pred eeeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 90 RHEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
.++||+|+||+||+|++ +++.||+|.++.... ...+.+|+.++++++||||+++++++.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFLSHAD-- 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCC--
Confidence 45799999999999986 356899999863321 1345679999999999999999998864332
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
..+|+++||+. ++|.+++.... ...+++..+..++.||+.||.|||++|++|||||
T Consensus 73 ----------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlk 135 (317)
T cd07868 73 ----------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 135 (317)
T ss_pred ----------------cEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCC
Confidence 23489999995 58888875321 2358999999999999999999999999999999
Q ss_pred CCceee----CCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCC
Q 048724 239 TENMLL----DANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 239 p~NIll----~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~P 310 (394)
|+|||+ +..+.+||+|||+++...... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|++|
T Consensus 136 p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 136 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred HHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 456789999999997543321 12234578999999999876 4589999999999999999999999
Q ss_pred CCCCChh---------hHHHHHHhc-c----------------------CCCC-------------CCCCCcHHHHHHHH
Q 048724 311 YPDLSFT---------DVSSAVVRQ-N----------------------LRPD-------------IPRCCPSSLASIMR 345 (394)
Q Consensus 311 f~~~~~~---------~~~~~~~~~-~----------------------~~~~-------------~~~~~~~~l~~li~ 345 (394)
|...... .....+... + .... .....+.++.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 9643211 111111000 0 0000 00113467889999
Q ss_pred HhchhCCCCCCCHHHHHH
Q 048724 346 KCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 346 ~cL~~dP~~Rpt~~~ll~ 363 (394)
+||+.||++|||++++++
T Consensus 296 ~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 296 KLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHhccCcccCCCHHHHhc
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=309.24 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=206.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||.|+||+||+|.. ++..+|+|++...... .....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--------TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--------hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC
Confidence 4788999999999999999987 6789999998632211 12467889999999999999999999887655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.. ++|+|++++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 73 ~~--------------------~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n 132 (267)
T cd06610 73 EL--------------------WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132 (267)
T ss_pred EE--------------------EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 54 899999999999999976433 568999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCC----ccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|++++++.++|+|||++......... .....++..|++||.+... .++.++|+||||+++|+|++|+.||...+.
T Consensus 133 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred EEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 99999999999999998754432221 1234688999999998776 788999999999999999999999987766
Q ss_pred hhHHHHHHhccCCCCCC-----CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIP-----RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
............ ...+ ..++..+.+++.+||+.||++|||+.++++.
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 213 MKVLMLTLQNDP-PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred hhhHHHHhcCCC-CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 555544433321 1111 2568899999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.15 Aligned_cols=246 Identities=25% Similarity=0.504 Sum_probs=192.6
Q ss_pred eeccCCceEEEEEEE-CCe---eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccC
Q 048724 92 EIARGTYGTVYRGAY-DGQ---DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~-~g~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
.||+|+||+||+|.. ++. .+++|.++.... ......+.+|+.+++.++||||+++++.|.+....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~--- 70 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--------SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY--- 70 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--------hHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc---
Confidence 599999999999976 333 455665542211 11246788999999999999999999998865554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
|+||||+++|+|.+++.+.. ...+++..++.++.||+.||+|||+++++||||||+|||++
T Consensus 71 -----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~ 133 (268)
T cd05086 71 -----------------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT 133 (268)
T ss_pred -----------------EEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc
Confidence 89999999999999997542 23467778889999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 246 ANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDG-------KPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
.++.++|+|||++...... ........++..|+|||.+.. ..++.++||||||+++|||++ |..||....
T Consensus 134 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 134 SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999998632211 111223567889999998753 245789999999999999997 577998777
Q ss_pred hhhHHHHHHhcc----CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 316 FTDVSSAVVRQN----LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 316 ~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
..+....+.... .++.++..+++.+.+++..|| .+|++||+++++++.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 666555544332 233444557889999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=317.03 Aligned_cols=247 Identities=27% Similarity=0.450 Sum_probs=203.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+.|.....||+|+||.||++.. ++..||||.++... ......+.+|+.+++.++|+||+++++.+...+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD 92 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence 4455567799999999999987 67899999885321 122356788999999999999999999887655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 93 ~~--------------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni 149 (292)
T cd06658 93 EL--------------------WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI 149 (292)
T ss_pred eE--------------------EEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 54 899999999999998843 3589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+++.++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|||++|+.||...+.......
T Consensus 150 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred EEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999987543333333335688999999999888899999999999999999999999987766555444
Q ss_pred HHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+.. ..... ....++..+.+++.+||..||++|||++++++.
T Consensus 230 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 230 IRD-NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHh-cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 322 22222 223468899999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=307.91 Aligned_cols=242 Identities=22% Similarity=0.360 Sum_probs=204.3
Q ss_pred eccCCceEEEEEEEC--CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAYD--GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||.|+||.||++++. ++.||+|++.... .........+.+|+.+++.++||||+++++.+.+...+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 68 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH------IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI------ 68 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc------chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc------
Confidence 799999999999984 8899999986432 11122346788999999999999999999998766555
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
|+++||+++++|.+++.+. ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+
T Consensus 69 --------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~ 132 (262)
T cd05572 69 --------------YMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132 (262)
T ss_pred --------------EEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCE
Confidence 8999999999999999654 458999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--hhhHHHHHHhccC
Q 048724 251 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS--FTDVSSAVVRQNL 328 (394)
Q Consensus 251 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~--~~~~~~~~~~~~~ 328 (394)
+|+|||++....... ......+++.|++||.+.+..++.++|+||||+++|+|++|..||.... ..+....+.....
T Consensus 133 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 211 (262)
T cd05572 133 KLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211 (262)
T ss_pred EEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC
Confidence 999999997554332 2223467889999999988889999999999999999999999998766 5555555554445
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVK 363 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~ 363 (394)
....+..+++++.++|.+||+.+|++||+ +.++++
T Consensus 212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 56667677999999999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.83 Aligned_cols=237 Identities=25% Similarity=0.453 Sum_probs=191.8
Q ss_pred eeccCCceEEEEEEEC--C-------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 92 EIARGTYGTVYRGAYD--G-------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~~--g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
.||+|+||.||+|.+. + ..||+|.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 6999999999999762 2 24888876421 1223467788999999999999999999998655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++||||+++|+|.+++..+. ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 73 ~~--------------------~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ni 131 (258)
T cd05078 73 ES--------------------IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNV 131 (258)
T ss_pred Cc--------------------EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 54 89999999999999996543 3689999999999999999999999999999999999
Q ss_pred eeCCCCc--------EEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhC-CCCCC
Q 048724 243 LLDANRT--------LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCC-DMPYP 312 (394)
Q Consensus 243 ll~~~~~--------vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg-~~Pf~ 312 (394)
+++.++. ++++|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++| ..||.
T Consensus 132 li~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 132 LLIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred EEecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 9987654 69999998864322 122467889999999986 4578999999999999999998 56776
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
..+...... .... +..++...+.++.+++.+||+.+|++|||++++++.|
T Consensus 208 ~~~~~~~~~-~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 208 ALDSQKKLQ-FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred hccHHHHHH-HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 655544332 2222 3445666778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=310.67 Aligned_cols=248 Identities=31% Similarity=0.503 Sum_probs=207.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+-|++.+.||.|+||.||+|.+ ++..||||++..... ......+.+|+.++++++||||+++++.+.+..
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 3467788999999999999987 678999998753221 122367888999999999999999999998665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+|+||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||
T Consensus 76 ~~--------------------~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni 132 (277)
T cd06641 76 KL--------------------WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred eE--------------------EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhE
Confidence 54 899999999999999853 3589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (277)
T cd06641 133 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212 (277)
T ss_pred EECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence 99999999999999987543332222334678899999999888889999999999999999999999987665555544
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+ .....+..+..++.++.+++.+||+.+|++||++.+++..
T Consensus 213 ~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 I-PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred H-hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3 3333445566789999999999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=310.11 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=205.2
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|+||.||+|.+ +++.||+|++..... ........+.+|+.++++++||||+++++.+.+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC------VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh------cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence 478899999999999999988 588999999874321 111234678889999999999999999998876555
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+|+||+.|++|.+++... ..+++..+..++.|+++||.|||++|++|+||+|+||+
T Consensus 75 ~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 132 (258)
T cd05578 75 M--------------------YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132 (258)
T ss_pred E--------------------EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 4 8999999999999999654 46999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh---hhHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF---TDVS 320 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~---~~~~ 320 (394)
++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ....
T Consensus 133 ~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (258)
T cd05578 133 LDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211 (258)
T ss_pred EcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 9999999999999987543322 22345688899999999988899999999999999999999999987764 2222
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH--HHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM--DEVV 362 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~--~~ll 362 (394)
. .... .....+..++..+.++|.+||+.||.+||++ ++++
T Consensus 212 ~-~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 A-KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred H-Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2 2221 3455667789999999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=305.74 Aligned_cols=249 Identities=28% Similarity=0.535 Sum_probs=209.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|++|.||+|++ +++.|+||++...... .....+..|+.++++++|+||+++++.+....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 3688899999999999999988 5889999998743311 23467889999999999999999999988665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCc
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVKTEN 241 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlkp~N 241 (394)
.. ++|+||+++++|.+++... ..+++..++.++.|++.||.|||+ .|++|+||+|+|
T Consensus 73 ~~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~n 130 (264)
T cd06623 73 EI--------------------SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN 130 (264)
T ss_pred eE--------------------EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHH
Confidence 54 8999999999999999654 569999999999999999999999 999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---hhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS---FTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~---~~~ 318 (394)
|+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+
T Consensus 131 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 210 (264)
T cd06623 131 LLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210 (264)
T ss_pred EEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH
Confidence 99999999999999998765433333234567889999999998889999999999999999999999997763 334
Q ss_pred HHHHHHhccCCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+. ....+..+.. ++..+.+++.+||+.+|++||++.++++.
T Consensus 211 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 211 LMQAIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 443333 3333445555 88999999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.34 Aligned_cols=254 Identities=26% Similarity=0.470 Sum_probs=209.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
.+|++.+.||+|+||.||+|.+ +++.||+|.+...... .........+.+|+.++++++|+||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS----QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc----chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 4788999999999999999987 6889999987543211 111223467889999999999999999999886543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. ..+++++||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 78 ~------------------~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni 137 (264)
T cd06653 78 E------------------KKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI 137 (264)
T ss_pred C------------------CEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 2 2248999999999999998653 4588999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........
T Consensus 138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 99999999999999997542211 112234688999999999988899999999999999999999999987766665
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.........++.++..+++.+.+++.+||. +|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 555555555666788899999999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=331.49 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=193.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
...|.+.+.||+|+||.||+|.+ +++.||||.... ..+.+|+.++++++|+|||++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 45799999999999999999998 568899996431 2345799999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|||++ .++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 233 ~~~--------------------~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~N 290 (461)
T PHA03211 233 GLT--------------------CLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTEN 290 (461)
T ss_pred CEE--------------------EEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHH
Confidence 544 8999999 57898888653 2469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC----
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS---- 315 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~---- 315 (394)
||++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+....
T Consensus 291 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 291 VLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred EEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 9999999999999999975432211 1223569999999999999999999999999999999999876542211
Q ss_pred ----hhhHHHHHHhccCC-------------------------CCCC-------CCCcHHHHHHHHHhchhCCCCCCCHH
Q 048724 316 ----FTDVSSAVVRQNLR-------------------------PDIP-------RCCPSSLASIMRKCWDANPDKRPVMD 359 (394)
Q Consensus 316 ----~~~~~~~~~~~~~~-------------------------~~~~-------~~~~~~l~~li~~cL~~dP~~Rpt~~ 359 (394)
...+...+...... +... ...+..+.+||.+||+.||++|||+.
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~ 450 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAA 450 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHH
Confidence 11222222111110 0000 12456889999999999999999999
Q ss_pred HHHHH
Q 048724 360 EVVKL 364 (394)
Q Consensus 360 ~ll~~ 364 (394)
|+|+.
T Consensus 451 elL~h 455 (461)
T PHA03211 451 ELLRL 455 (461)
T ss_pred HHhhC
Confidence 99975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.01 Aligned_cols=260 Identities=27% Similarity=0.511 Sum_probs=206.8
Q ss_pred ccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 87 LDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
|.+.+.||+|+||.||+|.+ ++..||||+++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-------SSDIEEFLREAACMKEFDHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-------hHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 56778999999999999976 3578999998643211 11235677899999999999999999988654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
.... .....+++++|+++|+|.+++.... ...+++..++.++.|++.||+|||++|++||||
T Consensus 74 ~~~~--------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~di 139 (273)
T cd05074 74 RAKG--------------RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDL 139 (273)
T ss_pred CCCC--------------cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 3210 0012378999999999998875322 224788999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~ 314 (394)
||+||+++.++.+||+|||+++....... ......+++.|++||.+....++.++||||||+++|+|++ |..||...
T Consensus 140 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 140 AARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred chhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999875432211 1122345678999999998889999999999999999999 89999877
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
...+....+... .....+..++..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 220 ENSEIYNYLIKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 766655554432 23334456789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=327.78 Aligned_cols=245 Identities=28% Similarity=0.452 Sum_probs=206.5
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|.-++.||.|+||-||-|++ +.+.||||.+.+... ....-.+++..|+.+|++++|||++.+.|+|....
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK------Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-- 99 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-- 99 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccccc------ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--
Confidence 44566899999999999987 778999999876543 22233577889999999999999999999987543
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
.+|+||||| -|+-.|++.-+ ++++.+..+..|+.+.+.||+|||+.+.||||||..|||+
T Consensus 100 ------------------TaWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 100 ------------------TAWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred ------------------hHHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 448999999 56888887654 4679999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
++.|.|||+|||.|.+... ...++|||.|||||++. .+.|+-++||||||+++.||...++|+-..+...-.+
T Consensus 160 se~g~VKLaDFGSAsi~~P----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 160 SEPGLVKLADFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred cCCCeeeeccccchhhcCc----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 9999999999999976432 23479999999999985 4679999999999999999999999988877766665
Q ss_pred HHHhccCCCCCC-CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIP-RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~-~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
-+. ++-.|.++ ..+++.|++|+..||++-|.+|||.+++++.
T Consensus 236 HIA-QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 236 HIA-QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHH-hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 554 34444444 4578999999999999999999999998764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=313.81 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=200.9
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.+ +++.||+|++...... ......+.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-------KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-------chhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 4688899999999999999998 5789999987643211 122356778999999999999999999987655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+|+||+++++|.++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||
T Consensus 74 ~~--------------------~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni 131 (286)
T cd07846 74 RL--------------------YLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131 (286)
T ss_pred eE--------------------EEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 54 8999999999998876432 3589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
++++++.++|+|||++..............++..|+|||.+.+ ..++.++||||||+++|+|++|++||+.....+...
T Consensus 132 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~ 211 (286)
T cd07846 132 LVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211 (286)
T ss_pred EECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence 9999999999999998765443333344567889999999875 457789999999999999999999997665443332
Q ss_pred HHHhc-------------------cC-CCC---------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQ-------------------NL-RPD---------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~-------------------~~-~~~---------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+... +. .+. ....++..+.+++.+||+.+|++||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 22210 00 000 12346788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=310.31 Aligned_cols=247 Identities=30% Similarity=0.527 Sum_probs=202.5
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---CCcceeeeeeecC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---HPNVTKFIGASMG 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~ 160 (394)
.|++.+.||+|+||.||+|.+ +++.||+|.++..... .....+.+|+.+++.++ |||++++++++.+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~ 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--------DDVSDIQREVALLSQLRQSQPPNITKYYGSYLK 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--------hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence 477888999999999999997 6789999998643211 11245778999999996 9999999999876
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... |+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+
T Consensus 74 ~~~~--------------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ 130 (277)
T cd06917 74 GPRL--------------------WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAA 130 (277)
T ss_pred CCEE--------------------EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHH
Confidence 5544 899999999999999854 36899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||+++.++.++|+|||++..............|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||........
T Consensus 131 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 210 (277)
T cd06917 131 NILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210 (277)
T ss_pred HEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 999999999999999998765444333344578899999998865 4578899999999999999999999987665444
Q ss_pred HHHHHhccCCCCCCC-CCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPR-CCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~-~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+. ....+.++. .++.++.+++.+||+.||++||++.++++.
T Consensus 211 ~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 211 MMLIP-KSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred hhccc-cCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 33221 112223333 378899999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=328.51 Aligned_cols=257 Identities=29% Similarity=0.495 Sum_probs=223.0
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
......|.+.+.||+|.|++|.+|++ ++..||||++++.. .+... ++.+.+|+++|+.++|||||+++.+.
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~------ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ------LNPSK-RQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc------cChHH-HHHHHHHHHHHHhcCCcceeeeeeee
Confidence 44578899999999999999999988 89999999997432 22222 34588999999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.....+ |+||||+.+|.+++++.++. ...+..+..++.|++.|++|||+++|+|||||
T Consensus 125 ~t~~~l--------------------ylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk 182 (596)
T KOG0586|consen 125 ETEATL--------------------YLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLK 182 (596)
T ss_pred eeccee--------------------EEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccc
Confidence 866665 89999999999999997765 47779999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
++|||++.+.++||+|||++..... .....+.+|++.|.|||.+.+..|+ +.+|+||+|+++|.|++|..||.+.+..
T Consensus 183 ~eNilL~~~mnikIaDfgfS~~~~~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 183 AENILLDENMNIKIADFGFSTFFDY-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred hhhcccccccceeeeccccceeecc-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 9999999999999999999987653 3445568999999999999998765 6999999999999999999999998888
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
+.....++.+++ ++..++.++.++|+++|-.+|.+|++++++.+.-+.-.
T Consensus 262 ~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 262 ELRPRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred cccchheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 887777777666 44457889999999999999999999999998665443
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=309.93 Aligned_cols=248 Identities=28% Similarity=0.534 Sum_probs=204.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||.|+||.||++.+ +++.||+|.+..... ......+.+|+.++++++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--------EAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--------hHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 3678889999999999999988 578999999864321 123467788999999999999999999987654
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCc
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVKTEN 241 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlkp~N 241 (394)
.. ++++||+++++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+|
T Consensus 73 ~~--------------------~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~n 131 (265)
T cd06605 73 DI--------------------SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131 (265)
T ss_pred EE--------------------EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHH
Confidence 44 89999999999999987643 578999999999999999999999 999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-----h
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS-----F 316 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~-----~ 316 (394)
|+++.++.++|+|||.+......... ...++..|+|||.+.+..++.++||||||+++|+|++|..||.... .
T Consensus 132 i~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 132 ILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred EEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 99999999999999998754322111 1578889999999999899999999999999999999999997542 2
Q ss_pred hhHHHHHHhccCCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....+. ....+..+.. ++.++.++|.+||..+|++|||+.+++..
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 210 FELLQYIV-NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHh-cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 22222222 2223334433 78999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=324.91 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=190.7
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
...+|++.+.||+|+||.||+|++ +++.||+|+.... ....|+.++++++||||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 346799999999999999999998 5678999975421 22358999999999999999999886
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... |+|+|++ .++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+
T Consensus 129 ~~~~--------------------~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 186 (357)
T PHA03209 129 GAIT--------------------CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTE 186 (357)
T ss_pred CCee--------------------EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 5554 8999999 46888888653 356999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChh--
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP-YPDLSFT-- 317 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~P-f~~~~~~-- 317 (394)
|||++.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||+++..| |......
T Consensus 187 Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~ 265 (357)
T PHA03209 187 NIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265 (357)
T ss_pred HEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHH
Confidence 999999999999999999743222 222345789999999999999999999999999999999986444 4332111
Q ss_pred -------hHHHHHHh-ccCC-CCCC------------------------------CCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 318 -------DVSSAVVR-QNLR-PDIP------------------------------RCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 318 -------~~~~~~~~-~~~~-~~~~------------------------------~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
.....+.. .+.. ..++ ..++.++.+||.+||+.||++|||+
T Consensus 266 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta 345 (357)
T PHA03209 266 EYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345 (357)
T ss_pred HHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH
Confidence 00001100 0000 0000 1346677889999999999999999
Q ss_pred HHHHHH
Q 048724 359 DEVVKL 364 (394)
Q Consensus 359 ~~ll~~ 364 (394)
.+++..
T Consensus 346 ~e~l~h 351 (357)
T PHA03209 346 EEILNY 351 (357)
T ss_pred HHHhcC
Confidence 999864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=314.15 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=203.2
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|+....||+|+||.||+|.. +++.||+|+++.... .....+.+|+.+++.++||||+++++.+.....
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---------QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---------chHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 344555799999999999987 688999999864321 113557789999999999999999999876555
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+|+||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||+|+||+
T Consensus 93 ~--------------------~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nil 149 (297)
T cd06659 93 L--------------------WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSIL 149 (297)
T ss_pred E--------------------EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeE
Confidence 4 899999999999988743 45899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|+.||......+....+
T Consensus 150 l~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 150 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred EccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999875443333333457889999999999888999999999999999999999999876655544433
Q ss_pred HhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..... ....+..++..+.++|.+||+.+|.+||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 230 RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred hccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 22211 112234578899999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=312.96 Aligned_cols=253 Identities=29% Similarity=0.427 Sum_probs=202.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||.|+||.||+|++ +++.||+|.++..... ......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-------EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 46789999999999999999998 5789999998744321 11224566899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.. ...|+|+||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+|
T Consensus 77 ~~------------------~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~n 136 (293)
T cd07843 77 NL------------------DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSN 136 (293)
T ss_pred CC------------------CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence 21 23499999996 59999886543 368999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.++|+|||++..............+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......+..
T Consensus 137 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~ 216 (293)
T cd07843 137 LLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216 (293)
T ss_pred EEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999987654433333445678899999998754 4688999999999999999999999877655444
Q ss_pred HHHHhc-----------------------------cCCCCCCCC-CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 321 SAVVRQ-----------------------------NLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 321 ~~~~~~-----------------------------~~~~~~~~~-~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+... .+...++.. +++.+.++|.+||+.+|++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 332210 011122222 5888999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=306.63 Aligned_cols=237 Identities=25% Similarity=0.457 Sum_probs=190.8
Q ss_pred eeeccCCceEEEEEEECCe------------eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 91 HEIARGTYGTVYRGAYDGQ------------DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~g~------------~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
+.||+|+||.||+|.+.+. .|++|+++.... . ...|.+|+.+++.++||||+++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---------~-~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---------D-SLAFFETASLMSQLSHKHLVKLYGVC 70 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---------h-HHHHHHHHHHHHcCCCcchhheeeEE
Confidence 3699999999999988322 478887653211 0 46788899999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. ... ++|+||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++|||||
T Consensus 71 ~~-~~~--------------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlk 128 (259)
T cd05037 71 VR-DEN--------------------IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVC 128 (259)
T ss_pred ec-CCc--------------------EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCc
Confidence 75 332 89999999999999997643 268999999999999999999999999999999
Q ss_pred CCceeeCCCC-------cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC--CCCccchHHHHHHHHHHHHh-CC
Q 048724 239 TENMLLDANR-------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK--PYNRKCDVYSFGICLWEIYC-CD 308 (394)
Q Consensus 239 p~NIll~~~~-------~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ellt-g~ 308 (394)
|+||+++.++ .++|+|||++..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |.
T Consensus 129 p~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 129 GKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred cceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 9999999877 799999999875432 1224567789999999876 78999999999999999999 58
Q ss_pred CCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 309 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
.||............. .. ...+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 205 ~p~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 205 EPLSTLSSSEKERFYQ-DQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCcccCCchhHHHHHh-cC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 8887765443333222 21 1222223488999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=308.42 Aligned_cols=244 Identities=26% Similarity=0.400 Sum_probs=198.3
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||+|+||+||++.+ +|+.||+|++.... .........+..|+.++++++||||+++++.+...+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------ 68 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR------LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL------ 68 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh------hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE------
Confidence 69999999999987 68899999986432 11122245667899999999999999999998765544
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
|+|+||+++++|.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++.++.+
T Consensus 69 --------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~ 134 (277)
T cd05577 69 --------------CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV 134 (277)
T ss_pred --------------EEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 999999999999999976555579999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhc--cC
Q 048724 251 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ--NL 328 (394)
Q Consensus 251 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~--~~ 328 (394)
+|+|||.+..... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+... ..
T Consensus 135 ~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 213 (277)
T cd05577 135 RISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213 (277)
T ss_pred EEccCcchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc
Confidence 9999999875432 22223356788999999998888999999999999999999999999765432111111111 12
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVK 363 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~ 363 (394)
....+..+++.+.++|.+||+.+|++|| ++.+++.
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 3445567899999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.64 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=202.5
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|+||.||+|++ +|+.||+|++...... ......+.+|+.++++++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-------GGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-------chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 578899999999999999987 6789999998743311 1223567889999999999999999999876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++|+||+ +++|.+++.... ..+++.+++.++.||+.||.|||+.|++|+||||+||+
T Consensus 74 ~--------------------~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (286)
T cd07832 74 F--------------------VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131 (286)
T ss_pred e--------------------EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEE
Confidence 4 8999999 999999986543 56999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||..........
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 132 ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred EcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 9999999999999987544322 123345789999999998654 46889999999999999999988887765544433
Q ss_pred HHHhccCCC----------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRP----------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+......+ ......+..+.+++.+||+.+|++|||+++++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 332210000 0112457899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=326.31 Aligned_cols=245 Identities=26% Similarity=0.410 Sum_probs=195.6
Q ss_pred ccccccceeeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
...+|.+.+.||+|+||.||++.. .+..||+|.+... ..+.+|+.++++++||||+++++++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 346799999999999999999875 3468999987532 2235799999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...... |++||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 156 ~~~~~~--------------------~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk 212 (392)
T PHA03207 156 RWKSTV--------------------CMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212 (392)
T ss_pred eeCCEE--------------------EEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 765544 89999995 689888833 4569999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+|||++.++.++|+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+...
T Consensus 213 p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999999987543221 122235799999999999999999999999999999999999999965432
Q ss_pred h---hHHHHHHh-------------------------ccCCCCC--C-----CCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 317 T---DVSSAVVR-------------------------QNLRPDI--P-----RCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 317 ~---~~~~~~~~-------------------------~~~~~~~--~-----~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
. .....+.. ...++.. + ..++.++.++|.+||..||++|||+.++
T Consensus 293 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~ 372 (392)
T PHA03207 293 KSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372 (392)
T ss_pred CCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence 1 11111110 0011111 1 1346788999999999999999999999
Q ss_pred HHH
Q 048724 362 VKL 364 (394)
Q Consensus 362 l~~ 364 (394)
+..
T Consensus 373 l~~ 375 (392)
T PHA03207 373 LSL 375 (392)
T ss_pred hhC
Confidence 985
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=309.13 Aligned_cols=245 Identities=26% Similarity=0.467 Sum_probs=203.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|...+.||+|++|.||++.+ +++.|++|.++.... .....+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---------hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 455567899999999999987 678999998853211 113457789999999999999999999876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+++||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+
T Consensus 91 ~--------------------~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil 147 (285)
T cd06648 91 L--------------------WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL 147 (285)
T ss_pred E--------------------EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEE
Confidence 4 899999999999999865 45899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+
T Consensus 148 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~ 227 (285)
T cd06648 148 LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227 (285)
T ss_pred EcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 99999999999998875443333333356889999999999888999999999999999999999999877665555544
Q ss_pred HhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 324 VRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 324 ~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
... ..+.. +..++..+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 228 RDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Hhc-CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 332 22222 2337899999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.25 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=202.1
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||+|.+ +|+.||||.++...... ........+..|+.++++++|+||+++++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE----AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc----ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence 477888999999999999987 57899999997543211 112234566789999999999999999999986544
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ ++||||+ +++|.+++.... ..+++..++.++.||++||.|||++|++|+||+|+||+
T Consensus 77 ~--------------------~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 134 (298)
T cd07841 77 I--------------------NLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL 134 (298)
T ss_pred E--------------------EEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEE
Confidence 4 8999999 999999996543 36999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++.++.++|+|||+++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||......+....
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 135 IASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred EcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 999999999999999865443333344567888999998854 5678899999999999999999888877665443333
Q ss_pred HHhccCC---------------------C-----CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 323 VVRQNLR---------------------P-----DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 323 ~~~~~~~---------------------~-----~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+...... . ......+..+.++|.+||+.+|++|||+.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 215 IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 3211000 0 011235788999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.34 Aligned_cols=255 Identities=24% Similarity=0.467 Sum_probs=208.1
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCccee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTK 153 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~ 153 (394)
-+.+..+.++++.+..||.|+.|+|+++++ +|...|||.++.... ....+++...+.++... ++|+||+
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--------kee~kRILmDldvv~~s~dcpyIV~ 155 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--------KEENKRILMDLDVVLKSHDCPYIVQ 155 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--------HHHHHHHHHhhhHHhhccCCCeeee
Confidence 345667788999999999999999999988 689999999875431 12235666788877777 5999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTI 232 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~i 232 (394)
.+|+|..+... +|.||.| +..++.++++ -.+++++..+-++...++.||.||.. +||
T Consensus 156 c~GyFi~n~dV--------------------~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~v 213 (391)
T KOG0983|consen 156 CFGYFITNTDV--------------------FICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGV 213 (391)
T ss_pred eeeEEeeCchH--------------------HHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcce
Confidence 99999987776 6688888 4466666654 35679999999999999999999985 689
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCC
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~ 309 (394)
+|||+||+|||+|+.|++||||||++....+. ...+...|.+.|||||.+.- ..|+.++||||||++++||.||..
T Consensus 214 iHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~y 292 (391)
T KOG0983|consen 214 IHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQY 292 (391)
T ss_pred eecccCccceEEccCCCEEeecccccceeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccC
Confidence 99999999999999999999999999755433 33444689999999999953 468999999999999999999999
Q ss_pred CCCCC-ChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 310 PYPDL-SFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 310 Pf~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
||.+. ...++...+.. ...+.++ ..+++.+.+|+..||.+|+.+||...++++
T Consensus 293 Py~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 293 PYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 99874 34455555544 3344444 348999999999999999999999999886
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=312.43 Aligned_cols=255 Identities=29% Similarity=0.406 Sum_probs=203.3
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||.||+|.+ +|+.||+|.++....... ....+.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-------IPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-------CcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 367899999999999999999988 688999999874332110 11234579999999999999999999875
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... ..+++||||+. ++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+
T Consensus 78 ~~~------------------~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 137 (309)
T cd07845 78 KHL------------------DSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137 (309)
T ss_pred CCC------------------CeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 432 22489999996 5898888653 356899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||+++.++.++|+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+.
T Consensus 138 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~ 217 (309)
T cd07845 138 NLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217 (309)
T ss_pred HEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999865433233333456788999999865 5678999999999999999999999988776665
Q ss_pred HHHHHhccC-----------------CCCCC-----------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNL-----------------RPDIP-----------RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~-----------------~~~~~-----------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+..... ....+ ...++++.++|.+||+.||++|||+++++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 218 LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 554432100 00000 1247889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.73 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=201.1
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.+ +++.||+|.++.... .......+.+|++++++++|+||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 3688999999999999999988 578999998864321 1223467889999999999999999999997655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++++||++++.|..+... ...+++..++.++.||+.||.|||+++++|+||+|+||
T Consensus 74 ~~--------------------~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 131 (288)
T cd07833 74 RL--------------------YLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131 (288)
T ss_pred EE--------------------EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 44 899999998777665533 34589999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|++||......+..
T Consensus 132 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 132 LVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred EECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999875443322 22335678899999999887 8899999999999999999999999866544333
Q ss_pred HHHHhc--c--------------C--------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 321 SAVVRQ--N--------------L--------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 321 ~~~~~~--~--------------~--------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...... . . ....+..++.++.+++++||..+|++|||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 222110 0 0 00123345889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=308.56 Aligned_cols=250 Identities=27% Similarity=0.496 Sum_probs=209.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|++...||+|+||.||+|.+ ++..|++|+++.... ....+.+|+.+++.++|+|++++++.+...
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----------NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----------hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 46688889999999999999998 488999999874321 235677899999999999999999998866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 88 ~~~--------------------~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~n 146 (286)
T cd06614 88 DEL--------------------WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146 (286)
T ss_pred CEE--------------------EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhh
Confidence 554 89999999999999997643 369999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++..............++..|++||.+.+..++.++||||||+++|+|++|+.||...+......
T Consensus 147 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~ 226 (286)
T cd06614 147 ILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF 226 (286)
T ss_pred EEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999998754433222333467889999999998889999999999999999999999998776655554
Q ss_pred HHHhccCCC-CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRP-DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....... ..+..++..+.++|.+||+.+|.+|||+.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 227 LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 443333221 1223478999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=309.13 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=196.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.. +++.||||.++....... ...+.+|+.++++++|+||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--------PFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--------chhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 57899999999999999999987 678999999874332111 13356799999999999999999998866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|
T Consensus 76 ~~~--------------------~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~n 133 (291)
T cd07844 76 KTL--------------------TLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133 (291)
T ss_pred CeE--------------------EEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHH
Confidence 554 899999974 9999886543 368999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-hhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~-~~~~ 319 (394)
|+++.++.++|+|||+++.............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+.
T Consensus 134 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 213 (291)
T cd07844 134 LLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213 (291)
T ss_pred EEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 99999999999999998753322222233457889999999875 458899999999999999999999997654 2221
Q ss_pred HHHHHhc-------------------cCCCC---------CCCCCc--HHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQ-------------------NLRPD---------IPRCCP--SSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~-------------------~~~~~---------~~~~~~--~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+... ..... .....+ ..+.+++.+||+.+|++|||+.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 214 LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1111100 00000 001233 78889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=307.78 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=200.3
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|++.+.||.|++|.||+|.+ +|+.||+|+++..... ......+.+|+.+++.++|||++++++++.+....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-------EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-------ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence 56788999999999999987 6889999998743211 11124567899999999999999999998765544
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
|+++||++ ++|.+++.......+++..++.++.|++.||.|||+++++||||+|+||++
T Consensus 74 --------------------~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~ 132 (283)
T cd07835 74 --------------------YLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132 (283)
T ss_pred --------------------EEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE
Confidence 89999994 699999876554569999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
+.++.++|+|||++..............+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+.......+
T Consensus 133 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 133 DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999987543333333344678899999988654 5788999999999999999999999876654433332
Q ss_pred HhccCC---------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLR---------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~---------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...... ......++..+.+++.+||+.+|.+|||+++++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 221000 01123467899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=311.27 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=202.3
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|++.+.||+|+||+||+|+. +++.||+|.+...... .......+.+|+.+++.++||||++++++|.+..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC------cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 5688889999999999999987 6889999998643211 1122356788999999999999999999998655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+|+||++ |+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 89 ~~--------------------~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI 146 (307)
T cd06607 89 TA--------------------WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI 146 (307)
T ss_pred eE--------------------EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence 54 89999996 5777777543 34689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||++...... ....+++.|+|||.+. ...++.++||||||+++|+|++|+.||........
T Consensus 147 l~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 147 LLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred EECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 9999999999999998754322 2346788999999874 45688899999999999999999999987765554
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
...+.........+..++..+.++|.+||+.+|++||++.+++...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 223 LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 4443322222222345788999999999999999999999998854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=302.47 Aligned_cols=251 Identities=29% Similarity=0.558 Sum_probs=212.5
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|+||.||++.+ +++.|++|++...... ......+.+|+++++.++|+|++++.+.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-------EKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-------hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence 578889999999999999998 4889999998643211 1224567789999999999999999999876544
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. ++|+||+++++|.+++.... ...+++..+..++.+++.||.|||++|++|+||+|+|
T Consensus 74 ~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n 133 (258)
T cd08215 74 L--------------------CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133 (258)
T ss_pred E--------------------EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence 3 89999999999999997643 3679999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+...
T Consensus 134 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 213 (258)
T cd08215 134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL 213 (258)
T ss_pred eEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH
Confidence 99999999999999999754433222233568889999999998889999999999999999999999998877766666
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...... ...++..++..+.+++.+||+.+|++|||+.++++.
T Consensus 214 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 KILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 654433 445566789999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.36 Aligned_cols=249 Identities=28% Similarity=0.489 Sum_probs=195.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHH-HHhCCCCcceeeeeeecCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV-WQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~ 161 (394)
++|++.+.||+|+||.||++++ +|+.||+|.++..... .. ...+..|..+ ++.++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~ 72 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QE-----QKRLLMDLDISMRSVDCPYTVTFYGALFRE 72 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence 4788999999999999999988 6889999998743211 11 1234445554 6667999999999999765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVK 238 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiH~Dlk 238 (394)
... |+++||++ |+|.+++... ....+++..++.++.||+.||.|||++ +++|||||
T Consensus 73 ~~~--------------------~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlk 131 (283)
T cd06617 73 GDV--------------------WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK 131 (283)
T ss_pred CcE--------------------EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence 554 89999996 6898888653 234689999999999999999999997 99999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC----CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG----KPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|+||+++.++.+||+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 132 p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 132 PSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred HHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 999999999999999999987543221 1223468889999998865 45688999999999999999999999754
Q ss_pred Ch-hhHHHHHHhccCCCCCC-CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 315 SF-TDVSSAVVRQNLRPDIP-RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 315 ~~-~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.. .+...... ....+..+ ..+|.++.++|.+||..+|.+||++.++++.
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 211 KTPFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccCHHHHHHHH-hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 32 22222232 22233333 4578999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.75 Aligned_cols=249 Identities=25% Similarity=0.447 Sum_probs=204.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||+|+||+||++.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---------PKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---------hHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 47889999999999999999986 678999999853221 1135677899999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 89 ~~~--------------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~N 145 (293)
T cd06647 89 DEL--------------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 145 (293)
T ss_pred CcE--------------------EEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHH
Confidence 544 899999999999999854 348899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++..............+++.|++||.+.+..++.++||||||+++|++++|..||...+......
T Consensus 146 ili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred EEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 99999999999999988754433333333468889999999988889999999999999999999999998765443332
Q ss_pred HHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.... .....+..++..+.+++.+||..+|++||++.+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222111 1112234567889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.03 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=199.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGT 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 161 (394)
++|++.+.||+|+||.||+|.+ +++.||||.++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-------EGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-------cCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 4688999999999999999988 6889999987643211 11235677899999999 569999999988754
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
+.. ....+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++||||+
T Consensus 74 ~~~---------------~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~ 137 (295)
T cd07837 74 EKN---------------GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137 (295)
T ss_pred CCC---------------CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 431 11235899999975 8988886543 2468999999999999999999999999999999
Q ss_pred CCceeeCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 239 TENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 239 p~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+||+++. ++.++|+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.
T Consensus 138 ~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred hHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999998 889999999998754333333334467889999998865 5578999999999999999999999987655
Q ss_pred hhHHHHHHhccC----------------------CC----CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 317 TDVSSAVVRQNL----------------------RP----DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 317 ~~~~~~~~~~~~----------------------~~----~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
......+...-. .+ .....++.++.++|.+||+.||.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 218 LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 443333221100 00 001246889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.76 Aligned_cols=262 Identities=32% Similarity=0.610 Sum_probs=224.4
Q ss_pred ccccccccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 148 (394)
.|++..+++.+.+.||+|.||.|++|... ...||||.++..... ...+.+..|+++|+.+ +|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--------~~~~~~~~El~~m~~~g~H 361 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--------SEKKDLMSELNVLKELGKH 361 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--------HHHHHHHHHHHHHHHhcCC
Confidence 79999999999999999999999998642 347999998744321 2357888999999999 79
Q ss_pred CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc------c--------CCCCHHHHH
Q 048724 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK------R--------KKLAFKVVI 214 (394)
Q Consensus 149 ~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~------~--------~~l~~~~~~ 214 (394)
+||+.++|+|.....+ ++|+||+..|+|.++++.++ . ..++...++
T Consensus 362 ~niv~llG~~t~~~~~--------------------~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLl 421 (609)
T KOG0200|consen 362 PNIVNLLGACTQDGPL--------------------YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLL 421 (609)
T ss_pred cchhhheeeeccCCce--------------------EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHH
Confidence 9999999999875554 89999999999999998654 0 138899999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCC--CCCCcCCccccCCCCCCcc
Q 048724 215 QIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGET--GTLGYMAPEVLDGKPYNRK 291 (394)
Q Consensus 215 ~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~--gt~~y~aPE~~~~~~~~~~ 291 (394)
.++.||+.||+||++.++|||||..+|||++.+..+||+|||+++...... ....... -+..|||||.+....|+.+
T Consensus 422 sfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 422 SFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred HHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc
Confidence 999999999999999999999999999999999999999999998433221 1111122 3567999999999999999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCC-hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 292 CDVYSFGICLWEIYC-CDMPYPDLS-FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 292 ~DvwslG~~l~ellt-g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
+||||||++|||+++ |..||++.. ..++ ...++.+.+.+.|..|++++.++|+.||+.+|++||++.++.+.++...
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 999999999999998 789999876 5555 4477889999999999999999999999999999999999999999853
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.73 Aligned_cols=243 Identities=24% Similarity=0.395 Sum_probs=183.8
Q ss_pred eeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 91 HEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
.+||+|+||+||+|+. ++..||+|.++.... ...+.+|+.++++++||||+++++++.....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----------SMSACREIALLRELKHPNVIALQKVFLSHSD--- 72 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---
Confidence 5799999999999986 346899998863221 1346689999999999999999999864332
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN-------KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..+|+|+||+. ++|.+++... ....+++..++.++.||+.||.|||++|++||||||
T Consensus 73 ---------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp 136 (317)
T cd07867 73 ---------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKP 136 (317)
T ss_pred ---------------CeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCH
Confidence 23489999995 5888877532 123588999999999999999999999999999999
Q ss_pred Cceee----CCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 240 ENMLL----DANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 240 ~NIll----~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
+|||+ +.++.+||+|||+++....... ......+|+.|+|||.+.+ ..++.++|||||||++|||+||++||
T Consensus 137 ~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 137 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred HHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 99999 4567899999999985433221 2233568899999999876 45889999999999999999999999
Q ss_pred CCCChhh---------HHHHHHh-----------------------ccC-CC------------CCCCCCcHHHHHHHHH
Q 048724 312 PDLSFTD---------VSSAVVR-----------------------QNL-RP------------DIPRCCPSSLASIMRK 346 (394)
Q Consensus 312 ~~~~~~~---------~~~~~~~-----------------------~~~-~~------------~~~~~~~~~l~~li~~ 346 (394)
....... ....+.. ... .. ......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 6432110 0000000 000 00 0011235678899999
Q ss_pred hchhCCCCCCCHHHHHH
Q 048724 347 CWDANPDKRPVMDEVVK 363 (394)
Q Consensus 347 cL~~dP~~Rpt~~~ll~ 363 (394)
||+.||.+|||+.++++
T Consensus 297 ~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 297 LLTMDPTKRITSEQALQ 313 (317)
T ss_pred HhccCcccccCHHHHhc
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=308.12 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=200.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|++|+||+|.+ +|+.||+|.++..... ......+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-------ccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 6789999999999999999987 6789999988643211 112356778999999999999999999998665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+||||++ ++|.+++.......+++..++.++.||+.||+|||+++++|+||+|+||
T Consensus 75 ~~--------------------~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~ni 133 (294)
T PLN00009 75 RL--------------------YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133 (294)
T ss_pred eE--------------------EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceE
Confidence 54 89999995 5888888655544578899999999999999999999999999999999
Q ss_pred eeCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 243 LLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 243 ll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
+++. ++.+||+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||......+..
T Consensus 134 ll~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~ 213 (294)
T PLN00009 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL 213 (294)
T ss_pred EEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9985 567999999999754333333334567889999998865 45788999999999999999999999876655444
Q ss_pred HHHHhccCC-------------------CC--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLR-------------------PD--------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~-------------------~~--------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
......... +. .....++++.+++.+||+.+|++||++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 214 FKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 333211000 00 113467889999999999999999999999873
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=330.09 Aligned_cols=246 Identities=28% Similarity=0.490 Sum_probs=204.0
Q ss_pred ceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
-.-+||+|+||+||-|++ +....|||-+..... ...+-+.+|+.+-++|+|.|||+++|.|..+..+
T Consensus 579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---------r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~-- 647 (1226)
T KOG4279|consen 579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---------REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFF-- 647 (1226)
T ss_pred ceEEeecCceeEEEeeccccceeEEEeeecccccc---------hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeE--
Confidence 345799999999999988 556789998763321 2236678899999999999999999998765554
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL--AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
-|.||.++||+|.++|+.+ =+++ ++.++-.+.+||++||.|||++.|||||||-+||||
T Consensus 648 ------------------kIFMEqVPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv 708 (1226)
T KOG4279|consen 648 ------------------KIFMEQVPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV 708 (1226)
T ss_pred ------------------EEEeecCCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE
Confidence 6899999999999999753 2456 888999999999999999999999999999999999
Q ss_pred C-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChhh-HH
Q 048724 245 D-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD-VS 320 (394)
Q Consensus 245 ~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~-~~ 320 (394)
+ -.|.+||+|||-++....-....-+..||.-|||||++.. ..|..++|||||||++.||.||++||-...... -.
T Consensus 709 NTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM 788 (1226)
T KOG4279|consen 709 NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM 788 (1226)
T ss_pred eeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh
Confidence 6 4789999999999865554444555789999999999975 468999999999999999999999996553322 22
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+.--+..+++|..++.+.+++|.+|+.++|.+||+++++|..
T Consensus 789 FkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 789 FKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 22222235788999999999999999999999999999999973
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.78 Aligned_cols=252 Identities=29% Similarity=0.536 Sum_probs=209.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|++|.||+|.. +++.|++|+++..... ......+.+|+.++++++||||+++++.+.....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-------EEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 467788999999999999998 5889999998744321 2234678899999999999999999999876521
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
...++++||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus 74 ------------------~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~ 133 (260)
T cd06606 74 ------------------NTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANIL 133 (260)
T ss_pred ------------------CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 22389999999999999997643 7999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-hhhHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FTDVS 320 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~-~~~~~ 320 (394)
++.++.++|+|||.+........ ......++..|++||.+.+..++.++||||||+++|+|++|..||.... .....
T Consensus 134 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (260)
T cd06606 134 VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213 (260)
T ss_pred EcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 99999999999999986544322 1234578899999999998889999999999999999999999998765 22222
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+........++..++..+.+++.+||+.+|++||++.+++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 214 YKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22222234456677789999999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.19 Aligned_cols=248 Identities=29% Similarity=0.531 Sum_probs=209.7
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|++|.||+++. +++.|++|.+...... ......+.+|++++++++|+|++++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence 477889999999999999987 5789999998744311 1234678899999999999999999999876544
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++++||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+
T Consensus 74 ~--------------------~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (254)
T cd06627 74 L--------------------YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131 (254)
T ss_pred E--------------------EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence 3 8999999999999998654 56999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||.+..............++..|+|||.+.+..++.++|||+||+++|+|++|..||............
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (254)
T cd06627 132 TTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211 (254)
T ss_pred ECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 99999999999999986544333333457889999999998888899999999999999999999999876654444443
Q ss_pred HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 324 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
. .......+..++..+.+++.+||..+|++|||+.+++.
T Consensus 212 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3 23345566778999999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=306.02 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=194.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|.+.+.||+|+||.||+|.. +|+.||+|+++...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--------VPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--------CcHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 46789999999999999999987 68899999986432211 113456799999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus 76 ~~~--------------------~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~N 133 (291)
T cd07870 76 ETL--------------------TFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQN 133 (291)
T ss_pred CeE--------------------EEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 544 89999995 67877775432 457888899999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChh-hH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFT-DV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~-~~ 319 (394)
|+++.++.++|+|||+++.............+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... +.
T Consensus 134 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 134 LLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred EEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 999999999999999987543333333345678999999998754 5788999999999999999999999765432 11
Q ss_pred HHHHHh-c---------------cCCCCC-----C---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVR-Q---------------NLRPDI-----P---------RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~-~---------------~~~~~~-----~---------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...... . ...... + ...+.++.+++.+||+.||++|||+.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 111100 0 000000 0 012578999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=305.63 Aligned_cols=252 Identities=27% Similarity=0.477 Sum_probs=201.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|+..+.||.|++|.||++.+ +++.||+|.+..... ......+.+|++++++++||||++++++|.+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--------PDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 3678899999999999999988 678999999864321 122466788999999999999999999986543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
. ...|+||||+++++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+
T Consensus 73 ~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~ 134 (287)
T cd06621 73 S------------------SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPS 134 (287)
T ss_pred C------------------CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 2 2348999999999999987542 2356889999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-----
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS----- 315 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~----- 315 (394)
||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 135 nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (287)
T cd06621 135 NILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212 (287)
T ss_pred HEEEecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC
Confidence 9999999999999999986433221 123457889999999998899999999999999999999999997652
Q ss_pred hhhHHHHHHhccCCCCCC------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIP------RCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
..+....+... ..+..+ ...++.+.+++.+||..+|++|||+.++++.-
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 213 PIELLSYIVNM-PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred hHHHHHHHhcC-CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 22222222221 111111 23467899999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.45 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=207.1
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|+..+.||+|+||.||+|++ ++..||+|.+...... .......+..|+.++++++|||++++++++.+..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ------SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC------chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3477788999999999999987 6789999998643221 1122356788999999999999999999988655
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++||||++ |+|.+++... ..++++..+..++.|++.||.|||++|++||||+|+||
T Consensus 99 ~~--------------------~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni 156 (317)
T cd06635 99 TA--------------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156 (317)
T ss_pred eE--------------------EEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence 54 89999996 5787777543 35689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||++..... .....+++.|+|||.+. +..++.++||||||+++|+|++|+.||........
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 157 LLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred EECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 999999999999999864322 22346888999999973 45688899999999999999999999987766665
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
...+............+++.+.+++.+||+.+|.+||++.++++.+..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 55555544433344567889999999999999999999999998766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=300.11 Aligned_cols=249 Identities=33% Similarity=0.571 Sum_probs=209.6
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|+||.||++++ +++.+|+|.+..... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-------SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence 478889999999999999987 678999999864321 11224566789999999999999999998876544
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. |+|+||+++++|.+++.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 74 ~--------------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~n 133 (256)
T cd08530 74 L--------------------CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133 (256)
T ss_pred E--------------------EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 4 89999999999999986522 3468999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++...... ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+......
T Consensus 134 i~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~ 211 (256)
T cd08530 134 ILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211 (256)
T ss_pred EEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999865443 2223568899999999999999999999999999999999999998887766665
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.. ...+..+..++.++.+++.+||+.+|++|||+.+++..
T Consensus 212 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 212 KVQR-GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHhc-CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 5543 33344556789999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=302.82 Aligned_cols=243 Identities=27% Similarity=0.450 Sum_probs=200.9
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||.|+||.||++++ +|+.|++|+++... .........+.+|+.++++++||||+++++.+......
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~------ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD------MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL------ 68 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh------hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE------
Confidence 68999999999998 48899999986332 12233456788899999999999999999888755444
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
|+++||+++++|.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+
T Consensus 69 --------------~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~ 132 (265)
T cd05579 69 --------------YLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132 (265)
T ss_pred --------------EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCE
Confidence 89999999999999996543 68999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCC--------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 251 KIADFGVARVEAQNPR--------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 251 kl~DFG~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
+|+|||++........ ......++..|++||...+..++.++||||||+++|++++|..||......+....
T Consensus 133 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (265)
T cd05579 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN 212 (265)
T ss_pred EEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999875332211 22334678899999999888899999999999999999999999988887777666
Q ss_pred HHhccCCCCCCCCC--cHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 323 VVRQNLRPDIPRCC--PSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 323 ~~~~~~~~~~~~~~--~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
+..... ..+..+ +..+.+++.+||+.+|.+|||+..+.+.|
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 213 ILNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HhcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 654333 233334 89999999999999999999994444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=305.18 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=200.6
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|++|.||+|++ +|+.||||.++...... ....+.+|+.++++++|+||+++++.+.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--------TPSTAIREISLMKELKHENIVRLHDVIHTENK 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--------chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence 578899999999999999998 68899999987543211 12456679999999999999999999987655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. ++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||
T Consensus 73 ~--------------------~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni 131 (284)
T cd07836 73 L--------------------MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNL 131 (284)
T ss_pred E--------------------EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 4 899999975 8988886543 34689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
++++++.++|+|||++..............++..|++||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+...
T Consensus 132 ~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 211 (284)
T cd07836 132 LINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211 (284)
T ss_pred EECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999999754333233334567889999998865 457889999999999999999999998776555444
Q ss_pred HHHhcc----------------CCCCC-----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQN----------------LRPDI-----------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~----------------~~~~~-----------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+.... +.... ...++..+.+++.+||+.||++||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 332110 00011 1235788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.73 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=221.5
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
+..+..++|+++++||+|+||.|.++++ +++.||+|++++-.. ........|..|-.+|..-+.+.||.++-
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM------lKr~~tA~F~EERDimv~~ns~Wiv~Lhy 142 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM------LKRAETACFREERDIMVFGNSEWIVQLHY 142 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH------hhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence 4567789999999999999999999988 788999999874221 11222477889999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|.+..++ |+||||++||+|..++.+.. ++++..+..++..|+.||.-||+.|+||||
T Consensus 143 AFQD~~~L--------------------YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRD 200 (1317)
T KOG0612|consen 143 AFQDERYL--------------------YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRD 200 (1317)
T ss_pred HhcCccce--------------------EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceecc
Confidence 99988887 89999999999999997654 699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeecccccccc-CCCCCccCCCCCCCcCCccccC----C-CCCCccchHHHHHHHHHHHHhCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEA-QNPRDMTGETGTLGYMAPEVLD----G-KPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~-~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~elltg~~P 310 (394)
|||+|||||..|++||+|||.+-... +........+|||.|++||++. + +.|+..+|+||+||++|||++|..|
T Consensus 201 iKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 201 IKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred CCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 99999999999999999999876544 3334455679999999999995 3 5699999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCC---HHHHHHH
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPV---MDEVVKL 364 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt---~~~ll~~ 364 (394)
|...+..+.+..|+...-...+| ..+|.+.++||.+.+. +|+.|.. ++++...
T Consensus 281 FYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 281 FYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 99999999999998775555555 4589999999999887 7888887 8887763
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=301.20 Aligned_cols=241 Identities=24% Similarity=0.401 Sum_probs=194.0
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHH-HHhCCCCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV-WQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||.|+||.||+|.+ +++.||+|+++.... ........+..|..+ ....+|+|++++++++...+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~--- 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM------IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL--- 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh------hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE---
Confidence 4699999999999988 678999999863321 111112233445444 4455899999999999766554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+
T Consensus 73 -----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~ 133 (260)
T cd05611 73 -----------------YLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT 133 (260)
T ss_pred -----------------EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 8999999999999999653 468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Q 048724 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~ 327 (394)
+.++|+|||++..... .....++..|++||.+.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus 134 ~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 134 GHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred CcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 9999999999875332 223468889999999988888999999999999999999999998887776665554433
Q ss_pred CC--CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 328 LR--PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 328 ~~--~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.. ......++..+.+++.+||+.+|++||++.++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 22 2233468999999999999999999997654444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=308.16 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=196.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 160 (394)
.++|+..+.||+|+||.||++.+ +++.||+|.+...... .....+.+|+.++.++. |+||+++++++..
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 45777888999999999999988 6789999998643211 22456788999999995 9999999998876
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHH---HhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL---IRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRD 236 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l---~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiH~D 236 (394)
.... +++|||+. ++|.++. .......+++..+..++.|++.||+|||+. +++|||
T Consensus 75 ~~~~--------------------~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 133 (288)
T cd06616 75 EGDC--------------------WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133 (288)
T ss_pred CCcE--------------------EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccC
Confidence 5443 88999985 4665543 223345799999999999999999999974 999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC---CCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK---PYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
|||+||+++.++.++|+|||+++...... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..
T Consensus 134 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 134 VKPSNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred CCHHHEEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 99999999999999999999987543221 22234688899999999765 688999999999999999999999976
Q ss_pred CChh-hHHHHHHhcc---CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 314 LSFT-DVSSAVVRQN---LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 314 ~~~~-~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.... +......... .....+..++.++.+|+.+||+.+|++|||+++++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 213 WNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5421 1111111111 1111223478999999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=305.63 Aligned_cols=249 Identities=28% Similarity=0.451 Sum_probs=208.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGT 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~ 161 (394)
++|.+.+.||+|+||.||+|+. +++.||+|++..... ........+.+|+.++++++ |+||+++++++.+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL------IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc------cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence 4688999999999999999988 688999999864221 11122366778999999998 99999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 75 ~~~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~n 132 (280)
T cd05581 75 ENL--------------------YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132 (280)
T ss_pred ceE--------------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 554 8999999999999999654 369999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC--------------------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP--------------------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l 301 (394)
|+++.++.++|+|||++....... .......++..|+|||...+..++.++||||||+++
T Consensus 133 i~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 212 (280)
T cd05581 133 ILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212 (280)
T ss_pred eEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHH
Confidence 999999999999999987543322 112234578899999999888899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH----HHHHH
Q 048724 302 WEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM----DEVVK 363 (394)
Q Consensus 302 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~----~~ll~ 363 (394)
+++++|..||.............. ....++..++..+.+++.+||+.+|++||++ ++++.
T Consensus 213 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 213 YQMLTGKPPFRGSNEYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHhCCCCCCCccHHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 999999999988776555544432 3345666789999999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=315.01 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=199.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||++...... ......+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-------VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-------hhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 47899999999999999999987 7889999998632211 11124566799999999999999999998754
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ......|+||||+. ++|.+.+... +++..+..++.|++.||+|||++|++||||||+|
T Consensus 88 ~~~--------------~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 88 KSL--------------EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred CCc--------------cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 332 01134589999995 5888887432 8899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+......
T Consensus 149 il~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 149 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred EEECCCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999999999754332 22233567889999999999999999999999999999999999998765433332
Q ss_pred HHHhccC--------------------CC---------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 322 AVVRQNL--------------------RP---------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 322 ~~~~~~~--------------------~~---------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
.+...-. ++ ..+...+..+.++|.+||+.||++|||+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 2211000 00 001134667899999999999999999999
Q ss_pred HHHH
Q 048724 361 VVKL 364 (394)
Q Consensus 361 ll~~ 364 (394)
++..
T Consensus 308 iL~~ 311 (353)
T cd07850 308 ALQH 311 (353)
T ss_pred HhcC
Confidence 9975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=295.41 Aligned_cols=247 Identities=30% Similarity=0.596 Sum_probs=205.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||+|++|.||++.+ +++.+++|+++.... .....+.+|+.++++++|+|++++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 477888999999999999998 478999999874321 224678889999999999999999999876544
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. ++++||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 72 ~--------------------~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~ 130 (253)
T cd05122 72 L--------------------WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130 (253)
T ss_pred E--------------------EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEE
Confidence 4 89999999999999986643 46899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.++|+|||.+........ .....++..|++||.+.+..++.++||||||+++|+|++|..||...+........
T Consensus 131 i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 131 LTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred EccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 99999999999999875443321 23457889999999999888999999999999999999999999877554444333
Q ss_pred HhccCCCCCCC--CCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLRPDIPR--CCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~~~~~~--~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.. ......+. .++..+.+++.+||+.||++|||+.++++.
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 210 AT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Hh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33 22222332 248899999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=302.32 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=190.0
Q ss_pred eeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHH---HHHhCCCCcceeeeeeecCCCcccc
Q 048724 92 EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA---VWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~---il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
.||+|+||.||++.. +++.||+|.++........ . ...+.+|.. ++...+||||+.+++++...+..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-- 72 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---G---ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL-- 72 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch---H---HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE--
Confidence 489999999999987 6789999998643321111 0 122333433 33344799999999998765554
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~ 246 (394)
++||||+++++|.+++..+ ..+++..+..++.|++.||.|||+++++||||||+||+++.
T Consensus 73 ------------------~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~ 132 (279)
T cd05633 73 ------------------CFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE 132 (279)
T ss_pred ------------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC
Confidence 8999999999999988653 46999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH-HHH
Q 048724 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS-AVV 324 (394)
Q Consensus 247 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~-~~~ 324 (394)
++.++|+|||++...... ......|++.|+|||.+. +..++.++|||||||++|+|++|..||.......... ...
T Consensus 133 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 210 (279)
T cd05633 133 HGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (279)
T ss_pred CCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH
Confidence 999999999998643322 122346899999999986 4568899999999999999999999996543222111 111
Q ss_pred hccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 325 RQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 325 ~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
.......++..+++++.++|.+||+.||++|| +++++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22234456677899999999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=312.50 Aligned_cols=266 Identities=26% Similarity=0.331 Sum_probs=206.2
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
.+|.+.+.||+|+||+||+|++ +++.||||.++..... ......+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-------RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-------cchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 5789999999999999999987 6889999998643211 111244567999999999999999999876433
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. .....|+|+||+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||
T Consensus 78 ~~---------------~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Ni 139 (337)
T cd07858 78 RE---------------AFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 139 (337)
T ss_pred cc---------------ccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 21 1123599999995 7899888543 4699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
+++.++.+||+|||++..............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+......
T Consensus 140 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 219 (337)
T cd07858 140 LLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK 219 (337)
T ss_pred EEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence 9999999999999999754433223334567889999998864 468899999999999999999999997655333222
Q ss_pred HHHhc-----------------------c---CCC---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHHHh
Q 048724 322 AVVRQ-----------------------N---LRP---DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAVNT 370 (394)
Q Consensus 322 ~~~~~-----------------------~---~~~---~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~~~ 370 (394)
.+... . ... .....+++++.++|.+||+.+|++|||++++++. +..+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 220 LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 11100 0 000 1123578899999999999999999999999987 777655
Q ss_pred ccCCC
Q 048724 371 SKGGG 375 (394)
Q Consensus 371 ~~~~~ 375 (394)
.....
T Consensus 300 ~~~~~ 304 (337)
T cd07858 300 PSDEP 304 (337)
T ss_pred cccCc
Confidence 54433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=320.03 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=225.6
Q ss_pred ccccccccceeeeccCCceEEEEEEECCee--EEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYDGQD--VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+.+.+++++..||-||||.|-+...+++. +|+|++++..- .. ....+.+..|-.||..++.|.||++|..|
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--Vd----tkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--VD----TKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--cc----hhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 566789999999999999999998886554 89999985432 11 12246677899999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+...+ |++||-|-||.|+..|++ ++.++......++..+++|+.|||++|||+||||
T Consensus 490 rd~kyv--------------------YmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLK 547 (732)
T KOG0614|consen 490 RDSKYV--------------------YMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLK 547 (732)
T ss_pred ccchhh--------------------hhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCC
Confidence 887776 889999999999999955 5679999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+|++++.+|.+||.|||+|+....... ..+.||||.|.|||++.++..+.++|.||||+++|||++|.+||.+.+...
T Consensus 548 PENllLd~~Gy~KLVDFGFAKki~~g~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 548 PENLLLDNRGYLKLVDFGFAKKIGSGRK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred hhheeeccCCceEEeehhhHHHhccCCc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 9999999999999999999998766544 445899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKLL 365 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~l 365 (394)
.+..++++--...+|..++....+||+++...+|.+|.. ..+|.+.-
T Consensus 627 tYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 627 TYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 999888877677889999999999999999999999974 56666543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.63 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=202.8
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC--CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD--GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKF 154 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 154 (394)
.+|.+..++|++.+.||+|+||.||+|.+. ++.||||.++..... .....+..|+.++.+. +||||+++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~~i~~~ 79 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--------EENKRILMDLDVVLKSHDCPYIVKC 79 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--------HHHHHHHHHHHHHHhccCCCchHhh
Confidence 457888999999999999999999999984 889999998743211 1124455677666666 59999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIV 233 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~ii 233 (394)
++++.+.... |++|||+. ++|.+++... ...+++..+..++.|++.||+|||+ .|++
T Consensus 80 ~~~~~~~~~~--------------------~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~ 137 (296)
T cd06618 80 YGYFITDSDV--------------------FICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVI 137 (296)
T ss_pred heeeecCCeE--------------------EEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEe
Confidence 9999876554 89999984 5787776553 3479999999999999999999997 6999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC----CCccchHHHHHHHHHHHHhCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP----YNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~ 309 (394)
||||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.
T Consensus 138 H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred cCCCcHHHEEEcCCCCEEECccccchhccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999987543222 222346788999999987553 7889999999999999999999
Q ss_pred CCCCCCh-hhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 310 PYPDLSF-TDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 310 Pf~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
||..... .+....+.... .+..+ ..++.++.+|+.+||+.||++||++.+++..-.
T Consensus 217 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 217 PYKNCKTEFEVLTKILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCcchhHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 9976432 23333333322 22222 347899999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.03 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=200.8
Q ss_pred ceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
....||+|+||.||++.. +++.||||.+.... ......+.+|+.+++.++|+||+++++.+...+..
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 92 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL-- 92 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE--
Confidence 346799999999999987 68899999875221 11245688899999999999999999998866554
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~ 246 (394)
|+||||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.
T Consensus 93 ------------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~ 151 (292)
T cd06657 93 ------------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH 151 (292)
T ss_pred ------------------EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 899999999999998743 35899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhc
Q 048724 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326 (394)
Q Consensus 247 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~ 326 (394)
++.++|+|||++..............+++.|++||.+.+..++.++|+||||+++|+|++|..||...........+ ..
T Consensus 152 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~ 230 (292)
T cd06657 152 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RD 230 (292)
T ss_pred CCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh
Confidence 99999999999865433322233356889999999998888899999999999999999999999876655544433 22
Q ss_pred cCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 327 NLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 327 ~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..... ....++..+.+++.+||+.+|.+||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 231 NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred hCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 22222 224578999999999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=312.44 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=201.2
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|++ +|+.||||.++.... ......+.+|+.++++++|+||+++++++....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--------QTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--------chhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 6899999999999999999987 688999999863211 112355678999999999999999998876543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. .....|+++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 77 ~~---------------~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Ni 137 (336)
T cd07849 77 FE---------------SFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNL 137 (336)
T ss_pred cc---------------ccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 21 1134589999996 588877743 4599999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+++.++.++|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...
T Consensus 138 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred EECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999875432211 1123467899999998754 568899999999999999999999997765433
Q ss_pred HHHHHHhc------------------------cCCCCC-----CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHH
Q 048724 319 VSSAVVRQ------------------------NLRPDI-----PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEA 367 (394)
Q Consensus 319 ~~~~~~~~------------------------~~~~~~-----~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~ 367 (394)
....+... ...... ....+.++.++|.+||+.+|++|||+.++++. ++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 218 QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 22211100 000000 12357789999999999999999999999996 666
Q ss_pred HHhc
Q 048724 368 VNTS 371 (394)
Q Consensus 368 ~~~~ 371 (394)
+...
T Consensus 298 ~~~~ 301 (336)
T cd07849 298 YHDP 301 (336)
T ss_pred cCCC
Confidence 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.02 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=192.0
Q ss_pred cccccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHH--HHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAE--AAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+...+|++.+.||+|+||+||+|.+. +..+|+|+............. ..........+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 44578999999999999999999873 346777765433221111000 00011122334455667799999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++....... ...+++++++. .++.+.+... ...++..+..|+.|++.||.|||+++++|
T Consensus 89 ~~~~~~~~~~~----------------~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 149 (294)
T PHA02882 89 YGCGSFKRCRM----------------YYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISH 149 (294)
T ss_pred EEeeeEecCCc----------------eEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 98765433210 12267888874 4777776442 34678889999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg 307 (394)
|||||+|||++.++.++|+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999997543211 111224699999999999999999999999999999999999
Q ss_pred CCCCCCCCh-hhHHHHH----HhccCCC-CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 308 DMPYPDLSF-TDVSSAV----VRQNLRP-DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 308 ~~Pf~~~~~-~~~~~~~----~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
..||..... ....... ...-... .....++..+.+++..||..+|++||++.++++.|+
T Consensus 230 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 999987632 2211111 1110011 122457899999999999999999999999998763
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=313.97 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=202.5
Q ss_pred cccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFI 155 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 155 (394)
+...+.-..|+++++||+||.+.||++.. +.+.||+|.+.... .......-|..|+.+|.+| .|.+||+++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-------ADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-------cCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 45667788999999999999999999988 45678888764322 2233457789999999999 699999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
++-..++.+ |+||||- ..+|..+|.++......+ .+..+..|++.++.++|+.||||-
T Consensus 427 DYEv~d~~l--------------------YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~gIVHS 484 (677)
T KOG0596|consen 427 DYEVTDGYL--------------------YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHGIVHS 484 (677)
T ss_pred eeeccCceE--------------------EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhceeec
Confidence 998765555 9999997 569999997765443334 788899999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCC--ccCCCCCCCcCCccccCCC-----------CCCccchHHHHHHHHH
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLDGK-----------PYNRKCDVYSFGICLW 302 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~ 302 (394)
||||.|+|+= .|.+||+|||+|.....+... ....+||+.||+||.+... ..+.++|||||||+||
T Consensus 485 DLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILY 563 (677)
T KOG0596|consen 485 DLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILY 563 (677)
T ss_pred CCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHH
Confidence 9999999985 578999999999865543321 2346899999999998532 2557999999999999
Q ss_pred HHHhCCCCCCCCC-hhhHHHHHHhccCCCCCCCCCc-HHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 303 EIYCCDMPYPDLS-FTDVSSAVVRQNLRPDIPRCCP-SSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 303 elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+|+.|+.||.... .-.-...+..-+..-++|..-+ .++.++|+.||.+||++||+..++|..
T Consensus 564 qMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 564 QMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 9999999997654 2222333333333335554333 349999999999999999999999863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=296.00 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=205.6
Q ss_pred ccccc-eeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 85 AKLDI-RHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 85 ~~~~~-~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
++|.+ .++||-|-.|.|..+.+ +|+.+|+|++... ...++|+++--.. .|||||.++++|.+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 45544 35799999999998877 7899999998521 3445788775555 79999999999864
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.-.. -..+.+|||+++||.|...+..+....+++.++..|+.||..|+.|||+.+|.||||||+
T Consensus 127 s~~~----------------rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpE 190 (400)
T KOG0604|consen 127 SYQG----------------RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPE 190 (400)
T ss_pred hccC----------------ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChh
Confidence 3221 234468999999999999999888888999999999999999999999999999999999
Q ss_pred ceeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-
Q 048724 241 NMLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF- 316 (394)
Q Consensus 241 NIll~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~- 316 (394)
|+|.+. +..+||+|||+|+... ......+.+.||.|.|||++....|+..+|+||+|+++|-|++|.+||.....
T Consensus 191 NLLyt~t~~na~lKLtDfGFAK~t~-~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 191 NLLYTTTSPNAPLKLTDFGFAKETQ-EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred heeeecCCCCcceEecccccccccC-CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 999964 5679999999998543 24556678999999999999999999999999999999999999999965442
Q ss_pred ---hhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 317 ---TDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 317 ---~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
..+...+..+.+.++-+ .++|...+++|+++|..+|.+|.|+++++..-+
T Consensus 270 aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 270 AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 23444554554443333 467899999999999999999999999987543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=298.33 Aligned_cols=253 Identities=30% Similarity=0.508 Sum_probs=204.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|.+.+.||+|+||+||++++ .+..+++|+++.......... ....+..|+.+++.++||||+++++.+.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN----ETVQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcc----hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 478889999999999999988 345677777654322111111 12345678999999999999999998876554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. ++|+||+++++|.+++.. .....+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 77 ~--------------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~n 136 (260)
T cd08222 77 F--------------------CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN 136 (260)
T ss_pred e--------------------EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhh
Confidence 4 899999999999998864 234569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++. +.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 137 ili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~ 215 (260)
T cd08222 137 IFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215 (260)
T ss_pred eEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 99975 56999999998764433333334567889999999988888999999999999999999999998766655554
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+. ....+..+..++.++.++|.+||..+|++||++.++++.
T Consensus 216 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 RIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 443 333445566789999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=299.82 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=191.1
Q ss_pred eeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHH---HHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 92 EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE---VAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E---~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
.||+|+||.||+|.. +++.||+|.+........ ... ..+..| ..+++..+||||+++++++...+..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-- 72 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGE---TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL-- 72 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc---hhH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE--
Confidence 489999999999987 678999999864321110 111 112233 3445556899999999998866554
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~ 246 (394)
|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.
T Consensus 73 ------------------~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~ 132 (278)
T cd05606 73 ------------------SFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 132 (278)
T ss_pred ------------------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC
Confidence 899999999999998854 346999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh---hhHHHH
Q 048724 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSF---TDVSSA 322 (394)
Q Consensus 247 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~---~~~~~~ 322 (394)
++.++|+|||++...... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ......
T Consensus 133 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~ 210 (278)
T cd05606 133 HGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (278)
T ss_pred CCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Confidence 999999999998743322 12235789999999999754 688999999999999999999999976632 222222
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
.......++..++.++.+++.+||..+|.+|| ++.++++.
T Consensus 211 --~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 211 --TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 22234556677899999999999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=303.46 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=202.9
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
...++|++.+.||+|+||.||+|.+ +|+.||+|+++...... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~ 76 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-------GFPITAIREIKILRQLNHRNIVNLKEIVT 76 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-------CchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence 4568899999999999999999998 57899999987543211 11245668999999999999999999987
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+..... ........+|+|+||+++ +|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|
T Consensus 77 ~~~~~~----------~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p 144 (302)
T cd07864 77 DKQDAL----------DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144 (302)
T ss_pred Ccchhh----------hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 654210 001122356999999975 777777543 34689999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
+||+++.++.+||+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||......
T Consensus 145 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999987543322 12222356788999998865 45788999999999999999999999876554
Q ss_pred hHHHHHHhccCCC----------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 318 DVSSAVVRQNLRP----------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+....+......+ .....+|..+.+++.+||+.+|++|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 225 AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4333332210000 011246889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=298.90 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=193.2
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTN 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 163 (394)
|++.+.||+|+||.||+|.. +++.||+|.++...... . .....+|+.+++++ +|+|++++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---E-----QVNNLREIQALRRLSPHPNILRLIEVLFDRKT 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---h-----hhhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence 56788999999999999987 67899999986432111 1 12234688888888 59999999999876521
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
...++|+||++ ++|.+++.... ..+++..++.++.|++.||.|||+.|++||||+|+||+
T Consensus 73 ------------------~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~ 132 (282)
T cd07831 73 ------------------GRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENIL 132 (282)
T ss_pred ------------------CcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence 22399999996 58888876532 46899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++. +.+||+|||+++...... ......++..|+|||.+. +..++.++|||||||++|||++|..||+..+..+....
T Consensus 133 l~~-~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 133 IKD-DILKLADFGSCRGIYSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210 (282)
T ss_pred EcC-CCeEEEecccccccccCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence 999 999999999997543322 222346788999999765 45578899999999999999999999987765443333
Q ss_pred HHhcc----------------CCCCC-----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQN----------------LRPDI-----------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~----------------~~~~~-----------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+.... ....+ ...++..+.++|.+||+.+|++||++++++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 22100 00011 12467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=309.42 Aligned_cols=251 Identities=23% Similarity=0.393 Sum_probs=195.3
Q ss_pred eeccC--CceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccC
Q 048724 92 EIARG--TYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 92 ~lG~G--~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
.||+| +||+||+|.+ +|+.||+|+++..... ....+.+.+|+.+++.++||||++++++|...+..
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~--- 74 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL--- 74 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce---
Confidence 56666 9999999988 7899999998643211 11236788899999999999999999999876554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+|+||+.+++|.+++.+.....+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 75 -----------------~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~ 137 (328)
T cd08226 75 -----------------WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD 137 (328)
T ss_pred -----------------EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC
Confidence 899999999999999977655568999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCC-------ccCCCCCCCcCCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 248 RTLKIADFGVARVEAQNPRD-------MTGETGTLGYMAPEVLDGK--PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+.++++||+.+......... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.......
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 217 (328)
T cd08226 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217 (328)
T ss_pred CcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH
Confidence 99999999865422111100 0112346679999999763 47899999999999999999999998765444
Q ss_pred HHHHHHhcc---------------------------------------------CCCCCCCCCcHHHHHHHHHhchhCCC
Q 048724 319 VSSAVVRQN---------------------------------------------LRPDIPRCCPSSLASIMRKCWDANPD 353 (394)
Q Consensus 319 ~~~~~~~~~---------------------------------------------~~~~~~~~~~~~l~~li~~cL~~dP~ 353 (394)
......... .+...+..+++.+.+|+++||+.||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 297 (328)
T cd08226 218 MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297 (328)
T ss_pred HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcc
Confidence 332221110 01111234677899999999999999
Q ss_pred CCCCHHHHHH--HHHHHH
Q 048724 354 KRPVMDEVVK--LLEAVN 369 (394)
Q Consensus 354 ~Rpt~~~ll~--~l~~~~ 369 (394)
+|||+.++++ .+..+.
T Consensus 298 ~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 298 KRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cCCCHHHHhhCHHHHHHH
Confidence 9999999986 444444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=306.51 Aligned_cols=246 Identities=25% Similarity=0.425 Sum_probs=211.8
Q ss_pred ccccccccceeeeccCCceEEEEEEEC--CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYD--GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 157 (394)
.+...+|.++.+||+|+||.|.+|... .+.+|||++++.. ....... +--..|-.+|... +-|.+++++.+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV--iiQdDDv----ectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV--IIQDDDV----ECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccce--eeecCcc----cceehhhhheecCCCCchHHHHHHH
Confidence 577889999999999999999999884 4689999998542 1111111 1223466777666 67899999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
|+.-+.+ |+||||+.||+|--.+++- +.+.+..+..++..|+-||-+||++|||+|||
T Consensus 419 FQTmDRL--------------------yFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDL 476 (683)
T KOG0696|consen 419 FQTMDRL--------------------YFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDL 476 (683)
T ss_pred hhhhhhe--------------------eeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeec
Confidence 9877776 8899999999998777553 56899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|.+||+++.+|++||+|||+++-.-.......+.+|||.|+|||++.-.+|+.++|+||+|++||||+.|++||.+.+..
T Consensus 477 KLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999985444445566789999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp 356 (394)
++...+...+. .+|+.+|.+..++.+..|.+.|.+|.
T Consensus 557 elF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 557 ELFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 99999987754 47888999999999999999999995
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.59 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=201.7
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|++.+.||.|++|.||+|.. +++.+++|.++..... ......+.+|+.++++++|+||+++++++.+....
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-------EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-------chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence 56778999999999999987 6889999998643321 12245677899999999999999999998766544
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
++|+||+++ +|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||++
T Consensus 74 --------------------~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 131 (283)
T cd05118 74 --------------------YLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI 131 (283)
T ss_pred --------------------EEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE
Confidence 899999965 8888886543 578999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
+.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||+..+..+....+
T Consensus 132 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 132 NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999997654433233335678899999998776 7899999999999999999999999887765544433
Q ss_pred HhccCCC----------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLRP----------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~~----------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
......+ .....++.++.++|.+||+.||.+||++++++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2211000 0112367899999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=302.83 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=200.2
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|...+.||+|+||+||+|++ +++.|++|.+...... .......+.+|+.+++.++|||++++++++.+....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ------TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC------chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 55567899999999999987 6889999998743321 111235677899999999999999999999876554
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
|+||||+. |+|.+++... ..++++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 97 --------------------~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili 154 (313)
T cd06633 97 --------------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 154 (313)
T ss_pred --------------------EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE
Confidence 89999995 5788777543 3468999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
+.++.++|+|||++.... ......++..|+|||.+. ...++.++||||||+++|+|++|..||...+......
T Consensus 155 ~~~~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 155 TEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred CCCCCEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999999999999986322 122357888999999984 4568889999999999999999999998776655554
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..............++..+.+++.+||+.+|.+||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4443333323334577889999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=301.81 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=203.4
Q ss_pred cccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 86 KLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
+|++.+.||+|+||.||+++. +++.||||+++.... .........+..|+.+++++ +||||+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence 477889999999999999875 457899999874321 12233446778899999999 6999999998887
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..... |+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||+|
T Consensus 76 ~~~~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p 133 (288)
T cd05583 76 TDTKL--------------------HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133 (288)
T ss_pred cCCEE--------------------EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 55444 8999999999999998643 4689999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCCCC-
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKP--YNRKCDVYSFGICLWEIYCCDMPYPDLS- 315 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~Pf~~~~- 315 (394)
+||+++.++.++|+|||+++....... ......++..|++||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 134 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 213 (288)
T cd05583 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213 (288)
T ss_pred HHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc
Confidence 999999999999999999875432211 122346889999999987654 7889999999999999999999996432
Q ss_pred ---hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 316 ---FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 316 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
..+....... .....+..++..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 214 QNSQSEISRRILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cchHHHHHHHHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 2222222222 23456667899999999999999999999988887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.48 Aligned_cols=247 Identities=25% Similarity=0.503 Sum_probs=199.7
Q ss_pred cceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
.+..+||+|+|-+||+|.+ +|-.||=--++..+ ....+...++|..|+.+|+.|+|||||++|..+.+...-
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d-----~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~- 116 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD-----VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK- 116 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHH-----hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc-
Confidence 4566899999999999988 45455432222111 112233358899999999999999999999999876663
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCCcee
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK--TIVHRDVKTENML 243 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--~iiH~Dlkp~NIl 243 (394)
.+.+|+|.+..|+|..|+++.+ .++.+.+..|++||++||.|||++ .|||||||.+|||
T Consensus 117 -----------------~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIF 177 (632)
T KOG0584|consen 117 -----------------TINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIF 177 (632)
T ss_pred -----------------eeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEE
Confidence 2378999999999999997764 488999999999999999999986 5999999999999
Q ss_pred eCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-ChhhHHH
Q 048724 244 LDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFTDVSS 321 (394)
Q Consensus 244 l~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~-~~~~~~~ 321 (394)
|+. .|.|||+|+|+|++....... ...|||.|||||++. ..|+..+||||||++++||+|+..||..- +..+++.
T Consensus 178 inG~~G~VKIGDLGLAtl~r~s~ak--svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK 254 (632)
T KOG0584|consen 178 VNGNLGEVKIGDLGLATLLRKSHAK--SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK 254 (632)
T ss_pred EcCCcCceeecchhHHHHhhccccc--eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH
Confidence 974 589999999999876543332 368999999999998 67999999999999999999999999764 5556666
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+..+.-...+.+--++++++||.+||.. .+.|||+.++|.
T Consensus 255 KV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 255 KVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 65444322233344488999999999999 899999999987
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=303.79 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=203.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|+..+.||+|+||.||+|++ ++..||+|.+...... .......+.+|+.+++.++|+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc------ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 4577788999999999999988 6788999988642211 1112356778999999999999999999987654
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++|+||+. |+|.+++... ...+++..+..++.|++.||.|||+++++||||+|+||
T Consensus 89 ~~--------------------~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 146 (308)
T cd06634 89 TA--------------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (308)
T ss_pred ee--------------------EEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence 44 89999996 6888777543 34689999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+++.++.++|+|||++...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||........
T Consensus 147 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 147 LLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred EECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 9999999999999998754322 2346788999999974 35678899999999999999999999987765555
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
...+.........+..++..+.++|.+||+.+|++||++.++++...-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred HHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 5444433332223446789999999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.57 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=211.3
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+++....||.|.||.||.|.. +|...|+|-++..... ......+.+|+.++..++|||+|++||+-.+.+.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-------cccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 445677899999999999987 8899999987644322 2223566789999999999999999999887776
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. +|.||||+||+|.+++... ...++.....+..|++.|+.|||++|||||||||.||+
T Consensus 1309 v--------------------~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~ 1366 (1509)
T KOG4645|consen 1309 V--------------------YIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANIL 1366 (1509)
T ss_pred H--------------------HHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCcccee
Confidence 6 7799999999999998553 34677778888999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCC----CccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 244 LDANRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
++.+|.+|++|||.|.....+.. ......||+.|||||++.+ +....++|||||||++.||+||+.||...+.
T Consensus 1367 Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1367 LDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred eecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 99999999999999986554432 2334679999999999965 4566799999999999999999999988776
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.-.+-.-+..+..|.+|..++++-+++|..||..||++|.++.|+++.
T Consensus 1447 e~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 EWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 655545566778899999999999999999999999999999887763
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=293.01 Aligned_cols=238 Identities=26% Similarity=0.402 Sum_probs=201.1
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||.|+||.||++.+ +++.||+|+++.... ........+..|+.++++++|+||+++++.+......
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI------IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL------ 68 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh------cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee------
Confidence 79999999999988 578999999874321 1112346778899999999999999999988765554
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 69 --------------~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~ 132 (250)
T cd05123 69 --------------YLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI 132 (250)
T ss_pred --------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcE
Confidence 8999999999999999654 358999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCC
Q 048724 251 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRP 330 (394)
Q Consensus 251 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 330 (394)
+|+|||.+..............++..|++||...+..++.++|+||||+++|++++|..||...+.......+.. ...
T Consensus 133 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~ 210 (250)
T cd05123 133 KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL 210 (250)
T ss_pred EEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC
Confidence 999999987644332233445788899999999988889999999999999999999999987776665555544 345
Q ss_pred CCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 331 DIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 331 ~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
.++...+..+.+++++||..||++||++.+
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 567778999999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=305.54 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=194.8
Q ss_pred cceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccC
Q 048724 88 DIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
.+.+.+|.|+++.|+++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~--- 74 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL--- 74 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE---
Confidence 3455566677777777777899999999874321 111235688999999999999999999998765554
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
+++|||+++|+|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.+
T Consensus 75 -----------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~ 137 (314)
T cd08216 75 -----------------YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD 137 (314)
T ss_pred -----------------EEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC
Confidence 899999999999999987655678999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC-------CccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 248 RTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 248 ~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+.++|+|||.+........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+...
T Consensus 138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred CceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999998864322111 1122456778999999876 458889999999999999999999998765443
Q ss_pred HHHHHHhccC--------------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNL--------------------------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~--------------------------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.......... .......++.++.+++.+||+.||++|||++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 218 MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 3322111110 000111234678899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.90 Aligned_cols=260 Identities=20% Similarity=0.333 Sum_probs=188.1
Q ss_pred cccccceeeeccCCceEEEEEEEC---CeeEEEEEeeccccccc--------chHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMV--------TSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~---g~~vavK~~~~~~~~~~--------~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
.++|++++.||+|+||+||++... +..+++|.+........ ...........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999998762 22333332211100000 0011122345688999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---RKKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
++++++...+.. |+|++++ +++|.+++.... ........+..|+.||+.||.|||+
T Consensus 227 ~l~~~~~~~~~~--------------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 227 KIEEILRSEANT--------------------YMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred cEeEEEEECCee--------------------EEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 999999876554 8899999 568877775432 1223466788899999999999999
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCC
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 308 (394)
+||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 286 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred CCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999999975443221 222357999999999999999999999999999999999987
Q ss_pred C-CCCCCC--hhhHHHHHHhc----------------------cCC---CCC-----CCCCcHHHHHHHHHhchhCCCCC
Q 048724 309 M-PYPDLS--FTDVSSAVVRQ----------------------NLR---PDI-----PRCCPSSLASIMRKCWDANPDKR 355 (394)
Q Consensus 309 ~-Pf~~~~--~~~~~~~~~~~----------------------~~~---~~~-----~~~~~~~l~~li~~cL~~dP~~R 355 (394)
. ||.... .......+... .+. ..+ ...++.++.++|.+||+.||.+|
T Consensus 366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence 5 443221 11111111110 000 000 01246678889999999999999
Q ss_pred CCHHHHHHH
Q 048724 356 PVMDEVVKL 364 (394)
Q Consensus 356 pt~~~ll~~ 364 (394)
||+.|++..
T Consensus 446 psa~elL~h 454 (501)
T PHA03210 446 PGAAELLAL 454 (501)
T ss_pred cCHHHHhhC
Confidence 999999874
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=306.97 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=201.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||.||+|.+ +|+.||+|.+...... ......+.+|+.+++++ +||||++++++|..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-------chhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 46889999999999999999987 6789999988532110 01124566799999999 99999999998865
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.. ..|+|+||++ ++|.+++... .+++..++.++.||+.||.|||++|++||||+|+
T Consensus 79 ~~~~------------------~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ 136 (337)
T cd07852 79 ENDK------------------DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPS 136 (337)
T ss_pred CCCc------------------eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 3322 2389999996 5999888543 6889999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCC-----CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNP-----RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 137 nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 137 NILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred HEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987543221 12223467889999998754 56788999999999999999999999876
Q ss_pred ChhhHHHHHHhccC--------------------------C---CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH-
Q 048724 315 SFTDVSSAVVRQNL--------------------------R---PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL- 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~--------------------------~---~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~- 364 (394)
...+....+..... . ......++.++.+++.+||+.+|++|||+.+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 54443322211100 0 01112368899999999999999999999999985
Q ss_pred -HHHHHhc
Q 048724 365 -LEAVNTS 371 (394)
Q Consensus 365 -l~~~~~~ 371 (394)
+..+...
T Consensus 297 ~~~~~~~~ 304 (337)
T cd07852 297 YVAQFHNP 304 (337)
T ss_pred hhhhhccC
Confidence 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=305.66 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=194.3
Q ss_pred cccceeeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.|++.+.||+|+||.||+|.+ +++.||+|.+..... ........+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE------QYTGISQSACREIALLRELKHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc------cccCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence 478889999999999999988 468999999875321 0111124567899999999999999999999865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. ...|+||||++ ++|.+++.... ...+++..++.++.|++.||.|||+++++|||||
T Consensus 75 ~~------------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk 135 (316)
T cd07842 75 AD------------------KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK 135 (316)
T ss_pred CC------------------ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 22 22499999996 47777775432 2368999999999999999999999999999999
Q ss_pred CCceeeCC----CCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCC
Q 048724 239 TENMLLDA----NRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 239 p~NIll~~----~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~P 310 (394)
|+||+++. ++.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++|
T Consensus 136 p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 136 PANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred HHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 99999998 89999999999875433221 2223467889999998866 4578999999999999999999999
Q ss_pred CCCCChhh---------HHHHHHh------------------------ccCCCCCC-----------CCCcHHHHHHHHH
Q 048724 311 YPDLSFTD---------VSSAVVR------------------------QNLRPDIP-----------RCCPSSLASIMRK 346 (394)
Q Consensus 311 f~~~~~~~---------~~~~~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~ 346 (394)
|....... ....+.. .......+ ...+..+.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 97544322 0000000 00011111 1456789999999
Q ss_pred hchhCCCCCCCHHHHHHH
Q 048724 347 CWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 347 cL~~dP~~Rpt~~~ll~~ 364 (394)
||+.||++|||+.+++..
T Consensus 296 ~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 296 LLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhcCCcccCcCHHHHhcC
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=297.37 Aligned_cols=239 Identities=22% Similarity=0.360 Sum_probs=190.1
Q ss_pred ccccceeee--ccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 85 AKLDIRHEI--ARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 85 ~~~~~~~~l--G~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
++|++.+.+ |.|+||.||++.. ++..+|+|+++..... ..|+.+...+ +||||+++++.|.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------------~~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------------AIEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------------hhhHHHHHHhhcCCCEEEEEEEEe
Confidence 455665555 9999999999987 6789999998632210 0122222222 7999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..+.. |+||||+++++|.+++..+ ..+++..++.++.|++.||.|||+.|++||||+|
T Consensus 80 ~~~~~--------------------~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 137 (267)
T PHA03390 80 TLKGH--------------------VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137 (267)
T ss_pred cCCee--------------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 66554 9999999999999999654 3799999999999999999999999999999999
Q ss_pred CceeeCCCC-cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 240 ENMLLDANR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 240 ~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+||+++.++ .++|+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 138 ~nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 138 ENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred HHEEEeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 999999888 9999999998754322 23468899999999999889999999999999999999999997554333
Q ss_pred HHHHHHh--ccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-HHHHHH
Q 048724 319 VSSAVVR--QNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-MDEVVK 363 (394)
Q Consensus 319 ~~~~~~~--~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-~~~ll~ 363 (394)
....... .......+..+++.+.++|.+||+.+|.+||+ ++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 2111111 12223445568999999999999999999995 688875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=334.08 Aligned_cols=268 Identities=29% Similarity=0.471 Sum_probs=195.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|+.+..||+||||.||+++. +|+.||||.+... . .......+.+|+.+|.+|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~------~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK------A--SDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc------h--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 46788899999999999999987 8999999998632 1 333456778899999999999999999665421
Q ss_pred CccccC-----------CC-------------------------------------------------------------
Q 048724 162 TNLKIP-----------SQ------------------------------------------------------------- 169 (394)
Q Consensus 162 ~~~~~~-----------~~------------------------------------------------------------- 169 (394)
..-... +|
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 110000 00
Q ss_pred -CCCCCC-------------------CCCCCC-------CceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHH
Q 048724 170 -SATSDS-------------------HNSLPS-------RACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 170 -~~~~~~-------------------~~~~~~-------~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~ 222 (394)
+.+++. .+.... ..+||-||||+..+|.+++.++.... .....|+++.+|++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILE 708 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHH
Confidence 000000 011111 46889999999988888886654211 46789999999999
Q ss_pred HHHHHHhCCCcccCCCCCceeeCCCCcEEEeecccccccc------------------CCCCCccCCCCCCCcCCccccC
Q 048724 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA------------------QNPRDMTGETGTLGYMAPEVLD 284 (394)
Q Consensus 223 ~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~ 284 (394)
||.|+|++|+|||||||.|||+++++.|||+|||+|+... .+....+...||.-|+|||.+.
T Consensus 709 GLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999999999999999999999999999999999997511 0112445678999999999997
Q ss_pred CC---CCCccchHHHHHHHHHHHHhCCCCCCCCCh-hhHHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 285 GK---PYNRKCDVYSFGICLWEIYCCDMPYPDLSF-TDVSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 285 ~~---~~~~~~DvwslG~~l~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
+. .|+.|+|+||||++++||+ .||+..-. ..+...+....+..+ +...--+.-+.+|++||+.||++|||+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 54 5999999999999999997 45654332 223333322222211 011122455789999999999999999
Q ss_pred HHHHH
Q 048724 359 DEVVK 363 (394)
Q Consensus 359 ~~ll~ 363 (394)
.++|.
T Consensus 866 ~eLL~ 870 (1351)
T KOG1035|consen 866 TELLN 870 (1351)
T ss_pred HHHhh
Confidence 99985
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=299.83 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=199.0
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||.||+|.. +++.||||.+....... .....+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-------GFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-------CchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 357899999999999999999988 68899999886432111 112345579999999999999999999876
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
..... .......++||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+
T Consensus 83 ~~~~~------------~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~ 148 (310)
T cd07865 83 KATPY------------NRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAA 148 (310)
T ss_pred ccccc------------cCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 44320 112345699999995 5888887543 246899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCC----CccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+
T Consensus 149 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred HEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999875432211 12234578889999988664 47889999999999999999999997765
Q ss_pred hhhHHHHHHhc--cCCC---------------CC-------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQ--NLRP---------------DI-------------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~--~~~~---------------~~-------------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.......+... ...+ .. +...+..+.++|.+||+.||.+|||+.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 229 EQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 44332221110 0000 00 11235678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=307.23 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=199.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||.||+|.. +|+.||+|++...... ......+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-------ccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 6788999999999999999987 6889999998643211 112355668999999999999999998876432
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. .....|+|+||+. ++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 78 ~----------------~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Ni 138 (334)
T cd07855 78 A----------------DFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138 (334)
T ss_pred C----------------CCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 1 1234589999995 6899988543 4599999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCC----CccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 243 LLDANRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..
T Consensus 139 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 218 (334)
T cd07855 139 LVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218 (334)
T ss_pred EEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH
Confidence 999999999999999875332211 1123468889999999865 56889999999999999999999999776543
Q ss_pred hHHHHHHhc------------------------cCCCCC-----CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 318 DVSSAVVRQ------------------------NLRPDI-----PRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 318 ~~~~~~~~~------------------------~~~~~~-----~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.....+... ...... ....+.++.++|.+||+.+|++||++.+++..-
T Consensus 219 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 322221110 000111 134688999999999999999999999998843
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=306.20 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=209.0
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
+.+..+.|...++||+||||.|+-++. +|+-+|.|.+.+..- ....-...-..|-.||.+++.+.||.+--+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi------Kkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI------KKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH------HHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 345668889999999999999997765 899999998753321 111122445578999999999999999888
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
|...+.+ |+|+..|.||+|.-.|.+.....+++..+..++.+|+-||++||+.+||+|||
T Consensus 254 feTkd~L--------------------ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDL 313 (591)
T KOG0986|consen 254 FETKDAL--------------------CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDL 313 (591)
T ss_pred ecCCCce--------------------EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccC
Confidence 8877776 99999999999998887777778999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS-- 315 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~-- 315 (394)
||+|||+|+.|+++|+|+|+|.-.... ......+||.+|||||++.+..|+.+.|+|||||++|||+.|+.||....
T Consensus 314 KPeNILLDd~GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 314 KPENILLDDHGHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred ChhheeeccCCCeEeeccceEEecCCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 999999999999999999999754433 33344699999999999999999999999999999999999999995432
Q ss_pred --hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 316 --FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 316 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
.+++.+.+... ...++..+|++.++|.+.+|++||++|...
T Consensus 393 vk~eEvdrr~~~~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 393 VKREEVDRRTLED--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhHHHHHHHHhcc--hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 33444444333 345678899999999999999999999743
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=299.06 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=199.9
Q ss_pred cccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 86 KLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
+|++.+.||+|+||.||++.. +|..||+|+++.... .......+.+..|+.+++++ +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-----hhcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence 478889999999999999876 578999999864221 11222346677899999999 6999999999887
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..... |+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|
T Consensus 76 ~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p 133 (290)
T cd05613 76 TDTKL--------------------HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133 (290)
T ss_pred cCCeE--------------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 65443 8999999999999999653 4688999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGK--PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
+|||++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.....
T Consensus 134 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred HHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 99999999999999999987543221 122235688999999998753 467899999999999999999999964322
Q ss_pred ----hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 317 ----TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 317 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
.++...... ..++++..+++.+.+++.+||+.+|++|| ++.+++..
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 214 KNSQAEISRRILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cccHHHHHHHhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 222222211 23456677899999999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=292.04 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=212.1
Q ss_pred hhhccCCCCCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh
Q 048724 68 REREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145 (394)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 145 (394)
......+....-|++..++++-++.||.|+||+|++-.+ +|+..|||.++.... +..++++..|.+...+
T Consensus 47 ~g~l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--------~keq~rll~e~d~~mk 118 (361)
T KOG1006|consen 47 TGTLKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--------EKEQKRLLMEHDTVMK 118 (361)
T ss_pred cCceecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--------hHHHHHHHHHHHHHHh
Confidence 334555666667888899999999999999999998877 799999999985542 2234667777765555
Q ss_pred C-CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh---cccCCCCHHHHHHHHHHHH
Q 048724 146 L-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR---NKRKKLAFKVVIQIALDLA 221 (394)
Q Consensus 146 l-~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qi~ 221 (394)
- ++||||++||++.. ++.|||.||.| ..+|+.+... ..+..+++..+-.|....+
T Consensus 119 s~~cp~IVkfyGa~F~--------------------EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV 177 (361)
T KOG1006|consen 119 SSNCPNIVKFYGALFS--------------------EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATV 177 (361)
T ss_pred hcCCcHHHHHhhhhhc--------------------CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeeh
Confidence 4 89999999999764 34569999999 4577665532 3345799999999999999
Q ss_pred HHHHHHHh-CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC--CCCCccchHHHHH
Q 048724 222 RGLSYLHS-KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFG 298 (394)
Q Consensus 222 ~~l~yLH~-~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG 298 (394)
.||.||.. ..|||||+||+|||++..|.|||||||++...... ...+...|...|||||.+.. ..|+.++||||||
T Consensus 178 ~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLG 256 (361)
T KOG1006|consen 178 DALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLG 256 (361)
T ss_pred hHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhc
Confidence 99999985 68999999999999999999999999999754433 23344688899999999953 4699999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-hhHHHHHHhccCC-CCCC---CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 299 ICLWEIYCCDMPYPDLSF-TDVSSAVVRQNLR-PDIP---RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 299 ~~l~elltg~~Pf~~~~~-~~~~~~~~~~~~~-~~~~---~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
++|||+.||..||..++. .+....++.+... ...+ ..++..+..+|..||.+|-+.||++.+++++--
T Consensus 257 ITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 257 ITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred ceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 999999999999988754 2333334333221 1112 236889999999999999999999999988543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=305.88 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=208.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|++.+.||.|+||.||+|+. +++.||||.+..... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 578899999999999999998 578999999864321 11223668889999999999999999999876542
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. .....|++|||++ ++|.+++.+. ..+++..++.++.||+.||.|||++|++||||||.||+
T Consensus 74 ~---------------~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nil 135 (330)
T cd07834 74 E---------------DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL 135 (330)
T ss_pred c---------------cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 1 1123599999996 5898888543 37999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 244 LDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||......+.
T Consensus 136 i~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~ 215 (330)
T cd07834 136 VNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215 (330)
T ss_pred EcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 9999999999999998654332 123345678899999999887 889999999999999999999999987776554
Q ss_pred HHHHHhccCCC-----------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 048724 320 SSAVVRQNLRP-----------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAV 368 (394)
Q Consensus 320 ~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~ 368 (394)
...+....-.+ .....++..+.++|.+||+.+|++||++++++.. ++.+
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 44433211000 0112367889999999999999999999999984 6666
Q ss_pred Hh
Q 048724 369 NT 370 (394)
Q Consensus 369 ~~ 370 (394)
..
T Consensus 296 ~~ 297 (330)
T cd07834 296 HD 297 (330)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.44 Aligned_cols=253 Identities=28% Similarity=0.377 Sum_probs=198.7
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC---CCCcceeeeeeecCC
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGASMGT 161 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~ 161 (394)
|++.+.||+|+||.||+|++ +++.||+|+++..... ......+.+|+.+++++ +|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 67788999999999999998 4789999999743321 11123455677777666 699999999999865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.. .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+|
T Consensus 74 ~~~---------------~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~n 137 (287)
T cd07838 74 RTD---------------RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137 (287)
T ss_pred cCC---------------CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 541 1122489999996 589998876554569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|.+||......+...
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~ 216 (287)
T cd07838 138 ILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216 (287)
T ss_pred EEEccCCCEEEeccCcceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH
Confidence 999999999999999987543221 1223457889999999998889999999999999999999999998877665554
Q ss_pred HHHhccCC------------------CCC-------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQNLR------------------PDI-------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~~~------------------~~~-------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+...... ... ....+..+.+++.+||+.||++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 44321100 000 0123577889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=303.88 Aligned_cols=260 Identities=22% Similarity=0.343 Sum_probs=204.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.. +++.||||+++.... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 46799999999999999999987 688999999853211 122235677899999999999999999998755
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+. ....+++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 87 ~~~~--------------~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~N 148 (343)
T cd07880 87 LSLD--------------RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN 148 (343)
T ss_pred cccc--------------ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 4431 112358999999 7899988743 458999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.........
T Consensus 149 ill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 149 LAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998754322 223467889999999876 45888999999999999999999999876544333
Q ss_pred HHHHhccCC-----------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH--HHHHHHH
Q 048724 321 SAVVRQNLR-----------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV--KLLEAVN 369 (394)
Q Consensus 321 ~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll--~~l~~~~ 369 (394)
..+...... ......+++.+.++|.+||+.||++|||+.+++ ..++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 322111000 011235788899999999999999999999999 4566654
Q ss_pred hc
Q 048724 370 TS 371 (394)
Q Consensus 370 ~~ 371 (394)
..
T Consensus 306 ~~ 307 (343)
T cd07880 306 DP 307 (343)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.86 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred cccc-ceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchH-----HHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 85 AKLD-IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSA-----EAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 85 ~~~~-~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
++|. +.+.||.|+||+||+|.+ +++.||||.++.......... ........+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 457799999999999987 688999999864432110000 00001124678999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++...... |+||||+. |+|.+++.. ...+++..+..++.|++.||+|||+.|++|+|
T Consensus 88 ~~~~~~~~--------------------~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 88 VYVEGDFI--------------------NLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred EEecCCcE--------------------EEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 98765544 89999996 699998854 34589999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccC--------------CCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHH
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQ--------------NPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICL 301 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l 301 (394)
|+|+||+++.++.++|+|||++..... .........+++.|+|||.+.+. .++.++|||||||++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 999999999999999999999875431 11122234567889999998764 468899999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHHhccC---CC-----------------------CCCCCCcHHHHHHHHHhchhCCCCC
Q 048724 302 WEIYCCDMPYPDLSFTDVSSAVVRQNL---RP-----------------------DIPRCCPSSLASIMRKCWDANPDKR 355 (394)
Q Consensus 302 ~elltg~~Pf~~~~~~~~~~~~~~~~~---~~-----------------------~~~~~~~~~l~~li~~cL~~dP~~R 355 (394)
|+|++|..||......+....+..... .. .....++..+.++|.+||+.+|++|
T Consensus 225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence 999999999987776554443322100 00 0012357889999999999999999
Q ss_pred CCHHHHHHH
Q 048724 356 PVMDEVVKL 364 (394)
Q Consensus 356 pt~~~ll~~ 364 (394)
||+++++..
T Consensus 305 ~s~~~~l~~ 313 (335)
T PTZ00024 305 ISAKEALKH 313 (335)
T ss_pred cCHHHHhcC
Confidence 999999973
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=320.84 Aligned_cols=254 Identities=27% Similarity=0.564 Sum_probs=219.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
.+...++||.|+||+||+|.| +|+ +||||++..... ......+.+|+-+|.+++|||+++++|+|.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--------~~~s~e~LdeAl~masldHpnl~RLLgvc~ 768 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--------PKASIELLDEALRMASLDHPNLLRLLGVCM 768 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--------chhhHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence 345567899999999999998 543 799998863221 111367889999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
... + .||++|+++|+|.+|++.+ +..+--+..+.|..||++||.|||.+.++||||..
T Consensus 769 ~s~-~--------------------qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaa 826 (1177)
T KOG1025|consen 769 LST-L--------------------QLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAA 826 (1177)
T ss_pred cch-H--------------------HHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhh
Confidence 655 2 6799999999999999875 46788999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccC--CCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTG--ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
+|||+.+-..+||+|||+++........... ....+.|||-|.++...|+.++|||||||++||++| |..||.+.+.
T Consensus 827 RNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 827 RNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred hheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 9999999999999999999977655444433 344688999999999999999999999999999987 8999999988
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
.++-.. ++.+.+...|..|+.++..+|.+||..|+..||+++++...+.+...
T Consensus 907 ~eI~dl-le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 907 EEIPDL-LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHhhHH-HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 887754 46667788899999999999999999999999999999999988754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=301.60 Aligned_cols=260 Identities=34% Similarity=0.578 Sum_probs=215.3
Q ss_pred cccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC--CCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL--DHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~~~~ 159 (394)
.+....++.++||+|.||.||+|..+++.||||++.... ++.|..|-+|++.. +|+||++|+++-.
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~------------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE------------KQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecCHHH------------HHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 456778899999999999999999999999999997322 47788888888765 8999999998765
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---------
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK--------- 230 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------- 230 (394)
..... ...++||++|.+.|+|.+||+.+ .++|....+|+..+++||+|||+.
T Consensus 275 r~t~~----------------~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp 335 (534)
T KOG3653|consen 275 RGTAD----------------RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKP 335 (534)
T ss_pred cCCcc----------------ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCC
Confidence 44422 24559999999999999999665 499999999999999999999963
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCCCC------CCccchHHHHHHHHH
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDGKP------YNRKCDVYSFGICLW 302 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~ 302 (394)
.|+|||||+.|||+.++++..|+|||+|...... ..+....+||.+|||||++.+.. .-.+.||||+|.+||
T Consensus 336 ~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 336 PIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW 415 (534)
T ss_pred ccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence 5999999999999999999999999999865432 23344579999999999997632 224789999999999
Q ss_pred HHHhC------------CCCCC-----CCChhhHHHHHHhccCCCCCCCC-----CcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 303 EIYCC------------DMPYP-----DLSFTDVSSAVVRQNLRPDIPRC-----CPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 303 elltg------------~~Pf~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
||++. ++||. ..+.+++...+++.+.|+.++.. -...+++.+..||..||+.|.|+.-
T Consensus 416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 99862 23453 34567777788888888888743 2467899999999999999999999
Q ss_pred HHHHHHHHHhcc
Q 048724 361 VVKLLEAVNTSK 372 (394)
Q Consensus 361 ll~~l~~~~~~~ 372 (394)
+.+.+.++....
T Consensus 496 v~eR~~~l~~~~ 507 (534)
T KOG3653|consen 496 VEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHhccC
Confidence 999999998665
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=294.23 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=198.4
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|++.+.||.|+||.||+|++ +++.+|+|+++.... .......+.+|+.++++++|+|++++++++.+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-------KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG-- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-------cccchHHHHHHHHHHHhccCCCeeeheeeEecCC--
Confidence 67888999999999999988 578999999975421 1122356778999999999999999999987651
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
....++|+||+++ +|.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||++
T Consensus 72 ----------------~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~ 133 (287)
T cd07840 72 ----------------KGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133 (287)
T ss_pred ----------------CCcEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence 1234999999974 8988885532 469999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 245 DANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++++.++|+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........
T Consensus 134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 134 NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999999999997543322 12233466888999998765 4578999999999999999999999987765444433
Q ss_pred HHhccCC-----------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNLR-----------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+...... ..+...++..+.+++.+||+.+|.+||+++++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 214 IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3221000 00111238889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=294.06 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=196.3
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCCCc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTN 163 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 163 (394)
|++.+.||+|+||+||+|+. +++.|+||.+...... . ......+|+..+++++ |+||+++++++.+...
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 72 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---W-----EECMNLREVKSLRKLNEHPNIVKLKEVFRENDE 72 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---h-----hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc
Confidence 56788999999999999998 5788999988633211 0 1123446899999998 9999999999886554
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+||||+ +|+|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+
T Consensus 73 ~--------------------~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~ 131 (283)
T cd07830 73 L--------------------YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL 131 (283)
T ss_pred E--------------------EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 4 8999999 889999987655457899999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++.++.++|+|||++...... .......++..|+|||.+. +..++.++|+||||+++|+|++|++||+.....+....
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 132 VSGPEVVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred EcCCCCEEEeecccceeccCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 999999999999999754332 2223346788999999875 45678999999999999999999999987665444332
Q ss_pred HHhc-----------------cCCCC-----------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQ-----------------NLRPD-----------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~-----------------~~~~~-----------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.... ..... .....+..+.+++.+||+.+|++|||+++++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 2210 00000 011236789999999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=303.27 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=203.5
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
|++. .+|.+.+.||+|+||.||+|++ +|+.||||+++.... .......+.+|+.+++.++||||++++++
T Consensus 11 ~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 11 WELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-------SEIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-------cccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 5553 5899999999999999999987 688999999864321 11123457789999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+....... .....|+|+||+. .+|..++ ...+++..+..++.|++.||+|||++|++||||
T Consensus 83 ~~~~~~~~--------------~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl 143 (342)
T cd07879 83 FTSAVSGD--------------EFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDL 143 (342)
T ss_pred ecccccCC--------------CCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 87544321 1133589999995 4777664 235899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||+||+++.++.++|+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus 144 kp~NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~ 220 (342)
T cd07879 144 KPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220 (342)
T ss_pred CHHHEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999875322 2233467889999999876 4688999999999999999999999987765
Q ss_pred hhHHHHHHhcc----------------------C----CCCC---CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HH
Q 048724 317 TDVSSAVVRQN----------------------L----RPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LL 365 (394)
Q Consensus 317 ~~~~~~~~~~~----------------------~----~~~~---~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l 365 (394)
......+.... . +..+ ...++..+.++|.+||+.||++||++.+++. .+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 44433322210 0 0000 1236778999999999999999999999995 47
Q ss_pred HHHHh
Q 048724 366 EAVNT 370 (394)
Q Consensus 366 ~~~~~ 370 (394)
+.++.
T Consensus 301 ~~~~~ 305 (342)
T cd07879 301 DSFRD 305 (342)
T ss_pred hhccc
Confidence 77654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=293.09 Aligned_cols=249 Identities=31% Similarity=0.463 Sum_probs=199.9
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|++.+.||+|+||.||+|+. +++.||+|+++.... .......+..|+.+++.++|+|++++++++.+....
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-------EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence 55677899999999999988 578999999875431 111235567899999999999999999998765444
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
++|+||++ ++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||++
T Consensus 74 --------------------~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~ 131 (282)
T cd07829 74 --------------------YLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131 (282)
T ss_pred --------------------EEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE
Confidence 89999997 59999997643 469999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
+.++.++|+|||.+..............++..|+|||.+.+. .++.++||||||+++|++++|..||......+....+
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 132 NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 999999999999987654333333344567889999998766 7899999999999999999999999877655443332
Q ss_pred Hhcc----------------CCC-----------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQN----------------LRP-----------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~----------------~~~-----------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.... ... ......+..+.+++.+||..+|++||++++++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 2100 000 0011247789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=301.13 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=198.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.... .......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 37899999999999999999986 688999999864321 111234567899999999999999999988643
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.... .....|++++++ +++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+|
T Consensus 89 ~~~~--------------~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 150 (345)
T cd07877 89 RSLE--------------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 150 (345)
T ss_pred cccc--------------ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHH
Confidence 3220 112347888877 8899888743 358999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.++|+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.....
T Consensus 151 Ill~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 151 LAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred EEEcCCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999875322 2233567889999998866 56888999999999999999999999876554433
Q ss_pred HHHHhccC------------------------CC-----CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 321 SAVVRQNL------------------------RP-----DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 321 ~~~~~~~~------------------------~~-----~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
..+..... .+ ......++.+.++|.+||+.||.+||++.+++..-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 32211100 00 00113578899999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.31 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=198.1
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
.+|.+.+.||.|+||.||+|.. +|+.||+|.+..... .....+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---------chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 6899999999999999999988 678999999864332 11356778999999999999999998876543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.... .+.........+|+|+||++ ++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||
T Consensus 76 ~~~~------~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Ni 145 (342)
T cd07854 76 SDLT------EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145 (342)
T ss_pred cccc------cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 2100 00111222345699999996 589888743 3589999999999999999999999999999999999
Q ss_pred eeC-CCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 243 LLD-ANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 243 ll~-~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
+++ .++.++|+|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 997 456789999999875432111 1122357889999998754 56888999999999999999999999776544
Q ss_pred hHHHHHHhcc-----------------------CCCC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 318 DVSSAVVRQN-----------------------LRPD-----IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~-----------------------~~~~-----~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+......... .... ....++.++.++|.+||+.||.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 4333322110 0000 11246788999999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=296.60 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=198.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||.|+||.||+|++ +++.||||.+......... ...+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-------PITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-------chhHHHHHHHHHhcCCCCccchhhheecc
Confidence 58999999999999999999988 6789999998643321111 13456799999999999999999987654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.... ......+++|+||+.+ +|...+... ...+++..+..++.|+++||.|||++|++|+||||+|
T Consensus 80 ~~~~------------~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~n 145 (311)
T cd07866 80 PDKS------------KRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAAN 145 (311)
T ss_pred cccc------------cccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3320 1123456899999964 777776543 3469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC-----------CccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCC
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR-----------DMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~ 309 (394)
|+++.++.++|+|||+++....... ..+...+++.|+|||.+.+ ..++.++||||||+++|+|++|++
T Consensus 146 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred EEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 9999999999999999975332211 1122356788999998765 458899999999999999999999
Q ss_pred CCCCCChhhHHHHHHhccCC---------------------CCCC-------CCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 310 PYPDLSFTDVSSAVVRQNLR---------------------PDIP-------RCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~---------------------~~~~-------~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
||.+.+.......+...... ...+ ...+..+.+++.+||+.||.+|||+.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 226 ILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 99876655444333221000 0000 1244678999999999999999999998
Q ss_pred HH
Q 048724 362 VK 363 (394)
Q Consensus 362 l~ 363 (394)
+.
T Consensus 306 l~ 307 (311)
T cd07866 306 LE 307 (311)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=303.79 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=200.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|.+ +++.||+|++..... .......+.+|+.++++++||||+++.+++...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 46799999999999999999988 578999998863211 111235566899999999999999999887654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.. .....+|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+|
T Consensus 87 ~~~--------------~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (343)
T cd07851 87 SSL--------------EDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN 148 (343)
T ss_pred ccc--------------cccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 431 0112358999999 6799998854 459999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 149 ill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 225 (343)
T cd07851 149 IAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225 (343)
T ss_pred eEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999754322 233467889999999865 46788999999999999999999999877655444
Q ss_pred HHHHhccCC--------------------------C---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLR--------------------------P---DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~--------------------------~---~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+...... . .....++..+.++|.+||+.+|++|||+.+|+..
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 433221000 0 0112358899999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.11 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=196.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||.|+||.||+|.. +++.||||.+...... ......+.+|+.+++.++||||++++++|...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-------PVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-------cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 46799999999999999999987 6889999987532211 11235677899999999999999999988643
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.. .+|+++||+ +++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+|
T Consensus 82 ~~-------------------~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~N 138 (328)
T cd07856 82 LE-------------------DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSN 138 (328)
T ss_pred CC-------------------cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 22 248999998 6799888743 358888999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||+........
T Consensus 139 ili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~ 215 (328)
T cd07856 139 ILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215 (328)
T ss_pred EeECCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999874322 2223467889999998765 57899999999999999999999999776543222
Q ss_pred HHHHh------------------------ccCCCC-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVR------------------------QNLRPD-----IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~------------------------~~~~~~-----~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+.. ...... ....++..+.++|.+||+.+|++|||+.+++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110 000001 113467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.95 Aligned_cols=244 Identities=28% Similarity=0.468 Sum_probs=202.4
Q ss_pred eeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccC
Q 048724 90 RHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 167 (394)
.++||.|.||+||-|++ +|+.||||++.+..-. .+. ...++.|+.||++++||.||.+...|...+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kq-----esqlR~EVaILq~l~HPGiV~le~M~ET~erv--- 638 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQ-----ESQLRNEVAILQNLHHPGIVNLECMFETPERV--- 638 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCC--Cch-----HHHHHHHHHHHHhcCCCCeeEEEEeecCCceE---
Confidence 45799999999999887 8999999999754422 221 25678899999999999999999988877666
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC-
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA- 246 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~- 246 (394)
++|||-+ .|+..+.|-....+.+++.....++.||+.||.|||-++|+|.||||+|||+..
T Consensus 639 -----------------FVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~ 700 (888)
T KOG4236|consen 639 -----------------FVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA 700 (888)
T ss_pred -----------------EEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC
Confidence 8999999 567777776667788999999999999999999999999999999999999954
Q ss_pred --CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 048724 247 --NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324 (394)
Q Consensus 247 --~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~ 324 (394)
-..+||||||+|+++...... ....|||.|+|||+++++.|+.+-|+||.|+++|.-++|..||.... ++..++.
T Consensus 701 ~~FPQvKlCDFGfARiIgEksFR-rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQ 777 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKSFR-RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQ 777 (888)
T ss_pred CCCCceeeccccceeecchhhhh-hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhh
Confidence 357999999999987654333 34689999999999999999999999999999999999999996532 2333332
Q ss_pred hcc--CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 325 RQN--LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 325 ~~~--~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
... +.+.....++.+..+||..+|+..-++|.|....+..
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 222 2333346689999999999999999999999887764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=298.06 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=194.4
Q ss_pred cccceeeeccCCceEEEEEEE--C--CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--D--GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
+|++.+.||+|+||.||++.+ + +..||+|.++..... ....+.+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-------KILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-------chhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 478889999999999999998 3 668999998632211 11235667899999999 69999999987543
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... .....|++++|+. ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+
T Consensus 74 ~~~----------------~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~ 134 (332)
T cd07857 74 FPG----------------NFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPG 134 (332)
T ss_pred ccc----------------cCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 211 1123488999985 699998854 346899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||+++.++.++|+|||+++...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+
T Consensus 135 Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 135 NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred HeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 9999999999999999997543211 11223468899999998765 568899999999999999999999998765
Q ss_pred hhhHHHHHHhc-------------------------cC-CC---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQ-------------------------NL-RP---DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~-------------------------~~-~~---~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.......+... .. .. .....++..+.+++.+||+.||++|||+.+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 43332221110 00 00 0112357899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.09 Aligned_cols=148 Identities=27% Similarity=0.462 Sum_probs=129.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|.+.+.||+|+||+||+|.+ +++.||||+++.... ........+..|+.+++.++||||+++++++...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM------INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 57899999999999999999998 488999999874321 1122346788899999999999999999988765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||+.|++|.+++... ..+++..++.|+.||+.||.|||+++|+||||||+|
T Consensus 77 ~~~--------------------~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~N 134 (669)
T cd05610 77 NNV--------------------YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134 (669)
T ss_pred CEE--------------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHH
Confidence 554 9999999999999999653 458999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccc
Q 048724 242 MLLDANRTLKIADFGVAR 259 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~ 259 (394)
||++.++.+||+|||+++
T Consensus 135 ILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 135 MLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEcCCCCEEEEeCCCCc
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=292.49 Aligned_cols=255 Identities=35% Similarity=0.607 Sum_probs=207.0
Q ss_pred ccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC--CCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL--DHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~~~~~~~ 162 (394)
.+.++.+.||+|.||.||+|.|.|..||||++...+ .+.+.+|.+|++.. +|+||+.|++.-..+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd------------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD------------ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc------------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 567788999999999999999999999999996332 26677888888865 9999999998754333
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcc
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK--------TIVH 234 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------~iiH 234 (394)
. .-..+|+|.+|-+.|||.|||.+ ..++....++++..++.||+|||.. .|.|
T Consensus 279 g----------------s~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 279 G----------------SWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred C----------------ceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 2 23456999999999999999965 4599999999999999999999952 4999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCCCC------CCccchHHHHHHHHHHH
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDGKP------YNRKCDVYSFGICLWEI 304 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el 304 (394)
||||+.|||+..++...|+|+|+|-...... ......+||-+|||||++...- --..+||||||+++||+
T Consensus 340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 9999999999999999999999996543321 2234578999999999996531 12478999999999999
Q ss_pred Hh----C------CCCCCC-----CChhhHHHHHHhccCCCCCCCCCc-----HHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 305 YC----C------DMPYPD-----LSFTDVSSAVVRQNLRPDIPRCCP-----SSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 305 lt----g------~~Pf~~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.. | .+||.+ .+.+++..-+..++++|.+|.... ..+.++|+.||..||.-|.|+=.+.+.
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 74 2 578844 445566655666778888875442 357789999999999999999999999
Q ss_pred HHHHHh
Q 048724 365 LEAVNT 370 (394)
Q Consensus 365 l~~~~~ 370 (394)
|.++..
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.19 Aligned_cols=241 Identities=25% Similarity=0.398 Sum_probs=201.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.+.|++...+|.|+||.|-.+.+ +++..++|++..... .-.+|+.++... +||||+++.+++.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------------~~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------------DNQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-------------ccccccchhhhhcCCCcceeecceecC
Confidence 56788888899999999999987 788999999975422 122466565555 89999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
..+. |+|||.+.|+-|.+.+...+ .....+..|+.+|+.|+.|||++|+|||||||+
T Consensus 388 ~~~~--------------------~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~ 444 (612)
T KOG0603|consen 388 GKEI--------------------YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPG 444 (612)
T ss_pred Ccee--------------------eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChh
Confidence 7766 89999999999888775433 333777789999999999999999999999999
Q ss_pred ceee-CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh-h
Q 048724 241 NMLL-DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT-D 318 (394)
Q Consensus 241 NIll-~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~-~ 318 (394)
|||+ +..++++|+|||.++..... ....+-|..|.|||++....|+.++||||||++||+|++|+.||...+.. +
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 9999 68899999999999854433 44468889999999999999999999999999999999999999776655 3
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
+...+ ..+.+...+|...++||.+||+.||.+||++.++...-+-
T Consensus 522 i~~~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 IHTRI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 33222 2344557899999999999999999999999999886555
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=312.55 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=216.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.+.|++..+||.|.+|.||+++. +++.+|+|+.....+.. ..+..|.++|+.+ +|||++.++|+|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----------eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----------EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----------HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 35677889999999999998866 88999999987655432 4556788999988 89999999999975
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.. ..+.+|+|||||.||+..|+++......+.|..+..|++.++.|+.+||++.++|||||-.
T Consensus 88 ~~~~---------------~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~ 152 (953)
T KOG0587|consen 88 KDPG---------------NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQ 152 (953)
T ss_pred ecCC---------------CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCc
Confidence 5442 4567799999999999999998766778999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||++.++.|||+|||++...........+..|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-+..
T Consensus 153 NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 153 NVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred eEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 999999999999999999887776666777899999999999953 357889999999999999999999998887
Q ss_pred hhhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 316 FTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 316 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.......+.+... ...-|...+.++-++|..||.+|-.+||++.++++
T Consensus 233 PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 7665555433221 11224667899999999999999999999998875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.28 Aligned_cols=243 Identities=24% Similarity=0.401 Sum_probs=197.8
Q ss_pred eeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCcccc
Q 048724 90 RHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~ 166 (394)
.+.||+|+|+.|-.++. +|..+|||++.+.. ...+.+..+|++++.++ .|+||++++.+|.++..+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F-- 151 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF-- 151 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE--
Confidence 45699999999998876 89999999997432 12357788999999999 699999999999988776
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~ 246 (394)
|+|||-+.||+|...|.+ ++.+++.++.++.++|+.||.+||.+||.||||||+|||..+
T Consensus 152 ------------------YLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 152 ------------------YLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred ------------------EEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 999999999999998865 457999999999999999999999999999999999999965
Q ss_pred CC---cEEEeecccccccc-------CCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 247 NR---TLKIADFGVARVEA-------QNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 247 ~~---~vkl~DFG~a~~~~-------~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
.. -||||||.+..-.. .......+.+|+..|||||+.. ...|+.++|.||||+++|-|++|++||
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 44 47999998865211 1223445578999999999874 246899999999999999999999999
Q ss_pred CCCC---------------hhhHHHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 312 PDLS---------------FTDVSSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 312 ~~~~---------------~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+.- .......+-.+.+..+- ...+|.+.++++..+|..++.+|.++.+++.
T Consensus 292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 292 VGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 6532 22233344444433221 1347899999999999999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.83 Aligned_cols=261 Identities=27% Similarity=0.453 Sum_probs=201.0
Q ss_pred cceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
...+.||+|+||.||+|++ +|+.||||.++.... ...++...+|+++|++++|+|||+++++=.+....
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~- 86 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--------LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG- 86 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcc--------cchHHHHHHHHHHHHHcCchhhhhhcccCCccccC-
Confidence 4456799999999999986 899999999875331 12246677899999999999999999875544321
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN-KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
. ....-.+|||||.||+|...|.+- +...|++.+++.++..++.||.|||++||+||||||.||++
T Consensus 87 ~-------------~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl 153 (732)
T KOG4250|consen 87 L-------------VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVL 153 (732)
T ss_pred c-------------ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Confidence 1 123337999999999999999652 23469999999999999999999999999999999999999
Q ss_pred C--CCC--cEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCC----
Q 048724 245 D--ANR--TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLS---- 315 (394)
Q Consensus 245 ~--~~~--~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~---- 315 (394)
- .+| .-||+|||.|+-..++. ..+...||+.|++||.+. .+.|+..+|.|||||++|+++||..||-...
T Consensus 154 ~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~ 232 (732)
T KOG4250|consen 154 QIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN 232 (732)
T ss_pred eecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence 4 333 46999999999665543 556689999999999998 4889999999999999999999999994332
Q ss_pred hhhHHHHHHhcc-------------------CCCCCCCCCcH----HHHHHHHHhchhCCCCCC--CHHHHHHHHHHHHh
Q 048724 316 FTDVSSAVVRQN-------------------LRPDIPRCCPS----SLASIMRKCWDANPDKRP--VMDEVVKLLEAVNT 370 (394)
Q Consensus 316 ~~~~~~~~~~~~-------------------~~~~~~~~~~~----~l~~li~~cL~~dP~~Rp--t~~~ll~~l~~~~~ 370 (394)
..++...+..++ ...++|-..+. .+...+..+|..+|++|. .+.+....+++|..
T Consensus 233 ~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 233 NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred cchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 222333322211 11122222233 355678889999999998 88888888888865
Q ss_pred c
Q 048724 371 S 371 (394)
Q Consensus 371 ~ 371 (394)
.
T Consensus 313 ~ 313 (732)
T KOG4250|consen 313 L 313 (732)
T ss_pred h
Confidence 3
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.85 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=207.2
Q ss_pred cccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKF 154 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 154 (394)
..|.+.+++|+++++||+|+|+.|.++++ +.+.+|+|++++.--.. .+...-...|-.+..+. +||.+|-+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd------dedidwvqtek~vfe~asn~pflvgl 316 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNNPFLVGL 316 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC------cccchhHHhhHHHHHhccCCCeEEeh
Confidence 46889999999999999999999999987 67899999997532110 11123344566666666 89999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
..+|.....+ ++|.||.+||+|--.+.+. ..++++.+..+...|+.||.|||++|||+
T Consensus 317 hscfqtesrl--------------------ffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiy 374 (593)
T KOG0695|consen 317 HSCFQTESRL--------------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIY 374 (593)
T ss_pred hhhhcccceE--------------------EEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeee
Confidence 9999877666 8899999999997666443 45999999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCC--
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYP-- 312 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~-- 312 (394)
||||.+|||++..|++||+|+|+++-...+....++.+|||.|+|||++++..|..++|+|+||++++||+.|+.||.
T Consensus 375 rdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 375 RDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred eeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 999999999999999999999999865566667778999999999999999999999999999999999999999993
Q ss_pred -----CCChhhHHHHH-HhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 048724 313 -----DLSFTDVSSAV-VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356 (394)
Q Consensus 313 -----~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp 356 (394)
..+.++...++ +... ..+|...+.....+++..|++||.+|.
T Consensus 455 gm~n~d~ntedylfqvilekq--iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 455 GMDNPDMNTEDYLFQVILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cCCCcccchhHHHHHHHhhhc--ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 23333444333 3333 346777888889999999999999995
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.75 Aligned_cols=218 Identities=21% Similarity=0.239 Sum_probs=178.4
Q ss_pred CCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCC
Q 048724 96 GTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATS 173 (394)
Q Consensus 96 G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~ 173 (394)
|.||.||++.+ +++.||+|.++... .+..|...+....||||+++++++.+....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~--------- 60 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSV--------- 60 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------------hhhhHHHHHHhcCCCceeehhhheecCCeE---------
Confidence 89999999988 78899999986421 122344555566799999999998765554
Q ss_pred CCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEe
Q 048724 174 DSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253 (394)
Q Consensus 174 ~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~ 253 (394)
|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++++
T Consensus 61 -----------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 127 (237)
T cd05576 61 -----------FLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLT 127 (237)
T ss_pred -----------EEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 8999999999999998654 358999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCC
Q 048724 254 DFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP 333 (394)
Q Consensus 254 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 333 (394)
|||.+...... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.|+...... ........++
T Consensus 128 df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~ 198 (237)
T cd05576 128 YFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIP 198 (237)
T ss_pred cccchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCc
Confidence 99987643322 22345677899999998888999999999999999999999887543211 1112233456
Q ss_pred CCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 334 RCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 334 ~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
..++..++++|.+||+.||++||++
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 6789999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=332.33 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=191.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..+.....||+|+||.||+|++ ++..||||.++.... ....|++++++++|||||+++|+|.+..
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------------IPSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------------ccHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 3456677899999999999987 688999998863221 1124688899999999999999998765
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCCcccCCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLH---SKTIVHRDVKT 239 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH---~~~iiH~Dlkp 239 (394)
.. |+||||+++|+|.++++ .+++..+..|+.|++.||+||| +.+++||||||
T Consensus 757 ~~--------------------~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 757 GA--------------------YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred CC--------------------EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 54 89999999999999994 2889999999999999999999 67999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--h
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--T 317 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~--~ 317 (394)
+||+++.++..++. ||....... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||..... .
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred HhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 99999988887775 665543211 1123678999999999999999999999999999999999999853211 1
Q ss_pred hHH---HHHH-----hccCCCCCC------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCC
Q 048724 318 DVS---SAVV-----RQNLRPDIP------RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGG 375 (394)
Q Consensus 318 ~~~---~~~~-----~~~~~~~~~------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~ 375 (394)
... .... ....++... .....++.+++.+||+.+|++|||+.++++.|+++.......
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccc
Confidence 111 0000 000111111 112345778999999999999999999999999997654433
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=254.33 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=205.0
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|+-.++||+|.||+||+|+. +++.||+|.++...++... -....+|+-+|+.++|.|||+++++...+..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-------pssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-------PSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-------cHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 466677899999999999987 7789999999866543222 2345679999999999999999998876665
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ -+|+||| ..+|..|...- ++.++...+..++.|+++||.++|++++.||||||.|+|
T Consensus 76 l--------------------tlvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnll 133 (292)
T KOG0662|consen 76 L--------------------TLVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLL 133 (292)
T ss_pred e--------------------EEeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEE
Confidence 5 7899999 45999888654 467999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSS 321 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~ 321 (394)
|+.+|.+||+|||+++....+.+..+....|..|.+|.++-+. -|+.+.|+||.||++.|+.. |.+-|++.+..+...
T Consensus 134 in~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 134 INRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred eccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 9999999999999999877776667778899999999999774 58899999999999999985 677799988877776
Q ss_pred HHHhccCC---CCC---------------C---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLR---PDI---------------P---------RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~---~~~---------------~---------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.+.--. ..+ | ...+..-++++.++|.-+|.+|.+++.+++.
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 66432100 000 1 1122345789999999999999999988763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=277.80 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=195.0
Q ss_pred cccccceeeeccCCceEEEEEEEC------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
+..|+.++.||+|+||.||+|..+ ...+|||.++..++...-+ ....+|+.+++.++|||++.+..+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-------~SAcREiaL~REl~h~nvi~Lv~V 95 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-------MSACREIALLRELKHPNVISLVKV 95 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-------HHHHHHHHHHHHhcCCcchhHHHH
Confidence 578999999999999999999652 2379999998665543322 344579999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK---RKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
|... +...++++||.+. +|...|+-++ ...++...+..|+.||+.|+.|||++-|+|
T Consensus 96 fl~~-------------------d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlH 155 (438)
T KOG0666|consen 96 FLSH-------------------DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLH 155 (438)
T ss_pred Hhcc-------------------CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheee
Confidence 8753 2334999999965 8888886432 357899999999999999999999999999
Q ss_pred cCCCCCceeeCCC----CcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHh
Q 048724 235 RDVKTENMLLDAN----RTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 235 ~Dlkp~NIll~~~----~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ellt 306 (394)
|||||.|||+..+ |.|||+|||++++....... ....+.|..|.|||.+.+. -|+++.|||+.||++.||++
T Consensus 156 RDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 156 RDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 9999999999877 89999999999976654322 2335678999999999874 69999999999999999999
Q ss_pred CCCCCCCCCh---------hhHHHHHHhc-c----------------------CCCCC------------CCCCcHHHHH
Q 048724 307 CDMPYPDLSF---------TDVSSAVVRQ-N----------------------LRPDI------------PRCCPSSLAS 342 (394)
Q Consensus 307 g~~Pf~~~~~---------~~~~~~~~~~-~----------------------~~~~~------------~~~~~~~l~~ 342 (394)
.++-|.+... .+....+..- + ++... .+.-++...+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 8776643210 0111111100 0 00000 0112455789
Q ss_pred HHHHhchhCCCCCCCHHHHHHH
Q 048724 343 IMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 343 li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
|+.++|+.||-+|.|++++++.
T Consensus 316 LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHhccCchhhccHHHHhcc
Confidence 9999999999999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=282.45 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=205.5
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
.-.++|-++..||+|||+.||+|-+ .++.||||+-...+. ...+..+...+...+|..|-+.|+||.||++|++|.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~--WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKN--WRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccc--hhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 3457788999999999999999977 677999998764443 233444555677778999999999999999999986
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK--TIVHRDV 237 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--~iiH~Dl 237 (394)
-+.+ .+|-|+|||+|.+|+-||+.+ +.++++.+..|+.||+.||.||.+. .|||-||
T Consensus 538 lDtd-------------------sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDL 596 (775)
T KOG1151|consen 538 LDTD-------------------SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDL 596 (775)
T ss_pred eccc-------------------cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeecc
Confidence 4332 349999999999999999665 4599999999999999999999965 6999999
Q ss_pred CCCceeeC---CCCcEEEeeccccccccCCCCC-------ccCCCCCCCcCCccccCC----CCCCccchHHHHHHHHHH
Q 048724 238 KTENMLLD---ANRTLKIADFGVARVEAQNPRD-------MTGETGTLGYMAPEVLDG----KPYNRKCDVYSFGICLWE 303 (394)
Q Consensus 238 kp~NIll~---~~~~vkl~DFG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~e 303 (394)
||.|||+- ..|.+||+|||++++...+... .....||..|++||.+.- ...+.++||||.||++|.
T Consensus 597 KPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 597 KPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred CCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 99999994 4578999999999976544322 234679999999999853 357889999999999999
Q ss_pred HHhCCCCCCCCCh-hhHHHHH-Hhc--cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 304 IYCCDMPYPDLSF-TDVSSAV-VRQ--NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 304 lltg~~Pf~~~~~-~~~~~~~-~~~--~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
++.|+-||..... .++.... +.. ...++....++.+.++||++||+..-++|....++..
T Consensus 677 ClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 9999999975432 2332211 111 1222333458999999999999999999999988875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=265.71 Aligned_cols=235 Identities=32% Similarity=0.517 Sum_probs=193.2
Q ss_pred CceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCC
Q 048724 97 TYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSD 174 (394)
Q Consensus 97 ~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~ 174 (394)
+||.||+|++ +|+.+|+|++....... ....+.+|+..+++++|+||+++++.+......
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~---------- 62 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--------KRERILREISILKKLKHPNIVRLYDVFEDEDKL---------- 62 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--------HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEE----------
Confidence 5899999998 46899999987433210 046788999999999999999999998765443
Q ss_pred CCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEee
Q 048724 175 SHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254 (394)
Q Consensus 175 ~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~D 254 (394)
++++||+++++|.+++.... .+++..++.++.+++.++.|||+.+++|+||+|.||+++.++.++|+|
T Consensus 63 ----------~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d 130 (244)
T smart00220 63 ----------YLVMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLAD 130 (244)
T ss_pred ----------EEEEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEcc
Confidence 89999999999999986543 389999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CChhhHHHHHHhccCCCCCC
Q 048724 255 FGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD-LSFTDVSSAVVRQNLRPDIP 333 (394)
Q Consensus 255 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~ 333 (394)
||.+....... ......++..|++||.+.+..++.++|||+||+++|++++|..||.. .......... .........
T Consensus 131 ~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 208 (244)
T smart00220 131 FGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI-GKPKPPFPP 208 (244)
T ss_pred ccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hccCCCCcc
Confidence 99997644321 33345788899999999988889999999999999999999999987 3444433333 322222222
Q ss_pred CC--CcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 334 RC--CPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 334 ~~--~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.. ++..+.+++.+||..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11 8899999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=289.57 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=200.9
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+...-|..++.||-|+||.|-++.- +...||+|.+++.+. .........+.|-.||...+.+.||+||-.|
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV------l~rnQvaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV------LMRNQVAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH------HhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 34556788899999999999998854 778999999975432 2222345667899999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.+.+ |+||+|++||++-.+|.+. +.|.+..+..++.++..|+++.|..|+||||||
T Consensus 699 QDkdnL--------------------YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiK 756 (1034)
T KOG0608|consen 699 QDKDNL--------------------YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 756 (1034)
T ss_pred ccCCce--------------------EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccC
Confidence 999988 8899999999999998654 568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeecccccccc--------CCC---C-------------------------------CccCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEA--------QNP---R-------------------------------DMTGETGTLG 276 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~--------~~~---~-------------------------------~~~~~~gt~~ 276 (394)
|+|||||.+|+|||+|||+++-.. ... + .....+||+.
T Consensus 757 PDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~n 836 (1034)
T KOG0608|consen 757 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPN 836 (1034)
T ss_pred ccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCc
Confidence 999999999999999999985210 000 0 0012359999
Q ss_pred cCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH--hccCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 048724 277 YMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV--RQNLRPDIPRCCPSSLASIMRKCWDANPDK 354 (394)
Q Consensus 277 y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cL~~dP~~ 354 (394)
|+|||++....|+..+|+||.|++||||+.|++||-.....+....+. +..+....-..++.+..++|.++. ..+++
T Consensus 837 yiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~ 915 (1034)
T KOG0608|consen 837 YIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADS 915 (1034)
T ss_pred ccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhh
Confidence 999999999999999999999999999999999998776665554442 333444445678999999998844 37777
Q ss_pred CC
Q 048724 355 RP 356 (394)
Q Consensus 355 Rp 356 (394)
|.
T Consensus 916 RL 917 (1034)
T KOG0608|consen 916 RL 917 (1034)
T ss_pred hh
Confidence 75
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=273.98 Aligned_cols=269 Identities=25% Similarity=0.444 Sum_probs=222.3
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 147 (394)
++.++..+...+++....+-+|.||.||+|.|. .+.|-+|.++... ..-....+.+|...+..+.
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--------S~iQv~~~L~es~lly~~s 345 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--------SQIQVNLLLQESMLLYGAS 345 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--------cHHHHHHHHHHHHHHhcCc
Confidence 344566777788888999999999999999762 3467778765221 2223467888999999999
Q ss_pred CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc------ccCCCCHHHHHHHHHHHH
Q 048724 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN------KRKKLAFKVVIQIALDLA 221 (394)
Q Consensus 148 h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~------~~~~l~~~~~~~i~~qi~ 221 (394)
|||+.++.+++...... -++++.++.-|+|..|+... ....++..++..++.|++
T Consensus 346 H~nll~V~~V~ie~~~~-------------------P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla 406 (563)
T KOG1024|consen 346 HPNLLSVLGVSIEDYAT-------------------PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLA 406 (563)
T ss_pred CCCccceeEEEeeccCc-------------------ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHH
Confidence 99999999998753332 27899999889999999732 223577788899999999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCC-CCC-ccCCCCCCCcCCccccCCCCCCccchHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN-PRD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~-~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 299 (394)
.|++|||+.|+||.||..+|.+|++.-.+||+|=.+++-.-.. ... -...-.+..||+||.+.+..|+.++||||||+
T Consensus 407 ~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGV 486 (563)
T KOG1024|consen 407 MAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGV 486 (563)
T ss_pred HHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHH
Confidence 9999999999999999999999999999999999888742211 111 11234678999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 300 CLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 300 ~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
+||||+| |+.||-..++.++...+ ..+++...|.+||+++..+|..||...|++||+++|+..-|.++...
T Consensus 487 llWELmtlg~~PyaeIDPfEm~~yl-kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 487 LLWELMTLGKLPYAEIDPFEMEHYL-KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHHhcCCCCccccCHHHHHHHH-hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 9999998 89999999999988655 67788889999999999999999999999999999999999988753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=277.82 Aligned_cols=248 Identities=25% Similarity=0.415 Sum_probs=199.0
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC--C----ccee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH--P----NVTK 153 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--~----nIv~ 153 (394)
+..++|.+...+|+|+||.|-.+.+ ++..||||+++ .....++.-.-|+++|+++++ | -+|+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik----------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK----------NVDKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHH----------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 3468899999999999999999877 56799999986 234445666679999999942 2 3778
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+.++|....+. |||+|.+ |-++.++|..++-.+++...+..+++|+++++++||+.+++
T Consensus 156 m~~wFdyrghi--------------------Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~ 214 (415)
T KOG0671|consen 156 MRDWFDYRGHI--------------------CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLT 214 (415)
T ss_pred eehhhhccCce--------------------EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhccee
Confidence 87888765554 9999999 77999999988878899999999999999999999999999
Q ss_pred ccCCCCCceeeCC--------------------CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccch
Q 048724 234 HRDVKTENMLLDA--------------------NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCD 293 (394)
Q Consensus 234 H~Dlkp~NIll~~--------------------~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 293 (394)
|-||||+|||+-+ +..|+|+|||.|+...+. .+..+.|..|.|||++.+-+++.++|
T Consensus 215 HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCD 291 (415)
T KOG0671|consen 215 HTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCD 291 (415)
T ss_pred ecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccC
Confidence 9999999999932 225899999999854332 24567899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhh---HHHHHHhc-----------------cCCCCCCCC------------------
Q 048724 294 VYSFGICLWEIYCCDMPYPDLSFTD---VSSAVVRQ-----------------NLRPDIPRC------------------ 335 (394)
Q Consensus 294 vwslG~~l~elltg~~Pf~~~~~~~---~~~~~~~~-----------------~~~~~~~~~------------------ 335 (394)
|||+||+|+|+++|..-|+.-++.+ +.+.++.. + +.+++..
T Consensus 292 vWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~ 370 (415)
T KOG0671|consen 292 VWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKK 370 (415)
T ss_pred ceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHH
Confidence 9999999999999999997766544 22222110 0 1111110
Q ss_pred -------CcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 336 -------CPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 336 -------~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...++.+||++||..||.+|+|+.|++..
T Consensus 371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 371 YMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 11358899999999999999999999863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=268.02 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=204.3
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
-...+.|+-..+||+|.||.||+|+. +|+.||+|.+-..... +..-..-.+|+.+|..++|+|++.++..|
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-------eGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-------EGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-------cCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 34567788888999999999999977 6788999976432211 11123345799999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
........ .....+|+|+.+|+. +|.-+|.+ ....++...+.+++.++..||.|+|+..|+|||+|
T Consensus 86 ~tk~Tp~~------------r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 86 RTKATPTN------------RDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred hhccCCcc------------cccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 75544311 134567999999965 88888754 33569999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCC----CCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQN----PRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
|.|+||+.+|.+||+|||+++..... ...++..+.|..|.+||.+.+ +.|+++.|||..||++.||+++.+-+++
T Consensus 152 aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 152 AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 99999999999999999999754322 234556778999999999876 5799999999999999999999998888
Q ss_pred CChhhHHHHHHh--ccCCC------------------CCCC-------------CCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 314 LSFTDVSSAVVR--QNLRP------------------DIPR-------------CCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 314 ~~~~~~~~~~~~--~~~~~------------------~~~~-------------~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
.+.......+.. +...+ ++++ .-+++..+|+.++|..||.+|+++.+
T Consensus 232 nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 232 NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 776665544321 01100 0111 11457789999999999999999999
Q ss_pred HHHHH
Q 048724 361 VVKLL 365 (394)
Q Consensus 361 ll~~l 365 (394)
++...
T Consensus 312 alnh~ 316 (376)
T KOG0669|consen 312 ALNHD 316 (376)
T ss_pred hhchh
Confidence 88643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=251.50 Aligned_cols=217 Identities=29% Similarity=0.460 Sum_probs=175.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 156 (394)
+++..+++.-+..||+|++|.|-+-++ +|+..|+|.++..-. ....++...|+++..+. .+|.+|.|||
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--------~q~q~r~L~dldi~~r~~~CPf~V~FyG 112 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--------SQEQKRLLMDLDIIMRTVDCPFTVHFYG 112 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--------hHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence 566677788888999999999866555 899999999863321 22346677788877666 8999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCc
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLHSK-TIV 233 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~ii 233 (394)
........ +|.||.| .-+|+.|.++ .....+++..+-+|+..++.||.|||++ .+|
T Consensus 113 a~~regdv--------------------wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vI 171 (282)
T KOG0984|consen 113 ALFREGDV--------------------WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVI 171 (282)
T ss_pred hhhccccE--------------------EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhh
Confidence 88766555 8999999 5688877654 3356799999999999999999999975 899
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC----CCCCCccchHHHHHHHHHHHHhCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD----GKPYNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~~l~elltg~~ 309 (394)
|||+||+||||+.+|+||+||||++..+.+... .+...|...|||||.+. ...|+.++||||||+++.||.+++.
T Consensus 172 HRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~ 250 (282)
T KOG0984|consen 172 HRDVKPSNILINYDGQVKICDFGISGYLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF 250 (282)
T ss_pred hccCCcceEEEccCCcEEEcccccceeehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence 999999999999999999999999986544332 33357888999999985 3479999999999999999999999
Q ss_pred CCCCC-ChhhHHHHHHhc
Q 048724 310 PYPDL-SFTDVSSAVVRQ 326 (394)
Q Consensus 310 Pf~~~-~~~~~~~~~~~~ 326 (394)
||+.+ +..+...+++..
T Consensus 251 PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 251 PYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cccccCCHHHHHHHHhcC
Confidence 99865 455555565543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.27 Aligned_cols=257 Identities=16% Similarity=0.193 Sum_probs=169.9
Q ss_pred cccccccccceeeeccCCceEEEEEEE--C----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--D----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
+....++|++.+.||+|+||+||+|++ + +..||||.++.... . +.+..+ .++...+.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-------~----e~~~~e--~l~~~~~~~~~~ 193 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-------V----EIWMNE--RVRRACPNSCAD 193 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-------h----HHHHHH--HHHhhchhhHHH
Confidence 455678999999999999999999988 4 67999998752210 0 111111 122222333333
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccC------------------CCCHHHHHH
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK------------------KLAFKVVIQ 215 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~------------------~l~~~~~~~ 215 (394)
++..+..... .......++|+||+.+++|.+++...... ...+..+..
T Consensus 194 ~~~~~~~~~~--------------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~ 259 (566)
T PLN03225 194 FVYGFLEPVS--------------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQT 259 (566)
T ss_pred HHHhhhcccc--------------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHH
Confidence 3322221100 01234569999999999999998653210 112345678
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCceeeCC-CCcEEEeeccccccccCC-CCCccCCCCCCCcCCccccCCC-------
Q 048724 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDA-NRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLDGK------- 286 (394)
Q Consensus 216 i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~-~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------- 286 (394)
++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+++..... ........+++.|+|||.+...
T Consensus 260 i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~ 339 (566)
T PLN03225 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 339 (566)
T ss_pred HHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCc
Confidence 9999999999999999999999999999985 579999999999743222 1122345789999999976322
Q ss_pred ---------------CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhcc---------CCCC----------C
Q 048724 287 ---------------PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN---------LRPD----------I 332 (394)
Q Consensus 287 ---------------~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~~----------~ 332 (394)
.++.++|||||||++|||+++..|+... .......+...+ .... .
T Consensus 340 ~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (566)
T PLN03225 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEV 418 (566)
T ss_pred cccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhh
Confidence 2344679999999999999977665321 111111111000 0000 0
Q ss_pred CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 333 PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 333 ~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+....+||.+||+.||++|||+.++++.
T Consensus 419 ~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 419 LDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred ccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 11123345689999999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=284.77 Aligned_cols=272 Identities=18% Similarity=0.238 Sum_probs=187.4
Q ss_pred ccccccccceeeeccCCceEEEEEEE------------------CCeeEEEEEeecccccccchHH-----HHHHHHHHH
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY------------------DGQDVAVKILDWAEDGMVTSAE-----AAAIRASFR 137 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------------------~g~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~ 137 (394)
....++|++.++||+|+||+||+|.+ .++.||||.++........... .....+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34688999999999999999999964 3457999998643221100000 001123344
Q ss_pred HHHHHHHhCCCCcc-----eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------
Q 048724 138 QEVAVWQKLDHPNV-----TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-------- 204 (394)
Q Consensus 138 ~E~~il~~l~h~nI-----v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-------- 204 (394)
.|+.++.+++|.++ ++++++|.....- ........++||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~------------g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~ 288 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTAD------------GAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLE 288 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhccccccc------------ccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHH
Confidence 57777778866654 6677776532110 0112234599999999999999986421
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC-CCcc
Q 048724 205 --------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMT 269 (394)
Q Consensus 205 --------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~ 269 (394)
...+++..++.++.|++.+|.|||+++++||||||+|||++.++.+||+|||++....... ....
T Consensus 289 e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 368 (507)
T PLN03224 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPL 368 (507)
T ss_pred HHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCcc
Confidence 1134677889999999999999999999999999999999999999999999986432211 1111
Q ss_pred CCCCCCCcCCccccCCCC--------------------CC--ccchHHHHHHHHHHHHhCCC-CCCCCChhhHH------
Q 048724 270 GETGTLGYMAPEVLDGKP--------------------YN--RKCDVYSFGICLWEIYCCDM-PYPDLSFTDVS------ 320 (394)
Q Consensus 270 ~~~gt~~y~aPE~~~~~~--------------------~~--~~~DvwslG~~l~elltg~~-Pf~~~~~~~~~------ 320 (394)
...+++.|+|||.+.... |+ .+.||||+||++|+|++|.. ||.........
T Consensus 369 ~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~ 448 (507)
T PLN03224 369 YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN 448 (507)
T ss_pred ccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc
Confidence 234578999999985432 11 24699999999999999975 77542211110
Q ss_pred -----HHHHhccCCCCCCCCCcHHHHHHHHHhchhCC---CCCCCHHHHHHH
Q 048724 321 -----SAVVRQNLRPDIPRCCPSSLASIMRKCWDANP---DKRPVMDEVVKL 364 (394)
Q Consensus 321 -----~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP---~~Rpt~~~ll~~ 364 (394)
..+............+++..++|+.+||..+| .+|+|++++|++
T Consensus 449 ~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 449 DLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111223333445678999999999999866 689999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=287.28 Aligned_cols=241 Identities=25% Similarity=0.422 Sum_probs=186.5
Q ss_pred cceeeeccCCceE-EEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccc
Q 048724 88 DIRHEIARGTYGT-VYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 88 ~~~~~lG~G~fg~-Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 165 (394)
.-.+.+|.|+-|+ ||+|.+.|+.||||++-. .......+|+..|+.- +|||||++++.-.+...+
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~------------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~- 578 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLE------------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL- 578 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhh------------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceE-
Confidence 3455689999986 689999999999998731 1124556899999998 799999999887666655
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
||..|.| ..+|.+++... ......-...+.+..|++.||++||+.+||||||||.|||
T Consensus 579 -------------------YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNIL 638 (903)
T KOG1027|consen 579 -------------------YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNIL 638 (903)
T ss_pred -------------------EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEE
Confidence 8999999 67999999763 1111111345788999999999999999999999999999
Q ss_pred eCC---C--CcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC-CCCCCCC
Q 048724 244 LDA---N--RTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDL 314 (394)
Q Consensus 244 l~~---~--~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~Pf~~~ 314 (394)
|+. + ..++|+|||+++...... .......||.+|+|||++....-+.++|||||||++|+.++| ..||.+.
T Consensus 639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 639 ISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred EEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 975 2 468999999998654432 234556899999999999988888899999999999999997 8899765
Q ss_pred ChhhHHHHHHhccCCCCCCC-CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPR-CCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+ .+++..+.....-. .-..+..+||.+|++++|..||++.+|+.
T Consensus 719 ~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 719 LERQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHhh--hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 4333 23434332211111 11128899999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=241.87 Aligned_cols=249 Identities=21% Similarity=0.376 Sum_probs=196.9
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFI 155 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~ 155 (394)
.|- ..++|++.+++|+|-|+.||.|.. +++.++||+++.-+ .+.+.+|+.||+.|. ||||++++
T Consensus 33 ~wg-~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------------kkKIkREikIL~nL~gg~NIi~L~ 99 (338)
T KOG0668|consen 33 DWG-NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------------KKKIKREIKILQNLRGGPNIIKLL 99 (338)
T ss_pred ecc-ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------------HHHHHHHHHHHHhccCCCCeeehh
Confidence 344 468999999999999999999985 78899999998433 467889999999995 99999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
++..++..- ...+|+||+.+.+...+. ..++...+..++.+++.||.|+|+.||+||
T Consensus 100 DiV~Dp~Sk------------------tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHR 156 (338)
T KOG0668|consen 100 DIVKDPESK------------------TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHR 156 (338)
T ss_pred hhhcCcccc------------------CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccc
Confidence 998765543 237899999988887665 347888899999999999999999999999
Q ss_pred CCCCCceeeCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCC-
Q 048724 236 DVKTENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYP- 312 (394)
Q Consensus 236 Dlkp~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~- 312 (394)
|+||.|++|+. ...++|+|+|+|..... .........+..|..||.+.. ..|+.+-|+|||||++..|++.+-||-
T Consensus 157 DVKPhNvmIdh~~rkLrlIDWGLAEFYHp-~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 157 DVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred cCCcceeeechhhceeeeeecchHhhcCC-CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 99999999985 46799999999976433 334445567778899999865 568999999999999999999998873
Q ss_pred CCChhhHHHHHH---------------------------hccCCCCC--------CCCCcHHHHHHHHHhchhCCCCCCC
Q 048724 313 DLSFTDVSSAVV---------------------------RQNLRPDI--------PRCCPSSLASIMRKCWDANPDKRPV 357 (394)
Q Consensus 313 ~~~~~~~~~~~~---------------------------~~~~~~~~--------~~~~~~~l~~li~~cL~~dP~~Rpt 357 (394)
+.++.+..-.+. ....+..+ ..-.+++..+|+.++|..|-.+|+|
T Consensus 236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 333322221111 01111111 1224689999999999999999999
Q ss_pred HHHHHHH
Q 048724 358 MDEVVKL 364 (394)
Q Consensus 358 ~~~ll~~ 364 (394)
++|++..
T Consensus 316 akEam~H 322 (338)
T KOG0668|consen 316 AKEAMAH 322 (338)
T ss_pred hHHHhcC
Confidence 9999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=257.19 Aligned_cols=279 Identities=25% Similarity=0.375 Sum_probs=208.3
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+.+-.+.||.|+||+||..++ +|+.||+|.+..- ..+-...+.+.+|+++|...+|.|++..+++......
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 344456899999999999988 8999999987522 2222234677889999999999999998887654332
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
-++ ..+|++.|.+ ..+|.+.|. ....++...+.-+++||++||.|||+.+|.||||||.|+|
T Consensus 127 dfF---------------qEiYV~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLL 188 (449)
T KOG0664|consen 127 SFF---------------QELYVLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLL 188 (449)
T ss_pred hHH---------------HHHHHHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEE
Confidence 222 2347888988 568887774 3456889999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCC-CCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 244 LDANRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
++.+..+||||||+++..... ...++....|..|.|||++.+ ..|+.+.||||.||++.|++..+.-|......+...
T Consensus 189 VNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~ 268 (449)
T KOG0664|consen 189 VNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ 268 (449)
T ss_pred eccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH
Confidence 999999999999999965433 345666788999999999987 469999999999999999998888887666554444
Q ss_pred HHH-----------------------hccCCC-CCC--------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 322 AVV-----------------------RQNLRP-DIP--------RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 322 ~~~-----------------------~~~~~~-~~~--------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.+. +...+. .++ ..-..+...++.++|..||++|.+..+.+..+..
T Consensus 269 lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~-- 346 (449)
T KOG0664|consen 269 MIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL-- 346 (449)
T ss_pred HHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc--
Confidence 332 111111 111 1123456788999999999999999988775432
Q ss_pred hccCCCCCCCCCCCceeEeccCCCC
Q 048724 370 TSKGGGMIPEDQAHGCLCFIPTRGP 394 (394)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (394)
+.+.....-+--|+|++-.++|
T Consensus 347 ---~e~R~r~~sCmC~~~~tt~~~~ 368 (449)
T KOG0664|consen 347 ---EEGRLRFHSCMCSCCYTKPNMP 368 (449)
T ss_pred ---cccceeeeeeeEeeeccCCCcc
Confidence 2333344444455555555543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=257.53 Aligned_cols=136 Identities=24% Similarity=0.391 Sum_probs=115.3
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-----C---Ccce
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-----H---PNVT 152 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---~nIv 152 (394)
...+|.+.++||.|.|+|||+|.+ ..+.||+|+.+. .....+.-..|+++|++++ | ..||
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 348999999999999999999988 567999999972 2334455668999999983 2 4799
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KT 231 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~ 231 (394)
+|++.|..... ...++|+|+|++ |.+|..+|....-..++...+.+|++||+.||.|||. .|
T Consensus 146 ~LlD~FkhsGp----------------NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 146 QLLDHFKHSGP----------------NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred eeeccceecCC----------------CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 99999975443 345679999999 8899999988777789999999999999999999995 69
Q ss_pred CcccCCCCCceeeC
Q 048724 232 IVHRDVKTENMLLD 245 (394)
Q Consensus 232 iiH~Dlkp~NIll~ 245 (394)
|||-||||+|||+.
T Consensus 209 IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 209 IIHTDLKPENVLLC 222 (590)
T ss_pred ccccCCCcceeeee
Confidence 99999999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=270.14 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=202.4
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC------Cccee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH------PNVTK 153 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h------~nIv~ 153 (394)
+--.+|.+....|+|-||+|.+|.+ .|+.||||+++... .+.+.=..|++||++|+. -|+++
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----------~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----------VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----------HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3346788999999999999999988 57899999998433 122333469999999953 48999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++..|...+++ |+|+|.+ ..+|.+.|++.. ...|....+..++.|++.||.+|...||
T Consensus 499 l~r~F~hknHL--------------------ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~v 557 (752)
T KOG0670|consen 499 LFRHFKHKNHL--------------------CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGV 557 (752)
T ss_pred HHHHhhhccee--------------------EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCe
Confidence 99999988887 9999999 679999997643 3468899999999999999999999999
Q ss_pred cccCCCCCceeeCCC-CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 233 VHRDVKTENMLLDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 233 iH~Dlkp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
+|.||||+|||++++ ..+||||||.|.....+ ..+....+..|.|||++.|.+|+...|+||.||+||||+||+.-|
T Consensus 558 lHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 558 LHADIKPDNILVNESKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred eecccCccceEeccCcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 999999999999875 46799999999754433 233345667899999999999999999999999999999999999
Q ss_pred CCCChhhHHHHHHhcc-----------------CCCCC-----------------------C-----------CCCc---
Q 048724 312 PDLSFTDVSSAVVRQN-----------------LRPDI-----------------------P-----------RCCP--- 337 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~-----------------~~~~~-----------------------~-----------~~~~--- 337 (394)
++.++.+++...+.-. +...+ | ..++
T Consensus 636 pG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq 715 (752)
T KOG0670|consen 636 PGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ 715 (752)
T ss_pred CCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence 9999888876543210 00000 0 0011
Q ss_pred ----HHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 338 ----SSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 338 ----~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..|++||.+||..||++|.|..++|..
T Consensus 716 ~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 716 PKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 358899999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=277.84 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=212.2
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|+....+|.|+||.||+|++ +++..|+|+++...... ..-+.+|+-+++.++|||||.++|.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---------~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---------FSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---------ccccccceeeeecCCCcChHHHHhhhhhh
Confidence 47899999999999999999988 78999999998543322 24456799999999999999999998877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ +|.||||.||+|.+.. +-.+++++.++...++..++|++|||++|-+|||||-.|
T Consensus 85 dkl--------------------wicMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGan 142 (829)
T KOG0576|consen 85 DKL--------------------WICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGAN 142 (829)
T ss_pred cCc--------------------EEEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccc
Confidence 766 8999999999999876 446789999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCcccc---CCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL---DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||+++.|.+|+.|||.+..+.....+.....||+.|||||+. +...|...+|||++|++..|+--.++|..+.....
T Consensus 143 illtd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr 222 (829)
T KOG0576|consen 143 ILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR 222 (829)
T ss_pred eeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH
Confidence 999999999999999998666555566668999999999987 35679999999999999999988899977777666
Q ss_pred HHHHHHhccCCCCC---CCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 319 VSSAVVRQNLRPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 319 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
........++.++. +...++.|.+|++.||.++|.+||+++.+|
T Consensus 223 ~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 223 ALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 66555555554432 245789999999999999999999998765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=235.85 Aligned_cols=210 Identities=38% Similarity=0.697 Sum_probs=180.7
Q ss_pred eccCCceEEEEEEEC--CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAYD--GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
||+|++|.||++... ++.+++|++....... ....+.+|+.+++.+.|++++++++++......
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~------ 66 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL------ 66 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE------
Confidence 689999999999995 8999999987443211 246788999999999999999999998765443
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC-CCc
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA-NRT 249 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~-~~~ 249 (394)
++++||+++++|.+++.... ..+++..++.++.++++++.+||+.|++|+||+|.||+++. ++.
T Consensus 67 --------------~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~ 131 (215)
T cd00180 67 --------------YLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK 131 (215)
T ss_pred --------------EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc
Confidence 89999999999999986542 35899999999999999999999999999999999999998 899
Q ss_pred EEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccC
Q 048724 250 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328 (394)
Q Consensus 250 vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 328 (394)
++|+|||.+..............+...|++||.+... .++.++|+|++|++++++
T Consensus 132 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------ 187 (215)
T cd00180 132 VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187 (215)
T ss_pred EEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------
Confidence 9999999997544332223335678899999999877 788999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 329 RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 329 ~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+.+++.+||+.+|++||++.++++.
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 678999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=243.64 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=197.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|.-++.+|.|.- .|--|-+ .+++||+|........... .++-.+|..++..++|+||++++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~-------akra~rel~l~~~v~~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH-------AKRAYRELKLMKCVNHKNIISLLNVFTPQ 87 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc-------chhhhhhhhhhhhhcccceeeeeeccCcc
Confidence 456777778999998 5655655 7899999987544221111 24455799999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+.. -...|+|||++ ..+|...+. -.++-..+..|++|++.|++|||+.||+||||||+|
T Consensus 88 ~~l~~--------------~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsn 148 (369)
T KOG0665|consen 88 KTLEE--------------FQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSN 148 (369)
T ss_pred ccHHH--------------HHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccc
Confidence 55422 23458999999 569988875 237788899999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|++..++.+||.|||+|+..... -.++....|..|.|||++.+..|...+||||+||++.||++|+.-|++.+..+...
T Consensus 149 ivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ 227 (369)
T KOG0665|consen 149 IVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN 227 (369)
T ss_pred ceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence 99999999999999999864433 45666788999999999999889999999999999999999999998776555444
Q ss_pred HHHhc---------------------cC--------CCCCC-----------CCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 322 AVVRQ---------------------NL--------RPDIP-----------RCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 322 ~~~~~---------------------~~--------~~~~~-----------~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
.+... .. ...+| ..-...+++++.+||..||++|.+++++
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 33221 00 00011 1113457899999999999999999999
Q ss_pred HHH
Q 048724 362 VKL 364 (394)
Q Consensus 362 l~~ 364 (394)
|..
T Consensus 308 L~H 310 (369)
T KOG0665|consen 308 LRH 310 (369)
T ss_pred hcC
Confidence 974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=263.81 Aligned_cols=205 Identities=26% Similarity=0.397 Sum_probs=167.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---CCcceeeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---HPNVTKFIGAS 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~ 158 (394)
..+|..++.+|.|+||.|++|++ +...|+||.+.+.+--......... .-..-.|+.||..++ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrk-LGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRK-LGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccc-cCccchhHHHHHHhhhcCccchhhhhhee
Confidence 45689999999999999999998 4568999998654311111111100 112335999999997 99999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecC-CCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL-PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
.+++.+ ||++|-- +|.+|.++|..+ +.+++..+..|++||+.|+++||++|||||||
T Consensus 639 Eddd~y--------------------yl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdi 696 (772)
T KOG1152|consen 639 EDDDYY--------------------YLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDI 696 (772)
T ss_pred ecCCee--------------------EEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceeccc
Confidence 988776 8888875 456999999654 45999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
|-+||.++.+|.+||+|||.+......+- ...+||..|.|||++.+.+| ...-|||+||++||.++....||.+
T Consensus 697 kdenvivd~~g~~klidfgsaa~~ksgpf--d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 697 KDENVIVDSNGFVKLIDFGSAAYTKSGPF--DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccccEEEecCCeEEEeeccchhhhcCCCc--ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999999999976544332 24689999999999999876 4678999999999999999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=230.69 Aligned_cols=211 Identities=35% Similarity=0.550 Sum_probs=173.1
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|.+.+.||.|++|+||++.. +++.+|+|.+...... .....+.+|+..++.++|+|++++++.+......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPL 72 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCce
Confidence 56778999999999999998 3689999998743321 1346788899999999999999999988765443
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
++++||+++++|.+++..... .+++..++.++.+++.++.+||+++++|+||+|.||++
T Consensus 73 --------------------~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v 131 (225)
T smart00221 73 --------------------YLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL 131 (225)
T ss_pred --------------------EEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 899999999999999865432 28899999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCcccc-CCCCCCccchHHHHHHHHHHHHhCCCCCCC-CChhhHHH
Q 048724 245 DANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVL-DGKPYNRKCDVYSFGICLWEIYCCDMPYPD-LSFTDVSS 321 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~Pf~~-~~~~~~~~ 321 (394)
+.++.++|+|||.+....... .......++..|++||.+ ....++.++|||+||+++++|++|+.||.. ........
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 132 GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 999999999999987654332 122335678889999998 667788899999999999999999999977 45543443
Q ss_pred HHHhc
Q 048724 322 AVVRQ 326 (394)
Q Consensus 322 ~~~~~ 326 (394)
..+..
T Consensus 212 ~~~~~ 216 (225)
T smart00221 212 DVWSF 216 (225)
T ss_pred HHHhc
Confidence 44333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=230.02 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=186.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGT 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 161 (394)
+.|++.+.||+|.||.+.++.+ +++.+++|.+...-. ..++|.+|...--.| .|.||+.-|++....
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----------t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----------TQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----------hHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 6789999999999999999998 567999998863321 147788888766566 689999888765433
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.. .+.+++||++-|+|..-+.. ..+.+.....++.|++.||.|+|++++||||||.+|
T Consensus 94 ~d-------------------~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eN 151 (378)
T KOG1345|consen 94 SD-------------------AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAEN 151 (378)
T ss_pred Cc-------------------eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccce
Confidence 32 33789999999999887733 458899999999999999999999999999999999
Q ss_pred eeeC--CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 242 MLLD--ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 242 Ill~--~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||- +...|||||||..+........ ..-+..|.+||.... -..++.+|||.||+++|.++||.+||+..
T Consensus 152 iLif~~df~rvKlcDFG~t~k~g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 152 ILIFDADFYRVKLCDFGLTRKVGTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred EEEecCCccEEEeeecccccccCceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 9993 3458999999998754332221 234567889988743 23567899999999999999999999754
Q ss_pred ChhhHH-H--HHHhccCCCCCC---CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 315 SFTDVS-S--AVVRQNLRPDIP---RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 315 ~~~~~~-~--~~~~~~~~~~~~---~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
...+.. . ....++..+..| ..+++.+..+.++-|..+|++|....++.++..
T Consensus 229 ~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 229 SIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 322211 1 112233334444 346888999999999999999965555555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=215.29 Aligned_cols=163 Identities=25% Similarity=0.368 Sum_probs=130.5
Q ss_pred CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCC
Q 048724 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETG 273 (394)
Q Consensus 194 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~g 273 (394)
|+|.+++..+ ...+++.+++.|+.|++.||.|||+++ ||+|||++.++.+++ ||++...... ...|
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g 66 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRV 66 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCC
Confidence 6899999653 356999999999999999999999998 999999999999999 9998754332 1368
Q ss_pred CCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh-hHHHHHHhccCCC-----CCCCCCcH--HHHHHHH
Q 048724 274 TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT-DVSSAVVRQNLRP-----DIPRCCPS--SLASIMR 345 (394)
Q Consensus 274 t~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~--~l~~li~ 345 (394)
++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+....... ..+...+. ++.+++.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 89999999999999999999999999999999999999765432 2222222211111 01122333 6999999
Q ss_pred HhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 346 KCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 346 ~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+||+.+|++||++.++++.+..+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=230.34 Aligned_cols=245 Identities=23% Similarity=0.393 Sum_probs=187.7
Q ss_pred cccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 157 (394)
.+.|....+||+|+|++||+|++ .+..||+|.+..... -..+..|+++|..+ .+.||+++.++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----------p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----------PSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----------chHHHHHHHHHHHhccchhhhcchhh
Confidence 35678888999999999999976 356899998864322 24577899999999 68999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...+.. ++|+||++.....+++.. ++...+..++..++.||.++|.+|||||||
T Consensus 104 ~rnnd~v--------------------~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDi 158 (418)
T KOG1167|consen 104 FRNNDQV--------------------AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDI 158 (418)
T ss_pred hccCCee--------------------EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCC
Confidence 9877776 899999999999998733 778899999999999999999999999999
Q ss_pred CCCceeeCC-CCcEEEeeccccccc-----------------cC-C--------------C------------CCccCCC
Q 048724 238 KTENMLLDA-NRTLKIADFGVARVE-----------------AQ-N--------------P------------RDMTGET 272 (394)
Q Consensus 238 kp~NIll~~-~~~vkl~DFG~a~~~-----------------~~-~--------------~------------~~~~~~~ 272 (394)
||.|+|.+. .+.-.|.|||+|... .. . + .......
T Consensus 159 KpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrA 238 (418)
T KOG1167|consen 159 KPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRA 238 (418)
T ss_pred CccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccC
Confidence 999999974 567799999998610 00 0 0 0001245
Q ss_pred CCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChh-hHHHHH---------------------Hh----
Q 048724 273 GTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT-DVSSAV---------------------VR---- 325 (394)
Q Consensus 273 gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~-~~~~~~---------------------~~---- 325 (394)
||++|.|||++.. ...+.+.||||.|+++..++++..||-..... +....+ ..
T Consensus 239 GT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~ 318 (418)
T KOG1167|consen 239 GTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNI 318 (418)
T ss_pred CCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccc
Confidence 9999999999865 45788999999999999999999998322100 000000 00
Q ss_pred ----------ccC-------------C-CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 326 ----------QNL-------------R-PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 326 ----------~~~-------------~-~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+ . ....+..+..+.+|+.+||..||.+|.|++++|+.
T Consensus 319 ~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 319 PTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 0 01112345688999999999999999999999973
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=266.28 Aligned_cols=202 Identities=21% Similarity=0.252 Sum_probs=143.1
Q ss_pred hCCC-CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHH
Q 048724 145 KLDH-PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARG 223 (394)
Q Consensus 145 ~l~h-~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~ 223 (394)
.+.| +||+.++++|.....- ......++.++||+ +++|.++|... ...+++..++.++.||++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~a 92 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLD-------------GLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEI 92 (793)
T ss_pred hhhHHHHHHHhhcccCCcccc-------------ccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHH
Confidence 3445 5888888876322211 01123346788887 67999999643 3469999999999999999
Q ss_pred HHHHHhCCCcccCCCCCceeeCCC-------------------CcEEEeeccccccccCCC----------------CCc
Q 048724 224 LSYLHSKTIVHRDVKTENMLLDAN-------------------RTLKIADFGVARVEAQNP----------------RDM 268 (394)
Q Consensus 224 l~yLH~~~iiH~Dlkp~NIll~~~-------------------~~vkl~DFG~a~~~~~~~----------------~~~ 268 (394)
|.|||++||+||||||+||||+.. +.+|++|||+++...... ...
T Consensus 93 l~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (793)
T PLN00181 93 VNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQ 172 (793)
T ss_pred HHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccc
Confidence 999999999999999999999654 445666666665321100 001
Q ss_pred cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhc
Q 048724 269 TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCW 348 (394)
Q Consensus 269 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL 348 (394)
....||+.|+|||.+.+..|+.++|||||||+||||++|.+|+.... .....+......+.. ....+...+++.+||
T Consensus 173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L 249 (793)
T PLN00181 173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQI-LLNWPKEASFCLWLL 249 (793)
T ss_pred cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhh-hhcCHHHHHHHHHhC
Confidence 11357888999999999999999999999999999999988875322 111122111111111 123456778999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 048724 349 DANPDKRPVMDEVVKL 364 (394)
Q Consensus 349 ~~dP~~Rpt~~~ll~~ 364 (394)
+++|.+||++.++++.
T Consensus 250 ~~~P~~Rps~~eil~h 265 (793)
T PLN00181 250 HPEPSCRPSMSELLQS 265 (793)
T ss_pred CCChhhCcChHHHhhc
Confidence 9999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-27 Score=222.79 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=200.8
Q ss_pred cccceeeeccCCceEEEEEEECC---eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC----Ccceeeeeee
Q 048724 86 KLDIRHEIARGTYGTVYRGAYDG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH----PNVTKFIGAS 158 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h----~nIv~l~~~~ 158 (394)
+|.+.+.||+|+||.||++.... ..+|+|+......... ..+..|..++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---------SVLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---------ccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 89999999999999999999833 4799998764332211 145568888888862 5888888776
Q ss_pred c-CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 159 M-GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 159 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
. ... ..|+||+.+ |.+|.++........++..++..|+.|++.+|.+||+.|++||||
T Consensus 90 ~~~~~--------------------~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDi 148 (322)
T KOG1164|consen 90 RSTED--------------------FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDI 148 (322)
T ss_pred cCCCc--------------------eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCc
Confidence 3 222 238999988 899999886665678999999999999999999999999999999
Q ss_pred CCCceeeCCC-----CcEEEeeccccc--cccCCC-------CC-ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 238 KTENMLLDAN-----RTLKIADFGVAR--VEAQNP-------RD-MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 238 kp~NIll~~~-----~~vkl~DFG~a~--~~~~~~-------~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
||.|+++... ..+.|.|||+++ ...... +. .....||..|.++....+...+++.|+||++.++.
T Consensus 149 Kp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~ 228 (322)
T KOG1164|consen 149 KPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLL 228 (322)
T ss_pred CHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHH
Confidence 9999999754 469999999998 321111 11 23456999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHhccCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPD---IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 303 elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
+++.|..||.................... .....+.++.+++..+-..+...+|....+...++......
T Consensus 229 el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 229 ELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 99999999977664333322222111111 33446788999998888899999999999999999887665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=217.74 Aligned_cols=255 Identities=29% Similarity=0.559 Sum_probs=217.1
Q ss_pred ccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
-|...++.+..+|.+...|..|+|+|.|..++.|+++-. .-...+.++|.+|.-.|+-+.||||++++|.|..
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr-------~~t~risrdfneefp~lrifshpnilpvlgacns 258 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVR-------EVTARISRDFNEEFPALRIFSHPNILPVLGACNS 258 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhh-------hcchhhcchhhhhCcceeeecCCchhhhhhhccC
Confidence 366778888889999999999999999999999998632 2334456889999999999999999999999988
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVK 238 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiH~Dlk 238 (394)
..++ .++..|++-|+|+..++.......+..++.+++.++++|++|||+.. |.---|.
T Consensus 259 ppnl--------------------v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~ln 318 (448)
T KOG0195|consen 259 PPNL--------------------VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLN 318 (448)
T ss_pred CCCc--------------------eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcc
Confidence 7776 78999999999999998877777888999999999999999999853 4444688
Q ss_pred CCceeeCCCCcEEEe--eccccccccCCCCCccCCCCCCCcCCccccCCCCCC---ccchHHHHHHHHHHHHhCCCCCCC
Q 048724 239 TENMLLDANRTLKIA--DFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN---RKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 239 p~NIll~~~~~vkl~--DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
+..++|+++.+.+|. |--++.. . ......|.||+||.+..++-+ .++|+|||++++||+.|...||.+
T Consensus 319 s~hvmidedltarismad~kfsfq---e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 319 SKHVMIDEDLTARISMADTKFSFQ---E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred cceEEecchhhhheecccceeeee---c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 999999998876664 3222211 1 123557899999999876544 489999999999999999999999
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.++.+.--.+...+++..+|..++..+..|+.-|++.||.+||.+..++-.|+++.
T Consensus 392 lspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 392 LSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999888888899999999999999999999999999999999999999888764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-26 Score=206.55 Aligned_cols=257 Identities=20% Similarity=0.334 Sum_probs=204.2
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGAS 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 158 (394)
+---+|.++++||+|+||+++.|+. +++.||||.-....+ ...+..|...++.| ..++|...|-+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----------APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----------APQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC-----------cchHHHHHHHHHHHcCCCCCCceeeec
Confidence 4456899999999999999999987 899999997643322 14566788888888 578888876443
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...-+ -.+|+|.+ |-+|+|++.-.. ..++.+++..+|.|++.-++|+|++.+|+||||
T Consensus 94 qeG~~--------------------NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIK 151 (449)
T KOG1165|consen 94 QEGKY--------------------NILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIK 151 (449)
T ss_pred cccch--------------------hhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccC
Confidence 32222 26799998 889999887544 469999999999999999999999999999999
Q ss_pred CCceeeCCC-----CcEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh
Q 048724 239 TENMLLDAN-----RTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 239 p~NIll~~~-----~~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 306 (394)
|+|+||... ..|-|+|||+|+...++. +......||.+||+-....++..+.+.|.-|||-++++.+-
T Consensus 152 PdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLR 231 (449)
T KOG1165|consen 152 PDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 231 (449)
T ss_pred ccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhcc
Confidence 999999643 468999999998644322 22334679999999999999999999999999999999999
Q ss_pred CCCCCCCCCh---hhHHHHHHhccCCCCC---CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 307 CDMPYPDLSF---TDVSSAVVRQNLRPDI---PRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 307 g~~Pf~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|..||.+... .+-+..+-......++ -..+|.++...|+-.=..+-.+-|+.+-+...+.++...
T Consensus 232 GsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 232 GSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred CCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 9999988643 3444444433333222 245789999999998888999999999999999888754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-26 Score=194.93 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=200.0
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC-Ccceeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-PNVTKFIGA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~ 157 (394)
.+..++|.+++.||.|+||.+|+|.. +|..||||+-+..... ..+.-|..+.+.|++ ..|..+.-+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----------pqL~yEskvY~iL~~g~GiP~i~~y 79 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----------PQLLYESKVYRILQGGVGIPHIRHY 79 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----------cchhHHHHHHHHhccCCCCchhhhh
Confidence 45678999999999999999999987 8999999987533221 345568899988854 455555544
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
..+...- .+||+.+ |-+|++++.-.. ..++.++++-++-|++.-++|+|.+++|||||
T Consensus 80 ~~e~~yn--------------------vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDI 137 (341)
T KOG1163|consen 80 GTEKDYN--------------------VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDI 137 (341)
T ss_pred ccccccc--------------------eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccC
Confidence 4443332 7899998 899999886433 35899999999999999999999999999999
Q ss_pred CCCceeeCC---CCcEEEeeccccccccCC-------CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC
Q 048724 238 KTENMLLDA---NRTLKIADFGVARVEAQN-------PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307 (394)
Q Consensus 238 kp~NIll~~---~~~vkl~DFG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg 307 (394)
||+|+|..- ...+.|+|||+|+...+. .+......||.+|.+-....+...+.+.|.-|+|.+|.++--|
T Consensus 138 KPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG 217 (341)
T KOG1163|consen 138 KPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRG 217 (341)
T ss_pred CccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecC
Confidence 999999963 356899999999854322 1222345799999998888888889999999999999999999
Q ss_pred CCCCCCCChh---hHHHHHHhccCCCCCC---CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 308 DMPYPDLSFT---DVSSAVVRQNLRPDIP---RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 308 ~~Pf~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
..||++.... +-...+.+.....++. +.+|.++...+.-|-..--++-|+..-+.+.+.-+.
T Consensus 218 ~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 218 SLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred CCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 9999887543 3333444444333322 557899999999999999999999888887777664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-24 Score=203.64 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=198.4
Q ss_pred ccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC-cceeeeeeecCCCccc
Q 048724 87 LDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP-NVTKFIGASMGTTNLK 165 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~ 165 (394)
|.+...||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++.+.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-- 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS------KEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-- 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch------hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE--
Confidence 677889999999999999988 7899999875432211 2357788999999999888 79999999854333
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll 244 (394)
.+++++++.+++|.+++..... ..+.......++.|++.++.|+|+.+++|||+||+||++
T Consensus 73 ------------------~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~ 134 (384)
T COG0515 73 ------------------LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL 134 (384)
T ss_pred ------------------EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 3899999999999977754321 268999999999999999999999999999999999999
Q ss_pred CCCC-cEEEeeccccccccCCCC------CccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 245 DANR-TLKIADFGVARVEAQNPR------DMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 245 ~~~~-~vkl~DFG~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
+..+ .++++|||.++....... ......++..|++||.+.+ ..++...|+|++|++++++++|..||...
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9888 799999999874433221 2355789999999999987 57888999999999999999999998776
Q ss_pred Ch----hhHHHHHHhccCC---CCCCCCC----cHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 315 SF----TDVSSAVVRQNLR---PDIPRCC----PSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 315 ~~----~~~~~~~~~~~~~---~~~~~~~----~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.. ......+...... ....... ...+.+++..|+..+|..|.+..+....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 215 KNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 63 3333333332221 1111111 2578999999999999999988887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=213.51 Aligned_cols=178 Identities=19% Similarity=0.172 Sum_probs=130.7
Q ss_pred ccccccccceeeeccCCceEEEEEEE---CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee-eee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK-FIG 156 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~-l~~ 156 (394)
..-.++|++.+.||+|+||+||+|.+ +++.||||++...... .........|.+|+.+|++++|+|+++ +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~----~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW----WSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc----cccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 34467899999999999999999987 4677899986421100 001123466899999999999999985 443
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
. . ..|+||||++|++|.. + .. .. ...++.|++++|.|||++||+|||
T Consensus 90 ~----~--------------------~~~LVmE~~~G~~L~~-~--~~---~~---~~~~~~~i~~aL~~lH~~gIiHrD 136 (365)
T PRK09188 90 T----G--------------------KDGLVRGWTEGVPLHL-A--RP---HG---DPAWFRSAHRALRDLHRAGITHND 136 (365)
T ss_pred c----C--------------------CcEEEEEccCCCCHHH-h--Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCC
Confidence 2 1 1289999999999963 2 11 11 146788999999999999999999
Q ss_pred C-CCCceeeCCCCcEEEeeccccccccCCC--------CCccCCCCCCCcCCccccCCC------CCCccchHH
Q 048724 237 V-KTENMLLDANRTLKIADFGVARVEAQNP--------RDMTGETGTLGYMAPEVLDGK------PYNRKCDVY 295 (394)
Q Consensus 237 l-kp~NIll~~~~~vkl~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvw 295 (394)
| ||+|||++.++.++|+|||+++...... .......+++.|+|||.+... ..+..+|-|
T Consensus 137 L~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 137 LAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9 9999999989999999999998543322 111234678889999998532 233446665
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=192.53 Aligned_cols=187 Identities=12% Similarity=0.117 Sum_probs=135.9
Q ss_pred cccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.++|.+.+.||.|+||.||++..++..+|||+++..................+.+|+..+.+++|++|..+..++.....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 47899999999999999999877788999999975432211111111112337899999999999999999888664322
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
-.+ ......+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++||||||.||+
T Consensus 110 ~~~------------~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nil 167 (232)
T PRK10359 110 KTL------------RYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFI 167 (232)
T ss_pred ccc------------cccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEE
Confidence 100 01234589999999999988731 333 24569999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 305 (394)
++.+| ++|+|||........... ...+....|+.++|+|+||+++..+.
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99888 999999988643221110 01333445677899999999887653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=195.61 Aligned_cols=216 Identities=21% Similarity=0.363 Sum_probs=158.5
Q ss_pred CCCcceeeeeeecCCCccccCCCCCCCC--------CCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHH
Q 048724 147 DHPNVTKFIGASMGTTNLKIPSQSATSD--------SHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIAL 218 (394)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~ 218 (394)
+|||||++.++|.+.-... |...+.+. ..-.+.+..+|+||..++ .+|..++..+ ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~l-Pda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVL-PDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccC-CchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHH
Confidence 5999999999998654431 11111111 112234678899999995 5999999554 366777888999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCceee--CCC--CcEEEeeccccccccC------CCCCccCCCCCCCcCCccccCCCC-
Q 048724 219 DLARGLSYLHSKTIVHRDVKTENMLL--DAN--RTLKIADFGVARVEAQ------NPRDMTGETGTLGYMAPEVLDGKP- 287 (394)
Q Consensus 219 qi~~~l~yLH~~~iiH~Dlkp~NIll--~~~--~~vkl~DFG~a~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~- 287 (394)
|+++|+.|||++|+.|||+|++|||+ +++ ..++|+|||++-.... ........-|...-||||+....+
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999999999999999999 333 3679999998743211 011122345778899999986432
Q ss_pred ----C-CccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 288 ----Y-NRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 288 ----~-~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
. -.++|.|+.|.+.||+++...||...-.........++..-+.+|..|++.+++++...|+.||++|++..=+.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 1 24899999999999999999999774433333333344456778899999999999999999999999887666
Q ss_pred HHHHH
Q 048724 363 KLLEA 367 (394)
Q Consensus 363 ~~l~~ 367 (394)
..|.-
T Consensus 509 Nvl~L 513 (598)
T KOG4158|consen 509 NVLNL 513 (598)
T ss_pred hHHHH
Confidence 65553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=222.38 Aligned_cols=251 Identities=26% Similarity=0.351 Sum_probs=185.5
Q ss_pred cceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
.....+|.|++|.|+.... .....+.|..+.. .. ...........+..|+-+-..+.|+|++..+..+.+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~--~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~- 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK--PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI- 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC--CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-
Confidence 3567899999998877655 3344444433210 00 0111111122266788888889999998887776654443
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
.-.||||++ +|..++... ..++...+..+++|++.|+.|+|..|+.||||||+|++++
T Consensus 397 -------------------~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~ 454 (601)
T KOG0590|consen 397 -------------------LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT 454 (601)
T ss_pred -------------------hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence 335999999 999998554 3588889999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 246 ANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDGKPYNR-KCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
.+|.+||+|||.+....... ......+|+..|+|||.+.+..|++ ..||||.|+++..|++|+.||......+..
T Consensus 455 ~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 455 ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 99999999999987543322 3345578999999999999999986 689999999999999999999655444332
Q ss_pred -HHHHhcc-CC-----CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 -SAVVRQN-LR-----PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 -~~~~~~~-~~-----~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....... .. ..+...++...+.+|.+||+.+|.+|.|+++|++.
T Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1111110 00 01123357788999999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=213.36 Aligned_cols=226 Identities=27% Similarity=0.392 Sum_probs=186.5
Q ss_pred eeccCCceEEEEEE-----ECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCCCccc
Q 048724 92 EIARGTYGTVYRGA-----YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 165 (394)
++|+|+||.|++.. +.|+.+|+|++++....... +.....|..++..++ ||.+|++.-.|.....+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-------~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl- 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-------RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKL- 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-------ccccccHHHHHhhccCCCceeeeeeeeccccch-
Confidence 47999999999643 36788999998865533211 124456788888886 99999999998876666
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
+++++|..||.|...+. ....+.+.....+...++.++.++|+.+++|||+|++||+++
T Consensus 73 -------------------~l~ld~~rgg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld 131 (612)
T KOG0603|consen 73 -------------------YLILDFLRGGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL 131 (612)
T ss_pred -------------------hHhhhhcccchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec
Confidence 78999999999987774 345688888889999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHh
Q 048724 246 ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~ 325 (394)
.+|++++.|||.++....... .|||..|||||+++ ....++|+||||++++||++|..||.. ++...+..
T Consensus 132 ~~Ghi~~tdfglske~v~~~~----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 132 LEGHIKLTDFGLSKEAVKEKI----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred ccCccccCCchhhhHhHhhhh----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 999999999999985432221 29999999999999 567889999999999999999999987 55555544
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH
Q 048724 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM 358 (394)
Q Consensus 326 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~ 358 (394)
. .+..|...+...++++..++..+|.+|.-.
T Consensus 202 ~--~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 A--ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred h--ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3 456778889999999999999999999644
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-25 Score=224.92 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=178.4
Q ss_pred cccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccc
Q 048724 86 KLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
++...+.||.+.|=.|.+|++..-.|+||++-+..+...- ....+++ .|++ ...+++||.+++..+-...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL----~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~---- 93 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL----RPFKQRL-EEIK-FALMKAPNCLPFQKVLVTD---- 93 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc----hHHHHHH-HHHH-HHhhcCCcccchHHHHHhh----
Confidence 6777889999999999999996556999998655533221 1112222 2333 5566999999997664433
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
+..|+|-+|..+ +|.|.|. .+..+..-+.+.|+.|++.||..+|..||+|||||.+||||+
T Consensus 94 ----------------kAAylvRqyvkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT 154 (1431)
T KOG1240|consen 94 ----------------KAAYLVRQYVKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT 154 (1431)
T ss_pred ----------------HHHHHHHHHHhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe
Confidence 334789899854 9999884 455688888899999999999999999999999999999999
Q ss_pred CCCcEEEeecccccc--c-cCCCCCccC----CCCCCCcCCccccCCC----------C-CCccchHHHHHHHHHHHHh-
Q 048724 246 ANRTLKIADFGVARV--E-AQNPRDMTG----ETGTLGYMAPEVLDGK----------P-YNRKCDVYSFGICLWEIYC- 306 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~--~-~~~~~~~~~----~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~ellt- 306 (394)
.-+.+.|+||...+. . .+++.+.+. .....+|+|||.+... . .+++.||||+||++.||++
T Consensus 155 SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~E 234 (1431)
T KOG1240|consen 155 SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLE 234 (1431)
T ss_pred eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhc
Confidence 999999999987652 1 122222222 2345689999998431 2 6789999999999999987
Q ss_pred CCCCCCCCChhhHHHHHHhcc-CC--CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 307 CDMPYPDLSFTDVSSAVVRQN-LR--PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 307 g~~Pf~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
|.+||.-.+ .. .....+ .. ..+.+.-+..++++|..|++.||++|.++++.|+.-
T Consensus 235 g~PlF~LSQ---L~-aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 235 GRPLFTLSQ---LL-AYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred CCCcccHHH---HH-hHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 688884211 11 011110 00 001122355799999999999999999999999873
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=182.28 Aligned_cols=146 Identities=16% Similarity=0.198 Sum_probs=108.4
Q ss_pred eeeeccCCceEEEEEEE-CCeeEEEEEeecccccccch-----------------HHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 90 RHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTS-----------------AEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
.+.||+|+||.||+|.. +|+.||||+++......... ............|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45799999999999988 79999999998543211110 0001112334569999999987776
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH-HhC
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYL-HSK 230 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~ 230 (394)
........ ...+|||||++|++|...+.. ...++...+..++.|++.+|.|| |+.
T Consensus 82 ~~p~~~~~----------------------~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~ 137 (190)
T cd05147 82 PCPEPILL----------------------KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC 137 (190)
T ss_pred CCCcEEEe----------------------cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 43322211 011799999998877654322 24689999999999999999999 799
Q ss_pred CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
|++||||||+|||++ ++.++|+|||+|..
T Consensus 138 giiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 138 RLVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 999999999999998 47899999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=191.80 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=149.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC-----------Ccc
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-----------PNV 151 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-----------~nI 151 (394)
..+.....||.|+++.||.+++ +|+.+|||+.....+. . ....+.+++|.-....+.+ .-+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~--~----~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l 85 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA--S----ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFL 85 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT--H----TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEeccccc--c----hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence 3556788999999999999999 7899999998755421 1 1123555555544444322 122
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh---cccC--CCCHHHHHHHHHHHHHHHHH
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR---NKRK--KLAFKVVIQIALDLARGLSY 226 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~---~~~~--~l~~~~~~~i~~qi~~~l~y 226 (394)
+++--.................. .-=...+++|+-+ .++|.+++.- .... .+.....+.+..|+++.+++
T Consensus 86 ~P~d~~~i~~~~~~~~~~~~~~~----~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~ 160 (288)
T PF14531_consen 86 VPLDLLRIPGKPPFFERGPGQSI----YWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVAN 160 (288)
T ss_dssp --SEEEEETTS-SEEEECETTEE----EEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEcCCCcceecCCCCcc----ceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHH
Confidence 22221111111111100000000 0000226788877 6799887642 2111 23345566777899999999
Q ss_pred HHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC--------CCCCccchHHHHH
Q 048724 227 LHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--------KPYNRKCDVYSFG 298 (394)
Q Consensus 227 LH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG 298 (394)
||..|++|+||+|+|++++.+|.+.|+||+........ ......+..|.+||.... -.++.+.|.|+||
T Consensus 161 Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 161 LHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp HHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred HhhcceEecccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 99999999999999999999999999999987643322 111344577899997643 2478899999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCC
Q 048724 299 ICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355 (394)
Q Consensus 299 ~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~R 355 (394)
+++|.|+|+..||........... ....-..+|..++.||..+|+.||.+|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999999975533221110 111112578999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=175.57 Aligned_cols=147 Identities=18% Similarity=0.160 Sum_probs=110.7
Q ss_pred eeeeccCCceEEEEEEE-CCeeEEEEEeecccccccc-----------------hHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 90 RHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVT-----------------SAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~-----------------~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
.+.||+|+||.||+|.+ +|+.||||+++........ ..........+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999988 6999999999865321100 00111123345689999999999887
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-K 230 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~ 230 (394)
.....+... ..|+||||++|+++...... ...++...+..++.|++.++.++|+ +
T Consensus 82 ~~p~~~~~~----------------------~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ 137 (190)
T cd05145 82 PVPEPILLK----------------------KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA 137 (190)
T ss_pred CCceEEEec----------------------CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 544333211 11799999998865433222 2457888999999999999999999 9
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARVE 261 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 261 (394)
|++||||||+||+++ ++.++|+|||++...
T Consensus 138 givHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 138 GLVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 999999999999998 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=172.72 Aligned_cols=187 Identities=14% Similarity=0.085 Sum_probs=138.4
Q ss_pred cceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCcccc
Q 048724 88 DIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~ 166 (394)
.+...|++|+||+||.+...+.+++.+.+..... .........+.+|+++|++| +|+++++++++. .
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~-----~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~--- 72 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPW-----WLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G--- 72 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchh-----hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C---
Confidence 4566899999999998888888898887752211 01111123578999999999 458899998752 1
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCceeeC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV-KTENMLLD 245 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl-kp~NIll~ 245 (394)
.|++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++
T Consensus 73 -----------------~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~ 126 (218)
T PRK12274 73 -----------------RHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ 126 (218)
T ss_pred -----------------EEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc
Confidence 2899999999999654311 1 2357789999999999999999999 79999999
Q ss_pred CCCcEEEeeccccccccCCCCC-------------ccCCCCCCCcCCccccCCC-CCC-ccchHHHHHHHHHHHHhCCCC
Q 048724 246 ANRTLKIADFGVARVEAQNPRD-------------MTGETGTLGYMAPEVLDGK-PYN-RKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~elltg~~P 310 (394)
.++.++|+|||++......... ..-...++.|++|+..+-- ..+ ...++++.|+-+|.++|+..|
T Consensus 127 ~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 127 EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 9999999999999854332210 0012357788888765432 333 467888999999999999988
Q ss_pred CC
Q 048724 311 YP 312 (394)
Q Consensus 311 f~ 312 (394)
+-
T Consensus 207 ~~ 208 (218)
T PRK12274 207 HW 208 (218)
T ss_pred cc
Confidence 64
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=201.93 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=180.3
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---CCcc
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---HPNV 151 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nI 151 (394)
...+.++....|.|.+.||+|+||.||+|.. +|+.||||+-+.... ...--. .+++.+|+ -+-|
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~----------~q~~~RLk~~~~~~~ 756 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYIC----------LQVMERLKPQMLPSI 756 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeeh----------HHHHHhhchhhhcch
Confidence 3456788889999999999999999999988 789999999875442 111011 12333333 1233
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
..+..++.- ...+++|+||.+-|+|.+++. ..+.+++..+..++.|++..+.+||..+
T Consensus 757 ~~~~~a~~~--------------------~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~ 814 (974)
T KOG1166|consen 757 MHISSAHVF--------------------QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG 814 (974)
T ss_pred HHHHHHHcc--------------------CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc
Confidence 333333221 234489999999999999995 5677999999999999999999999999
Q ss_pred CcccCCCCCceeeC-------CCCcEEEeecccccc--ccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 232 IVHRDVKTENMLLD-------ANRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 232 iiH~Dlkp~NIll~-------~~~~vkl~DFG~a~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
|||+||||+|+||. ....++|+|||.+-- .-.+.......++|-.+-++|+..|+++++.+|.|.|+.+++
T Consensus 815 IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 815 IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVH 894 (974)
T ss_pred eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHH
Confidence 99999999999993 234689999998852 112234455568899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHhccC----CCCCCCCCc-HHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 303 EIYCCDMPYPDLSFTDVSSAVVRQNL----RPDIPRCCP-SSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 303 elltg~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
-|++|+.-- ...+. +..++.... +-..++...+|+.|-..=|...++...|+.+..
T Consensus 895 ~mLFG~y~q------------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 895 VMLFGKYME------------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHHHHHHH------------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 999996310 11110 011111111 223467777888555555888888888887653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-20 Score=166.71 Aligned_cols=142 Identities=24% Similarity=0.363 Sum_probs=113.4
Q ss_pred eeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 91 HEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
+.||+|++|.||+|.+.|..|++|+........ ...........+.+|+.++..+.|++++....++.+....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~------ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRH-PELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF------ 74 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcC-hHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC------
Confidence 579999999999999999999999865322111 1112223345678899999999999887766665544333
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
+++|||++|++|.+++.... . .+..++.+++.+|.++|+.|++|+|++|.|||++ ++.+
T Consensus 75 --------------~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~ 133 (211)
T PRK14879 75 --------------IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKI 133 (211)
T ss_pred --------------EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCE
Confidence 89999999999999985421 2 7889999999999999999999999999999999 7889
Q ss_pred EEeecccccc
Q 048724 251 KIADFGVARV 260 (394)
Q Consensus 251 kl~DFG~a~~ 260 (394)
+|+|||.+..
T Consensus 134 ~liDf~~a~~ 143 (211)
T PRK14879 134 YLIDFGLAEF 143 (211)
T ss_pred EEEECCcccC
Confidence 9999998863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=166.99 Aligned_cols=138 Identities=20% Similarity=0.297 Sum_probs=103.3
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-----CCCcceeeeeeecCCCcc
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-----DHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~l~~~~~~~~~~ 164 (394)
...||+|+||.||....++.. +||++...... ....+.+|+.+++.+ +||||++++|++.++...
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~---------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG---------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc---------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 457999999999973334444 69988643211 125678999999999 579999999999865421
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEec--CCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHH-HHHHhCCCcccCCCCCc
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEY--LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGL-SYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l-~yLH~~~iiH~Dlkp~N 241 (394)
...+.+|+|| +++|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|
T Consensus 77 ----------------g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~N 135 (210)
T PRK10345 77 ----------------GYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQN 135 (210)
T ss_pred ----------------eEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 0112478999 5579999999542 36655 35677888777 99999999999999999
Q ss_pred eeeCC----CCcEEEeecccc
Q 048724 242 MLLDA----NRTLKIADFGVA 258 (394)
Q Consensus 242 Ill~~----~~~vkl~DFG~a 258 (394)
||++. ++.++|+||+.+
T Consensus 136 ILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEeccCCCCCcEEEEECCCC
Confidence 99963 347999995544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-21 Score=184.47 Aligned_cols=209 Identities=32% Similarity=0.589 Sum_probs=164.8
Q ss_pred HHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHH
Q 048724 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~ 222 (394)
|+.+.|.|+.+++|.+.+.... ++|.+||..|+|.|.+... ...+++.....++++|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~--------------------~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~ 59 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEM--------------------IVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISK 59 (484)
T ss_pred CcccchhhhhhheeeEecCCce--------------------EEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHH
Confidence 3567899999999999877554 8899999999999999763 356889999999999999
Q ss_pred HHHHHHhCCC-cccCCCCCceeeCCCCcEEEeeccccccccC--CCCCccCCCCCCCcCCccccCCC-------CCCccc
Q 048724 223 GLSYLHSKTI-VHRDVKTENMLLDANRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLDGK-------PYNRKC 292 (394)
Q Consensus 223 ~l~yLH~~~i-iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~ 292 (394)
||.|||...| .|+.+++.|.+++....+||+|||+...... .........-..-|.|||.+++. ..+.+.
T Consensus 60 Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~g 139 (484)
T KOG1023|consen 60 GLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKG 139 (484)
T ss_pred HHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccC
Confidence 9999998765 9999999999999999999999999876532 11111112234579999999763 146789
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCC----hhhHHHHHHhcc---CCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 293 DVYSFGICLWEIYCCDMPYPDLS----FTDVSSAVVRQN---LRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 293 DvwslG~~l~elltg~~Pf~~~~----~~~~~~~~~~~~---~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
||||||++++|+++-..||.... ..++...+...+ +++.+. ..+++.+..+++.||..+|+.||+++++-.
T Consensus 140 diYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 140 DIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99999999999999999997532 234444443312 333333 135668999999999999999999999999
Q ss_pred HHHHHHhcc
Q 048724 364 LLEAVNTSK 372 (394)
Q Consensus 364 ~l~~~~~~~ 372 (394)
.++.+....
T Consensus 220 ~~~~~~~~~ 228 (484)
T KOG1023|consen 220 KLLTINKGG 228 (484)
T ss_pred hhhhhcccc
Confidence 999887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-21 Score=195.59 Aligned_cols=205 Identities=26% Similarity=0.429 Sum_probs=155.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
-.+|+.++.|-.|+||-||..++ +.+++|+|+-+. -.|++ ||..+-+.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---------------------~lilR-----nilt~a~n---- 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---------------------NLILR-----NILTFAGN---- 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc---------------------chhhh-----ccccccCC----
Confidence 47899999999999999999977 578899965431 11121 23333211
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. ++| |+-.+.++. -++++-. ++.+++|||+.||+|||+||+|
T Consensus 132 p----------------------fvv------gDc~tllk~--~g~lPvd--------mvla~Eylh~ygivhrdlkpdn 173 (1205)
T KOG0606|consen 132 P----------------------FVV------GDCATLLKN--IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDN 173 (1205)
T ss_pred c----------------------cee------chhhhhccc--CCCCcch--------hhHHhHhhccCCeecCCCCCCc
Confidence 1 223 344444422 2334432 3789999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC-------------C--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP-------------R--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~-------------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 306 (394)
++|+.-|++|++|||+++...-.. + .....+||+.|+|||++....|...+|+|++|+++||.+.
T Consensus 174 llIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLV 253 (1205)
T KOG0606|consen 174 LLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 253 (1205)
T ss_pred ceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhe
Confidence 999999999999999987421100 0 0112489999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCC
Q 048724 307 CDMPYPDLSFTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRP 356 (394)
Q Consensus 307 g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rp 356 (394)
|..||.+...++.+..++.... .++-....+++.++++.++|+.+|..|.
T Consensus 254 gcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 254 GCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred eeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 9999999999998887766543 2333455789999999999999999995
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=167.75 Aligned_cols=148 Identities=20% Similarity=0.220 Sum_probs=111.3
Q ss_pred cccceeeeccCCceEEEEEE-E--CCeeEEEEEeecccccccc---------------hHHHHHHHHHHHHHHHHHHhCC
Q 048724 86 KLDIRHEIARGTYGTVYRGA-Y--DGQDVAVKILDWAEDGMVT---------------SAEAAAIRASFRQEVAVWQKLD 147 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~-~--~g~~vavK~~~~~~~~~~~---------------~~~~~~~~~~~~~E~~il~~l~ 147 (394)
.|.+.+.||+|+||.||+|. + +|+.||||+++........ ..........+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 3 7899999999754321000 0011123345678999999997
Q ss_pred CCc--ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Q 048724 148 HPN--VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLS 225 (394)
Q Consensus 148 h~n--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~ 225 (394)
+.+ +.++++.. ..++||||++|++|..+... ...+....+..++.|++.++.
T Consensus 109 ~~~i~~p~~~~~~------------------------~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~ 162 (237)
T smart00090 109 EAGVPVPKPIAWR------------------------RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMR 162 (237)
T ss_pred hcCCCCCeeeEec------------------------CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHH
Confidence 532 33443321 12799999999888765422 234666778899999999999
Q ss_pred HHHhCC-CcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 226 YLHSKT-IVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 226 yLH~~~-iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
+||++| ++||||||+||+++ ++.++|+|||.+..
T Consensus 163 ~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 163 KLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred HHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 999999 99999999999999 88999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=159.88 Aligned_cols=138 Identities=22% Similarity=0.355 Sum_probs=106.5
Q ss_pred eeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCC
Q 048724 92 EIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSA 171 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~ 171 (394)
.||+|+||+||+|.++|..|++|+....... ............+.+|+.+++.+.|+++.....++.....
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-------- 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYR-HPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-------- 71 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCc-CchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC--------
Confidence 4899999999999999999999986532211 1111222234667889999999988765544444333322
Q ss_pred CCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEE
Q 048724 172 TSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251 (394)
Q Consensus 172 ~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vk 251 (394)
.++||||++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++
T Consensus 72 ------------~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~ 129 (199)
T TIGR03724 72 ------------KTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLY 129 (199)
T ss_pred ------------CEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEE
Confidence 2899999999999998744211 7899999999999999999999999999999 78999
Q ss_pred Eeecccccc
Q 048724 252 IADFGVARV 260 (394)
Q Consensus 252 l~DFG~a~~ 260 (394)
++|||++..
T Consensus 130 liDfg~a~~ 138 (199)
T TIGR03724 130 LIDFGLGKY 138 (199)
T ss_pred EEECCCCcC
Confidence 999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.2e-21 Score=181.25 Aligned_cols=171 Identities=23% Similarity=0.484 Sum_probs=130.7
Q ss_pred CCceEEEEecCCCCCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 181 SRACCVVVEYLPGGTLKKFLIRN-KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 181 ~~~~~iv~e~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
...+||.|++|...+|.+||... .....++...+.++.|++.|+.| +|.+|+|+||.||++..+..+||+|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 34578999999999999999743 33457788899999999999999 999999999999999999999999999987
Q ss_pred cccCC------CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccC-CCC
Q 048724 260 VEAQN------PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNL-RPD 331 (394)
Q Consensus 260 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~-~~~ 331 (394)
..... ....+...||..||+||.+.+..|+.++|||+||++|+|++. -..+|... -....++.+. .+.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRDGIIPPE 480 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----HhhhhhhcCCCChH
Confidence 43322 234556789999999999999999999999999999999986 23232211 1111122222 212
Q ss_pred CCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 048724 332 IPRCCPSSLASIMRKCWDANPDKRPVMD 359 (394)
Q Consensus 332 ~~~~~~~~l~~li~~cL~~dP~~Rpt~~ 359 (394)
+.... +.-..|+.++|.+.|.+||++.
T Consensus 481 ~~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 481 FLQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred HhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 22222 3446899999999999999443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-19 Score=180.72 Aligned_cols=142 Identities=21% Similarity=0.278 Sum_probs=111.7
Q ss_pred ccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 87 LDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
|...+.||+|+||+||+|.+.+..+++|+...... .............+.+|+.+++.++|++++....++.+....
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~-- 411 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGY-RHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK-- 411 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccc-cchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC--
Confidence 34578999999999999999777777765432111 111112223346788999999999999998877666543333
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~ 246 (394)
++||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .
T Consensus 412 ------------------~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~ 462 (535)
T PRK09605 412 ------------------TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-R 462 (535)
T ss_pred ------------------EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-E
Confidence 89999999999999884 346789999999999999999999999999999 5
Q ss_pred CCcEEEeecccccc
Q 048724 247 NRTLKIADFGVARV 260 (394)
Q Consensus 247 ~~~vkl~DFG~a~~ 260 (394)
++.++|+|||+++.
T Consensus 463 ~~~~~liDFGla~~ 476 (535)
T PRK09605 463 DDRLYLIDFGLGKY 476 (535)
T ss_pred CCcEEEEeCccccc
Confidence 78899999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-19 Score=157.64 Aligned_cols=143 Identities=21% Similarity=0.246 Sum_probs=107.2
Q ss_pred ccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchH-------------HHHHHHHHHHHHHHHHHhCCCCc--
Q 048724 87 LDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSA-------------EAAAIRASFRQEVAVWQKLDHPN-- 150 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~-------------~~~~~~~~~~~E~~il~~l~h~n-- 150 (394)
|.+.+.||+|+||.||++.. +|+.||||+++.......... ........+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66678899999999999988 789999999875431110000 00112234677899999997774
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK 230 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 230 (394)
++..++. ...++||||++|++|.+... ......++.+++.++.++|+.
T Consensus 97 v~~~~~~------------------------~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~ 144 (198)
T cd05144 97 VPKPIDW------------------------NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKH 144 (198)
T ss_pred CCceeec------------------------CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHC
Confidence 4444331 11289999999999976542 134567889999999999999
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARVE 261 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 261 (394)
|++||||+|.||+++.++.++|+|||++...
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=144.06 Aligned_cols=142 Identities=23% Similarity=0.224 Sum_probs=95.7
Q ss_pred eeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHH---------------HHHHHHHHHHHHHHHhCCCCc--c
Q 048724 90 RHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEA---------------AAIRASFRQEVAVWQKLDHPN--V 151 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~---------------~~~~~~~~~E~~il~~l~h~n--I 151 (394)
.+.||+|+||+||+|.+ +|+.||||+++............ .........|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988 58999999987543211000000 000111234555666654332 3
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHH-HHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK-FLIRNKRKKLAFKVVIQIALDLARGLSYLHS- 229 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~- 229 (394)
.+.++.. ..++||||++++++.. .+.... .. ..+..++.+++.++.++|.
T Consensus 82 ~~~~~~~------------------------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~ 133 (187)
T cd05119 82 PKPIDLN------------------------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE 133 (187)
T ss_pred CceEecC------------------------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc
Confidence 3333321 1289999999854321 111110 11 5678899999999999999
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.|++|+||||+||+++ ++.++|+|||.+..
T Consensus 134 ~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 134 AGLVHGDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred cCcCcCCCChhhEEEE-CCcEEEEECccccc
Confidence 9999999999999999 88999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.7e-17 Score=147.08 Aligned_cols=147 Identities=16% Similarity=0.175 Sum_probs=107.9
Q ss_pred eeec-cCCceEEEEEEECCeeEEEEEeecccccc-cch---HHHHHHHHHHHHHHHHHHhCCCCcc--eeeeeeecCCCc
Q 048724 91 HEIA-RGTYGTVYRGAYDGQDVAVKILDWAEDGM-VTS---AEAAAIRASFRQEVAVWQKLDHPNV--TKFIGASMGTTN 163 (394)
Q Consensus 91 ~~lG-~G~fg~Vy~~~~~g~~vavK~~~~~~~~~-~~~---~~~~~~~~~~~~E~~il~~l~h~nI--v~l~~~~~~~~~ 163 (394)
..|| .||.|+||.+...+..++||.++....-. ... .........+.+|+.++.+++|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 89999999998888999999886432100 000 0011224567889999999988775 667666443222
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPG-GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. ....++|+|+++| .+|.+++.. ..++... +.+|+.+|.+||++||+||||||.||
T Consensus 117 ~----------------~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NI 173 (239)
T PRK01723 117 L----------------FYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNI 173 (239)
T ss_pred c----------------ceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhE
Confidence 1 0112599999997 699988844 2355543 56899999999999999999999999
Q ss_pred eeCCCCcEEEeecccccc
Q 048724 243 LLDANRTLKIADFGVARV 260 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~ 260 (394)
|++.++.++|+|||.+..
T Consensus 174 Lv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEcCCCCEEEEECCCccc
Confidence 999888999999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.8e-19 Score=178.35 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=192.6
Q ss_pred cccccceeeeccCCceEEEEEEE---CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeec
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASM 159 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~ 159 (394)
...|.+.+.||+|+|+.|-+... ....+|+|.+..... ..........|..+-..+. |+|++.+++...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~-------~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~ 91 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK-------SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS 91 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCC-------ccchhhhcCccccccccccccccccccCCccC
Confidence 46778888899999999987765 334567776543320 1111234445777777775 999999998877
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLH-SKTIVHRDVK 238 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~iiH~Dlk 238 (394)
..+.. +++.+|..|+++.+.+........+....-.++.|+..++.|+| ..++.|+|||
T Consensus 92 ~~~~~--------------------~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ik 151 (601)
T KOG0590|consen 92 SPRSY--------------------LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIK 151 (601)
T ss_pred CCccc--------------------ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCC
Confidence 66554 78999999999988773222224666677889999999999999 9999999999
Q ss_pred CCceeeCCCC-cEEEeeccccccccC-CC--CCccCCCC-CCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 239 TENMLLDANR-TLKIADFGVARVEAQ-NP--RDMTGETG-TLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 239 p~NIll~~~~-~vkl~DFG~a~~~~~-~~--~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
|+|.+++..+ .+++.|||+|..... .. ......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||.
T Consensus 152 P~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 152 PSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred CccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence 9999999999 999999999986544 22 23344678 9999999999885 45678999999999999999999997
Q ss_pred CCChhhHHH-HHHhcc--CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 313 DLSFTDVSS-AVVRQN--LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 313 ~~~~~~~~~-~~~~~~--~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
......... .+.... .........+....+++.+++..+|+.|.+.+++...-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 232 FPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred ccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence 655443221 111111 123344567888999999999999999999988866443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=131.28 Aligned_cols=132 Identities=27% Similarity=0.301 Sum_probs=108.1
Q ss_pred ceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC--CcceeeeeeecCCCcccc
Q 048724 89 IRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH--PNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~~ 166 (394)
+.+.||.|.++.||++...+..+++|..+.... ...+.+|+.+++.+.| .+++++++++...+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~--- 67 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----------GADREREVAILQLLARKGLPVPKVLASGESDGW--- 67 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc---
Confidence 356799999999999999888999999864321 2467789999999966 588888877654333
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCcee
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK---TIVHRDVKTENML 243 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---~iiH~Dlkp~NIl 243 (394)
.++++||++|+++..+ +......++.++++++.+||.. +++|+|++|.||+
T Consensus 68 -----------------~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil 121 (155)
T cd05120 68 -----------------SYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL 121 (155)
T ss_pred -----------------cEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEE
Confidence 3899999998877543 4556677889999999999984 7999999999999
Q ss_pred eCCCCcEEEeecccccc
Q 048724 244 LDANRTLKIADFGVARV 260 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~ 260 (394)
++..+.+++.|||.+..
T Consensus 122 ~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 122 VDDGKILGIIDWEYAGY 138 (155)
T ss_pred EECCcEEEEEecccccC
Confidence 99889999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-14 Score=143.88 Aligned_cols=161 Identities=17% Similarity=0.201 Sum_probs=107.9
Q ss_pred cccccceeeeccCCceEEEEEEE-C-CeeEEEEEeeccccccc-------------------------chHHHHHHHHHH
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY-D-GQDVAVKILDWAEDGMV-------------------------TSAEAAAIRASF 136 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~-~-g~~vavK~~~~~~~~~~-------------------------~~~~~~~~~~~~ 136 (394)
+..|+. +.||.|++|.||+|+. + |+.||||++++...... .........+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 556776 7899999999999998 4 89999999985531110 011222344555
Q ss_pred HHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccC----CCCHHH
Q 048724 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK----KLAFKV 212 (394)
Q Consensus 137 ~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~----~l~~~~ 212 (394)
.+|+++.+.. +|+.++...|.+.+.+++|...... ...-++||||++|++|.++-.-...+ .+.+..
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~-------st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~ 268 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDY-------CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG 268 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeeccc-------CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence 6666666665 4777777666666655554332221 12237999999999998753211111 244444
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC----cEEEeeccccccc
Q 048724 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR----TLKIADFGVARVE 261 (394)
Q Consensus 213 ~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~----~vkl~DFG~a~~~ 261 (394)
+..++.|++ ..|++|+|+||.||+++.++ .++++|||+....
T Consensus 269 v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 269 VEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 444455544 59999999999999999887 9999999998644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-15 Score=147.82 Aligned_cols=149 Identities=19% Similarity=0.252 Sum_probs=97.0
Q ss_pred eeeccCCceEEEEEEE-CCeeEEEEEeecccccccch-------------------------HHHHHHHH------HHHH
Q 048724 91 HEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTS-------------------------AEAAAIRA------SFRQ 138 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~-------------------------~~~~~~~~------~~~~ 138 (394)
+.||.|++|.||+|+. +|+.||||+.+......... .-...... +|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 89999999987543111100 00011111 2444
Q ss_pred HHHHHHhCC----CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHH
Q 048724 139 EVAVWQKLD----HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVI 214 (394)
Q Consensus 139 E~~il~~l~----h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~ 214 (394)
|+..+.++. |.+-+.+-.++.+- ...-++||||++|++|.++...... ..+ ..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-------------------~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~ 259 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-------------------TSERVLTMEWIDGIPLSDIAALDEA-GLD---RK 259 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-------------------cCCceEEEEeECCcccccHHHHHhc-CCC---HH
Confidence 554444442 22222222222110 1123899999999999887643221 122 34
Q ss_pred HHHHHHHH-HHHHHHhCCCcccCCCCCceeeCCCCcEEEeecccccccc
Q 048724 215 QIALDLAR-GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262 (394)
Q Consensus 215 ~i~~qi~~-~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~ 262 (394)
.++.+++. .+..+|..|++|+|+||.||+++.++.++|+|||++....
T Consensus 260 ~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 260 ALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 56666665 4788999999999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.4e-14 Score=119.20 Aligned_cols=127 Identities=19% Similarity=0.187 Sum_probs=94.2
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce-eeeeeecCCCccccCC
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT-KFIGASMGTTNLKIPS 168 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~~~~ 168 (394)
++.|+.|.++.||+++..+..|++|+....... ...+..|+.+++.+.+.+++ +++.... ..
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----------~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~----- 65 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----------LINRENEAENSKLAAEAGIGPKLYYFDP--ET----- 65 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc----------ccCHHHHHHHHHHHHHhCCCCceEEEeC--CC-----
Confidence 356899999999999998999999987532210 12356788888888554443 4444321 11
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC-----cccCCCCCcee
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI-----VHRDVKTENML 243 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i-----iH~Dlkp~NIl 243 (394)
.++||||++|.++.+.- . ....++.+++++|+.||+.++ +|+|++|.||+
T Consensus 66 ---------------~~lv~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil 120 (170)
T cd05151 66 ---------------GVLITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFL 120 (170)
T ss_pred ---------------CeEEEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEE
Confidence 27899999998886430 1 112456789999999999885 99999999999
Q ss_pred eCCCCcEEEeeccccc
Q 048724 244 LDANRTLKIADFGVAR 259 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~ 259 (394)
++ ++.++++|||.+.
T Consensus 121 ~~-~~~~~liDf~~a~ 135 (170)
T cd05151 121 LD-DGRLWLIDWEYAG 135 (170)
T ss_pred EE-CCeEEEEeccccc
Confidence 98 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.3e-14 Score=127.41 Aligned_cols=203 Identities=23% Similarity=0.345 Sum_probs=142.4
Q ss_pred HHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHH
Q 048724 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDL 220 (394)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi 220 (394)
|-++.|.|||+++.++.+...-. .....++.||+..|+|..+|++.+ .+.+......+|+.||
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e---------------~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqI 185 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEE---------------KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQI 185 (458)
T ss_pred HHHHHHHHHHHHHHhhccccccc---------------ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 44557999999999987665531 123478999999999999998633 3467888899999999
Q ss_pred HHHHHHHHhC--CCcccCCCCCceeeCCCCcEEEeeccccccc----cCCCCCccCCCCCCCcCCccccCCCCCCccchH
Q 048724 221 ARGLSYLHSK--TIVHRDVKTENMLLDANRTLKIADFGVARVE----AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDV 294 (394)
Q Consensus 221 ~~~l~yLH~~--~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 294 (394)
+.||.|||+. .++|+++..+.|++..+|-+|++---..... ...........+.++|.+||.=..-..+-++||
T Consensus 186 lsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI 265 (458)
T KOG1266|consen 186 LSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDI 265 (458)
T ss_pred HhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhh
Confidence 9999999975 5999999999999999998888632221110 000111222456788999998666666778999
Q ss_pred HHHHHHHHHHHhCCCC-CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 295 YSFGICLWEIYCCDMP-YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 295 wslG~~l~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
|+||....+|..+..- -...+.......+... +-......-++++.+||+..|+.||++++++...
T Consensus 266 y~fgmcAlemailEiq~tnseS~~~~ee~ia~~-----i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 266 YKFGMCALEMAILEIQSTNSESKVEVEENIANV-----IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred hhhhHHHHHHHHheeccCCCcceeehhhhhhhh-----eeeccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 9999999999887643 2222221111111111 1111123346789999999999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-14 Score=138.96 Aligned_cols=250 Identities=21% Similarity=0.224 Sum_probs=178.4
Q ss_pred ccccccceeeecc--CCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeee
Q 048724 83 ELAKLDIRHEIAR--GTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFI 155 (394)
Q Consensus 83 ~~~~~~~~~~lG~--G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 155 (394)
.-..+.+.+.+|. |.+|.||.+.. ++..+|+|.-+......... ..=.+|+...+.+ .|+|.++.+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-------~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-------KRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-------ccccchhhcccccCccccccccC
Confidence 3456677888999 99999998765 56789999844332211111 1112466665666 589999988
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHH----HHHHHHhCC
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR----GLSYLHSKT 231 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~----~l~yLH~~~ 231 (394)
..+.+.+.+ ++-+|+| +.+|.++.... ...++...++.+..+... ||.++|+.+
T Consensus 185 ~~~e~~~~l--------------------fiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~ 242 (524)
T KOG0601|consen 185 PAWEGSGIL--------------------FIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN 242 (524)
T ss_pred cccccCCcc--------------------eeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc
Confidence 777766665 7888988 57888776542 234778888899999888 999999999
Q ss_pred CcccCCCCCceeeCCC-CcEEEeeccccccccCCCCCc-----cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHH
Q 048724 232 IVHRDVKTENMLLDAN-RTLKIADFGVARVEAQNPRDM-----TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 305 (394)
++|-|+||.||++..+ ...+++|||+........... ....+...|++||..++- ++...|+|++|.+..+..
T Consensus 243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~ 321 (524)
T KOG0601|consen 243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAI 321 (524)
T ss_pred ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhH
Confidence 9999999999999988 889999999987654433111 122678899999987755 678999999999999998
Q ss_pred hCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 306 CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 306 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
++..+.....+....+ +....+..++-...+.++...+..|++.+|..|++++.++.
T Consensus 322 l~~~~~~~g~~~~W~~-~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 322 LGSHLPSVGKNSSWSQ-LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hhcccccCCCCCCccc-cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 8855433221111111 10111222333345677888999999999999998877654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-12 Score=110.02 Aligned_cols=151 Identities=21% Similarity=0.305 Sum_probs=113.1
Q ss_pred ceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCC
Q 048724 89 IRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 168 (394)
....|-+|+-+.|+++.+.|+.+.||-= +.+.-.....+..-.+.+..+|+.+|.++.--.|.-..=+|.+...-
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~R-f~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~---- 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKER-FSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG---- 85 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeec-ccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC----
Confidence 5668999999999999999999999842 22333344556666788889999999998543433322233332222
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPG-GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
+|+|||++| .++.+++...-...........++..|-+.+.-||.+++||+||..+||++..+
T Consensus 86 ----------------~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~ 149 (229)
T KOG3087|consen 86 ----------------QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSD 149 (229)
T ss_pred ----------------eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecC
Confidence 789999977 488888876554445555557889999999999999999999999999999654
Q ss_pred C---cEEEeecccccc
Q 048724 248 R---TLKIADFGVARV 260 (394)
Q Consensus 248 ~---~vkl~DFG~a~~ 260 (394)
+ .+.+.|||++..
T Consensus 150 ~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 150 GNQITPILIDFGLSSV 165 (229)
T ss_pred CCcCceEEEeecchhc
Confidence 4 358999999864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.9e-13 Score=117.08 Aligned_cols=143 Identities=14% Similarity=0.143 Sum_probs=100.1
Q ss_pred eeeeccCCceEEEEEEEC--------CeeEEEEEeeccccccc-----------------chHHHHHHHHHHHHHHHHHH
Q 048724 90 RHEIARGTYGTVYRGAYD--------GQDVAVKILDWAEDGMV-----------------TSAEAAAIRASFRQEVAVWQ 144 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~--------g~~vavK~~~~~~~~~~-----------------~~~~~~~~~~~~~~E~~il~ 144 (394)
...||.|--+.||.|... +..+|||+.+....... ...........-.+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457999999999999763 36899999864321100 01112223333448999999
Q ss_pred hCCC--CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHH-HHHhcccCCCCHHHHHHHHHHHH
Q 048724 145 KLDH--PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK-FLIRNKRKKLAFKVVIQIALDLA 221 (394)
Q Consensus 145 ~l~h--~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qi~ 221 (394)
++.. -++.+++++.. -+|||||+.+..+.. .+.+ ..++......+..+++
T Consensus 82 rl~~~Gv~vP~pi~~~~------------------------~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~ 134 (197)
T cd05146 82 RMQKAGIPCPEVVVLKK------------------------HVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVL 134 (197)
T ss_pred HHHHcCCCCCeEEEecC------------------------CEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHH
Confidence 9843 45666665421 188999997654422 2221 2355666778889999
Q ss_pred HHHHHH-HhCCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 222 RGLSYL-HSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 222 ~~l~yL-H~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.+|..| |+.|+||+||++.||+++ ++.+.|+|||.+..
T Consensus 135 ~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 135 SMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence 999999 899999999999999997 46799999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.8e-12 Score=108.28 Aligned_cols=139 Identities=24% Similarity=0.318 Sum_probs=101.9
Q ss_pred eeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCC
Q 048724 91 HEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
..+++|+-+.+|.+.+.|..+++|. +..+.-........--+.+-.+|+.++.+++--.|...+=++.+....
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~------ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG------ 74 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC------
Confidence 3588999999999988887777774 223333333344444567778899999998644443333333333332
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcE
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~v 250 (394)
.|+|||++|-.|.+++... ...++..+-.-+.-||..||+|+||.++||++..++ +
T Consensus 75 --------------~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i 130 (204)
T COG3642 75 --------------LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-I 130 (204)
T ss_pred --------------EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-E
Confidence 6899999999999888553 245667777788889999999999999999998655 9
Q ss_pred EEeecccccc
Q 048724 251 KIADFGVARV 260 (394)
Q Consensus 251 kl~DFG~a~~ 260 (394)
.++|||++..
T Consensus 131 ~~IDfGLg~~ 140 (204)
T COG3642 131 YFIDFGLGEF 140 (204)
T ss_pred EEEECCcccc
Confidence 9999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.4e-14 Score=143.53 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=183.1
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
+....+.+.+.+-+-.|+++.++.+.- +|...++|+......-. ... .+....+-.++-.-.+|-++...-.
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~--~~~----~~s~r~~s~~~i~p~~P~v~~~~~s 872 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR--TND----YESIRSKSNILITPRSPAVVRSFPS 872 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc--ccc----ccccCCccCccccCCCCceecccCC
Confidence 677888999999999999999998876 45555555543211100 000 0111122222222234555544332
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+. .....+++++|+.+++|...++.. +..+.......+..++.+++|||...+.|+|+
T Consensus 873 ~~--------------------~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~ 930 (1205)
T KOG0606|consen 873 FP--------------------CRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDL 930 (1205)
T ss_pred CC--------------------CCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccc
Confidence 22 233458999999999999988553 45777777788889999999999999999999
Q ss_pred CCCceeeCCCCcEEEeecccccccc------C-------------------------CCCCccCCCCCCCcCCccccCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEA------Q-------------------------NPRDMTGETGTLGYMAPEVLDGK 286 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~------~-------------------------~~~~~~~~~gt~~y~aPE~~~~~ 286 (394)
+|.|+++..++..+++|||...... . +........+|+.|.+||.+.+.
T Consensus 931 ~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~ 1010 (1205)
T KOG0606|consen 931 KPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR 1010 (1205)
T ss_pred cccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc
Confidence 9999999999999999998332100 0 00011224589999999999999
Q ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCC-CCCCCCCcHHHHHHHHHhchhCCCCCCCHH
Q 048724 287 PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR-PDIPRCCPSSLASIMRKCWDANPDKRPVMD 359 (394)
Q Consensus 287 ~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~ 359 (394)
.....+|+|++|++++|.++|.+||......++..++...... +.-+...+++.++++...|..+|.+|..+.
T Consensus 1011 ~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1011 RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999999999999999999888777654432 233456789999999999999999997665
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-11 Score=121.33 Aligned_cols=163 Identities=18% Similarity=0.278 Sum_probs=122.3
Q ss_pred CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEE
Q 048724 107 DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCV 186 (394)
Q Consensus 107 ~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 186 (394)
++.+|.|.+.+.... .......+-++-|+.++||||++++..+.....+ ||
T Consensus 36 ~~~~vsVF~~~~~~~---------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~--------------------yl 86 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTL--------------------YL 86 (690)
T ss_pred cCCceEEEEEeCCCc---------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCce--------------------EE
Confidence 677888888875432 1123345667889999999999999988766655 89
Q ss_pred EEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC
Q 048724 187 VVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLH-SKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265 (394)
Q Consensus 187 v~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 265 (394)
|+|-+ ..|..++.+ +....+...+.||+.||.||| ..+++|++|.-..|+++..|..||++|-++.......
T Consensus 87 vTErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 87 VTERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN 159 (690)
T ss_pred Eeecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence 99998 488888854 346677778899999999998 6789999999999999999999999998875433222
Q ss_pred CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC
Q 048724 266 RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307 (394)
Q Consensus 266 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg 307 (394)
........-..|..|+.+.... ...|.|-|||++++++.|
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1111122223466666554333 356999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.2e-13 Score=131.77 Aligned_cols=250 Identities=19% Similarity=0.200 Sum_probs=175.2
Q ss_pred cccccceeeeccCCceEEEEEEE---CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
..+|..+..||.|.|+.|+.... .+..|++|-+...-... ..+ ..-..|+.+...+ -|.+++..+..+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~d-----i~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASD-----IFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--Hhh-----hcchhhhhHhhHhhcccccCCCCCCcc
Confidence 46788999999999999997654 56789999776433211 111 1122455555555 5788888766665
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..... |+-.|||.++++...+. -...+.+...+++..|++.++.++|+..++|+|++|
T Consensus 337 ~~r~~--------------------~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~p 394 (524)
T KOG0601|consen 337 QLRQG--------------------YIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKP 394 (524)
T ss_pred ccccc--------------------cCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchhhhcccccc
Confidence 44443 67889999998876662 234578888999999999999999999999999999
Q ss_pred CceeeCCC-CcEEEeeccccccccCCCCCccCCCCCCCcC--CccccCCCCCCccchHHHHHHHHHHHHhCCC-CCCCCC
Q 048724 240 ENMLLDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYM--APEVLDGKPYNRKCDVYSFGICLWEIYCCDM-PYPDLS 315 (394)
Q Consensus 240 ~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~~l~elltg~~-Pf~~~~ 315 (394)
+||++..+ +.-+++|||+.+..... .......-+++ ++.......+..++|+++||..+.+.+++.. ++....
T Consensus 395 sni~i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~ 471 (524)
T KOG0601|consen 395 SNILISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ 471 (524)
T ss_pred cceeeccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc
Confidence 99999875 77899999998632111 11122223333 5555566788899999999999999999864 332221
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
. ..+..+.-+..+ .....+..+.+.+...++..||.+.++..+..-++..
T Consensus 472 ~-----~~i~~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 472 S-----LTIRSGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred c-----eeeecccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 1 111222222223 3347888999999999999999999988777666544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.1e-10 Score=106.69 Aligned_cols=216 Identities=19% Similarity=0.269 Sum_probs=152.0
Q ss_pred ceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCC
Q 048724 98 YGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDS 175 (394)
Q Consensus 98 fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~ 175 (394)
-.+.|++.. +|..|++|+++........ ....-++.|+++.|.|+|+|..+|......
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---------k~t~lve~wkkl~h~NvV~frevf~t~tF~----------- 348 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---------KDTSLVEAWKKLCHTNVVPFREVFLTYTFG----------- 348 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---------cchHHHHHHHHhccCceeehhhhhhhhccC-----------
Confidence 457789876 8999999999433221111 112357889999999999999998733222
Q ss_pred CCCCCCCceEEEEecCCCC-CHHHHHHhcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 176 HNSLPSRACCVVVEYLPGG-TLKKFLIRNK-------------RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 176 ~~~~~~~~~~iv~e~~~gg-sL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
...+++|++|+++. +|.++...+. ....++..+|.++.|+..||.++|+.|+..+-|.|.+
T Consensus 349 -----D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~k 423 (655)
T KOG3741|consen 349 -----DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKK 423 (655)
T ss_pred -----cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhH
Confidence 23458999999964 7777654322 2246789999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCC-CCCCChhhH-
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP-YPDLSFTDV- 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~P-f~~~~~~~~- 319 (394)
||++.+..++|...|+..+...+. . +-+.+ -.+-|.=.||.+++.|.||..- +........
T Consensus 424 Ilv~G~~RIriS~C~i~Dvl~~d~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~ 486 (655)
T KOG3741|consen 424 ILVTGKMRIRISGCGIMDVLQEDP------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH 486 (655)
T ss_pred eEeeCcceEEEecccceeeecCCC------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence 999988889998888766543332 0 11111 2356888999999999999532 111111111
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.. .+...++.++++++.-....++++ -+.++++.++
T Consensus 487 ~~---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 LT---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HH---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 11 123347888999999988888886 5677777654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=101.09 Aligned_cols=132 Identities=27% Similarity=0.324 Sum_probs=84.8
Q ss_pred EEEEEEE-CCeeEEEEEeeccccc------------c-----cchHHHHHHHHHHHHHHHHHHhCCCC--cceeeeeeec
Q 048724 100 TVYRGAY-DGQDVAVKILDWAEDG------------M-----VTSAEAAAIRASFRQEVAVWQKLDHP--NVTKFIGASM 159 (394)
Q Consensus 100 ~Vy~~~~-~g~~vavK~~~~~~~~------------~-----~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~ 159 (394)
.||.|.. +|..+|||+.+..... . .........+....+|...|.++..- ++.+++++-.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 4899987 7889999998653110 0 01123344466778899999999755 4666665432
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCC--CCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP--GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSY-LHSKTIVHRD 236 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~y-LH~~~iiH~D 236 (394)
. +|||||++ |..+..+.... ++......++.+++..+.. +|..|++|+|
T Consensus 81 ~------------------------~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGD 132 (188)
T PF01163_consen 81 N------------------------VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGD 132 (188)
T ss_dssp T------------------------EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS
T ss_pred C------------------------EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecC
Confidence 1 78999998 65665443211 2234456677788885555 5799999999
Q ss_pred CCCCceeeCCCCcEEEeecccccc
Q 048724 237 VKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
|.+.||+++++ .+.|+|||.+..
T Consensus 133 Ls~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 133 LSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp -STTSEEEETT-CEEE--GTTEEE
T ss_pred CChhhEEeecc-eEEEEecCccee
Confidence 99999999877 899999998863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=8e-10 Score=101.60 Aligned_cols=152 Identities=14% Similarity=0.089 Sum_probs=99.8
Q ss_pred eccCCceEEEEEEECCeeEEEEEeecccccccchHHHH--HHHHHHHHHHHHHHhCCCCc--ceeeeeeecCCCccccCC
Q 048724 93 IARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAA--AIRASFRQEVAVWQKLDHPN--VTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 93 lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~--~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~~~ 168 (394)
+-......|++..+.|+.|.||.............-.. .-...+.+|...+.+|...+ .++++++.......
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~---- 105 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP---- 105 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC----
Confidence 33333444678888899999997642221000000000 00013668888888874333 33444444321111
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC-
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGG-TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA- 246 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~- 246 (394)
.....++|+|++++. +|.+++........+......++.+++..+.-||..|++|+|+++.|||++.
T Consensus 106 -----------~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 106 -----------ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLP 174 (268)
T ss_pred -----------ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEecc
Confidence 012348999999886 8999986433345667778899999999999999999999999999999974
Q ss_pred ------CCcEEEeeccccc
Q 048724 247 ------NRTLKIADFGVAR 259 (394)
Q Consensus 247 ------~~~vkl~DFG~a~ 259 (394)
+..+.|+||+.+.
T Consensus 175 ~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred ccCCCCCceEEEEECCccc
Confidence 4679999999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-10 Score=103.83 Aligned_cols=142 Identities=21% Similarity=0.246 Sum_probs=102.7
Q ss_pred eeeccCCceEEEEEEECC-eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC--cceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAYDG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP--NVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~~~~~~~~~ 167 (394)
+.|+.|..+.||++...+ ..+++|+....... .....+..|+.+++.+.+. ++.+++.+......
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~---- 71 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV---- 71 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc----
Confidence 468999999999998854 89999987543211 0124567899999999653 45666666543220
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS------------------ 229 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------------------ 229 (394)
....++||||++|.++.+.+.. ..++......++.+++++|..||+
T Consensus 72 -------------~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 72 -------------LGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred -------------cCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 1223899999999988765421 246677777778888888888873
Q ss_pred --------------------------------------CCCcccCCCCCceeeCC--CCcEEEeecccccc
Q 048724 230 --------------------------------------KTIVHRDVKTENMLLDA--NRTLKIADFGVARV 260 (394)
Q Consensus 230 --------------------------------------~~iiH~Dlkp~NIll~~--~~~vkl~DFG~a~~ 260 (394)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999988 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=97.62 Aligned_cols=140 Identities=24% Similarity=0.272 Sum_probs=98.2
Q ss_pred ceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccc-------------hHHHHHHHHHHHHHHHHHHhCCCC--cce
Q 048724 89 IRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVT-------------SAEAAAIRASFRQEVAVWQKLDHP--NVT 152 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~-------------~~~~~~~~~~~~~E~~il~~l~h~--nIv 152 (394)
++..||-|--|.||.|.. +|.++|||.-+.+...... .......+....+|.++|.+|... .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 456799999999999998 7999999976543211100 011122244556899999999544 566
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
+.+++-. =++||||++|-.|... +++......++..|++-+.-+-..|+
T Consensus 175 ~P~~~nR------------------------HaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~Gi 223 (304)
T COG0478 175 KPIAWNR------------------------HAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGI 223 (304)
T ss_pred Ccccccc------------------------ceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCc
Confidence 6654421 2799999999777532 12333444555556666555558999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccc
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
||+|+.+-||+++++|.+.++||-.+.
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccc
Confidence 999999999999999999999997764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.6e-08 Score=100.52 Aligned_cols=159 Identities=16% Similarity=0.222 Sum_probs=95.5
Q ss_pred eeeccCCceEEEEEEE-CCeeEEEEEeecccccc-------------------------cchHHHHHHHHHHHHHHHHHH
Q 048724 91 HEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGM-------------------------VTSAEAAAIRASFRQEVAVWQ 144 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~-------------------------~~~~~~~~~~~~~~~E~~il~ 144 (394)
..|+.++-|.||+|+. +|+.||||+.+++-... ......+...+.+..|++..+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4799999999999999 69999999997652111 111222233333333333322
Q ss_pred hCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Q 048724 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGL 224 (394)
Q Consensus 145 ~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l 224 (394)
.- .|.-++-..|.+.+.+++|.-..... ..-.++|||++|..+.+...... ..++.+.+.....++. +
T Consensus 211 EA--~n~~~~~~nf~~~~~v~VP~V~we~t-------~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 211 EA--ANAERFRENFKDDPDVYVPKVYWEYT-------TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--L 278 (517)
T ss_pred HH--HHHHHHHHHcCCCCCeEeceeehhcc-------CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--H
Confidence 21 12222223333444444433322211 12278999999999988753332 3355433333222221 2
Q ss_pred HHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccc
Q 048724 225 SYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261 (394)
Q Consensus 225 ~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~ 261 (394)
..+=..|++|.|.+|.||+++.+|.+.+.|||+....
T Consensus 279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 3333489999999999999999999999999998643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-10 Score=114.51 Aligned_cols=144 Identities=23% Similarity=0.357 Sum_probs=104.9
Q ss_pred HHHHHHHHHHh-CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC----Ccc-----CCCCCCCcCCccccCCCCC
Q 048724 219 DLARGLSYLHS-KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR----DMT-----GETGTLGYMAPEVLDGKPY 288 (394)
Q Consensus 219 qi~~~l~yLH~-~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~----~~~-----~~~gt~~y~aPE~~~~~~~ 288 (394)
+++.|+.|+|. .++||++|.|++|.++.++..||+.|+++........ .+. .......|.|||.+.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 34489999995 6899999999999999999999999998864332111 111 1234568999999999888
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhcc---CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 289 NRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQN---LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 289 ~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+.++|+||||+++|.++. |+.-+......... ...... -....+..+|.++++=|.+++..++..||++..+..
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 899999999999999994 55444333222222 111111 122345678999999999999999999997776643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-08 Score=96.11 Aligned_cols=186 Identities=17% Similarity=0.357 Sum_probs=134.7
Q ss_pred eEEEEecCCCC-CHHHHHHh----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeecccc
Q 048724 184 CCVVVEYLPGG-TLKKFLIR----NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258 (394)
Q Consensus 184 ~~iv~e~~~gg-sL~~~l~~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a 258 (394)
..++|..++|. .+.+++.- ..-....|..+++.++.++.+.+-||..|.+-+|+.++|+|+++++.|.|.|=...
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 46788888765 34444421 12235789999999999999999999999999999999999999999999985544
Q ss_pred ccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhC-CCCCCCCCh--------h-hHHHHH
Q 048724 259 RVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF--------T-DVSSAV 323 (394)
Q Consensus 259 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg-~~Pf~~~~~--------~-~~~~~~ 323 (394)
.+. .+.....+..|.+.|.+||.-+ +..-+...|.|.||+++++++.| +.||.+... + ++....
T Consensus 165 qi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 165 QIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 332 3445556678999999999875 34456788999999999999887 899966431 1 111100
Q ss_pred ------HhccCCC---CCC-CCCcHHHHHHHHHhchhC--CCCCCCHHHHHHHHHHHHh
Q 048724 324 ------VRQNLRP---DIP-RCCPSSLASIMRKCWDAN--PDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 324 ------~~~~~~~---~~~-~~~~~~l~~li~~cL~~d--P~~Rpt~~~ll~~l~~~~~ 370 (394)
...++++ .+| ..+++++..+..+|+..- +.-|||++..+..|..++.
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0111111 111 336889999999999643 5689999999998887764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.5e-08 Score=86.42 Aligned_cols=148 Identities=16% Similarity=0.130 Sum_probs=105.2
Q ss_pred eccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC--cceeeeeeecCCCccccCCCC
Q 048724 93 IARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP--NVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~~~~~~~~~~~~ 170 (394)
-|+||-+-|++....|+.+-+|.....-..... -..-+..|.+|...+.+|..- .+.+....-.....
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r---~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~------- 95 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR---YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIE------- 95 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCccccccc---CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccC-------
Confidence 467999999998888888999976411111100 011146788899999988432 24444422111111
Q ss_pred CCCCCCCCCCCCceEEEEecCCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCc
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPG-GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~ 249 (394)
.....+||+|-++| -+|.+++.+....+.+......++.+++..+.-||+.|+.|+|+.+.||+++.++.
T Consensus 96 ---------~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~ 166 (216)
T PRK09902 96 ---------GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGK 166 (216)
T ss_pred ---------CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCC
Confidence 11234789998854 49999986655556788888899999999999999999999999999999986666
Q ss_pred --EEEeeccccc
Q 048724 250 --LKIADFGVAR 259 (394)
Q Consensus 250 --vkl~DFG~a~ 259 (394)
+.++||--++
T Consensus 167 ~~v~lIDlEk~r 178 (216)
T PRK09902 167 AEAGFLDLEKSR 178 (216)
T ss_pred eeEEEEEhhccc
Confidence 9999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-08 Score=88.89 Aligned_cols=109 Identities=21% Similarity=0.287 Sum_probs=82.5
Q ss_pred HHHHHHHHHHHhCCCC--cceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCC-CHHHHHHhcccCCCCH
Q 048724 134 ASFRQEVAVWQKLDHP--NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG-TLKKFLIRNKRKKLAF 210 (394)
Q Consensus 134 ~~~~~E~~il~~l~h~--nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~gg-sL~~~l~~~~~~~l~~ 210 (394)
....+|...+..|... .+.+.+++....... ....++|+|++++. +|.+++..... .+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~----------------~~~s~lite~l~~~~~L~~~~~~~~~--~~~ 117 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGG----------------GYRSYLITEALPGAQDLRDLLQQWEQ--LDP 117 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC----------------ceeEEEEEEeCCCcccHHHHHHhhcc--cch
Confidence 4566787777777432 344555555432221 13448999999985 89999865332 667
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC---cEEEeecccccc
Q 048724 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR---TLKIADFGVARV 260 (394)
Q Consensus 211 ~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~---~vkl~DFG~a~~ 260 (394)
.....++.+++..+.-||.+|++|+|+++.|||++.++ .+.|+||+-++.
T Consensus 118 ~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 118 SQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 77889999999999999999999999999999998877 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.9e-08 Score=87.26 Aligned_cols=145 Identities=15% Similarity=0.146 Sum_probs=93.7
Q ss_pred cccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHH-----HHHHHHHHHHhC---CCCcceeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRA-----SFRQEVAVWQKL---DHPNVTKFI 155 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~-----~~~~E~~il~~l---~h~nIv~l~ 155 (394)
..+|.+.+++-......|.+-..+|+.+++|..+..... ....... ...+.+..+..+ ......+++
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r-----~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRR-----PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhh-----HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 467777888888888888888889999999987643211 1111111 112233333333 233444444
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
.+.......+ ....+++|||++|..|.++.. +++ .++..+++++.-||+.|+.|+
T Consensus 105 l~~ekk~~~~---------------~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HG 159 (229)
T PF06176_consen 105 LAAEKKIFRY---------------TSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHG 159 (229)
T ss_pred eeeeeeeccc---------------eeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccC
Confidence 4433222211 123368999999999876541 333 244567788999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccc
Q 048724 236 DVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
|++|.|++++.++ +++.||+..+
T Consensus 160 D~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 160 DPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred CCCcCcEEEECCc-EEEEECcccc
Confidence 9999999998655 8999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.1e-07 Score=76.69 Aligned_cols=130 Identities=26% Similarity=0.339 Sum_probs=92.4
Q ss_pred ccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce-eeeeeecCCCccc
Q 048724 87 LDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT-KFIGASMGTTNLK 165 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~ 165 (394)
....+.||+|++|.||++.|.|..+|+|+-+.... +..+..|+++|..++-.++. +++.+-.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-----------r~~l~kEakiLeil~g~~~~p~vy~yg~------ 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-----------RRNLEKEAKILEILAGEGVTPEVYFYGE------ 86 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-----------hhhHHHHHHHHHHhhhcCCCceEEEech------
Confidence 34567899999999999999999999998764332 46677899999999766554 3333321
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC-CCceee
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK-TENMLL 244 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk-p~NIll 244 (394)
.++.|||+.|-+|.++.... +... +..+++.---|-..||-|+.|. |...+|
T Consensus 87 ------------------~~i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vl 139 (201)
T COG2112 87 ------------------DFIRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVL 139 (201)
T ss_pred ------------------hhhhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEE
Confidence 15679999998998765321 2222 3355566555677899999886 444444
Q ss_pred CCCCcEEEeecccccc
Q 048724 245 DANRTLKIADFGVARV 260 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~ 260 (394)
-.++.+.|+||.-|+.
T Consensus 140 v~~~~~~iIDFd~At~ 155 (201)
T COG2112 140 VNDRDVYIIDFDSATF 155 (201)
T ss_pred ecCCcEEEEEccchhh
Confidence 4455899999998874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6e-07 Score=79.93 Aligned_cols=143 Identities=23% Similarity=0.209 Sum_probs=92.2
Q ss_pred eeeeccCCceEEEEEEE-CCeeEEEEEeecccccccc---------------hHHHHHHHHHHHHHHHHHHhCC--CCcc
Q 048724 90 RHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVT---------------SAEAAAIRASFRQEVAVWQKLD--HPNV 151 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~---------------~~~~~~~~~~~~~E~~il~~l~--h~nI 151 (394)
...|..|--+.||+|.. ++..+|||+.+........ .........-...|..-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 44788899999999986 6889999998743211100 0111111222334666666662 3334
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHH-HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK-KFLIRNKRKKLAFKVVIQIALDLARGLSYLHS- 229 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~-~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~- 229 (394)
.+.+++.. -.+||||+....+- =.| ...++...+...+..++++.+.-|-.
T Consensus 133 P~Pi~~~~------------------------nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 133 PEPIAFRN------------------------NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred CCceeecC------------------------CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 44444332 16899999543110 001 11123344677788888888888866
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++||+||..-|||+. ++.+.|+|||.|..
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccc
Confidence 9999999999999999 88899999998864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-06 Score=75.64 Aligned_cols=153 Identities=22% Similarity=0.329 Sum_probs=100.3
Q ss_pred cccccceeeeccCCc-eEEEEEEECCeeEEEEEeec---cccccc---------chHHHHHHHHHHHHHHHHHHhC---C
Q 048724 84 LAKLDIRHEIARGTY-GTVYRGAYDGQDVAVKILDW---AEDGMV---------TSAEAAAIRASFRQEVAVWQKL---D 147 (394)
Q Consensus 84 ~~~~~~~~~lG~G~f-g~Vy~~~~~g~~vavK~~~~---~~~~~~---------~~~~~~~~~~~~~~E~~il~~l---~ 147 (394)
..+++.++.||.|+- |.||+++..|+.+|+|+++. ...... ...........|..|.....+| .
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378999999999999 99999999999999999332 211100 0011123455788888877777 3
Q ss_pred CCcc--eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Q 048724 148 HPNV--TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLS 225 (394)
Q Consensus 148 h~nI--v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~ 225 (394)
+.++ |+++|+..-...-.+..... +...........||-||.+... .+... =+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~--~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQ--RGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhc--ccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHH
Confidence 4556 99999986442111100000 0111122334568999887644 12222 2456778888
Q ss_pred HHHhCCCcccCCCCCceeeCCCCcEEEeecccc
Q 048724 226 YLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258 (394)
Q Consensus 226 yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a 258 (394)
.+|..||+-+|+++.|.. + -+|+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999999988 3 389999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5e-07 Score=89.83 Aligned_cols=160 Identities=18% Similarity=0.243 Sum_probs=87.7
Q ss_pred eeeccCCceEEEEEEE-CCeeEEEEEeecccccccc----------------------hHHHHHHHHHHHHHHHHHHhCC
Q 048724 91 HEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVT----------------------SAEAAAIRASFRQEVAVWQKLD 147 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~----------------------~~~~~~~~~~~~~E~~il~~l~ 147 (394)
+.||.-+.|.||+|+. +|+.||||+.+.+-..... ..-..++.+.+.+|++.++.-+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4699999999999998 7899999998765221110 0111222233333333332221
Q ss_pred CCcceeeeeeecCCC---ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Q 048724 148 HPNVTKFIGASMGTT---NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGL 224 (394)
Q Consensus 148 h~nIv~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l 224 (394)
|.-++-..|.+.+ .+++|...... ...-.++|||++|..+.|.-.-.. ..++...+..-+.+...
T Consensus 247 --Nae~~~~~f~~~~~~~~V~VP~Vy~~~-------st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~-- 314 (538)
T KOG1235|consen 247 --NAERFRENFKDFSLLTYVLVPKVYWDL-------STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL-- 314 (538)
T ss_pred --hHHHHHHHHHhcccccceeCCeehhhc-------CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--
Confidence 1111111111111 11111111110 112268999999997765432222 23555544333333222
Q ss_pred HHHHhCCCcccCCCCCceeeCC----CCcEEEeecccccccc
Q 048724 225 SYLHSKTIVHRDVKTENMLLDA----NRTLKIADFGVARVEA 262 (394)
Q Consensus 225 ~yLH~~~iiH~Dlkp~NIll~~----~~~vkl~DFG~a~~~~ 262 (394)
..+=..|++|.|-+|.||++.. ++.+.+.|||+.....
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2222478999999999999983 6789999999986543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.3e-06 Score=77.03 Aligned_cols=135 Identities=12% Similarity=0.168 Sum_probs=77.7
Q ss_pred eeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc--ceeeeeeecCCCccccCC
Q 048724 91 HEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN--VTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~~~ 168 (394)
..||+|..+.||+. .|..+++|..+... . .....+|.++++.+..-. +.+.+++..+...
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~-------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----- 68 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----D-------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----- 68 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----C-------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe-----
Confidence 46999999999984 35578889875321 1 133467888888885333 3455555443333
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCC-HHHHH--------------Hh-----cc--cCCCCHHHH-HHHHHH------
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGT-LKKFL--------------IR-----NK--RKKLAFKVV-IQIALD------ 219 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggs-L~~~l--------------~~-----~~--~~~l~~~~~-~~i~~q------ 219 (394)
+.+|||+++|.+ +...+ -+ +. ......... ..+..+
T Consensus 69 ---------------~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~ 133 (226)
T TIGR02172 69 ---------------LGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDF 133 (226)
T ss_pred ---------------eeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccC
Confidence 377999998863 21111 00 00 001111110 001000
Q ss_pred ----HHH-HHHHHH----hCCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 220 ----LAR-GLSYLH----SKTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 220 ----i~~-~l~yLH----~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
+.. ...+|. ...++|+|+.|.||++++++ +.|+||+.+.
T Consensus 134 ~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 134 VPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 111 122222 12468999999999999888 9999999885
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.9e-06 Score=74.68 Aligned_cols=142 Identities=22% Similarity=0.268 Sum_probs=81.4
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC--cceeeeeeecCCCccccC
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP--NVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~~~~~~~~~ 167 (394)
++.|+.|..+.||+...++..+++|+.... .....+..|..+++.+... .+.+++.........
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~--- 67 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN--- 67 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET---
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-----------CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc---
Confidence 457999999999999997789999997522 1135566788888888433 355666544322221
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHH----------------HHHh---cc--cCCCCHHH---------HHHH-
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKK----------------FLIR---NK--RKKLAFKV---------VIQI- 216 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~----------------~l~~---~~--~~~l~~~~---------~~~i- 216 (394)
...+++|++++|.++.. .+.. .. ...+.... ....
T Consensus 68 --------------~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (239)
T PF01636_consen 68 --------------GFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWT 133 (239)
T ss_dssp --------------SEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHH
T ss_pred --------------ccceEEEEEeccccccccccccccccccccchhhhhhccccccccccccccccccccccccccccc
Confidence 22489999999988877 1111 10 00111100 0000
Q ss_pred -----------HHHHHH-HHHHHH-------hCCCcccCCCCCceeeC-CCCcEEEeeccccc
Q 048724 217 -----------ALDLAR-GLSYLH-------SKTIVHRDVKTENMLLD-ANRTLKIADFGVAR 259 (394)
Q Consensus 217 -----------~~qi~~-~l~yLH-------~~~iiH~Dlkp~NIll~-~~~~vkl~DFG~a~ 259 (394)
...+.. .+..++ ...++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 134 ARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 011122 233333 24599999999999999 56666799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-05 Score=73.72 Aligned_cols=135 Identities=15% Similarity=0.149 Sum_probs=79.6
Q ss_pred eccCCc-eEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCCCccccCCCC
Q 048724 93 IARGTY-GTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 93 lG~G~f-g~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~ 170 (394)
|-.|.. ..||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~------- 66 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP------------TYELEREAERLRWLAGKLPVPEVIDYGSDDGR------- 66 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc------------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc-------
Confidence 445555 7899987767789999875321 123556888888873 3345566666543322
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHHHHH-------------------hcc--cCCCCHH--HHH-HHHH--------
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKKFLI-------------------RNK--RKKLAFK--VVI-QIAL-------- 218 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~-------------------~~~--~~~l~~~--~~~-~i~~-------- 218 (394)
.++|||+++|.+|..... ... ..++... ... ....
T Consensus 67 -------------~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (244)
T cd05150 67 -------------AWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVD 133 (244)
T ss_pred -------------cEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcC
Confidence 288999999988764320 000 0011100 000 0000
Q ss_pred -----------HHHHHHHHHH-------hCCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 219 -----------DLARGLSYLH-------SKTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 219 -----------qi~~~l~yLH-------~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.+...+..|- ...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 134 EDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 0111122221 2348999999999999988778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.3e-05 Score=67.30 Aligned_cols=97 Identities=26% Similarity=0.283 Sum_probs=77.9
Q ss_pred HHHHHHHhCCC-CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHH---HHhcccCCCCHHHH
Q 048724 138 QEVAVWQKLDH-PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF---LIRNKRKKLAFKVV 213 (394)
Q Consensus 138 ~E~~il~~l~h-~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~---l~~~~~~~l~~~~~ 213 (394)
.|.-+++.+++ +++++++|.|-. +++.||...+++... +. .-...+|..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------------------------~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R 61 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------------------------FYVVEYVGAGSLYGIYRPLS--QFLQSPWEQR 61 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------------------------EEEEEeecCccccccccccc--cccccCHHHH
Confidence 57888888865 699999999843 679999987755321 10 1123689999
Q ss_pred HHHHHHHHHHHHHHHh---CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 214 IQIALDLARGLSYLHS---KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 214 ~~i~~qi~~~l~yLH~---~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.+|+.++++.+.+|+. ..+.-.|++|+|+-+++++.+|++|...+..
T Consensus 62 ~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 62 AKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred HHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 9999999999999997 3477789999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.6e-05 Score=84.13 Aligned_cols=203 Identities=17% Similarity=0.194 Sum_probs=139.8
Q ss_pred HHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHH
Q 048724 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVV 213 (394)
Q Consensus 134 ~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~ 213 (394)
....-|...+.++.|+|++.++.+-....... -...+..++|..-++...+.. -..++..+.
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g----------------~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~ 288 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRG----------------IVLDVLQEICSKVELRSLLQS--VGSIPLETL 288 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcch----------------HHHHHHHhhcCccchHHHHhh--ccccCHHHH
Confidence 44455778888889999999988765433321 122467788888888887754 346888899
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCC---ceeeCCCCcEEEe--eccccccccCCCCCccCCCCCCCcCCccccCCCCC
Q 048724 214 IQIALDLARGLSYLHSKTIVHRDVKTE---NMLLDANRTLKIA--DFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY 288 (394)
Q Consensus 214 ~~i~~qi~~~l~yLH~~~iiH~Dlkp~---NIll~~~~~vkl~--DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 288 (394)
+.+..++..|+.|+|+....|.-+..+ +-..+..+.+.++ ||+.+........ ......+..+.+||....+.+
T Consensus 289 r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~ 367 (1351)
T KOG1035|consen 289 RILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTA 367 (1351)
T ss_pred HHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccc
Confidence 999999999999999986655555444 3344455666666 8888765443322 222345667888888877666
Q ss_pred Cc--cchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 289 NR--KCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 289 ~~--~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
+. ..|+|++|.+...+..|..+-.... .... -.+..+...+.+.+.+|+..++++|+++.+++...-
T Consensus 368 ~~~r~~dL~~lgll~~~~~~~~~i~~~~~---~~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 368 KKSRLTDLWCLGLLLLQLSQGEDISEKSA---VPVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhhHHHHHHHHHhhhhhcCccccccc---chhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 55 4799999999999988765421110 0000 112223337888999999999999999999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.6e-07 Score=89.78 Aligned_cols=184 Identities=19% Similarity=0.187 Sum_probs=127.7
Q ss_pred ccceeeeccCCceEEEEEEECC-eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc-ceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAYDG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN-VTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~ 164 (394)
+.....+++|+++.+++.+.+. +....+.+... ....-++++|.+++||| .+..++-+...
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E--- 306 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------------LSRRLAIELLDKVNNPNPVVRYLEDYDGE--- 306 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------------hhhHHHHHHHHHccCCCCcccccccCCcc---
Confidence 4455668999999999988743 33335555311 22335789999999999 55544433332
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGG-TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
...+++++++.++ +....... ....+...+...+...-+++++|||+.--+|+| ||+
T Consensus 307 -----------------~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l 364 (829)
T KOG0576|consen 307 -----------------DYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NIL 364 (829)
T ss_pred -----------------cccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccc
Confidence 3348899999877 22211110 111244455566667778899999988778998 887
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
.++ +..+.+||+....+.... ......+++.++|||......+....|+|++|.-..++.-|-+|-
T Consensus 365 ~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 365 GSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 765 668999999887544332 344568999999999999999999999999998777777676664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.7e-05 Score=82.25 Aligned_cols=81 Identities=15% Similarity=0.180 Sum_probs=54.6
Q ss_pred eeeeccCCceEEEEEEECC----eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcc--eeeeeeecCCC
Q 048724 90 RHEIARGTYGTVYRGAYDG----QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNV--TKFIGASMGTT 162 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nI--v~l~~~~~~~~ 162 (394)
...|+.|.++.+|+....+ ..+++|+....... .. ...+.+|+.+|+.+. |.++ .+++++|.+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QS------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--cc------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 4578999999999987743 46788876432210 00 245678999999995 6665 77777776543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCC
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggs 195 (394)
.+ ...|+||||++|..
T Consensus 115 v~-----------------G~~flVME~v~G~~ 130 (822)
T PLN02876 115 VI-----------------GTAFYIMEYLEGRI 130 (822)
T ss_pred cC-----------------CCceEEEEecCCcc
Confidence 22 22389999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00014 Score=63.73 Aligned_cols=136 Identities=21% Similarity=0.305 Sum_probs=87.7
Q ss_pred eeeccCCceEEEEEEECCeeEEEEEeecccccccc-------hHHHHHHHHHHHHHHHHHHhCC------CCcceeeeee
Q 048724 91 HEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVT-------SAEAAAIRASFRQEVAVWQKLD------HPNVTKFIGA 157 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~-------~~~~~~~~~~~~~E~~il~~l~------h~nIv~l~~~ 157 (394)
..||+|+.-.||..- .+....||+.+........ ..........+.+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 469999999999643 3456788988755400000 0000011244555665555554 7899999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCC------CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG------GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~g------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
...+..+ .+|+|.+.+ -+|.+++.+ ..++. . +...+-+-..||-+.+
T Consensus 86 veT~~G~--------------------Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~ 138 (199)
T PF10707_consen 86 VETNLGL--------------------GLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHH 138 (199)
T ss_pred EecCCce--------------------EEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcC
Confidence 8876655 567777642 378888843 33555 3 3334445667888899
Q ss_pred CcccCCCCCceeeCCC--C--cEEEee
Q 048724 232 IVHRDVKTENMLLDAN--R--TLKIAD 254 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~--~--~vkl~D 254 (394)
|+.+|++|.||++... + .+.|+|
T Consensus 139 Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 139 IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CeecCCCcccEEEEecCCCceEEEEEe
Confidence 9999999999999532 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.7e-05 Score=67.92 Aligned_cols=31 Identities=29% Similarity=0.476 Sum_probs=26.0
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.+++|+|+.|.||+++.++..-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998766567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00026 Score=66.46 Aligned_cols=79 Identities=11% Similarity=0.058 Sum_probs=55.3
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC---CcceeeeeeecCCCcccc
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH---PNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h---~nIv~l~~~~~~~~~~~~ 166 (394)
.+.||.|..+.||+....+..+.+|..+.... ...+..|+..|+.+.. -.+.++++++.....
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~-----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--- 84 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFST-----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--- 84 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEeccccc-----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc---
Confidence 45799999999999877555688888542111 1467789999998843 357788877654321
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCH
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTL 196 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL 196 (394)
....++|||+++|+++
T Consensus 85 --------------~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 --------------PGPDVLLLERLRGVSV 100 (297)
T ss_pred --------------CCCeEEEEeccCCEec
Confidence 1234899999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.6e-05 Score=73.45 Aligned_cols=141 Identities=19% Similarity=0.230 Sum_probs=92.4
Q ss_pred ccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccch-------------HHHHHHHHHHHHHHHHHHhCC-CC-c
Q 048724 87 LDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTS-------------AEAAAIRASFRQEVAVWQKLD-HP-N 150 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~-------------~~~~~~~~~~~~E~~il~~l~-h~-n 150 (394)
+.++..||-|--+.||.+.+ .|++.++|.-+.+......- ......+-...+|...|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 34677899999999999888 69999999654332111000 011111233446888888873 22 2
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK 230 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 230 (394)
+.+.+++.. -|+|||++.|-+|...- ...+.++ +...+..-+.-|-.+
T Consensus 174 VPkpiD~~R------------------------H~Vvmelv~g~Pl~~v~-----~v~d~~~---ly~~lm~~Iv~la~~ 221 (465)
T KOG2268|consen 174 VPKPIDHNR------------------------HCVVMELVDGYPLRQVR-----HVEDPPT---LYDDLMGLIVRLANH 221 (465)
T ss_pred CCCcccccc------------------------eeeHHHhhcccceeeee-----ecCChHH---HHHHHHHHHHHHHHc
Confidence 333333322 28999999998886432 1223333 344445556667789
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
|+||+|..--||++++++.++++||-..-
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhh
Confidence 99999999999999999999999997553
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.4e-06 Score=91.98 Aligned_cols=165 Identities=12% Similarity=0.037 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCC
Q 048724 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKK 207 (394)
Q Consensus 130 ~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~ 207 (394)
+.+++....|..-++...|+++...+.-..... +..-|.+++|+.+|.+.+.|.+.- ..+
T Consensus 1270 ePlkemll~e~de~~~~~h~~~~~~p~rI~ps~------------------s~ee~~r~~~~~~g~~f~iIikg~ee~~~ 1331 (2724)
T KOG1826|consen 1270 EPLKEMLLSERDELREAKHYLTEVDPLRIPPSE------------------STEEYIRSLYVEFGKLFSIIIKGLEESPD 1331 (2724)
T ss_pred hHHHHhhhhhhhhhhhhhceeeecccccCCCCC------------------ChHHHHHHHHHHHhHHHHHHHhccccCCc
Confidence 344555566766777778988876654332222 223488999999999999987643 233
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-----CCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccc
Q 048724 208 LAFKVVIQIALDLARGLSYLHSK-----TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV 282 (394)
Q Consensus 208 l~~~~~~~i~~qi~~~l~yLH~~-----~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~ 282 (394)
+...-+.....+.+.+..-+|+. -.+|++||+-|.+|..+..++++++|+.++............+++.|++|++
T Consensus 1332 ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1332 LDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred chhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHH
Confidence 44444444444446666666643 2689999999999999999999999999854433333344577888999999
Q ss_pred cCCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 283 LDGKPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 283 ~~~~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
.+.-.++.++|+|..|+.+|+..-|..+|-
T Consensus 1412 ~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1412 KNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 988888989999999999999988877763
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.3e-05 Score=69.53 Aligned_cols=135 Identities=19% Similarity=0.219 Sum_probs=77.3
Q ss_pred eeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc-eeeeeeecCCCccccCCCC
Q 048724 92 EIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV-TKFIGASMGTTNLKIPSQS 170 (394)
Q Consensus 92 ~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~~~~~~ 170 (394)
.+..|-.+.+|+...++..+++|+........ .-...+|..+++.+....+ .++++.+.
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~---------~~~r~~E~~~l~~l~~~g~~P~~i~~~~----------- 62 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKAL---------GVDRQREYQILQALSALGLAPKPILVNE----------- 62 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccc---------cCcHHHHHHHHHHHHhcCCCCceEEEeC-----------
Confidence 35678888999988888889999764321110 0123568888888854333 33333321
Q ss_pred CCCCCCCCCCCCceEEEEecCCCCCHHH--------------HHHh---cc--cCCCCHH-HHHHHHHHH---------H
Q 048724 171 ATSDSHNSLPSRACCVVVEYLPGGTLKK--------------FLIR---NK--RKKLAFK-VVIQIALDL---------A 221 (394)
Q Consensus 171 ~~~~~~~~~~~~~~~iv~e~~~ggsL~~--------------~l~~---~~--~~~l~~~-~~~~i~~qi---------~ 221 (394)
-++|+||++|..+.. .+.+ .. ..+++.. .+..+..++ .
T Consensus 63 -------------~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 129 (256)
T TIGR02721 63 -------------HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWL 129 (256)
T ss_pred -------------CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHH
Confidence 167999999876531 1111 11 1112211 111221111 1
Q ss_pred HHHHHHHh--------CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 222 RGLSYLHS--------KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 222 ~~l~yLH~--------~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
..+..+-. ..++|+|+.|.||+++.++ +.|+||..+..
T Consensus 130 ~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 130 RLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred HHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 11222211 2589999999999999877 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00058 Score=61.62 Aligned_cols=29 Identities=21% Similarity=0.470 Sum_probs=26.1
Q ss_pred CCcccCCCCCceeeCC-CCcEEEeeccccc
Q 048724 231 TIVHRDVKTENMLLDA-NRTLKIADFGVAR 259 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~-~~~vkl~DFG~a~ 259 (394)
+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999997 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0012 Score=62.32 Aligned_cols=148 Identities=20% Similarity=0.280 Sum_probs=82.1
Q ss_pred ccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc--ceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN--VTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~ 164 (394)
...++.++.|....+|+...++..+++|+.+.... . ..+..|.+++..|.... +.+++..... ..
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~----~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g--~~ 90 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK----A-------EELPFFLALTTHLAARGLPVPKPVKSRDG--RQ 90 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCCC----H-------HHHHHHHHHHHHHHHCCCCCCccccCCCC--Ce
Confidence 34456788888889999877666788998753210 1 22345667777764322 3344332111 00
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHH-----------HH---HHhcccC---C------C-CHHHHH------
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK-----------KF---LIRNKRK---K------L-AFKVVI------ 214 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~-----------~~---l~~~~~~---~------l-~~~~~~------ 214 (394)
+ ....+..+++++|++|.++. .. ++..... . + .|....
T Consensus 91 -~-----------~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (307)
T TIGR00938 91 -L-----------STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEA 158 (307)
T ss_pred -e-----------hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhc
Confidence 0 00123458999999885431 11 1110000 0 0 011100
Q ss_pred ------HHHHHHHHHHHHHH-------hCCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 215 ------QIALDLARGLSYLH-------SKTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 215 ------~i~~qi~~~l~yLH-------~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.....+...++++. ..+++|+|+++.||+++.++.+.|.||+.+.
T Consensus 159 ~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 159 APQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 00112334455554 2689999999999999988767899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.001 Score=62.29 Aligned_cols=144 Identities=21% Similarity=0.222 Sum_probs=82.8
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc--ceeeeeeecCCCccccC
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN--VTKFIGASMGTTNLKIP 167 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~~ 167 (394)
.+.|..|....+|+....+..+++|+..... ...+..|+.++..+.+.+ +.+++.... ...+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~------------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~-g~~~--- 82 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKVS------------AEELPFFLALLDHLAERGLPVPRPIADRD-GEYL--- 82 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCCC------------hHhccHHHHHHHHHHHCCCCCCccccCCC-CcEe---
Confidence 5568888888999987767789999875311 134556777777774332 444443211 1100
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHH-----------HH---Hhccc---C------CCCHHHHH----------
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKK-----------FL---IRNKR---K------KLAFKVVI---------- 214 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~-----------~l---~~~~~---~------~l~~~~~~---------- 214 (394)
....+..++|++|++|..+.. .+ +.... . ...+....
T Consensus 83 ----------~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 152 (296)
T cd05153 83 ----------SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSA 152 (296)
T ss_pred ----------eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCH
Confidence 001234589999999876421 11 11000 0 00111100
Q ss_pred HHHHHHHHHHHHHHh-------CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 215 QIALDLARGLSYLHS-------KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 215 ~i~~qi~~~l~yLH~-------~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.....+..++.++.+ .+++|+|+.|.||+++.++.+.|.||+.+.
T Consensus 153 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 153 EDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 011112334444443 479999999999999988777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00069 Score=63.70 Aligned_cols=29 Identities=31% Similarity=0.490 Sum_probs=26.1
Q ss_pred CCcccCCCCCceeeCCC----CcEEEeeccccc
Q 048724 231 TIVHRDVKTENMLLDAN----RTLKIADFGVAR 259 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~----~~vkl~DFG~a~ 259 (394)
+++|+|+.|.||+++.+ +.+.|+||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 57999999999999874 789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0034 Score=59.45 Aligned_cols=30 Identities=27% Similarity=0.491 Sum_probs=26.1
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.++||+|++|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866656899999885
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.004 Score=60.60 Aligned_cols=81 Identities=20% Similarity=0.072 Sum_probs=49.2
Q ss_pred eeeccCCceEEEEEEEC-C-eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---CCcceeeeeeecCCCccc
Q 048724 91 HEIARGTYGTVYRGAYD-G-QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---HPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~-g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~ 165 (394)
+.||.|.+..||++... | +.|+||........... .......++..|.+.|+.+. ..++++++.+.. +
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~--~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~--- 104 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGE--SWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--E--- 104 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccc--cccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--C---
Confidence 57999999999999884 4 48999985421110000 00011245556777777762 245667766532 1
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGT 195 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggs 195 (394)
..++||||+++..
T Consensus 105 -----------------~~~lVME~L~~~~ 117 (401)
T PRK09550 105 -----------------LAVTVMEDLSDHK 117 (401)
T ss_pred -----------------CCEEEEecCCCcc
Confidence 2378999998643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0021 Score=60.82 Aligned_cols=146 Identities=20% Similarity=0.261 Sum_probs=92.2
Q ss_pred cceeeeccCCceEEEEEEE-CCeeEEEEEeecccc-----------------cccchHHHHHHHHHHHHHHHHHHhCCCC
Q 048724 88 DIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAED-----------------GMVTSAEAAAIRASFRQEVAVWQKLDHP 149 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~-----------------~~~~~~~~~~~~~~~~~E~~il~~l~h~ 149 (394)
++-+.|..|--+.||.|+. +|..+|||+++-... +.-......-++.-...|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3455688888899999987 788999999864321 0111112222233344577777777544
Q ss_pred cceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHH-HHHHhcccCCCCHHHHHHHHHHHHHHHHHH-
Q 048724 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK-KFLIRNKRKKLAFKVVIQIALDLARGLSYL- 227 (394)
Q Consensus 150 nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~-~~l~~~~~~~l~~~~~~~i~~qi~~~l~yL- 227 (394)
.|.-.- ++.+ ..-.|||+|+....-. -.| +...++...+..+-.|++.-|.-|
T Consensus 227 GIP~Pe-------PIlL---------------k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY 281 (520)
T KOG2270|consen 227 GIPCPE-------PILL---------------KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLY 281 (520)
T ss_pred CCCCCC-------ceee---------------ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHH
Confidence 432110 0000 1116899999432211 111 223467777777778888888777
Q ss_pred HhCCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 228 HSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 228 H~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
|..++||.||.--|+|+. +|.+.|+|.+.+.
T Consensus 282 ~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 282 QKCRLVHADLSEFNLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred HHhceeccchhhhhheEE-CCEEEEEEccccc
Confidence 568999999999999996 5789999988763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0053 Score=56.98 Aligned_cols=30 Identities=27% Similarity=0.530 Sum_probs=25.2
Q ss_pred CCcccCCCCCceeeCCCCc-EEEeecccccc
Q 048724 231 TIVHRDVKTENMLLDANRT-LKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~-vkl~DFG~a~~ 260 (394)
.++|+|++|.||+++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 46999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.01 Score=57.00 Aligned_cols=29 Identities=28% Similarity=0.576 Sum_probs=25.7
Q ss_pred CCcccCCCCCceeeCC-CCcEEEeeccccc
Q 048724 231 TIVHRDVKTENMLLDA-NRTLKIADFGVAR 259 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~-~~~vkl~DFG~a~ 259 (394)
.++|+|+++.||++++ ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999976 4789999999885
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0085 Score=56.46 Aligned_cols=29 Identities=24% Similarity=0.455 Sum_probs=25.5
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 668999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.012 Score=56.30 Aligned_cols=29 Identities=21% Similarity=0.392 Sum_probs=24.7
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
..++|||+.+.||+++.++ ++++||.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 4689999999999997665 7899998775
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.021 Score=53.69 Aligned_cols=30 Identities=27% Similarity=0.578 Sum_probs=27.2
Q ss_pred CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++|+|+++.|++++.++-+=+.||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 379999999999999888899999999975
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0067 Score=59.76 Aligned_cols=153 Identities=20% Similarity=0.263 Sum_probs=90.5
Q ss_pred HHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHH
Q 048724 136 FRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQ 215 (394)
Q Consensus 136 ~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~ 215 (394)
+.--..+++.+.|+|...++.+..... ....+|+|++ +.+|++.+..+. +.....
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~-------------------~r~IVV~e~~-~~Sled~~~~~~---l~~~s~-- 83 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKH-------------------ERVIVVMEHY-TMSLEDILKTGN---LKDESL-- 83 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCcc-------------------ceEEEEehhh-ccchHHHHHhcc---cchhhh--
Confidence 334567888999999999987754322 2357899999 779999886543 111110
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHH
Q 048724 216 IALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVY 295 (394)
Q Consensus 216 i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 295 (394)
+ .|+-+. -|+ ++++| -++. .. .... .+++|||
T Consensus 84 --------~--------~~~~~~-~~~-------~~~td-~~~t----~~---~~~~----------------~pKsdVw 115 (725)
T KOG1093|consen 84 --------L--------AHGVLH-LNI-------IYITD-HFLT----KY---PSPI----------------GPKSDVW 115 (725)
T ss_pred --------c--------ccccce-ehh-------hhccc-cccc----cC---CCCC----------------Ccchhhh
Confidence 0 222111 122 23333 1110 00 0001 1389999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCC----------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 296 SFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRP----------DIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 296 slG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
++|.++.++..|..-+......+....+..-.... .+...++..+.+++.+|+...|..||...++
T Consensus 116 sl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 116 SLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 99999999999987766655555444332211110 1112356778889999999999988855443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.022 Score=54.31 Aligned_cols=29 Identities=24% Similarity=0.452 Sum_probs=25.4
Q ss_pred CcccCCCCCceeeCC-CCcEEEeecccccc
Q 048724 232 IVHRDVKTENMLLDA-NRTLKIADFGVARV 260 (394)
Q Consensus 232 iiH~Dlkp~NIll~~-~~~vkl~DFG~a~~ 260 (394)
++|+|+.+.||++++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999974 57899999998853
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0065 Score=53.90 Aligned_cols=30 Identities=27% Similarity=0.523 Sum_probs=21.2
Q ss_pred CCcccCCCCCceee-CCCCcEEEeecccccc
Q 048724 231 TIVHRDVKTENMLL-DANRTLKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll-~~~~~vkl~DFG~a~~ 260 (394)
.++|+|+.|.||++ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 57999999999999 7889999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.017 Score=53.74 Aligned_cols=74 Identities=23% Similarity=0.250 Sum_probs=45.2
Q ss_pred ceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---CCcceeeeeeecCCCccc
Q 048724 89 IRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---HPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~ 165 (394)
-.+.++.|....+|+...+++.+.||+-.... ...|..|++-|+.|. --.+.+++++....+.-
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~------------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~- 87 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSESG------------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA- 87 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG------------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC-
T ss_pred eeEecCCCChhheEEEECCCccEEEEecChhh------------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc-
Confidence 34578999999999988888899999876222 145677888888773 34566777776543332
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCC
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGG 194 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~gg 194 (394)
++|+||++.+
T Consensus 88 -------------------fLlle~l~~~ 97 (288)
T PF03881_consen 88 -------------------FLLLEFLEMG 97 (288)
T ss_dssp -------------------EEEEE-----
T ss_pred -------------------eEEEEeecCC
Confidence 8999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.08 Score=51.58 Aligned_cols=80 Identities=11% Similarity=0.020 Sum_probs=48.8
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---CCcceeeeeeecCCCcccc
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---HPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~ 166 (394)
.+.||.|....||+....+..++||.-......... .......+-..|+..|+.+. ..++.+++.++.+.
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga--~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~----- 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGE--SWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM----- 109 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCc--cccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-----
Confidence 567999999999998877778999976522211000 00000122233566666553 24777888776522
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPG 193 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~g 193 (394)
.+++|||+++
T Consensus 110 -----------------~vlvME~L~~ 119 (418)
T PLN02756 110 -----------------ALIGMRYLEP 119 (418)
T ss_pred -----------------CEEEEeecCC
Confidence 2679999976
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.018 Score=54.32 Aligned_cols=30 Identities=23% Similarity=0.344 Sum_probs=27.5
Q ss_pred CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
+++|+|+.++|+|++.++.+-++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999988999999998863
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.076 Score=51.63 Aligned_cols=29 Identities=24% Similarity=0.246 Sum_probs=24.3
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
..++|.|+.+.||+.++ +.+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 46799999999999865 459999998875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.033 Score=53.91 Aligned_cols=29 Identities=21% Similarity=0.391 Sum_probs=24.8
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
+.++||||+|.||++++++ +|+.|.-++.
T Consensus 227 ~aLlHGDlHtGSI~v~~~~-~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKNDS-TKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCCc-eEEEcccccc
Confidence 4589999999999999764 7999988775
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.044 Score=52.01 Aligned_cols=71 Identities=18% Similarity=0.262 Sum_probs=55.9
Q ss_pred CceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 182 RACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 182 ~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
...|++|++- |++|.- + +.-.++++..|+.+.+..++-+..+ .+-|||+.-.||||+ +|+|.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3447888886 666642 1 2356788889999888877777643 689999999999999 89999999999985
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.2 Score=47.65 Aligned_cols=28 Identities=25% Similarity=0.316 Sum_probs=24.1
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 4 57899999885
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.029 Score=53.95 Aligned_cols=58 Identities=22% Similarity=0.255 Sum_probs=43.1
Q ss_pred EEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccCCCCCceeeC
Q 048724 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSY-LHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 185 ~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~y-LH~~~iiH~Dlkp~NIll~ 245 (394)
.++-+|..|-++..++.... .+++...+++.-.+.|+-- |--.+++|.|++|.||++-
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 57788888999999985533 4555666666666666433 3457899999999999994
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.29 Score=48.58 Aligned_cols=28 Identities=21% Similarity=0.466 Sum_probs=23.9
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.++|.|+-+.|||.+.++ ++|+||-.|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 479999999999986554 9999998875
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.1 Score=47.59 Aligned_cols=75 Identities=19% Similarity=0.231 Sum_probs=52.2
Q ss_pred eeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHH---HHHHhCCCCcceeeeeeecCCCccc
Q 048724 90 RHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV---AVWQKLDHPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~il~~l~h~nIv~l~~~~~~~~~~~ 165 (394)
...+..|..+.|+.++. +|+++++|+...... +..|. ..|+..+-...|++++.-.+..
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~--------------~~~E~~g~~~L~~w~G~GaVrll~~d~~~~--- 69 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE--------------AEHEARGEAALRWWNGRGAVRLLAADPERG--- 69 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc--------------chhhhhHHhHhheeCCCCceeeeccccccc---
Confidence 34577899999999976 899999999763221 11233 5577778888999997753222
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecC-CCCCHHHHH
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYL-PGGTLKKFL 200 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~-~ggsL~~~l 200 (394)
.+++|.+ ++-+|.+..
T Consensus 70 -------------------AlLLErl~~g~~L~~~~ 86 (253)
T PF04655_consen 70 -------------------ALLLERLDPGRSLASLP 86 (253)
T ss_pred -------------------hhhhhhccCCCchhhcc
Confidence 5688888 445776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.34 Score=53.33 Aligned_cols=30 Identities=33% Similarity=0.629 Sum_probs=25.8
Q ss_pred CCCcccCCCCCceeeCCCC--cEE-Eeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANR--TLK-IADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~--~vk-l~DFG~a~ 259 (394)
.++||+|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999998775 555 99999875
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.032 Score=44.69 Aligned_cols=44 Identities=23% Similarity=0.387 Sum_probs=33.8
Q ss_pred eeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC
Q 048724 91 HEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 146 (394)
..||.|+.|.||+|+. +|+.||||+.+... ...+..++.+++.+
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i------------~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGI------------EEQIEADLRILRRL 61 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHH------------HHHHHHHHHHHHHH
Confidence 4699999999999998 69999999987432 34555666666544
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 394 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-43 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-43 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-38 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-37 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-37 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-36 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-36 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-36 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-36 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-36 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-36 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-36 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-35 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-35 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-35 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-34 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-34 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-34 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-34 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-34 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-34 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-34 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-34 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-34 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-34 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-34 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-34 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-34 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-34 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-34 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-34 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-34 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-34 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-34 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-34 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-33 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-33 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-33 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-33 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-33 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-33 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-33 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-33 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-31 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-31 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-31 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-31 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-31 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-30 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-30 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-30 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-30 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-30 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-30 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-30 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-30 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-30 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-30 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-30 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-30 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-30 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-30 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-30 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-30 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-30 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-30 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-30 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-30 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-29 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-29 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-29 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-28 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-28 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-28 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-28 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-28 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-28 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-28 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-28 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-28 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-28 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-28 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-28 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-28 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-28 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-28 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-28 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-28 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-28 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-28 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-28 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-28 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-28 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-28 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-28 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-28 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-28 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-28 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-28 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-28 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-28 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-28 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-28 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-27 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-27 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-27 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-27 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-27 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-27 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-27 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-27 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-27 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-27 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-27 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-27 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-26 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-26 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-26 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-26 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-26 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-26 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-26 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-26 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-26 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-26 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-26 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-26 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-26 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-26 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-26 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-25 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-25 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-25 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-25 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-25 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-25 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-25 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-25 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-25 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-25 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-25 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-25 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-25 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-25 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-25 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-25 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-25 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-25 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-25 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-25 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-25 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-25 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-25 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-25 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-25 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-25 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-25 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-25 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-25 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-25 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-25 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-25 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-25 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-25 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-25 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-25 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-25 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-25 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-25 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-25 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-25 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-25 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-25 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-25 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-25 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-25 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-25 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-25 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-25 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-24 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-24 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-24 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-24 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-24 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-24 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-24 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-24 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-24 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-24 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-24 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-24 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-24 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-24 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-24 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-24 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-24 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-23 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-23 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-23 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-23 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-23 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-23 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-23 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-23 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-23 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-23 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-23 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-23 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-23 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-23 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-23 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-23 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-23 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-23 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-23 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-23 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-22 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-22 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-22 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-22 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-22 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-22 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-22 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-22 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-22 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-22 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-22 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-22 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-22 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-22 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-22 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-22 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-22 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-22 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-22 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-22 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-22 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-22 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-22 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-22 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-22 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-22 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-22 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-22 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-22 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-22 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-22 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-22 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-22 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-21 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-21 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-21 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-21 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-21 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-21 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-21 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-21 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-21 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-21 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-21 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-21 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-20 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-20 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-20 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-19 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-19 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-19 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-19 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-19 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-16 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-134
Identities = 102/297 (34%), Positives = 161/297 (54%), Gaps = 30/297 (10%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
++ +I L+I+ +I G++GTV+R + G DVAVKIL A F
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILM-------EQDFHAERVNEFL 82
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
+EVA+ ++L HPN+ F+GA NL +V EYL G+L
Sbjct: 83 REVAIMKRLRHPNIVLFMGAVTQPPNL--------------------SIVTEYLSRGSLY 122
Query: 198 KFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANRTLKIAD 254
+ L ++ R++L + + +A D+A+G++YLH++ IVHR++K+ N+L+D T+K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 255 FGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
FG++R++A GT +MAPEVL +P N K DVYSFG+ LWE+ P+ +L
Sbjct: 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371
+ V +AV + R +IPR +A+I+ CW P KRP ++ LL + S
Sbjct: 243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-126
Identities = 70/295 (23%), Positives = 131/295 (44%), Gaps = 35/295 (11%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
+ I+ +L+ ++ G +++G + G D+ VK+L + + F
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-------STRKSRDFN 55
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
+E + HPNV +GA S P+ ++ ++P G+L
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQ------------------SPPAPHPTLITHWMPYGSLY 97
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANRTLKIADF 255
L + ++ ALD+ARG+++LH+ I + + ++++D + T +I+
Sbjct: 98 NVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157
Query: 256 GVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN---RKCDVYSFGICLWEIYCCDMPYP 312
V G ++APE L KP + R D++SF + LWE+ ++P+
Sbjct: 158 DVKFS-----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212
Query: 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
DLS ++ V + LRP IP ++ +M+ C + +P KRP D +V +LE
Sbjct: 213 DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 354 bits (910), Expect = e-122
Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 41/305 (13%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIR 133
K+ + +++ +I +G +G V++G D VA+K L + E
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE--GETEMIEKF 67
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F++EV + L+HPN+ K G +V+E++P
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMH----------------------NPPRMVMEFVPC 105
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLD-----A 246
G L L +K + + V +++ LD+A G+ Y+ ++ IVHRD+++ N+ L A
Sbjct: 106 GDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEI 304
K+ADFG+++ ++G G +MAPE + + Y K D YSF + L+ I
Sbjct: 165 PVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221
Query: 305 YCCDMPYPDLSFTDVS--SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
+ P+ + S+ + + + + LRP IP CP L +++ CW +P KRP +V
Sbjct: 222 LTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 363 KLLEA 367
K L
Sbjct: 282 KELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-122
Identities = 86/300 (28%), Positives = 142/300 (47%), Gaps = 41/300 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
EI+ A+L + I G +G VYR + G +VAVK D + + + RQE
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPD-----EDISQTIENVRQE 56
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
++ L HPN+ G + NL C+V+E+ GG L +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNL--------------------CLVMEFARGGPLNRV 96
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSK---TIVHRDVKTENMLLD--------ANR 248
L K++ +++ A+ +ARG++YLH + I+HRD+K+ N+L+ +N+
Sbjct: 97 L---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153
Query: 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308
LKI DFG+AR + G +MAPEV+ +++ DV+S+G+ LWE+ +
Sbjct: 154 ILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+P+ + V+ V L IP CP A +M CW+ +P RP ++ L +
Sbjct: 212 VPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 352 bits (904), Expect = e-121
Identities = 86/311 (27%), Positives = 143/311 (45%), Gaps = 42/311 (13%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
I+ ++++ + RG +G V + + +DVA+K ++ + R +F
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-----------RKAFIV 50
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E+ +++HPN+ K GA + C+V+EY GG+L
Sbjct: 51 ELRQLSRVNHPNIVKLYGACL----------------------NPVCLVMEYAEGGSLYN 88
Query: 199 FLIRNKRK-KLAFKVVIQIALDLARGLSYLHS---KTIVHRDVKTENMLLDAN-RTLKIA 253
L + + L ++G++YLHS K ++HRD+K N+LL A LKI
Sbjct: 89 VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148
Query: 254 DFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD 313
DFG A + MT G+ +MAPEV +G Y+ KCDV+S+GI LWE+ P+ +
Sbjct: 149 DFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 314 LSFTDVS-SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372
+ V RP + + P + S+M +CW +P +RP M+E+VK++ +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
Query: 373 GGGMIPEDQAH 383
G P
Sbjct: 266 PGADEPLQYPC 276
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 352 bits (904), Expect = e-121
Identities = 76/329 (23%), Positives = 153/329 (46%), Gaps = 50/329 (15%)
Query: 59 EKHLSRVWSREREVLPRKT----EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVK 114
E +LS + +R +T +EW+I +L+I I +G +G VY G + G +VA++
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIR 61
Query: 115 ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSD 174
++D D +F++EV +++ H NV F+GA M +L
Sbjct: 62 LIDIERDN-------EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL---------- 104
Query: 175 SHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234
++ G TL + R+ + L QIA ++ +G+ YLH+K I+H
Sbjct: 105 ----------AIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 235 RDVKTENMLLDANRTLKIADFGVARVEA-----QNPRDMTGETGTLGYMAPEVL------ 283
+D+K++N+ D N + I DFG+ + + + + G L ++APE++
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 284 ---DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRC-CPSS 339
D P+++ DV++ G +E++ + P+ + + ++P++ +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMKPNLSQIGMGKE 271
Query: 340 LASIMRKCWDANPDKRPVMDEVVKLLEAV 368
++ I+ CW ++RP +++ +LE +
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-118
Identities = 91/315 (28%), Positives = 152/315 (48%), Gaps = 39/315 (12%)
Query: 62 LSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAED 121
+ + ++WEI ++ + I G++GTVY+G + G DVAVK+L+
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP 59
Query: 122 GMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPS 181
+F+ EV V +K H N+ F+G S P
Sbjct: 60 T-------PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-------------------PQ 93
Query: 182 RACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
+V ++ G +L L K K +I IA ARG+ YLH+K+I+HRD+K+ N
Sbjct: 94 --LAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN 150
Query: 242 MLLDANRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVL---DGKPYNRKCDVYS 296
+ L + T+KI DFG+A +++ +G++ +MAPEV+ D PY+ + DVY+
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 210
Query: 297 FGICLWEIYCCDMPYPDLSFTD-VSSAVVRQNLRPDIPRC---CPSSLASIMRKCWDANP 352
FGI L+E+ +PY +++ D + V R +L PD+ + CP + +M +C
Sbjct: 211 FGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKR 270
Query: 353 DKRPVMDEVVKLLEA 367
D+RP ++ +E
Sbjct: 271 DERPSFPRILAEIEE 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-107
Identities = 81/319 (25%), Positives = 132/319 (41%), Gaps = 43/319 (13%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
+ L + +G +G + + + + + +F
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMK-------ELIRFDEETQRTFL 55
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
+EV V + L+HPNV KFIG L + EY+ GGTL+
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRL--------------------NFITEYIKGGTLR 95
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+ ++ + + + A D+A G++YLHS I+HRD+ + N L+ N+ + +ADFG+
Sbjct: 96 GII-KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL 154
Query: 258 ARVEAQNP--------------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
AR+ + G +MAPE+++G+ Y+ K DV+SFGI L E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214
Query: 304 IYCCDMPYPDLSFTDVSSAV-VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
I PD + + VR L P CP S I +C D +P+KRP ++
Sbjct: 215 IIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274
Query: 363 KLLEAVNTSKGGGMIPEDQ 381
LE + G + Q
Sbjct: 275 HWLETLRMHLAGHLPLGPQ 293
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-106
Identities = 87/334 (26%), Positives = 136/334 (40%), Gaps = 71/334 (21%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
++ + +I +G YG V+ G + G+ VAVK+ E AS+ +
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------------EASWFR 78
Query: 139 EVAVWQ--KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
E ++Q + H N+ FI A + T ++ +Y G+L
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQ----------------LYLITDYHENGSL 122
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--------IVHRDVKTENMLLDANR 248
+L K L K ++++A GL +LH++ I HRD+K++N+L+ N
Sbjct: 123 YDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 249 TLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLDG------KPYNRKCDVYSFG 298
T IAD G+A + + GT YM PEVLD D+YSFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
Query: 299 ICLWEIYCC----------DMPYPDL-----SFTDVSSAVVRQNLRPDIPRC-----CPS 338
+ LWE+ +PY DL S+ D+ V + LRP P C
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299
Query: 339 SLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372
+ +M +CW NP R V K L ++ S+
Sbjct: 300 QMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-105
Identities = 90/338 (26%), Positives = 138/338 (40%), Gaps = 71/338 (21%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
+ ++ I +G +G V+RG + G++VAVKI E S+ +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------------ERSWFR 83
Query: 139 EVAVWQ--KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
E ++Q L H N+ FI A +V +Y G+L
Sbjct: 84 EAEIYQTVMLRHENILGFIAADNKDNGTWTQ----------------LWLVSDYHEHGSL 127
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--------IVHRDVKTENMLLDANR 248
+L R + + +I++AL A GL++LH + I HRD+K++N+L+ N
Sbjct: 128 FDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184
Query: 249 TLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLDG------KPYNRKCDVYSFG 298
T IAD G+A GT YMAPEVLD ++ D+Y+ G
Sbjct: 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
Query: 299 ICLWEIYCC---------------DMPYPDLSFTDVSSAVVRQNLRPDIP---RCCP--S 338
+ WEI D+ D S ++ V Q LRP+IP + C
Sbjct: 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 304
Query: 339 SLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGM 376
+A IMR+CW AN R + K L ++ +G M
Sbjct: 305 VMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-105
Identities = 83/323 (25%), Positives = 139/323 (43%), Gaps = 71/323 (21%)
Query: 87 LDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ-- 144
+ + + +G YG V+RG++ G++VAVKI ++ S+ +E ++
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE------------KSWFRETELYNTV 57
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
L H N+ FI + M + + ++ Y G+L +L +
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQ----------------LWLITHYHEMGSLYDYL---Q 98
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKT--------IVHRDVKTENMLLDANRTLKIADFG 256
L ++I L +A GL++LH + I HRD+K++N+L+ N IAD G
Sbjct: 99 LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 257 VARVEAQNPRD----MTGETGTLGYMAPEVLDGKP------YNRKCDVYSFGICLWEIYC 306
+A + +Q+ GT YMAPEVLD ++ D+++FG+ LWE+
Sbjct: 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
Query: 307 C---------------DMPYPDLSFTDVSSAVVRQNLRPDIPR-----CCPSSLASIMRK 346
D+ D SF D+ V RP+IP +SLA +M++
Sbjct: 219 RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE 278
Query: 347 CWDANPDKRPVMDEVVKLLEAVN 369
CW NP R + K L ++
Sbjct: 279 CWYQNPSARLTALRIKKTLTKID 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-101
Identities = 83/332 (25%), Positives = 135/332 (40%), Gaps = 71/332 (21%)
Query: 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
TE + L + ARG +G V++ + VAVKI + + S+
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD------------KQSW 63
Query: 137 RQEVAVWQ--KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
+ E V+ + H N+ +FIGA T++ + ++ + G
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD----------------LWLITAFHEKG 107
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT----------IVHRDVKTENMLL 244
+L FL K +++ + IA +ARGL+YLH I HRD+K++N+LL
Sbjct: 108 SLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 245 DANRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSF 297
N T IADFG+A ++ D G+ GT YMAPEVL+G + + D+Y+
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 298 GICLWEIYCCDMPY----------------PDLSFTDVSSAVVRQNLRPDIPRCCPS--- 338
G+ LWE+ S D+ VV + RP +
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 339 --SLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
L + +CWD + + R V + + +
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = e-100
Identities = 87/358 (24%), Positives = 144/358 (40%), Gaps = 82/358 (22%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
E ++L L + I RG YG VY+G+ D + VAVK+ +A R +F
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------RQNFI 53
Query: 138 QEVAVWQ--KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195
E +++ ++H N+ +FI T + +V+EY P G+
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVT---------------ADGRMEYLLVMEYYPNGS 98
Query: 196 LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT---------IVHRDVKTENMLLDA 246
L K+L + ++A + RGL+YLH++ I HRD+ + N+L+
Sbjct: 99 LXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155
Query: 247 NRTLKIADFGVARVEAQNPR--------DMTGETGTLGYMAPEVLDG-------KPYNRK 291
+ T I+DFG++ N E GT+ YMAPEVL+G + ++
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215
Query: 292 CDVYSFGICLWEIY--CCD-----------MPYPDL-----SFTDVSSAVVRQNLRPDIP 333
D+Y+ G+ WEI+ C D M + +F D+ V R+ RP P
Sbjct: 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP 275
Query: 334 RCC------PSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS--KGGGMIPEDQAH 383
SL + CWD + + R + + + + + P H
Sbjct: 276 EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-69
Identities = 95/339 (28%), Positives = 147/339 (43%), Gaps = 42/339 (12%)
Query: 41 DLFFRADKIDFKSWDIQLEKHLSRVW----SREREVLPR--KTEEWEIELAKLDIRHEIA 94
D +R + F S L HL + VL R ++W + L + +I
Sbjct: 65 DNLYRLEGEGFPSI-PLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIG 123
Query: 95 RGTYGTVYRGAYDGQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152
RG +G V+ G VAVK E ++A F QE + ++ HPN+
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKSC--RETLP------PDLKAKFLQEARILKQYSHPNIV 175
Query: 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKV 212
+ IG + +V+E + GG FL R + +L K
Sbjct: 176 RLIGVCTQKQPI--------------------YIVMELVQGGDFLTFL-RTEGARLRVKT 214
Query: 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET 272
++Q+ D A G+ YL SK +HRD+ N L+ LKI+DFG++R EA +G
Sbjct: 215 LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274
Query: 273 GTLGY--MAPEVLDGKPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLR 329
+ APE L+ Y+ + DV+SFGI LWE + PYP+LS V + R
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGR 333
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
P CP ++ +M +CW P +RP + + L+++
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-66
Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 41/298 (13%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
W + + +L + I +G +G V G Y G VAVK + D +F
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--KNDAT---------AQAFL 234
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
E +V +L H N+ + +G + L +V EY+ G+L
Sbjct: 235 AEASVMTQLRHSNLVQLLGVI--------------VEEKGGL-----YIVTEYMAKGSLV 275
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+L R L +++ +LD+ + YL VHRD+ N+L+ + K++DFG+
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 258 ARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIY-CCDMPYPD 313
+ + + + + + APE L K ++ K DV+SFGI LWEIY +PYP
Sbjct: 336 TKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389
Query: 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371
+ DV V + + D P CP ++ +M+ CW + RP ++ + LE + T
Sbjct: 390 IPLKDVVPR-VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 5e-65
Identities = 82/340 (24%), Positives = 145/340 (42%), Gaps = 51/340 (15%)
Query: 43 FFRADKIDFKSWDIQLEKHLSRVW-----------SREREVLPRKTEEWEIELAKLDIRH 91
F+ + + F + +L H + + P + + WEI L +
Sbjct: 136 FYISPRSTFSTLQ-ELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK 194
Query: 92 EIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
++ G +G V+ Y+ VAVK + + +F E V + L H
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTM----------KPGSMSVEAFLAEANVMKTLQHDK 244
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ K + + ++ E++ G+L FL ++ K
Sbjct: 245 LVKLHAVV----------------TKEPI-----YIITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
+I + +A G++++ + +HRD++ N+L+ A+ KIADFG+ARV N + T
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--EYTA 341
Query: 271 ETGTLG---YMAPEVLDGKPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQ 326
G + APE ++ + K DV+SFGI L EI +PYP +S +V A + +
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LER 400
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
R P CP L +IM +CW P++RP + + +L+
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-64
Identities = 77/298 (25%), Positives = 136/298 (45%), Gaps = 35/298 (11%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG--QDVAVKILDWAEDGMVTSAEAA 130
+ ++WE+E + ++H++ G YG VY G + VAVK T E
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK----------TLKEDT 257
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
F +E AV +++ HPN+ + +G T ++ E+
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPF------------------YIITEF 297
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250
+ G L +L R++++ V++ +A ++ + YL K +HR++ N L+ N +
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357
Query: 251 KIADFGVARVEAQNPRDMTGETG-TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY-CCD 308
K+ADFG++R+ + + + APE L ++ K DV++FG+ LWEI
Sbjct: 358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 417
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
PYP + + V + ++ R + P CP + +MR CW NP RP E+ + E
Sbjct: 418 SPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 7e-64
Identities = 90/356 (25%), Positives = 146/356 (41%), Gaps = 52/356 (14%)
Query: 43 FFRADKIDFKSWDIQLEKHLSR------------VWSREREVLPRKTEEWEIELAKLDIR 90
F+ + F S QL + S+ + + + + WEI L +
Sbjct: 131 FYITSRTQFNSLQ-QLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLE 189
Query: 91 HEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
++ +G +G V+ G ++G VA+K L +F QE V +KL H
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL----------KPGTMSPEAFLQEAQVMKKLRHE 239
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ + + +V EY+ G+L FL K L
Sbjct: 240 KLVQLYAV---------------------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR 278
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
++ +A +A G++Y+ VHRD++ N+L+ N K+ADFG+AR+ N + T
Sbjct: 279 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EYT 336
Query: 270 GETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVR 325
G + + APE + K DV+SFGI L E+ +PYP + +V V
Sbjct: 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VE 395
Query: 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQ 381
+ R P CP SL +M +CW P++RP + + LE TS P +
Sbjct: 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 8e-64
Identities = 78/322 (24%), Positives = 136/322 (42%), Gaps = 36/322 (11%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVTSA 127
L K E+ I + + + +G +G+V +D VAVK+L + ++ S+
Sbjct: 11 LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIASS 67
Query: 128 EAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
+ F +E A ++ DHP+V K +G S S V+
Sbjct: 68 D----IEEFLREAACMKEFDHPHVAKLVGVS--------------LRSRAKGRLPIPMVI 109
Query: 188 VEYLPGGTLKKFL----IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
+ ++ G L FL I L + +++ +D+A G+ YL S+ +HRD+ N +
Sbjct: 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL-DGKPYNRKCDVYSFGIC 300
L + T+ +ADFG++R G L ++A E L D Y DV++FG+
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVT 228
Query: 301 LWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMD 359
+WEI PY + ++ + + R P C + +M +CW A+P +RP
Sbjct: 229 MWEIMTRGQTPYAGIENAEIYNYL-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT 287
Query: 360 EVVKLLEAVNTSKGGGMIPEDQ 381
+ LE + +D
Sbjct: 288 CLRMELENILGHLSVLSTSQDP 309
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 41/298 (13%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
W + + +L + I +G +G V G Y G VAVK + D +F
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--KNDAT---------AQAFL 62
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
E +V +L H N+ + +G + L +V EY+ G+L
Sbjct: 63 AEASVMTQLRHSNLVQLLGVI--------------VEEKGGL-----YIVTEYMAKGSLV 103
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+L R L +++ +LD+ + YL VHRD+ N+L+ + K++DFG+
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163
Query: 258 ARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPD 313
+ + + + + + APE L K ++ K DV+SFGI LWEIY +PYP
Sbjct: 164 TKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217
Query: 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371
+ DV V + + D P CP ++ +M+ CW + RP ++ + LE + T
Sbjct: 218 IPLKDVVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-63
Identities = 93/356 (26%), Positives = 145/356 (40%), Gaps = 52/356 (14%)
Query: 43 FFRADKIDFKSWDIQLEKHLSRVW----SREREVLPRKT--------EEWEIELAKLDIR 90
F+ + F S QL + S+ R V P + WEI L +
Sbjct: 214 FYITSRTQFNSLQ-QLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLE 272
Query: 91 HEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
++ +G +G V+ G ++G VA+K L +F QE V +KL H
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL----------KPGTMSPEAFLQEAQVMKKLRHE 322
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ + + +V EY+ G+L FL K L
Sbjct: 323 KLVQLYAV---------------------VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR 361
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
++ +A +A G++Y+ VHRD++ N+L+ N K+ADFG+AR+ N + T
Sbjct: 362 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EYT 419
Query: 270 GETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVR 325
G + APE + K DV+SFGI L E+ +PYP + +V V
Sbjct: 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VE 478
Query: 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQ 381
+ R P CP SL +M +CW P++RP + + LE TS P +
Sbjct: 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-63
Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 39/298 (13%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAI 132
P +EWE+ L + + G +G V+ G Y+G VAVK L + +
Sbjct: 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL----------KQGSMS 51
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
+F E + ++L H + + +Q ++ EY+
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYAVV---------TQEPI------------YIITEYME 90
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
G+L FL KL ++ +A +A G++++ + +HRD++ N+L+ + KI
Sbjct: 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150
Query: 253 ADFGVARVEAQNPRDMTGETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-D 308
ADFG+AR+ N + T G + APE ++ + K DV+SFGI L EI
Sbjct: 151 ADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+PYP ++ +V + + R P CP L +MR CW P+ RP D + +LE
Sbjct: 209 IPYPGMTNPEVIQN-LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-62
Identities = 93/309 (30%), Positives = 137/309 (44%), Gaps = 43/309 (13%)
Query: 73 LPRKTEEWEIELAKLDIR--HEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVT 125
L + + I + L + I RG +G VY G D AVK L+ +
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN----RITD 66
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185
E + F E + + HPNV +G S S
Sbjct: 67 IGE----VSQFLTEGIIMKDFSHPNVLSLLGIC--------------LRSEGSP-----L 103
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
VV+ Y+ G L+ F+ RN+ K +I L +A+G+ YL SK VHRD+ N +LD
Sbjct: 104 VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162
Query: 246 ANRTLKIADFGVAR-VEAQNPRDMTGETGTL---GYMAPEVL-DGKPYNRKCDVYSFGIC 300
T+K+ADFG+AR + + + +TG +MA E L K + K DV+SFG+
Sbjct: 163 EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVL 221
Query: 301 LWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMD 359
LWE+ PYPD++ D++ + Q R P CP L +M KCW + RP
Sbjct: 222 LWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 280
Query: 360 EVVKLLEAV 368
E+V + A+
Sbjct: 281 ELVSRISAI 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-62
Identities = 80/323 (24%), Positives = 133/323 (41%), Gaps = 39/323 (12%)
Query: 60 KHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-----VAVK 114
H S + R E L K E+ I+ L + + G +G+V G +D VAVK
Sbjct: 9 HHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK 68
Query: 115 ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSD 174
+ D F E A + HPNV + +G + ++ IP
Sbjct: 69 TM--KLDNSSQRE-----IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP----- 116
Query: 175 SHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-----KKLAFKVVIQIALDLARGLSYLHS 229
V++ ++ G L +L R K + + +++ +D+A G+ YL +
Sbjct: 117 ----------MVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN 165
Query: 230 KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL-DGK 286
+ +HRD+ N +L + T+ +ADFG+++ G + ++A E L D
Sbjct: 166 RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 225
Query: 287 PYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMR 345
Y K DV++FG+ +WEI PYP + ++ + R P C L IM
Sbjct: 226 -YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LHGHRLKQPEDCLDELYEIMY 283
Query: 346 KCWDANPDKRPVMDEVVKLLEAV 368
CW +P RP + LE +
Sbjct: 284 SCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-62
Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 39/298 (13%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFR 137
+W I+ ++L EI G +G V+ G + + VA+K + E A F
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI----------REGAMSEEDFI 51
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
+E V KL HP + + G L C+V E++ G L
Sbjct: 52 EEAEVMMKLSHPKLVQLYGVC--------------------LEQAPICLVTEFMEHGCLS 91
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+L R +R A + ++ + LD+ G++YL ++HRD+ N L+ N+ +K++DFG+
Sbjct: 92 DYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 150
Query: 258 ARVEAQNPRDMTGETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPD 313
R + T TGT + +PEV Y+ K DV+SFG+ +WE++ +PY +
Sbjct: 151 TRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
Query: 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371
S ++V + R PR + + IM CW P+ RP +++ L + S
Sbjct: 209 RSNSEVVED-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 6e-62
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 26/274 (9%)
Query: 92 EIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I G +G V++ DG+ +K + + +EV KLDH
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------------NEKAEREVKALAKLDHV 64
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ + G G S +S S + +E+ GTL++++ + + +KL
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKC----LFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
+ +++ + +G+ Y+HSK +++RD+K N+ L + +KI DFG+ +N T
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRT 179
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR 329
GTL YM+PE + + Y ++ D+Y+ G+ L E+ + S
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SKFFTDLRD 233
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
I ++++K P+ RP E+++
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 8e-62
Identities = 73/294 (24%), Positives = 127/294 (43%), Gaps = 39/294 (13%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASF 136
WEI+ L E+ G +G V G + GQ DVA+K++ E + F
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI----------KEGSMSEDEF 66
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
+E V L H + + G R ++ EY+ G L
Sbjct: 67 IEEAKVMMNLSHEKLVQLYGVC--------------------TKQRPIFIITEYMANGCL 106
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+L R R + + ++++ D+ + YL SK +HRD+ N L++ +K++DFG
Sbjct: 107 LNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165
Query: 257 VARVEAQNPRDMTGETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYP 312
++R + + T G+ + PEVL ++ K D+++FG+ +WEIY MPY
Sbjct: 166 LSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
Query: 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ ++ + + Q LR P + +IM CW D+RP ++ +
Sbjct: 224 RFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 8e-62
Identities = 69/322 (21%), Positives = 134/322 (41%), Gaps = 54/322 (16%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD------VAVKILDWAEDGMVTSAEAAA 131
+ + E L ++ +G +G+V YD VAVK L +
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRD--- 57
Query: 132 IRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
F +E+ + + L H N+ K+ G + +++EYL
Sbjct: 58 ----FEREIEILKSLQHDNIVKYKGVCYSAGRRNL------------------KLIMEYL 95
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
P G+L+ +L + ++++ ++Q + +G+ YL +K +HRD+ T N+L++ +K
Sbjct: 96 PYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 252 IADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEI--YC 306
I DFG+ +V Q+ + + + APE L ++ DV+SFG+ L+E+ Y
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 307 CD--------------MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANP 352
+ + ++ N R P CP + IM +CW+ N
Sbjct: 215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNV 273
Query: 353 DKRPVMDEVVKLLEAVNTSKGG 374
++RP ++ ++ + + G
Sbjct: 274 NQRPSFRDLALRVDQIRDNMAG 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 8e-62
Identities = 71/322 (22%), Positives = 135/322 (41%), Gaps = 54/322 (16%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD------VAVKILDWAEDGMVTSAEAAA 131
+ + E L ++ +G +G+V YD VAVK L +
Sbjct: 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRD--- 88
Query: 132 IRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
F +E+ + + L H N+ K+ G S +L +++EYL
Sbjct: 89 ----FEREIEILKSLQHDNIVKYKGVC-------------YSAGRRNL-----KLIMEYL 126
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
P G+L+ +L + ++++ ++Q + +G+ YL +K +HRD+ T N+L++ +K
Sbjct: 127 PYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185
Query: 252 IADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEI--YC 306
I DFG+ +V Q+ + + + APE L ++ DV+SFG+ L+E+ Y
Sbjct: 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245
Query: 307 CD--------------MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANP 352
+ + ++ N R P CP + IM +CW+ N
Sbjct: 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNV 304
Query: 353 DKRPVMDEVVKLLEAVNTSKGG 374
++RP ++ ++ + G
Sbjct: 305 NQRPSFRDLALRVDQIRDQMAG 326
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-61
Identities = 80/297 (26%), Positives = 136/297 (45%), Gaps = 39/297 (13%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQ--DVAVKILDWAEDGMVTSAEAAAIR 133
++WE+E + ++H++ G YG VY G + VAVK L E
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----------KEDTMEV 53
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F +E AV +++ HPN+ + +G T ++ E++
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLGVC--TREPPF------------------YIITEFMTY 93
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
G L +L R++++ V++ +A ++ + YL K +HRD+ N L+ N +K+A
Sbjct: 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 254 DFGVARVEAQNPRDMTGETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DM 309
DFG++R+ + T G + APE L ++ K DV++FG+ LWEI
Sbjct: 154 DFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
PYP + + V + ++ R + P CP + +MR CW NP RP E+ + E
Sbjct: 212 PYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-61
Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 39/293 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQ-DVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
E++ ++ + E+ G +G V G + GQ DVAVK++ E + F Q
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI----------KEGSMSEDEFFQ 52
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E KL HP + KF G + I +V EY+ G L
Sbjct: 53 EAQTMMKLSHPKLVKFYGVC--SKEYPI------------------YIVTEYISNGCLLN 92
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
+L R+ K L ++++ D+ G+++L S +HRD+ N L+D + +K++DFG+
Sbjct: 93 YL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
Query: 259 RVEAQNPRDMTGETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDL 314
R + GT + APEV Y+ K DV++FGI +WE++ MPY
Sbjct: 152 RYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
+ ++V V Q R P ++ IM CW P+KRP +++ +E
Sbjct: 210 TNSEVVLK-VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-61
Identities = 82/309 (26%), Positives = 136/309 (44%), Gaps = 43/309 (13%)
Query: 73 LPRKTEEWEIELAKLDIR--HEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVT 125
L + ++ I ++ I +G +G VY G Y Q A+K ++
Sbjct: 7 LLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--------SLS 58
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185
+F +E + + L+HPNV IG P
Sbjct: 59 RITEMQQVEAFLREGLLMRGLNHPNVLALIGIM-------------------LPPEGLPH 99
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
V++ Y+ G L +F+ R+ ++ K +I L +ARG+ YL + VHRD+ N +LD
Sbjct: 100 VLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD 158
Query: 246 ANRTLKIADFGVAR-VEAQNPRDMTGETGTL---GYMAPEVL-DGKPYNRKCDVYSFGIC 300
+ T+K+ADFG+AR + + + + A E L + + K DV+SFG+
Sbjct: 159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVL 217
Query: 301 LWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMD 359
LWE+ PY + D++ + Q R P CP SL +M++CW+A+P RP
Sbjct: 218 LWELLTRGAPPYRHIDPFDLTHF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFR 276
Query: 360 EVVKLLEAV 368
+V +E +
Sbjct: 277 VLVGEVEQI 285
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 9e-61
Identities = 89/304 (29%), Positives = 132/304 (43%), Gaps = 41/304 (13%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVTSAEAA 130
+ + I RG +G VY G D AVK L+ + E
Sbjct: 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN----RITDIGE-- 133
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
+ F E + + HPNV +G S S VV+ Y
Sbjct: 134 --VSQFLTEGIIMKDFSHPNVLSLLGIC--------------LRSEGSP-----LVVLPY 172
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250
+ G L+ F+ RN+ K +I L +A+G+ +L SK VHRD+ N +LD T+
Sbjct: 173 MKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 231
Query: 251 KIADFGVAR-VEAQNPRDMTGETGTL---GYMAPEVL-DGKPYNRKCDVYSFGICLWEIY 305
K+ADFG+AR + + + +TG +MA E L K + K DV+SFG+ LWE+
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELM 290
Query: 306 C-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
PYPD++ D++ + Q R P CP L +M KCW + RP E+V
Sbjct: 291 TRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349
Query: 365 LEAV 368
+ A+
Sbjct: 350 ISAI 353
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-60
Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 51/309 (16%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAA 130
+EWE+ K+ + E+ +G++G VY G G VA+K V A +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK--------TVNEAASM 69
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
R F E +V ++ + +V + +G + V++E
Sbjct: 70 RERIEFLNEASVMKEFNCHHVVRLLGVV--------------------SQGQPTLVIMEL 109
Query: 191 LPGGTLKKFLIRNKRKK---------LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
+ G LK +L R+ R + +IQ+A ++A G++YL++ VHRD+ N
Sbjct: 110 MTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168
Query: 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL-DGKPYNRKCDVYSFG 298
++ + T+KI DFG+ R + G G L +M+PE L DG + DV+SFG
Sbjct: 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFG 227
Query: 299 ICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV 357
+ LWEI + PY LS V V+ D P CP L +MR CW NP RP
Sbjct: 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPS 286
Query: 358 MDEVVKLLE 366
E++ ++
Sbjct: 287 FLEIISSIK 295
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-60
Identities = 77/319 (24%), Positives = 138/319 (43%), Gaps = 52/319 (16%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSA 127
+ + E L ++ G +G V YD G+ VAVK L G
Sbjct: 10 ATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--- 66
Query: 128 EAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
A ++E+ + + L H N+ K+ G T D N + ++
Sbjct: 67 -----IADLKKEIEILRNLYHENIVKYKGIC-------------TEDGGNGI-----KLI 103
Query: 188 VEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247
+E+LP G+LK++L + K+ K ++ A+ + +G+ YL S+ VHRD+ N+L+++
Sbjct: 104 MEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162
Query: 248 RTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
+KI DFG+ + + T + + + APE L + DV+SFG+ L E+
Sbjct: 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 305 --YC-------------CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD 349
YC + ++ T + + +++ R P CP + +MRKCW+
Sbjct: 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWE 281
Query: 350 ANPDKRPVMDEVVKLLEAV 368
P R +++ EA+
Sbjct: 282 FQPSNRTSFQNLIEGFEAL 300
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-60
Identities = 86/317 (27%), Positives = 129/317 (40%), Gaps = 56/317 (17%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAE 128
I+ + ++ E+ G +G V+ VAVK L T A
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----TLAA 60
Query: 129 AAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
R F++E + L H ++ KF G +V
Sbjct: 61 ----RKDFQREAELLTNLQHEHIVKFYGVC---------GDG-----------DPLIMVF 96
Query: 189 EYLPGGTLKKFL--------------IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234
EY+ G L KFL R + +L ++ IA +A G+ YL S+ VH
Sbjct: 97 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVH 156
Query: 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL-DGKPYNRK 291
RD+ T N L+ AN +KI DFG++R G L +M PE + K + +
Sbjct: 157 RDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTE 215
Query: 292 CDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
DV+SFG+ LWEI+ P+ LS T+V + Q + PR CP + +M CW
Sbjct: 216 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-ITQGRVLERPRVCPKEVYDVMLGCWQR 274
Query: 351 NPDKRPVMDEVVKLLEA 367
P +R + E+ K+L A
Sbjct: 275 EPQQRLNIKEIYKILHA 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-59
Identities = 74/307 (24%), Positives = 123/307 (40%), Gaps = 37/307 (12%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVTSAE 128
P ++ I L + ++ G++G V RG +D VAVK L D +
Sbjct: 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL--KPDVLSQPEA 64
Query: 129 AAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
F +EV LDH N+ + G + +V
Sbjct: 65 MDD----FIREVNAMHSLDHRNLIRLYGVVLTPPM---------------------KMVT 99
Query: 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
E P G+L L R + + + A+ +A G+ YL SK +HRD+ N+LL
Sbjct: 100 ELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD 158
Query: 249 TLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+KI DFG+ R QN + + APE L + ++ D + FG+ LWE++
Sbjct: 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
Query: 306 -CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
P+ L+ + + + ++ R P CP + ++M +CW P+ RP +
Sbjct: 219 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278
Query: 365 LEAVNTS 371
L +
Sbjct: 279 LLEAQPT 285
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 1e-59
Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 44/298 (14%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVTSAEAAAIR 133
++ I + + + G +G VY G Y VAVK +D + + E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEK---- 59
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F E + + LDHP++ K IG I + T +++E P
Sbjct: 60 --FMSEAVIMKNLDHPHIVKLIG---------IIEEEPT------------WIIMELYPY 96
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
G L +L + L ++ +L + + ++YL S VHRD+ N+L+ + +K+
Sbjct: 97 GELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 155
Query: 254 DFGVARVEAQNPRDMTGETGTL---GYMAPEVL-DGKPYNRKCDVYSFGICLWEIY-CCD 308
DFG++R D + T +M+PE + + + DV+ F +C+WEI
Sbjct: 156 DFGLSRYIEDE--DYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGK 212
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
P+ L DV + + R P CP L ++M +CWD +P RP E+V L
Sbjct: 213 QPFFWLENKDVIGV-LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 76/330 (23%), Positives = 137/330 (41%), Gaps = 53/330 (16%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDG------QDVAVKILDWAEDGMVTSAEAAA 131
+ E L ++ +G +G+V YD VAVK L G +
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRD--- 70
Query: 132 IRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
F++E+ + + L + K+ G S G + +V+EYL
Sbjct: 71 ----FQREIQILKALHSDFIVKYRGVSYGPGRQSL------------------RLVMEYL 108
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLK 251
P G L+ FL + R +L ++ + + +G+ YL S+ VHRD+ N+L+++ +K
Sbjct: 109 PSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 167
Query: 252 IADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIY-CC 307
IADFG+A++ + + + APE L ++R+ DV+SFG+ L+E++ C
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227
Query: 308 DMPY--------------PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPD 353
D + + + + + R P CP+ + +M+ CW +P
Sbjct: 228 DKSCSPSAEFLRMMGCERDVPALSRLLEL-LEEGQRLPAPPACPAEVHELMKLCWAPSPQ 286
Query: 354 KRPVMDEVVKLLEAVNTSKGGGMIPEDQAH 383
RP + L+ + + G AH
Sbjct: 287 DRPSFSALGPQLDMLWSGSRGCETHAFTAH 316
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-59
Identities = 84/312 (26%), Positives = 123/312 (39%), Gaps = 55/312 (17%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAA 130
+ E+ + + + G +G VY G G VAVK + +
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--------TLPEVCSE 74
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
F E + K +H N+ + IG S L S +++E
Sbjct: 75 QDELDFLMEALIISKFNHQNIVRCIGVS--------------------LQSLPRFILMEL 114
Query: 191 LPGGTLKKFLIRN-----KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+ GG LK FL + LA ++ +A D+A G YL +HRD+ N LL
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174
Query: 246 A---NRTLKIADFGVARVEAQNPRDMTGETGTLGY-----MAPEVL-DGKPYNRKCDVYS 296
R KI DFG+AR + G M PE +G + K D +S
Sbjct: 175 CPGPGRVAKIGDFGMARDIYRA--SYY-RKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWS 230
Query: 297 FGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
FG+ LWEI+ MPYP S +V V R D P+ CP + IM +CW P+ R
Sbjct: 231 FGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 356 PVMDEVVKLLEA 367
P +++ +E
Sbjct: 290 PNFAIILERIEY 301
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-59
Identities = 71/327 (21%), Positives = 134/327 (40%), Gaps = 54/327 (16%)
Query: 72 VLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG------QDVAVKILDWAEDGMVT 125
+ + L ++ G +G V YD + VAVK L
Sbjct: 18 LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH- 76
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185
R+ ++QE+ + + L H ++ K+ G SL
Sbjct: 77 -------RSGWKQEIDILRTLYHEHIIKYKGCC-------------EDAGAASL-----Q 111
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+V+EY+P G+L+ +L R + ++ A + G++YLH++ +HRD+ N+LLD
Sbjct: 112 LVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLW 302
+R +KI DFG+A+ + + + APE L + DV+SFG+ L+
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 303 EI--YC-------------CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKC 347
E+ +C + ++ ++ + + R P CP+ + +M+ C
Sbjct: 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-LERGERLPRPDKCPAEVYHLMKNC 287
Query: 348 WDANPDKRPVMDEVVKLLEAVNTSKGG 374
W+ RP + ++ +L+ V+ G
Sbjct: 288 WETEASFRPTFENLIPILKTVHEKYQG 314
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-59
Identities = 78/303 (25%), Positives = 133/303 (43%), Gaps = 42/303 (13%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVTSA 127
+ T ++EI+ ++++ I G +G V++G Y + VA+K +
Sbjct: 3 MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSV- 59
Query: 128 EAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
R F QE ++ DHP++ K IG ++
Sbjct: 60 -----REKFLQEALTMRQFDHPHIVKLIGVITENPV---------------------WII 93
Query: 188 VEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247
+E G L+ FL + ++ L +I A L+ L+YL SK VHRD+ N+L+ +N
Sbjct: 94 MELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN 152
Query: 248 RTLKIADFGVARVEAQNPRDMTGETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
+K+ DFG++R + + +MAPE ++ + + DV+ FG+C+WEI
Sbjct: 153 DCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210
Query: 305 YCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P+ + DV + R +P CP +L S+M KCW +P +RP E+
Sbjct: 211 LMHGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269
Query: 364 LLE 366
L
Sbjct: 270 QLS 272
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-59
Identities = 79/319 (24%), Positives = 124/319 (38%), Gaps = 61/319 (19%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAE 128
I+ + ++ E+ G +G V+ VAVK L A +
Sbjct: 32 DACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----- 86
Query: 129 AAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
R F++E + L H ++ +F G P +V
Sbjct: 87 ----RQDFQREAELLTMLQHQHIVRFFGVCT-----------------EGRPL---LMVF 122
Query: 189 EYLPGGTLKKFLIRN-------------KRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235
EY+ G L +FL + L ++ +A +A G+ YL VHR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLG-----YMAPEVL-DGKPYN 289
D+ T N L+ +KI DFG++R D G +M PE + K +
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYST--DYY-RVGGRTMLPIRWMPPESILYRK-FT 238
Query: 290 RKCDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCW 348
+ DV+SFG+ LWEI+ P+ LS T+ + Q + PR CP + +IMR CW
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC-ITQGRELERPRACPPEVYAIMRGCW 297
Query: 349 DANPDKRPVMDEVVKLLEA 367
P +R + +V L+A
Sbjct: 298 QREPQQRHSIKDVHARLQA 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-59
Identities = 84/316 (26%), Positives = 124/316 (39%), Gaps = 55/316 (17%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTS 126
++ E+ + + + G +G VY G G VAVK +
Sbjct: 60 SSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--------TLPE 111
Query: 127 AEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCV 186
+ F E + K +H N+ + IG S L S +
Sbjct: 112 VCSEQDELDFLMEALIISKFNHQNIVRCIGVS--------------------LQSLPRFI 151
Query: 187 VVEYLPGGTLKKFLIRN-----KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
++E + GG LK FL + LA ++ +A D+A G YL +HRD+ N
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211
Query: 242 MLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGY-----MAPEVL-DGKPYNRKC 292
LL R KI DFG+AR + G M PE +G + K
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRA--GYY-RKGGCAMLPVKWMPPEAFMEGI-FTSKT 267
Query: 293 DVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDAN 351
D +SFG+ LWEI+ MPYP S +V V R D P+ CP + IM +CW
Sbjct: 268 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQ 326
Query: 352 PDKRPVMDEVVKLLEA 367
P+ RP +++ +E
Sbjct: 327 PEDRPNFAIILERIEY 342
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-59
Identities = 80/317 (25%), Positives = 136/317 (42%), Gaps = 39/317 (12%)
Query: 60 KHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQ-----DVAVK 114
+ + + E ++ EIE +++ I I G G V G VA+K
Sbjct: 24 QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 115 ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSD 174
L R F E ++ + DHPN+ + G
Sbjct: 84 AL--KAGYTERQ------RRDFLSEASIMGQFDHPNIIRLEGVVT--------------- 120
Query: 175 SHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234
R +V EY+ G+L FL R + ++ + + G+ YL VH
Sbjct: 121 -----RGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRK 291
RD+ N+L+D+N K++DFG++RV +P TG + + APE + + ++
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA 234
Query: 292 CDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
DV+SFG+ +WE+ + PY +++ DV S+ V + R P CP +L +M CW
Sbjct: 235 SDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHK 293
Query: 351 NPDKRPVMDEVVKLLEA 367
+ +RP ++V +L+A
Sbjct: 294 DRAQRPRFSQIVSVLDA 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-58
Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 40/298 (13%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDG------QDVAVKILDWAEDGMVTSAEAAAI 132
EI + + + I G +G VY+G VA+K L
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQ------ 89
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
R F E + + H N+ + G + S+ ++ EY+
Sbjct: 90 RVDFLGEAGIMGQFSHHNIIRLEG---------VISKYKPM-----------MIITEYME 129
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
G L KFL R K + + ++ + +A G+ YL + VHRD+ N+L+++N K+
Sbjct: 130 NGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 188
Query: 253 ADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-D 308
+DFG++RV +P +G + + APE + + + DV+SFGI +WE+ +
Sbjct: 189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
PY +LS +V A + R P CPS++ +M +CW +RP ++V +L+
Sbjct: 249 RPYWELSNHEVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-58
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 65/331 (19%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGM 123
+L K E ++ +I G +G V++ G VAVK+L E+
Sbjct: 33 LLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEAS 90
Query: 124 VTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRA 183
+A F++E A+ + D+PN+ K +G +
Sbjct: 91 ADM------QADFQREAALMAEFDNPNIVKLLGVCAVGKPM------------------- 125
Query: 184 CCVVVEYLPGGTLKKFLIRNKR-----------------------KKLAFKVVIQIALDL 220
C++ EY+ G L +FL R+ L+ + IA +
Sbjct: 126 -CLLFEYMAYGDLNEFL-RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183
Query: 221 ARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYM 278
A G++YL + VHRD+ T N L+ N +KIADFG++R + +M
Sbjct: 184 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM 243
Query: 279 APEVL-DGKPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCC 336
PE + + Y + DV+++G+ LWEI+ PY ++ +V V N P C
Sbjct: 244 PPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENC 301
Query: 337 PSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
P L ++MR CW P RP + ++L+
Sbjct: 302 PLELYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-58
Identities = 85/325 (26%), Positives = 135/325 (41%), Gaps = 56/325 (17%)
Query: 69 EREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-------VAVKIL-DWAE 120
E LP +WE +L + + RG +G V G D VAVK+L + A
Sbjct: 11 HCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA- 69
Query: 121 DGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLKIPSQSATSDSHNSL 179
T +E + E+ + + H NV +GA +
Sbjct: 70 ----THSE----HRALMSELKILIHIGHHLNVVNLLGAC----------------TKPGG 105
Query: 180 PSRACCVVVEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGL 224
P V+VE+ G L +L R+KR L + +I + +A+G+
Sbjct: 106 P---LMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 161
Query: 225 SYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEV 282
+L S+ +HRD+ N+LL +KI DFG+AR ++P + L +MAPE
Sbjct: 162 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 221
Query: 283 LDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLA 341
+ + Y + DV+SFG+ LWEI+ PYP + + +++ R P +
Sbjct: 222 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 281
Query: 342 SIMRKCWDANPDKRPVMDEVVKLLE 366
M CW P +RP E+V+ L
Sbjct: 282 QTMLDCWHGEPSQRPTFSELVEHLG 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-57
Identities = 72/305 (23%), Positives = 138/305 (45%), Gaps = 45/305 (14%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD------VAVKILDWAEDGMV 124
+ L R +E E + K + G +GTVY+G + + VA+K L E
Sbjct: 6 QALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSP 58
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
+ + E V +D+P+V + +G + +T
Sbjct: 59 KANKE------ILDEAYVMASVDNPHVCRLLGICLTSTVQ-------------------- 92
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
++ + +P G L ++ R + + + ++ + +A+G++YL + +VHRD+ N+L+
Sbjct: 93 -LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLW 302
+ +KI DFG+A++ ++ E G + +MA E + + Y + DV+S+G+ +W
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210
Query: 303 EIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
E+ PY + +++SS + + R P C + IMRKCW + D RP E+
Sbjct: 211 ELMTFGSKPYDGIPASEISSI-LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269
Query: 362 VKLLE 366
+
Sbjct: 270 IIEFS 274
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 1e-57
Identities = 78/317 (24%), Positives = 128/317 (40%), Gaps = 63/317 (19%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAAAI 132
EI L+ + E+ +G VY+G G Q VA+K L +
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK--DKAEGPL------ 55
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
R FR E + +L HPNV +G P ++ Y
Sbjct: 56 REEFRHEAMLRARLQHPNVVCLLGVVT-----------------KDQPL---SMIFSYCS 95
Query: 193 GGTLKKFLIRN--------------KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238
G L +FL+ + L + + +A G+ YL S +VH+D+
Sbjct: 96 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA 155
Query: 239 TENMLLDANRTLKIADFGVAR-VEAQNPRDMTGETGTLG-----YMAPE-VLDGKPYNRK 291
T N+L+ +KI+D G+ R V A + + +MAPE ++ GK ++
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGK-FSID 210
Query: 292 CDVYSFGICLWEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
D++S+G+ LWE++ PY S DV + R P CP+ + ++M +CW+
Sbjct: 211 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNE 269
Query: 351 NPDKRPVMDEVVKLLEA 367
P +RP ++ L A
Sbjct: 270 FPSRRPRFKDIHSRLRA 286
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-57
Identities = 78/300 (26%), Positives = 132/300 (44%), Gaps = 42/300 (14%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-----VAVKILDWAEDGMVTSAEAA 130
T ++EI+ ++++ I G +G V++G Y + VA+K +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSV---- 434
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
R F QE ++ DHP++ K IG +++E
Sbjct: 435 --REKFLQEALTMRQFDHPHIVKLIGVITENPV---------------------WIIMEL 471
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTL 250
G L+ FL + ++ L +I A L+ L+YL SK VHRD+ N+L+ +N +
Sbjct: 472 CTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530
Query: 251 KIADFGVARVEAQNPRDMTGETGTL---GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307
K+ DFG++R + + +MAPE ++ + + DV+ FG+C+WEI
Sbjct: 531 KLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 588
Query: 308 -DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
P+ + DV + R +P CP +L S+M KCW +P +RP E+ L
Sbjct: 589 GVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-57
Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 39/298 (13%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIR 133
E++ + I + G +G V G VA+K L R
Sbjct: 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQ------R 90
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F E ++ + DHPN+ + G S+ +V EY+
Sbjct: 91 RDFLGEASIMGQFDHPNIIRLEGVV--------------------TKSKPVMIVTEYMEN 130
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
G+L FL R + ++ + +A G+ YL VHRD+ N+L+++N K++
Sbjct: 131 GSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVS 189
Query: 254 DFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DM 309
DFG+ RV +P G + + +PE + + + DV+S+GI LWE+ +
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
PY ++S DV A V + R P CP++L +M CW + + RP +++V +L+
Sbjct: 250 PYWEMSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-57
Identities = 74/303 (24%), Positives = 131/303 (43%), Gaps = 40/303 (13%)
Query: 78 EEWEIELAKLDI-RHEIARGTYGTVYRGAYDGQ----DVAVKILDWAEDGMVTSAEAAAI 132
++ ++ L I E+ G +G+V +G Y + DVA+K+L +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------- 53
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
+E + +LD+P + + IG +V+E
Sbjct: 54 TEEMMREAQIMHQLDNPYIVRLIGVCQAEAL---------------------MLVMEMAG 92
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
GG L KFL KR+++ V ++ ++ G+ YL K VHRD+ N+LL KI
Sbjct: 93 GGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 151
Query: 253 ADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-D 308
+DFG+++ + T + L + APE ++ + ++ + DV+S+G+ +WE
Sbjct: 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
PY + +V + + Q R + P CP L ++M CW + RP V + + A
Sbjct: 212 KPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
Query: 369 NTS 371
S
Sbjct: 271 YYS 273
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-56
Identities = 73/302 (24%), Positives = 132/302 (43%), Gaps = 40/302 (13%)
Query: 74 PRKTEEWEIELAKLDIRH-EIARGTYGTVYRGAYDGQ----DVAVKILDWAEDGMVTSAE 128
+ +E ++ L + E+ G +GTV +G Y + VAVKIL + + +
Sbjct: 5 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALK 62
Query: 129 AAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
E V Q+LD+P + + IG ++S +V+
Sbjct: 63 DE-----LLAEANVMQQLDNPYIVRMIGIC-------------EAESW--------MLVM 96
Query: 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
E G L K+L + + + K +I++ ++ G+ YL VHRD+ N+LL
Sbjct: 97 EMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 154
Query: 249 TLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
KI+DFG+++ + +T + + APE ++ ++ K DV+SFG+ +WE +
Sbjct: 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
Query: 306 CC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
PY + ++V++ + + R P CP + +M CW + + RP V
Sbjct: 215 SYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 273
Query: 365 LE 366
L
Sbjct: 274 LR 275
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-56
Identities = 59/314 (18%), Positives = 116/314 (36%), Gaps = 62/314 (19%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQD---------VAVKILDWAEDGMVTSAEAA 130
+I L + +GT+ +++G V +K+LD + S
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNYSES-- 58
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
F + ++ KL H ++ G + +V E+
Sbjct: 59 -----FFEAASMMSKLSHKHLVLNYGVC--------------------VCGDENILVQEF 93
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA---- 246
+ G+L +L + + + +++A LA + +L T++H +V +N+LL
Sbjct: 94 VKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152
Query: 247 ----NRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVL-DGKPYNRKCDVYSFG 298
+K++D G++ + + + ++ PE + + K N D +SFG
Sbjct: 153 KTGNPPFIKLSDPGIS-------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG 205
Query: 299 ICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV 357
LWEI D P L + P+ LA+++ C D PD RP
Sbjct: 206 TTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLPAPKAAE--LANLINNCMDYEPDHRPS 262
Query: 358 MDEVVKLLEAVNTS 371
+++ L ++ T
Sbjct: 263 FRAIIRDLNSLFTP 276
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-56
Identities = 64/302 (21%), Positives = 124/302 (41%), Gaps = 40/302 (13%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD------VAVKILDWAEDGMVTSA 127
K + +L + G +GTV++G + + V +K+++ A
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 128 EAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
+ LDH ++ + +G G++ +V
Sbjct: 62 --------VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ---------------------LV 92
Query: 188 VEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247
+YLP G+L + R R L ++++ + +A+G+ YL +VHR++ N+LL +
Sbjct: 93 TQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP 151
Query: 248 RTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+++ADFGVA + + + + +MA E + Y + DV+S+G+ +WE+
Sbjct: 152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
Query: 306 -CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
PY L +V + + R P+ C + +M KCW + + RP E+
Sbjct: 212 TFGAEPYAGLRLAEVPDL-LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270
Query: 365 LE 366
Sbjct: 271 FT 272
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-56
Identities = 81/320 (25%), Positives = 132/320 (41%), Gaps = 64/320 (20%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG----QDVAVKIL-DWAEDGMVTSAE 128
P T ++ + + I G +G V + D A+K + ++A + +
Sbjct: 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDD 68
Query: 129 AAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
F E+ V KL HPN+ +GA L +
Sbjct: 69 ----HRDFAGELEVLCKLGHHPNIINLLGACEHRGYL--------------------YLA 104
Query: 188 VEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLSYLHSKTI 232
+EY P G L FL R R L+ + ++ A D+ARG+ YL K
Sbjct: 105 IEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 163
Query: 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLG-----YMAPEVLDGKP 287
+HRD+ N+L+ N KIADFG++R + ++ T+G +MA E L+
Sbjct: 164 IHRDLAARNILVGENYVAKIADFGLSRGQ-----EVY-VKKTMGRLPVRWMAIESLNYSV 217
Query: 288 YNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRK 346
Y DV+S+G+ LWEI PY ++ ++ + Q R + P C + +MR+
Sbjct: 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQ 276
Query: 347 CWDANPDKRPVMDEVVKLLE 366
CW P +RP +++ L
Sbjct: 277 CWREKPYERPSFAQILVSLN 296
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-55
Identities = 78/303 (25%), Positives = 125/303 (41%), Gaps = 55/303 (18%)
Query: 88 DIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + +G +G V R A D + A+K + E+ ++ EV +
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE----------KLSTILSEVMLLAS 58
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+H V ++ A + N P + S + +EY GTL +
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKST-------LFIQMEYCENGTLYDLIHSENL 111
Query: 206 ---KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV-- 260
+ +++ QI LSY+HS+ I+HRD+K N+ +D +R +KI DFG+A+
Sbjct: 112 NQQRDEYWRLFRQILE----ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 261 ------------EAQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIYCC 307
+ ++T GT Y+A EVLDG YN K D+YS GI +E
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE---- 223
Query: 308 DMPYPDLSFTDVSSAVVRQNLR-------PDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360
M YP T + + + LR PD I+R D +P+KRP
Sbjct: 224 -MIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280
Query: 361 VVK 363
++
Sbjct: 281 LLN 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-55
Identities = 84/317 (26%), Positives = 131/317 (41%), Gaps = 57/317 (17%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAA 130
+WE +L + G +G V G VAVK M+ +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--------MLKPSAHL 67
Query: 131 AIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
R + E+ V L +H N+ +GA T V+ E
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGAC--TIGGPT------------------LVITE 107
Query: 190 YLPGGTLKKFLIRNKRKK-----------------LAFKVVIQIALDLARGLSYLHSKTI 232
Y G L FL R KR L + ++ + +A+G+++L SK
Sbjct: 108 YCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166
Query: 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNR 290
+HRD+ N+LL R KI DFG+AR + + L +MAPE + Y
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226
Query: 291 KCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD 349
+ DV+S+GI LWE++ PYP + ++++ R P P+ + IM+ CWD
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
Query: 350 ANPDKRPVMDEVVKLLE 366
A+P KRP ++V+L+E
Sbjct: 287 ADPLKRPTFKQIVQLIE 303
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-55
Identities = 84/324 (25%), Positives = 134/324 (41%), Gaps = 67/324 (20%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-------VAVKIL-DWAEDGMVTSAEA 129
+WE L + + G +G V + VAVK+L + A + +E
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSE- 69
Query: 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
E V ++++HP+V K GA L ++VE
Sbjct: 70 ---LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL--------------------LLIVE 106
Query: 190 YLPGGTLKKFLIRNKR-----------------------KKLAFKVVIQIALDLARGLSY 226
Y G+L+ FL R R + L +I A +++G+ Y
Sbjct: 107 YAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165
Query: 227 LHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL- 283
L +VHRD+ N+L+ R +KI+DFG++R + + G + +MA E L
Sbjct: 166 LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225
Query: 284 DGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLAS 342
D Y + DV+SFG+ LWEI PYP + + + ++ R + P C +
Sbjct: 226 DHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-LKTGHRMERPDNCSEEMYR 283
Query: 343 IMRKCWDANPDKRPVMDEVVKLLE 366
+M +CW PDKRPV ++ K LE
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDLE 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-55
Identities = 88/325 (27%), Positives = 141/325 (43%), Gaps = 60/325 (18%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG---------QDVAVKILDWAED 121
E + +WE KL + + G +G V G VAVK+L +D
Sbjct: 21 EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDD 78
Query: 122 GMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLP 180
+ E+ + + + H N+ +GA T + +
Sbjct: 79 ATEKD------LSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPL-------------- 116
Query: 181 SRACCVVVEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLS 225
V+VEY G L+++L R +R +++ FK ++ LARG+
Sbjct: 117 ----YVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 171
Query: 226 YLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL 283
YL S+ +HRD+ N+L+ N +KIADFG+AR G L +MAPE L
Sbjct: 172 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 284 -DGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLA 341
D Y + DV+SFG+ +WEI+ PYP + ++ +++ R D P C + L
Sbjct: 232 FDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-LKEGHRMDKPANCTNELY 289
Query: 342 SIMRKCWDANPDKRPVMDEVVKLLE 366
+MR CW A P +RP ++V+ L+
Sbjct: 290 MMMRDCWHAVPSQRPTFKQLVEDLD 314
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ RG +G V+ + D + A+K + + + E A R +EV KL+HP
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIR------LPNRELA--REKVMREVKALAKLEHPG 64
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ ++ A + + S L + ++ LK ++ N R +
Sbjct: 65 IVRYFNAWLEKNT---TEKLQPSSPKVYL-----YIQMQLCRKENLKDWM--NGRCTIEE 114
Query: 211 ---KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV------- 260
V + I L +A + +LHSK ++HRD+K N+ + +K+ DFG+
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 261 -----EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
TG+ GT YM+PE + G Y+ K D++S G+ L+E+ P+
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF---- 227
Query: 316 FTDVSSAVVRQNLR----PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
T + ++R P + +++ +P +RP +++
Sbjct: 228 STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-55
Identities = 89/325 (27%), Positives = 142/325 (43%), Gaps = 60/325 (18%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD---------VAVKILDWAED 121
E + +WE KL + + G +G V G D VAVK+L +D
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD 124
Query: 122 GMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLP 180
+ E+ + + + H N+ +GA T + +
Sbjct: 125 ATEKD------LSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPL-------------- 162
Query: 181 SRACCVVVEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLS 225
V+VEY G L+++L R +R +++ FK ++ LARG+
Sbjct: 163 ----YVIVEYASKGNLREYL-RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 217
Query: 226 YLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL 283
YL S+ +HRD+ N+L+ N +KIADFG+AR G L +MAPE L
Sbjct: 218 YLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277
Query: 284 -DGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLA 341
D Y + DV+SFG+ +WEI+ PYP + ++ + ++ R D P C + L
Sbjct: 278 FDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELY 335
Query: 342 SIMRKCWDANPDKRPVMDEVVKLLE 366
+MR CW A P +RP ++V+ L+
Sbjct: 336 MMMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-55
Identities = 87/318 (27%), Positives = 140/318 (44%), Gaps = 60/318 (18%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD---------VAVKILDWAEDGMVTSAE 128
WE+ +L + + G +G V G D VAVK M+ S
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--------MLKSDA 113
Query: 129 AAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
+ E+ + + + H N+ +GA T + + V+
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGAC--TQDGPL------------------YVI 153
Query: 188 VEYLPGGTLKKFLIRNKR---------------KKLAFKVVIQIALDLARGLSYLHSKTI 232
VEY G L+++L + +R ++L+ K ++ A +ARG+ YL SK
Sbjct: 154 VEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212
Query: 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL-DGKPYN 289
+HRD+ N+L+ + +KIADFG+AR G L +MAPE L D Y
Sbjct: 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YT 271
Query: 290 RKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCW 348
+ DV+SFG+ LWEI+ PYP + ++ +++ R D P C + L +MR CW
Sbjct: 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCW 330
Query: 349 DANPDKRPVMDEVVKLLE 366
A P +RP ++V+ L+
Sbjct: 331 HAVPSQRPTFKQLVEDLD 348
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-55
Identities = 64/281 (22%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 83 ELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
+ K +I G++G DG+ +K ++ + ++S E R R+EV
Sbjct: 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---MSSKE----REESRREV 74
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
AV + HPN+ ++ + +L +V++Y GG L K +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSL--------------------YIVMDYCEGGDLFKRI 114
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
K ++ + + L ++H + I+HRD+K++N+ L + T+++ DFG+ARV
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
GT Y++PE+ + KPYN K D+++ G L+E+ + S ++
Sbjct: 175 LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234
Query: 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
++ + P + L S++ + + NP RP ++ +
Sbjct: 235 LKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-55
Identities = 70/316 (22%), Positives = 130/316 (41%), Gaps = 32/316 (10%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAA 131
+ + LA I +I RG + VYR DG VA+K + + A
Sbjct: 21 ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ------IFDLMDAK 74
Query: 132 IRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
RA +E+ + ++L+HPNV K+ + + L +V+E
Sbjct: 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL--------------------NIVLELA 114
Query: 192 PGGTLKKFLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249
G L + + K++K V + + L L ++HS+ ++HRD+K N+ + A
Sbjct: 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV 174
Query: 250 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309
+K+ D G+ R + GT YM+PE + YN K D++S G L+E+
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 310 PY--PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
P+ ++ + + + + P L ++ C + +P+KRP + V + +
Sbjct: 235 PFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
Query: 368 VNTSKGGGMIPEDQAH 383
++ + H
Sbjct: 295 MHACTASSLEHHHHHH 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-54
Identities = 69/286 (24%), Positives = 128/286 (44%), Gaps = 35/286 (12%)
Query: 88 DIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ + I G+YG R DG+ + K LD+ +T AE + EV + ++
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---MTEAE----KQMLVSEVNLLRE 61
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L HPN+ ++ + TN + +V+EY GG L + + +
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTL------------------YIVMEYCEGGDLASVITKGTK 103
Query: 206 KKLAF--KVVIQIALDLARGLSYLHSK-----TIVHRDVKTENMLLDANRTLKIADFGVA 258
++ + V+++ L L H + T++HRD+K N+ LD + +K+ DFG+A
Sbjct: 104 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
Query: 259 RVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318
R+ + GT YM+PE ++ YN K D++S G L+E+ P+ S +
Sbjct: 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364
++ + R IP L I+ + + RP ++E+++
Sbjct: 224 LAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 81/314 (25%), Positives = 121/314 (38%), Gaps = 55/314 (17%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-------VAVKILDWAEDGMVTSAEAA 130
E+WE L + G +G V G VAVK+L EA
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK--STAHADEKEA- 95
Query: 131 AIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
E+ + L H N+ +GA T + V+ E
Sbjct: 96 -----LMSELKIMSHLGQHENIVNLLGAC--THGGPV------------------LVITE 130
Query: 190 YLPGGTLKKFLIRNKR-------------KKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236
Y G L FL R K + + ++ + +A+G+++L SK +HRD
Sbjct: 131 YCCYGDLLNFL-RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDV 294
V N+LL KI DFG+AR + + L +MAPE + Y + DV
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 295 YSFGICLWEIYCC-DMPYP-DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANP 352
+S+GI LWEI+ PYP L + V+ + P P ++ SIM+ CW P
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKL-VKDGYQMAQPAFAPKNIYSIMQACWALEP 308
Query: 353 DKRPVMDEVVKLLE 366
RP ++ L+
Sbjct: 309 THRPTFQQICSFLQ 322
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 71/305 (23%), Positives = 137/305 (44%), Gaps = 45/305 (14%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD------VAVKILDWAEDGMV 124
+ L R +E E + K + G +GTVY+G + + VA+K L E
Sbjct: 6 QALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSP 58
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
+ + E V +D+P+V + +G + +T
Sbjct: 59 KANKE------ILDEAYVMASVDNPHVCRLLGICLTSTVQ-------------------- 92
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
++ + +P G L ++ R + + + ++ + +A+G++YL + +VHRD+ N+L+
Sbjct: 93 -LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLW 302
+ +KI DFG+A++ ++ E G + +MA E + + Y + DV+S+G+ +W
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210
Query: 303 EIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
E+ PY + +++SS + + R P C + IM KCW + D RP E+
Sbjct: 211 ELMTFGSKPYDGIPASEISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 269
Query: 362 VKLLE 366
+
Sbjct: 270 IIEFS 274
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-54
Identities = 80/322 (24%), Positives = 128/322 (39%), Gaps = 62/322 (19%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAA 130
+WE L+ + G +G V G VAVK M+ +
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--------MLKEKADS 89
Query: 131 AIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
+ R + E+ + +L H N+ +GA T + I ++ E
Sbjct: 90 SEREALMSELKMMTQLGSHENIVNLLGAC--TLSGPI------------------YLIFE 129
Query: 190 YLPGGTLKKFLIRNKRKK----------------------LAFKVVIQIALDLARGLSYL 227
Y G L +L R+KR+K L F+ ++ A +A+G+ +L
Sbjct: 130 YCCYGDLLNYL-RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188
Query: 228 HSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLDG 285
K+ VHRD+ N+L+ + +KI DFG+AR + + L +MAPE L
Sbjct: 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248
Query: 286 KPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIM 344
Y K DV+S+GI LWEI+ PYP + +++ + D P + IM
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM 308
Query: 345 RKCWDANPDKRPVMDEVVKLLE 366
+ CW + KRP + L
Sbjct: 309 QSCWAFDSRKRPSFPNLTSFLG 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-54
Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 42/300 (14%)
Query: 86 KLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
++ G + V G +DG A+K + + R ++E +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL------CHEQQD---REEAQREADMH 80
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ +HPN+ + + + +++ + GTL + R
Sbjct: 81 RLFNHPNILRLVAYCLRERG----------------AKHEAWLLLPFFKRGTLWNEIERL 124
Query: 204 KRKKLAF--KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV- 260
K K ++ + L + RGL +H+K HRD+K N+LL + D G
Sbjct: 125 KDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
Query: 261 --------EAQNPRDMTGETGTLGYMAPEVLDGKPY---NRKCDVYSFGICLWEIYCCDM 309
+A +D + T+ Y APE+ + + + + DV+S G L+ + +
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 310 PYPDLSFTDVS-SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
PY + S + V+ L S+L ++ +P +RP + ++ LEA+
Sbjct: 245 PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 34/271 (12%)
Query: 92 EIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
EI RG++ TVY+G +VA L D +T +E R F++E + + L HP
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSE----RQRFKEEAEMLKGLQHP 85
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ +F S +T + +V E + GTLK +L R K +
Sbjct: 86 NIVRFYD-----------SWESTVKGKKCI-----VLVTELMTSGTLKTYLKRFK--VMK 127
Query: 210 FKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANR-TLKIADFGVARVEAQNPR 266
KV+ + +GL +LH++T I+HRD+K +N+ + ++KI D G+A ++ +
Sbjct: 128 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FTDVSSAVVR 325
GT +MAPE+ + K Y+ DVY+FG+C+ E+ + PY + + V
Sbjct: 188 --KAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244
Query: 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+ + I+ C N D+R
Sbjct: 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 75/311 (24%), Positives = 135/311 (43%), Gaps = 47/311 (15%)
Query: 77 TEEWEIELAKLDIRH--------EIARGTYGTVYRGAYDGQ----DVAVKILDWAEDGMV 124
++ E++ KL ++ E+ G +G+V +G Y + DVA+K+L +
Sbjct: 320 SDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEK 377
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
E +E + +LD+P + + IG
Sbjct: 378 ADTEE------MMREAQIMHQLDNPYIVRLIGVCQAEAL--------------------- 410
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+V+E GG L KFL KR+++ V ++ ++ G+ YL K VHR++ N+LL
Sbjct: 411 MLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLDGKPYNRKCDVYSFGICL 301
KI+DFG+++ + T + L + APE ++ + ++ + DV+S+G+ +
Sbjct: 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529
Query: 302 WEIY-CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360
WE PY + +V + + Q R + P CP L ++M CW + RP
Sbjct: 530 WEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT 588
Query: 361 VVKLLEAVNTS 371
V + + A S
Sbjct: 589 VEQRMRACYYS 599
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 63/314 (20%), Positives = 109/314 (34%), Gaps = 67/314 (21%)
Query: 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAI 132
R T E+ +I G +G+V++ DG A+K G +
Sbjct: 8 RYTTEFHEL-------EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-------SVD 53
Query: 133 RASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
+ +EV L H +V ++ A ++ + EY
Sbjct: 54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM--------------------LIQNEYC 93
Query: 192 PGGTLKKFLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN-- 247
GG+L + N R FK + + L + RGL Y+HS ++VH D+K N+ +
Sbjct: 94 NGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSI 153
Query: 248 -----------------RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-DGKPYN 289
KI D G + E G ++A EVL + +
Sbjct: 154 PNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQV-EEGDSRFLANEVLQENYTHL 209
Query: 290 RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD 349
K D+++ + + P P +RQ P IP+ +++
Sbjct: 210 PKADIFALALTVVCA-AGAEPLPRN---GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 350 ANPDKRPVMDEVVK 363
+P++RP +VK
Sbjct: 266 PDPERRPSAMALVK 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 50/296 (16%)
Query: 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAI 132
E++ E + R + +GTYG VY G + +A+K + +
Sbjct: 12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-------- 63
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
+E+A+ + L H N+ +++G+ +KI +E +P
Sbjct: 64 -QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI--------------------FMEQVP 102
Query: 193 GGTLKKFLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA-NRT 249
GG+L L+R+K L + + GL YLH IVHRD+K +N+L++ +
Sbjct: 103 GGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV 161
Query: 250 LKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLDGKP--YNRKCDVYSFGICLWEIYC 306
LKI+DFG + R+ NP T TGTL YMAPE++D P Y + D++S G + E+
Sbjct: 162 LKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220
Query: 307 CDMPYPDLS------FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
P+ +L F V + P+IP + + + KC++ +PDKR
Sbjct: 221 GKPPFYELGEPQAAMF-----KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-49
Identities = 67/276 (24%), Positives = 102/276 (36%), Gaps = 39/276 (14%)
Query: 92 EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148
+ G+YG V++ DG+ AVK G + RA EV +K+ H
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PKD----RARKLAEVGSHEKVGQH 116
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
P + A L + E G +L++ L
Sbjct: 117 PCCVRLEQAWEEGGIL--------------------YLQTELC-GPSLQQH-CEAWGASL 154
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
V D L++LHS+ +VH DVK N+ L K+ DFG+
Sbjct: 155 PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214
Query: 269 TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN- 327
E G YMAPE+L G Y DV+S G+ + E+ C+M P +RQ
Sbjct: 215 VQE-GDPRYMAPELLQG-SYGTAADVFSLGLTILEV-ACNMELP---HGGEGWQQLRQGY 268
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
L P+ S L S++ + +P R + ++
Sbjct: 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-49
Identities = 66/319 (20%), Positives = 115/319 (36%), Gaps = 49/319 (15%)
Query: 51 FKSWDIQLEKHLSRVWSRE----REVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRG-- 104
+ S +L++ E E L E+ E+ + + + RG++G V+R
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79
Query: 105 AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164
G AVK + + +E+ L P + GA +
Sbjct: 80 KQTGFQCAVKKVR--------------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWV 125
Query: 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGL 224
I +E L GG+L + + + L + GL
Sbjct: 126 NI--------------------FMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGL 163
Query: 225 SYLHSKTIVHRDVKTENMLLDAN-RTLKIADFGVARVEAQNPRDMTGET-----GTLGYM 278
YLH++ I+H DVK +N+LL ++ + DFG A + + T GT +M
Sbjct: 164 EYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 279 APEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN-LRPDIPRCCP 337
APEV+ GKP + K D++S + + P+ + + + +IP C
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283
Query: 338 SSLASIMRKCWDANPDKRP 356
A +++ P R
Sbjct: 284 PLTAQAIQEGLRKEPVHRA 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 79/316 (25%), Positives = 122/316 (38%), Gaps = 84/316 (26%)
Query: 93 IARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRAS------FRQEVAVWQKL 146
+ G +G VY+G + VAVK L D + F QE+ V K
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVD-----------ITTEELKQQFDQEIKVMAKC 87
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCV-------VVEYLPGGTLKKF 199
H N+ + +G V Y+P G+L
Sbjct: 88 QHENLVELLG---------------------------FSSDGDDLCLVYVYMPNGSLLDR 120
Query: 200 L-IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA 258
L + L++ + +IA A G+++LH +HRD+K+ N+LLD T KI+DFG+A
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 259 RVEAQNPRDMTGET----GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC----CDMP 310
R + T T GT YMAPE L G+ K D+YSFG+ L EI D
Sbjct: 181 RASEKF--AQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 311 YPDLS--------FTDVSSAVVRQNLR----PDIPRCCPSSL---ASIMRKCWDANPDKR 355
+ + + + +S+ S+ +C +KR
Sbjct: 238 REPQLLLDIKEEIEDE------EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 356 PVMDEVVKLLEAVNTS 371
P + +V +LL+ + S
Sbjct: 292 PDIKKVQQLLQEMTAS 307
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-47
Identities = 58/327 (17%), Positives = 120/327 (36%), Gaps = 71/327 (21%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ RG +G V+ + D + A+K + R +EV KL+HP
Sbjct: 14 MGRGGFGVVFEAKNKVDDCNYAIKR--------IRLPNRELAREKVMREVKALAKLEHPG 65
Query: 151 VTKFIGA---------------------------------SMGTTNLKIPSQSATSDSHN 177
+ ++ A + ++ +T ++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 178 SLPSRAC----CVVVEYLPGGTLKKFLIRNKRKKLA-FKVVIQIALDLARGLSYLHSKTI 232
L + + ++ LK ++ R + V + I + +A + +LHSK +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 233 VHRDVKTENMLLDANRTLKIADFGVARV------------EAQNPRDMTGETGTLGYMAP 280
+HRD+K N+ + +K+ DFG+ TG+ GT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 281 EVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR----PDIPRCC 336
E + G Y+ K D++S G+ L+E+ + T + + ++R P +
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLY---SFS----TQMERVRIITDVRNLKFPLLFTQK 298
Query: 337 PSSLASIMRKCWDANPDKRPVMDEVVK 363
+++ +P +RP ++++
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-46
Identities = 67/308 (21%), Positives = 119/308 (38%), Gaps = 45/308 (14%)
Query: 86 KLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
+L +R +A G + VY + G++ A+K L E + QEV
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL------SNEEEK---NRAIIQEVCFM 79
Query: 144 QKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
+KL HPN+ +F A+ + + ++ E G ++
Sbjct: 80 KKLSGHPNIVQFCSAA------------SIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 203 NKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENMLLDANRTLKIADFGVARV 260
R L+ V++I R + ++H + I+HRD+K EN+LL T+K+ DFG A
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 261 EAQNPR------------DMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIY 305
+ P + T Y PE++D P K D+++ G L+ +
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 306 CCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365
P+ D +V + S++R NP++R + EVV L
Sbjct: 248 FRQHPFED----GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
Query: 366 EAVNTSKG 373
+ + ++
Sbjct: 304 QEIAAARN 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-45
Identities = 79/352 (22%), Positives = 127/352 (36%), Gaps = 64/352 (18%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQD-------VAVKILDWAEDGM 123
E LP +WE +L + + RG +G V G D VAVK M
Sbjct: 8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--------M 59
Query: 124 VTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGA------------------------- 157
+ + + E+ + + H NV +GA
Sbjct: 60 LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
Query: 158 ------------------SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL--K 197
DS S S A VE + +
Sbjct: 120 SKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+ + L + +I + +A+G+ +L S+ +HRD+ N+LL +KI DFG+
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 258 ARVEAQNPRDMTGETGTL--GYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDL 314
AR ++P + L +MAPE + + Y + DV+SFG+ LWEI+ PYP +
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ +++ R P + M CW P +RP E+V+ L
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 53/286 (18%), Positives = 102/286 (35%), Gaps = 48/286 (16%)
Query: 93 IARGTYGTVYRG-AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN- 150
I G V++ Q A+K ++ S+R E+A KL +
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVN-------LEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 151 -VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ + + + +V+E L +L K+K +
Sbjct: 89 KIIRLYDYEITDQYI--------------------YMVMEC-GNIDLNSWLK--KKKSID 125
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
++ + +H IVH D+K N L+ + LK+ DFG+A + +
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 184
Query: 270 GET--GTLGYMAPEVLDGKP-----------YNRKCDVYSFGICLWEIYCCDMPYPDL-S 315
++ GT+ YM PE + + K DV+S G L+ + P+ + +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
A++ N + P L +++ C +P +R + E+
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 54/286 (18%), Positives = 106/286 (37%), Gaps = 48/286 (16%)
Query: 93 IARGTYGTVYRG-AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN- 150
I G V++ Q A+K ++ + A+ + S+R E+A KL +
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLD-SYRNEIAYLNKLQQHSD 69
Query: 151 -VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
+ + + + +V+E L +L K+K +
Sbjct: 70 KIIRLYDYEITDQYI--------------------YMVMEC-GNIDLNSWLK--KKKSID 106
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
++ + +H IVH D+K N L+ + LK+ DFG+A + +
Sbjct: 107 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 165
Query: 270 GET--GTLGYMAPEVLDGKP-----------YNRKCDVYSFGICLWEIYCCDMPYPDL-S 315
++ GT+ YM PE + + K DV+S G L+ + P+ + +
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
A++ N + P L +++ C +P +R + E+
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 84/321 (26%), Positives = 128/321 (39%), Gaps = 77/321 (23%)
Query: 81 EIELA--KLDIRHEIARGTYGTVYRGA-YDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
++E A D + I G +G VY+G DG VA+K + E F
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE-------FE 83
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCV-------VVEY 190
E+ HP++ IG C + +Y
Sbjct: 84 TEIETLSFCRHPHLVSLIG---------------------------FCDERNEMILIYKY 116
Query: 191 LPGGTLKKFLIRNKRKK--LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
+ G LK+ L + ++++ ++I + ARGL YLH++ I+HRDVK+ N+LLD N
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF 176
Query: 249 TLKIADFGVARVEAQNPRDMTGET-------GTLGYMAPE-VLDGKPYNRKCDVYSFGIC 300
KI DFG+++ + +T GTLGY+ PE + G+ K DVYSFG+
Sbjct: 177 VPKITDFGISKKGTE-----LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVV 230
Query: 301 LWEIYCCDMPY-PDLSFTDVS--------------SAVVRQNLRPDIPRCCPSSLASIMR 345
L+E+ C L V+ +V NL I
Sbjct: 231 LFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAV 290
Query: 346 KCWDANPDKRPVMDEVVKLLE 366
KC + + RP M +V+ LE
Sbjct: 291 KCLALSSEDRPSMGDVLWKLE 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 57/312 (18%), Positives = 112/312 (35%), Gaps = 55/312 (17%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRG-AYDGQDVAVKILDWAEDGMVT 125
S E + K + I +I G V++ Q A+K ++ +
Sbjct: 45 SSANECISVKGRIYSIL-------KQIGSGGSSKVFQVLNEKKQIYAIKYVN------LE 91
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPN--VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRA 183
A+ + S+R E+A KL + + + + +
Sbjct: 92 EADNQTLD-SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI------------------- 131
Query: 184 CCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
+V+E L +L K+K + ++ + +H IVH D+K N L
Sbjct: 132 -YMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 187
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKP-----------YNR 290
+ + LK+ DFG+A + + ++ G + YM PE + +
Sbjct: 188 IV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 291 KCDVYSFGICLWEIYCCDMPYPDL-SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD 349
K DV+S G L+ + P+ + + A++ N + P L +++ C
Sbjct: 247 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 306
Query: 350 ANPDKRPVMDEV 361
+P +R + E+
Sbjct: 307 RDPKQRISIPEL 318
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 44/294 (14%)
Query: 77 TEEWEIELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAE---DGMVTSAEAAA 131
+++ + L +I + +G +G VY R +A+K+L A+ G+
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE------- 53
Query: 132 IRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
R+EV + L HPN+ + G T + + ++EY
Sbjct: 54 --HQLRREVEIQSHLRHPNILRLYGYFHDATRVYL--------------------ILEYA 91
Query: 192 PGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249
P GT+ + L + + ++ + ++A LSY HSK ++HRD+K EN+LL +
Sbjct: 92 PLGTVYRELQKLSKFDEQRTATYITELAN----ALSYCHSKRVIHRDIKPENLLLGSAGE 147
Query: 250 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309
LKIADFG + V A + R GTL Y+ PE+++G+ ++ K D++S G+ +E
Sbjct: 148 LKIADFGWS-VHAPSSRRTD-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P+ ++ + + R P ++ + NP +RP++ EV++
Sbjct: 206 PFEANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 70/312 (22%), Positives = 118/312 (37%), Gaps = 49/312 (15%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGT-VYRGAYDGQDVAVKILDWAEDGMVT 125
S E++ +T + + + G GT VYRG +D +DVAVK ++
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR-------ILP 58
Query: 126 SAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
+ A +EV + ++ D HPNV ++ I
Sbjct: 59 ECFSFA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYI------------------ 95
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+E TL++ + K I + GL++LHS IVHRD+K N+L+
Sbjct: 96 --AIELC-AATLQE-YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI 151
Query: 245 -----DANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDG---KPYNRKCD 293
I+DFG+ + A +G GT G++APE+L + D
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 294 VYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLAS-IMRKCWDAN 351
++S G + + P+ + + +L P +A ++ K +
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 352 PDKRPVMDEVVK 363
P KRP V+K
Sbjct: 272 PQKRPSAKHVLK 283
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 80/310 (25%), Positives = 122/310 (39%), Gaps = 76/310 (24%)
Query: 93 IARGTYGTVYRGA-YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151
+ RG +G VY+G DG VAVK L F+ EV + H N+
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLK--------EERTQGGELQFQTEVEMISMAVHRNL 89
Query: 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCV-------VVEYLPGGTLKKFL--IR 202
+ G C+ V Y+ G++ L
Sbjct: 90 LRLRG---------------------------FCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 203 NKRKKLAFKVVIQIALDLARGLSYLHSKT---IVHRDVKTENMLLDANRTLKIADFGVAR 259
+ L + +IAL ARGL+YLH I+HRDVK N+LLD + DFG+A+
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 260 VEAQNPRDMTGET----GTLGYMAPE-VLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
+ T T GT+G++APE + GK + K DV+ +G+ L E+ + DL
Sbjct: 183 L---MDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF-DL 237
Query: 315 SFTDVSSA------------------VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+ +V +L+ + L + C ++P +RP
Sbjct: 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297
Query: 357 VMDEVVKLLE 366
M EVV++LE
Sbjct: 298 KMSEVVRMLE 307
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 34/295 (11%), Positives = 90/295 (30%), Gaps = 34/295 (11%)
Query: 92 EIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
+ G V+ D +D A+K+ + + + + + +L
Sbjct: 69 PLRVGDRSVVFL-VRDVERLEDFALKVFT------MGAENSRSELERLHEATFAAARLLG 121
Query: 149 PNVT------KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL-- 200
+ + + S P + S + +++ L+
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFST 180
Query: 201 ---IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
+ R + + L R + L SK +VH +N+ + + L + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 258 ARVEAQNPRDMTGETGTLGYMAPEVLDGK--PYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
+ + Y E L+ + + + G+ ++ ++C +P+ ++
Sbjct: 241 LWKVGTRGPAS---SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 316 FTDVSSAVVRQNLRPDIP----RCC---PSSLASIMRKCWDANPDKRPVMDEVVK 363
S P C P + +++ + + + +R + E ++
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 71/310 (22%), Positives = 116/310 (37%), Gaps = 36/310 (11%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+++ + G +G V R G+ VA+K + R + E+ + +K
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR--------QELSPKNRERWCLEIQIMKK 68
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV-EYLPGGTLKKFLIRNK 204
L+HPNV D L ++ EY GG L+K+L + +
Sbjct: 69 LNHPNVVSAR---------------EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE 113
Query: 205 RK-KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR---TLKIADFGVARV 260
L + + D++ L YLH I+HRD+K EN++L KI D G A+
Sbjct: 114 NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
Q T GTL Y+APE+L+ K Y D +SFG +E P+
Sbjct: 174 LDQGEL-CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232
Query: 321 SAVVRQNLRPDIPRC-CPSSLASIMRKCWDANPDKRPVMDEVVKLLEA---VNTSKGGGM 376
VR+ I + N + ++ + L+ + + G
Sbjct: 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT- 291
Query: 377 IPEDQAHGCL 386
P++ GC
Sbjct: 292 DPQNPNVGCF 301
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 43/293 (14%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRAS 135
+ W+ L EI RG YG+V + + GQ +AVK + T E +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR------STVDEK--EQKQ 66
Query: 136 FRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
++ V + D P + +F GA + I +E +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWI--------------------CMELMSTS 106
Query: 195 TLK--KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT-IVHRDVKTENMLLDANRTLK 251
K K++ + +++ +I L + L++L I+HRD+K N+LLD + +K
Sbjct: 107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166
Query: 252 IADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG----KPYNRKCDVYSFGICLWEIYCC 307
+ DFG++ + + T + G YMAPE +D + Y+ + DV+S GI L+E+
Sbjct: 167 LCDFGISG-QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 308 DMPYPDL-SFTDVSSAVVRQN---LRPDIPRCCPSSLASIMRKCWDANPDKRP 356
PYP S D + VV+ + L R S + + C + KRP
Sbjct: 226 RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-41
Identities = 53/327 (16%), Positives = 107/327 (32%), Gaps = 69/327 (21%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + +G V+RG G A+K+ + + + +E V +K
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVD------VQMREFEVLKK 63
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+H N+ K +R +++E+ P G+L L
Sbjct: 64 LNHKNIVKLF------------------AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN 105
Query: 206 K-KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFGVARV 260
L + + D+ G+++L IVHR++K N++ D K+ DFG AR
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDG--------KPYNRKCDVYSFGICLWEIYCCDMPYP 312
+ + GT Y+ P++ + K Y D++S G+ + +P+
Sbjct: 166 LEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 313 DLSFTDVSSAVVRQNLR---------------------------PDIPRCCPSSLASIMR 345
+ V+ + + + R L ++
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 346 KCWDANPDKRPVMDEVVKLLEAVNTSK 372
+A+ +K D+ +
Sbjct: 285 NILEADQEKCWGFDQFFAETSDILHRM 311
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 53/318 (16%), Positives = 105/318 (33%), Gaps = 69/318 (21%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + +G V+RG G A+K+ + + + +E V +K
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFN--NISFLRPVD------VQMREFEVLKK 63
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+H N+ K +R +++E+ P G+L L
Sbjct: 64 LNHKNIVKLF------------------AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN 105
Query: 206 K-KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFGVARV 260
L + + D+ G+++L IVHR++K N++ D K+ DFG AR
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDG--------KPYNRKCDVYSFGICLWEIYCCDMPYP 312
+ GT Y+ P++ + K Y D++S G+ + +P+
Sbjct: 166 LEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 313 DLSFTDVSSAVVRQNLR---------------------------PDIPRCCPSSLASIMR 345
+ V+ + + + R L ++
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 346 KCWDANPDKRPVMDEVVK 363
+A+ +K D+
Sbjct: 285 NILEADQEKCWGFDQFFA 302
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 66/310 (21%), Positives = 126/310 (40%), Gaps = 40/310 (12%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMV 124
R L +K + E++ + E+ G G V++ ++ G +A K++
Sbjct: 15 KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--- 71
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
AIR +E+ V + + P + F GA + I
Sbjct: 72 -----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI------------------ 108
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRDVKTENML 243
+E++ GG+L + L + R + +++ ++++ + +GL+YL K I+HRDVK N+L
Sbjct: 109 --CMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
+++ +K+ DFGV+ Q M GT YM+PE L G Y+ + D++S G+ L
Sbjct: 165 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
E+ P P D + + + + + +
Sbjct: 222 EMAVGRYPIPP---PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIF 278
Query: 363 KLLEAVNTSK 372
+LL+ +
Sbjct: 279 ELLDYIVNEP 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 68/295 (23%), Positives = 131/295 (44%), Gaps = 44/295 (14%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAE---DGMVTSAEAA 130
+ + + + DI + +G +G VY R + +A+K+L ++ +G+
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE------ 58
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
R+E+ + L HPN+ + + +++E+
Sbjct: 59 ---HQLRREIEIQSHLRHPNILRMYNYFHDRKRI--------------------YLMLEF 95
Query: 191 LPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
P G L K L ++ R ++ + + ++A L Y H + ++HRD+K EN+L+
Sbjct: 96 APRGELYKELQKHGRFDEQRSATFMEELAD----ALHYCHERKVIHRDIKPENLLMGYKG 151
Query: 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308
LKIADFG + V A + R T GTL Y+ PE+++GK ++ K D++ G+ +E
Sbjct: 152 ELKIADFGWS-VHAPSLRRRT-MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P+ S T+ +V +L+ P ++ K +P +R + V++
Sbjct: 210 PPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 1e-39
Identities = 41/294 (13%), Positives = 90/294 (30%), Gaps = 27/294 (9%)
Query: 87 LDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAE----DGMVTSAEAAAIRASFRQE 139
L + + A D G+ V + + E + + E R
Sbjct: 80 LVRGTVLGQEDPYAYLE-ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG--GTLK 197
Q H FI + + + + + + T
Sbjct: 139 KNQKQAKVHLR---FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 198 KFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADF 255
+ L+ + K L +Q+ L + R L+ LH +VH ++ +++LD + + F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 256 GVARVEAQNPRDMTGET-GTLGYMAPEVLDGKP-----YNRKCDVYSFGICLWEIYCCDM 309
+ + G A +L D ++ G+ ++ I+C D+
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P D + S + R P + +++ + R + + ++
Sbjct: 316 PNTDDAALGGSEWIFRSCKNI------PQPVRALLEGFLRYPKEDRLLPLQAME 363
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 69/296 (23%), Positives = 124/296 (41%), Gaps = 53/296 (17%)
Query: 89 IRHEIARGTYGTVYRGAYD---GQDVAVKIL--DWAEDGMVTSAEAAAIRASFRQEVAVW 143
I ++ G TVY A D VA+K + E F +EV
Sbjct: 15 IVDKLGGGGMSTVYL-AEDTILNIKVAIKAIFIPPREK--------EETLKRFEREVHNS 65
Query: 144 QKLDHPNVTKF--IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
+L H N+ + L V+EY+ G TL +++
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYL----------------------VMEYIEGPTLSEYI- 102
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
L+ I + G+ + H IVHRD+K +N+L+D+N+TLKI DFG+A+
Sbjct: 103 -ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161
Query: 262 AQNPRDMTGET-GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
++ T GT+ Y +PE G+ + D+YS GI L+E+ + P+ + +
Sbjct: 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG----ETA 217
Query: 321 SAVVRQNLRPDIPRC-------CPSSLASIMRKCWDANPDKRPV-MDEVVKLLEAV 368
++ ++++ +P P SL++++ + + + R + E+ L +V
Sbjct: 218 VSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-39
Identities = 59/272 (21%), Positives = 115/272 (42%), Gaps = 33/272 (12%)
Query: 95 RGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152
+G++ VY + G +VA+K++D A + + EV + +L HP++
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKV 212
+ +N + +V+E G + ++L +N+ K +
Sbjct: 75 ELYN-YFEDSN-YV------------------YLVLEMCHNGEMNRYL-KNRVKPFSENE 113
Query: 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA-RVEAQNPRDMTGE 271
+ G+ YLHS I+HRD+ N+LL N +KIADFG+A +++ + + T
Sbjct: 114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-L 172
Query: 272 TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPD 331
GT Y++PE+ + + DV+S G + + P+ + + + VV +
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-- 230
Query: 332 IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+P ++ + NP R + V+
Sbjct: 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 71/300 (23%), Positives = 113/300 (37%), Gaps = 55/300 (18%)
Query: 92 EIARGTYGTVY--RGAYDGQDVAVKILD-----------------WAEDGMVTSAEAAAI 132
EI +G+YG V D A+K+L +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
QE+A+ +KLDHPNV K + + +V E +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL------------------YMVFELVN 121
Query: 193 GGTLKKFLIRNKRK---KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249
G + + + A + G+ YLH + I+HRD+K N+L+ +
Sbjct: 122 QGPV--MEVPTLKPLSEDQARFYFQDLIK----GIEYLHYQKIIHRDIKPSNLLVGEDGH 175
Query: 250 LKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDG--KPYN-RKCDVYSFGICLWEI 304
+KIADFGV+ D GT +MAPE L K ++ + DV++ G+ L+
Sbjct: 176 IKIADFGVSNE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLR-PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P+ D + S + Q L PD P L ++ + D NP+ R V+ E+
Sbjct: 234 VFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAE-DLKDLITRMLDKNPESRIVVPEIKL 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-39
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 43/234 (18%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVW 143
+I +G++G V++G + VA+KI L+ AED + +QE+ V
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI----------EDIQQEITVL 74
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ D P VTK+ G+ + T L I ++EYL GG+ L
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWI--------------------IMEYLGGGSALDLL--- 111
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ L + I ++ +GL YLHS+ +HRD+K N+LL + +K+ADFGVA Q
Sbjct: 112 EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQ 168
Query: 264 NPRDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
GT +MAPEV+ Y+ K D++S GI E+ + P+ +L
Sbjct: 169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-39
Identities = 63/291 (21%), Positives = 98/291 (33%), Gaps = 76/291 (26%)
Query: 89 IRHEIARGTYGTVYRGAYD---GQDVAVKIL--DWAEDGMVTSAEAAAIRASFRQEVAVW 143
+R + RG G VY A D + VA+K++ + D R ++E
Sbjct: 38 LRRLVGRGGMGDVYE-AEDTVRERIVALKLMSETLSSD--------PVFRTRMQREARTA 88
Query: 144 QKLDHPNV-----------TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
+L P+V ++ + +
Sbjct: 89 GRLQEPHVVPIHDFGEIDGQLYV-------------------------------DMRLIN 117
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
G L L R LA + I + L H+ HRDVK EN+L+ A+ +
Sbjct: 118 GVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYL 175
Query: 253 ADFGVARVEAQNPRDMTGET-GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311
DFG+A G T GTL YMAPE + D+Y+ L+E P
Sbjct: 176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP- 234
Query: 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
+ +V+ ++ IPR PS++ P D V+
Sbjct: 235 ----YQGDQLSVMGAHINQAIPR--PSTV----------RPGIPVAFDAVI 269
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 7e-39
Identities = 55/326 (16%), Positives = 101/326 (30%), Gaps = 78/326 (23%)
Query: 73 LPRKTEEWEIELA--KLDIRHEIARGTYGTVYRG-------AYDGQDVAVKILD----WA 119
LP + E +L + + H + G + VY A + Q +K+ W
Sbjct: 51 LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW- 109
Query: 120 EDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSL 179
E + Q + + KF A +
Sbjct: 110 EFYIG------------TQLMERLKPSMQHMFMKFYSAHLFQNG---------------- 141
Query: 180 PSRACCVVVEYLPGGTLKKFLIRNKR---KKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236
+V E GTL + K K + +VI A+ + + +H I+H D
Sbjct: 142 ----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGD 197
Query: 237 VKTENMLL-----------DANRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVL 283
+K +N +L D + L + D G + P+ T + T G+ E+L
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257
Query: 284 DGKPYNRKCDVYSFGICLWEIYCCDMP--------------YPDLSFTDVSSAVVRQNLR 329
KP+N + D + ++ + + L D+ + L
Sbjct: 258 SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVML- 316
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKR 355
+IP C ++R+ +
Sbjct: 317 -NIPDCHHLPSLDLLRQKLKKVFQQH 341
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 34/274 (12%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +G + + A + A KI+ + R E+++ + L H +
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPK------SLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
V F G + + VV+E +L + R RK L
Sbjct: 103 VVGFHGF-FEDND-FV------------------FVVLELCRRRSLLELHKR--RKALTE 140
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA-RVEAQNPRDMT 269
+ G YLH ++HRD+K N+ L+ + +KI DFG+A +VE R
Sbjct: 141 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR 329
GT Y+APEVL K ++ + DV+S G ++ + P+ + + +
Sbjct: 201 -LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 259
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
IP+ AS+++K +P RP ++E++
Sbjct: 260 --IPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 34/274 (12%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +G + + A + A KI+ + R E+++ + L H +
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPK------SLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
V F G + + VV+E +L + R RK L
Sbjct: 77 VVGFHGF-FEDND-FV------------------FVVLELCRRRSLLELHKR--RKALTE 114
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVA-RVEAQNPRDMT 269
+ G YLH ++HRD+K N+ L+ + +KI DFG+A +VE R
Sbjct: 115 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR 329
GT Y+APEVL K ++ + DV+S G ++ + P+ + + +
Sbjct: 175 -LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 233
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
IP+ AS+++K +P RP ++E++
Sbjct: 234 --IPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 53/293 (18%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
E++ L+ E+ RG YG V + + GQ +AVK + T +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR------ATVNSQ--EQKRLLM 54
Query: 139 EVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
++ + + D P F GA ++ I +E + +L
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWI--------------------CMELM-DTSLD 93
Query: 198 KFLIRNKRKKLAF--KVVIQIALDLARGLSYLHSKT-IVHRDVKTENMLLDANRTLKIAD 254
KF + K ++ +IA+ + + L +LHSK ++HRDVK N+L++A +K+ D
Sbjct: 94 KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCD 153
Query: 255 FGVARVEAQNPRDMTGET--GTLGYMAPEVLDG----KPYNRKCDVYSFGICLWEIYCCD 308
FG++ D+ + G YMAPE ++ K Y+ K D++S GI + E+
Sbjct: 154 FGIS---GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
Query: 309 MPYPDL-SFTDVSSAVVRQNLRPDIPR----CCPSSLASIMRKCWDANPDKRP 356
PY + VV + P+ + +C N +RP
Sbjct: 211 FPYDSWGTPFQQLKQVVEE----PSPQLPADKFSAEFVDFTSQCLKKNSKERP 259
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 63/301 (20%), Positives = 122/301 (40%), Gaps = 42/301 (13%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMV 124
++ L + ++ E+ L+ E+ GT G V++ + G +AVK +
Sbjct: 7 GKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR------R 60
Query: 125 TSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRA 183
+ + ++ V K D P + + G + T++ I
Sbjct: 61 SGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI----------------- 101
Query: 184 CCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT-IVHRDVKTENM 242
+E + K L + + + +++ ++ + + + L YL K ++HRDVK N+
Sbjct: 102 ---AMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSF 297
LLD +K+ DFG++ + + G YMAPE +D Y+ + DV+S
Sbjct: 157 LLDERGQIKLCDFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215
Query: 298 GICLWEIYCCDMPYPDL-SFTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKR 355
GI L E+ PY + + +V + V+++ S ++ C + KR
Sbjct: 216 GISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275
Query: 356 P 356
P
Sbjct: 276 P 276
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 76/309 (24%), Positives = 126/309 (40%), Gaps = 55/309 (17%)
Query: 89 IRHEIARGTYGTVYRGAYD---GQDVAVKIL--DWAEDGMVTSAEAAAIRASFRQE---V 140
+ + G V+ A D +DVAVK+L D A D + FR+E
Sbjct: 16 LGEILGFGGMSEVHL-ARDLRDHRDVAVKVLRADLARD--------PSFYLRFRREAQNA 66
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
A L+HP + + + LP +V+EY+ G TL+ +
Sbjct: 67 A---ALNHPAI------------VAVYDTGEAETPAGPLPY----IVMEYVDGVTLRDIV 107
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+ + K I++ D + L++ H I+HRDVK N+++ A +K+ DFG+AR
Sbjct: 108 --HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 261 EAQNPRDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317
A + +T GT Y++PE G + + DVYS G L+E+ + P FT
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FT 220
Query: 318 -DVSSAVVRQNLRPDIPR------CCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370
D +V Q++R D + L +++ K NP+ R ++ +
Sbjct: 221 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY--QTAAEMRADLVR 278
Query: 371 SKGGGMIPE 379
G
Sbjct: 279 VHNGEPPEA 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 69/232 (29%), Positives = 105/232 (45%), Gaps = 40/232 (17%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D+ ++ G+YG+VY+ + GQ VA+K + D +E+++ Q+
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----------LQEIIKEISIMQQ 80
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
D P+V K+ G+ T+L I V+EY G++ +IR +
Sbjct: 81 CDSPHVVKYYGSYFKNTDLWI--------------------VMEYCGAGSVSD-IIRLRN 119
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
K L + I +GL YLH +HRD+K N+LL+ K+ADFGVA Q
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---GQLT 176
Query: 266 RDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
M GT +MAPEV+ YN D++S GI E+ PY D+
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 53/330 (16%), Positives = 108/330 (32%), Gaps = 65/330 (19%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILD--------WAEDGMV 124
L + +E + + I + +G + + D + A+K +
Sbjct: 19 LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
+ F+ E+ + + + G + + ++
Sbjct: 79 DKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYD-EV------------------ 118
Query: 185 CVVVEYLPGGTLKKFLIRNKR------KKLAFKVVIQIALDLARGLSYLHS-KTIVHRDV 237
++ EY+ ++ KF + +V+ I + SY+H+ K I HRDV
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKP--YNRKCD 293
K N+L+D N +K++DFG + + GT +M PE + K D
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMVDKKI----KGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 294 VYSFGICLWE--------------------IYCCDMPYPDLSFTDVSSAVVRQNLRPDIP 333
++S GICL+ I ++ YP + +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP--LDRNHFLYPLTNKKSTCSN 292
Query: 334 RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ ++ NP +R ++ +K
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-37
Identities = 37/295 (12%), Positives = 88/295 (29%), Gaps = 40/295 (13%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ + G+ V + + E + ++EV + L
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTER------PPSNAIKQMKEEVLRLRLLRGIK 134
Query: 151 VTKFIGASMGTTN----LKIPSQSATSD--SHNSLPSRACCVVVEYLPGGTLKKFL---- 200
K + +K P + + L+ F
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 201 -IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
+ K L +Q+ L + R L+ LH +VH ++ +++LD + + F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 260 VEAQNPRDMTGETGTLGYMAPEVL-----------DGKPYNRKCDVYSFGICLWEIYCCD 308
+ + + G+ PE+ D ++ G+ ++ I+C D
Sbjct: 255 RDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+P + S + R + P + +++ + R + + ++
Sbjct: 311 LPITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 66/285 (23%), Positives = 126/285 (44%), Gaps = 57/285 (20%)
Query: 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
K +I +G GTVY GQ+VA++ ++ + + E+ V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN------LQQQPK---KELIINEILVM 71
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
++ +PN+ ++ + + L + V+EYL GG+L +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWV--------------------VMEYLAGGSLTDVV--- 108
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ + + + + L +LHS ++HRD+K++N+LL + ++K+ DFG AQ
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQ 165
Query: 264 NPRDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS----- 315
+ + + GT +MAPEV+ K Y K D++S GI E+ + PY + +
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMR----KCWDANPDKRP 356
+ ++ N P++ P L++I R +C + + +KR
Sbjct: 226 Y------LIATNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRG 262
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 69/303 (22%), Positives = 121/303 (39%), Gaps = 42/303 (13%)
Query: 72 VLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILD----WAEDGMVT 125
+ +K + ++ G YG V + A+K++
Sbjct: 26 YVRKKEGKIG---ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDD 82
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185
+ E+++ + LDHPN+ K +
Sbjct: 83 NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL------------------- 123
Query: 186 VVVEYLPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
V E+ GG L + +I + + A ++ QI G+ YLH IVHRD+K EN+L
Sbjct: 124 -VTEFYEGGELFEQIINRHKFDECDAANIMKQIL----SGICYLHKHNIVHRDIKPENIL 178
Query: 244 L---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGIC 300
L ++ +KI DFG++ +++ + + GT Y+APEVL K YN KCDV+S G+
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVI 236
Query: 301 LWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCP-SSLA-SIMRKCWDANPDKRPVM 358
++ + C P+ + D+ V + D S A +++ + +KR
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 359 DEV 361
+E
Sbjct: 297 EEA 299
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 32/237 (13%)
Query: 72 VLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEA 129
+L ++ E ++ I +G + V R GQ AVKI+D A+ ++
Sbjct: 12 ILDMADDDVLFE-DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK----FTSSP 66
Query: 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
++E ++ L HP++ + + L + V E
Sbjct: 67 GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM--------------------VFE 106
Query: 190 YLPGGTLKKFLIRNKRKKLAF--KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL--- 244
++ G L +++ + V + L Y H I+HRDVK +LL
Sbjct: 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK 166
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301
+ + +K+ FGVA ++ G GT +MAPEV+ +PY + DV+ G+ L
Sbjct: 167 ENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-37
Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 57/285 (20%)
Query: 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
LD +I G+ G V G+ VAVK++D R EV +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---------LRKQQRRELLFNEVVIM 96
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ H NV + + + L + ++E+L GG L +
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWV--------------------LMEFLQGGALTDIV--- 133
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ +L + + + + + L+YLH++ ++HRD+K++++LL + +K++DFG AQ
Sbjct: 134 SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC---AQ 190
Query: 264 NPRDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS----- 315
+D+ GT +MAPEV+ Y + D++S GI + E+ + PY S
Sbjct: 191 ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
Query: 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMR----KCWDANPDKRP 356
+R + P + ++ ++R + +P +R
Sbjct: 251 K------RLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERA 287
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 41/228 (17%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + G G V + VA++I+ + + ++ EA + E+ + +K
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA-LNVETEIEILKK 196
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+HP + K N + +V+E + GG L ++ NKR
Sbjct: 197 LNHPCIIKI---------------------KNFFDAEDYYIVLELMEGGELFDKVVGNKR 235
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARV 260
+ Q+ L + YLH I+HRD+K EN+LL + + +KI DFG +++
Sbjct: 236 LKEATCKLYFYQMLL----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFG----ICL 301
+ M GT Y+APEVL YNR D +S G ICL
Sbjct: 292 LGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 74/299 (24%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 72 VLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEA 129
+ T + + + + +G++G V GQ+ AVK++ + V
Sbjct: 16 FVQHSTAIFS---DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ---VKQKTD 69
Query: 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
+ S +EV + ++LDHPN+ K + V E
Sbjct: 70 ---KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL--------------------VGE 106
Query: 190 YLPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL--- 244
GG L +I KR + A +++ Q+ G++Y+H IVHRD+K EN+LL
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARIIRQVL----SGITYMHKNKIVHRDLKPENLLLESK 162
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
+ ++I DFG++ + + M + GT Y+APEVL G Y+ KCDV+S G+ L+ +
Sbjct: 163 SKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYIL 220
Query: 305 YCCDMPYPDLSFTDVSSAVVRQNLRPDIPRC-CPSSLA-SIMRKCWDANPDKRPVMDEV 361
P+ + D+ V + ++P+ S A ++RK P R +
Sbjct: 221 LSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 42/283 (14%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ G YG V + A+KI+ ++ + + + +EVAV +
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-------KTSVSTSSNSKLLEEVAVLKL 92
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LDHPN+ K D N +V+E GG L +I +
Sbjct: 93 LDHPNIMKLYDF--------------FEDKRN------YYLVMECYKGGELFDEIIHRMK 132
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARV 260
+ A ++ Q+ G++YLH IVHRD+K EN+LL + + +KI DFG++ V
Sbjct: 133 FNEVDAAVIIKQVL----SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
+ M GT Y+APEVL K Y+ KCDV+S G+ L+ + P+ + ++
Sbjct: 189 FENQKK-MKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246
Query: 321 SAVVRQNLR-PDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEV 361
V + S A ++++ + +R +
Sbjct: 247 RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 55/246 (22%), Positives = 97/246 (39%), Gaps = 41/246 (16%)
Query: 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAE 128
LP + + + RG V R + ++ AVKI+D G ++ E
Sbjct: 4 AALPGSHSTHGFY-ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE 62
Query: 129 AAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187
+R + +EV + +K+ HPN+ + T + V
Sbjct: 63 VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL--------------------V 102
Query: 188 VEYLPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
+ + G L +L +K K++ + + LH IVHRD+K EN+LLD
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALL----EVICALHKLNIVHRDLKPENILLD 158
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG------KPYNRKCDVYSFG- 298
+ +K+ DFG + + + GT Y+APE+++ Y ++ D++S G
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
Query: 299 ---ICL 301
L
Sbjct: 218 IMYTLL 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ + GTYG VY+G + GQ A+K++D D +QE+ + +K
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----------EEEEIKQEINMLKK 76
Query: 146 L-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
H N+ + GA + + Q +V+E+ G++ + K
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQ--------------LWLVMEFCGAGSVTDLIKNTK 122
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
L + + I ++ RGLS+LH ++HRD+K +N+LL N +K+ DFGV+ AQ
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQL 179
Query: 265 PRDMTGET---GTLGYMAPEVL-----DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
R + GT +MAPEV+ Y+ K D++S GI E+ P D+
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMR----KCWDANPDKRPVMDEVVK 363
+ R PR + + C N +RP ++++K
Sbjct: 240 MRALFLIPRN----PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 43/238 (18%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+I E+ G +G VY+ G A K+++ ++ + E+ +
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIE---------TKSEEELEDYIVEIEILAT 72
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
DHP + K +GA L +++E+ PGG + ++
Sbjct: 73 CDHPYIVKLLGAYYHDGKL--------------------WIMIEFCPGGAVDA-IMLELD 111
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ L + + + L++LHSK I+HRD+K N+L+ +++ADFGV+ A+N
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS---AKNL 168
Query: 266 RDMTGET---GTLGYMAPEV-----LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
+ + GT +MAPEV + PY+ K D++S GI L E+ + P+ +L+
Sbjct: 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 44/240 (18%), Positives = 91/240 (37%), Gaps = 40/240 (16%)
Query: 88 DIRHEIARG--TYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
++ I +G TV Y G+ V V+ ++ + + + + E+ V
Sbjct: 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN------LEACSNEMVT-FLQGELHVS 80
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ +HPN+ + + L VV ++ G+ K + +
Sbjct: 81 KLFNHPNIVPYRATFIADNEL--------------------WVVTSFMAYGSAKDLICTH 120
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV-ARVEA 262
+ + I + + L Y+H VHR VK ++L+ + + ++ + +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 263 QNPRDMTGET------GTLGYMAPEVL--DGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
R L +++PEVL + + Y+ K D+YS GI E+ +P+ D+
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 44/284 (15%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILD---WAEDGMVTSAEAAAIRASFRQEVAV 142
+ G +G V+ ++V VK + ED + + + E+A+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT----LEIAI 82
Query: 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
+++H N+ K + V+ ++ G L F+ R
Sbjct: 83 LSRVEHANIIKVLDI-FEN------------------QGFFQLVMEKHGSGLDLFAFIDR 123
Query: 203 NKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+ R + LA + Q+ + YL K I+HRD+K EN+++ + T+K+ DFG A
Sbjct: 124 HPRLDEPLASYIFRQLV----SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
+ T GT+ Y APEVL G PY + +++S G+ L+ + + P+ + +
Sbjct: 180 LERGKLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEET 236
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
A + P L S++ P++R ++++V
Sbjct: 237 VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 46/243 (18%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKI--LDWAEDGMVTSAEAAAIRASFRQEVAVW 143
+++ I G V + VA+K L+ + M +E+
Sbjct: 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM----------DELLKEIQAM 67
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ HPN+ + + + L +V++ L GG++ +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDEL--------------------WLVMKLLSGGSVLDIIKHI 107
Query: 204 KRKKLAFKVVI---QIAL---DLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
K V+ IA ++ GL YLH +HRDVK N+LL + +++IADFGV
Sbjct: 108 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167
Query: 258 ARVEAQNPRDMTGET-----GTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPY 311
+ A + GT +MAPEV++ + Y+ K D++SFGI E+ PY
Sbjct: 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
Query: 312 PDL 314
Sbjct: 228 HKY 230
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 62/311 (19%), Positives = 118/311 (37%), Gaps = 72/311 (23%)
Query: 88 DIRHEIARGTYGTV-YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
+ G+ GTV ++G++ G+ VAVK + + E+ + +
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA------------LMEIKLLTES 65
Query: 147 D-HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
D HPNV ++ + + L + +E L+ +
Sbjct: 66 DDHPNVIRYYC---------------SETTDRFL-----YIALELC-NLNLQDLVESKNV 104
Query: 206 -----KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD-------------AN 247
K I + +A G+++LHS I+HRD+K +N+L+ N
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 248 RTLKIADFGVARV----EAQNPRDMTGETGTLGYMAPEVLDG-------KPYNRKCDVYS 296
+ I+DFG+ + ++ ++ +GT G+ APE+L+ + R D++S
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 297 FGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLAS-----IMRKCWDA 350
G + I P+ D + S ++R D +C ++ + D
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 351 NPDKRPVMDEV 361
+P KRP +V
Sbjct: 283 DPLKRPTAMKV 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 6e-36
Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 53/288 (18%)
Query: 89 IRHEIARGTYGTVYRGAYD----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
++ IA G G +Y A D G+ V +K L + D A +A E
Sbjct: 84 VKGCIAHGGLGWIYL-ALDRNVNGRPVVLKGLVHSGD--------AEAQAMAMAERQFLA 134
Query: 145 KLDHPNVTKF--IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
++ HP++ + + +V+EY+ G +LK+
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGY-----------------IVMEYVGGQSLKRSK-- 175
Query: 203 NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
+KL I L++ LSYLHS +V+ D+K EN++L + LK+ D G
Sbjct: 176 --GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS--- 229
Query: 263 QNPRDMTGET-GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ G GT G+ APE++ P D+Y+ G L +
Sbjct: 230 --RINSFGYLYGTPGFQAPEIVRTGPTVA-TDIYTVGRTLAALTLDLPTRNG----RYVD 282
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-MDEVVKLLEAV 368
+ + S ++R+ D +P +R +E+ L V
Sbjct: 283 GLPEDDPVLKTYD----SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 52/288 (18%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+I + +G++G V + Q+ AVK+++ ++ ++ +EV + +K
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-------KASAKNKDTSTILREVELLKK 77
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LDHPN+ K DS + +V E GG L +I+ KR
Sbjct: 78 LDHPNIMKLFEI--------------LEDSSS------FYIVGELYTGGELFDEIIKRKR 117
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARV 260
+ A +++ Q+ G++Y+H IVHRD+K EN+LL + + +KI DFG++
Sbjct: 118 FSEHDAARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
QN + M GT Y+APEVL G Y+ KCDV+S G+ L+ + P+ + D+
Sbjct: 174 FQQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 321 SAVVRQNLR------PDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEV 361
V I S A ++RK +P R +
Sbjct: 232 KRVETGKYAFDLPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 9e-36
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 44/222 (19%)
Query: 88 DIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
+ G + V+ G+ A+K + + +S E+AV +
Sbjct: 12 IFMEVLGSGAFSEVFL-VKQRLTGKLFALKCIKKSPAFR---------DSSLENEIAVLK 61
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
K+ H N+ TT+ + V++ + GG L ++
Sbjct: 62 KIKHENIVTLEDIYESTTHYYL--------------------VMQLVSGGELFDRILERG 101
Query: 205 R--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVAR 259
+K A V+ Q+ + YLH IVHRD+K EN+L + N + I DFG+++
Sbjct: 102 VYTEKDASLVIQQVL----SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301
+E M+ GT GY+APEVL KPY++ D +S G+
Sbjct: 158 MEQNGI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 38/280 (13%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G+YG V + AVKIL + + + EA + E+ + ++L H N
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-----EIQLLRRLRHKN 67
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF-LIRNKR--KK 207
V + + K+ +V+EY G + + KR
Sbjct: 68 VIQLVDVLYNEEKQKM------------------YMVMEYCVCGMQEMLDSVPEKRFPVC 109
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
A Q+ GL YLHS+ IVH+D+K N+LL TLKI+ GVA D
Sbjct: 110 QAHGYFCQLID----GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 268 MTGET--GTLGYMAPEVLDG-KPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323
T T G+ + PE+ +G ++ K D++S G+ L+ I P+ + + +
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
Query: 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ + IP C L+ +++ + P KR + ++ +
Sbjct: 226 GKGSYA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 39/233 (16%)
Query: 88 DIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
EI G++G VY A D + VA+K + + ++ +EV Q
Sbjct: 57 SDLREIGHGSFGAVYF-ARDVRNSEVVAIKKMS------YSGKQSNEKWQDIIKEVRFLQ 109
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
KL HPN ++ G + + V+EY G L+
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWL--------------------VMEYCLGSASD--LLEVH 147
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
+K L + + +GL+YLHS ++HRDVK N+LL +K+ DFG A +
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIM 204
Query: 265 PRDMTGETGTLGYMAPEV---LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
+ GT +MAPEV +D Y+ K DV+S GI E+ P ++
Sbjct: 205 APANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-35
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 34/304 (11%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ I +G+YG V A+KI++ + + + + EV + +K
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD----VERIKTEVRLMKK 84
Query: 146 LDHPNVTKFIGA--------------SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYL 191
L HPN+ + G K+ S ++ +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 192 PGGTLKKFLIRNKRKKLAF----KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL--D 245
I R+ L F K++ I + L YLH++ I HRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 246 ANRTLKIADFGVARV----EAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGI 299
+ +K+ DFG+++ MT + GT ++APEVL+ + Y KCD +S G+
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 300 CLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPV 357
L + +P+P ++ D S V+ + L + P ++ + N D+R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 358 MDEV 361
Sbjct: 325 AMRA 328
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D++ E+ +G + V R G + A KI++ T +A +E + +K
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-------TKKLSARDFQKLEREARICRK 61
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L HPN+ + + + + V + + GG L + ++ +
Sbjct: 62 LQHPNIVRLHDSIQEESFHYL--------------------VFDLVTGGELFEDIVAREF 101
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARV 260
+ A + QI ++Y HS IVHR++K EN+LL +K+ADFG+A
Sbjct: 102 YSEADASHCIQQIL----ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFG----ICL 301
+ G GT GY++PEVL PY++ D+++ G I L
Sbjct: 158 VNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 76/284 (26%), Positives = 130/284 (45%), Gaps = 45/284 (15%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ I +G + V G++VA+KI+D T +++ FR EV + +
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIID------KTQLNPTSLQKLFR-EVRIMKI 70
Query: 146 LDHPNVTKF---IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
L+HPN+ K I T + +++EY GG + +L+
Sbjct: 71 LNHPNIVKLFEVI-----ETEKTL------------------YLIMEYASGGEVFDYLVA 107
Query: 203 NKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+ R +K A QI + Y H K IVHRD+K EN+LLDA+ +KIADFG +
Sbjct: 108 HGRMKEKEARSKFRQIV----SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
+ G Y APE+ GK Y+ + DV+S G+ L+ + +P+ + ++
Sbjct: 164 FTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
V+R R IP + +++++ NP KR +++++K
Sbjct: 223 RERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 42/246 (17%)
Query: 63 SRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAE 120
+ R E + + ++ D++ E+ +G + V R + G + A KI++
Sbjct: 10 GQQMGRGSEFMMNASTKFS---DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN--- 63
Query: 121 DGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLP 180
T +A +E + +KL HPN+ + + + +
Sbjct: 64 ----TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL-------------- 105
Query: 181 SRACCVVVEYLPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238
V + + GG L + ++ + + A + QI ++Y HS IVHR++K
Sbjct: 106 ------VFDLVTGGELFEDIVAREFYSEADASHCIQQIL----ESIAYCHSNGIVHRNLK 155
Query: 239 TENMLL---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVY 295
EN+LL +K+ADFG+A +E + G GT GY++PEVL PY++ D++
Sbjct: 156 PENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 296 SFGICL 301
+ G+ L
Sbjct: 215 ACGVIL 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-34
Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D+ + G YG V + VAVKI+D A + ++E+ + +
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKM 61
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+H NV KF G N + +EY GG L + +
Sbjct: 62 LNHENVVKFYGH-RREGN-IQ------------------YLFLEYCSGGELFDRIEPDIG 101
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ A + Q+ G+ YLH I HRD+K EN+LLD LKI+DFG+A V
Sbjct: 102 MPEPDAQRFFHQLMA----GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 264 NPRDMTGET--GTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
N R+ GTL Y+APE+L + ++ DV+S GI L + ++P+ S +
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 321 SAVVRQNLRPDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEVVK 363
+ ++ P S +++ K NP R + ++ K
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-34
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 52/288 (18%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+I + +G++G V + Q+ AVK+++ ++ ++ +EV + +K
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-------KASAKNKDTSTILREVELLKK 77
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LDHPN+ K +++ I V E GG L +I+ KR
Sbjct: 78 LDHPNIMKLFEILEDSSSFYI--------------------VGELYTGGELFDEIIKRKR 117
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARV 260
+ A +++ Q+ G++Y+H IVHRD+K EN+LL + + +KI DFG++
Sbjct: 118 FSEHDAARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
QN + M GT Y+APEVL Y+ KCDV+S G+ L+ + P+ + D+
Sbjct: 174 FQQNTK-MKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 321 SAVVRQNLR------PDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEV 361
V I S A ++RK +P R +
Sbjct: 232 KRVETGKYAFDLPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ E+ G + V + G++ A K + ++S+ R +EV + ++
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRR---LSSSRRGVSREEIEREVNILRE 64
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+ HPN+ ++ + +++E + GG L FL ++
Sbjct: 65 IRHPNIITLHDIF---------------ENKTDV-----VLILELVSGGELFDFLA--EK 102
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFGVARVE 261
+ L Q + G+ YLHSK I H D+K EN++L N +K+ DFG+A
Sbjct: 103 ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+ GT ++APE+++ +P + D++S G+
Sbjct: 163 EAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 43/229 (18%)
Query: 88 DIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
+ + G G V A++ + VA+KI+ + + ++ EA + E+ + +
Sbjct: 13 IMSKTLGSGACGEVKL-AFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEILK 70
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
KL+HP + K N + +V+E + GG L ++ NK
Sbjct: 71 KLNHPCIIKI---------------------KNFFDAEDYYIVLELMEGGELFDKVVGNK 109
Query: 205 R--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVAR 259
R + Q+ L + YLH I+HRD+K EN+LL + + +KI DFG ++
Sbjct: 110 RLKEATCKLYFYQMLL----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFG----ICL 301
+ + M GT Y+APEVL YNR D +S G ICL
Sbjct: 166 ILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 56/290 (19%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + G +G+VY G D VA+K ++ +D + E EV + +K
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE--KDRISDWGELPNGTRVPM-EVVLLKK 102
Query: 146 LDH--PNVTK---FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY-LPGGTLKKF 199
+ V + + +++E P L F
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSF------------------VLILERPEPVQDLFDF 139
Query: 200 LIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR-TLKIADFG 256
+ ++LA Q+ + + H+ ++HRD+K EN+L+D NR LK+ DFG
Sbjct: 140 ITERGALQEELARSFFWQVL----EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195
Query: 257 VARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPD 313
+ +D GT Y PE + Y+ R V+S GI L+++ C D+P+
Sbjct: 196 SGAL----LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
Query: 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++ V + S ++R C P RP +E+
Sbjct: 252 DE--EIIRGQVF------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ E+ +G + V R GQ+ A I++ T +A +E + +
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN-------TKKLSARDHQKLEREARICRL 66
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L HPN+ + + + + + + + GG L + ++ +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYL--------------------IFDLVTGGELFEDIVAREY 106
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARV 260
+ A + QI + + H +VHR++K EN+LL +K+ADFG+A
Sbjct: 107 YSEADASHCIQQIL----EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301
+ G GT GY++PEVL PY + D+++ G+ L
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 40/279 (14%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G YG V + VAVKI+D A + ++E+ + + L+H N
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKMLNHEN 66
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--KKL 208
V KF G N + +EY GG L + + +
Sbjct: 67 VVKFYGH-RREGN-IQ------------------YLFLEYCSGGELFDRIEPDIGMPEPD 106
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
A + Q+ G+ YLH I HRD+K EN+LLD LKI+DFG+A V N R+
Sbjct: 107 AQRFFHQLMA----GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 269 TGET--GTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
GTL Y+APE+L + ++ DV+S GI L + ++P+ S + + +
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222
Query: 326 QNLRPDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEVVK 363
+ P S +++ K NP R + ++ K
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 58/314 (18%)
Query: 66 WSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGM 123
P ++ E A+ + + +G +GTV+ G D VA+K++
Sbjct: 12 APPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNR--- 68
Query: 124 VTSAEAAAIRASFRQEVAVWQKLD----HPNVTK---FIGASMGTTNLKIPSQSATSDSH 176
V + + EVA+ K+ HP V + + T +
Sbjct: 69 VLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF---------------ETQEG- 112
Query: 177 NSLPSRACCVVVEY-LPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIV 233
+V+E LP L ++ + + Q+ + + HS+ +V
Sbjct: 113 -------FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQHCHSRGVV 161
Query: 234 HRDVKTENMLLDANR-TLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYN- 289
HRD+K EN+L+D R K+ DFG + D GT Y PE + Y+
Sbjct: 162 HRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDFDGTRVYSPPEWISRHQYHA 217
Query: 290 RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWD 349
V+S GI L+++ C D+P+ ++ A + P +++R+C
Sbjct: 218 LPATVWSLGILLYDMVCGDIPFERDQ--EILEAELH------FPAHVSPDCCALIRRCLA 269
Query: 350 ANPDKRPVMDEVVK 363
P RP ++E++
Sbjct: 270 PKPSSRPSLEEILL 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 60/286 (20%), Positives = 115/286 (40%), Gaps = 46/286 (16%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ ++ G +G V+ G + +K ++ + E+ V +
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTIN--------KDRSQVPMEQIEAEIEVLKS 76
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LDHPN+ K N+ I V+E GG L + ++ +
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYI--------------------VMETCEGGELLERIVSAQA 116
Query: 206 K------KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFG 256
+ +++ Q+ L+Y HS+ +VH+D+K EN+L + +KI DFG
Sbjct: 117 RGKALSEGYVAELMKQMM----NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
+A + + T GT YMAPEV KCD++S G+ ++ + +P+ S
Sbjct: 173 LAELFKSDEH-STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEV 361
+V + + + A ++++ +P++RP +V
Sbjct: 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-33
Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ GT+G V G G VAVKIL+ + + I+ +E+ + HP+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIK----REIQNLKLFRHPH 72
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--KKL 208
+ K + T +V+EY+ GG L ++ ++ R +
Sbjct: 73 IIKLY-QVISTPT-DF------------------FMVMEYVSGGELFDYICKHGRVEEME 112
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
A ++ QI + Y H +VHRD+K EN+LLDA+ KIADFG++ + +
Sbjct: 113 ARRLFQQILS----AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 269 TGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
T G+ Y APEV+ G+ Y + D++S G+ L+ + C +P+ D + +
Sbjct: 169 T-SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
IP S+A+++ +P KR + ++ +
Sbjct: 228 FY--IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 46/242 (19%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMV 124
+ + + ++ E+ RG VYR + A+K+L D
Sbjct: 38 VPDYWIDGSNRDALS---DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--- 91
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
+ R E+ V +L HPN+ K T + +
Sbjct: 92 --------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL------------------ 125
Query: 185 CVVVEYLPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242
V+E + GG L ++ ++ A V QI ++YLH IVHRD+K EN+
Sbjct: 126 --VLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENGIVHRDLKPENL 179
Query: 243 LL---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
L + LKIADFG++++ ++ M GT GY APE+L G Y + D++S GI
Sbjct: 180 LYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
Query: 300 CL 301
Sbjct: 239 IT 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D + I RG V R + G + AVKI++ + ++ + +R + R+E + ++
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAE-RLSPEQLEEVREATRRETHILRQ 155
Query: 146 L-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
+ HP++ I + ++ + + V + + G L +L
Sbjct: 156 VAGHPHIITLIDSYESSSFMFL--------------------VFDLMRKGELFDYLTEKV 195
Query: 205 R--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
+K ++ + +S+LH+ IVHRD+K EN+LLD N ++++DFG +
Sbjct: 196 ALSEKETRSIMRSLL----EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 263 QNPRDMTGETGTLGYMAPEVLDG------KPYNRKCDVYSFG----ICL 301
+ + GT GY+APE+L Y ++ D+++ G L
Sbjct: 252 PGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 50/234 (21%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 72 VLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEA 129
+ P K ++ E DI E+ G + V + G + A K + + ++
Sbjct: 2 MEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ---SRASRR 55
Query: 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
R +EV++ +++ H NV ++ + +++E
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVY---------------ENRTDV-----VLILE 95
Query: 190 YLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----D 245
+ GG L FL +++ L+ + + G++YLH+K I H D+K EN++L
Sbjct: 96 LVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153
Query: 246 ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+K+ DFG+A + GT ++APE+++ +P + D++S G+
Sbjct: 154 PIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 60/288 (20%), Positives = 116/288 (40%), Gaps = 54/288 (18%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + I RG++G V A K + V + F+QE+ + +
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVD------RFKQEIEIMKS 62
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
LDHPN+ + T++ + V+E GG L + ++ +
Sbjct: 63 LDHPNIIRLYETFEDNTDIYL--------------------VMELCTGGELFERVVHKRV 102
Query: 206 --KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARV 260
+ A +++ + ++Y H + HRD+K EN L + LK+ DFG+A
Sbjct: 103 FRESDAARIMKDVL----SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
M + GT Y++P+VL+G Y +CD +S G+ ++ + C P+ + ++V
Sbjct: 159 FKPGKM-MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216
Query: 321 SAVVRQNLR------PDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEV 361
+ ++ S A S++R+ +P +R +
Sbjct: 217 LKIREGTFTFPEKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 47/218 (21%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
DI E+ G + V + G + A K + + ++ R +EV++ ++
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ---SRASRRGVCREEIEREVSILRQ 71
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+ HPN+ ++ + +++E + GG L FL ++
Sbjct: 72 VLHPNIITLHDVY---------------ENRTDV-----VLILELVSGGELFDFLA--QK 109
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFGVARVE 261
+ L+ + + G++YLH+K I H D+K EN++L +K+ DFG+A
Sbjct: 110 ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+ GT ++APE+++ +P + D++S G+
Sbjct: 170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 56/248 (22%), Positives = 93/248 (37%), Gaps = 38/248 (15%)
Query: 59 EKHLSRVWSREREVLPRKTEEWEIELAKLDIRH-EIARGTYGTVYRGA--YDGQDVAVKI 115
H S V + + E + + E+ RG + V + GQ+ A K
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFN---NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 116 LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-PNVTKFIGASMGTTNLKIPSQSATSD 174
L RA E+AV + P V T+ +
Sbjct: 62 LK-------KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI---------- 104
Query: 175 SHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234
+++EY GG + + + ++ VI++ + G+ YLH IVH
Sbjct: 105 ----------ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154
Query: 235 RDVKTENMLL---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRK 291
D+K +N+LL +KI DFG++R + GT Y+APE+L+ P
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYDPITTA 213
Query: 292 CDVYSFGI 299
D+++ GI
Sbjct: 214 TDMWNIGI 221
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D E+ G + V + G A K + S+ R +EV++ ++
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRR---TKSSRRGVSREDIEREVSILKE 70
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+ HPNV T++ +++E + GG L FL ++
Sbjct: 71 IQHPNVITLHEVYENKTDV--------------------ILILELVAGGELFDFLA--EK 108
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFGVARVE 261
+ L + + + G+ YLHS I H D+K EN++L +KI DFG+A
Sbjct: 109 ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+ GT ++APE+++ +P + D++S G+
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 58/293 (19%)
Query: 90 RHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV-WQKL 146
+ + G G V GQ A+K+L + RQEV WQ
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--------------ARQEVDHHWQAS 79
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCV--VVEYLPGGTLKKFLIRNK 204
P++ + D + ++ C+ ++E + GG L +
Sbjct: 80 GGPHIVCIL------------------DVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARVE 261
+ + +I D+ + +LHS I HRDVK EN+L + + LK+ DFG A+
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
QN + T Y+APEVL + Y++ CD++S G+ ++ + C P+ + +S
Sbjct: 182 TQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 322 AVVRQNLR----------PDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEVVK 363
+ R+ ++ S A ++R +P +R + + +
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 48/218 (22%)
Query: 92 EIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-H 148
+ G++ + Q AVKI+ + A+ ++E+ + + H
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS------------KRMEANTQKEITALKLCEGH 65
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF-LIRNKRK- 206
PN+ K + + V+E L GG L F I+ K+
Sbjct: 66 PNIVKLHEVFHDQLHTFL--------------------VMELLNGGEL--FERIKKKKHF 103
Query: 207 --KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARVE 261
A ++ ++ +S++H +VHRD+K EN+L + N +KI DFG AR++
Sbjct: 104 SETEASYIMRKLV----SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+ + + TL Y APE+L+ Y+ CD++S G+
Sbjct: 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 50/223 (22%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV-WQ 144
+++ +I G+Y R + AVKI+D S +E+ + +
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDP------TEEIEILLR 71
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF-LIRN 203
HPN+ + + V E + GG L I
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYV--------------------VTELMKGGEL--LDKILR 109
Query: 204 KRK---KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL----DANRTLKIADFG 256
++ + A V+ I + + YLH++ +VHRD+K N+L +++I DFG
Sbjct: 110 QKFFSEREASAVLFTIT----KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
A+ + T ++APEVL+ + Y+ CD++S G+
Sbjct: 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGV 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-31
Identities = 74/254 (29%), Positives = 116/254 (45%), Gaps = 51/254 (20%)
Query: 58 LEKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD--GQDVAVK- 114
+ H RE E+++ KL+ ++ GTYG VY+ A D G+ VA+K
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQ----KLE---KVGEGTYGVVYK-AKDSQGRIVALKR 52
Query: 115 I-LDWAEDGM-VTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSAT 172
I LD ++G+ T AIR E+++ ++L HPN+ I L
Sbjct: 53 IRLDAEDEGIPST-----AIR-----EISLLKELHHPNIVSLIDVIHSERCL-------- 94
Query: 173 SDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232
+V E++ LKK ++ + L + L RG+++ H I
Sbjct: 95 ------------TLVFEFMEKD-LKK-VLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKC 292
+HRD+K +N+L++++ LK+ADFG+AR R T E TL Y AP+VL G
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG------S 194
Query: 293 DVYSFGICLWEIYC 306
YS + +W I C
Sbjct: 195 KKYSTSVDIWSIGC 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 58/302 (19%), Positives = 108/302 (35%), Gaps = 73/302 (24%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVK--ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
I G+YG V++ GQ VA+K + + + + A+R E+ + ++L H
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI----KKIALR-----EIRMLKQLKH 61
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
PN+ + L + V EY T+ + ++ +
Sbjct: 62 PNLVNLLEVFRRKRRLHL--------------------VFEYCDH-TVLH-ELDRYQRGV 99
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
+V I + +++ H +HRDVK EN+L+ + +K+ DFG AR+
Sbjct: 100 PEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159
Query: 269 TGETGTLGYMAPEVLDG-KPYNRKCDVYSFG------------------------IC--- 300
E T Y +PE+L G Y DV++ G I
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 301 ------LWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDK 354
+++ + + + D + L P +L +++ C +P +
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPED---MEPLELKFPNISYPAL-GLLKGCLHMDPTE 275
Query: 355 RP 356
R
Sbjct: 276 RL 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 39/276 (14%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G++G V Q VA+K + + + + +E++ + L HP+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS------RQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--KKL 208
+ K + T I +V+EY GG L +++ KR +
Sbjct: 71 IIKLYDV-ITTPT-DI------------------VMVIEYA-GGELFDYIVEKKRMTEDE 109
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
+ QI + Y H IVHRD+K EN+LLD N +KIADFG++ +
Sbjct: 110 GRRFFQQII----CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165
Query: 269 TGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
T G+ Y APEV++GK Y + DV+S GI L+ + +P+ D ++ V
Sbjct: 166 T-SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+P S++R+ A+P +R + E+ +
Sbjct: 225 YV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 56/287 (19%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I G +G R + VAVK ++ AAI + ++E+ + L HPN
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE----------RGAAIDENVQREIINHRSLRHPN 77
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--KKL 208
+ +F + + +H +++EY GG L + + R +
Sbjct: 78 IVRFK-------------EVILTPTH-------LAIIMEYASGGELYERICNAGRFSEDE 117
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT--LKIADFGVARVEAQNPR 266
A Q+ G+SY HS I HRD+K EN LLD + LKI DFG ++ + +
Sbjct: 118 ARFFFQQLLS----GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
Query: 267 DMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
+ GT Y+APEVL + Y+ + DV+S G+ L+ + P F D
Sbjct: 174 PKS-TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP-----FEDPEEPRDY 227
Query: 326 QNLRPDIPRC---CPSSL------ASIMRKCWDANPDKRPVMDEVVK 363
+ I P + ++ + + A+P R + E+
Sbjct: 228 RKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 93 IARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ GT+G V G G VAVKIL+ + + IR +E+ + HP+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIR----REIQNLKLFRHPH 77
Query: 151 VTKF---IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-- 205
+ K I +T I +V+EY+ GG L ++ +N R
Sbjct: 78 IIKLYQVI-----STPSDI------------------FMVMEYVSGGELFDYICKNGRLD 114
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+K + ++ QI G+ Y H +VHRD+K EN+LLDA+ KIADFG++ + +
Sbjct: 115 EKESRRLFQQILS----GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 168
Query: 266 RDMTGET--GTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
T G+ Y APEV+ G+ Y + D++S G+ L+ + C +P+ D +
Sbjct: 169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK 227
Query: 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ P+ S+ S+++ +P KR + ++ +
Sbjct: 228 ICDGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 40/238 (16%)
Query: 68 REREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVT 125
+ ++ K + + G +G V++ G +A KI+
Sbjct: 73 FDHRIVTAKQGAVN-SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII--------- 122
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185
+ + E++V +LDH N+ + A +S N +
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF---------------ESKNDI-----V 162
Query: 186 VVVEYLPGGTLKKF-LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+V+EY+ GG L F I ++ L I + G+ ++H I+H D+K EN+L
Sbjct: 163 LVMEYVDGGEL--FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220
Query: 245 DANRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
NR +KI DFG+AR + GT ++APEV++ + D++S G+
Sbjct: 221 -VNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 69/239 (28%), Positives = 111/239 (46%), Gaps = 43/239 (17%)
Query: 69 EREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRG---AYDGQDVAVK--ILDWAEDGM 123
E++ L R +++E + EI G YG V++ G+ VA+K + E+GM
Sbjct: 2 EKDGLCRADQQYE----CVA---EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM 54
Query: 124 -VTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSL 179
++ IR EVAV + L +HPNV L + +D L
Sbjct: 55 PLS-----TIR-----EVAVLRHLETFEHPNVV----------RLFDVCTVSRTDRETKL 94
Query: 180 PSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239
+V E++ L +L + + + + + L RGL +LHS +VHRD+K
Sbjct: 95 -----TLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148
Query: 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFG 298
+N+L+ ++ +K+ADFG+AR+ +T TL Y APEVL Y D++S G
Sbjct: 149 QNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 47/219 (21%)
Query: 92 EIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV-WQKLDH 148
+ G G V + + A+K+L R+EV + W+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------------ARREVELHWRASQC 114
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC-CVVVEYLPGGTLKKFLIR-NKRK 206
P++ + + N R C +V+E L GG L R R
Sbjct: 115 PHIVRIVDVY-----------------ENLYAGRKCLLIVMECLDGGEL---FSRIQDRG 154
Query: 207 KLAF--KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVAR-V 260
AF + +I + + YLHS I HRDVK EN+L N LK+ DFG A+
Sbjct: 155 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214
Query: 261 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+ N +T T Y+APEVL + Y++ CD++S G+
Sbjct: 215 TSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 41/217 (18%), Positives = 77/217 (35%), Gaps = 38/217 (17%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
I ++ RG +G V+R + K + + ++E+++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-------VKGTD---QVLVKKEISILNI 57
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF-LIRNK 204
H N+ + +S L ++ E++ G + F I
Sbjct: 58 ARHRNILHLHESF---------------ESMEEL-----VMIFEFISGLDI--FERINTS 95
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL--DANRTLKIADFGVARVEA 262
+L + ++ + L +LHS I H D++ EN++ + T+KI +FG AR
Sbjct: 96 AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
Y APEV + D++S G
Sbjct: 156 PGDN-FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 44/216 (20%)
Query: 96 GTYGTVYRGAYD--GQDVAVK--ILDWAEDGM-VTSAEAAAIRASFRQEVAVWQKLDHPN 150
GTYG VY+ A + G+ A+K L+ ++G+ T IR E+++ ++L H N
Sbjct: 13 GTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPST-----TIR-----EISILKELKHSN 61
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ K L +V E+L LKK + L
Sbjct: 62 IVKLYDVIHTKKRL--------------------VLVFEHLDQD-LKKL-LDVCEGGLES 99
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
L L G++Y H + ++HRD+K +N+L++ LKIADFG+AR R T
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
Query: 271 ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
E TL Y AP+VL G YS I +W + C
Sbjct: 160 EIVTLWYRAPDVLMG------SKKYSTTIDIWSVGC 189
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 67/302 (22%), Positives = 117/302 (38%), Gaps = 73/302 (24%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
+ G+YG V + + G+ VA+K L+ +D MV + A+R E+ + ++L H
Sbjct: 33 VGEGSYGMVMK-CRNKDTGRIVAIKKFLESDDDKMV---KKIAMR-----EIKLLKQLRH 83
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
N+ + + V E++ T+ L L
Sbjct: 84 ENLVNLLEVCKKKKRWYL--------------------VFEFVDH-TILDDL-ELFPNGL 121
Query: 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268
++VV + + G+ + HS I+HRD+K EN+L+ + +K+ DFG AR A
Sbjct: 122 DYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181
Query: 269 TGETGTLGYMAPEVLDG-KPYNRKCDVYSFG------------------------IC--- 300
E T Y APE+L G Y + DV++ G I
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241
Query: 301 ------LWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDK 354
E++ + + + ++ R+ L P+ + + +KC +PDK
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKE---REPLERRYPKLSEVVI-DLAKKCLHIDPDK 297
Query: 355 RP 356
RP
Sbjct: 298 RP 299
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 96 GTYGTVYRG--AYDGQDVAVK-I-LDWAEDGM-VTSAEAAAIRASFRQEVAVWQKLDHPN 150
GTYGTV++ + VA+K + LD ++G+ + A+R E+ + ++L H N
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-----ALR-----EICLLKELKHKN 62
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
+ + L + V E+ LKK + L
Sbjct: 63 IVRLHDVLHSDKKLTL--------------------VFEFCDQ-DLKK-YFDSCNGDLDP 100
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
++V L +GL + HS+ ++HRD+K +N+L++ N LK+A+FG+AR R +
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 271 ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
E TL Y P+VL G +YS I +W C
Sbjct: 161 EVVTLWYRPPDVLFG------AKLYSTSIDMWSAGC 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 66/242 (27%), Positives = 106/242 (43%), Gaps = 53/242 (21%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVK-----ILDWAEDGM-V 124
+ + + +E KLD + G + TVY+ Q VA+K A+DG+
Sbjct: 5 VKSRAKRYE----KLD---FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINR 57
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
T A+R E+ + Q+L HPN+ + A +N+
Sbjct: 58 T-----ALR-----EIKLLQELSHPNIIGLLDAFGHKSNI-------------------- 87
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+V +++ L+ +I++ L + L +GL YLH I+HRD+K N+LL
Sbjct: 88 SLVFDFMETD-LEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
D N LK+ADFG+A+ R T + T Y APE+L G +Y G+ +W +
Sbjct: 146 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAV 199
Query: 305 YC 306
C
Sbjct: 200 GC 201
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
DI E+ G +G V+R G+ K ++ + + + E+++ +
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFIN---------TPYPLDKYTVKNEISIMNQ 104
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF-LIRNK 204
L HP + A + + +++E+L GG L F I +
Sbjct: 105 LHHPKLINLHDAF---------------EDKYEM-----VLILEFLSGGEL--FDRIAAE 142
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL--DANRTLKIADFGVARVEA 262
K++ VI GL ++H +IVH D+K EN++ ++KI DFG+A +
Sbjct: 143 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KL 201
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+ T T + APE++D +P D+++ G+
Sbjct: 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 88 DIRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
DI E+ G +G V+R G + A K + + + + R+E+
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFV---------MTPHESDKETVRKEIQTMSV 210
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L HP + A + N + ++ E++ GG L + + ++
Sbjct: 211 LRHPTLVNLHDAF---------------EDDNEM-----VMIYEFMSGGELFEKVA-DEH 249
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR--TLKIADFGVARVEAQ 263
K++ ++ + +GL ++H VH D+K EN++ R LK+ DFG+
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 264 NPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299
+ TGT + APEV +GKP D++S G+
Sbjct: 310 KQS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 44/219 (20%)
Query: 93 IARGTYGTVYRGAYD--GQDVAVK--ILDWAEDGM-VTSAEAAAIRASFRQEVAVWQKLD 147
+ GTY TVY+G VA+K L+ E+G T AIR EV++ + L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLE-HEEGAPCT-----AIR-----EVSLLKDLK 58
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
H N+ +L + V EYL LK++L +
Sbjct: 59 HANIVTLHDIIHTEKSLTL--------------------VFEYLDK-DLKQYL-DDCGNI 96
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ V L RGL+Y H + ++HRD+K +N+L++ LK+ADFG+AR ++ +
Sbjct: 97 INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
E TL Y P++L G YS I +W + C
Sbjct: 157 YDNEVVTLWYRPPDILLG------STDYSTQIDMWGVGC 189
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 47/236 (19%)
Query: 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK--ILDWAEDGM----VT 125
T +E + EI G YGTVY+ A D G VA+K + G ++
Sbjct: 6 MATSRYE----PVA---EIGVGAYGTVYK-ARDPHSGHFVALKSVRVPNGGGGGGGLPIS 57
Query: 126 SAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSR 182
+R EVA+ ++L +HPNV L ++ +D +
Sbjct: 58 -----TVR-----EVALLRRLEAFEHPNVV----------RLMDVCATSRTDREIKV--- 94
Query: 183 ACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242
+V E++ L+ +L + L + + + RGL +LH+ IVHRD+K EN+
Sbjct: 95 --TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151
Query: 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFG 298
L+ + T+K+ADFG+AR +T TL Y APEVL Y D++S G
Sbjct: 152 LVTSGGTVKLADFGLAR-IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 56/278 (20%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G++ TV R ++ A+KIL+ ++ + + E V +LDHP
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTR----ERDVMSRLDHP- 90
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
F L Q + Y G L K++ +
Sbjct: 91 ---FF------VKLYFTFQDDEK----------LYFGLSYAKNGELLKYIRKIGS----- 126
Query: 211 KVVIQIALDLAR--------GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
R L YLH K I+HRD+K EN+LL+ + ++I DFG A+V +
Sbjct: 127 -----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181
Query: 263 QNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
+ + GT Y++PE+L K + D+++ G ++++ P F +
Sbjct: 182 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGN 236
Query: 321 SAVVRQN---LRPDIPRCCPSSLASIMRKCWDANPDKR 355
++ Q L D P ++ K + KR
Sbjct: 237 EYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 74/267 (27%), Positives = 121/267 (45%), Gaps = 36/267 (13%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +GT+G V R G+ A+KIL ++ ++ E A E V Q HP
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVT----ESRVLQNTRHP- 65
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
F+ T LK Q+ R C V+EY GG L F + +R
Sbjct: 66 ---FL------TALKYAFQT---------HDRLC-FVMEYANGGELF-FHLSRERVFTEE 105
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
+ A ++ L YLHS+ +V+RD+K EN++LD + +KI DFG+ + E +
Sbjct: 106 RARFYGA-EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMK 163
Query: 271 ET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL 328
T GT Y+APEVL+ Y R D + G+ ++E+ C +P+ + + ++ + +
Sbjct: 164 -TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 329 RPDIPRCCPSSLASIMRKCWDANPDKR 355
R PR S++ +P +R
Sbjct: 223 R--FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 51/222 (22%)
Query: 96 GTYGTVYRGAYD---GQDVAVK--ILDWAEDGM-VTSAEAAAIRASFRQEVAVWQKLDHP 149
GTYG VY+ A D + VA+K L+ E+G+ T AIR EV++ ++L H
Sbjct: 45 GTYGEVYK-AIDTVTNETVAIKRIRLEHEEEGVPGT-----AIR-----EVSLLKELQHR 93
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ + L + + EY LKK++ +K ++
Sbjct: 94 NIIELKSVIHHNHRLHL--------------------IFEYAEN-DLKKYM--DKNPDVS 130
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT-----LKIADFGVARVEAQN 264
+V+ L G+++ HS+ +HRD+K +N+LL + LKI DFG+AR
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 265 PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
R T E TL Y PE+L G YS + +W I C
Sbjct: 191 IRQFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIAC 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 43/236 (18%)
Query: 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVK--ILDWAEDGM-VTSAE 128
+ ++E KL I +GT+G V++ GQ VA+K +++ ++G +T
Sbjct: 13 CDEVSKYE----KLAK---IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--- 62
Query: 129 AAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
A+R E+ + Q L H NV I + + + +V
Sbjct: 63 --ALR-----EIKILQLLKHENVVNLIEI-------------CRTKASPYNRCKGSIYLV 102
Query: 189 -EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247
++ L L+ N K + ++ L GL Y+H I+HRD+K N+L+ +
Sbjct: 103 FDFCEH-DLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 160
Query: 248 RTLKIADFGVARV----EAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
LK+ADFG+AR + P T TL Y PE+L G + Y D++ G
Sbjct: 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 47/220 (21%)
Query: 96 GTYGTVYRG--AYDGQDVAVK--ILDWAEDGM-VTSAEAAAIRASFRQEVAVWQKLDHPN 150
GTY TVY+G G VA+K LD +E+G T AIR E+++ ++L H N
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVKLD-SEEGTPST-----AIR-----EISLMKELKHEN 64
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL----IRNKRK 206
+ + L + V E++ LKK++ + N +
Sbjct: 65 IVRLYDVIHTENKLTL--------------------VFEFMDN-DLKKYMDSRTVGNTPR 103
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR 266
L +V L +GL++ H I+HRD+K +N+L++ LK+ DFG+AR
Sbjct: 104 GLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
+ E TL Y AP+VL G YS I +W C
Sbjct: 164 TFSSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGC 197
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 41/272 (15%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I +G++G V + + A+K ++ + V E + E+ + Q L+HP
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQK--CVERNEVRNVFK----ELQIMQGLEHP- 75
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
F+ NL Q +VV+ L GG L+ + ++ F
Sbjct: 76 ---FL------VNLWYSFQDEED----------MFMVVDLLLGGDLR-YHLQQNVH---F 112
Query: 211 K---VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
K V + I +L L YL ++ I+HRD+K +N+LLD + + I DF +A
Sbjct: 113 KEETVKLFIC-ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA-MLPRETQ 170
Query: 268 MTGETGTLGYMAPEVL---DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324
+T GT YMAPE+ G Y+ D +S G+ +E+ PY S T V
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
Query: 325 R-QNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ P + S+++K + NPD+R
Sbjct: 231 TFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 55/227 (24%), Positives = 87/227 (38%), Gaps = 57/227 (25%)
Query: 95 RGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNV 151
G + V Q+ AVKI++ + IR+ +EV + + H NV
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIE---------KQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF-LIRNKRK---K 207
+ I + V E + GG++ I +R
Sbjct: 74 LELIEFFEEEDRFYL--------------------VFEKMRGGSI--LSHIHKRRHFNEL 111
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARVEAQN 264
A VV +A L +LH+K I HRD+K EN+L + +KI DF + N
Sbjct: 112 EASVVVQDVA----SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 265 PRDMTGET-------GTLGYMAPEVLDG-----KPYNRKCDVYSFGI 299
T G+ YMAPEV++ Y+++CD++S G+
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 59/272 (21%), Positives = 110/272 (40%), Gaps = 38/272 (13%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ RG +G V+ + G+ A K L+ + + E + K+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMV----EKKILAKVHSR- 245
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
FI +L ++ T C+V+ + GG ++ + F
Sbjct: 246 ---FI------VSLAYAFETKT----------DLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 211 K---VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ + A + GL +LH + I++RD+K EN+LLD + ++I+D G+A
Sbjct: 287 QEPRAIFYTA-QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD----LSFTDVSSAV 323
G GT G+MAPE+L G+ Y+ D ++ G+ L+E+ P+ + ++ V
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405
Query: 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ Q + P + +P+KR
Sbjct: 406 LEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +GT+G V + G+ A+KIL ++ +V E A E V Q HP
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLT----ENRVLQNSRHP- 208
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
F+ T LK Q+ R C V+EY GG L F + +R
Sbjct: 209 ---FL------TALKYSFQT---------HDRLC-FVMEYANGGELF-FHLSRERVFSED 248
Query: 211 KVVIQIALDLARGLSYLHS-KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
+ A ++ L YLHS K +V+RD+K EN++LD + +KI DFG+ + ++ M
Sbjct: 249 RARFYGA-EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 270 GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR 329
GT Y+APEVL+ Y R D + G+ ++E+ C +P+ + + ++ + +R
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 330 PDIPRCCPSSLASIMRKCWDANPDKR 355
PR S++ +P +R
Sbjct: 368 --FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 60/269 (22%), Positives = 109/269 (40%), Gaps = 35/269 (13%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ +G +G V + G+ A K L+ + + A E + +K++
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALN----EKQILEKVNSR- 244
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
F+ +L ++ A C+V+ + GG LK + +
Sbjct: 245 ---FV------VSLAYAYETKD----------ALCLVLTLMNGGDLKFHIYHMGQAGFPE 285
Query: 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTG 270
+ A ++ GL LH + IV+RD+K EN+LLD + ++I+D G+A V + + G
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKG 344
Query: 271 ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD----LSFTDVSSAVVRQ 326
GT+GYMAPEV+ + Y D ++ G L+E+ P+ + +V V
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKR 355
S+ + +P +R
Sbjct: 405 PEE--YSERFSPQARSLCSQLLCKDPAER 431
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 57/173 (32%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V+EYL GG L K A ++ GL +LHSK IV+RD+K +N+LL
Sbjct: 94 FFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
D + +KIADFG+ + E T T GT Y+APE+L G+ YN D +SFG+ L+
Sbjct: 152 DKDGHIKIADFGMCK-ENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
E+ P+ ++ ++ N PR ++ K + P+KR
Sbjct: 210 EMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 73/297 (24%), Positives = 119/297 (40%), Gaps = 56/297 (18%)
Query: 25 KALLSKVSDMKSPSNKDLF---FRADKIDFKSWDIQLEKHLSRVWSREREVLPRKTEEWE 81
+ + + + D KS N D A D ++ K++ SR ++ + K +
Sbjct: 7 EKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTI-NKIRDLR 65
Query: 82 IELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
++ ++ I RG +G V R + A+K+L E M+ +++A E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWE----E 119
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+ + P ++ L Q R +V+EY+PGG L
Sbjct: 120 RDIMAFANSP----WV------VQLFYAFQD----------DRYLYMVMEYMPGGDLV-N 158
Query: 200 LIRNKRKKLAFKVVIQIALDLAR--------GLSYLHSKTIVHRDVKTENMLLDANRTLK 251
L+ N + AR L +HS +HRDVK +NMLLD + LK
Sbjct: 159 LMSNYD----------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208
Query: 252 IADFGVARVEAQNPRDMTGET-GTLGYMAPEVLDGKP----YNRKCDVYSFGICLWE 303
+ADFG + GT Y++PEVL + Y R+CD +S G+ L+E
Sbjct: 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 8/173 (4%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V+E++ GG L K ++ A ++ L +LH K I++RD+K +N+LL
Sbjct: 100 FFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
D K+ADFG+ + E T T GT Y+APE+L Y D ++ G+ L+
Sbjct: 158 DHEGHCKLADFGMCK-EGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
E+ C P+ + D+ A++ + P I++ NP R
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 54/263 (20%)
Query: 59 EKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKIL 116
+K+++ ++ R +E ++ +I I RG + V + GQ A+KI+
Sbjct: 36 DKYVADFLQWAEPIVVR-LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94
Query: 117 DWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSH 176
+ + M+ E + FR+E V D +I T L Q
Sbjct: 95 NKWD--MLKRGEVS----CFREERDVLVNGDRR----WI------TQLHFAFQDE----- 133
Query: 177 NSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR--------GLSYLH 228
N L +V+EY GG L L+ +++ ++AR + +H
Sbjct: 134 NYL-----YLVMEYYVGGDLL-TLLSKFGERIP--------AEMARFYLAEIVMAIDSVH 179
Query: 229 SKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET-GTLGYMAPEVLDGK- 286
VHRD+K +N+LLD +++ADFG + + GT Y++PE+L
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 287 ------PYNRKCDVYSFGICLWE 303
Y +CD ++ G+ +E
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYE 262
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 42/264 (15%)
Query: 59 EKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKIL 116
EK++ + K ++ + +I I RG +G V + + A+KIL
Sbjct: 49 EKNILEYLEWAKPFT-SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL 107
Query: 117 DWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSH 176
+ E M+ AE A FR+E V D +I T L Q
Sbjct: 108 NKWE--MLKRAE----TACFREERDVLVNGDSK----WI------TTLHYAFQDD----- 146
Query: 177 NSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236
N+L +V++Y GG L L+ +L ++ ++ + +H VHRD
Sbjct: 147 NNL-----YLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET----GTLGYMAPEVLDGKP----- 287
+K +N+L+D N +++ADFG + D T ++ GT Y++PE+L
Sbjct: 201 IKPDNILMDMNGHIRLADFGSC---LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 288 YNRKCDVYSFGICLWEIYCCDMPY 311
Y +CD +S G+C++E+ + P+
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPF 281
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 69/275 (25%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK-LDHP 149
I RG+Y V R + A+K++ ++ + + ++ E V+++ +HP
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVK--KELVNDDEDIDWVQT----EKHVFEQASNHP 70
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
F+ L Q+ SR V+EY+ GG L F ++ +RK
Sbjct: 71 ----FL------VGLHSCFQT---------ESRLF-FVIEYVNGGDLM-FHMQRQRKLPE 109
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
A +++ L+YLH + I++RD+K +N+LLD+ +K+ D+G+ + E P D T
Sbjct: 110 EHARFYSA-EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTT 167
Query: 270 GET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
T GT Y+APE+L G+ Y D ++ G+ ++E+ P+ + +D
Sbjct: 168 S-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226
Query: 328 L-------RPDIPRCCPSSLASIMRKCWDANPDKR 355
L + IPR AS+++ + +P +R
Sbjct: 227 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 37/268 (13%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK-LDHP 149
+ +G++G V + AVKIL +D ++ + E V P
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMV----EKRVLALPGKPP 402
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
F+ T L Q+ R V+EY+ GG L + +
Sbjct: 403 ----FL------TQLHSCFQT---------MDR-LYFVMEYVNGGDL--MYHIQQVGRFK 440
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
+ A ++A GL +L SK I++RD+K +N++LD+ +KIADFG+ + E T
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTT 499
Query: 270 GET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
T GT Y+APE++ +PY + D ++FG+ L+E+ P+ ++ +++ N
Sbjct: 500 K-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
Query: 328 LRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ P+ +I + +P KR
Sbjct: 559 VA--YPKSMSKEAVAICKGLMTKHPGKR 584
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 49/173 (28%), Positives = 88/173 (50%), Gaps = 8/173 (4%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
V+EY+ GG L + + + A ++A GL +L SK I++RD+K +N++L
Sbjct: 97 YFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 245 DANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302
D+ +KIADFG+ + E T T GT Y+APE++ +PY + D ++FG+ L+
Sbjct: 155 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 303 EIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
E+ P+ ++ +++ N+ P+ +I + +P KR
Sbjct: 213 EMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 68/275 (24%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK-LDHP 149
I RG+Y V R + A++++ ++ + + ++ E V+++ +HP
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVK--KELVNDDEDIDWVQT----EKHVFEQASNHP 113
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
F+ L Q+ SR V+EY+ GG L F ++ +RK
Sbjct: 114 ----FL------VGLHSCFQT---------ESRLF-FVIEYVNGGDLM-FHMQRQRKLPE 152
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
A +++ L+YLH + I++RD+K +N+LLD+ +K+ D+G+ + E P D T
Sbjct: 153 EHARFYSA-EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTT 210
Query: 270 GET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQN 327
T GT Y+APE+L G+ Y D ++ G+ ++E+ P+ + +D
Sbjct: 211 S-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269
Query: 328 L-------RPDIPRCCPSSLASIMRKCWDANPDKR 355
L + IPR AS+++ + +P +R
Sbjct: 270 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 64/277 (23%), Positives = 126/277 (45%), Gaps = 54/277 (19%)
Query: 93 IARGTYGTVY-----RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+ +G++G V+ G+ Q A+K+L A + + + E + +++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKA---TLKVRDRVRTKM----ERDILVEVN 84
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL-------KKFL 200
HP FI L Q+ + +++++L GG L F
Sbjct: 85 HP----FI------VKLHYAFQT---------EGKLY-LILDFLRGGDLFTRLSKEVMFT 124
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+ + LA ++AL L +LHS I++RD+K EN+LLD +K+ DFG+++
Sbjct: 125 EEDVKFYLA-----ELAL----ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK- 174
Query: 261 EAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318
E+ + + GT+ YMAPEV++ + + + D +SFG+ ++E+ +P+ +
Sbjct: 175 ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+ +++ L +P+ S++R + NP R
Sbjct: 234 TMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 54/278 (19%)
Query: 93 IARGTYGTVY-----RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
+ +G YG V+ GA G+ A+K+L + +V +A+ A + E + +++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKD---TAHTKAERNILEEVK 79
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
HP FI +L Q+ + +++EYL GG L + +
Sbjct: 80 HP----FI------VDLIYAFQT---------GGKLY-LILEYLSGGELF-MQLEREGI- 117
Query: 208 LAFKVVIQIALDLAR--------GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
F D A L +LH K I++RD+K EN++L+ +K+ DFG+ +
Sbjct: 118 --FM------EDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 260 VEAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317
E+ + +T T GT+ YMAPE+L +NR D +S G ++++ P+ +
Sbjct: 170 -ESIHDGTVTH-TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227
Query: 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
+++ L +P +++K N R
Sbjct: 228 KTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASR 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 64/301 (21%), Positives = 118/301 (39%), Gaps = 55/301 (18%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVY--RGAYDGQDVAVKILDWAEDGMV 124
+ + +L + D + G++G V + G A+KILD + +V
Sbjct: 23 KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VV 80
Query: 125 TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC 184
+ E + Q ++ P F+ L+ + ++
Sbjct: 81 KLKQIEHTLN----EKRILQAVNFP----FL------VKLEFSFKDNSN----------L 116
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVI------QIALDLARGLSYLHSKTIVHRDVK 238
+V+EY+ GG + +R + F QI L YLHS +++RD+K
Sbjct: 117 YMVMEYVAGGEMF-SHLRRIGR---FSEPHARFYAAQIVL----TFEYLHSLDLIYRDLK 168
Query: 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGET----GTLGYMAPEVLDGKPYNRKCDV 294
EN+L+D +++ DFG A+ + G T GT +APE++ K YN+ D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKR-------VKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 295 YSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDK 354
++ G+ ++E+ P+ + +V +R P S L ++R + K
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTK 279
Query: 355 R 355
R
Sbjct: 280 R 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR--------GLSYLHSKTIVHRD 236
V++Y+ GG L + ++ +R F AR L YLHS IV+RD
Sbjct: 115 YFVLDYINGGELF-YHLQRERC---FL------EPRARFYAAEIASALGYLHSLNIVYRD 164
Query: 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYNRKCDV 294
+K EN+LLD+ + + DFG+ + E T T GT Y+APEVL +PY+R D
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 295 YSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDK 354
+ G L+E+ P+ + ++ ++ + L+ + +S ++ + K
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTK 280
Query: 355 R 355
R
Sbjct: 281 R 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 51/273 (18%)
Query: 93 IARGTYGTVY--RGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
+ G++G V+ R ++G+ A+K+L +V + E + + HP
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTND----ERLMLSIVTHP- 66
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAF 210
FI + Q A ++++Y+ GG L L+R ++ F
Sbjct: 67 ---FI------IRMWGTFQDAQQ----------IFMIMDYIEGGELF-SLLRKSQR---F 103
Query: 211 KVVI------QIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
+ ++ L L YLHSK I++RD+K EN+LLD N +KI DFG A+
Sbjct: 104 PNPVAKFYAAEVCL----ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--- 156
Query: 265 PRDMTGET--GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
D+T T GT Y+APEV+ KPYN+ D +SFGI ++E+ P+ D +
Sbjct: 157 -PDVTY-TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214
Query: 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
++ LR P + ++ + + +R
Sbjct: 215 ILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 89 IRHEIARGTYGTVYRG----AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
++ RGTYG VY+ D +D A+K ++ G+ SA R E+A+ +
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSA----CR-----EIALLR 73
Query: 145 KLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
+L HPNV + + K+ ++ +Y L +I+
Sbjct: 74 ELKHPNVISLQKVFLSHADRKV------------------WLLFDYAEH-DLWH-IIKFH 113
Query: 205 RKKLAFKVVIQIALD--------LARGLSYLHSKTIVHRDVKTENMLLDANR----TLKI 252
R A K +Q+ + G+ YLH+ ++HRD+K N+L+ +KI
Sbjct: 114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173
Query: 253 ADFGVARVEAQNPRDMTGETG---TLGYMAPEVLDG-KPYNRKCDVYSFG 298
AD G AR+ + + T Y APE+L G + Y + D+++ G
Sbjct: 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 41/176 (23%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL 244
+++ + GG L + + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 268 SFILDLMNGGDLH-YHLSQHGVFSEADMRFYAA-EIILGLEHMHNRFVVYRDLKPANILL 325
Query: 245 DANRTLKIADFGVARVEAQNPRDMT-GETGTLGYMAPEVL-DGKPYNRKCDVYSFGICLW 302
D + ++I+D G+A + GT GYMAPEVL G Y+ D +S G L+
Sbjct: 326 DEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 303 EIYCCDMPYPDLSFTD---VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKR 355
++ P+ D + + + +P L S++ + ++R
Sbjct: 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRR 436
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 45/217 (20%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
I G++G VY+ A G+ VA+K +L R E+ + +KLDH
Sbjct: 62 IGNGSFGVVYQ-AKLCDSGELVAIKKVLQDKRF-------------KNR-ELQIMRKLDH 106
Query: 149 PNVTKFIGASMGTTNLK---IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
N+ + L+ S + + +L V++Y+P T+ + R
Sbjct: 107 CNIVR----------LRYFFYSSGEKKDEVYLNL-------VLDYVPE-TVYRVARHYSR 148
Query: 206 KKLAF-KVVIQIAL-DLARGLSYLHSKTIVHRDVKTENMLLDANR-TLKIADFGVARVEA 262
K + +++ + L R L+Y+HS I HRD+K +N+LLD + LK+ DFG A+
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208
Query: 263 QNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
+ + Y APE++ G Y DV+S G
Sbjct: 209 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 62/323 (19%), Positives = 121/323 (37%), Gaps = 65/323 (20%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD--GQDVAVK-ILDWAEDGMVTSAEAAAIRA 134
E + + ++ I+ G+YG V D G VA+K + + DG + + +
Sbjct: 16 ELHAM-QSPYTVQRFISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 135 --SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
R E+ + HPN+ ++ + + + + L +V L
Sbjct: 74 KRVLR-EIRLLNHFHHPNILGLR-------DIFVHFEE---PAMHKL------YLVTELM 116
Query: 193 GGTLKKFLIRNKRKKLA---FKVVI-QIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
L + +I ++R ++ + + I GL LH +VHRD+ N+LL N
Sbjct: 117 RTDLAQ-VIHDQRIVISPQHIQYFMYHIL----LGLHVLHEAGVVHRDLHPGNILLADNN 171
Query: 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIYCC 307
+ I DF +AR + + + T Y APE+ + K + + D++S G + E++
Sbjct: 172 DITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 308 DMPYPDLSFTD-------------------VSSAVVRQNLRPDIPRCCPSSLASI----- 343
+ +F + SS R LR + + ++
Sbjct: 231 KALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290
Query: 344 ------MRKCWDANPDKRPVMDE 360
+ K + NP +R ++
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQ 313
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 54/253 (21%), Positives = 97/253 (38%), Gaps = 53/253 (20%)
Query: 63 SRVWSRER---EVLPRKTEE-WEIELAKLD--------IRHEIARGTYGTVYRGAY--DG 108
V SR R +V + E W+ E ++ + ++ RG Y V+ +
Sbjct: 2 GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 61
Query: 109 QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIP 167
+ V VKIL + R E+ + + L PN+
Sbjct: 62 EKVVVKILK-------PVKKKKIKR-----EIKILENLRGGPNIITLA------------ 97
Query: 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYL 227
D SR +V E++ K+ + L + ++ + L Y
Sbjct: 98 ------DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYC 146
Query: 228 HSKTIVHRDVKTENMLLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-DG 285
HS I+HRDVK N+++D +R L++ D+G+A ++ + + PE+L D
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDY 205
Query: 286 KPYNRKCDVYSFG 298
+ Y+ D++S G
Sbjct: 206 QMYDYSLDMWSLG 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 41/232 (17%)
Query: 92 EIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
+ G++G V +D G+ A+K V R E+ + + LDH
Sbjct: 14 TLGTGSFGIVCE-VFDIESGKRFALK--------KVLQDPRYKNR-----ELDIMKVLDH 59
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC------------------VVVEY 190
N+ K + T + + D + V++EY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 191 LPGGTLKKFLIRNKRKKLAFKVV-IQIAL-DLARGLSYLHSKTIVHRDVKTENMLLDANR 248
+P TL K L R + + I I + L R + ++HS I HRD+K +N+L+++
Sbjct: 120 VPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 249 -TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
TLK+ DFG A+ + + Y APE++ G Y D++S G
Sbjct: 179 NTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 32/292 (10%), Positives = 75/292 (25%), Gaps = 75/292 (25%)
Query: 89 IRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ ++ A D + VA+ +D + +
Sbjct: 35 LLIFHGGVPPLQFWQ-ALDTALDRQVALTFVD------PQGVLPDDVLQETLSRTLRLSR 87
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+D P V + + + VV E++ GG+L++
Sbjct: 88 IDKPGVARVLDV----------------VHTRAGG----LVVAEWIRGGSLQEVA----D 123
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ I+ LA H + + + + + +A
Sbjct: 124 TSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---------- 173
Query: 266 RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
M N + D+ G L+ + P P+ + R
Sbjct: 174 ----------ATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 326 Q---------NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
++ DIP ++++ + + R ++ L++
Sbjct: 217 DTAGQPIEPADIDRDIPF----QISAVAARSVQGDGGIRSA-STLLNLMQQA 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 44/216 (20%)
Query: 93 IARGTYGTVYRGAYD--GQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
I G++G V++ A +VA+K +L R E+ + + + HP
Sbjct: 48 IGNGSFGVVFQ-AKLVESDEVAIKKVLQDKRF---------KNR-----ELQIMRIVKHP 92
Query: 150 NVTKFIGASMGTTNLK---IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
NV LK + + +L V+EY+P T+ + +
Sbjct: 93 NVVD----------LKAFFYSNGDKKDEVFLNL-------VLEYVPE-TVYRASRHYAKL 134
Query: 207 KLAF-KVVIQIAL-DLARGLSYLHSKTIVHRDVKTENMLLDANR-TLKIADFGVARVEAQ 263
K ++I++ + L R L+Y+HS I HRD+K +N+LLD LK+ DFG A++
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 264 NPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
+ Y APE++ G Y D++S G
Sbjct: 195 G-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 56/293 (19%), Positives = 98/293 (33%), Gaps = 76/293 (25%)
Query: 89 IRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV-WQK 145
+ G G V + + A+K+L R+EV + W+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------------ARREVELHWRA 67
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRAC-CVVVEYLPGGTLKKFLIRNK 204
P++ + + N R C +V+E L GG L +
Sbjct: 68 SQCPHIVRIVDVY-----------------ENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARVE 261
+ + +I + + YLHS I HRDVK EN+L N LK+ DFG
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----- 165
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
A E G+ Y++ CD++S G+ ++ + C P+ +S
Sbjct: 166 ----------------FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
Query: 322 AVVRQNLR----------PDIPRCCPSSLA-SIMRKCWDANPDKRPVMDEVVK 363
+ + ++ S ++R P +R + E +
Sbjct: 209 GMKTRIRMGQYEFPNPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 39/187 (20%), Positives = 86/187 (45%), Gaps = 29/187 (15%)
Query: 185 CVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR--------GLSYLHSKTIVHRD 236
++++Y+ GG L + + + F + L +LH I++RD
Sbjct: 135 HLILDYINGGELF-THLSQRER---FT------EHEVQIYVGEIVLALEHLHKLGIIYRD 184
Query: 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDG--KPYNRKC 292
+K EN+LLD+N + + DFG+++ + + GT+ YMAP+++ G +++
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 293 DVYSFGICLWEIYCCDMPY----PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCW 348
D +S G+ ++E+ P+ S ++S +++ P+ + ++++
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLL 301
Query: 349 DANPDKR 355
+P KR
Sbjct: 302 MKDPKKR 308
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 93 IARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
+GT+GTV + G VA+K ++ R Q + L H
Sbjct: 31 AGQGTFGTVQL-GKEKSTGMSVAIKKVIQDPRF---------RNRE--LQIMQDLAVLHH 78
Query: 149 PNVTKFIGASMGTTNLK--IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
PN+ + L+ + L VV+EY+P TL + R+
Sbjct: 79 PNIVQ----------LQSYFYTLGERDRRDIYL-----NVVMEYVPD-TLHRCCRNYYRR 122
Query: 207 KLAFKVV-IQIAL-DLARGLSYLH--SKTIVHRDVKTENMLLD-ANRTLKIADFGVARVE 261
++A + I++ L L R + LH S + HRD+K N+L++ A+ TLK+ DFG A+
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 262 AQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298
+ + + Y APE++ G + Y D++S G
Sbjct: 183 SPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 56/247 (22%)
Query: 87 LDIRHEIAR----GTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
D R+ + R G + TV+ A D VA+KI+ + EAA E
Sbjct: 17 KDARYILVRKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYT----EAAED------E 65
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHN-----------SLPSRACCVVV 188
+ + Q++ N ++ + +++ +V
Sbjct: 66 IKLLQRV----------------NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF 109
Query: 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT-IVHRDVKTENMLLD-- 245
E L G L + + + + + V QI+ L GL Y+H + I+H D+K EN+L++
Sbjct: 110 EVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168
Query: 246 ----ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301
+KIAD G A ++ T T Y +PEVL G P+ D++S +
Sbjct: 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 225
Query: 302 WEIYCCD 308
+E+ D
Sbjct: 226 FELITGD 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 34/230 (14%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRA 134
+ + L + I G G V AYD ++VA+K + ++ A RA
Sbjct: 57 TFTV-LKRYQNLKPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTH------AKRA 108
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
+R E+ + + ++H N+ + N+ P ++ + +V+E +
Sbjct: 109 -YR-ELVLMKCVNHKNIISLL-------NVFTPQKTLEEF-------QDVYLVMELM-DA 151
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
L + + + +L + + + + G+ +LHS I+HRD+K N+++ ++ TLKI D
Sbjct: 152 NLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
Query: 255 FGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
FG+AR + MT T Y APEV+ G Y D++S G + E+
Sbjct: 208 FGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 34/230 (14%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRA 134
+ + L + I G G V AYD ++VA+K + ++ A RA
Sbjct: 20 TFTV-LKRYQNLKPIGSGAQGIVCA-AYDAILERNVAIKKLSRPFQNQTH------AKRA 71
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
+R E+ + + ++H N+ + N+ P +S + + +V+E +
Sbjct: 72 -YR-ELVLMKCVNHKNIIGLL-------NVFTPQKSL--EEFQDV-----YIVMELM-DA 114
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
L + + + +L + + + + G+ +LHS I+HRD+K N+++ ++ TLKI D
Sbjct: 115 NLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 255 FGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304
FG+AR + MT T Y APEV+ G Y D++S G + E+
Sbjct: 171 FGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 73/272 (26%), Positives = 115/272 (42%), Gaps = 67/272 (24%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK-ILDWAEDG 122
S+ +PR +W+I + +IRH I G+YG V AYD + VA+K IL ED
Sbjct: 36 SKPTASMPRPHSDWQI-PDRYEIRHLIGTGSYGHVCE-AYDKLEKRVVAIKKILRVFEDL 93
Query: 123 MVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSR 182
+ R R E+A+ +L+H +V K + ++ IP + + L
Sbjct: 94 ID------CKRI-LR-EIAILNRLNHDHVVKVL-------DIVIPKDV---EKFDEL--- 132
Query: 183 ACCVVVEYLPGGT-LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
VV+E + KK L R L + + +L G+ Y+HS I+HRD+K N
Sbjct: 133 --YVVLEIA--DSDFKK-LFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 242 MLLDANRTLKIADFGVARV---------------------------EAQNPRDMTGETGT 274
L++ + ++K+ DFG+AR R +TG T
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
Query: 275 LGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306
Y APE++ + Y+ I +W I C
Sbjct: 247 RWYRAPELILL------QENYTEAIDVWSIGC 272
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 39/233 (16%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRA 134
WE+ + G YG+V A D G+ VA+K + + + A RA
Sbjct: 19 AWELP-KTYVSPTHVGSGAYGSVCS-AIDKRSGEKVAIKKLSRPFQSEIF------AKRA 70
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
+R E+ + + + H NV + ++ P+ S + L V+ ++
Sbjct: 71 -YR-ELLLLKHMQHENVIGLL-------DVFTPASSLRNFYDFYL-------VMPFM-QT 113
Query: 195 TLKKFLIRNKRKKLAFKVVI-QIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
L+K ++ K + + ++ Q+ +GL Y+HS +VHRD+K N+ ++ + LKI
Sbjct: 114 DLQK-IMGLKFSEEKIQYLVYQML----KGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 254 DFGVARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIY 305
DFG+AR +MTG T Y APEV L YN+ D++S G + E+
Sbjct: 169 DFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRAS 135
WE+ + + G YG+V A+D G VAVK L ++ A R
Sbjct: 24 IWEV-PERYQNLSPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIH-----AKRT- 75
Query: 136 FRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195
+R E+ + + + H NV + ++ P++S + L V + G
Sbjct: 76 YR-ELRLLKHMKHENVIGLL-------DVFTPARSLEEFNDVYL-------VTHLM-GAD 119
Query: 196 LKKFLIRNKRKKLAFKVVI-QIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
L + K + +I QI RGL Y+HS I+HRD+K N+ ++ + LKI D
Sbjct: 120 LNNIVKCQKLTDDHVQFLIYQIL----RGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 255 FGVARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEI 304
FG+AR A +MTG T Y APE+ L+ YN+ D++S G + E+
Sbjct: 176 FGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 54/236 (22%), Positives = 101/236 (42%), Gaps = 33/236 (13%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRAS 135
+++ ++ + G G V+ A D + VA+K +V + + A
Sbjct: 6 GFDL-GSRYMDLKPLGCGGNGLVFS-AVDNDCDKRVAIK-------KIVLTDPQSVKHA- 55
Query: 136 FRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195
R E+ + ++LDH N+ K L T D + + +V EY+ T
Sbjct: 56 LR-EIKIIRRLDHDNIVKVFEI------LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET 106
Query: 196 -LKKFLIRNKRKKLAFKVVI-QIALDLARGLSYLHSKTIVHRDVKTENMLLDA-NRTLKI 252
L L + + ++ + Q+ RGL Y+HS ++HRD+K N+ ++ + LKI
Sbjct: 107 DLANVLEQGPLLEEHARLFMYQLL----RGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 253 ADFGVARV---EAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEI 304
DFG+AR+ + ++ T Y +P + L Y + D+++ G E+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 67/336 (19%), Positives = 126/336 (37%), Gaps = 82/336 (24%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEA 129
+P++ + I + ++ + G YG V A G+ VA+K ++ + +
Sbjct: 1 MPKRIV-YNI-SSDFQLKSLLGEGAYGVVCS-ATHKPTGEIVAIKKIEPFDKPLF----- 52
Query: 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
A+R R E+ + + H N+ + S ++ + ++ E
Sbjct: 53 -ALRT-LR-EIKILKHFKHENIITIFNI------QRPDSFENFNEVY---------IIQE 94
Query: 190 YLPGGT-LKKFLIRNKRKKLAFKVVI--QIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246
+ T L + +I + Q R + LH ++HRD+K N+L+++
Sbjct: 95 LM--QTDLHR-VISTQMLSDDHIQYFIYQTL----RAVKVLHGSNVIHRDLKPSNLLINS 147
Query: 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYM----------APEV-LDGKPYNRKCDVY 295
N LK+ DFG+AR+ ++ D + TG M APEV L Y+R DV+
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 296 SFGICLWEIY--------------------CCDMPYPDLSFTDVSSAVVRQNLRPDIPRC 335
S G L E++ P+ D + S R+ ++ +P
Sbjct: 208 SCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIK-SLPMY 266
Query: 336 CPSSLASI-----------MRKCWDANPDKRPVMDE 360
+ L + +++ +P KR E
Sbjct: 267 PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 54/236 (22%)
Query: 87 LDIRHEIA----RGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
+ R+E+ +G++G V + AYD Q VA+K+ +R
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKM----------------VR------ 131
Query: 140 VAVWQKLDHPNVTKFIGASMGTTN-LKIPSQSATSDSHNSLPSRAC-------CVVVEYL 191
N +F + L+ + ++ N + C+ E L
Sbjct: 132 ----------NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL-DANRT- 249
L + + +NK + + +V + A + + L LH I+H D+K EN+LL R+
Sbjct: 182 -SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 250 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+K+ DFG + E Q + + Y APEV+ G Y D++S G L E+
Sbjct: 241 IKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 40/234 (17%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK-ILDWAEDGMVTSAEAAAIRA 134
WE+ A + G YG V A D G VA+K + + + A RA
Sbjct: 20 AWEV-RAVYRDLQPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELF------AKRA 71
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
+R E+ + + + H NV + ++ P ++ D +V+ ++ G
Sbjct: 72 -YR-ELRLLKHMRHENVIGLL-------DVFTPDETL--DDFTDF-----YLVMPFM-GT 114
Query: 195 TLKKFLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
L K L+++++ +V Q+ +GL Y+H+ I+HRD+K N+ ++ + LKI
Sbjct: 115 DLGK-LMKHEKLGEDRIQFLVYQML----KGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 169
Query: 253 ADFGVARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIY 305
DFG+AR +MTG T Y APEV L+ Y + D++S G + E+
Sbjct: 170 LDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 40/236 (16%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRAS 135
+++ + I G YG V AYD VA+K + E R
Sbjct: 22 VFDVG-PRYTNLSYIGEGAYGMVCS-AYDNLNKVRVAIKKISPFEHQTY------CQRT- 72
Query: 136 FRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195
R E+ + + H N+ ++ P+ D + +V + +
Sbjct: 73 LR-EIKILLRFRHENIIGINDI------IRAPTIEQMKDVY---------IVQDLM-ETD 115
Query: 196 LKKFLIRNKRKKLAFK--VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
L K L++ + + QI RGL Y+HS ++HRD+K N+LL+ LKI
Sbjct: 116 LYK-LLKTQHLSNDHICYFLYQIL----RGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 254 DFGVARV---EAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIY 305
DFG+ARV + + +T T Y APE+ L+ K Y + D++S G L E+
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 62/260 (23%), Positives = 105/260 (40%), Gaps = 57/260 (21%)
Query: 67 SREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD---GQDVAVK-ILDWAEDG 122
S + + + + I+H I RG+YG VY AYD ++VA+K + ED
Sbjct: 9 SGRENLYFQGIKNVHV-PDNYIIKHLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRMFEDL 66
Query: 123 MVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSR 182
+ R R E+ + +L + + +L IP + L
Sbjct: 67 ID------CKRI-LR-EITILNRLKSDYIIRLY-------DLIIPD---DLLKFDEL--- 105
Query: 183 ACCVVVEYLPGGT-LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241
+V+E + LKK L + L + + I +L G +++H I+HRD+K N
Sbjct: 106 --YIVLEIA--DSDLKK-LFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPAN 159
Query: 242 MLLDANRTLKIADFGVARVEAQNP----------------------RDMTGETGTLGYMA 279
LL+ + ++K+ DFG+AR + +T T Y A
Sbjct: 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRA 219
Query: 280 PEV-LDGKPYNRKCDVYSFG 298
PE+ L + Y + D++S G
Sbjct: 220 PELILLQENYTKSIDIWSTG 239
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 56/238 (23%)
Query: 87 LDIRHEI----ARGTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
R+EI +G++G V + AYD + VA+KI I+
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVK-AYDRVEQEWVAIKI----------------IK------ 88
Query: 140 VAVWQKLDHPNVTKFIGASMGTTN-LKIPSQSATSDSHNSLPSRAC-------CVVVEYL 191
N F+ + L++ ++ T + + + C+V E L
Sbjct: 89 ----------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138
Query: 192 PGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK--TIVHRDVKTENMLL--DAN 247
L L + ++ + + A + L +L + +I+H D+K EN+LL
Sbjct: 139 -SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 248 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+KI DFG + Q + + Y +PEVL G PY+ D++S G L E++
Sbjct: 198 SAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 5e-16
Identities = 42/247 (17%), Positives = 76/247 (30%), Gaps = 40/247 (16%)
Query: 86 KLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
KL +I G +G V++ D VA+KI+ +V + E+ + ++
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFE-EILPEIIISKE 79
Query: 146 L---------DHPNVTKFIGASMGTTNLKIPSQSA------TSDSHNSLPSR----ACCV 186
L + A T S N P +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 187 VVEYLPGGT-LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
V+E+ GG L++ + A ++ Q+ LA + L HRD+ N+LL
Sbjct: 140 VLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLK 196
Query: 246 ANRTLKIADFG-------------VARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYNR 290
K+ V+ ++ R M ++ G +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD-GDY 255
Query: 291 KCDVYSF 297
+ D+Y
Sbjct: 256 QFDIYRL 262
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 49/231 (21%), Positives = 89/231 (38%), Gaps = 44/231 (19%)
Query: 93 IARGTYGTVYRG----------AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV 142
R G +Y Q ++K+ A+DG + + + RA+ +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLD--AKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 143 WQKL---DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
W+KL + +G G D + L V+ L G +L+
Sbjct: 108 WKKLYSTPLLAIPTCMGF--GVHQ----------DKYRFL-------VLPSL-GRSLQSA 147
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI--ADFGV 257
L + + L+ + V+Q+A L L +LH VH +V EN+ +D ++ A +G
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 258 ARV-------EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301
A A + G L +++ ++ G +R+ D+ S G C+
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 22/99 (22%)
Query: 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV--------------------- 260
+ + YLHS ++HRD+K N+LL+A +K+ADFG++R
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 261 EAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFG 298
+ +T T Y APE+ L Y + D++S G
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 39/230 (16%)
Query: 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I G +G +Y + A V E F E+ +Q++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH---------VVKVEYQENGPLFS-ELKFYQRVAKKD 94
Query: 151 VTKFIGASMGTTNLKIP------SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
K L IP S+ + V+E L G L+K I +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM-------VMERL-GIDLQK--ISGQ 144
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI--ADFGVARV-- 260
V+Q+ + + L Y+H VH D+K N+LL ++ AD+G++
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 261 -----EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+ G GT+ + + + G +R+ DV G C+ +
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM--LR 252
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 60/275 (21%), Positives = 102/275 (37%), Gaps = 86/275 (31%)
Query: 89 IRHEIARGTYGTVYRGAYDGQD---VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ ++ G + TV+ ++D Q VA+K+ V SAE A E+ + +
Sbjct: 41 VIRKLGWGHFSTVWL-SWDIQGKKFVAMKV--------VKSAEHYTETA--LDEIRLLKS 89
Query: 146 L-----DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
+ + PN + + + + + +H C+V E L G L K++
Sbjct: 90 VRNSDPNDPN-REMVVQLLDDFKISGVN-----GTH-------ICMVFEVL-GHHLLKWI 135
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKT-IVHRDVKTENMLL--------------- 244
I++ + L V +I + +GL YLH+K I+H D+K EN+LL
Sbjct: 136 IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195
Query: 245 ----------------------------------DANRTLKIADFGVARVEAQNPRDMTG 270
+KIAD G A ++ T
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TE 252
Query: 271 ETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+ T Y + EVL G YN D++S +E+
Sbjct: 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 41/234 (17%), Positives = 82/234 (35%), Gaps = 44/234 (18%)
Query: 93 IARGTYGTVYRGA-YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ-----EVAVWQKL 146
I +G +G +Y + V E+ +Q+
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDA------------PCVVKVEPSDNGPLFTELKFYQRA 90
Query: 147 DHPNVTKFIGASMGTTNLKIP------SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
P + + L +P S+ + +++ G L+K
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM-------IMDRF-GSDLQKIY 142
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI--ADFGVA 258
N ++ + K V+Q++L + L Y+H VH D+K N+LL+ ++ D+G+A
Sbjct: 143 EANAKR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 259 RV-------EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+A GT+ + + + +G +R+ D+ G C+ I
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM--IQ 253
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 50/262 (19%), Positives = 91/262 (34%), Gaps = 84/262 (32%)
Query: 87 LDIRHEIAR----GTYGTVYRGAYD---GQDVAVKILDWAEDGMVTSAEAAAIRA--SFR 137
L+ + R GT+G V + AVK+ +R +
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKV----------------VRNIKKYT 75
Query: 138 Q----EVAVWQKL--DHPNVTKFIGASMGTTNLKIPSQSATSDS---HNSLPSRACCVVV 188
+ E + +K+ D N + ++ + C++
Sbjct: 76 RSAKIEADILKKIQNDDINNNNIV-------KYH--------GKFMYYDHM-----CLIF 115
Query: 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248
E L G +L + + RN + + +++ + L+YL ++ H D+K EN+LLD
Sbjct: 116 EPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174
Query: 249 -------------------------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL 283
+K+ DFG A ++ T Y APEV+
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVI 231
Query: 284 DGKPYNRKCDVYSFGICLWEIY 305
++ D++SFG L E+Y
Sbjct: 232 LNLGWDVSSDMWSFGCVLAELY 253
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 60/254 (23%), Positives = 89/254 (35%), Gaps = 72/254 (28%)
Query: 87 LDIRHEIA----RGTYGTVYRGAYD----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
L R+EI GT+G V D VA+KI IR
Sbjct: 17 LQERYEIVGNLGEGTFGKVVE-CLDHARGKSQVALKI----------------IR----- 54
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTN-LKIPSQSATSDSHNSLPSRAC-------CVVVEY 190
NV K+ A+ N LK + + + C+ E
Sbjct: 55 -----------NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL 103
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR-- 248
L G +FL N + V +A L L +LH + H D+K EN+L +
Sbjct: 104 L-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162
Query: 249 -----------------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRK 291
++++ADFG A + ++ T T Y PEV+ + +
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQP 219
Query: 292 CDVYSFGICLWEIY 305
CDV+S G L+E Y
Sbjct: 220 CDVWSIGCILFEYY 233
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 54/260 (20%), Positives = 93/260 (35%), Gaps = 84/260 (32%)
Query: 87 LDIRHEIAR----GTYGTVYRGAYD----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
L R+EI G +G V D G+ VAVKI ++
Sbjct: 12 LSARYEIVDTLGEGAFGKVVE-CIDHKAGGRHVAVKI----------------VK----- 49
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTN-LKIPSQSATSDSHNSLPSRAC-------CVVVEY 190
NV ++ A+ L+ + + + + + C+V E
Sbjct: 50 -----------NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL 98
Query: 191 LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR-- 248
L G + F+ N + ++A + + +++LHS + H D+K EN+L +
Sbjct: 99 L-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157
Query: 249 -----------------TLKIADFGVARVEAQNP------RDMTGETGTLGYMAPEVLDG 285
+K+ DFG A + ++ R Y APEV+
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH---------YRAPEVILA 208
Query: 286 KPYNRKCDVYSFGICLWEIY 305
+++ CDV+S G L E Y
Sbjct: 209 LGWSQPCDVWSIGCILIEYY 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 61/305 (20%), Positives = 115/305 (37%), Gaps = 54/305 (17%)
Query: 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRAS-FRQEVAVWQK 145
+ +I G++G +Y G G++VA+K+ E + E +++
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIYKM 60
Query: 146 LDH-PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
+ + +N +V+E L G +L+ L
Sbjct: 61 MQGGVGIPTIRW-------------CGAEGDYN-------VMVMELL-GPSLED-LFNFC 98
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT---LKIADFGVAR-- 259
+K + K V+ +A + + Y+HSK +HRDVK +N L+ + + I DFG+A+
Sbjct: 99 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
Query: 260 VEAQN-----PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
+A+ R+ TGT Y + G +R+ D+ S G L +P+ L
Sbjct: 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
Query: 315 SFTDVSSAVVR-----QNLRPD-IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
R + + + + PS A+ + C D +P + +L +
Sbjct: 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278
Query: 369 NTSKG 373
+G
Sbjct: 279 FHRQG 283
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 48/233 (20%)
Query: 89 IRHEIARGTYGTVYRGA--YDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
+ +I G +G + G Y + VA+K+ E RA Q
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKL------------EPMKSRAP--------QLH 52
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
K +G+ G + +N +V+E L G +L+ L +
Sbjct: 53 LEYRFYKQLGSGDGIPQVY---YFGPCGKYN-------AMVLELL-GPSLED-LFDLCDR 100
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL-----DANRTLKIADFGVAR-- 259
+ K V+ IA+ L + Y+HSK +++RDVK EN L+ + + I DF +A+
Sbjct: 101 TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
Query: 260 VEAQN-----PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307
++ + R+ TGT YM+ GK +R+ D+ + G +Y
Sbjct: 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMF--MYFL 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 50/231 (21%), Positives = 93/231 (40%), Gaps = 50/231 (21%)
Query: 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRAS-FRQEVAVWQK 145
+ +I G++G +Y G ++VA+K+ E + E +++
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIYRI 58
Query: 146 L-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
L + +N +V++ L G +L+ L
Sbjct: 59 LQGGTGIPNVRW-------------FGVEGDYN-------VLVMDLL-GPSLED-LFNFC 96
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT---LKIADFGVA--- 258
+KL+ K V+ +A + + ++HSK+ +HRD+K +N L+ R + I DFG+A
Sbjct: 97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Query: 259 RVEAQN----PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
R + + R+ TGT Y + G +R+ D+ S G L +Y
Sbjct: 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL--MY 205
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 45/233 (19%), Positives = 86/233 (36%), Gaps = 52/233 (22%)
Query: 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRAS-FRQEVAVWQK 145
+ I G++G ++ G + Q VA+K E A R E ++
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTYKL 61
Query: 146 LDH-PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
L + HN +V++ L G +L+ L+
Sbjct: 62 LAGCTGIPNVYY-------------FGQEGLHN-------VLVIDLL-GPSLED-LLDLC 99
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN-----RTLKIADFGVAR 259
+K + K V A + + +H K++V+RD+K +N L+ + + DFG+ +
Sbjct: 100 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
Query: 260 --VEAQN-----PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305
+ R+ +GT YM+ G+ +R+ D+ + G +Y
Sbjct: 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF--MY 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 5e-05
Identities = 39/267 (14%), Positives = 76/267 (28%), Gaps = 78/267 (29%)
Query: 130 AAIRASFRQEVAVWQKLDHPN---VTKFIGASMGTTNLKIPSQSAT--------SDSHNS 178
+ I S R +A W H N +T I +S+ L+ +H
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSL--NVLEPAEYRKMFDRLSVFPPSAH-- 386
Query: 179 LPSRACCVV----VEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234
+P+ ++ ++ + K + L K + S ++
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKL----HKYSLVEK-------QPKESTISIPS---IY 432
Query: 235 RDVKTENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCD 293
++K + A +R++ V D + P LD Y
Sbjct: 433 LELKVKLENEYALHRSI------VDHYNIPKTFD-------SDDLIPPYLDQ--Y----- 472
Query: 294 VYSF-GICLWEIYCCDMP---------YPDLSFTDVSSAVVRQNLRPD-IPRCCPSSLAS 342
YS G + + P + D F + Q +R D S+ +
Sbjct: 473 FYSHIG---HHLKNIEHPERMTLFRMVFLDFRF-------LEQKIRHDSTAWNASGSILN 522
Query: 343 IM---RKCWDANPDKRPVMDEVVKLLE 366
+ + D P + +V +
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAIL 549
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.2 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.56 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.4 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.33 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.93 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.16 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-62 Score=454.32 Aligned_cols=264 Identities=34% Similarity=0.636 Sum_probs=220.7
Q ss_pred cccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..|+|..+++++.++||+|+||+||+|++.+ .||||+++.... . ....+.|.+|+.+|++++|||||+++|+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~---~----~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP---T----PEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSC---C----HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC---C----HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4699999999999999999999999999866 599999874332 1 1224678999999999999999999998
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+. .+ |||||||+||+|.++|... ...+++.++..|+.||+.||+|||+++||||||
T Consensus 101 ~~~~-~~--------------------~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDl 158 (307)
T 3omv_A 101 MTKD-NL--------------------AIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158 (307)
T ss_dssp ECSS-SC--------------------EEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred EECC-eE--------------------EEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCcc
Confidence 8542 22 8999999999999999654 356999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||+||||++++.+||+|||+|+..... .......+||+.|||||++.+ .+|+.++|||||||++|||+||+.||.
T Consensus 159 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp CSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999864322 223345689999999999853 468999999999999999999999999
Q ss_pred CCChhhHHHHHHhccCC-C---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 313 DLSFTDVSSAVVRQNLR-P---DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
+.+........+..+.. + ..+..+|+++.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 87766655555554433 2 34567899999999999999999999999999999998743
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-62 Score=456.26 Aligned_cols=263 Identities=29% Similarity=0.517 Sum_probs=227.0
Q ss_pred cccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
+.|..++|.+.+.||+|+||+||+|++ ++..||||+++... ....+.|.+|+.+|++++|||||
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnIV 78 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIV 78 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---------hHHHHHHHHHHHHHHhCCCCCCc
Confidence 356778999999999999999999986 36789999997432 12246789999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-----------cCCCCHHHHHHHHHHHH
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-----------RKKLAFKVVIQIALDLA 221 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~ 221 (394)
+++|+|.+.+.+ |||||||++|+|.++|.... ...+++.+++.|+.||+
T Consensus 79 ~l~g~~~~~~~~--------------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 138 (299)
T 4asz_A 79 KFYGVCVEGDPL--------------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138 (299)
T ss_dssp CEEEEECSSSSE--------------------EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHH
T ss_pred cEEEEEeeCCEE--------------------EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHH
Confidence 999999876665 89999999999999997632 34699999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 299 (394)
.||.|||+++||||||||+|||++.++.+||+|||+|+....... ......||+.|||||.+.+..|+.++|||||||
T Consensus 139 ~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gv 218 (299)
T 4asz_A 139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218 (299)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHH
Confidence 999999999999999999999999999999999999985433221 122346899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 300 CLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 300 ~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
++|||+| |+.||.+.+..++...+.. +.+++.|..+|+++.+||.+||+.||++|||+++|+..|+++..+.
T Consensus 219 vl~Ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 219 VLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 9999998 8999999998888877755 4456778889999999999999999999999999999999997654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=454.40 Aligned_cols=261 Identities=28% Similarity=0.527 Sum_probs=226.7
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
-+++..+++++.++||+|+||+||+|++ +++.||||+++..... ...+.|.+|+.++++++||||
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--------~~~~~f~~E~~il~~l~HpNI 91 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--------PLREEFRHEAMLRARLQHPNV 91 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------CHHHHHHHHHHHHHCCCTTB
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--------HHHHHHHHHHHHHHhCCCCCC
Confidence 3567889999999999999999999986 3578999999743321 123678999999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHHHHHH
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIA 217 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~ 217 (394)
|+++|+|.+.+.+ |||||||++|+|.++|.... ...+++..++.|+
T Consensus 92 V~l~g~~~~~~~~--------------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 151 (308)
T 4gt4_A 92 VCLLGVVTKDQPL--------------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151 (308)
T ss_dssp CCEEEEECSSSSC--------------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHH
T ss_pred CCcceEEEECCEE--------------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHH
Confidence 9999999876665 89999999999999996532 2469999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCCCCCCccchHH
Q 048724 218 LDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDGKPYNRKCDVY 295 (394)
Q Consensus 218 ~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 295 (394)
.||+.||+|||+++||||||||+||||++++.+||+|||+++..... ........||+.|||||.+.+..|+.++|||
T Consensus 152 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVw 231 (308)
T 4gt4_A 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 231 (308)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhh
Confidence 99999999999999999999999999999999999999999854322 2223446899999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 296 SFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 296 slG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
||||++|||+| |..||.+.+..++...+. .+.+++.|..||+++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999998 899999999888887664 4556678889999999999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-61 Score=456.27 Aligned_cols=262 Identities=29% Similarity=0.541 Sum_probs=223.1
Q ss_pred cccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
+.+..++|.+.++||+|+||+||+|++ +++.||||+++... ....+.|.+|+.+|++++|||||
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnIV 106 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTMLQHQHIV 106 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 567778999999999999999999986 36789999997322 12246799999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-------------cCCCCHHHHHHHHHH
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-------------RKKLAFKVVIQIALD 219 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~q 219 (394)
+++|+|.+...+ |||||||++|+|.+++.... ..++++.+++.|+.|
T Consensus 107 ~l~g~~~~~~~~--------------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 166 (329)
T 4aoj_A 107 RFFGVCTEGRPL--------------------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166 (329)
T ss_dssp CEEEEECSSSSE--------------------EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHH
T ss_pred cEEEEEEECCEE--------------------EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHH
Confidence 999999876665 99999999999999997542 246999999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHH
Q 048724 220 LARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSF 297 (394)
Q Consensus 220 i~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 297 (394)
|+.||+|||+++||||||||+||||+.++.+||+|||+++...... .......||+.|||||++.+..|+.++|||||
T Consensus 167 ia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~ 246 (329)
T 4aoj_A 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246 (329)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccch
Confidence 9999999999999999999999999999999999999998543322 22234679999999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 298 GICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 298 G~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
||++|||+| |+.||.+.+..++...+.. +.+++.|..+|+++.+||.+||+.||++|||+++|++.|+.+...
T Consensus 247 Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 247 GVVLWEIFTYGKQPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHHTTSCCTTCSSCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 999999999 8999999998888877654 456778889999999999999999999999999999999999765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-62 Score=462.85 Aligned_cols=254 Identities=25% Similarity=0.464 Sum_probs=218.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
.+++|++++.||+|+||+||+|++ +|+.||||+++.... .. ...+.+.+|+.+|++++|||||+++++|.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---SS----KEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS---CH----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC---CH----HHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 468999999999999999999998 689999999975432 11 124678899999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |||||||+||+|.++|.......+++..++.|+.||+.||.|||++|||||||||+
T Consensus 95 ~~~~--------------------yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 154 (350)
T 4b9d_A 95 NGSL--------------------YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154 (350)
T ss_dssp TTEE--------------------EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGG
T ss_pred CCEE--------------------EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence 6665 99999999999999998766667899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||||+.++.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++.
T Consensus 155 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 155 NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp GEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred HEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 99999999999999999986543322233457999999999999999999999999999999999999999999998888
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+..... ++.+..+|+++++||.+||++||++|||++++++.
T Consensus 235 ~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 235 LKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 88876654 45667799999999999999999999999999873
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=451.20 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=219.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|++.++||+|+||+||+|++ +|+.||||+++...... .+.+.+|+.+|++++|||||+++++|.+.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---------GGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---------HHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35799999999999999999998 68999999997544321 24577899999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |||||||+||+|.+++.+ ..+++..+..|+.||+.||+|||++|||||||||+|
T Consensus 144 ~~~--------------------~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 200 (346)
T 4fih_A 144 DEL--------------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200 (346)
T ss_dssp TEE--------------------EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CEE--------------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 665 999999999999999864 359999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|||+.+|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+...
T Consensus 201 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 280 (346)
T 4fih_A 201 ILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 280 (346)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 99999999999999999876555555566799999999999999999999999999999999999999999988888777
Q ss_pred HHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+..... ....+..+|+++++||.+||+.||++|||++|+++.
T Consensus 281 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 281 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 6654321 223345689999999999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-61 Score=447.49 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=221.6
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.++||+|+||+||+|++ +|+.||||+++... .......+.+.+|+.+|++++|||||+++++|.+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~------~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH------CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 357899999999999999999998 78999999997432 1112224678899999999999999999999998
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |||||||+||+|.+++.+. +.+++..+..|+.||+.||+|||++||+||||||+
T Consensus 104 ~~~~--------------------yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPe 161 (311)
T 4aw0_A 104 DEKL--------------------YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 161 (311)
T ss_dssp SSEE--------------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCEE--------------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 7766 9999999999999999654 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|||++.++.+||+|||+|+..... .......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 162 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 241 (311)
T 4aw0_A 162 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241 (311)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999865432 223445789999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+...+.... ..+|..+++++++||.+||++||++|||++|++.
T Consensus 242 ~~~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 242 IFAKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 888887764 4567789999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=455.90 Aligned_cols=272 Identities=28% Similarity=0.543 Sum_probs=232.4
Q ss_pred CCCCcccccccccccceeeeccCCceEEEEEEECC-------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC
Q 048724 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146 (394)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 146 (394)
+-...+|+|..++|++.+.||+|+||+||+|.+.+ +.||||+++.... ....+.|.+|+.+|+++
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--------~~~~~~~~~E~~il~~l 124 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHI 124 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHH
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--------hHHHHHHHHHHHHHHHc
Confidence 33445799999999999999999999999998732 5799999974321 11246788999999999
Q ss_pred CC-CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHH
Q 048724 147 DH-PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFK 211 (394)
Q Consensus 147 ~h-~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~ 211 (394)
+| ||||+++|+|..... .+|||||||++|+|.++|+... +..+++.
T Consensus 125 ~hhpnIV~l~g~~~~~~~-------------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~ 185 (353)
T 4ase_A 125 GHHLNVVNLLGACTKPGG-------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 185 (353)
T ss_dssp CCCTTBCCEEEEECCTTS-------------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHH
T ss_pred CCCCcEEEEEEEEEecCC-------------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHH
Confidence 65 899999999865432 2389999999999999997643 2458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCC
Q 048724 212 VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYN 289 (394)
Q Consensus 212 ~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 289 (394)
.+..|+.||+.||+|||+++||||||||+|||+++++.+||+|||+|+....... .....+||+.|||||++.+..|+
T Consensus 186 ~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~ 265 (353)
T 4ase_A 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence 9999999999999999999999999999999999999999999999986543322 23345789999999999999999
Q ss_pred ccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 290 RKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 290 ~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.++|||||||++|||+| |..||.+.+..+.....+..+.+++.|..+++++.++|.+||+.||++|||+.+|++.|+.+
T Consensus 266 ~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 266 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 99999999999999998 89999988766666666677788889999999999999999999999999999999999998
Q ss_pred Hhcc
Q 048724 369 NTSK 372 (394)
Q Consensus 369 ~~~~ 372 (394)
..+.
T Consensus 346 lq~~ 349 (353)
T 4ase_A 346 LQAN 349 (353)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 7543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-60 Score=447.75 Aligned_cols=270 Identities=23% Similarity=0.310 Sum_probs=226.5
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
++....+.|++.++||+|+||+||+|++ +|+.||||+++.... ..+|+.++++++|||||++++
T Consensus 52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------------~~~E~~il~~l~HpnIV~l~~ 117 (336)
T 4g3f_A 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------------RVEELVACAGLSSPRIVPLYG 117 (336)
T ss_dssp BCCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CTHHHHTTTTCCCTTBCCEEE
T ss_pred hhhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------------HHHHHHHHHhCCCCCCCcEEE
Confidence 3455667899999999999999999998 689999999974321 236999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|.+.+.+ |||||||+||+|.++|.+. +.+++..+..|+.||+.||+|||++||||||
T Consensus 118 ~~~~~~~~--------------------~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 175 (336)
T 4g3f_A 118 AVREGPWV--------------------NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGD 175 (336)
T ss_dssp EEEETTEE--------------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred EEEECCEE--------------------EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 99876665 8999999999999999654 4699999999999999999999999999999
Q ss_pred CCCCceeeCCCC-cEEEeeccccccccCCCC-----CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 237 VKTENMLLDANR-TLKIADFGVARVEAQNPR-----DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 237 lkp~NIll~~~~-~vkl~DFG~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
|||+||||+.+| .+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||+||+.|
T Consensus 176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 255 (336)
T 4g3f_A 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255 (336)
T ss_dssp CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999887 699999999986543211 12235799999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccCC-CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC---CCCCCCCCCc
Q 048724 311 YPDLSFTDVSSAVVRQNLR-PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG---GMIPEDQAHG 384 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~---~~~~~~~~~~ 384 (394)
|.+.+..++...+...... ..++..+|+++.+||.+||++||++|||+.|+++.|..+.....+ .++.+...|.
T Consensus 256 f~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp STTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred CCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 9988877777777665433 246778999999999999999999999999999999888754333 3344444443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=432.71 Aligned_cols=249 Identities=26% Similarity=0.487 Sum_probs=204.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++.+.||+|+||+||+|++ +|+.||||+++.... ........+.+|+.+|++++|||||++++++.+.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL------AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc------CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 57899999999999999999987 689999999974321 1222346788999999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+||||+ +|+|.+++.++ +.+++..+..++.||+.||+|||++||+||||||+|
T Consensus 86 ~~~--------------------~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~N 142 (275)
T 3hyh_A 86 DEI--------------------IMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPEN 142 (275)
T ss_dssp SEE--------------------EEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTT
T ss_pred CEE--------------------EEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHH
Confidence 665 9999999 78999999654 569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||++.++.+||+|||+|+..... ......+||+.|||||++.+..| +.++|||||||++|+|+||+.||.+.+.....
T Consensus 143 ILl~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 143 LLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp EEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eEECCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999999864432 23345789999999999998876 57999999999999999999999998888887
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+.... ..+|..+|+++++||.+||+.||++|||++|+++.
T Consensus 222 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 222 KNISNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 7776553 45677899999999999999999999999999984
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-59 Score=452.91 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=219.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|++.++||+|+||+||+|++ +|+.||||+++...... .+.+.+|+.+|++++|||||+++++|.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---------GGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 36799999999999999999998 68999999997544321 24577899999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|
T Consensus 221 ~~~--------------------~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~N 277 (423)
T 4fie_A 221 DEL--------------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277 (423)
T ss_dssp TEE--------------------EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTT
T ss_pred CEE--------------------EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 665 999999999999999854 359999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|||+.+|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+...
T Consensus 278 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 357 (423)
T 4fie_A 278 ILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 357 (423)
T ss_dssp EEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 99999999999999999876555555566799999999999999999999999999999999999999999988888877
Q ss_pred HHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+..... ....+..+|+++++||.+||+.||++|||+.|+++.
T Consensus 358 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 358 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 7654421 233446789999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-60 Score=440.98 Aligned_cols=252 Identities=24% Similarity=0.419 Sum_probs=213.2
Q ss_pred ccccccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
.+..++|++++.||+|+||+||+|++ +++.||||+++........ ...+.+|+.+|++++|||||+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~ 92 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMERDILVEVNHPFIVKLH 92 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-------CC------CCCCCCCCTTEECEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-------HHHHHHHHHHHHHCCCCCCCeEE
Confidence 34567899999999999999999976 4678999999754321111 13467899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
++|.+.+.+ |+|||||+||+|.+++.+. +.+++..+..++.||+.||+|||++||+||
T Consensus 93 ~~~~~~~~~--------------------~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 150 (304)
T 3ubd_A 93 YAFQTEGKL--------------------YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYR 150 (304)
T ss_dssp EEEEETTEE--------------------EEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEECCEE--------------------EEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 999876665 9999999999999999654 469999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||||+|||++.++.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+
T Consensus 151 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp SCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 99999999999999999999999865444444556789999999999999999999999999999999999999999999
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVK 363 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~ 363 (394)
..+....+.... ..+|..+|+++++||.+||++||++||| ++|+++
T Consensus 231 ~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 231 RKETMTMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 988888887654 4567789999999999999999999998 467775
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=428.95 Aligned_cols=249 Identities=29% Similarity=0.520 Sum_probs=206.3
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|++.++||+|+||+||+|.+ ++..||+|++..... . ....+.|.+|+.+|++++|||||+++++|.+...
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~----~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~- 99 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---T----KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK- 99 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---C----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---C----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-
Confidence 36778899999999999998 678999999974432 1 1124678999999999999999999999864211
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCce
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENM 242 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiH~Dlkp~NI 242 (394)
.+..+|||||||+||+|.+++.+. ..+++..+..|+.||+.||+|||++| ||||||||+||
T Consensus 100 ---------------~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NI 162 (290)
T 3fpq_A 100 ---------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162 (290)
T ss_dssp ---------------TEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGE
T ss_pred ---------------CCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhe
Confidence 012348999999999999999654 56999999999999999999999998 99999999999
Q ss_pred eeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||+ .++.+||+|||+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+........
T Consensus 163 Ll~~~~g~vKl~DFGla~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~ 239 (290)
T 3fpq_A 163 FITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239 (290)
T ss_dssp EESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred eEECCCCCEEEEeCcCCEeCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH
Confidence 997 478999999999985432 23345689999999999876 59999999999999999999999998765544443
Q ss_pred HHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+..+. ...++..+++++++||.+||+.||++|||++++++
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4434333 33455678899999999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=423.85 Aligned_cols=258 Identities=33% Similarity=0.504 Sum_probs=205.5
Q ss_pred ccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 85 AKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
.+|.+.++||+|+||+||+|+++|+.||||+++... .. ...+..|+..+.+++|||||+++|+|.+.+..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~------~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ER----SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG------HH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc------hh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 468888999999999999999999999999986322 11 12234566667788999999999999765431
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccC
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK--------TIVHRD 236 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------~iiH~D 236 (394)
...+|||||||++|+|.++++. ..+++..+..++.|++.||+|||++ +|||||
T Consensus 73 ----------------~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 73 ----------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp ----------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred ----------------ceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 1234899999999999999965 3599999999999999999999987 999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCC----CccCCCCCCCcCCccccCCC------CCCccchHHHHHHHHHHHHh
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLDGK------PYNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ellt 306 (394)
|||+||||+.++.+||+|||+|+....... .....+||+.|||||++.+. .++.++|||||||++|||+|
T Consensus 134 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t 213 (303)
T 3hmm_A 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH
Confidence 999999999999999999999986543322 12235799999999999764 36779999999999999999
Q ss_pred CCCCCC----------CC-----ChhhHHHHHHhccCCCCCCCC-----CcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 307 CDMPYP----------DL-----SFTDVSSAVVRQNLRPDIPRC-----CPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 307 g~~Pf~----------~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
|.+||. .. ....+...+.....++.+|.. ++..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 214 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 976653 21 223444445556677777643 3457899999999999999999999999999
Q ss_pred HHHhc
Q 048724 367 AVNTS 371 (394)
Q Consensus 367 ~~~~~ 371 (394)
++...
T Consensus 294 ~l~~~ 298 (303)
T 3hmm_A 294 QLSQQ 298 (303)
T ss_dssp HHHHC
T ss_pred HHHHH
Confidence 99754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=418.41 Aligned_cols=260 Identities=23% Similarity=0.422 Sum_probs=193.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++++.||+|+||+||+|++ +|+.||||+++.... ....+.+.+|+.+|++++|||||+++++|.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--------ELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 35799999999999999999998 689999999975431 11246788999999999999999999999765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
+.... .........+|+|||||+||+|.+++..... ...++..++.|+.||+.||+|||++||+||||||+
T Consensus 76 ~~~~~--------~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~ 147 (299)
T 4g31_A 76 NTTEK--------LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPS 147 (299)
T ss_dssp C------------------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred Ccccc--------ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHH
Confidence 43211 0111123346999999999999999975432 23566778999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCC------------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPR------------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 308 (394)
|||++.++.+||+|||+|+....... ..+..+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 148 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 148 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp GEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred HeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 99999999999999999986433211 1234579999999999999999999999999999999996
Q ss_pred CCCCCCChh-hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 309 MPYPDLSFT-DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 309 ~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
||...... .....+ .....++.....++.+.+||.+||+.||++|||+.++++
T Consensus 226 -Pf~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 -PFSTQMERVRTLTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -CCSSHHHHHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccHHHHHHHHH-hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 77543221 112222 221112222234567889999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=417.81 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=211.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++++.||+|+||+||+|++ +|+.||||+++..... ....+.+.+|+.+|++++|||||++++++....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-------VTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-------hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 5799999999999999999998 7899999999743321 112356778999999999999999999987543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. .....+|||||||+ |+|.+++.+ ...+++..+..|+.||+.||.|||++|||||||||+||
T Consensus 127 ~~--------------~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI 189 (398)
T 4b99_A 127 PY--------------GEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 189 (398)
T ss_dssp CT--------------TTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred cc--------------ccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccc
Confidence 22 12345699999995 689999854 45799999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCC----CCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 243 LLDANRTLKIADFGVARVEAQN----PRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|++.++.+||+|||+|+..... .......+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+..
T Consensus 190 l~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp EECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999999854322 2234457899999999998875 5799999999999999999999999998888
Q ss_pred hHHHHHHhccCCCC----------------------C-------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPD----------------------I-------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~----------------------~-------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+....+......+. . ...+++++.+||.+||..||++|||++|+++.
T Consensus 270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 77766653321111 0 12468899999999999999999999999983
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=427.38 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=210.4
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+.+++|+++++||+|+||+||+|++ +|+.||||+++....... ...........++.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~---~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT---TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh---hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 34578999999999999999999998 789999999974321100 0111112223456777788999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.+.+ |+|||||+||+|.++|.+. +.+++..+..|+.||+.||.|||++||||||||
T Consensus 262 ~~~~~l--------------------ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 262 HTPDKL--------------------SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp ECSSEE--------------------EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred EECCEE--------------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 987776 9999999999999999654 469999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCC--
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLS-- 315 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~-- 315 (394)
|+||||+.+|++||+|||+|+..... .....+||+.|||||++. +..|+.++|||||||++|||++|.+||.+.+
T Consensus 320 PeNILld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 320 PANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred hHHeEEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999999865433 234569999999999996 4679999999999999999999999997543
Q ss_pred -hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 316 -FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 316 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
...+...+... ...+|..+|+++++||.+||++||++|++ +++|++.
T Consensus 398 ~~~~i~~~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 398 DKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHhhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 33344444333 45677889999999999999999999998 7888763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=399.16 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=195.6
Q ss_pred ccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeee
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGAS 158 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 158 (394)
++|++.+.||+|+||+||+|++ +++.||||++..... ...+.+|+++|+.+ +|||||+++++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----------PIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----------HHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----------HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 6799999999999999999976 367899999864321 24567899999998 799999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.+.+ |+|||||+||+|.+++. .+++.++..++.||+.||+|||++||+|||||
T Consensus 90 ~~~~~~--------------------~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiK 144 (361)
T 4f9c_A 90 RKNDHV--------------------VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVK 144 (361)
T ss_dssp EETTEE--------------------EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EECCEE--------------------EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCC
Confidence 877665 89999999999999982 48999999999999999999999999999999
Q ss_pred CCceeeCCC-CcEEEeeccccccccCCC----------------------------CCccCCCCCCCcCCccccCCC-CC
Q 048724 239 TENMLLDAN-RTLKIADFGVARVEAQNP----------------------------RDMTGETGTLGYMAPEVLDGK-PY 288 (394)
Q Consensus 239 p~NIll~~~-~~vkl~DFG~a~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~ 288 (394)
|+|||++.+ +.+||+|||+|+...... ...+..+||+.|+|||++.+. .|
T Consensus 145 PeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y 224 (361)
T 4f9c_A 145 PSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQ 224 (361)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCC
T ss_pred HHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence 999999876 799999999997432211 112345799999999999775 58
Q ss_pred CccchHHHHHHHHHHHHhCCCCCCCCC-hhhHHHHHHhc------------------------------------c----
Q 048724 289 NRKCDVYSFGICLWEIYCCDMPYPDLS-FTDVSSAVVRQ------------------------------------N---- 327 (394)
Q Consensus 289 ~~~~DvwslG~~l~elltg~~Pf~~~~-~~~~~~~~~~~------------------------------------~---- 327 (394)
+.++||||+||++|||++|+.||...+ ..+....+... .
T Consensus 225 ~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 304 (361)
T 4f9c_A 225 TTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSS 304 (361)
T ss_dssp CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----
T ss_pred CCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccc
Confidence 999999999999999999999995433 32222222110 0
Q ss_pred ------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 328 ------------LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 328 ------------~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+....+|+++.+||.+||+.||++|||++|+++
T Consensus 305 ~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 305 TPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 001122457899999999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=425.77 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=218.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++.+.||+|+||+||+|++ +|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---------SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---------hhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 57899999999999999999998 789999999874321 1135678899999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |||||||+||+|.++|.+. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 227 ~~~--------------------~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N 285 (573)
T 3uto_A 227 NEM--------------------VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285 (573)
T ss_dssp SEE--------------------EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 665 8999999999999998543 3569999999999999999999999999999999999
Q ss_pred eeeCCC--CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDAN--RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~--~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||++.+ +.+||+|||+|+..... ......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+.
T Consensus 286 ill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~ 364 (573)
T 3uto_A 286 IMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364 (573)
T ss_dssp EEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 999854 89999999999865433 333446899999999999999999999999999999999999999999999888
Q ss_pred HHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+........ .+..+|+++++||.+||+.||++|||+.|+++.
T Consensus 365 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 888876654432 335689999999999999999999999999873
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=389.02 Aligned_cols=268 Identities=38% Similarity=0.663 Sum_probs=223.9
Q ss_pred CcccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
...|++..++|++.+.||+|+||+||+|+++|+.||||++...... ......+.+|+.++++++||||+++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH-------AERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCS-------HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3467888999999999999999999999999999999998743321 112356889999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKT--IV 233 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~--ii 233 (394)
++.+...+ ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++| ++
T Consensus 102 ~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~iv 161 (309)
T 3p86_A 102 AVTQPPNL--------------------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161 (309)
T ss_dssp EECSTTCC--------------------EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred EEEECCce--------------------EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Confidence 99876655 89999999999999996533 234999999999999999999999999 99
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
||||||+|||++.++.+||+|||+++.............||+.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 162 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp CTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999997544433334456899999999999999999999999999999999999999999
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
.+..+....+.........+..+++++.+||.+||+.||++|||+.++++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9888887777666677788889999999999999999999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=398.96 Aligned_cols=296 Identities=27% Similarity=0.544 Sum_probs=243.9
Q ss_pred ceEEecCCCCCChHHHHHHHhhhhhhhh-h---ccC---C------CCCcccccccccccceeeeccCCceEEEEEEECC
Q 048724 42 LFFRADKIDFKSWDIQLEKHLSRVWSRE-R---EVL---P------RKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDG 108 (394)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~---~------~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g 108 (394)
.++......|.++...+..+....-... + ... + .....|++..++|++.+.||+|+||+||+|.++|
T Consensus 137 ~~~i~~~~~F~sl~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~ 216 (450)
T 1k9a_A 137 KLSIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG 216 (450)
T ss_dssp EEESSSSSCBSSHHHHHHHHHHCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETT
T ss_pred ceEeccccccccHHHHHhhhcccccchhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecC
Confidence 4555556678887776655432211100 0 000 0 0135689999999999999999999999999999
Q ss_pred eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEE
Q 048724 109 QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188 (394)
Q Consensus 109 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~ 188 (394)
+.||||+++.... .+.|.+|+.+|++++||||+++++++..... .+|+||
T Consensus 217 ~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------------------~~~iv~ 266 (450)
T 1k9a_A 217 NKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-------------------GLYIVT 266 (450)
T ss_dssp EEEEEEEESSCTT-----------SHHHHHHHHHHHTCCCTTBCCEEEEEECTTS-------------------CEEEEE
T ss_pred CeEEEEEeCCchH-----------HHHHHHHHHHHHhccCCCEEEEEEEEEcCCC-------------------ceEEEE
Confidence 9999999974321 2568899999999999999999999865432 238999
Q ss_pred ecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCc
Q 048724 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM 268 (394)
Q Consensus 189 e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 268 (394)
||+++|+|.+++.......+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---Q 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---c
Confidence 9999999999998766556899999999999999999999999999999999999999999999999999743322 1
Q ss_pred cCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHh
Q 048724 269 TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKC 347 (394)
Q Consensus 269 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 347 (394)
....+++.|+|||.+.+..++.++||||||+++|||++ |..||...+..++...+ ..+.+...+..+|+.+.+||.+|
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~c 422 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYDVMKNC 422 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-HTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHH
Confidence 22467889999999999999999999999999999998 99999998888777655 45567778889999999999999
Q ss_pred chhCCCCCCCHHHHHHHHHHHHhc
Q 048724 348 WDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 348 L~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|+.||++|||+.++++.|+++...
T Consensus 423 l~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 423 WHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=399.58 Aligned_cols=303 Identities=26% Similarity=0.504 Sum_probs=249.4
Q ss_pred CCceEEecCCCCCChHHHHHHHhhhhhhh----------hhccCCCCCcccccccccccceeeeccCCceEEEEEEE-CC
Q 048724 40 KDLFFRADKIDFKSWDIQLEKHLSRVWSR----------EREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY-DG 108 (394)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g 108 (394)
...++......|.++...+..+....... .....+.....|++..++|++.+.||+|+||+||+|.+ ++
T Consensus 133 ~g~~~i~~~~~F~sl~eLv~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~ 212 (454)
T 1qcf_A 133 NGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212 (454)
T ss_dssp TSCEESSSSSCBSSHHHHHHHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTT
T ss_pred CCcEEEeCccccCCHHHHHHHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCc
Confidence 34577777778888887776553321110 00111223567999999999999999999999999999 57
Q ss_pred eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEE
Q 048724 109 QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188 (394)
Q Consensus 109 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~ 188 (394)
..||||+++.... . .+.|.+|+.+|++++|||||++++++.. +. .|+||
T Consensus 213 ~~vavK~~~~~~~---~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~--------------------~~lv~ 261 (454)
T 1qcf_A 213 TKVAVKTMKPGSM---S-------VEAFLAEANVMKTLQHDKLVKLHAVVTK-EP--------------------IYIIT 261 (454)
T ss_dssp EEEEEEEECTTSB---C-------HHHHHHHHHHHTTCCCTTBCCEEEEECS-SS--------------------CEEEE
T ss_pred cEEEEEEecCCCc---c-------HHHHHHHHHHHhhCCCCCEeeEEEEEeC-Cc--------------------cEEEE
Confidence 8899999975331 1 3678899999999999999999999862 22 38999
Q ss_pred ecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC-CC
Q 048724 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RD 267 (394)
Q Consensus 189 e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~ 267 (394)
||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 99999999999976555578999999999999999999999999999999999999999999999999998643221 11
Q ss_pred ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 048724 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRK 346 (394)
Q Consensus 268 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 346 (394)
.....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..++...+. .+.+.+.+..+|+++.+||.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence 223456789999999998889999999999999999999 999999998888776664 455667788899999999999
Q ss_pred hchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 347 CWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 347 cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
||+.||++|||+++|++.|+++.+....
T Consensus 421 cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred HccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999765443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=393.62 Aligned_cols=298 Identities=30% Similarity=0.541 Sum_probs=242.2
Q ss_pred eEEecCCCCCChHHHHHHHhhhhhhhh-----hccCCCCCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEE
Q 048724 43 FFRADKIDFKSWDIQLEKHLSRVWSRE-----REVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKI 115 (394)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~ 115 (394)
+|..+...|.++...++.+........ ....+.....|++..++|++.+.||+|+||+||+|++ +++.||||+
T Consensus 67 ~~~~~~~~F~sl~~LI~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~ 146 (377)
T 3cbl_A 67 LYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146 (377)
T ss_dssp CCCC----CCSHHHHHHHHHHHTCCC-----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEE
T ss_pred eEEecceeccchHHHHHHHhhccCCcccccCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEE
Confidence 555566778888887777654322111 0111234568999999999999999999999999998 588999999
Q ss_pred eecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCC
Q 048724 116 LDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195 (394)
Q Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggs 195 (394)
++.... ......|.+|+.++++++||||+++++++.....+ |+||||+++|+
T Consensus 147 ~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--------------------~lv~e~~~~g~ 198 (377)
T 3cbl_A 147 CRETLP--------PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI--------------------YIVMELVQGGD 198 (377)
T ss_dssp CCTTSC--------HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC--------------------EEEEECCTTCB
T ss_pred ccccCC--------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc--------------------EEEEEcCCCCC
Confidence 873311 12235688899999999999999999999866555 89999999999
Q ss_pred HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCc--cCCCC
Q 048724 196 LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM--TGETG 273 (394)
Q Consensus 196 L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~--~~~~g 273 (394)
|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++......... ....+
T Consensus 199 L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~ 277 (377)
T 3cbl_A 199 FLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277 (377)
T ss_dssp HHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEE
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCC
Confidence 99999754 3468999999999999999999999999999999999999999999999999997533221111 11235
Q ss_pred CCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCC
Q 048724 274 TLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANP 352 (394)
Q Consensus 274 t~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP 352 (394)
++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+ ..+.+.+.+..+|+++.+||.+||+.||
T Consensus 278 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP 356 (377)
T 3cbl_A 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQCWAYEP 356 (377)
T ss_dssp EGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 678999999988889999999999999999998 99999998877766554 4555677788899999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHh
Q 048724 353 DKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 353 ~~Rpt~~~ll~~l~~~~~ 370 (394)
++|||++++++.|+++..
T Consensus 357 ~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 357 GQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=387.37 Aligned_cols=268 Identities=31% Similarity=0.580 Sum_probs=229.1
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL- 146 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 146 (394)
...|++..++|++.+.||+|+||+||+|.+. +..||||+++.... ......+.+|+.+++.+
T Consensus 73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~ 144 (370)
T 2psq_A 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--------EKDLSDLVSEMEMMKMIG 144 (370)
T ss_dssp CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--------HHHHHHHHHHHHHHHHSC
T ss_pred cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--------HHHHHHHHHHHHHHHHhc
Confidence 3458888999999999999999999999862 34699999974321 12246788999999999
Q ss_pred CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--------------CCCCHHH
Q 048724 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------------KKLAFKV 212 (394)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------------~~l~~~~ 212 (394)
+||||++++++|.+...+ |+||||+++|+|.+++..... ..+++..
T Consensus 145 ~hpnIv~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPL--------------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204 (370)
T ss_dssp CCTTBCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHH
T ss_pred CCCCEeeEEEEEccCCCE--------------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHH
Confidence 899999999999876655 899999999999999976432 3589999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCc
Q 048724 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNR 290 (394)
Q Consensus 213 ~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 290 (394)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.
T Consensus 205 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 284 (370)
T 2psq_A 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284 (370)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc
Confidence 99999999999999999999999999999999999999999999998543322 2233356788999999999999999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 291 KCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 291 ~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
++|||||||++|||++ |..||.+....+....+ ..+.+...+..++.++.++|.+||+.||++|||+.++++.|+++.
T Consensus 285 ~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 285 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999 99999998887777554 445566778889999999999999999999999999999999997
Q ss_pred hccC
Q 048724 370 TSKG 373 (394)
Q Consensus 370 ~~~~ 373 (394)
+...
T Consensus 364 ~~~~ 367 (370)
T 2psq_A 364 TLTT 367 (370)
T ss_dssp HHHC
T ss_pred HHhc
Confidence 6543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=380.99 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=220.4
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+..++|++.+.||+|+||+||+|++ +|+.||||+++.... ........+.+|+.+++.++||||++++++|.
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh------hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 4578999999999999999999988 688999999974311 11112356778999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+.+.+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 76 ~~~~~--------------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 133 (337)
T 1o6l_A 76 THDRL--------------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp CSSEE--------------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred eCCEE--------------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCH
Confidence 76665 8999999999999998654 4699999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+....
T Consensus 134 ~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999999998544333444557899999999999999999999999999999999999999998888888
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
...+.... ..+|..+++++.+||.+||+.||++|| +++++++.
T Consensus 214 ~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 214 FELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 77776654 446778999999999999999999999 89999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=397.50 Aligned_cols=304 Identities=28% Similarity=0.471 Sum_probs=245.8
Q ss_pred CceEEecCCCCCChHHHHHHHhhhhhhhh-------h----ccCCCCCcccccccccccceeeeccCCceEEEEEEEC-C
Q 048724 41 DLFFRADKIDFKSWDIQLEKHLSRVWSRE-------R----EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD-G 108 (394)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~----~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-g 108 (394)
..++......|.++..++..+........ . .........|++..++|++.+.||+|+||+||+|.+. +
T Consensus 129 g~~~~~~~~~F~Sl~~Li~~y~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~ 208 (452)
T 1fmk_A 129 GGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208 (452)
T ss_dssp SCEESSTTSEESSHHHHHHHHTTCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT
T ss_pred CCEEEecCcccCCHHHHHHHhhhccccchhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCC
Confidence 45777777889999888776543221100 0 0011225679999999999999999999999999994 4
Q ss_pred eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEE
Q 048724 109 QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188 (394)
Q Consensus 109 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~ 188 (394)
..||||+++.... . .+.|.+|+.+|++++||||+++++++.+ .. .|+||
T Consensus 209 ~~vavK~~~~~~~---~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~--------------------~~iv~ 257 (452)
T 1fmk_A 209 TRVAIKTLKPGTM---S-------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP--------------------IYIVT 257 (452)
T ss_dssp EEEEEEECCTTSS---C-------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS--------------------CEEEE
T ss_pred ceEEEEEeccCCC---C-------HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc--------------------eEEEe
Confidence 6899999975331 1 2568899999999999999999999864 22 28999
Q ss_pred ecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC-CC
Q 048724 189 EYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RD 267 (394)
Q Consensus 189 e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~ 267 (394)
||+++|+|.+++.......+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++...... ..
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999999976555679999999999999999999999999999999999999999999999999998543321 12
Q ss_pred ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHH
Q 048724 268 MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRK 346 (394)
Q Consensus 268 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 346 (394)
.....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+ ..+.+.+.+..+|..+.+||.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHH
Confidence 223456789999999998899999999999999999999 99999998888877665 4556677788899999999999
Q ss_pred hchhCCCCCCCHHHHHHHHHHHHhccCCCC
Q 048724 347 CWDANPDKRPVMDEVVKLLEAVNTSKGGGM 376 (394)
Q Consensus 347 cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~ 376 (394)
||+.||++|||++++++.|+.+........
T Consensus 417 cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred HccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 999999999999999999999986655444
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=369.08 Aligned_cols=261 Identities=28% Similarity=0.613 Sum_probs=226.8
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.|.+..++|++.+.||+|+||+||+|.+ +++.||+|+++..... .+.+.+|+.++++++||||++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~ 73 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGV 73 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 5889999999999999999999999998 7889999999744321 2457889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+.... |+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||
T Consensus 74 ~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~di 132 (269)
T 4hcu_A 74 CLEQAPI--------------------CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132 (269)
T ss_dssp ECSSSSE--------------------EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EecCCce--------------------EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCc
Confidence 9866554 8999999999999999653 356999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 133 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred chheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 9999999999999999999997543221 12233567788999999998889999999999999999999 999999988
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
..+....+. .......+..+++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 213 NSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHh-cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 887776654 4455666777899999999999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=373.62 Aligned_cols=249 Identities=24% Similarity=0.439 Sum_probs=216.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||++....... ...+.+|+.++++++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---------HHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 57899999999999999999987 78899999987543221 25677899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+||||++||+|.+++... .+++..++.++.|++.||.|||++|++||||||+|
T Consensus 90 ~~~--------------------~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 146 (297)
T 3fxz_A 90 DEL--------------------WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146 (297)
T ss_dssp TEE--------------------EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CEE--------------------EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHH
Confidence 554 8999999999999999653 59999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||++..............||+.|+|||.+.+..++.++|||||||++|+|++|..||..........
T Consensus 147 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 226 (297)
T 3fxz_A 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (297)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999865554444555789999999999999999999999999999999999999998887766665
Q ss_pred HHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.... .....+..++..+.+||.+||+.||++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 554433 2344566789999999999999999999999999873
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=378.97 Aligned_cols=251 Identities=27% Similarity=0.494 Sum_probs=219.5
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
...++|++.+.||+|+||+||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4468999999999999999999998 7899999999754321 122356788999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
....+ |+||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||
T Consensus 85 ~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp 142 (328)
T 3fe3_A 85 TEKTL--------------------YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142 (328)
T ss_dssp CSSEE--------------------EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred ECCEE--------------------EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCH
Confidence 66555 8999999999999999654 4599999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+|||++.++.+||+|||++...... ......+||+.|+|||.+.+..++ .++|||||||++|+|++|..||.+.+..+
T Consensus 143 ~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 143 ENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp GGEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HHEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999999754432 334456899999999999888765 79999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+..... .+|..+++++.+||.+||+.||.+|||++++++.
T Consensus 222 ~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 222 LRERVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8887776644 4566789999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=367.86 Aligned_cols=261 Identities=26% Similarity=0.503 Sum_probs=228.4
Q ss_pred ccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+.+..++|++.+.||+|+||+||+|+++++.||||+++..... ....+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS-------TRKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCC-------HHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccC-------HHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 36778899999999999999999999999999999999754311 11235688999999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRD 236 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiH~D 236 (394)
.+... ...++||||+++|+|.+++.......+++..++.++.|++.||.|||++| ++|||
T Consensus 77 ~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~d 138 (271)
T 3kmu_A 77 QSPPA------------------PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA 138 (271)
T ss_dssp CTTTS------------------SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCC
T ss_pred ccCCC------------------CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCC
Confidence 76522 22389999999999999998765557999999999999999999999999 99999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCc---cchHHHHHHHHHHHHhCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNR---KCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~elltg~~Pf~~ 313 (394)
|||+||+++.++.++|+|||++.... .....+|+.|+|||.+.+..++. ++||||||+++|+|++|..||..
T Consensus 139 ikp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 139 LNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp CSGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred CccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999999999999999875322 22357899999999998765444 79999999999999999999999
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
.+..+...........+..+..+++++.+++.+||+.||++|||++++++.|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 214 LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 99888888888888888888899999999999999999999999999999999885
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=385.20 Aligned_cols=273 Identities=27% Similarity=0.533 Sum_probs=231.1
Q ss_pred cCCCCCcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHH
Q 048724 72 VLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144 (394)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~ 144 (394)
..+.....|++..++|++.+.||+|+||+||+|.+ +++.||||+++.... ....+.+.+|+.+++
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~ 80 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILI 80 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHH
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--------HHHHHHHHHHHHHHH
Confidence 34555668999999999999999999999999984 347899999974321 111366889999999
Q ss_pred hC-CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc------------------
Q 048724 145 KL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR------------------ 205 (394)
Q Consensus 145 ~l-~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~------------------ 205 (394)
++ +||||+++++++.+... ..++||||+++|+|.+++.....
T Consensus 81 ~l~~hpniv~~~~~~~~~~~-------------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 141 (359)
T 3vhe_A 81 HIGHHLNVVNLLGACTKPGG-------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141 (359)
T ss_dssp HHCCCTTBCCEEEEECSTTS-------------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------
T ss_pred hhcCCcceeeeeeeeecCCC-------------------ceEEEEEecCCCcHHHHHHhccccccccccccchhhccccc
Confidence 99 89999999999876443 23899999999999999976432
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 206 ----------------------------------------------KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 206 ----------------------------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..+++..++.++.||+.||.|||++||+||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp 221 (359)
T 3vhe_A 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 221 (359)
T ss_dssp ------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred ccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 1289999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~ 316 (394)
+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 222 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 222 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 99999999999999999997543322 12334567889999999998999999999999999999998 9999998876
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
.+..............+..+++++.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 302 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 6666666666667778888999999999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=383.14 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=213.2
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 157 (394)
.+..++|++.+.||+|+||+||+|++ +|+.||||+++... .........+.+|..+++.+ +||||++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~------~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV------ILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH------hcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 45678999999999999999999988 68899999997421 11222345677899999998 79999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+...+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||
T Consensus 93 ~~~~~~~--------------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 150 (353)
T 3txo_A 93 FQTPDRL--------------------FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDL 150 (353)
T ss_dssp EECSSEE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred EEeCCEE--------------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Confidence 9876665 8999999999999999654 46999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 151 kp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 151 KLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999985443334445578999999999999888999999999999999999999999999988
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH------HHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM------DEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~------~~ll~ 363 (394)
+....+.... ..++..++.++.+||.+||+.||++||++ +++++
T Consensus 231 ~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 231 DLFEAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 8888887654 34567789999999999999999999998 77776
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=382.15 Aligned_cols=275 Identities=29% Similarity=0.549 Sum_probs=232.8
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 146 (394)
....|++..++|.+.+.||+|+||+||+|++. +..||||+++.... ......+.+|+.+++++
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l 131 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--------EKDLSDLISEMEMMKMI 131 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHH
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--------HHHHHHHHHHHHHHHHh
Confidence 44578999999999999999999999999862 25799999874321 12246788999999999
Q ss_pred -CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--------------CCCCHH
Q 048724 147 -DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------------KKLAFK 211 (394)
Q Consensus 147 -~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------------~~l~~~ 211 (394)
+||||+++++++...... |+||||+++|+|.+++..... ..+++.
T Consensus 132 ~~hpnIv~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~ 191 (382)
T 3tt0_A 132 GKHKNIINLLGACTQDGPL--------------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191 (382)
T ss_dssp CCCTTBCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHH
T ss_pred cCCchhhhheeeeccCCce--------------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHH
Confidence 999999999999876655 899999999999999976542 359999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCC
Q 048724 212 VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYN 289 (394)
Q Consensus 212 ~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 289 (394)
.++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++
T Consensus 192 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 999999999999999999999999999999999999999999999998543322 223335678899999999999999
Q ss_pred ccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 290 RKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 290 ~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.++|||||||++|+|++ |..||......+....+ ........+..+++++.+||.+||+.||++|||+.++++.|+++
T Consensus 272 ~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999 99999988887776555 45556677788999999999999999999999999999999999
Q ss_pred HhccCCCCCCC
Q 048724 369 NTSKGGGMIPE 379 (394)
Q Consensus 369 ~~~~~~~~~~~ 379 (394)
.........+.
T Consensus 351 ~~~~~~~~~~~ 361 (382)
T 3tt0_A 351 VALTSNQEMGY 361 (382)
T ss_dssp HHHSCSCC---
T ss_pred HHHHhcCCCCC
Confidence 87655544433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=397.13 Aligned_cols=297 Identities=26% Similarity=0.554 Sum_probs=245.7
Q ss_pred ceEEecCCCCCChHHHHHHHhhhhhhh--------hhcc------CCCCCcccccccccccceeeeccCCceEEEEEEE-
Q 048724 42 LFFRADKIDFKSWDIQLEKHLSRVWSR--------EREV------LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY- 106 (394)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~- 106 (394)
.++......|.++...+..+....-.. .+.. .......|++...+|++.+.||+|+||+||+|.+
T Consensus 163 ~~~~~~~~~F~sl~eLv~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~ 242 (495)
T 1opk_A 163 KLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK 242 (495)
T ss_dssp CEESSTTSCBSSHHHHHHHHTTCCTTSSSCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEG
T ss_pred ceEeccCccchhHHHHhhhhcccccccchhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEc
Confidence 455555667888877666553211100 0000 0112467999999999999999999999999998
Q ss_pred -CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceE
Q 048724 107 -DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185 (394)
Q Consensus 107 -~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (394)
++..||||+++..... .+.|.+|+.+|++++|||||+++++|.....+ |
T Consensus 243 ~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~--------------------~ 292 (495)
T 1opk_A 243 KYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF--------------------Y 292 (495)
T ss_dssp GGTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--------------------E
T ss_pred CCCeEEEEEEecCcccc----------hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE--------------------E
Confidence 4789999999743321 35688999999999999999999999876655 8
Q ss_pred EEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC
Q 048724 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265 (394)
Q Consensus 186 iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~ 265 (394)
+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999999987666779999999999999999999999999999999999999999999999999998653322
Q ss_pred -CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHH
Q 048724 266 -RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASI 343 (394)
Q Consensus 266 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 343 (394)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..++...+ ....+...+..+++.+.+|
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHH
Confidence 12223456789999999998889999999999999999999 99999998887776554 5566777888899999999
Q ss_pred HHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 344 MRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 344 i~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
|.+||+.||++|||+.+|++.|+.+.
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=365.69 Aligned_cols=258 Identities=33% Similarity=0.688 Sum_probs=214.8
Q ss_pred ccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
++..++|++.+.||+|+||+||+|.++|+.||||+++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcc-----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 466789999999999999999999999999999998743221 112224678899999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT---IVHRDV 237 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~---iiH~Dl 237 (394)
.... |+||||+++++|.+++. ...+++..++.++.|++.||.|||++| ++||||
T Consensus 78 ~~~~--------------------~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 78 EPNL--------------------CLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp C--C--------------------EEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred CCce--------------------EEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 6554 89999999999999984 346999999999999999999999999 899999
Q ss_pred CCCceeeCC--------CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCC
Q 048724 238 KTENMLLDA--------NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 238 kp~NIll~~--------~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~ 309 (394)
||+||+++. ++.+||+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCC
T ss_pred chHHEEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999985 6789999999997543322 223578999999999998889999999999999999999999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
||...+.................+..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 213 PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99998888888777777777778888999999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=376.54 Aligned_cols=265 Identities=29% Similarity=0.553 Sum_probs=224.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE--C---CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--D---GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+++..++|++.+.||+|+||+||+|.+ + +..||||+++.... ....+.+.+|+.++++++||||+++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~ 115 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--------ERQRRDFLSEASIMGQFDHPNIIRL 115 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--------HHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 567789999999999999999999988 2 34599999974321 1224678899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++.+.... |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 116 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 174 (325)
T 3kul_A 116 EGVVTRGRLA--------------------MIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174 (325)
T ss_dssp EEEECGGGCC--------------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEEeCCcc--------------------EEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 9999876555 8999999999999999653 356999999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMP 310 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~P 310 (394)
|||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 175 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 254 (325)
T 3kul_A 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254 (325)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999986543221 1222356778999999998889999999999999999999 9999
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
|......+....+. .......+..++..+.+||.+||+.||++|||+.++++.|+.+......
T Consensus 255 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 255 YWNMTNRDVISSVE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred cccCCHHHHHHHHH-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 99988888776654 4456667788999999999999999999999999999999999866443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=400.96 Aligned_cols=305 Identities=28% Similarity=0.469 Sum_probs=251.1
Q ss_pred CCceEEecCCCCCChHHHHHHHhhhhhhhh-------h----ccCCCCCcccccccccccceeeeccCCceEEEEEEEC-
Q 048724 40 KDLFFRADKIDFKSWDIQLEKHLSRVWSRE-------R----EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYD- 107 (394)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~----~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~- 107 (394)
...++......|.++..++..+........ . .........|++..++|++.+.||+|+||+||+|.+.
T Consensus 211 ~g~~~i~~~~~F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 290 (535)
T 2h8h_A 211 SGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 290 (535)
T ss_dssp CSCEEEETTEEESSHHHHHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT
T ss_pred CCcEEeeccccccChHHhheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECC
Confidence 345788888889999988776643321110 0 0011225679999999999999999999999999994
Q ss_pred CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEE
Q 048724 108 GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVV 187 (394)
Q Consensus 108 g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv 187 (394)
+..||||+++.... . .+.|.+|+.+|++++||||+++++++.+ .. +|+|
T Consensus 291 ~~~vavK~~~~~~~---~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~--------------------~~lv 339 (535)
T 2h8h_A 291 TTRVAIKTLKPGTM---S-------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP--------------------IYIV 339 (535)
T ss_dssp TEEEEEEEECTTSS---C-------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS--------------------CEEE
T ss_pred CceEEEEEeCCCCC---C-------HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc--------------------ceEe
Confidence 46899999975331 1 2568899999999999999999999864 22 2899
Q ss_pred EecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC-C
Q 048724 188 VEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-R 266 (394)
Q Consensus 188 ~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~ 266 (394)
|||+++|+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999999976555679999999999999999999999999999999999999999999999999997543211 1
Q ss_pred CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHH
Q 048724 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMR 345 (394)
Q Consensus 267 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 345 (394)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+ ..+.+...+..++..+.+||.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMC 498 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHH
Confidence 1223456789999999988889999999999999999999 99999998888877665 455666778889999999999
Q ss_pred HhchhCCCCCCCHHHHHHHHHHHHhccCCCC
Q 048724 346 KCWDANPDKRPVMDEVVKLLEAVNTSKGGGM 376 (394)
Q Consensus 346 ~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~ 376 (394)
+||+.||++|||+++|++.|+.+........
T Consensus 499 ~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 499 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred HHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 9999999999999999999999876655444
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=365.35 Aligned_cols=269 Identities=29% Similarity=0.561 Sum_probs=227.7
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
..+|++..++|++.+.||+|+||+||+|.+ ++..||||+++..... ...+.+|+.++++++||||++++
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~ 74 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVRLY 74 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----------HHHHHHHHHHHHhCCCcCcceEE
Confidence 457999999999999999999999999998 5668999998743321 25678899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.+. . .++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||
T Consensus 75 ~~~~~~-~--------------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 133 (279)
T 1qpc_A 75 AVVTQE-P--------------------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133 (279)
T ss_dssp EEECSS-S--------------------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred EEEcCC-C--------------------cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 987632 2 3899999999999999965444469999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 134 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999998654322 12223457789999999988889999999999999999999 9999998
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCCC
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMI 377 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~~ 377 (394)
....+....+ ........+..++.++.+++.+||+.||++|||+.++++.|+++.....+...
T Consensus 214 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 214 MTNPEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp CCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred cCHHHHHHHH-hcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 8877776655 34455666778999999999999999999999999999999999877655443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=368.05 Aligned_cols=264 Identities=29% Similarity=0.612 Sum_probs=230.6
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
....|++..++|++.+.||+|+||+||+|.+ ++..||+|+++.... ..+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~ 73 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQ 73 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----------HHHHHHHHHHHHHhCCCCCEee
Confidence 4467999999999999999999999999998 488999999874321 1356788999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+++++.+.... |+||||+++++|.+++.......+++..++.++.|++.||.|||++|++
T Consensus 74 ~~~~~~~~~~~--------------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 133 (288)
T 3kfa_A 74 LLGVCTREPPF--------------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133 (288)
T ss_dssp EEEEECSSSSE--------------------EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred EEEEEccCCCE--------------------EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999866554 8999999999999999876667799999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPY 311 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf 311 (394)
||||||+||+++.++.++|+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 134 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~ 213 (288)
T 3kfa_A 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213 (288)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998644332 12233456788999999998899999999999999999999 99999
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
...+.......+ ........+..+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 214 PGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp TTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHH-hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 988877776554 4455667778899999999999999999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=370.82 Aligned_cols=271 Identities=29% Similarity=0.534 Sum_probs=231.9
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-C
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-D 147 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 147 (394)
....|++..++|++.+.||+|+||+||+|++ +++.||||+++.... ....+.+.+|+.+++++ +
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~ 85 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYLGN 85 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCC
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--------HHHHHHHHHHHHHHhhccc
Confidence 4567899999999999999999999999985 457899999974321 11236788999999999 9
Q ss_pred CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc----------------CCCCHH
Q 048724 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR----------------KKLAFK 211 (394)
Q Consensus 148 h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~----------------~~l~~~ 211 (394)
||||+++++++.+.... ++||||+++|+|.+++..... ..+++.
T Consensus 86 h~~i~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (313)
T 1t46_A 86 HMNIVNLLGACTIGGPT--------------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145 (313)
T ss_dssp CTTBCCEEEEECSSSSC--------------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred CCCeeeEEEEEecCCCc--------------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHH
Confidence 99999999999876554 899999999999999976542 248999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCC
Q 048724 212 VVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYN 289 (394)
Q Consensus 212 ~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 289 (394)
.++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........ ......+|+.|+|||.+.+..++
T Consensus 146 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 225 (313)
T 1t46_A 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC
Confidence 9999999999999999999999999999999999999999999999975443322 12234567899999999888999
Q ss_pred ccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 290 RKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 290 ~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.++||||||+++|+|++ |..||.....................+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 226 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 99999999999999998 99999888776666666666667777788999999999999999999999999999999999
Q ss_pred HhccCC
Q 048724 369 NTSKGG 374 (394)
Q Consensus 369 ~~~~~~ 374 (394)
.....+
T Consensus 306 ~~~~~~ 311 (313)
T 1t46_A 306 ISESTN 311 (313)
T ss_dssp HHHTCC
T ss_pred HHHhhc
Confidence 865443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=378.55 Aligned_cols=270 Identities=27% Similarity=0.492 Sum_probs=226.9
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 148 (394)
..+|++..++|++.+.||+|+||+||+|.+ ++..||||+++.... ......+.+|+.+++++ +|
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h 108 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------SSEREALMSELKMMTQLGSH 108 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCC
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--------HHHHHHHHHHHHHHHhhcCC
Confidence 346899999999999999999999999986 345799999973321 12246788999999999 99
Q ss_pred CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc---------------------CC
Q 048724 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR---------------------KK 207 (394)
Q Consensus 149 ~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~---------------------~~ 207 (394)
|||+++++++...+.. |+||||+++|+|.+++..... ..
T Consensus 109 p~iv~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (344)
T 1rjb_A 109 ENIVNLLGACTLSGPI--------------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168 (344)
T ss_dssp TTBCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred CCeeeEEEEEeeCCcc--------------------EEEEecCCCCcHHHHHhhccccccccccchhhhccccccccccc
Confidence 9999999999876554 899999999999999976432 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCC
Q 048724 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDG 285 (394)
Q Consensus 208 l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~ 285 (394)
+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence 79999999999999999999999999999999999999999999999999975433221 1223457889999999988
Q ss_pred CCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 286 KPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 286 ~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..++.++||||||+++|+|++ |..||.....................+..+++++.+||.+||+.||++|||+.++++.
T Consensus 249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 889999999999999999998 9999998877776667777777777888899999999999999999999999999999
Q ss_pred HHHHHhccCC
Q 048724 365 LEAVNTSKGG 374 (394)
Q Consensus 365 l~~~~~~~~~ 374 (394)
|+.+.....+
T Consensus 329 l~~~~~~~~~ 338 (344)
T 1rjb_A 329 LGCQLADAEE 338 (344)
T ss_dssp HHHHC-----
T ss_pred HHHHHHHHHH
Confidence 9998765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=364.75 Aligned_cols=262 Identities=26% Similarity=0.542 Sum_probs=224.0
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
...|++..++|++.+.||+|+||+||+|.+ ++..||||+++..... ...+.+|+.++++++||||++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----------HHHHHHHHHHHhcCCCCCEeeEE
Confidence 457899999999999999999999999998 5668999999744321 24578899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.+.... |+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||
T Consensus 86 ~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 144 (283)
T 3gen_A 86 GVCTKQRPI--------------------FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144 (283)
T ss_dssp EEECSSSSE--------------------EEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEecCCCe--------------------EEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 999766554 8999999999999999653 3469999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
||||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 145 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp SCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999997543221 12233457788999999998889999999999999999998 9999998
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
....+....+. .......+..+++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 225 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 225 FTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp SCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhHHHHHHh-cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 88877776654 445566677789999999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=362.74 Aligned_cols=260 Identities=29% Similarity=0.551 Sum_probs=224.0
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.|++..++|++.+.||+|+||+||+|.+ ++..||+|+++..... ...+.+|+.++++++||||++++++
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~ 71 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----------EDEFFQEAQTMMKLSHPKLVKFYGV 71 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4678889999999999999999999988 5668999999754321 2457889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+.... ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||
T Consensus 72 ~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 130 (268)
T 3sxs_A 72 CSKEYPI--------------------YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130 (268)
T ss_dssp ECSSSSE--------------------EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSC
T ss_pred EccCCce--------------------EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCc
Confidence 9766554 8999999999999999764 346999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
||+||+++.++.++|+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 131 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp SGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 9999999999999999999997543332 12233456778999999998889999999999999999999 999999888
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
..+....+. .......+..+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 211 NSEVVLKVS-QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred hHHHHHHHH-cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 877776654 344555667789999999999999999999999999999998853
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=378.42 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=216.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 156 (394)
..+..++|++.+.||+|+||+||+|++ +|+.||||+++.... ........+..|..+++.+ +||||+++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV------LMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh------hhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 456689999999999999999999998 688999999974321 1111235567789999877 9999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.+...+ |+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 86 ~~~~~~~~--------------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 143 (345)
T 1xjd_A 86 TFQTKENL--------------------FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRD 143 (345)
T ss_dssp EEECSSEE--------------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred EEEeCCEE--------------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 99876665 8999999999999999654 4699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 144 lkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999999998543333344557899999999999999999999999999999999999999999888
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH-HHHH
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMD-EVVK 363 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~-~ll~ 363 (394)
.+....+.... +.++..++.++.+||.+||+.||++||++. ++++
T Consensus 224 ~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 224 EELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 88887776553 456777999999999999999999999997 6653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=385.44 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=218.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-------SARDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 47899999999999999999987 789999999974431 112246688999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~--------------------~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~N 140 (444)
T 3soa_A 83 GHH--------------------YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPEN 140 (444)
T ss_dssp SEE--------------------EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTT
T ss_pred CEE--------------------EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 665 8999999999999999654 569999999999999999999999999999999999
Q ss_pred eeeC---CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLD---ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~---~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||++ .++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 141 Ill~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~ 220 (444)
T 3soa_A 141 LLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220 (444)
T ss_dssp EEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence 9998 4678999999999866554444556789999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+.......+.+ ..+++++.+||.+||+.||++|||+.++++.
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 888887765544333 4689999999999999999999999999973
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=377.53 Aligned_cols=268 Identities=30% Similarity=0.465 Sum_probs=217.1
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
...++|.+..++|++.+.||+|+||+||+|++.++.||||+++... . ....+..|+.++++++||||+++
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~----~~~~~~~E~~~l~~l~hpniv~~ 83 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD------K----QSWQNEYEVYSLPGMKHENILQF 83 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG------H----HHHHHHHHHHTSTTCCCTTBCCE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc------h----HHHHHHHHHHHHhcCCCCCchhh
Confidence 4566789999999999999999999999999999999999986332 1 12344568999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK---- 230 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---- 230 (394)
++++...... ...+|+||||+++|+|.+++... .+++..++.++.|++.||.|||+.
T Consensus 84 ~~~~~~~~~~----------------~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l 144 (322)
T 3soc_A 84 IGAEKRGTSV----------------DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGL 144 (322)
T ss_dssp EEEEEEECSS----------------SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEE
T ss_pred cceeccCCCC----------------CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 9999764431 12348999999999999999653 499999999999999999999999
Q ss_pred ------CCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCC-----CCCccchHHHH
Q 048724 231 ------TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGK-----PYNRKCDVYSF 297 (394)
Q Consensus 231 ------~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvwsl 297 (394)
|++||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+. .++.++|||||
T Consensus 145 ~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp TTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred ccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 99999999999999999999999999997544322 223335799999999999873 45668899999
Q ss_pred HHHHHHHHhCCCCCCCCC----------------hhhHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhchhCCCCCC
Q 048724 298 GICLWEIYCCDMPYPDLS----------------FTDVSSAVVRQNLRPDIPR-----CCPSSLASIMRKCWDANPDKRP 356 (394)
Q Consensus 298 G~~l~elltg~~Pf~~~~----------------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cL~~dP~~Rp 356 (394)
||++|||++|+.||.+.. .............++..+. .++.++.+||.+||+.||++||
T Consensus 225 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (322)
T 3soc_A 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304 (322)
T ss_dssp HHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc
Confidence 999999999999996532 2222333333333343332 2345699999999999999999
Q ss_pred CHHHHHHHHHHHHhc
Q 048724 357 VMDEVVKLLEAVNTS 371 (394)
Q Consensus 357 t~~~ll~~l~~~~~~ 371 (394)
|+.++++.|+++...
T Consensus 305 s~~ell~~L~~l~~~ 319 (322)
T 3soc_A 305 SAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHH
Confidence 999999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=364.48 Aligned_cols=261 Identities=30% Similarity=0.622 Sum_probs=220.3
Q ss_pred CcccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
...|.+..++|++.+.||+|+||+||+|.++|+.||||+++... ..+.+.+|+.++++++||||+++++
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLG 81 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEE
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34688999999999999999999999999999999999986332 1356888999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++..... ..|+||||+++++|.+++.......+++..++.++.|++.||.|||++|++|||
T Consensus 82 ~~~~~~~-------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 142 (278)
T 1byg_A 82 VIVEEKG-------------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142 (278)
T ss_dssp EECCC---------------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEcCCC-------------------ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 8764332 238999999999999999776555589999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
|||+||+++.++.+||+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 143 LAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp CSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred CCcceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998754322 223467889999999998889999999999999999998 999999888
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
..+....+ ........+..+++.+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 220 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 220 LKDVVPRV-EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp GGGHHHHH-TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 77776554 44456667788999999999999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=375.80 Aligned_cols=265 Identities=29% Similarity=0.537 Sum_probs=225.2
Q ss_pred cccccccccccceeeeccCCceEEEEEEECC-------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDG-------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n 150 (394)
..+++..++|++.+.||+|+||+||+|++.+ +.||||+++.... ......+.+|+.++++++|||
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~ 111 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDNPN 111 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHHTCCCTT
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCC
Confidence 3467788999999999999999999998843 7899999874321 123467889999999999999
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----------------------cCCC
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----------------------RKKL 208 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----------------------~~~l 208 (394)
|+++++++.+.... |+||||+++|+|.+++.... ...+
T Consensus 112 iv~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (343)
T 1luf_A 112 IVKLLGVCAVGKPM--------------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171 (343)
T ss_dssp BCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHTCC----------------------CCC
T ss_pred EEEEEEEEccCCce--------------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCC
Confidence 99999999876554 89999999999999997642 1569
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCC
Q 048724 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGK 286 (394)
Q Consensus 209 ~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 286 (394)
++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+.
T Consensus 172 ~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 999999999999999999999999999999999999999999999999997543221 222335678999999999988
Q ss_pred CCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 287 PYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 287 ~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.++.++||||||+++|+|++ |..||......+....+.. +.....+..++.++.++|.+||+.||++|||+.++++.|
T Consensus 252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 89999999999999999999 9999998888777766544 344556778999999999999999999999999999999
Q ss_pred HHHHhc
Q 048724 366 EAVNTS 371 (394)
Q Consensus 366 ~~~~~~ 371 (394)
+++...
T Consensus 331 ~~~~~~ 336 (343)
T 1luf_A 331 QRMCER 336 (343)
T ss_dssp HHTTC-
T ss_pred HHHHhh
Confidence 998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=374.19 Aligned_cols=265 Identities=31% Similarity=0.511 Sum_probs=216.9
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.+.+..++|.+.+.||+|+||+||+|.+ +++.||+|++.... ......+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~~~~ 74 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---------EETQRTFLKEVKVMRCLEHPNVLKFIG 74 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCcCcccEEE
Confidence 3556789999999999999999999998 58899999885321 122467889999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.+.... ++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|++|||
T Consensus 75 ~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~d 133 (310)
T 3s95_A 75 VLYKDKRL--------------------NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133 (310)
T ss_dssp EEEETTEE--------------------EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEecCCee--------------------EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 99876554 8999999999999999763 35699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCC--------------ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRD--------------MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
|||+|||++.++.+||+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|
T Consensus 134 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 213 (310)
T 3s95_A 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213 (310)
T ss_dssp CSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence 9999999999999999999999754322111 11457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHH-HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 303 EIYCCDMPYPDLSFTDVSS-AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 303 elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
+|++|..||.......... ...........+..+++.+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 214 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 214 EIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999986543211100 0000011122456788999999999999999999999999999999986543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=359.64 Aligned_cols=261 Identities=28% Similarity=0.613 Sum_probs=225.7
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
+|.+..++|++.+.||+|+||+||+|.+ +++.||+|+++..... .+.+.+|+.++++++||||++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~ 71 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGV 71 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 5889999999999999999999999998 7789999999754321 2567889999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+.... ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||
T Consensus 72 ~~~~~~~--------------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 130 (267)
T 3t9t_A 72 CLEQAPI--------------------CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130 (267)
T ss_dssp ECSSSSC--------------------EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred EccCCCe--------------------EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9876554 8999999999999999654 356899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 315 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~ 315 (394)
||+||+++.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 131 ~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred chheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 9999999999999999999997543211 12233467789999999998889999999999999999999 899999888
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
..+....+. .......+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 211 ~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 211 NSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHh-cCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 777776654 4445566777899999999999999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=369.31 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=217.4
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+..++|++.+.||+|+||+||+|+. +|+.||+|+++.... ........+.+|..+++.++||||+++++++.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 3468999999999999999999988 688999999974321 11112356778999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+...+ |+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 77 ~~~~~--------------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 134 (318)
T 1fot_A 77 DAQQI--------------------FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 134 (318)
T ss_dssp CSSEE--------------------EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred eCCEE--------------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 76655 8999999999999999653 4699999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+|||++.++.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+....
T Consensus 135 ~NIll~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 211 (318)
T 1fot_A 135 ENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211 (318)
T ss_dssp GGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred heEEEcCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999985432 23346899999999999999999999999999999999999999998888888
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~ 363 (394)
...+.... ..++..++.++.++|.+||+.||++|| +++++++
T Consensus 212 ~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 212 YEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 87776654 346677899999999999999999999 8999886
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=375.28 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=217.2
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 157 (394)
.+..++|++.+.||+|+||+||+|++ +|+.||||+++.... ........+..|..++..+ +||||++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV------IQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH------HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 35678999999999999999999998 467899999974321 1111235677899999888 89999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+...+ |+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 90 ~~~~~~~--------------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 147 (353)
T 2i0e_A 90 FQTMDRL--------------------YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147 (353)
T ss_dssp EECSSEE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred EEcCCEE--------------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccC
Confidence 9876655 8999999999999999654 45999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 148 kp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 148 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999985433334445578999999999999999999999999999999999999999998888
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
++...+.... ..+|..++.++.+||.+||+.||++||+ ++++++.
T Consensus 228 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 228 ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 8888877654 4467789999999999999999999995 5777653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=379.19 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=211.8
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 156 (394)
..+..++|++.++||+|+||+||+|++ +++.||||+++...... ......+..|..++.++ +|||||++++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~------~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 120 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND------DEDIDWVQTEKHVFEQASNHPFLVGLHS 120 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----------CCHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC------HHHHHHHHHHHHHHHhcCCCCCcCeeEE
Confidence 456788999999999999999999988 67899999998543211 11124567899999887 8999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|.+...+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+|||
T Consensus 121 ~~~~~~~~--------------------~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 178 (396)
T 4dc2_A 121 CFQTESRL--------------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRD 178 (396)
T ss_dssp EEECSSEE--------------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred EEEECCEE--------------------EEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecc
Confidence 99876665 8999999999999999654 4699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS- 315 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~- 315 (394)
|||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 179 LKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~ 258 (396)
T 4dc2_A 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258 (396)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC
T ss_pred CCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 9999999999999999999999854444444556789999999999999999999999999999999999999996431
Q ss_pred --------hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH------HHHHH
Q 048724 316 --------FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM------DEVVK 363 (394)
Q Consensus 316 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~------~~ll~ 363 (394)
.......+... ...+|..++.++.+||.+||+.||++||++ .++++
T Consensus 259 ~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 259 SDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ------CCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccccchhhHHHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 22233344333 455777899999999999999999999985 56655
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=369.14 Aligned_cols=266 Identities=29% Similarity=0.546 Sum_probs=227.5
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~ 149 (394)
...|++..++|.+.+.||+|+||.||+|.+ +++.||||+++.... ....+.+.+|+.++++++||
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp 86 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--------PSELRDLLSEFNVLKQVNHP 86 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHTTCCCT
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--------HHHHHHHHHHHHHHhhCCCC
Confidence 457889999999999999999999999976 237899999874321 12236688999999999999
Q ss_pred cceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc----------------------CC
Q 048724 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR----------------------KK 207 (394)
Q Consensus 150 nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~----------------------~~ 207 (394)
||+++++++.+.... |+||||+++|+|.+++..... ..
T Consensus 87 ~iv~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (314)
T 2ivs_A 87 HVIKLYGACSQDGPL--------------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146 (314)
T ss_dssp TBCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred ceeeEEEEEecCCce--------------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence 999999999866554 899999999999999976432 34
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCC
Q 048724 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDG 285 (394)
Q Consensus 208 l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~ 285 (394)
+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....... ......+++.|+|||.+.+
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 226 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence 89999999999999999999999999999999999999999999999999975433221 2233467889999999998
Q ss_pred CCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 286 KPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 286 ~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..++.++||||||+++|+|++ |..||...........+ ........+..+++++.+++.+||+.||++|||+.++++.
T Consensus 227 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 889999999999999999999 99999988887776554 4445566778899999999999999999999999999999
Q ss_pred HHHHHhc
Q 048724 365 LEAVNTS 371 (394)
Q Consensus 365 l~~~~~~ 371 (394)
|+++...
T Consensus 306 l~~~~~~ 312 (314)
T 2ivs_A 306 LEKMMVK 312 (314)
T ss_dssp HHHHHHT
T ss_pred HHHHHhh
Confidence 9998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=371.61 Aligned_cols=252 Identities=23% Similarity=0.404 Sum_probs=212.4
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGAS 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 158 (394)
+..++|++.+.||+|+||+||+|++ +++.||||+++..... . ......+.+|..+++++ +||||++++++|
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~----~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--D----DEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--S----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--c----hHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 4578999999999999999999998 6889999999754321 1 12235677899999988 899999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+...+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 80 ~~~~~~--------------------~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 137 (345)
T 3a8x_A 80 QTESRL--------------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLK 137 (345)
T ss_dssp ECSSEE--------------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred EeCCEE--------------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 876655 8999999999999999654 469999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC----
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL---- 314 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~---- 314 (394)
|+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 138 p~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 217 (345)
T 3a8x_A 138 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217 (345)
T ss_dssp GGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--
T ss_pred HHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccc
Confidence 9999999999999999999985433334445578999999999999999999999999999999999999999652
Q ss_pred -----ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH------HHHHH
Q 048724 315 -----SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM------DEVVK 363 (394)
Q Consensus 315 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~------~~ll~ 363 (394)
........+... ...+|..++.++.+||.+||+.||++||++ .++++
T Consensus 218 ~~~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 218 NPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -----CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ccccccHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 222333344433 345677899999999999999999999985 56665
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=367.59 Aligned_cols=264 Identities=26% Similarity=0.510 Sum_probs=214.7
Q ss_pred ccccccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
++..++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|+.++++++||||+++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~ 76 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---------EEHLRDFEREIEILKSLQHDNIVKY 76 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 45678999999999999999999984 57899999986332 1223578899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++...+.. .+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++|++|
T Consensus 77 ~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (295)
T 3ugc_A 77 KGVCYSAGRR------------------NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIH 137 (295)
T ss_dssp EEEECHHHHT------------------SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEecCCCC------------------ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 9998654331 2389999999999999997643 45999999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
|||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 138 ~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp SCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence 99999999999999999999999986433221 122345677899999999889999999999999999999999988
Q ss_pred CCCChhh---------------HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 312 PDLSFTD---------------VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 312 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
....... ..........+.+.+..+++++.++|.+||+.||++|||+.++++.|+++...-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 5432110 111223445566677889999999999999999999999999999999997653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=378.51 Aligned_cols=264 Identities=30% Similarity=0.525 Sum_probs=223.0
Q ss_pred ccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
.+++..++|++.+.||+|+||+||+|++ ++..||||+++.... . .....+.+|+.++++++||||
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~hpnI 136 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS----E----QDELDFLMEALIISKFNHQNI 136 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC----H----HHHHHHHHHHHHHHHCCCTTB
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC----h----hhHHHHHHHHHHHHhCCCCCC
Confidence 3567788999999999999999999984 456899999863221 1 113467889999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHH
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-----KKLAFKVVIQIALDLARGLSY 226 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~y 226 (394)
+++++++.+.... |+||||+++|+|.+++..... ..+++..++.++.||+.||.|
T Consensus 137 v~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 196 (367)
T 3l9p_A 137 VRCIGVSLQSLPR--------------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196 (367)
T ss_dssp CCEEEEECSSSSC--------------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEecCCCC--------------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHH
Confidence 9999999876655 899999999999999976432 358999999999999999999
Q ss_pred HHhCCCcccCCCCCceeeCCCC---cEEEeeccccccccC--CCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHH
Q 048724 227 LHSKTIVHRDVKTENMLLDANR---TLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301 (394)
Q Consensus 227 LH~~~iiH~Dlkp~NIll~~~~---~vkl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l 301 (394)
||++||+||||||+|||++.++ .+||+|||+++.... .........+|+.|+|||.+.+..++.++|||||||++
T Consensus 197 LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999999998554 599999999974322 11222335678999999999888999999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 302 WEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 302 ~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|||++ |..||......+....+.. ......+..++..+.+||.+||+.||++|||+.++++.|+.+...
T Consensus 277 ~ellt~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 99998 9999999888887766544 445666778999999999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=366.14 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=212.3
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccch-----------------HHHHHHHHHHHHHHHH
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTS-----------------AEAAAIRASFRQEVAV 142 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~i 142 (394)
+..++|++.+.||+|+||+||+|.+ +++.||||+++......... .......+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4578999999999999999999987 68899999997543211000 0011223568899999
Q ss_pred HHhCCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHH
Q 048724 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~ 222 (394)
+++++||||+++++++.+... ..+|+||||+++++|.+++ ....+++..++.++.||+.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~------------------~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~ 148 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNE------------------DHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIK 148 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSS------------------SEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCCC------------------CEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHH
Confidence 999999999999999875322 2349999999999998764 3356999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC---CCccchHHHHHH
Q 048724 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP---YNRKCDVYSFGI 299 (394)
Q Consensus 223 ~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~ 299 (394)
||.|||++|++||||||+|||++.++.+||+|||+++.............||+.|+|||.+.+.. ++.++|||||||
T Consensus 149 ~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 228 (298)
T 2zv2_A 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228 (298)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHH
T ss_pred HHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHH
Confidence 99999999999999999999999999999999999986544333344568999999999998765 377899999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 300 CLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 300 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
++|+|++|..||...........+.......+....+++++.+||.+||+.||++|||+.++++.
T Consensus 229 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 229 TLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999999999998887777766666555544456789999999999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=362.52 Aligned_cols=263 Identities=30% Similarity=0.581 Sum_probs=213.2
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
..+|++..++|++.+.||+|+||+||+|.+. +..||+|+++... .....+.+.+|+.++++++||||
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i 78 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--------SDSVREKFLQEALTMRQFDHPHI 78 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--------SHHHHHHHHHHHHHHHTCCCTTB
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCcc
Confidence 3468889999999999999999999999872 3469999886322 12234678899999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
+++++++.+. . .|+||||+++++|.+++... ...+++..++.++.|++.||.|||++|
T Consensus 79 v~~~~~~~~~-~--------------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 136 (281)
T 1mp8_A 79 VKLIGVITEN-P--------------------VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR 136 (281)
T ss_dssp CCEEEEECSS-S--------------------CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceEEEEEccC-c--------------------cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999997432 2 38999999999999999654 346999999999999999999999999
Q ss_pred CcccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 232 IVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
++||||||+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~ 216 (281)
T 1mp8_A 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216 (281)
T ss_dssp CCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred eecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999997543322 12223456789999999998889999999999999999996 999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
||......+....+.. ......+..+++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 217 pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 217 PFQGVKNNDVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TTTTCCGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9998888777766544 34556777899999999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=376.39 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=216.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|++.+.||+|+||+||+|++ +|+.||+|+++......... ......+.+|+.++++++||||++++++|.+.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc---hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 36799999999999999999998 68899999998654221100 00135678899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~--------------------~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N 145 (361)
T 2yab_A 88 TDV--------------------VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145 (361)
T ss_dssp SEE--------------------EEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CEE--------------------EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 655 899999999999999954 3569999999999999999999999999999999999
Q ss_pred eeeCCCC----cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 242 MLLDANR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 242 Ill~~~~----~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||++.++ .+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 146 Ill~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~ 224 (361)
T 2yab_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (361)
T ss_dssp EEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred EEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9998776 7999999999865432 2334568999999999999999999999999999999999999999998888
Q ss_pred hHHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 318 DVSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+....+.......+ .+..++..+++||.+||..||++|||+.++++
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 88877765544322 22568999999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=364.95 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=215.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +++.||+|++...... .......+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE------KEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC------CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc------cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 57899999999999999999987 6889999998643321 122346788999999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||++|++|.+++... .++++..++.++.|++.||.|||++|++||||||+|
T Consensus 84 ~~~--------------------~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 141 (294)
T 4eqm_A 84 DCY--------------------YLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQN 141 (294)
T ss_dssp SEE--------------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CeE--------------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 555 8999999999999999654 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 142 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 221 (294)
T 4eqm_A 142 ILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221 (294)
T ss_dssp EEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred EEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999997543322 2223357999999999999999999999999999999999999999988877666
Q ss_pred HHHHhccCCC---CCCCCCcHHHHHHHHHhchhCCCCCC-CHHHHHHHHHHHHh
Q 048724 321 SAVVRQNLRP---DIPRCCPSSLASIMRKCWDANPDKRP-VMDEVVKLLEAVNT 370 (394)
Q Consensus 321 ~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~Rp-t~~~ll~~l~~~~~ 370 (394)
.......... ..+..+|+.+.++|.+||+.||++|| +++++.+.|+.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 5554433221 23456899999999999999999998 99999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=372.76 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=216.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||+|+++..... . ...+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---A----RDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---H----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 46899999999999999999998 6889999999754321 1 1235688999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||++||+|.+++.. +..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~~--------------------~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~N 158 (362)
T 2bdw_A 101 SFH--------------------YLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 158 (362)
T ss_dssp SEE--------------------EEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred CEE--------------------EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHH
Confidence 655 899999999999999854 3569999999999999999999999999999999999
Q ss_pred eeeCCC---CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDAN---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~---~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||++.+ +.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 159 Ill~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 159 LLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp EEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999764 45999999999765432 23345689999999999999999999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+.......+.+ ..+++++.+||.+||+.||++|||+.++++.
T Consensus 238 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 238 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 887776665543333 4579999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=377.98 Aligned_cols=262 Identities=28% Similarity=0.576 Sum_probs=212.8
Q ss_pred cccccccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
.++...+|++.+.||+|+||+||+|++. +..||||+++.... ....+.|.+|+.++++++||||+++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~ 111 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--------EKQRRDFLGEASIMGQFDHPNIIRL 111 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--------HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 4567789999999999999999999863 56799999874321 1224678899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++.+.... |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 112 ~~~~~~~~~~--------------------~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (373)
T 2qol_A 112 EGVVTKSKPV--------------------MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170 (373)
T ss_dssp EEEECSSSSC--------------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEeeCCce--------------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 9999876554 8999999999999999654 346999999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMP 310 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~P 310 (394)
|||||+|||++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 171 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred CCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999865432211 112345778999999998899999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|......+....+ ..+.+.+.+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 251 ~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 251 YWEMSNQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TTTCCHHHHHHHH-HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHH-HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 9988887777655 34445556678999999999999999999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=372.28 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=219.0
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
....++|++.+.||+|+||+||+|++ +|+.||||+++.... ........+.+|+.+++.++||||+++++++
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh------ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34578999999999999999999998 688999999974321 1112245678899999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+...+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 111 ~~~~~~--------------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 168 (350)
T 1rdq_E 111 KDNSNL--------------------YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168 (350)
T ss_dssp ECSSEE--------------------EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred EcCCEE--------------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCc
Confidence 876655 8999999999999999754 459999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+|||++.++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 169 p~NIll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 245 (350)
T 1rdq_E 169 PENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cceEEECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence 99999999999999999999854332 234689999999999999999999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
....+.... ..++..++.++.++|.+||+.||++||+ ++++++.
T Consensus 246 ~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 246 IYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 887777654 4567789999999999999999999998 8888763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=366.55 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=209.2
Q ss_pred cccccccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
..+..++|++.+.||+|+||+||+|+. +|+.||+|+++..... ........+.+|+.++++++||||+++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~ 86 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-----RNAKDTAHTKAERNILEEVKHPFIVDL 86 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCCE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHHhCCCCCccce
Confidence 456678999999999999999999986 5789999999743211 111223567789999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++.....+ |+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 87 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH 144 (327)
T 3a62_A 87 IYAFQTGGKL--------------------YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIY 144 (327)
T ss_dssp EEEEECSSCE--------------------EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eEEEEcCCEE--------------------EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 9999876555 8999999999999999654 46899999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||||+|||++.++.+||+|||+++.............||+.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 145 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp CCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999975433333344568999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
+..+....+.... ..++..++.++.+||.+||+.||++|| ++.++++.
T Consensus 225 ~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 225 NRKKTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp SHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 8888777776653 346677899999999999999999999 78888763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=363.23 Aligned_cols=252 Identities=28% Similarity=0.425 Sum_probs=207.9
Q ss_pred ccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
-.++|++.+.||+|+||+||+|++ +|+.||||+++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-------DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-------cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 368999999999999999999998 788999999864321 222346678899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||++ |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~~~--------------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~N 149 (311)
T 3niz_A 92 RCL--------------------TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQN 149 (311)
T ss_dssp SCE--------------------EEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHh
Confidence 554 89999997 5888888654 3569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||++.++.+||+|||+++.............+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+..
T Consensus 150 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 229 (311)
T 3niz_A 150 LLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229 (311)
T ss_dssp EEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH
T ss_pred EEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999866544444555688999999999876 56899999999999999999999999887766665
Q ss_pred HHHHhccCCCC----------------------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 321 SAVVRQNLRPD----------------------------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 321 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+......+. ....+++++.+||.+||+.||++|||++++++
T Consensus 230 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 55433110000 11346789999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=369.71 Aligned_cols=266 Identities=29% Similarity=0.524 Sum_probs=227.7
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC--C-----eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD--G-----QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 148 (394)
...|++..++|++.+.||+|+||+||+|.+. + ..||+|+++.... ......+.+|+.+++++ +|
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h 109 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--------ADEKEALMSELKIMSHLGQH 109 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCC
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--------hHHHHHHHHHHHHHHhhcCC
Confidence 3468999999999999999999999999873 2 3799999874321 11246788999999999 89
Q ss_pred CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc------------cCCCCHHHHHHH
Q 048724 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK------------RKKLAFKVVIQI 216 (394)
Q Consensus 149 ~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~------------~~~l~~~~~~~i 216 (394)
|||+++++++...... |+||||+++|+|.+++.... ...+++..++.+
T Consensus 110 ~~iv~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (333)
T 2i1m_A 110 ENIVNLLGACTHGGPV--------------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169 (333)
T ss_dssp TTBCCEEEEECSSSSC--------------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHH
T ss_pred CCeeeEEEEEecCCce--------------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHH
Confidence 9999999999876655 89999999999999997643 245899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchH
Q 048724 217 ALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDV 294 (394)
Q Consensus 217 ~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 294 (394)
+.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||
T Consensus 170 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 249 (333)
T 2i1m_A 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249 (333)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHH
Confidence 99999999999999999999999999999999999999999975433221 1223456789999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 295 YSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 295 wslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
||||+++|+|++ |..||.....................+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 250 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 999999999998 9999998877666666667777777788899999999999999999999999999999998864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=373.44 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=213.8
Q ss_pred cccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
..+.+..++|++.+.||+|+||+||+|.+ +++.||+|+++... .........+.+|+.+++.++|||||+++
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 81 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK------CVERNEVRNVFKELQIMQGLEHPFLVNLW 81 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh------cccHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 34677889999999999999999999988 67899999987432 11112235678899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
++|.+...+ |+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||
T Consensus 82 ~~~~~~~~~--------------------~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHr 139 (384)
T 4fr4_A 82 YSFQDEEDM--------------------FMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHR 139 (384)
T ss_dssp EEEECSSEE--------------------EEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EEEEeCCEE--------------------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 999876665 899999999999999965 3469999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 140 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 140 DMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcHHHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 99999999999999999999999865432 33445789999999999974 458999999999999999999999997
Q ss_pred CCCh---hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-HHHHHH
Q 048724 313 DLSF---TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-MDEVVK 363 (394)
Q Consensus 313 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-~~~ll~ 363 (394)
.... ......+.. ....++..++..+.+||.+||+.||++||+ +++++.
T Consensus 219 ~~~~~~~~~~~~~~~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 219 IRSSTSSKEIVHTFET--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCTTSCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCccHHHHHHHHhh--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 5433 333333322 245567789999999999999999999998 777765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=368.00 Aligned_cols=270 Identities=30% Similarity=0.578 Sum_probs=228.2
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEE---------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAY---------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 145 (394)
...+.|++..++|++.+.||+|+||+||+|.+ ++..||||+++.... ......+.+|+.++++
T Consensus 25 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~ 96 (334)
T 2pvf_A 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--------EKDLSDLVSEMEMMKM 96 (334)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--------HHHHHHHHHHHHHHHH
T ss_pred CCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--------HHHHHHHHHHHHHHHH
Confidence 34567999999999999999999999999986 346799999874321 1224668899999999
Q ss_pred C-CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--------------CCCCH
Q 048724 146 L-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------------KKLAF 210 (394)
Q Consensus 146 l-~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------------~~l~~ 210 (394)
+ +||||+++++++.....+ |+||||+++|+|.+++..... ..+++
T Consensus 97 l~~hp~iv~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 156 (334)
T 2pvf_A 97 IGKHKNIINLLGACTQDGPL--------------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156 (334)
T ss_dssp HCCCTTBCCEEEEECSSSCC--------------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCH
T ss_pred hhcCCCEeeEEEEEccCCce--------------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCH
Confidence 9 999999999999876554 899999999999999976432 24899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCC
Q 048724 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPY 288 (394)
Q Consensus 211 ~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 288 (394)
..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..+
T Consensus 157 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 236 (334)
T 2pvf_A 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236 (334)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc
Confidence 9999999999999999999999999999999999999999999999997544322 12233467889999999988889
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 289 NRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 289 ~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
+.++||||||+++|+|++ |..||......+....+.. ......+..++..+.++|.+||+.||++|||+.++++.|++
T Consensus 237 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 315 (334)
T 2pvf_A 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315 (334)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999 9999998887777665543 44566777899999999999999999999999999999999
Q ss_pred HHhccC
Q 048724 368 VNTSKG 373 (394)
Q Consensus 368 ~~~~~~ 373 (394)
+.....
T Consensus 316 l~~~~~ 321 (334)
T 2pvf_A 316 ILTLTT 321 (334)
T ss_dssp HHHHHC
T ss_pred HHhccc
Confidence 976543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=383.06 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=217.9
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
++.+..++|++.+.||+|+||+||+|++ +++.||+|+++.... ........+.+|+.+++.++|||||++++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM------IKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH------HHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh------hhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4567789999999999999999999998 678999999974211 01111234778999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|.+...+ |+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+|||
T Consensus 137 ~~~~~~~~--------------------~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrD 193 (410)
T 3v8s_A 137 AFQDDRYL--------------------YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193 (410)
T ss_dssp EEECSSEE--------------------EEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEEECCEE--------------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 99876665 899999999999999864 3589999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCC----CCccchHHHHHHHHHHHHhCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKP----YNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~Pf 311 (394)
|||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 194 LKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 999999999999999999999976443321 233568999999999997655 788999999999999999999999
Q ss_pred CCCChhhHHHHHHhcc--CCCCCCCCCcHHHHHHHHHhchhCCCC--CCCHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQN--LRPDIPRCCPSSLASIMRKCWDANPDK--RPVMDEVVKL 364 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~ 364 (394)
...+..+....+.... ...+....++.++++||.+||+.+|.+ ||++++|++.
T Consensus 274 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 274 YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 9988888887776543 233333468999999999999999988 9999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=368.54 Aligned_cols=250 Identities=17% Similarity=0.262 Sum_probs=215.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +++.||+|+++... . ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------T----DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------H----HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------c----cHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 47899999999999999999998 68899999986321 1 135677899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||++||+|.+++... ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 74 ~~~--------------------~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~N 132 (321)
T 1tki_A 74 EEL--------------------VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132 (321)
T ss_dssp TEE--------------------EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 655 8999999999999998543 3469999999999999999999999999999999999
Q ss_pred eeeCC--CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDA--NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~--~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||++. ++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+.
T Consensus 133 Il~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 211 (321)
T 1tki_A 133 IIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211 (321)
T ss_dssp EEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEEccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 99987 789999999999865432 223345789999999999998899999999999999999999999999888888
Q ss_pred HHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 320 SSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 320 ~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
...+......... ...++.++.+||.+||+.||++|||+.++++.-
T Consensus 212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 8777766544322 246899999999999999999999999999844
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=358.10 Aligned_cols=272 Identities=27% Similarity=0.503 Sum_probs=229.2
Q ss_pred cccccccccccee-eeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 79 EWEIELAKLDIRH-EIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 79 ~~~~~~~~~~~~~-~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
+|.+..++|.+.+ .||+|+||+||+|.+ ++..||||+++.... ....+.+.+|+.++++++||||++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~ 74 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KADTEEMMREAQIMHQLDNPYIVR 74 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--------hhHHHHHHHHHHHHHhCCCCCEeE
Confidence 4677888998887 999999999999985 567899999974321 122467889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+++++.. +. .++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++
T Consensus 75 ~~~~~~~-~~--------------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 132 (287)
T 1u59_A 75 LIGVCQA-EA--------------------LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFV 132 (287)
T ss_dssp EEEEEES-SS--------------------EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEecC-CC--------------------cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 9999843 22 38999999999999998643 35699999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
||||||+||+++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999986533221 1223456889999999988889999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQ 381 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~ 381 (394)
||......+....+ ....++..+..+++++.++|.+||+.||++||++.++++.|+.+..+......+...
T Consensus 213 p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 283 (287)
T 1u59_A 213 PYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283 (287)
T ss_dssp TTTTCCTHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred CcccCCHHHHHHHH-hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence 99988877766555 344556677889999999999999999999999999999999998776666655443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=359.14 Aligned_cols=260 Identities=33% Similarity=0.651 Sum_probs=212.9
Q ss_pred ccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
.++.++|++.+.||+|+||+||+|++.++.||||+++... ..+.|.+|+.++++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-----------ERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3567899999999999999999999999999999986321 13678899999999999999999998763
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCCcccC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-KKLAFKVVIQIALDLARGLSYLHS---KTIVHRD 236 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~---~~iiH~D 236 (394)
. .|+||||+++|+|.+++..... ..+++..++.++.|+++||.|||+ +|++|||
T Consensus 73 ~----------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~d 130 (307)
T 2eva_A 73 P----------------------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130 (307)
T ss_dssp T----------------------TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCC
T ss_pred C----------------------cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCC
Confidence 1 2899999999999999975432 247899999999999999999999 8999999
Q ss_pred CCCCceeeCCCCc-EEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 237 VKTENMLLDANRT-LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 237 lkp~NIll~~~~~-vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||+|||++.++. +||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 131 LKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp CSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred CChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 9999999988876 799999999754322 223578999999999999999999999999999999999999997654
Q ss_pred hhhH-HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCC
Q 048724 316 FTDV-SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGM 376 (394)
Q Consensus 316 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~ 376 (394)
.... ..........+..+..++..+.+++.+||+.||++|||+.++++.|+.+.....+..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 208 GPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp SSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred ccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 3222 112233445566677899999999999999999999999999999999987655443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=375.38 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=208.5
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHH-HHhCCCCcceeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV-WQKLDHPNVTKFIGA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~l~~~ 157 (394)
.+..++|++.+.||+|+||+||+|++ +++.||||+++...... ......+..|..+ ++.++||||++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~------~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK------KKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh------hHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 35578999999999999999999998 57899999997543211 1112345566666 567899999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
|.+...+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||
T Consensus 108 ~~~~~~~--------------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 165 (373)
T 2r5t_A 108 FQTADKL--------------------YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165 (373)
T ss_dssp EECSSEE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEeCCEE--------------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 9876665 8999999999999999654 46899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 166 kp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 245 (373)
T 2r5t_A 166 KPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 245 (373)
T ss_dssp CGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH
T ss_pred CHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999986444444455678999999999999999999999999999999999999999998888
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
+....+.... ..++..++.++.+||.+||+.||.+||++.+
T Consensus 246 ~~~~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 246 EMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 8888777654 3456779999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=368.56 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=210.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||+++........ ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP----GLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS----SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc----cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 36799999999999999999988 6889999998643210000 00135688999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..+ |+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~--------------------~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp 158 (351)
T 3c0i_A 99 GML--------------------YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKP 158 (351)
T ss_dssp TEE--------------------EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CEE--------------------EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCh
Confidence 554 89999999999998886543 33589999999999999999999999999999999
Q ss_pred CceeeCCCCc---EEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 240 ENMLLDANRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~~~~---vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
+|||++.++. +||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||... .
T Consensus 159 ~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~ 237 (351)
T 3c0i_A 159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-K 237 (351)
T ss_dssp GGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-H
T ss_pred HHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-H
Confidence 9999976554 99999999986554433344568999999999999999999999999999999999999999874 3
Q ss_pred hhHHHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
......+......... ...++.++.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 238 ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4444455444433221 1468999999999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=384.40 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=211.4
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.+.+..++|++.+.||+|+||+||+|.+ +|+.||||+++.... ........+.+|+.+++.++||||+++++
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 215 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI------VAKDEVAHTLTENRVLQNSRHPFLTALKY 215 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH------C-------------CCCCCSCTTSCCEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh------hhhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence 4566788999999999999999999988 688999999974321 11122356678999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCccc
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHR 235 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~ 235 (394)
+|.+.+.+ |+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ +||+||
T Consensus 216 ~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr 273 (446)
T 4ejn_A 216 SFQTHDRL--------------------CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273 (446)
T ss_dssp EEEETTEE--------------------EEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred EEeeCCEE--------------------EEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC
Confidence 99876655 8999999999999999654 469999999999999999999998 999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp CCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999999864444444556789999999999999999999999999999999999999999988
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVK 363 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~ 363 (394)
.......+.... ..++..+++++.+||.+||+.||++|| +++++++
T Consensus 354 ~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 354 HEKLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 888887776654 346677999999999999999999999 9999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=358.22 Aligned_cols=251 Identities=29% Similarity=0.415 Sum_probs=204.5
Q ss_pred ccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
++|++.+.||+|+||+||+|.+ +|+.||+|+++....... ....+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-------IPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc-------cchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 6899999999999999999998 688999999865432111 12556789999999999999999999986655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
+ |+||||+++ +|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||
T Consensus 75 ~--------------------~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 132 (288)
T 1ob3_A 75 L--------------------VLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132 (288)
T ss_dssp E--------------------EEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred E--------------------EEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 4 899999975 999988653 356999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
++.++.+||+|||+++.............+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....
T Consensus 133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 212 (288)
T 1ob3_A 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (288)
T ss_dssp ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999865444344445678999999999976 4589999999999999999999999998877666655
Q ss_pred HHhccC----------------CC-----------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 323 VVRQNL----------------RP-----------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 323 ~~~~~~----------------~~-----------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+..... .+ .....++.++.+||.+||+.||++|||++++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 543110 00 1123578999999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=364.65 Aligned_cols=275 Identities=26% Similarity=0.479 Sum_probs=213.1
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEEC--Ce---eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYD--GQ---DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--g~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n 150 (394)
..+++.+..++|++.+.||+|+||+||+|.+. +. .||||+++.... .....+.+.+|+.++++++|||
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ 86 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-------ASSDIEEFLREAACMKEFDHPH 86 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------CHHHHHHHHHHHHHTTCCCTT
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-------CHHHHHHHHHHHHHHHHCCCCc
Confidence 34567788899999999999999999999873 32 799999864321 1122467889999999999999
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHH
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR----KKLAFKVVIQIALDLARGLSY 226 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~l~y 226 (394)
|+++++++....... .....++||||+++|+|.+++..... ..+++..++.++.||+.||.|
T Consensus 87 iv~~~~~~~~~~~~~--------------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 152 (323)
T 3qup_A 87 VAKLVGVSLRSRAKG--------------RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152 (323)
T ss_dssp BCCCCEEEECC---------------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHH
T ss_pred eehhhceeecccccc--------------CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHH
Confidence 999999987654421 11223899999999999999975432 258999999999999999999
Q ss_pred HHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHH
Q 048724 227 LHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEI 304 (394)
Q Consensus 227 LH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el 304 (394)
||++|++||||||+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|+|
T Consensus 153 LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 153 LSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp HHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence 999999999999999999999999999999997543322 122234567889999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 305 YC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 305 lt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
++ |..||......+....+... .....+..+++++.+|+.+||+.||++|||+.++++.|+++....
T Consensus 233 l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 233 MTRGQTPYAGIENAEIYNYLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhCCCCCccccChHHHHHHHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 99 99999998888877666543 345566779999999999999999999999999999999997643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=364.38 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=214.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|++.+.||+|+||+||+|.+ +|+.||+|+++......... ......+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 36799999999999999999998 68899999997544221100 00135678899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 87 ~~~--------------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 144 (326)
T 2y0a_A 87 TDV--------------------ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144 (326)
T ss_dssp SEE--------------------EEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHH
Confidence 554 899999999999999954 3569999999999999999999999999999999999
Q ss_pred eeeCCCC----cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 242 MLLDANR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 242 Ill~~~~----~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||++.++ .+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 145 Ill~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 223 (326)
T 2y0a_A 145 IMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223 (326)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred EEEecCCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 9998877 7999999999865332 2334467999999999999999999999999999999999999999988877
Q ss_pred hHHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 318 DVSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+....+........ ....++..+.+||.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 77766655443322 12467899999999999999999999999997
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=366.30 Aligned_cols=258 Identities=25% Similarity=0.550 Sum_probs=213.6
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCee----EEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQD----VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+..++|++.+.||+|+||+||+|++ +++. ||+|.++... .......+.+|+.++++++||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--------CHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 4568899999999999999999987 4544 5777765221 112246788999999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
++|.... .++|+||+++|+|.+++... ...+++..++.|+.||+.||.|||++||+||
T Consensus 84 ~~~~~~~---------------------~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~ 141 (327)
T 3poz_A 84 GICLTST---------------------VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 141 (327)
T ss_dssp EEEESSS---------------------EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEecCC---------------------eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence 9997543 27899999999999999764 3569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 142 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 9999999999999999999999986543322 2223456889999999999999999999999999999999 999999
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
..........+ ........+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 222 GIPASEISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCCGGGHHHHH-HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 88877776554 4455566777899999999999999999999999999999998864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=356.96 Aligned_cols=259 Identities=30% Similarity=0.617 Sum_probs=216.9
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+..++|++.+.||+|+||+||+|++ +++.||||++....... ........+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG--ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC--CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc--chhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 4568999999999999999999998 68899999986543221 1111111257889999999999999999999985
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDV 237 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiH~Dl 237 (394)
+.. ++||||+++|+|.+++... ...+++..++.++.|++.||.|||++| ++||||
T Consensus 94 ~~~----------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~di 150 (287)
T 4f0f_A 94 NPP----------------------RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150 (287)
T ss_dssp TTT----------------------EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCC
T ss_pred CCC----------------------eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCC
Confidence 422 6899999999999988654 357999999999999999999999999 999999
Q ss_pred CCCceeeCCCCc-----EEEeeccccccccCCCCCccCCCCCCCcCCccccC--CCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 238 KTENMLLDANRT-----LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD--GKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 238 kp~NIll~~~~~-----vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
||+|||++.++. +||+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|+|++|..|
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 227 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred CcceEEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 999999987776 99999999974322 234467999999999994 45678899999999999999999999
Q ss_pred CCCCChhhH--HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 311 YPDLSFTDV--SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 311 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
|........ ..........+..+..+++++.++|.+||+.||++|||+.++++.|+++
T Consensus 228 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 228 FDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 987655443 4455566677788888999999999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=366.25 Aligned_cols=273 Identities=27% Similarity=0.538 Sum_probs=228.6
Q ss_pred CCCCCcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh
Q 048724 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145 (394)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 145 (394)
.+....+|++..++|++.+.||+|+||+||+|.+ +++.||||+++.... ......+.+|+.++++
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~ 86 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIH 86 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHH
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--------cHHHHHHHHHHHHHHh
Confidence 3445567889999999999999999999999974 357899999974321 1123568899999999
Q ss_pred C-CCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--------------CCCCH
Q 048724 146 L-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------------KKLAF 210 (394)
Q Consensus 146 l-~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------------~~l~~ 210 (394)
+ +||||+++++++...+. .+++||||+++|+|.+++..... ..+++
T Consensus 87 l~~hp~iv~~~~~~~~~~~-------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 147 (316)
T 2xir_A 87 IGHHLNVVNLLGACTKPGG-------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147 (316)
T ss_dssp HCCCTTBCCEEEEECCTTS-------------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEH
T ss_pred cccCCCeeeEEEEEecCCC-------------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCH
Confidence 9 79999999999875433 23899999999999999976432 12889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCC
Q 048724 211 KVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPY 288 (394)
Q Consensus 211 ~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 288 (394)
..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....... ......+|+.|+|||.+.+..+
T Consensus 148 ~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 99999999999999999999999999999999999999999999999975433221 1223457889999999998899
Q ss_pred CccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHH
Q 048724 289 NRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367 (394)
Q Consensus 289 ~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~ 367 (394)
+.++||||||+++|+|++ |..||.....................+..+++.+.+++.+||+.||++|||+.++++.|+.
T Consensus 228 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999999999998 9999988776555555555566667777899999999999999999999999999999999
Q ss_pred HHhcc
Q 048724 368 VNTSK 372 (394)
Q Consensus 368 ~~~~~ 372 (394)
+....
T Consensus 308 ~~~~~ 312 (316)
T 2xir_A 308 LLQAN 312 (316)
T ss_dssp HHHHH
T ss_pred HHhhh
Confidence 87643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=361.79 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=211.8
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
.|+..+.||+|+||+||+|++ +|+.||||+++...... ...+.+|+.++++++||||+++++++...+.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 467778999999999999988 68999999997543221 3567789999999999999999999987655
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
. |+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||
T Consensus 117 ~--------------------~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 117 L--------------------WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL 173 (321)
T ss_dssp E--------------------EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred E--------------------EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 4 899999999999999853 45999999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 048724 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~ 323 (394)
++.++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred ECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999986554433444568999999999999999999999999999999999999999888777766655
Q ss_pred HhccCC-CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 324 VRQNLR-PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 324 ~~~~~~-~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...... ...+..+++.+.++|.+||+.||++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 443221 12234578999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=358.48 Aligned_cols=264 Identities=34% Similarity=0.669 Sum_probs=207.5
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
....+++..++|++.+.||+|+||+||+|++.+ .||||+++..... ....+.+.+|+.++++++||||++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT-------PQQLQAFKNEVGVLRKTRHVNILLFM 86 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCC-------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCC-------HHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 455689999999999999999999999998865 4999998744321 12246788999999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.. .. .++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||
T Consensus 87 ~~~~~-~~--------------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 144 (289)
T 3og7_A 87 GYSTA-PQ--------------------LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144 (289)
T ss_dssp EEECS-SS--------------------CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeccC-Cc--------------------cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 97543 22 38999999999999998643 3569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
||||+||+++.++.+||+|||+++..... ........||+.|+|||.+. +..++.++||||||+++|+|++|..|
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (289)
T 3og7_A 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224 (289)
T ss_dssp CCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999754321 12223457899999999986 56788899999999999999999999
Q ss_pred CCCCChhhHHHHHH-hccCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 311 YPDLSFTDVSSAVV-RQNLRPD---IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 311 f~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
|......+...... .....+. ....+|+.+.+||.+||+.||++|||+.++++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 225 YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 98866555444443 3333332 23468999999999999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=354.29 Aligned_cols=254 Identities=29% Similarity=0.495 Sum_probs=216.2
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
....++|++.+.||+|+||+||+|.+ +++.||||++.... .........+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc------cchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 34578999999999999999999988 56789999986321 12223356788999999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.... ++||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 79 ~~~~~~--------------------~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlk 136 (279)
T 3fdn_A 79 HDATRV--------------------YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIK 136 (279)
T ss_dssp ECSSEE--------------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCC
T ss_pred ecCCEE--------------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence 876554 8999999999999999654 459999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+||+++.++.++|+|||++...... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+
T Consensus 137 p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 137 PENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp GGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred hHhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 99999999999999999998643322 2234578999999999999999999999999999999999999999888877
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
....+... ....+..++..+.+||.+||+.||++|||+.++++.-.
T Consensus 215 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 215 TYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HHHHHHHT--CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred HHHHHHhC--CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 77666543 44567778999999999999999999999999998644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=354.06 Aligned_cols=272 Identities=24% Similarity=0.403 Sum_probs=225.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||+|+++..... ......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-------ARDFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 47899999999999999999988 5889999999754321 11235678899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 78 ~~~--------------------~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 135 (284)
T 3kk8_A 78 SFH--------------------YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 135 (284)
T ss_dssp SEE--------------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CEE--------------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHH
Confidence 554 8999999999999988654 469999999999999999999999999999999999
Q ss_pred eeeCCCCc---EEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~---vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+++.++. +||+|||++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 136 il~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 136 LLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp EEESSSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 99976554 999999999754432 23344679999999999999999999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCce
Q 048724 319 VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIPEDQAHGC 385 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~~~~~~~~~~ 385 (394)
....+.........+ ..+++++.++|.+||+.||++|||+.++++.-.=-........+...++.-|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~~ 283 (284)
T 3kk8_A 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 283 (284)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCCCCCC
T ss_pred HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcCCCccc
Confidence 887776665543333 4689999999999999999999999999996443333444444555555444
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=357.08 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=206.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++.+.||+|+||+||+|.+ +|+.||||+++...... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 73 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-------THHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-------CcchHHHHHHHHHhcCCCCCEeeEEeEEEeC
Confidence 36899999999999999999998 68899999997544221 1235677899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||+++ +|.+++... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 74 ~~~--------------------~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~N 131 (292)
T 3o0g_A 74 KKL--------------------TLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp TEE--------------------EEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CEE--------------------EEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 554 899999975 666666443 3569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC-CCccchHHHHHHHHHHHHhCCCC-CCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~P-f~~~~~~~~ 319 (394)
||++.++.+||+|||+++.............+|+.|+|||.+.+.. ++.++|||||||++|+|++|..| |...+..+.
T Consensus 132 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp EEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred EEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 9999999999999999986655445555678899999999997765 89999999999999999988776 566665555
Q ss_pred HHHHHhccCC---------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNLR---------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+...... ......++.++.+||.+||+.||++|||++++++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 5554331110 0112347899999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=356.48 Aligned_cols=263 Identities=28% Similarity=0.541 Sum_probs=219.9
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
..|.+..++|++.+.||+|+||+||+|.+. +..||+|+++.... ....+.+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~ 76 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--------LDNKEKFMSEAVIMKNLDHPHIV 76 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--------HHHHHHHHHHHHHHHHHCCTTBC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--------chHHHHHHHHHHHHHhCCCCCcc
Confidence 357788899999999999999999999872 23599999874321 11246788999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++++++.+.. .|+||||+++++|.+++... ...+++..++.++.|++.||.|||++|+
T Consensus 77 ~~~~~~~~~~---------------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i 134 (281)
T 3cc6_A 77 KLIGIIEEEP---------------------TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINC 134 (281)
T ss_dssp CEEEEECSSS---------------------CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEEEcCCC---------------------CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999976422 28999999999999999754 3568999999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCC
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMP 310 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~P 310 (394)
+||||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.|
T Consensus 135 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p 214 (281)
T 3cc6_A 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214 (281)
T ss_dssp CCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999997543322 12233467889999999988889999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|......+....+.. ......+..+++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 215 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 215 FFWLENKDVIGVLEK-GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TTTSCGGGHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCChHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 988777777655543 345556777999999999999999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=372.95 Aligned_cols=262 Identities=20% Similarity=0.336 Sum_probs=213.0
Q ss_pred CCcccccccccccceeeeccC--CceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 76 KTEEWEIELAKLDIRHEIARG--TYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G--~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
....+....++|++.+.||+| +||+||+|++ +|+.||||+++..... ......+.+|+.+++.++||||
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni 88 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-------NEMVTFLQGELHVSKLFNHPNI 88 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-------hHHHHHHHHHHHHHHhCCCCCC
Confidence 334566778999999999999 9999999998 6889999999754321 1234678889999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
|++++++.+...+ |+||||+++|+|.+++.......+++..++.++.||+.||.|||++|
T Consensus 89 v~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 148 (389)
T 3gni_B 89 VPYRATFIADNEL--------------------WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG 148 (389)
T ss_dssp CCEEEEEEETTEE--------------------EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CcEeEEEEECCEE--------------------EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999876655 89999999999999998765677999999999999999999999999
Q ss_pred CcccCCCCCceeeCCCCcEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHH
Q 048724 232 IVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLW 302 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ 302 (394)
|+||||||+|||++.++.+||+|||.+....... .......||+.|+|||.+.+ ..++.++|||||||++|
T Consensus 149 ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 228 (389)
T 3gni_B 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228 (389)
T ss_dssp EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHH
Confidence 9999999999999999999999999886422111 11223478999999999987 67999999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHhccC--------------------------------------------CCCCCCCCcH
Q 048724 303 EIYCCDMPYPDLSFTDVSSAVVRQNL--------------------------------------------RPDIPRCCPS 338 (394)
Q Consensus 303 elltg~~Pf~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~ 338 (394)
+|++|+.||.+.+..+.......... ..+.+..+++
T Consensus 229 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 308 (389)
T 3gni_B 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308 (389)
T ss_dssp HHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCH
T ss_pred HHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCH
Confidence 99999999987665554433221111 1123455789
Q ss_pred HHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 339 SLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 339 ~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+.+||.+||+.||++|||+.++++.
T Consensus 309 ~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 309 HFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 99999999999999999999999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=364.82 Aligned_cols=264 Identities=30% Similarity=0.550 Sum_probs=224.3
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~ 149 (394)
..+|++..++|++.+.||+|+||+||+|++. ++.||||+++.... ......+.+|+.++++++||
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~ 88 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--------MRERIEFLNEASVMKEFNCH 88 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--------HHHHHHHHHHHHHGGGCCCT
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--------HHHHHHHHHHHHHHHhcCCC
Confidence 4578999999999999999999999999763 57899999863321 11235688999999999999
Q ss_pred cceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--------CCCCHHHHHHHHHHHH
Q 048724 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--------KKLAFKVVIQIALDLA 221 (394)
Q Consensus 150 nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~qi~ 221 (394)
||+++++++.+.... ++||||+++|+|.+++..... ..+++..++.++.||+
T Consensus 89 ~i~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 148 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPT--------------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148 (322)
T ss_dssp TBCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred CEeeeEEEEccCCcc--------------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHH
Confidence 999999999766554 899999999999999975331 4579999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 299 (394)
.||.|||++|++||||||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+
T Consensus 149 ~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228 (322)
T ss_dssp HHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence 99999999999999999999999999999999999997543221 1122345688999999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 300 CLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 300 ~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
++|+|++ |..||......+....+.... ....+..++..+.++|.+||+.||++|||+.++++.|+++.
T Consensus 229 il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 229 VLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHhcCCCccccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 9999999 899999888877776665443 34566779999999999999999999999999999998763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=360.15 Aligned_cols=278 Identities=26% Similarity=0.479 Sum_probs=219.8
Q ss_pred ccCCCCCcccccccccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh
Q 048724 71 EVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145 (394)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 145 (394)
+.+......+.+..++|.+.+.||+|+||+||+|.+ ++..||||+++..... ......+.+|+.++++
T Consensus 20 eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~ 92 (313)
T 3brb_A 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-------QREIEEFLSEAACMKD 92 (313)
T ss_dssp ----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-------HHHHHHHHHHHHHHHT
T ss_pred HhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-------hhHHHHHHHHHHHHhc
Confidence 444556677888999999999999999999999977 2347999998743321 1123568899999999
Q ss_pred CCCCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc----ccCCCCHHHHHHHHHHHH
Q 048724 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN----KRKKLAFKVVIQIALDLA 221 (394)
Q Consensus 146 l~h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~ 221 (394)
++||||+++++++.+..... ....++||||+++|+|.+++... ....+++..++.++.||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~---------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 157 (313)
T 3brb_A 93 FSHPNVIRLLGVCIEMSSQG---------------IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157 (313)
T ss_dssp CCCTTBCCCCEEEEC----------------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHH
T ss_pred CCCCCeeeeeEEEeeccccC---------------CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHH
Confidence 99999999999987654321 12358999999999999998542 235699999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGI 299 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 299 (394)
.||.|||++|++||||||+||+++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+
T Consensus 158 ~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 237 (313)
T 3brb_A 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237 (313)
T ss_dssp HHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHH
Confidence 99999999999999999999999999999999999997543221 1222345788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 300 CLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 300 ~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
++|+|++ |..||...........+.. ......+..+++.+.++|.+||+.||++|||+.++++.|+++...
T Consensus 238 il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 238 TMWEIATRGMTPYPGVQNHEMYDYLLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCccCCHHHHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999 8999998888877766544 445666778999999999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=371.05 Aligned_cols=252 Identities=27% Similarity=0.464 Sum_probs=211.0
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|.+.+.||+|+||+||+|.+ +++.||||+++... .........+.+|+.+++.++||||+++++++..
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL------LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH------ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 368999999999999999999998 78899999986321 1111223568899999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
...+ |+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+
T Consensus 81 ~~~~--------------------~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 137 (336)
T 3h4j_B 81 PTDI--------------------VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137 (336)
T ss_dssp SSEE--------------------EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTT
T ss_pred CCEE--------------------EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchh
Confidence 6655 8999999 78999988654 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|||++.++.+||+|||++...... ......+||+.|+|||.+.+..+ +.++|||||||++|+|++|..||........
T Consensus 138 NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 138 NLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp TEEECTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred hEEEcCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 999999999999999999754332 33345689999999999998876 6899999999999999999999987654433
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
...+ .......+..+++++.+||.+||+.||.+|||++++++.-.
T Consensus 217 ~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 217 FKKV--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp BCCC--CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred HHHH--HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 3222 11234456778999999999999999999999999998543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=363.52 Aligned_cols=263 Identities=28% Similarity=0.553 Sum_probs=217.7
Q ss_pred cccccccccceeeeccCCceEEEEEEEC------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYD------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
+++..++|++.+.||+|+||+||+|.+. +..||||+++.... ......+.+|+.++++++||||++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~ 110 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--------EKQRVDFLGEAGIMGQFSHHNIIR 110 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--------HHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4677889999999999999999999872 23599999874321 122456889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+++++.+.... ++||||+++|+|.+++... ...+++..++.++.||+.||.|||++|++
T Consensus 111 ~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 169 (333)
T 1mqb_A 111 LEGVISKYKPM--------------------MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYV 169 (333)
T ss_dssp EEEEECSSSSE--------------------EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEecCCCc--------------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99999765554 8999999999999999654 35699999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
||||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 170 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999986443221 1122346788999999998899999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
||......+....+. ...+...+..++..+.+++.+||+.||++||++.++++.|+++....
T Consensus 250 pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 250 PYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TTTTCCHHHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CcccCCHHHHHHHHH-CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 999888877776654 44455667789999999999999999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=382.84 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=217.9
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
++.+..++|++.++||+|+||+||+|++ +++.||||+++.... ........+.+|..++..++||||+++++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM------LKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH------HHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh------hhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3556678999999999999999999998 578999999974211 11111234778999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|.+...+ |+||||++||+|.+++.+. ...+++..++.++.||+.||.|||++||+|||
T Consensus 142 ~~~~~~~~--------------------~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrD 200 (437)
T 4aw2_A 142 AFQDDNNL--------------------YLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200 (437)
T ss_dssp EEECSSEE--------------------EEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEeeCCEE--------------------EEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 99876665 8999999999999999653 35699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
|||+|||++.++.+||+|||+++...... ......+||+.|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 201 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P 280 (437)
T 4aw2_A 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280 (437)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred cCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence 99999999999999999999997544332 2233468999999999986 56789999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccCCCCCC---CCCcHHHHHHHHHhchhCCCC--CCCHHHHHHH
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIP---RCCPSSLASIMRKCWDANPDK--RPVMDEVVKL 364 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cL~~dP~~--Rpt~~~ll~~ 364 (394)
|...+..+....+........+| ..+++++++||++||..+|++ ||+++++++.
T Consensus 281 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 281 FYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp TCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 99998888887776543233333 458999999999999988888 9999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=359.21 Aligned_cols=255 Identities=33% Similarity=0.588 Sum_probs=204.7
Q ss_pred ccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh--CCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK--LDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~ 160 (394)
-.++|++.+.||+|+||+||+|+++|+.||||+++... ...+..|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------------EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 35789999999999999999999999999999986322 1345567777776 799999999998764
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------hCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLH--------SKTI 232 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~i 232 (394)
.... ....|+||||+++|+|.+++.. ..+++..++.++.|++.||.||| ++|+
T Consensus 74 ~~~~----------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 74 SRHS----------------STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp EETT----------------EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred ccCC----------------CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 3221 1234899999999999999943 46999999999999999999999 9999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCCC----ccCCCCCCCcCCccccCCC------CCCccchHHHHHHHHH
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLDGK------PYNRKCDVYSFGICLW 302 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ 302 (394)
+||||||+|||++.++.+||+|||+++........ .....||+.|+|||.+.+. .++.++||||||+++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 99999999999999999999999999754333221 2234799999999999876 4557999999999999
Q ss_pred HHHhC----------CCCCCCCC-----hhhHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 303 EIYCC----------DMPYPDLS-----FTDVSSAVVRQNLRPDIPR-----CCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 303 elltg----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
||++| ..||.... .............++..+. .++.++.+||.+||+.||++|||+.+++
T Consensus 215 el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 99999 88885432 2222222223333444432 2567899999999999999999999999
Q ss_pred HHHHHH
Q 048724 363 KLLEAV 368 (394)
Q Consensus 363 ~~l~~~ 368 (394)
+.|+++
T Consensus 295 ~~L~~i 300 (301)
T 3q4u_A 295 KTLTKI 300 (301)
T ss_dssp HHHHHH
T ss_pred HHHhcc
Confidence 999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=357.54 Aligned_cols=264 Identities=28% Similarity=0.511 Sum_probs=220.5
Q ss_pred ccccccccccccee-eeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 78 EEWEIELAKLDIRH-EIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 78 ~~~~~~~~~~~~~~-~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
.++.+..++|++.+ .||+|+||+||+|.+ +++.||||+++... ......+.+.+|+.+++.++||||+
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~ 81 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-------NDPALKDELLAEANVMQQLDNPYIV 81 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-------cCHHHHHHHHHHHHHHHhCCCCCEE
Confidence 45677889999998 999999999999965 35789999987432 1222356788999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++++++. .+. .++||||+++++|.+++... ..+++..++.++.||+.||.|||++|+
T Consensus 82 ~~~~~~~-~~~--------------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i 138 (291)
T 1xbb_A 82 RMIGICE-AES--------------------WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 138 (291)
T ss_dssp CEEEEEE-SSS--------------------EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEEEC-CCC--------------------cEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 9999983 222 38999999999999999653 459999999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CC
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CD 308 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~ 308 (394)
+||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 139 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 218 (291)
T 1xbb_A 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 218 (291)
T ss_dssp ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred EcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999975433221 1222456788999999988889999999999999999999 99
Q ss_pred CCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 309 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
.||......+....+ .....+..+..+++.+.++|.+||+.||++|||+.++++.|+.+....
T Consensus 219 ~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 219 KPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 999988887766555 444456677889999999999999999999999999999999997654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=378.46 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=215.4
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
++.+..++|++.+.||+|+||+||+|++ +|+.||||+++... .........+.+|..++..++||||+++++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~------~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD------MLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH------hhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 4567789999999999999999999998 68999999997321 111122345778999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|.+...+ |+||||++||+|.+++.+.. ..+++..++.++.||+.||.|||++||+|||
T Consensus 129 ~~~~~~~~--------------------~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrD 187 (412)
T 2vd5_A 129 AFQDENYL--------------------YLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187 (412)
T ss_dssp EEECSSEE--------------------EEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEeeCCEE--------------------EEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99876665 89999999999999997542 4699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccC-------CCCCCccchHHHHHHHHHHHHhCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLD-------GKPYNRKCDVYSFGICLWEIYCCD 308 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~elltg~ 308 (394)
|||+|||++.++.+||+|||+++....... .....+||+.|+|||++. +..++.++|||||||++|||++|+
T Consensus 188 LKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 999999999999999999999976543322 233468999999999986 457899999999999999999999
Q ss_pred CCCCCCChhhHHHHHHhccCC---CCCCCCCcHHHHHHHHHhchhCCCCC---CCHHHHHHH
Q 048724 309 MPYPDLSFTDVSSAVVRQNLR---PDIPRCCPSSLASIMRKCWDANPDKR---PVMDEVVKL 364 (394)
Q Consensus 309 ~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~R---pt~~~ll~~ 364 (394)
.||...+..+....+...... +..+..+|.++++||.+||. +|.+| |+++++++.
T Consensus 268 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 268 TPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 999998888877777643322 22335789999999999999 99998 589999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=366.46 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=201.4
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
....++|++.+.||+|+||+||++++ +++.||||+++..... ...+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~ 85 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----------DENVQREIINHRSLRHPNIVRFKEVI 85 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----------CHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----------cHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34568999999999999999999998 6889999999754321 14567899999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+...+ |+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 86 ~~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlk 143 (361)
T 3uc3_A 86 LTPTHL--------------------AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143 (361)
T ss_dssp ECSSEE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCC
T ss_pred eeCCEE--------------------EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 876655 8999999999999999653 469999999999999999999999999999999
Q ss_pred CCceeeCCCCc--EEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCC
Q 048724 239 TENMLLDANRT--LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRK-CDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 239 p~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|+|||++.++. +||+|||+++..... .......||+.|+|||.+.+..++.+ +|||||||++|+|++|+.||....
T Consensus 144 p~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 144 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp GGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred HHHEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 99999987665 999999999743222 22334579999999999988877655 899999999999999999997754
Q ss_pred h----hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 316 F----TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 316 ~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
. ......+.......+....+++++.+||.+||+.||++|||+.++++.-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 223 EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp -CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred cHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 3 33334444444444444468999999999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=360.52 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=196.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||+++....... ...+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--------PSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS--------CHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc--------HHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 46899999999999999999987 688999999975432211 24567899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+ |+||||++ |+|.+++.... ...+++..+..++.||+.||.|||++||+||||
T Consensus 76 ~~~--------------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl 134 (317)
T 2pmi_A 76 NKL--------------------TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134 (317)
T ss_dssp TEE--------------------EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred CeE--------------------EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 554 89999997 59999987543 235899999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||+|||++.++.+||+|||+++.............+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999999865444444445688999999999976 4689999999999999999999999998887
Q ss_pred hhHHHHHHhccC--------------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNL--------------------------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~--------------------------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....+..... .+..+..++.++.+||.+||+.||++|||+.++++.
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 215 EEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 776655543110 001123578899999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=358.66 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=210.6
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CC-------eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DG-------QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
++..++|++.+.||+|+||+||+|.+ ++ ..||+|+++.... ...+.+.+|+.++++++||||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---------NYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---------GGHHHHHHHHHHHHTSCCTTB
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---------HHHHHHHHHHHHHHhCCCCCE
Confidence 56678999999999999999999987 33 4699999864321 113668899999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
+++++++.+.... ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 75 v~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ 133 (289)
T 4fvq_A 75 VLNYGVCVCGDEN--------------------ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT 133 (289)
T ss_dssp CCEEEEECCTTCC--------------------EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEEEeCCCC--------------------EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 9999999876554 89999999999999997643 45999999999999999999999999
Q ss_pred CcccCCCCCceeeCCCCc--------EEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHH
Q 048724 232 IVHRDVKTENMLLDANRT--------LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLW 302 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~~~--------vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ 302 (394)
++||||||+|||++.++. +||+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|
T Consensus 134 ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 209 (289)
T 4fvq_A 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209 (289)
T ss_dssp CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence 999999999999988876 999999998643221 22357889999999987 77999999999999999
Q ss_pred HHHhC-CCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCC
Q 048724 303 EIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGM 376 (394)
Q Consensus 303 elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~ 376 (394)
+|++| .+||............ .. ....+..++.++.+++.+||+.||++|||+.++++.|+++.+.....-
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 210 EICSGGDKPLSALDSQRKLQFY-ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHH-HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred HHHcCCCCCccccchHHHHHHh-hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 99995 5566655554444332 22 344556678899999999999999999999999999999987544433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=357.89 Aligned_cols=266 Identities=26% Similarity=0.461 Sum_probs=208.2
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||+||+|.+ +|+.||||+++..... . ......+.+|+.++++++||||+++++++..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--D----AKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC--C----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc--C----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 467899999999999999999987 6889999998743211 1 1224678889999999999999999999986
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.... ++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|||||
T Consensus 104 ~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~ 163 (310)
T 2wqm_A 104 DNEL--------------------NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK 163 (310)
T ss_dssp TTEE--------------------EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred CCcE--------------------EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCc
Confidence 6554 8999999999999999652 24568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--h
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS--F 316 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~--~ 316 (394)
|+||+++.++.+||+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||.... .
T Consensus 164 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 243 (310)
T 2wqm_A 164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243 (310)
T ss_dssp GGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH
T ss_pred HHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH
Confidence 99999999999999999999765443333344578999999999999999999999999999999999999997543 2
Q ss_pred hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
......+.........+..++.++.++|.+||+.||++|||+.++++.|+++......
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 3334444333333333467899999999999999999999999999999999876443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=379.66 Aligned_cols=253 Identities=26% Similarity=0.504 Sum_probs=218.2
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+..++|.+.+.||+|+||+||+|++ +|+.||||+++... .........+.+|+.+++.++||||+++++++
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH------HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh------ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45578999999999999999999998 68999999997432 11112246788999999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.....+ |+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 86 ~~~~~~--------------------~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLk 143 (476)
T 2y94_A 86 STPSDI--------------------FMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143 (476)
T ss_dssp ECSSEE--------------------EEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred EECCEE--------------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCccccc
Confidence 876655 899999999999999854 4569999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|+|||++.++.+||+|||++...... ......+||+.|+|||.+.+..+ +.++|||||||++|+|++|..||......
T Consensus 144 p~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 222 (476)
T 2y94_A 144 PENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222 (476)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH
T ss_pred HHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH
Confidence 99999999999999999999865432 23345689999999999998765 68999999999999999999999988877
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.....+.... ...+..+++++.+||.+||+.||++|||+.++++.
T Consensus 223 ~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 223 TLFKKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 7777665543 34566789999999999999999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=364.31 Aligned_cols=258 Identities=24% Similarity=0.515 Sum_probs=214.0
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCee----EEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQD----VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+..++|++.+.||+|+||+||+|.+ +++. ||+|++........ ...+.+|+.++++++||||++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--------FQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC--------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH--------HHHHHHHHHHHhcCCCCCcCeEE
Confidence 4467899999999999999999988 4554 77777653321111 13456799999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.+. . .++||||+++|+|.+++... +..+++..++.++.||+.||.|||++||+||
T Consensus 82 ~~~~~~-~--------------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 139 (325)
T 3kex_A 82 GLCPGS-S--------------------LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHR 139 (325)
T ss_dssp EEECBS-S--------------------EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEcCC-c--------------------cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 988532 2 38999999999999999654 3569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 140 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp CCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999986543322 2234567889999999998889999999999999999999 999999
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
.....+....+ ........+..++.++.++|.+||+.||++|||+.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 220 GLRLAEVPDLL-EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TSCTTHHHHHH-HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ccCHHHHHHHH-HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 88777766555 4444566677789999999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=365.24 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=207.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +++.||||+++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--------cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 47899999999999999999988 688999999864321 11135677899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 78 ~~~--------------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~N 135 (323)
T 3tki_A 78 NIQ--------------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135 (323)
T ss_dssp SEE--------------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CeE--------------------EEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHH
Confidence 655 899999999999998843 3469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||++.++.+||+|||+++...... .......||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.......
T Consensus 136 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 215 (323)
T 3tki_A 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (323)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS
T ss_pred EEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999999999999999997543221 22334689999999999987765 778999999999999999999998766543
Q ss_pred HHH-HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 319 VSS-AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 319 ~~~-~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
... ..............++..+.+||.+||+.||++|||+.++++.-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 332 22233223333356899999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=362.67 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=210.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++..... ..+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----------PQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----------CCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----------HHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 47899999999999999999996 7899999998744321 3467899999999 99999999999887
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... |+||||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 77 ~~~~--------------------~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 134 (330)
T 2izr_A 77 GKYN--------------------AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPE 134 (330)
T ss_dssp TTEE--------------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCcc--------------------EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 5554 8999999 99999999764 357999999999999999999999999999999999
Q ss_pred ceeeCCCCc-----EEEeeccccccccCCCC-------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCC
Q 048724 241 NMLLDANRT-----LKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308 (394)
Q Consensus 241 NIll~~~~~-----vkl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 308 (394)
|||++.++. +||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 135 Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 135 NFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214 (330)
T ss_dssp GEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 999998887 99999999985433221 123568999999999999999999999999999999999999
Q ss_pred CCCCCCChhh---HHHHHHhccCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 309 MPYPDLSFTD---VSSAVVRQNLRPD---IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 309 ~Pf~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
.||....... ....+........ ....+| ++.+++..||+.||.+||++.+|++.|+++....
T Consensus 215 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 215 LPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp CTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 9998754333 2333322211111 123355 9999999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=355.39 Aligned_cols=264 Identities=27% Similarity=0.494 Sum_probs=215.5
Q ss_pred ccccccccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
...+....|++.+.||+|+||+||+|++ +++.||||+++..... .....+.+|+.+++.++||||+
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--------NHIADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--------hhHHHHHHHHHHHHhCCCCCee
Confidence 3445567899999999999999999984 6789999998743211 1136678999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++++++..... ..+++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|+
T Consensus 87 ~~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i 147 (302)
T 4e5w_A 87 KYKGICTEDGG------------------NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQY 147 (302)
T ss_dssp CEEEEEEC---------------------CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eeeeEEecCCC------------------ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCc
Confidence 99999986532 22389999999999999996543 569999999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCC
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~ 309 (394)
+||||||+||+++.++.+||+|||++....... .......+|..|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 148 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence 999999999999999999999999998654332 12234568888999999998889999999999999999999998
Q ss_pred CCCCC--------------ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 310 PYPDL--------------SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 310 Pf~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
|+... ..................+..+++.+.+||.+||+.||++|||+.++++.|+++.
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 228 SDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 75321 1222222334455566677889999999999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=353.49 Aligned_cols=258 Identities=19% Similarity=0.310 Sum_probs=213.8
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGAS 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 158 (394)
+..++|++.+.||+|+||+||+|.+ +|+.||||+++.... ...+.+|+.+++.+ +|+|++++++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----------APQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----------cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 4467899999999999999999996 789999999864332 13466899999999 899999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...... ++||||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|||||
T Consensus 76 ~~~~~~--------------------~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 133 (298)
T 1csn_A 76 QEGLHN--------------------VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 133 (298)
T ss_dssp EETTEE--------------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred CCCcee--------------------EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 765554 8999999 99999999754 3469999999999999999999999999999999
Q ss_pred CCceeeCCCCc-----EEEeeccccccccCCCC-------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh
Q 048724 239 TENMLLDANRT-----LKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 239 p~NIll~~~~~-----vkl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 306 (394)
|+|||++.++. +||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 134 p~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 213 (298)
T 1csn_A 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 213 (298)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc
Confidence 99999987765 99999999986443221 2334579999999999999999999999999999999999
Q ss_pred CCCCCCCCC---hhhHHHHHHhccCCC---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 307 CDMPYPDLS---FTDVSSAVVRQNLRP---DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 307 g~~Pf~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
|+.||.... .......+....... .....+|+++.+++.+||+.||++|||+++|++.|+++....
T Consensus 214 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 214 GSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp SSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 999998743 333333332222111 123468999999999999999999999999999999997653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=354.71 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=189.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++... .........+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh------hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 57899999999999999999997 78899999986321 11112246788999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 84 ~~~--------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 142 (278)
T 3cok_A 84 NYV--------------------YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSN 142 (278)
T ss_dssp SEE--------------------EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGG
T ss_pred CeE--------------------EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 554 8999999999999998653 3569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.+||+|||++..............+|+.|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 143 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (278)
T 3cok_A 143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222 (278)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred EEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH
Confidence 99999999999999999865433333334678999999999999899999999999999999999999998766555443
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+.. .....+..++.++.++|.+||+.||++|||+.++++
T Consensus 223 ~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 223 KVVL--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCS--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhh--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 3322 233456678999999999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=366.04 Aligned_cols=248 Identities=21% Similarity=0.398 Sum_probs=208.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||+++.... ...+|++++.++ +||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------------DPTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------------CCHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------------ChHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 47899999999999999999998 688999999975432 123578888887 89999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
...+ |+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 88 ~~~~--------------------~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~ 145 (342)
T 2qr7_A 88 GKYV--------------------YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145 (342)
T ss_dssp SSEE--------------------EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CCEE--------------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHH
Confidence 6655 8999999999999999653 46999999999999999999999999999999999
Q ss_pred ceeeCCC----CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCC---
Q 048724 241 NMLLDAN----RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD--- 313 (394)
Q Consensus 241 NIll~~~----~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~--- 313 (394)
|||+..+ +.+||+|||+++............+||+.|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp GEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred HEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 9998533 359999999998655444444557899999999999888889999999999999999999999975
Q ss_pred CChhhHHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 314 LSFTDVSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
....++...+........ .+..+++++.+||.+||+.||++|||+.++++.-.
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 345556666655544322 33568999999999999999999999999998533
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=363.09 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=213.0
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|++.+.||+|+||+||+|++ +|+.||||+++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC------HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc------chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 5688999999999999999987 7899999999744321 1223467889999999999999999999998665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+||||+. |+|.+++... ...+++..++.++.|++.||.|||++|++||||||+||
T Consensus 128 ~~--------------------~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 185 (348)
T 1u5q_A 128 TA--------------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185 (348)
T ss_dssp EE--------------------EEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred eE--------------------EEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 54 89999996 6888888643 35799999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|++.++.+||+|||+++.... .....||+.|+|||.+. +..++.++|||||||++|||++|+.||...+....
T Consensus 186 ll~~~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 186 LLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261 (348)
T ss_dssp EEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EECCCCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999975432 22357999999999984 56789999999999999999999999988887777
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
...+.........+..++..+.+||.+||+.||++|||+.++++...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 66666655444455678999999999999999999999999987644
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=363.13 Aligned_cols=267 Identities=27% Similarity=0.512 Sum_probs=217.0
Q ss_pred cccccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
++.++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|+.++++++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---------PDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---------HHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 5568999999999999999999984 57899999987432 11236688999999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++...+. ...|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||
T Consensus 91 ~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~ 151 (327)
T 3lxl_A 91 GVSYGPGR------------------QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHR 151 (327)
T ss_dssp EEEECSSS------------------CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred EEEecCCC------------------ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 99874333 22489999999999999997643 469999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 152 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999986543321 2233467888999999998889999999999999999999999985
Q ss_pred CCChh--------------hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCC
Q 048724 313 DLSFT--------------DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGM 376 (394)
Q Consensus 313 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~ 376 (394)
..... ...............+..+++.+.+||.+||+.||++|||+.++++.|+.+.....+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 232 SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp SHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred cccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 43221 22223344555667778899999999999999999999999999999999976554443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=380.75 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=215.6
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+..++|++.+.||+|+||+||+|++ +|+.||||+++.... ........+.+|+.++++++||||++++++|
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL------KKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh------hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 35678999999999999999999998 689999999974321 1112235678899999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
.+...+ |+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 255 ~~~~~l--------------------~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrD 314 (543)
T 3c4z_A 255 ETKTDL--------------------CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314 (543)
T ss_dssp ECSSEE--------------------EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred eeCCEE--------------------EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 876665 89999999999999997643 45699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC-
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS- 315 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~- 315 (394)
|||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 315 LKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred CChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 9999999999999999999999865444333444689999999999999999999999999999999999999997653
Q ss_pred ---hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH-----HHHHH
Q 048724 316 ---FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM-----DEVVK 363 (394)
Q Consensus 316 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~-----~~ll~ 363 (394)
...+...+... ...++..+++++.+||.+||+.||++||++ ++++.
T Consensus 395 ~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 395 KVENKELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred chhHHHHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 34455555443 345667899999999999999999999965 66665
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=350.58 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=217.3
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..+..++|++.+.||+|+||+||+|++ +++.||||++.... .........+.+|+.+++.++||||++++++
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 82 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ------LEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc------cchHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 345678999999999999999999998 57899999986321 1112224678899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+.... |+||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||
T Consensus 83 ~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 140 (284)
T 2vgo_A 83 FHDRKRI--------------------YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDI 140 (284)
T ss_dssp EECSSEE--------------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred EEcCCEE--------------------EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 9865554 8999999999999999654 45999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+||+++.++.+||+|||++...... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 141 ~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 218 (284)
T 2vgo_A 141 KPENLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218 (284)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CHHHEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence 999999999999999999998754322 223457899999999999999999999999999999999999999988877
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+....+... ...++..++..+.++|.+||+.||++|||+.++++.
T Consensus 219 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 219 ETHRRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 776666543 345667789999999999999999999999999984
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=358.22 Aligned_cols=260 Identities=21% Similarity=0.327 Sum_probs=210.0
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||+||+|.+ +|+.||||+++...... ....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--------hHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 357899999999999999999998 58899999997433211 12556789999999999999999999875
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
.... ..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 79 ~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 140 (319)
T 4euu_A 79 TTTR------------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (319)
T ss_dssp TTTC------------------CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CCCc------------------eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 5432 34899999999999999976433 3499999999999999999999999999999999
Q ss_pred Cceee----CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC--------CCCCCccchHHHHHHHHHHHHhC
Q 048724 240 ENMLL----DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD--------GKPYNRKCDVYSFGICLWEIYCC 307 (394)
Q Consensus 240 ~NIll----~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~elltg 307 (394)
+|||+ +.++.+||+|||+++..... .......||+.|+|||.+. +..++.++|||||||++|||++|
T Consensus 141 ~NIll~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 141 GNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp GGEEEEECTTSCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred HHEEEeccCCCCceEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999 77888999999999865433 2333467999999999985 57789999999999999999999
Q ss_pred CCCCCCCCh----hhHHHHHHhccCC-----------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 308 DMPYPDLSF----TDVSSAVVRQNLR-----------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 308 ~~Pf~~~~~----~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
..||..... .+....+...... ..++..++..+.++|.+||+.||++|||+++
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 999964332 3333344332211 0112234568899999999999999999999
Q ss_pred HHHHHHHHH
Q 048724 361 VVKLLEAVN 369 (394)
Q Consensus 361 ll~~l~~~~ 369 (394)
+++...+..
T Consensus 300 ll~h~~d~~ 308 (319)
T 4euu_A 300 FFAETSDIL 308 (319)
T ss_dssp HHHHHHHHT
T ss_pred hhhccHHHh
Confidence 999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=359.97 Aligned_cols=258 Identities=26% Similarity=0.554 Sum_probs=212.4
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeE----EEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDV----AVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~v----avK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
+..++|++.+.||+|+||+||+|.+ +++.| |+|.++...... ....+.+|+.++++++||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--------ANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--------CHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--------HHHHHHHHHHHHHhCCCCCeeEEE
Confidence 4568899999999999999999988 55554 666664322111 135678899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.... .++|++|+++|+|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~---------------------~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 141 (327)
T 3lzb_A 84 GICLTST---------------------VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 141 (327)
T ss_dssp EEEESSS---------------------EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEecCC---------------------ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCC
Confidence 9987543 27899999999999999764 3569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 142 Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999986433221 2223456788999999999999999999999999999999 999999
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
.....+....+ ........+..++.++.++|.+||+.||.+|||+.++++.|+++..
T Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 222 GIPASEISSIL-EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCCGGGHHHHH-HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 88887776555 4455566777899999999999999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.48 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=212.0
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFI 155 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 155 (394)
+.....++|++.+.||+|+||+||+|++ +|+.||||+++..... ...+.+|+.+++++ +||||++++
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----------THHHHHHHHHHHHHCCSTTBCCEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----------HHHHHHHHHHHHhccCCCCeeeee
Confidence 3444578999999999999999999998 7889999998754321 25677899999999 899999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++...... ......|+||||+++|+|.+++.......+++..++.++.||+.||.|||++|++||
T Consensus 88 ~~~~~~~~~--------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 153 (326)
T 2x7f_A 88 GAFIKKNPP--------------GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 153 (326)
T ss_dssp EEEEECC----------------CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eEEeeccCc--------------cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999754321 012345999999999999999987655679999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
||||+|||++.++.+||+|||++..............|++.|+|||.+. +..++.++||||||+++|+|++|..|
T Consensus 154 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred CCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999976543333334457899999999987 56788999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
|...........+.........+..++..+.++|.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 234 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp TTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 988877766666555544444456789999999999999999999999999883
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=363.07 Aligned_cols=263 Identities=29% Similarity=0.472 Sum_probs=212.6
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+...++|++.+.||+|+||+||+|++ +|+.||||++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---------GIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---------HHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 344568999999999999999999998 6889999988643221 135688999999999999999999998
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
.+.+.. ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++|++|||
T Consensus 105 ~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~d 164 (321)
T 2qkw_B 105 DERNEM--------------------ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164 (321)
T ss_dssp CCTTCC--------------------EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cCCCeE--------------------EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCC
Confidence 766554 89999999999999886433 23589999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||+||+++.++.+||+|||+++..... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 9999999999999999999999753322 11223346899999999998888999999999999999999999999754
Q ss_pred ChhhHHH------HHHh-cc--------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 315 SFTDVSS------AVVR-QN--------LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 315 ~~~~~~~------~~~~-~~--------~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
...+... .... .. .....+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 3322110 0101 11 11112233467899999999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=360.58 Aligned_cols=262 Identities=29% Similarity=0.544 Sum_probs=218.8
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCee--EEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQD--VAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIG 156 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 156 (394)
+..++|++.+.||+|+||+||+|++ ++.. ||+|.++.... ......+.+|+.+++++ +||||+++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 93 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------KDDHRDFAGELEVLCKLGHHPNIINLLG 93 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--------hHHHHHHHHHHHHHHhccCCCchhhhce
Confidence 5568999999999999999999987 5664 49998863221 11235678899999999 9999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHHHHHHHHHHH
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~ 222 (394)
++.+.... |+||||+++|+|.+++.... ...+++..++.++.||+.
T Consensus 94 ~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 153 (327)
T 1fvr_A 94 ACEHRGYL--------------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153 (327)
T ss_dssp EEEETTEE--------------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred eeeeCCce--------------------EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 99866554 89999999999999997542 246999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 223 ~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
||.|||++|++||||||+|||++.++.+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|
T Consensus 154 aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 154 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 999999999999999999999999999999999999743221 1223346788999999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 303 EIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 303 ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
+|++ |..||......+....+ ........+..+++.+.+||.+||+.||++|||+.++++.|+.+.....
T Consensus 233 ellt~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHG-GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHcCCCCCCCCCcHHHHHHHh-hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 9998 99999988877766554 3445566677899999999999999999999999999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=361.48 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=195.7
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
-.++|++.+.||+|+||+||+|++ +++.||||+++.... .+.+.+|+.++++++||||+++++++.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----------KKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----------HHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 357799999999999999999998 577899999974321 2557789999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... ++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+
T Consensus 120 ~~~~--------------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 177 (349)
T 2w4o_A 120 PTEI--------------------SLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177 (349)
T ss_dssp SSEE--------------------EEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCeE--------------------EEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcc
Confidence 6554 899999999999999854 356999999999999999999999999999999999
Q ss_pred ceeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 241 NMLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 241 NIll~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|||++. ++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 178 NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 178 NLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp GEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred cEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 999975 889999999999754332 2233467999999999999999999999999999999999999999776655
Q ss_pred h-HHHHHHhccCCC--CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 D-VSSAVVRQNLRP--DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~-~~~~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
. ....+....... +....++.++.+||.+||+.||++|||+.++++.
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4 444444433322 2335689999999999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=368.54 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=214.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||+|++..... . ....+.+|+.++++++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----L----DKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----H----HHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-----h----hHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 47899999999999999999988 688999999874321 1 134678999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 121 ~~~--------------------~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N 179 (387)
T 1kob_A 121 YEM--------------------VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179 (387)
T ss_dssp SEE--------------------EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHH
Confidence 554 8999999999999998543 3469999999999999999999999999999999999
Q ss_pred eeeCC--CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDA--NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~--~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 180 Ill~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 258 (387)
T 1kob_A 180 IMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 258 (387)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred eEEecCCCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH
Confidence 99974 577999999999865432 222335799999999999999999999999999999999999999998888777
Q ss_pred HHHHHhccCC--CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+...... ......+++++.+||.+||+.||++|||+.++++.
T Consensus 259 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 7777665433 23335689999999999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=355.33 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=215.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||+|+++..... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 57899999999999999999998 6889999999754321 12246788999999999999999999988643
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ccc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSKT-----IVH 234 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~-----iiH 234 (394)
.. ..+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++| ++|
T Consensus 78 ~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH 139 (279)
T 2w5a_A 78 TN------------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139 (279)
T ss_dssp GG------------------TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred CC------------------ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence 22 22389999999999999997643 345999999999999999999999999 999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||||+||+++.++.+||+|||+++.............+++.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 99999999999999999999999976543322222346899999999999989999999999999999999999999988
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
+..+....+... ....++..++.++.++|.+||+.||++|||+.++++.++
T Consensus 220 ~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 220 SQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CHHHHHHHHhhc-ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 877776665444 344567789999999999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=359.76 Aligned_cols=263 Identities=26% Similarity=0.399 Sum_probs=210.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +++.||||+++..... .......+.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR------DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT------SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC------CHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 57899999999999999999997 7889999999743221 123346788999999999999999999998754
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ....|+||||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~----------------~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 146 (311)
T 3ork_A 85 TPA----------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 146 (311)
T ss_dssp ETT----------------EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCC----------------CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 432 11238999999999999999654 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 147 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 226 (311)
T 3ork_A 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226 (311)
T ss_dssp EEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999999997543322 12223568999999999999999999999999999999999999999888877
Q ss_pred HHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHH-HHHHHHHHHHh
Q 048724 319 VSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMD-EVVKLLEAVNT 370 (394)
Q Consensus 319 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~-~ll~~l~~~~~ 370 (394)
...........+. ....++.++.++|.+||+.||++||+.. ++...+.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 227 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 7766655543322 1245899999999999999999999555 45556666643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=368.28 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=198.1
Q ss_pred cccccce-eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh-CCCCcceeeeeeec
Q 048724 84 LAKLDIR-HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK-LDHPNVTKFIGASM 159 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~~ 159 (394)
.++|.+. +.||+|+||+||+|.+ +|+.||||+++.. ..+.+|+.++.+ .+||||++++++|.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 4677776 6899999999999988 6889999998621 345578887744 58999999999986
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
.... ....+|+||||++||+|.+++.......+++..++.|+.||+.||.|||++||+||||||
T Consensus 126 ~~~~----------------~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 189 (400)
T 1nxk_A 126 NLYA----------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189 (400)
T ss_dssp EEET----------------TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred eccc----------------CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCc
Confidence 4110 012348999999999999999765555799999999999999999999999999999999
Q ss_pred CceeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 240 ENMLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
+|||++. ++.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 190 ~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 190 ENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999987 789999999999854322 233456889999999999999999999999999999999999999976543
Q ss_pred hh----HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 317 TD----VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 317 ~~----~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
.. ....+....+....+ ..++.++.+||.+||+.||++|||+.++++.-.
T Consensus 269 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 22 334444444433222 468999999999999999999999999998644
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=360.02 Aligned_cols=262 Identities=32% Similarity=0.576 Sum_probs=202.4
Q ss_pred ccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHH--HHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV--WQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~i--l~~l~h~nIv~l~~ 156 (394)
++.+..++|++.+.||+|+||+||+|+++++.||||+++... ...+..|.++ +..++||||+++++
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------RQNFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------------hhhHHHHHHHHHHHhccCcchhhhee
Confidence 466788999999999999999999999999999999997432 1223334444 44589999999998
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC------
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK------ 230 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------ 230 (394)
.+...... ....+|+||||+++|+|.+++... ..++..++.++.||+.||.|||++
T Consensus 75 ~~~~~~~~---------------~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~ 136 (336)
T 3g2f_A 75 GDERVTAD---------------GRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDH 136 (336)
T ss_dssp EEEEECTT---------------SCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGG
T ss_pred cccccccC---------------CCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccc
Confidence 65421111 123458999999999999999653 368999999999999999999999
Q ss_pred ---CCcccCCCCCceeeCCCCcEEEeeccccccccCC--------CCCccCCCCCCCcCCccccCC-------CCCCccc
Q 048724 231 ---TIVHRDVKTENMLLDANRTLKIADFGVARVEAQN--------PRDMTGETGTLGYMAPEVLDG-------KPYNRKC 292 (394)
Q Consensus 231 ---~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~ 292 (394)
||+||||||+|||++.++.+||+|||+++..... ........||+.|+|||.+.+ ..++.++
T Consensus 137 ~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 216 (336)
T 3g2f_A 137 YKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQV 216 (336)
T ss_dssp CBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHH
T ss_pred cccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccccc
Confidence 9999999999999999999999999999754321 112223579999999999987 4566789
Q ss_pred hHHHHHHHHHHHHhCCCCCC-CCC-----------------hhhHHHHHHhccCCCCCCCC------CcHHHHHHHHHhc
Q 048724 293 DVYSFGICLWEIYCCDMPYP-DLS-----------------FTDVSSAVVRQNLRPDIPRC------CPSSLASIMRKCW 348 (394)
Q Consensus 293 DvwslG~~l~elltg~~Pf~-~~~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cL 348 (394)
|||||||++|||++|..||. ... ..+..........++.++.. +++.+.+||.+||
T Consensus 217 DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (336)
T 3g2f_A 217 DMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296 (336)
T ss_dssp HHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHS
T ss_pred chHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHh
Confidence 99999999999999966652 211 11222222233344555543 3458999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHh
Q 048724 349 DANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 349 ~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+.||++|||+.++++.|+++..
T Consensus 297 ~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 297 DQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCChhhCcchHHHHHHHHHHHH
Confidence 9999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=355.73 Aligned_cols=262 Identities=22% Similarity=0.356 Sum_probs=207.4
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||+||+|.+ +++.||||+++.... ........+.+|+.++++++||||+++++++..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS------SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG------GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc------cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 368999999999999999999997 688999999874321 122335678899999999999999999999986
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... |+|+||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 106 ~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 163 (309)
T 2h34_A 106 DGQL--------------------YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163 (309)
T ss_dssp TTEE--------------------EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCeE--------------------EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChH
Confidence 5554 8999999999999999654 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|||++.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 164 NILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp GEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred HEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 9999999999999999987543322 222345789999999999999999999999999999999999999987765544
Q ss_pred HHHHHhccCC--CCCCCCCcHHHHHHHHHhchhCCCCCC-CHHHHHHHHHHHHhccC
Q 048724 320 SSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKRP-VMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 320 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cL~~dP~~Rp-t~~~ll~~l~~~~~~~~ 373 (394)
...+ ..... ...+..+|..+.++|.+||+.||++|| +++++++.|+.+.....
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 244 GAHI-NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHH-HSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHh-ccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 3333 33222 134566899999999999999999999 99999999998865443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=352.86 Aligned_cols=263 Identities=27% Similarity=0.508 Sum_probs=215.0
Q ss_pred cccccccccceeeeccCCceEEEEEEE---CCe--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY---DGQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
..+..++|++.+.||+|+||+||+|++ +++ .||||+++.... ......+.+.+|+.++++++||||+++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL------SQPEAMDDFIREVNAMHSLDHRNLIRL 86 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc------CCHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 456678999999999999999999986 223 699999864321 112234678899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++.... .++|+||+++++|.+++... ...+++..++.++.|++.||.|||++|++|
T Consensus 87 ~~~~~~~~---------------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 144 (291)
T 1u46_A 87 YGVVLTPP---------------------MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144 (291)
T ss_dssp EEEECSSS---------------------CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEccCC---------------------ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99987543 28999999999999999764 356999999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMP 310 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~P 310 (394)
|||||+||+++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 145 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 224 (291)
T 1u46_A 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224 (291)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999976543321 1223457788999999988889999999999999999999 9999
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
|...+..+....+.........+..++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 225 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 999988888877777666667777899999999999999999999999999999998864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=386.61 Aligned_cols=265 Identities=27% Similarity=0.510 Sum_probs=219.6
Q ss_pred cccccccccccee-eeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 79 EWEIELAKLDIRH-EIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 79 ~~~~~~~~~~~~~-~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
.|.+..+++.+.+ .||+|+||+||+|.+ ++..||||+++...... ..+.|.+|+.+|++++|||||+
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~~E~~il~~l~hpniv~ 400 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--------DTEEMMREAQIMHQLDNPYIVR 400 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--------THHHHHHHHHHHTTCCCTTBCC
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--------HHHHHHHHHHHHHhCCCCCEee
Confidence 3555666666666 899999999999987 34579999997542211 1367889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
++++|... . .|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 401 l~~~~~~~-~--------------------~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ii 458 (613)
T 2ozo_A 401 LIGVCQAE-A--------------------LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFV 458 (613)
T ss_dssp EEEEEESS-S--------------------EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEeccC-C--------------------eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 99998642 2 38999999999999999653 45699999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 459 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999986433221 1122345689999999998899999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
||......++...+ ..+.+...+..+++++.+||.+||+.||++||++.++++.|+.+..+...
T Consensus 539 Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 539 PYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp TTTTCCSHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 99998888777665 44556778888999999999999999999999999999999998765433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=390.17 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=218.2
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFI 155 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 155 (394)
...+..++|++.+.||+|+||+||+|++ +++.||||+++.... ........+..|..++..+ +||||++++
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV------IQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH------HHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc------ccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3456788999999999999999999998 678899999974321 1111235667899999888 799999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.+.+.+ |+||||++||+|.+++... ..+++..++.|+.||+.||.|||++||+||
T Consensus 409 ~~~~~~~~~--------------------~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHr 466 (674)
T 3pfq_A 409 SCFQTMDRL--------------------YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466 (674)
T ss_dssp EECBCSSEE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECC
T ss_pred EEEEeCCEE--------------------EEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence 999876665 8999999999999999754 469999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||||+||||+.++.+||+|||+++............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 467 DLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999999864444444556789999999999999999999999999999999999999999999
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCH-----HHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVM-----DEVVK 363 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~-----~~ll~ 363 (394)
..++...+.... ..+|..+++++.+||.+||+.||++||++ ++|++
T Consensus 547 ~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 547 EDELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 888888887654 45677899999999999999999999987 67665
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.32 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=217.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|.+.+.||+|+||+||+|.+ +++.||+|++....... ......+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC------HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 57899999999999999999998 57899999987443211 12246788899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.. ++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 88 ~~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 145 (294)
T 2rku_A 88 DFV--------------------FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 145 (294)
T ss_dssp SEE--------------------EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 554 8999999999999988653 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||......+...
T Consensus 146 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 225 (294)
T 2rku_A 146 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 225 (294)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999865444344445679999999999999999999999999999999999999999887777665
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.+... ....+..++..+.+++.+||+.||++|||++++++.-
T Consensus 226 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 226 RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 55443 3456677899999999999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=356.36 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=203.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||++..... .......+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-------DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK 74 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-------chHHHHHHHHHHHHHHhCCCCCccchhheeecC
Confidence 46899999999999999999998 588999999864321 223346778899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|
T Consensus 75 ~~~--------------------~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~N 132 (311)
T 4agu_A 75 RRL--------------------HLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPEN 132 (311)
T ss_dssp TEE--------------------EEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CeE--------------------EEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhh
Confidence 554 899999999999988754 3569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|+++.++.+||+|||++..............+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+..
T Consensus 133 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 212 (311)
T 4agu_A 133 ILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212 (311)
T ss_dssp EEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999865544444445689999999999875 67899999999999999999999999988776655
Q ss_pred HHHHhcc-------------------CCCCC----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQN-------------------LRPDI----------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~-------------------~~~~~----------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+.... ..... ...++.++.+||.+||+.||++|||++++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 4443210 00000 13478899999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=381.33 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=215.9
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+..++|++.+.||+|+||.||+|++ +|+.||||+++.... ........+.+|+.+|+.++|||||++++++.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh------hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 6678999999999999999999998 689999999974321 11112356778999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+...+ |+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||
T Consensus 255 ~~~~l--------------------~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKP 314 (576)
T 2acx_A 255 TKDAL--------------------CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314 (576)
T ss_dssp CSSEE--------------------EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred eCCEE--------------------EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCch
Confidence 76655 9999999999999999766555699999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC----
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS---- 315 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~---- 315 (394)
+|||++.++.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 315 eNILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~ 393 (576)
T 2acx_A 315 ENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393 (576)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC
T ss_pred heEEEeCCCCeEEEecccceecccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh
Confidence 9999999999999999999865432 23344689999999999999999999999999999999999999998753
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
...+...+.. ....++..+++++.+||.+||+.||++|| +++++++.
T Consensus 394 ~~~i~~~i~~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 394 REEVERLVKE--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHhhc--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 2334433333 34456778999999999999999999999 78898863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=361.59 Aligned_cols=240 Identities=23% Similarity=0.408 Sum_probs=181.3
Q ss_pred eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~ 167 (394)
+.||+|+||+||+|.+ +|+.||||++.... ...+.+|+.+++.+. ||||+++++++.+....
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~--- 81 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT--- 81 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE---
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh------------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE---
Confidence 7899999999999998 58899999986321 245678999999996 99999999999876655
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCC
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN 247 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~ 247 (394)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 -----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~ 142 (325)
T 3kn6_A 82 -----------------FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142 (325)
T ss_dssp -----------------EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-
T ss_pred -----------------EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC
Confidence 8999999999999999654 569999999999999999999999999999999999999766
Q ss_pred C---cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh-------h
Q 048724 248 R---TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF-------T 317 (394)
Q Consensus 248 ~---~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~-------~ 317 (394)
+ .+||+|||+++.............+|+.|+|||.+.+..++.++||||||+++|+|++|..||..... .
T Consensus 143 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 222 (325)
T 3kn6_A 143 NDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222 (325)
T ss_dssp ---CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred CCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence 5 89999999998655444444556789999999999999999999999999999999999999976432 3
Q ss_pred hHHHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+....+......... ...+++++.+||.+||+.||++|||++++++.
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 344444333222111 13579999999999999999999999998854
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.23 Aligned_cols=261 Identities=28% Similarity=0.381 Sum_probs=207.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC---CCCcceeeeee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGA 157 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~ 157 (394)
..++|++.+.||+|+||+||+|++ +|+.||||+++......... .....+.+|+.+++.+ +||||++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG----GLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS----CCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc----ccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 457899999999999999999996 78899999987543211100 0012345667666666 59999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.....- ....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++|++||||
T Consensus 83 ~~~~~~~---------------~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 146 (308)
T 3g33_A 83 CATSRTD---------------REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 146 (308)
T ss_dssp EEECCSS---------------SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred eeccCCC---------------CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 8754421 1123489999996 69999998766666999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..
T Consensus 147 kp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 147 KPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp CTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred CHHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999999754432 2334467899999999999999999999999999999999999999988877
Q ss_pred hHHHHHHhccCCC---C----------------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRP---D----------------------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~---~----------------------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+....+......+ . ....++.++.+||.+||+.||++|||+.++++.
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 7766654321100 0 113478899999999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=367.72 Aligned_cols=273 Identities=19% Similarity=0.294 Sum_probs=208.1
Q ss_pred cccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchH--HHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSA--EAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
+..++|++.+.||+|+||+||+|.+. ++.||||+++.......... ........+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 44579999999999999999999872 47899999874431100000 0001112344566777888999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++++++.....- ....|+||||+ |++|.+++... ...+++..++.|+.||+.||.|||++||
T Consensus 112 ~~~~~~~~~~~~----------------~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i 173 (364)
T 3op5_A 112 KYWGSGLHDKNG----------------KSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEY 173 (364)
T ss_dssp CEEEEEEEEETT----------------EEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEeeeeeccCC----------------cceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 999998754220 12248999999 99999999763 3569999999999999999999999999
Q ss_pred cccCCCCCceeeC--CCCcEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHH
Q 048724 233 VHRDVKTENMLLD--ANRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303 (394)
Q Consensus 233 iH~Dlkp~NIll~--~~~~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e 303 (394)
+||||||+|||++ .++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++||
T Consensus 174 iHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~e 253 (364)
T 3op5_A 174 VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253 (364)
T ss_dssp ECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred EEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHH
Confidence 9999999999998 88999999999997543221 11123459999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHhccCCCC---------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 304 IYCCDMPYPDLSFTDVSSAVVRQNLRPD---------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 304 lltg~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
|++|+.||.+.................. ....+|.++.+++..||+.||++||++.++++.|+++....
T Consensus 254 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 254 WLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 9999999985432222211111111100 12457999999999999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=349.12 Aligned_cols=260 Identities=31% Similarity=0.542 Sum_probs=215.2
Q ss_pred cccceeeeccCCceEEEEEEE--CC---eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DG---QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
.|.+.+.||+|+||+||+|.+ ++ ..||+|+++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--------MQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 456679999999999999986 33 2799999864221 1124678899999999999999999999875
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.. .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||++|++||||||+
T Consensus 94 ~~~~-------------------~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~ 153 (298)
T 3pls_A 94 PEGL-------------------PHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAAR 153 (298)
T ss_dssp SSSC-------------------CEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CCCC-------------------cEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc
Confidence 4432 27899999999999999653 456899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCC----CCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC-CCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQN----PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLS 315 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~Pf~~~~ 315 (394)
||+++.++.+||+|||+++..... ........+++.|+|||.+.+..++.++||||||+++|+|++| .+||...+
T Consensus 154 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp GEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 999999999999999999743221 1223345678899999999999999999999999999999995 56666666
Q ss_pred hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 316 FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
..+....+ ........+..+++.+.+++.+||+.||.+|||++++++.|+++...-.+
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 234 PFDLTHFL-AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp GGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHh-hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 66665544 44455666778999999999999999999999999999999999765433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=345.96 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=214.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ ++..||+|++....... ...+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---------VDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---------HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 36799999999999999999998 56789999987543211 35678899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 79 ~~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~N 136 (277)
T 3f3z_A 79 TDI--------------------YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPEN 136 (277)
T ss_dssp SEE--------------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CeE--------------------EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHH
Confidence 554 8999999999999998654 459999999999999999999999999999999999
Q ss_pred eee---CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLL---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|++ +.++.++|+|||++...... .......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||......+
T Consensus 137 il~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (277)
T 3f3z_A 137 FLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214 (277)
T ss_dssp EEESSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH
Confidence 999 78899999999999754432 233446799999999998765 8999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHH
Q 048724 319 VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAVN 369 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~~ 369 (394)
....+.......... ..+++.+.++|.+||+.||++|||+.++++ .+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 215 VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 777776654432211 257999999999999999999999999997 444443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=347.42 Aligned_cols=250 Identities=24% Similarity=0.452 Sum_probs=206.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|.+.+.||+|+||+||+|.+ ++..||+|++........ ...+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--------MEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--------HHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 37899999999999999999988 678999999875432211 35678899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
... |+||||+++|+|.+++... ....+++..++.++.|++.||.|||++|++||||||
T Consensus 93 ~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp 152 (285)
T 3is5_A 93 HNM--------------------YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP 152 (285)
T ss_dssp SEE--------------------EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred CeE--------------------EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCH
Confidence 554 8999999999999998653 235799999999999999999999999999999999
Q ss_pred Cceee---CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 240 ENMLL---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
+||++ +.++.+||+|||++...... .......+|+.|+|||.+. ..++.++||||||+++|+|++|..||.....
T Consensus 153 ~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 153 ENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp GGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 99999 45678999999999754332 2233467999999999986 4588999999999999999999999999888
Q ss_pred hhHHHHHHhccCCCCC-CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 317 TDVSSAVVRQNLRPDI-PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 317 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+.............. ...+++++.+||.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 7777666544433222 2347899999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=366.50 Aligned_cols=264 Identities=30% Similarity=0.431 Sum_probs=211.1
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
..++.+..++|++.+.||+|+||+||+|.+ +|+.||||+++...... ....+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--------GELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------------CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--------HHHHHHHHHHHHHhccCCCccceE
Confidence 345667789999999999999999999987 68899999987433211 113578899999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--RKKLAFKVVIQIALDLARGLSYLHSK--- 230 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~--- 230 (394)
+++...... ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++
T Consensus 94 ~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 153 (326)
T 3uim_A 94 GFCMTPTER--------------------LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153 (326)
T ss_dssp EEECCSSCC--------------------EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred EEEecCCce--------------------EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 999876655 89999999999999997643 23599999999999999999999999
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCC
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~ 309 (394)
|++||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 154 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (326)
T 3uim_A 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233 (326)
T ss_dssp CEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCC
T ss_pred CeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCC
Confidence 99999999999999999999999999998654322 22333569999999999988889999999999999999999999
Q ss_pred CCCCC----ChhhHHHHHHhccC-------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 310 PYPDL----SFTDVSSAVVRQNL-------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 310 Pf~~~----~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
||... .............. ....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred cccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 99521 11111111111111 1111222347899999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=356.64 Aligned_cols=262 Identities=31% Similarity=0.546 Sum_probs=217.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
.++..++|++.+.||+|+||+||+|++ ++..||||+++.... ......+.+|+.++++++||||+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--------EQDELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--------hhhHHHHHHHHHHHhhCCCCCCC
Confidence 457789999999999999999999983 456899999863221 11235678899999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHH
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-----KKLAFKVVIQIALDLARGLSYL 227 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~yL 227 (394)
++++++.+.... |+||||+++++|.+++..... ..+++..++.++.||+.||.||
T Consensus 97 ~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L 156 (327)
T 2yfx_A 97 RCIGVSLQSLPR--------------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156 (327)
T ss_dssp CEEEEECSSSSC--------------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEcCCCCc--------------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999876554 899999999999999976532 3589999999999999999999
Q ss_pred HhCCCcccCCCCCceeeCC---CCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHH
Q 048724 228 HSKTIVHRDVKTENMLLDA---NRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLW 302 (394)
Q Consensus 228 H~~~iiH~Dlkp~NIll~~---~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ 302 (394)
|++|++||||||+|||++. +..+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|
T Consensus 157 H~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 236 (327)
T 2yfx_A 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236 (327)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence 9999999999999999984 4569999999997433221 1222346788999999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 303 EIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 303 ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+|++ |..||......+....+. .......+..++..+.++|.+||+.||++|||+.++++.|+.+..
T Consensus 237 ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 237 EIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCcCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 9998 999999888777666554 344556677899999999999999999999999999999998865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=351.09 Aligned_cols=261 Identities=32% Similarity=0.563 Sum_probs=214.8
Q ss_pred cccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
..+|++.+.||+|+||+||+|.+. +..||+|.++.... ......+.+|+.++++++||||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------IGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--------HHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 457889999999999999999862 23589998864221 11236688999999999999999999986
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...+. ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 96 ~~~~~-------------------~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dik 155 (298)
T 3f66_A 96 LRSEG-------------------SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155 (298)
T ss_dssp CCSSS-------------------CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EcCCC-------------------ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence 54332 238999999999999999653 3568999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPD 313 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~ 313 (394)
|+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||..
T Consensus 156 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 156 ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999997543211 22233567889999999998899999999999999999999 6778887
Q ss_pred CChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 314 LSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
....+....+.. ......+..+++.+.+++.+||+.||++|||++++++.|+++...-.
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 236 VNTFDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp SCTTTHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 777776655543 44555677789999999999999999999999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=345.24 Aligned_cols=253 Identities=25% Similarity=0.491 Sum_probs=208.1
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
.+..++|++.+.||+|+||.||+|.+ +|+.||||+++... .........+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc------ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 45578999999999999999999998 68899999986322 11122346788999999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...... |+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+|||
T Consensus 81 ~~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 138 (276)
T 2h6d_A 81 STPTDF--------------------FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138 (276)
T ss_dssp ECSSEE--------------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCC
T ss_pred ecCCeE--------------------EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 866554 8999999999999999654 458999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|+||+++.++.++|+|||++...... .......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||......
T Consensus 139 p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 217 (276)
T 2h6d_A 139 PENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP 217 (276)
T ss_dssp GGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhEEECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 99999999999999999999754332 22234578999999999988765 58999999999999999999999888777
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.....+... ....+..++..+.++|.+||+.||++|||+.++++.
T Consensus 218 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 218 TLFKKIRGG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhcC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 766665443 334567789999999999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=374.16 Aligned_cols=251 Identities=29% Similarity=0.490 Sum_probs=214.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +++.||||+++....... ....+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-------DTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-------HHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 47899999999999999999998 688999999864322111 135678899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 151 (486)
T 3mwu_A 94 SSF--------------------YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151 (486)
T ss_dssp SEE--------------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred CEE--------------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHH
Confidence 655 8999999999999988654 469999999999999999999999999999999999
Q ss_pred eeeC---CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLD---ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~---~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||++ .++.+||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+
T Consensus 152 il~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 229 (486)
T 3mwu_A 152 ILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (486)
T ss_dssp EEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9995 4567999999999755433 23344689999999999986 48999999999999999999999999998888
Q ss_pred HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
....+.........+ ..+++++.+||.+||+.||++|||+.++++.-
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 888877766554443 46899999999999999999999999999853
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=358.45 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=217.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|.+.+.||+|+||+||++.+ +++.||+|++...... .......+.+|+.+++.++||||+++++++.+.
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL------KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 47899999999999999999998 5789999998744321 112346788899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 114 ~~~--------------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 171 (335)
T 2owb_A 114 DFV--------------------FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 171 (335)
T ss_dssp SEE--------------------EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CeE--------------------EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchh
Confidence 554 8999999999999998653 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||......+...
T Consensus 172 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 251 (335)
T 2owb_A 172 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251 (335)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence 99999999999999999865444344445679999999999999899999999999999999999999999887777666
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+... ...++..++..+.+||.+||+.||++|||+.++++.
T Consensus 252 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 252 RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 65544 334667789999999999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=347.54 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=201.9
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
|++..++|++.+.||+|+||+||+|.+ +|+.||||+++.... .......+.++...++.++||||++++++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~ 74 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-------SQEQKRLLMDLDISMRTVDCPFTVTFYGA 74 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-------HHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-------cHHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence 567789999999999999999999998 789999999864321 11223445556666888899999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcc
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLHSK-TIVH 234 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiH 234 (394)
+.+.... |+||||++ |+|.+++.. .....+++..++.++.|++.||.|||++ |++|
T Consensus 75 ~~~~~~~--------------------~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H 133 (290)
T 3fme_A 75 LFREGDV--------------------WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133 (290)
T ss_dssp EECSSSE--------------------EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCC
T ss_pred eeccCCE--------------------EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence 9866554 89999996 588888764 2345799999999999999999999998 9999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCcccc----CCCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL----DGKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
|||||+||+++.++.+||+|||+++...... ......||+.|+|||.+ .+..++.++||||||+++|+|++|..|
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred CCCCHHHEEECCCCCEEEeecCCcccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999997544332 22335799999999996 566789999999999999999999999
Q ss_pred CCCC-ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHH
Q 048724 311 YPDL-SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAVN 369 (394)
Q Consensus 311 f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~~ 369 (394)
|... ..................+..+++++.+++.+||+.||++|||+.++++ .++...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp SCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 9864 3334444444444444444578999999999999999999999999998 454443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.37 Aligned_cols=261 Identities=28% Similarity=0.519 Sum_probs=216.9
Q ss_pred ccccccccccce-eeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 79 EWEIELAKLDIR-HEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 79 ~~~~~~~~~~~~-~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
+|.+....+.+. +.||+|+||+||+|.+ .++.||||+++...... ...+.+.+|+.++++++|||||+
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~ 434 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-------ALKDELLAEANVMQQLDNPYIVR 434 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-------GGHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCEee
Confidence 455555666554 4799999999999966 35789999997543211 12367889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+++++... . .++||||+++|+|.+++... ..+++..++.|+.||+.||.|||++||+
T Consensus 435 l~~~~~~~-~--------------------~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ii 491 (635)
T 4fl3_A 435 MIGICEAE-S--------------------WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFV 491 (635)
T ss_dssp EEEEEESS-S--------------------EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEecC-C--------------------EEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 99998642 2 38999999999999999653 4699999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 492 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 571 (635)
T 4fl3_A 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571 (635)
T ss_dssp CSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998653322 11223456788999999999899999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
||.+....++...+ ..+.+...+..+++++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 572 Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 572 PYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp SSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99998888877665 4455677788899999999999999999999999999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=360.97 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=210.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ ++..||+|+++...... ........+.+|+.++++++||||+++++++.+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ----INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc----cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 47899999999999999999988 67899999987432110 0112346788999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-------------------------------------
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK------------------------------------- 204 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~------------------------------------- 204 (394)
... |+||||++||+|.+++....
T Consensus 101 ~~~--------------------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (345)
T 3hko_A 101 QYI--------------------CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES 160 (345)
T ss_dssp SEE--------------------EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEE
T ss_pred CeE--------------------EEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 554 89999999999999884210
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC--cEEEeeccccccccCCC----CCccCCCCCCCc
Q 048724 205 -RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR--TLKIADFGVARVEAQNP----RDMTGETGTLGY 277 (394)
Q Consensus 205 -~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~--~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y 277 (394)
...+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||+++...... .......||+.|
T Consensus 161 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 161 LDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence 11246788999999999999999999999999999999998766 89999999997543211 123346799999
Q ss_pred CCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCC
Q 048724 278 MAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPD 353 (394)
Q Consensus 278 ~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~ 353 (394)
+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+.........+ ..+++.+.+||.+||+.||.
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 99999975 678999999999999999999999999998888888777766544433 24789999999999999999
Q ss_pred CCCCHHHHHHH
Q 048724 354 KRPVMDEVVKL 364 (394)
Q Consensus 354 ~Rpt~~~ll~~ 364 (394)
+|||+.++++.
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999883
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=347.34 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=220.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||+++..................+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 58899999999999999999998 67899999998655433344455566788899999999995 9999999999976
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... ++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+
T Consensus 96 ~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 153 (298)
T 1phk_A 96 NTFF--------------------FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 153 (298)
T ss_dssp SSEE--------------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCeE--------------------EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence 5554 8999999999999999653 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD------GKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+++.++.+||+|||++...... .......+++.|+|||.+. ...++.++||||||+++|+|++|..||...
T Consensus 154 Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 154 NILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp GEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 999999999999999999754432 2334467899999999984 456889999999999999999999999988
Q ss_pred ChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
........+.........+ ..++..+.++|.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 8877777776665544333 458999999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.58 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=208.1
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC--Ccceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH--PNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~ 156 (394)
..+..++|++.+.||+|+||+||+|.+ +++.||||+++..... ......+.+|+.++++++| |||+++++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 76 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-------hHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence 345678899999999999999999988 7789999999754321 1223678899999999976 99999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.....+ |+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 77 ~~~~~~~~--------------------~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrD 133 (343)
T 3dbq_A 77 YEITDQYI--------------------YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133 (343)
T ss_dssp EEECSSEE--------------------EEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred eEeeCCEE--------------------EEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99876654 899995 588999999653 5699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCC-----------CCCCccchHHHHHHHHHH
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDG-----------KPYNRKCDVYSFGICLWE 303 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~e 303 (394)
|||+|||++ ++.+||+|||+++....... ......||+.|+|||.+.+ ..++.++|||||||++|+
T Consensus 134 ikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~e 212 (343)
T 3dbq_A 134 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212 (343)
T ss_dssp CCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHH
T ss_pred CCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHH
Confidence 999999997 67899999999985433221 2234579999999999854 678899999999999999
Q ss_pred HHhCCCCCCCCCh-hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 304 IYCCDMPYPDLSF-TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 304 lltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
|++|..||..... ......+........++..++.++.+||.+||+.||++|||+.++++...
T Consensus 213 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 213 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 9999999986543 33444445555666777888999999999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=360.09 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=199.0
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
...++|++.+.||+|+||+||+|.+ +++.||||+++.... .......+.+|+.++++++||||+++++++.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-------EEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-------ccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3468999999999999999999987 789999999964331 1222356778999999999999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+...+ |+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 104 ~~~~~--------------------~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp 160 (329)
T 3gbz_A 104 HNHRL--------------------HLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP 160 (329)
T ss_dssp ETTEE--------------------EEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cCCEE--------------------EEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCH
Confidence 76655 89999997 5999999654 4599999999999999999999999999999999
Q ss_pred Cceee-----CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 240 ENMLL-----DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 240 ~NIll-----~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
+|||+ +..+.+||+|||+++.............+|+.|+|||.+.+. .++.++|||||||++|+|++|..||..
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 99999 445569999999998655444444556789999999999874 589999999999999999999999998
Q ss_pred CChhhHHHHHHhccCCCC----------------C------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 314 LSFTDVSSAVVRQNLRPD----------------I------------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
....+....+......+. . +..+++++.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 887776666543211110 0 0116789999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=357.83 Aligned_cols=261 Identities=26% Similarity=0.498 Sum_probs=214.7
Q ss_pred cccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
...|++.+.||+|+||+||++.+ +++.||||+++.... ......+.+|+.++++++||||++++++
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--------PQHRSGWKQEIDILRTLYHEHIIKYKGC 101 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence 34459999999999999988865 578999999974321 1224678899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+... ..+++||||+++|+|.+++... .+++..++.++.||+.||.|||++|++||||
T Consensus 102 ~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Di 160 (318)
T 3lxp_A 102 CEDAGA------------------ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDL 160 (318)
T ss_dssp EEETTT------------------TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EecCCC------------------ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 976432 2248999999999999998543 4999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 161 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred chheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 99999999999999999999986543321 122346788899999999888999999999999999999999998653
Q ss_pred Chh--------------hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 315 SFT--------------DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 315 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
... ...............+..++.++.+||.+||+.||++|||+.++++.|+.+...-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred chhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 221 11222334555667778899999999999999999999999999999999976543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=350.37 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=218.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.+.|++.+.||+|+||+||+|.+ +++.||||+++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--------EIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--------THHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--------HHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 36799999999999999999987 68899999997543211 135688999999999999999999999865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 93 ~~~--------------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 149 (303)
T 3a7i_A 93 TKL--------------------WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAAN 149 (303)
T ss_dssp TEE--------------------EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CeE--------------------EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhe
Confidence 554 899999999999999843 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.+||+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 150 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 229 (303)
T 3a7i_A 150 VLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229 (303)
T ss_dssp EEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence 99999999999999999765444333445679999999999999999999999999999999999999999887777665
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
.+.. ...+..+..++..+.+||.+||+.||++|||+.++++...-.
T Consensus 230 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 230 LIPK-NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp HHHH-SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred Hhhc-CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 5543 345566778999999999999999999999999999865443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=354.64 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=214.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++......... ......+.+|+.++++++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc---chhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 46799999999999999999998 68899999997644321100 00135678999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 88 ~~~--------------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~N 145 (321)
T 2a2a_A 88 TDV--------------------VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145 (321)
T ss_dssp SEE--------------------EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CEE--------------------EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHH
Confidence 554 899999999999999965 3468999999999999999999999999999999999
Q ss_pred eeeCCCC----cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 242 MLLDANR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 242 Ill~~~~----~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|+++.++ .+||+|||++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 146 Il~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 224 (321)
T 2a2a_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (321)
T ss_dssp EEESCTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred EEEecCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999887 7999999999765432 2234467999999999999999999999999999999999999999988877
Q ss_pred hHHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+....+........ .+..++..+.+||.+||+.||++|||+.++++.
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 77766654433221 225688999999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=351.93 Aligned_cols=258 Identities=30% Similarity=0.488 Sum_probs=207.6
Q ss_pred ccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 87 LDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
|...+.||+|+||+||+|.++++.||||++........ ....+.+.+|+.++++++||||+++++++.+....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-- 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-----EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-- 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT-----TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch-----HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce--
Confidence 44568999999999999999999999999864332111 12246788999999999999999999999876655
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~ 245 (394)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 106 ------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 106 ------------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167 (307)
T ss_dssp ------------------EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred ------------------EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc
Confidence 89999999999999997533 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH----
Q 048724 246 ANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV---- 319 (394)
Q Consensus 246 ~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~---- 319 (394)
.++.+||+|||++........ ......||+.|+|||.+.+. ++.++||||||+++|+|++|..||........
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999975433221 12335789999999998764 78999999999999999999999976543321
Q ss_pred HHHHHhc---------cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 320 SSAVVRQ---------NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 320 ~~~~~~~---------~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
...+... ......+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111110 01112223356789999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=364.02 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=207.1
Q ss_pred ceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
..+.||+|+||+||+|.+ +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+...+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-- 161 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---------KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI-- 161 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE--
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE--
Confidence 367899999999999988 688999999974321 1235788999999999999999999999876555
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceee--
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL-- 244 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll-- 244 (394)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 162 ------------------~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 222 (373)
T 2x4f_A 162 ------------------VLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222 (373)
T ss_dssp ------------------EEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred ------------------EEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec
Confidence 8999999999999988653 3469999999999999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 048724 245 DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324 (394)
Q Consensus 245 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~ 324 (394)
+.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.
T Consensus 223 ~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 301 (373)
T 2x4f_A 223 RDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301 (373)
T ss_dssp TTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 56789999999999865433 22334579999999999999999999999999999999999999999988888777776
Q ss_pred hccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 048724 325 RQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAV 368 (394)
Q Consensus 325 ~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~ 368 (394)
........ ...+++++.+||.+||+.||++|||+.++++ +++..
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 65443322 2468999999999999999999999999998 44433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=355.40 Aligned_cols=259 Identities=33% Similarity=0.587 Sum_probs=205.9
Q ss_pred ccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC--CCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL--DHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l~~~~~~ 160 (394)
-.++|++.+.||+|+||+||+|+++|+.||||++.... ...+..|.+++..+ +||||+++++++..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------------EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------------cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 35789999999999999999999999999999986322 12334455555554 99999999999876
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--------CC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK--------TI 232 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------~i 232 (394)
...- ....|+||||+++|+|.+++... .+++..++.++.|++.||.|||++ |+
T Consensus 103 ~~~~----------------~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 103 GTGS----------------WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp SCGG----------------GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred CCCC----------------CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 5221 12348999999999999999543 599999999999999999999998 99
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCCC----ccCCCCCCCcCCccccCCCCCCcc------chHHHHHHHHH
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLDGKPYNRK------CDVYSFGICLW 302 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~ 302 (394)
+||||||+|||++.++.+||+|||+++........ .....||+.|+|||.+.+..++.. +|||||||++|
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 99999999999999999999999999754332211 124579999999999988766655 99999999999
Q ss_pred HHHhC----------CCCCCCCC-----hhhHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 303 EIYCC----------DMPYPDLS-----FTDVSSAVVRQNLRPDIPR-----CCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 303 elltg----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
||++| ..||.... .............++..+. .++.++.+||.+||+.||++|||+.+++
T Consensus 244 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 99999 77775432 2233333333444454543 4677899999999999999999999999
Q ss_pred HHHHHHHhcc
Q 048724 363 KLLEAVNTSK 372 (394)
Q Consensus 363 ~~l~~~~~~~ 372 (394)
+.|+.+..+.
T Consensus 324 ~~L~~l~~~~ 333 (337)
T 3mdy_A 324 KTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHhhc
Confidence 9999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=359.52 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=210.0
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-----CC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-----HP 149 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----h~ 149 (394)
..+..+-.++|++.+.||+|+||+||+|++ +++.||||+++... .....+..|+.+++.+. ||
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----------KYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----------HHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----------hhhhhhHHHHHHHHHhcccCCCCC
Confidence 344556678999999999999999999998 78899999986321 12355677999999996 99
Q ss_pred cceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 150 nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
||+++++++...+.. |+||||+ +++|.+++.......+++..++.++.||+.||.|||+
T Consensus 97 ~iv~~~~~~~~~~~~--------------------~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 155 (360)
T 3llt_A 97 NIVKYHGKFMYYDHM--------------------CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155 (360)
T ss_dssp GBCCEEEEEEETTEE--------------------EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CeecccceeeECCee--------------------EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999876554 8999999 9999999987666679999999999999999999999
Q ss_pred CCCcccCCCCCceeeCC-------------------------CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC
Q 048724 230 KTIVHRDVKTENMLLDA-------------------------NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD 284 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~-------------------------~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 284 (394)
+||+||||||+|||++. ++.+||+|||+++..... .....||+.|+|||++.
T Consensus 156 ~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVIL 232 (360)
T ss_dssp TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHT
T ss_pred CCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHc
Confidence 99999999999999975 788999999999854332 23467899999999999
Q ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCC------------------------CCC-------
Q 048724 285 GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRP------------------------DIP------- 333 (394)
Q Consensus 285 ~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------~~~------- 333 (394)
+..++.++|||||||++|+|++|+.||......+....+....... .++
T Consensus 233 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 312 (360)
T 3llt_A 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312 (360)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence 9999999999999999999999999998877666555443211100 011
Q ss_pred -------------CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 334 -------------RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 334 -------------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...++.+.+||.+||+.||++|||+.++++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 112377889999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=364.71 Aligned_cols=261 Identities=33% Similarity=0.585 Sum_probs=208.4
Q ss_pred ccccceeeeccCCceEEEEEEE--C-C--eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--D-G--QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~-g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
..|++.+.||+|+||+||+|++ + + ..||||.++..... .....|.+|+.++++++||||+++++++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--------GEVSQFLTEGIIMKDFSHPNVLSLLGICL 160 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--------HHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--------HHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 4577889999999999999987 2 2 36899988642211 12467889999999999999999999875
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
..+. ..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 161 ~~~~-------------------~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 220 (373)
T 3c1x_A 161 RSEG-------------------SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 220 (373)
T ss_dssp CCSS-------------------CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cCCC-------------------CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccch
Confidence 4322 238999999999999999653 34689999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~ 314 (394)
+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus 221 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp GGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred heEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 99999999999999999997543221 11233467789999999999999999999999999999999 78899887
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
...+....+. .+.+...+..++..+.++|.+||+.||++|||+.++++.|+++...-.+
T Consensus 301 ~~~~~~~~~~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 301 NTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CSSCHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 7776665553 3445566778999999999999999999999999999999999865443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=348.37 Aligned_cols=265 Identities=23% Similarity=0.421 Sum_probs=212.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||+|+||+||+|.+ +|+.||+|+++... ..+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------------EKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 36799999999999999999998 58999999997432 2456799999999999999999988642
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
....... ............++||||+++++|.+++.......+++..++.++.||+.||.|||++|++||||||+|
T Consensus 77 ~~~~~~~----~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 152 (284)
T 2a19_B 77 DYDPETS----SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152 (284)
T ss_dssp EEC-------------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCcccc----cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 2110000 000001112346899999999999999987666779999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|+++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||... .....
T Consensus 153 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~ 229 (284)
T 2a19_B 153 IFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT 229 (284)
T ss_dssp EEEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred EEEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence 999999999999999997654332 233457999999999999999999999999999999999999887421 12222
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
.+ . ...++..++..+.++|.+||+.||++|||+.++++.|+.+....
T Consensus 230 ~~-~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 DL-R---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HH-H---TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred Hh-h---cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 22 1 22355678999999999999999999999999999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=364.83 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=197.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||++..... . ......+.+|+.+++.+. ||||+++++++..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---N----STDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C---C----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc---C----hHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 57899999999999999999988 688999999863321 1 112356678999999996 9999999999875
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+. ..+|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 81 ~~~------------------~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~ 138 (388)
T 3oz6_A 81 DND------------------RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPS 138 (388)
T ss_dssp TTS------------------SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCC------------------CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH
Confidence 432 23499999996 699998865 35999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCC---------------------CCCccCCCCCCCcCCccccCC-CCCCccchHHHHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQN---------------------PRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFG 298 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG 298 (394)
|||++.++.+||+|||+++..... ....+..+||+.|+|||++.+ ..++.++||||||
T Consensus 139 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 218 (388)
T 3oz6_A 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218 (388)
T ss_dssp GEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred HeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHH
Confidence 999999999999999999754221 112334579999999999976 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHhccCCC---------------------------------------------CCC
Q 048724 299 ICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRP---------------------------------------------DIP 333 (394)
Q Consensus 299 ~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~ 333 (394)
|++|||++|++||++.+..+....+....-.+ ..+
T Consensus 219 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (388)
T 3oz6_A 219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298 (388)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccc
Confidence 99999999999999888776665553211000 011
Q ss_pred CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 334 RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 334 ~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+++++.+||.+||+.||++|||++++++.
T Consensus 299 ~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 299 ADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 2578999999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=357.94 Aligned_cols=255 Identities=26% Similarity=0.360 Sum_probs=205.2
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++..... .........+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS----EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc----hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 57899999999999999999988 5889999998743211 11112234677899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++||||+++ +|.+++... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~--------------------~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 142 (346)
T 1ua2_A 85 SNI--------------------SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN 142 (346)
T ss_dssp TCC--------------------EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred Cce--------------------EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHH
Confidence 554 899999975 898888553 3568999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||++.++.+||+|||+++.............+|+.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+..
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~ 222 (346)
T 1ua2_A 143 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222 (346)
T ss_dssp EEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999999865544444555789999999999976 45899999999999999999999999988877776
Q ss_pred HHHHhccCCC---CC-----------------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLRP---DI-----------------------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~---~~-----------------------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+......+ .+ ...++.++.+||.+||+.||++|||+.++++.
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 6654421111 00 13467899999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=348.52 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=212.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|.+.+.||+|+||+||+|++ +|+.||+|+++..... ....+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---------RDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---------chHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 46899999999999999999998 6889999999743211 124677899999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 79 ~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~N 136 (304)
T 2jam_A 79 THY--------------------YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136 (304)
T ss_dssp SEE--------------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGG
T ss_pred CEE--------------------EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 554 8999999999999998654 469999999999999999999999999999999999
Q ss_pred eee---CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLL---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|++ +.++.++|+|||++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 137 Il~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 214 (304)
T 2jam_A 137 LLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214 (304)
T ss_dssp CEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999 77889999999998753321 2223468999999999999999999999999999999999999999888887
Q ss_pred HHHHHHhccCCC--CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRP--DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+....... ..+..+++++.++|.+||+.||++|||+.++++.
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 215 LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 777776654432 3345689999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=357.00 Aligned_cols=256 Identities=24% Similarity=0.445 Sum_probs=217.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||.||+|++ +|+.||||+++..... ............+.+|+.+++++ +||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER-LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSC-CCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-cCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 36799999999999999999998 5899999999765432 22334455567889999999999 89999999999986
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... |+||||++|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+
T Consensus 172 ~~~~--------------------~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~ 229 (365)
T 2y7j_A 172 SSFM--------------------FLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE 229 (365)
T ss_dssp SSEE--------------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCEE--------------------EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 6554 8999999999999999653 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD------GKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||++.++.+||+|||++...... .......||+.|+|||.+. ...++.++|||||||++|+|++|..||...
T Consensus 230 NIl~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 230 NILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp GEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999765432 2334568999999999985 336888999999999999999999999988
Q ss_pred ChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
........+.........+ ..++..+.++|.+||+.||++|||+.++++
T Consensus 309 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 309 RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 8777777666554443322 467899999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=358.03 Aligned_cols=274 Identities=21% Similarity=0.313 Sum_probs=216.2
Q ss_pred CCCCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
....+.+.+..++|++.+.||+|+||+||+|.+ +|+.||||++.... ......+.+|+.+++.++||||
T Consensus 18 ~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i 88 (317)
T 2buj_A 18 YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---------QQDREEAQREADMHRLFNHPNI 88 (317)
T ss_dssp SEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---------HHHHHHHHHHHHHHHTCCCTTB
T ss_pred eecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---------HHHHHHHHHHHHHHhhcCCCCe
Confidence 344456778889999999999999999999997 78899999986422 1124677899999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
+++++++..... .....|+||||+++|+|.+++... ....+++..++.++.||+.||.|||+
T Consensus 89 v~~~~~~~~~~~----------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 152 (317)
T 2buj_A 89 LRLVAYCLRERG----------------AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152 (317)
T ss_dssp CCCCEEEEEEET----------------TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEEeccC----------------CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999863211 112348999999999999999753 24569999999999999999999999
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC---------CccCCCCCCCcCCccccCCCC---CCccchHHHH
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR---------DMTGETGTLGYMAPEVLDGKP---YNRKCDVYSF 297 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvwsl 297 (394)
+|++||||||+|||++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++|||||
T Consensus 153 ~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 232 (317)
T 2buj_A 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232 (317)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHH
T ss_pred CCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHH
Confidence 9999999999999999999999999998864321110 011235799999999997654 6889999999
Q ss_pred HHHHHHHHhCCCCCCCCC--hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 298 GICLWEIYCCDMPYPDLS--FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 298 G~~l~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
|+++|+|++|..||.... ..... .........+.+..++.++.++|.+||+.||++|||+.++++.|+.+.....
T Consensus 233 G~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 233 GCVLYAMMFGEGPYDMVFQKGDSVA-LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHHHHHHHSSCTTHHHHHTTSCHH-HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred HHHHHHHHhCCCChhhhhcccchhh-HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 999999999999995421 11122 2223344444556789999999999999999999999999999999875433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=372.37 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=211.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ ++..||||+++....... ....+.+|+.+++.++||||++++++|.+.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-------SNSKLLEEVAVLKLLDHPNIMKLYDFFEDK 108 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-------TTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 35799999999999999999998 678999999975432111 135678899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 109 ~~~--------------------~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 166 (494)
T 3lij_A 109 RNY--------------------YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPEN 166 (494)
T ss_dssp SEE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CEE--------------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhh
Confidence 555 8999999999999988654 469999999999999999999999999999999999
Q ss_pred eeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||++. ++.+||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+
T Consensus 167 il~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 167 LLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp EEESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99976 455999999999865432 33445689999999999874 58999999999999999999999999999888
Q ss_pred HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 048724 319 VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAV 368 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~ 368 (394)
....+.........+ ..+++.+.+||.+||+.||++|||+.++++. ++..
T Consensus 245 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 888887765544333 4689999999999999999999999999974 4444
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=359.52 Aligned_cols=269 Identities=25% Similarity=0.510 Sum_probs=218.5
Q ss_pred CCCCcccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
.....+|++..++|++.+.||+|+||+||+|.+.+ .||+|+++........ .+.+.+|+.++++++||||++
T Consensus 22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~ 93 (319)
T 2y4i_B 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ-------LKAFKREVMAYRQTRHENVVL 93 (319)
T ss_dssp CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC-------CCCCCTTGGGGTTCCCTTBCC
T ss_pred ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH-------HHHHHHHHHHHhcCCCCCEeE
Confidence 34567899999999999999999999999999865 5999998754322111 134667999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+++++.+.... ++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++
T Consensus 94 ~~~~~~~~~~~--------------------~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 152 (319)
T 2y4i_B 94 FMGACMSPPHL--------------------AIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152 (319)
T ss_dssp CCEEEECSSCE--------------------EEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEecCCce--------------------EEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99999876554 8999999999999998553 34699999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccC-----CCCCccCCCCCCCcCCccccCC---------CCCCccchHHHHHH
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQ-----NPRDMTGETGTLGYMAPEVLDG---------KPYNRKCDVYSFGI 299 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~ 299 (394)
||||||+||+++ ++.+||+|||+++.... .........|++.|+|||.+.+ ..++.++||||||+
T Consensus 153 H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp CCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred ccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 999999999998 67999999999864321 1122333568999999999874 45788999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 300 CLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 300 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
++|+|++|..||...........+.........+..++.++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 232 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 232 IWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999999888877776665443333333468899999999999999999999999999999987554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=357.83 Aligned_cols=270 Identities=23% Similarity=0.412 Sum_probs=201.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++..... ...+.+.+|+.++++++||||++++++|.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 76 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--------LAREKVMREVKALAKLEHPGIVRYFNAWLET 76 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--------THHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence 46899999999999999999998 6889999999754321 1236788999999999999999999998754
Q ss_pred Cccc---------cC----------------------------CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc
Q 048724 162 TNLK---------IP----------------------------SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204 (394)
Q Consensus 162 ~~~~---------~~----------------------------~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~ 204 (394)
.... +. .................++||||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 156 (332)
T 3qd2_B 77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156 (332)
T ss_dssp CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence 4310 00 0000000011122334799999999999999997643
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC------------CCccCC
Q 048724 205 R-KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP------------RDMTGE 271 (394)
Q Consensus 205 ~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~------------~~~~~~ 271 (394)
. ...++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... ......
T Consensus 157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 157 SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred CccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 2 346677899999999999999999999999999999999999999999999998654331 122345
Q ss_pred CCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhC
Q 048724 272 TGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDAN 351 (394)
Q Consensus 272 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~d 351 (394)
.||+.|+|||.+.+..++.++||||||+++|+|++|..|+.. ........ .....+......++++.+||.+||+.|
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~ 313 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDV-RNLKFPLLFTQKYPQEHMMVQDMLSPS 313 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHHHCSS
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHh-hccCCCcccccCChhHHHHHHHHccCC
Confidence 799999999999999999999999999999999998776421 11112112 111111122345678899999999999
Q ss_pred CCCCCCHHHHHHH
Q 048724 352 PDKRPVMDEVVKL 364 (394)
Q Consensus 352 P~~Rpt~~~ll~~ 364 (394)
|++|||+.++++.
T Consensus 314 p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 314 PTERPEATDIIEN 326 (332)
T ss_dssp GGGSCCHHHHHHS
T ss_pred CCcCCCHHHHhhc
Confidence 9999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=374.98 Aligned_cols=253 Identities=28% Similarity=0.450 Sum_probs=217.6
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
-.++|++.+.||+|+||+||+|.+ +|+.||||++.......... ...+.+|+.++++++||||+++++++.+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC------HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH------HHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 357899999999999999999998 68899999997543221111 3567889999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
...+ |+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 98 ~~~~--------------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 155 (484)
T 3nyv_A 98 KGYF--------------------YLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE 155 (484)
T ss_dssp SSEE--------------------EEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCEE--------------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence 6555 8999999999999998653 56999999999999999999999999999999999
Q ss_pred ceee---CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 241 NMLL---DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 241 NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|||+ +.++.+||+|||+++..... .......||+.|+|||.+.+ .++.++|||||||++|+|++|.+||...+..
T Consensus 156 Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 156 NLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp GEEESSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999 56789999999999865433 22334579999999999976 5899999999999999999999999999988
Q ss_pred hHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
+....+.........+ ..+++++.+||.+||+.||++|||+.++++.-
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 8888887776555444 46899999999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=362.10 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=208.5
Q ss_pred cccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC--CCcceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD--HPNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~ 156 (394)
..+...+|++.+.||+|+||+||+|.+ +++.||||+++..... ......+.+|+.++++++ ||||+++++
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~ 123 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-------HHHHHHHHHHHHHHHHcccCCCeEEEEEE
Confidence 344557799999999999999999988 6889999999754321 122467889999999996 599999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++...+.+ |+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 124 ~~~~~~~~--------------------~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrD 180 (390)
T 2zmd_A 124 YEITDQYI--------------------YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180 (390)
T ss_dssp EEECSSEE--------------------EEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred EEecCCEE--------------------EEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 98876554 89999 5688999999754 4689999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCC-----------CCCCccchHHHHHHHHHH
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDG-----------KPYNRKCDVYSFGICLWE 303 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~e 303 (394)
|||+|||++ ++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 181 lkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e 259 (390)
T 2zmd_A 181 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259 (390)
T ss_dssp CCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence 999999996 58899999999985433221 2234679999999999864 368899999999999999
Q ss_pred HHhCCCCCCCCCh-hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 304 IYCCDMPYPDLSF-TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 304 lltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
|++|..||..... ......+........++..++.++.+||.+||+.||++|||+.++++.-
T Consensus 260 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 260 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 9999999987543 3444555555566677777899999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=357.97 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=200.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++.+.||+|+||+||+|.+ +++.||||+++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--------GAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--------ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 36899999999999999999998 6889999998643211 1112345699999999999999999999866
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||++ |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 73 ~~~--------------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~N 130 (324)
T 3mtl_A 73 KSL--------------------TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQN 130 (324)
T ss_dssp SCE--------------------EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGG
T ss_pred CEE--------------------EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHH
Confidence 554 89999996 5999988664 3469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||++.++.+||+|||+++.............+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 131 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (324)
T 3mtl_A 131 LLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210 (324)
T ss_dssp EEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999865444444445678999999999876 56899999999999999999999999998877766
Q ss_pred HHHHhccCCC---C-------------------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLRP---D-------------------------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~~---~-------------------------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+......+ . ....+++++.+||.+||+.||++|||++++++.
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 6554321110 0 012468899999999999999999999999983
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=345.47 Aligned_cols=261 Identities=21% Similarity=0.388 Sum_probs=214.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|.+ +|+.||+|+++......... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR---GVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc---chHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 6799999999999999999998 58899999997543221100 001356789999999999999999999998665
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 82 ~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 139 (283)
T 3bhy_A 82 DV--------------------VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139 (283)
T ss_dssp EE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred eE--------------------EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHE
Confidence 54 8999999999999999653 4699999999999999999999999999999999999
Q ss_pred eeCCCC----cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 243 LLDANR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 243 ll~~~~----~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
+++.++ .+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+
T Consensus 140 l~~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 218 (283)
T 3bhy_A 140 MLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218 (283)
T ss_dssp EESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred EEecCCCCCCceEEEecccceeccCC-CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence 998876 8999999999754332 22334578999999999999999999999999999999999999999888777
Q ss_pred HHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHHhc
Q 048724 319 VSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAVNTS 371 (394)
Q Consensus 319 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~~~~ 371 (394)
....+........ ....++..+.+++.+||+.||++|||+.++++ .++.++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 219 TLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 7666544433221 22467899999999999999999999999998 56666543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=372.41 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=213.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeeccccccc----chHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMV----TSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.++|++.+.||+|+||+||+|++ +++.||||+++....... .........+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 47899999999999999999998 678999999975432110 000111234678899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+...+ |+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 115 ~~~~~~~--------------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dl 172 (504)
T 3q5i_A 115 FEDKKYF--------------------YLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDI 172 (504)
T ss_dssp EECSSEE--------------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEcCCEE--------------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 9876655 8999999999999998654 46999999999999999999999999999999
Q ss_pred CCCceeeCCCC---cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 238 KTENMLLDANR---TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~---~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
||+|||++.++ .+||+|||+++..... .......||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+.
T Consensus 173 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 173 KPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp SGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cHHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998765 6999999999865433 23445689999999999875 5899999999999999999999999999
Q ss_pred ChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
+..+....+.........+ ..+++++.+||.+||+.||.+|||++++++.-
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 251 NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 9888888887765543322 56899999999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=347.39 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=211.8
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
..++....++|.....||+|+||+||+|.+ +++.||||+++..... ....+.+|+.+++.++||||+++
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~ 84 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---------YSQPLHEEIALHKHLKHKNIVQY 84 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------------HHHHHHHHHHHTCCCTTBCCE
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 345667777888888999999999999998 6789999998744321 13567889999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
++++...... ++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++
T Consensus 85 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 144 (295)
T 2clq_A 85 LGSFSENGFI--------------------KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144 (295)
T ss_dssp EEEEEETTEE--------------------EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred eeEEEeCCcE--------------------EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 9999865554 89999999999999997643 23577999999999999999999999999
Q ss_pred ccCCCCCceeeCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC--CCCccchHHHHHHHHHHHHhCCCC
Q 048724 234 HRDVKTENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK--PYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 234 H~Dlkp~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~P 310 (394)
|+||||+||+++. ++.+||+|||++..............|++.|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus 145 H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (295)
T 2clq_A 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224 (295)
T ss_dssp CCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred ccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999987 8999999999997654333333446789999999999764 388999999999999999999999
Q ss_pred CCCCChhh-HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 311 YPDLSFTD-VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 311 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
|....... ...........+.++..++.++.++|.+||+.||++|||+.+++..
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 225 FYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 97643322 2222223345567778899999999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=345.20 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=210.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||++...... ..+.+|+.+++.++|++++..+..+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----------CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----------hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 47899999999999999999996 7899999998744321 3477899999999998877777666432
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 77 ~-------------------~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 135 (296)
T 3uzp_A 77 G-------------------DYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135 (296)
T ss_dssp T-------------------TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred C-------------------CceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 2 2348999999 99999999643 3569999999999999999999999999999999999
Q ss_pred eeeC---CCCcEEEeeccccccccCCCC-------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 242 MLLD---ANRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 242 Ill~---~~~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
||++ .++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 136 Il~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 9994 788999999999986443321 123457999999999999999999999999999999999999999
Q ss_pred CCCCh---hhHHHHHHhccCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCC
Q 048724 312 PDLSF---TDVSSAVVRQNLRPD---IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGG 374 (394)
Q Consensus 312 ~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~ 374 (394)
..... ......+........ .+..+|+++.+++.+||+.||++|||+.++++.|+++......
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 216 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 76432 223323322222111 2356899999999999999999999999999999999765443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=362.05 Aligned_cols=269 Identities=20% Similarity=0.328 Sum_probs=202.7
Q ss_pred cccccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchH--HHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSA--EAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+..++|++.+.||+|+||+||+|.+ ++..||||++........... ........+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 4457899999999999999999998 457899999875432110000 011112346788999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++..... .....|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|
T Consensus 114 ~~~~~~~~~----------------~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH 174 (345)
T 2v62_A 114 YGSGLTEFK----------------GRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVH 174 (345)
T ss_dssp EEEEEEESS----------------SCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ecccccccC----------------CCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 999876210 123349999999 999999986543 7999999999999999999999999999
Q ss_pred cCCCCCceeeCCCC--cEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHH
Q 048724 235 RDVKTENMLLDANR--TLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIY 305 (394)
Q Consensus 235 ~Dlkp~NIll~~~~--~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 305 (394)
|||||+|||++.++ .+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|+|+
T Consensus 175 ~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 254 (345)
T 2v62_A 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254 (345)
T ss_dssp SCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999998777 99999999997543211 1123457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHhccCCCCCC---------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 306 CCDMPYPDLSFTDVSSAVVRQNLRPDIP---------RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 306 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
+|+.||....................++ ..++.++.++|.+||+.||++|||++++++.|+.+.
T Consensus 255 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 255 CGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred hCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 9999996532222111111111111122 268999999999999999999999999999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=354.34 Aligned_cols=258 Identities=34% Similarity=0.572 Sum_probs=211.3
Q ss_pred cccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHh--CCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK--LDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|+++|+.||||+++... ...+.+|.++++. ++||||+++++++...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------------ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 4789999999999999999999999999999986321 2456678888888 6999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLH--------SKTIV 233 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~ii 233 (394)
... ...+|+||||+++|+|.+++.+ ..+++..++.++.|++.||.||| ++|++
T Consensus 109 ~~~----------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 169 (342)
T 1b6c_B 109 NGT----------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169 (342)
T ss_dssp CSS----------------CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred CCc----------------cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCee
Confidence 421 1235999999999999999965 35999999999999999999999 89999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCC----CccCCCCCCCcCCccccCCCC------CCccchHHHHHHHHHH
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLDGKP------YNRKCDVYSFGICLWE 303 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~e 303 (394)
||||||+|||++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|+
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 249 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHH
Confidence 999999999999999999999999975443321 223457999999999998752 3368999999999999
Q ss_pred HHhC----------CCCCCCCC-----hhhHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 304 IYCC----------DMPYPDLS-----FTDVSSAVVRQNLRPDIPR-----CCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 304 lltg----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
|++| ..||.... .......+.....++.++. .++..+.+||.+||+.||++|||+.++++
T Consensus 250 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999 78886542 2334444444445555553 34568999999999999999999999999
Q ss_pred HHHHHHhcc
Q 048724 364 LLEAVNTSK 372 (394)
Q Consensus 364 ~l~~~~~~~ 372 (394)
.|+++....
T Consensus 330 ~L~~i~~~~ 338 (342)
T 1b6c_B 330 TLSQLSQQE 338 (342)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHHh
Confidence 999997653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=347.52 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=208.0
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||+||+|.+ +|+.||||+++.... ...+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----------LQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----------CHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----------HHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 357899999999999999999998 588999999975321 2567789999999999999999999986
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... |+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+
T Consensus 96 ~~~~--------------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~ 154 (314)
T 3com_A 96 NTDL--------------------WIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154 (314)
T ss_dssp TTEE--------------------EEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCEE--------------------EEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHH
Confidence 5554 8999999999999998643 356999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||+++.++.+||+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|..||.........
T Consensus 155 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 234 (314)
T 3com_A 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234 (314)
T ss_dssp GEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred HEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999976544433444567999999999999999999999999999999999999999887766655
Q ss_pred HHHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+.... .....+..++..+.++|.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4443332 1222345679999999999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=353.17 Aligned_cols=270 Identities=26% Similarity=0.396 Sum_probs=200.5
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCccee
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTK 153 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~ 153 (394)
.+.+++...+|++.+.||+|+||+||+|.+ +++.||||++.... ......+.+|+.+++++. ||||++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---------EEKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---------HHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---------hHHHHHHHHHHHHHHHhccCCChhh
Confidence 345677788999999999999999999998 78899999985332 112356788999999995 999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN-KRKKLAFKVVIQIALDLARGLSYLHSKT- 231 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~- 231 (394)
+++++....... ......+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++|
T Consensus 91 ~~~~~~~~~~~~------------~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ 157 (337)
T 3ll6_A 91 FCSAASIGKEES------------DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP 157 (337)
T ss_dssp EEEEEEECTTTS------------TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred cccccccccccc------------ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 999985332210 112344689999995 7999988652 3456999999999999999999999999
Q ss_pred -CcccCCCCCceeeCCCCcEEEeeccccccccCCCCC------------ccCCCCCCCcCCcccc---CCCCCCccchHH
Q 048724 232 -IVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD------------MTGETGTLGYMAPEVL---DGKPYNRKCDVY 295 (394)
Q Consensus 232 -iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dvw 295 (394)
++||||||+|||++.++.+||+|||+++........ .....+|+.|+|||.+ .+..++.++|||
T Consensus 158 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~ 237 (337)
T 3ll6_A 158 PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237 (337)
T ss_dssp CCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHH
T ss_pred CEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHH
Confidence 999999999999999999999999999764432211 1134689999999998 567789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 296 SFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 296 slG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
|||+++|+|++|..||......... ........+..++..+.+||.+||+.||++|||+.++++.|+.+....
T Consensus 238 slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 238 ALGCILYLLCFRQHPFEDGAKLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp HHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCcchhHHHhh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999765543322 333344455667889999999999999999999999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=357.47 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=206.7
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
+....++|++.+.||+|+||+||+|++ +|+.||||++...... ......+.+|+.++++++||||++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 92 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMREIKLLKQLRHENLVNLLEV 92 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-------hHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 445678999999999999999999998 5889999998643321 2224567789999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+.+.... |+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||
T Consensus 93 ~~~~~~~--------------------~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 150 (331)
T 4aaa_A 93 CKKKKRW--------------------YLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150 (331)
T ss_dssp EEETTEE--------------------EEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred eecCCEE--------------------EEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCc
Confidence 9866554 899999999999887643 346999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||+|||++.++.+||+|||+++.............+|+.|+|||.+.+. .++.++||||||+++|+|++|..||.....
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp CGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999999997654444444456899999999999875 789999999999999999999999998876
Q ss_pred hhHHHHHHhcc-------------------CC-CCC---------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQN-------------------LR-PDI---------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~-------------------~~-~~~---------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....+.... .. +.. ...+++.+.+||.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 231 IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 66554443210 00 000 12478999999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.29 Aligned_cols=256 Identities=27% Similarity=0.490 Sum_probs=208.8
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
......|.+.+.||+|+||+||+|.+ ++..||+|++...... ....+.+.+|+.++++++||||+++++++
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 94 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-------KSERQRFKEEAEMLKGLQHPNIVRFYDSW 94 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 34456689999999999999999988 6778999998743321 12246788999999999999999999988
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRD 236 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiH~D 236 (394)
..... ....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| ++|||
T Consensus 95 ~~~~~----------------~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~d 156 (290)
T 1t4h_A 95 ESTVK----------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156 (290)
T ss_dssp EEESS----------------SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSC
T ss_pred ccccC----------------CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECC
Confidence 64321 123358999999999999999654 46999999999999999999999999 99999
Q ss_pred CCCCceeeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 237 VKTENMLLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 237 lkp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||+|||++ .++.+||+|||++...... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||....
T Consensus 157 ikp~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 157 LKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CCHHHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 999999997 7899999999999754332 2234579999999998875 48999999999999999999999998755
Q ss_pred hhhHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
............. ....+..+++++.++|.+||+.||++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 234 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp SHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 5444434333332 333456678999999999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=353.87 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=211.0
Q ss_pred cccccce-eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 84 LAKLDIR-HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
.+.|.+. +.||+|+||+||+|.+ +++.||||+++........ ...+.+|+.+++.+ +||||+++++++.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-------RAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC-------HHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH-------HHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 4566666 8899999999999988 5899999999754432211 35677899999999 5799999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+...+ |+||||+++|+|.+++.......+++..++.++.||+.||.|||++|++||||||
T Consensus 100 ~~~~~--------------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp 159 (327)
T 3lm5_A 100 NTSEI--------------------ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP 159 (327)
T ss_dssp CSSEE--------------------EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred eCCeE--------------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCh
Confidence 76655 8999999999999998665556799999999999999999999999999999999
Q ss_pred CceeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 240 ENMLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
+|||++. ++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 160 ~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 160 QNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp GGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEEecCCCCCcEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999987 789999999999865432 223346799999999999999999999999999999999999999999888
Q ss_pred hhHHHHHHhccCC--CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....+...... ......++..+.+||.+||+.||++|||++++++.
T Consensus 239 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 7777666554433 33345689999999999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=348.18 Aligned_cols=250 Identities=26% Similarity=0.476 Sum_probs=207.2
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +++.||+|++...... ....+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---------ELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---------HHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 57899999999999999999998 5889999998643211 135678899999999999999999999865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 89 ~~~--------------------~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (302)
T 2j7t_A 89 GKL--------------------WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147 (302)
T ss_dssp -CE--------------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred CeE--------------------EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHH
Confidence 554 8999999999999998653 3569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCcccc-----CCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-----DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|+++.++.+||+|||++..............||+.|+|||.+ .+..++.++||||||+++|+|++|..||...+.
T Consensus 148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp EEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 999999999999999976422221222335789999999998 467789999999999999999999999998887
Q ss_pred hhHHHHHHhccCC-CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 317 TDVSSAVVRQNLR-PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 317 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
......+...... ...+..++..+.++|.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 228 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 7766665544322 2234568999999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=355.92 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=209.8
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.++..++|++.+.||+|+||+||+|.+ +++.||+|+++.... ......+.+|+.++++++||||++++++
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 99 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGA 99 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--------HHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence 356678999999999999999999998 588999999974321 1234678899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TIVHRD 236 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~iiH~D 236 (394)
+.+.... |+||||+++++|.+++... ..+++..+..++.|++.||.|||++ |++|||
T Consensus 100 ~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 157 (360)
T 3eqc_A 100 FYSDGEI--------------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157 (360)
T ss_dssp EEETTEE--------------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSC
T ss_pred EEECCEE--------------------EEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 9876554 8999999999999999654 4599999999999999999999986 999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
|||+|||++.++.+||+|||++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 158 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 158 VKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp CSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999753322 12235789999999999999999999999999999999999999987665
Q ss_pred hhHHHH------------------------------------------HHhccCCCCCCCCCcHHHHHHHHHhchhCCCC
Q 048724 317 TDVSSA------------------------------------------VVRQNLRPDIPRCCPSSLASIMRKCWDANPDK 354 (394)
Q Consensus 317 ~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~ 354 (394)
.+.... +.........+..++.++.+||.+||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 315 (360)
T 3eqc_A 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315 (360)
T ss_dssp HHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTT
T ss_pred HHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhh
Confidence 443221 11111122222457899999999999999999
Q ss_pred CCCHHHHHHH
Q 048724 355 RPVMDEVVKL 364 (394)
Q Consensus 355 Rpt~~~ll~~ 364 (394)
|||++++++.
T Consensus 316 Rpt~~ell~h 325 (360)
T 3eqc_A 316 RADLKQLMVH 325 (360)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhhC
Confidence 9999999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=350.42 Aligned_cols=248 Identities=25% Similarity=0.312 Sum_probs=196.7
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
..++|++.+.||+|+||+||+|.+ +|+.||||++...... .. . ...+..|+..+.++ +||||++++++|.
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~---~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PK---D-RARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS---HH---H-HHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC---hH---H-HHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 347899999999999999999998 6889999998643221 11 1 23334455555544 9999999999998
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+...+ |+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 128 ~~~~~--------------------~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 185 (311)
T 3p1a_A 128 EGGIL--------------------YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKP 185 (311)
T ss_dssp ETTEE--------------------EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred eCCEE--------------------EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 66555 8999999 77999988664 35699999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+|||++.++.+||+|||++...... .......||+.|+|||.+.+ .++.++|||||||++|||++|..|+.... .
T Consensus 186 ~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~ 260 (311)
T 3p1a_A 186 ANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---G 260 (311)
T ss_dssp GGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H
T ss_pred HHEEECCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H
Confidence 9999999999999999998754332 22334579999999999886 68999999999999999999976654322 2
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+........++..+++++.++|.+||+.||++|||+.++++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 222322223333456689999999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=345.85 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=206.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +++.||||++..... ...+.+|+.+++.++|++++..+..+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----------chHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 36899999999999999999996 788999998764322 13467899999999988888777766432
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 77 ~-------------------~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 135 (296)
T 4hgt_A 77 G-------------------DYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135 (296)
T ss_dssp T-------------------TEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred C-------------------CceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 2 2248999999 99999998653 3469999999999999999999999999999999999
Q ss_pred eee---CCCCcEEEeeccccccccCCCC-------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 242 MLL---DANRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 242 Ill---~~~~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
||+ +.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 136 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 4hgt_A 136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 999 7889999999999986443221 223457899999999999999999999999999999999999999
Q ss_pred CCCChh---hHHHHHHhccCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 312 PDLSFT---DVSSAVVRQNLRPD---IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 312 ~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
...... .....+........ ....+|+++.+++.+||+.||++|||++++++.|+++....+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 216 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 764322 22222222221111 225579999999999999999999999999999999986544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=352.02 Aligned_cols=264 Identities=26% Similarity=0.524 Sum_probs=215.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
..+..++|++.+.||+|+||+||+|++ +++.||||+++.... ...+.+.+|+.++++++||||++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~ 106 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---------EHLRDFEREIEILKSLQHDNIVK 106 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---------HHHHHHHHHHHHHHhCCCCCeee
Confidence 345678899999999999999999984 578999999874321 12367889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+++++..... ..+++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++
T Consensus 107 ~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 167 (326)
T 2w1i_A 107 YKGVCYSAGR------------------RNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYI 167 (326)
T ss_dssp EEEEECC----------------------CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEEecCC------------------CceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 9999875432 1238999999999999999764 34699999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCCC---ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
||||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 168 H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999865433221 2234577889999999888899999999999999999999998
Q ss_pred CCCCChh-----------h----HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 311 YPDLSFT-----------D----VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 311 f~~~~~~-----------~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|...... . .....+....+.+.+..++.++.++|.+||+.||++|||+.++++.|+.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp GGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 7532110 0 11122344445666778999999999999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=366.71 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=201.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-------ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 57899999999999999999988 689999999974321 112245678899999999999999999999765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ ......|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 134 ~~~--------------~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~N 194 (464)
T 3ttj_A 134 KTL--------------EEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194 (464)
T ss_dssp CST--------------TTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred Ccc--------------ccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHh
Confidence 432 112346999999965 5766662 248999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 195 Ill~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~ 273 (464)
T 3ttj_A 195 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273 (464)
T ss_dssp EEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999865432 23445689999999999999999999999999999999999999999988776665
Q ss_pred HHHhccCC--------------------CCC---------CCC-----------CcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 322 AVVRQNLR--------------------PDI---------PRC-----------CPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 322 ~~~~~~~~--------------------~~~---------~~~-----------~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
.+...... +.. +.. .++++.+||.+||+.||++|||++++
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 55432100 000 000 15679999999999999999999999
Q ss_pred HHH
Q 048724 362 VKL 364 (394)
Q Consensus 362 l~~ 364 (394)
++.
T Consensus 354 L~H 356 (464)
T 3ttj_A 354 LQH 356 (464)
T ss_dssp HTS
T ss_pred hcC
Confidence 874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=343.51 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=204.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|.+ +++.||||+++...... . ....+.+|+.++..+ +||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~----~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS---V----DEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS---H----HHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc---H----HHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 47899999999999999999998 68999999997543211 1 135677899999999 99999999999986
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR--KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+.. ++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++|||||
T Consensus 83 ~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik 142 (289)
T 1x8b_A 83 DDHM--------------------LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIK 142 (289)
T ss_dssp TTEE--------------------EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred CCeE--------------------EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCC
Confidence 6554 899999999999999976432 569999999999999999999999999999999
Q ss_pred CCceeeCCC-------------------CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHH
Q 048724 239 TENMLLDAN-------------------RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFG 298 (394)
Q Consensus 239 p~NIll~~~-------------------~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG 298 (394)
|+|||++.+ ..+||+|||.+...... ....||+.|+|||.+.+. .++.++||||||
T Consensus 143 p~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG 218 (289)
T 1x8b_A 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALA 218 (289)
T ss_dssp GGGEEEC--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHH
T ss_pred HHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHH
Confidence 999999844 47999999999764332 234689999999999876 566899999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 299 ICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 299 ~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+++|+|++|.+|+..... ...+ .....+.++..+++++.++|.+||+.||++|||+.++++.
T Consensus 219 ~il~~l~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 219 LTVVCAAGAEPLPRNGDQ---WHEI-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHHTTCCCCCSSSHH---HHHH-HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhcCCCCCcchhH---HHHH-HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 999999999887654322 2222 3444566778899999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=344.75 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=211.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|.+ +++.||+|+++..... ........+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-----RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-----HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-----ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 47899999999999999999988 6789999999743211 0012246788999999999999999999998543
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.. ...|+||||++++ |.+++.......+++..++.++.||+.||.|||++|++||||||+|
T Consensus 79 ~~------------------~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~N 139 (305)
T 2wtk_C 79 EK------------------QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139 (305)
T ss_dssp ---------------------CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CC------------------CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence 22 2349999999876 8888877666789999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCC--CCCccCCCCCCCcCCccccCCCC--CCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 242 MLLDANRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLDGKP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|+++.++.+||+|||++...... ........||+.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..
T Consensus 140 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (305)
T 2wtk_C 140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY 219 (305)
T ss_dssp EEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence 99999999999999999754322 12223457899999999998654 377999999999999999999999988877
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+....+... ...++..+++.+.++|.+||+.||++|||+.++++.
T Consensus 220 ~~~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 220 KLFENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 777666554 345667799999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=356.25 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=206.8
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
|++ .++|++.+.||+|+||+||+|.+ +|+.||||++..... .......+.+|+.+++.++||||++++++
T Consensus 21 ~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 92 (367)
T 1cm8_A 21 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-------SELFAKRAYRELRLLKHMRHENVIGLLDV 92 (367)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-------SHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred eee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-------CHHHHHHHHHHHHHHHhCCCcCCCCceee
Confidence 444 47899999999999999999998 688999999864321 12234677899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+....... ....+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||
T Consensus 93 ~~~~~~~~--------------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dl 154 (367)
T 1cm8_A 93 FTPDETLD--------------DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDL 154 (367)
T ss_dssp ECSCSSTT--------------TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EecCCccc--------------cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 87654320 113359999999 8899999865 35999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 155 kp~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 155 KPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CHHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999986432 2344688999999999876 6799999999999999999999999998877
Q ss_pred hhHHHHHHhccCC-----------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HH
Q 048724 317 TDVSSAVVRQNLR-----------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LL 365 (394)
Q Consensus 317 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l 365 (394)
.+....+...... ..+...+++.+.+||.+||+.||++|||+.++++ .+
T Consensus 232 ~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 6655544321100 0122457899999999999999999999999998 34
Q ss_pred HHH
Q 048724 366 EAV 368 (394)
Q Consensus 366 ~~~ 368 (394)
+.+
T Consensus 312 ~~~ 314 (367)
T 1cm8_A 312 ESL 314 (367)
T ss_dssp TTT
T ss_pred Hhh
Confidence 444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=348.06 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=198.7
Q ss_pred ccccce-eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 85 AKLDIR-HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 85 ~~~~~~-~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
+.|++. +.||+|+||+||+|.+ +++.||||+++..... ....+.+|+.++.++ +||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---------IRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---------CHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 567774 7899999999999987 7889999999754321 135677899999985 79999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |+||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+
T Consensus 83 ~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 140 (316)
T 2ac3_A 83 EDRF--------------------YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140 (316)
T ss_dssp TTEE--------------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCEE--------------------EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH
Confidence 6554 8999999999999999664 46999999999999999999999999999999999
Q ss_pred ceeeCCCCc---EEEeeccccccccCCC-------CCccCCCCCCCcCCccccCC-----CCCCccchHHHHHHHHHHHH
Q 048724 241 NMLLDANRT---LKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDG-----KPYNRKCDVYSFGICLWEIY 305 (394)
Q Consensus 241 NIll~~~~~---vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell 305 (394)
|||++.++. +||+|||++....... .......||+.|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999987765 9999999987532211 11223469999999999875 55889999999999999999
Q ss_pred hCCCCCCCCCh---------------hhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 306 CCDMPYPDLSF---------------TDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 306 tg~~Pf~~~~~---------------~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+|..||..... ......+.......+.. ..++..+.+||.+||+.||++|||+.++++.
T Consensus 221 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99999976542 22333443333322111 3578999999999999999999999999883
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=361.37 Aligned_cols=276 Identities=22% Similarity=0.325 Sum_probs=209.0
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
++...++|++.+.||+|+||+||+|.+ +|+.||||++..... ...+|+.+++.++||||++++++
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------------~~~~E~~il~~l~hpnIv~l~~~ 68 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------------YKNRELDIMKVLDHVNIIKLVDY 68 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHTTCCCTTBCCEEEE
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------------hHHHHHHHHHHcCCCCccchhhe
Confidence 345578999999999999999999988 789999999864322 12369999999999999999999
Q ss_pred ecCCCccccCCCC------------------CCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHH
Q 048724 158 SMGTTNLKIPSQS------------------ATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIA 217 (394)
Q Consensus 158 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~ 217 (394)
|............ .............+++||||++ |+|.+.+.. .....+++..++.++
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~ 147 (383)
T 3eb0_A 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI 147 (383)
T ss_dssp EEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred eeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHH
Confidence 8654321000000 0000001123345789999997 588887764 234579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCceeeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHH
Q 048724 218 LDLARGLSYLHSKTIVHRDVKTENMLLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVY 295 (394)
Q Consensus 218 ~qi~~~l~yLH~~~iiH~Dlkp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw 295 (394)
.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||.+.+. .++.++|||
T Consensus 148 ~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 148 YQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999999999999999999999999997 6889999999999854332 233346789999999998765 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHhccC---------------------------CCCCCCCCcHHHHHHHHHhc
Q 048724 296 SFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNL---------------------------RPDIPRCCPSSLASIMRKCW 348 (394)
Q Consensus 296 slG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cL 348 (394)
||||++|+|++|+.||.+.+..+....+..... ...++..++.++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 999999999999999998887776665543110 00134557899999999999
Q ss_pred hhCCCCCCCHHHHHH--HHHHHHh
Q 048724 349 DANPDKRPVMDEVVK--LLEAVNT 370 (394)
Q Consensus 349 ~~dP~~Rpt~~~ll~--~l~~~~~ 370 (394)
+.||++|||+.++++ +++.++.
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999996 5666654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=342.32 Aligned_cols=251 Identities=29% Similarity=0.403 Sum_probs=207.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +++.||||+++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREG 77 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--------THHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--------hhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence 47899999999999999999988 6889999999744321 1135678899999999999999999999865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 78 ~~~--------------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 135 (276)
T 2yex_A 78 NIQ--------------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135 (276)
T ss_dssp TEE--------------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CEE--------------------EEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHH
Confidence 554 899999999999998843 3469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+++.++.+||+|||++....... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.......
T Consensus 136 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred EEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999999999999999997543221 12334578999999999988765 779999999999999999999998765443
Q ss_pred H-HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 V-SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
. ...+............++..+.++|.+||+.||++|||+.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 2 223322222222334689999999999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=364.09 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=189.6
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.|.+ .++|++.+.||+|+||+||+|.+ +|+.||||++...... ....+.+.+|+.+|++++|||||++++
T Consensus 48 ~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~ 119 (458)
T 3rp9_A 48 DWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-------LIDCKRILREIAILNRLNHDHVVKVLD 119 (458)
T ss_dssp SCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-------HHHHHHHHHHHHHHHhCCCCCCCceEE
Confidence 4544 37899999999999999999987 6889999998643211 112366889999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++.....- ....+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~~---------------~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrD 181 (458)
T 3rp9_A 120 IVIPKDVE---------------KFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRD 181 (458)
T ss_dssp ECCCSCTT---------------TCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred EEecCCcc---------------cCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCC
Confidence 98644321 123469999998 6799999854 35699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCC---------------------------CCccCCCCCCCcCCcccc-CCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNP---------------------------RDMTGETGTLGYMAPEVL-DGKPY 288 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~ 288 (394)
|||+|||++.++.+||+|||+++...... ...+..+||+.|+|||++ .+..|
T Consensus 182 lKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 261 (458)
T 3rp9_A 182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261 (458)
T ss_dssp CCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCC
T ss_pred CChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCC
Confidence 99999999999999999999998643211 123445789999999976 56779
Q ss_pred CccchHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------hhHHHHHHh------------
Q 048724 289 NRKCDVYSFGICLWEIYC-----------CDMPYPDLSF--------------------TDVSSAVVR------------ 325 (394)
Q Consensus 289 ~~~~DvwslG~~l~ellt-----------g~~Pf~~~~~--------------------~~~~~~~~~------------ 325 (394)
+.++|||||||++|||++ |+++|++... .+....+..
T Consensus 262 ~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~ 341 (458)
T 3rp9_A 262 TEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341 (458)
T ss_dssp CTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHT
T ss_pred CcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhh
Confidence 999999999999999998 6777765431 111111100
Q ss_pred ----------ccCC-------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 326 ----------QNLR-------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 326 ----------~~~~-------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+. ......+++++.+||.+||..||++|||++++++.
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00113468999999999999999999999999983
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=363.82 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=196.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|.+.+.||+|+||+||+|.+ +++.||||++......... .........+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS-AREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC---------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccc-cccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 47899999999999999999988 6789999999754322111 11122234578899999999999999999997532
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. .|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 213 ~---------------------~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 269 (419)
T 3i6u_A 213 D---------------------YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269 (419)
T ss_dssp E---------------------EEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred c---------------------eEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 2 3899999999999988844 4569999999999999999999999999999999999
Q ss_pred eeeCCC---CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 242 MLLDAN---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 242 Ill~~~---~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||++.+ +.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 270 Ill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 270 VLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp EEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred EEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 999754 45999999999865432 22344679999999999864 568889999999999999999999998654
Q ss_pred hhhHHHHHHhccCCCC---CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRPD---IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
................ ....+++.+.+||.+||+.||++|||+.++++.
T Consensus 349 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 349 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 4333322323222211 124579999999999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=349.37 Aligned_cols=257 Identities=25% Similarity=0.445 Sum_probs=195.3
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.|.+..++|++.+.||+|+||+||+|.+ +++.||||+++.... ......+.+|+.++++++||||+++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 80 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--------QTSMDELLKEIQAMSQCHHPNIVSYYT 80 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--------chhHHHHHHHHHHHhhcCCCCEeeEEE
Confidence 4788899999999999999999999987 788999998863321 122356788999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN------KRKKLAFKVVIQIALDLARGLSYLHSK 230 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~------~~~~l~~~~~~~i~~qi~~~l~yLH~~ 230 (394)
++...+.. ++||||+++++|.+++... ....+++..++.++.||+.||.|||++
T Consensus 81 ~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 140 (303)
T 2vwi_A 81 SFVVKDEL--------------------WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140 (303)
T ss_dssp EEESSSCE--------------------EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeecCCc--------------------EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99876554 8999999999999999642 235699999999999999999999999
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccccccCCC-----CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHH
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-----RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEI 304 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el 304 (394)
|++||||||+||+++.++.+||+|||++....... .......||+.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 141 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 220 (303)
T 2vwi_A 141 GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220 (303)
T ss_dssp TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHH
T ss_pred CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999987543221 11223578999999999875 5689999999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHhccCC--------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 305 YCCDMPYPDLSFTDVSSAVVRQNLR--------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 305 ltg~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
++|..||.................. ......++.++.++|.+||+.||++|||+.++++
T Consensus 221 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 221 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9999999888776666544433211 1223567899999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=355.30 Aligned_cols=272 Identities=18% Similarity=0.249 Sum_probs=210.4
Q ss_pred ccccccceeeeccCCceEEEEEEEC----------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAYD----------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~~----------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
..++|++.+.||+|+||+||+|++. ++.||||+++.. ..+.+|+.++++++||||+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchh
Confidence 3589999999999999999999883 679999998732 3467899999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++++.+.......++...... .......|+||||+ +++|.+++.......+++..++.++.||+.||.|||++|+
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~----~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 180 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFG----VHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEE----EETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhhhhhccCCccCccchhhcc----ccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 965554432222111100000 00134569999999 9999999987655679999999999999999999999999
Q ss_pred cccCCCCCceeeCCCC--cEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHH
Q 048724 233 VHRDVKTENMLLDANR--TLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~--~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e 303 (394)
+||||||+|||++.++ .+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|+
T Consensus 181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 9999999999999988 89999999997543221 11233579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC--hhhHHHHHHh-ccCCCCCC------CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccC
Q 048724 304 IYCCDMPYPDLS--FTDVSSAVVR-QNLRPDIP------RCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKG 373 (394)
Q Consensus 304 lltg~~Pf~~~~--~~~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~ 373 (394)
|++|+.||.... ...+...... ......+. ..++.++.+||.+||+.||++|||++++++.|+++.....
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 999999998753 2222222111 11111111 2468999999999999999999999999999999976543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=360.83 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=206.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC------CCCcceeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL------DHPNVTKFI 155 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~l~ 155 (394)
..+|++.+.||+|+||+||+|.+ +++.||||+++... .....+.+|+.+++.+ +|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----------RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----------chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 46799999999999999999988 67899999996321 1234566788888877 577999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.....+ |+||||+. ++|.+++.......+++..++.|+.||+.||.|||++||+||
T Consensus 166 ~~~~~~~~~--------------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 224 (429)
T 3kvw_A 166 ENFTFRNHI--------------------CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224 (429)
T ss_dssp EEEEETTEE--------------------EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECS
T ss_pred eecccCCeE--------------------EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 999866555 89999995 699999987666679999999999999999999999999999
Q ss_pred CCCCCceeeCCCCc--EEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 236 DVKTENMLLDANRT--LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 236 Dlkp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
||||+|||++.++. +||+|||+++.... ......||+.|+|||.+.+..++.++|||||||++|||++|.+||.+
T Consensus 225 DlKp~NILl~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 225 DLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHeEEccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99999999998887 99999999975432 23346899999999999999999999999999999999999999998
Q ss_pred CChhhHHHHHHhccCCC---------------------------------------------------------CCCCCC
Q 048724 314 LSFTDVSSAVVRQNLRP---------------------------------------------------------DIPRCC 336 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~~---------------------------------------------------------~~~~~~ 336 (394)
.+..+....+......+ .++...
T Consensus 302 ~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 381 (429)
T 3kvw_A 302 EDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381 (429)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCC
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccc
Confidence 88776665543210000 011234
Q ss_pred cHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 337 PSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 337 ~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
++.+.+||.+||+.||++|||+.++++.
T Consensus 382 ~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 382 DPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 7889999999999999999999999983
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=353.69 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=204.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +++.||||+++.......... .......+.+|+.++++++||||++++++|.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWI-EDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEE-EETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 46899999999999999999987 788999999975432110000 000013456799999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG-TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
..+ ++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 102 ~~~--------------------~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 159 (335)
T 3dls_A 102 GFF--------------------QLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDE 159 (335)
T ss_dssp SEE--------------------EEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CEE--------------------EEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHH
Confidence 655 8999999777 999998653 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|||++.++.+||+|||+++..... .......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.....
T Consensus 160 NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--- 235 (335)
T 3dls_A 160 NIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--- 235 (335)
T ss_dssp GEEECTTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---
T ss_pred HEEEcCCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---
Confidence 999999999999999999865433 22334579999999999988876 7899999999999999999999975321
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
. .......+..+++++.+||.+||+.||++|||+.++++.
T Consensus 236 ---~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---T--VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---G--TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---H--HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 112233455689999999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=378.47 Aligned_cols=263 Identities=30% Similarity=0.580 Sum_probs=221.0
Q ss_pred CcccccccccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
...|++..++|++.+.||+|+||+||+|.+. +..||||+++... .....+.+.+|+.++++++||||
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~HpnI 453 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--------SDSVREKFLQEALTMRQFDHPHI 453 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--------CHHHHHHHHHHHHHHHhCCCCCC
Confidence 3567888899999999999999999999872 3579999886322 12234678899999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
+++++++.+. . .|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++|
T Consensus 454 v~l~~~~~~~-~--------------------~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g 511 (656)
T 2j0j_A 454 VKLIGVITEN-P--------------------VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR 511 (656)
T ss_dssp CCEEEEECSS-S--------------------CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CeEEEEEecC-c--------------------eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999998532 2 28999999999999999754 346999999999999999999999999
Q ss_pred CcccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 232 IVHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
|+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 512 ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~ 591 (656)
T 2j0j_A 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591 (656)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999998543322 12223456789999999988899999999999999999997 999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
||.+....+....+.. +.+...+..+++.+.++|.+||+.||++|||+.++++.|+.+..
T Consensus 592 Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 592 PFQGVKNNDVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp TTTTCCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9999888887766644 34556778899999999999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=361.30 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=210.2
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||+||+|.+ +|+.||||+++...... ....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--------hHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 357899999999999999999998 58899999997433211 12556789999999999999999999875
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
.... ..|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 79 ~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 140 (396)
T 4eut_A 79 TTTR------------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (396)
T ss_dssp TTTC------------------CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCCC------------------eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH
Confidence 5432 34899999999999999965432 2399999999999999999999999999999999
Q ss_pred Cceee----CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC--------CCCCccchHHHHHHHHHHHHhC
Q 048724 240 ENMLL----DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--------KPYNRKCDVYSFGICLWEIYCC 307 (394)
Q Consensus 240 ~NIll----~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~elltg 307 (394)
+|||+ +.++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|
T Consensus 141 ~NIll~~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 141 GNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp GGEEEEECTTSCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHEEEeecCCCceeEEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 99999 77788999999999864332 23334679999999999864 4677899999999999999999
Q ss_pred CCCCCCC----ChhhHHHHHHhccCCC-----------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 308 DMPYPDL----SFTDVSSAVVRQNLRP-----------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 308 ~~Pf~~~----~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
+.||... ...+....+....... .++..++..+.++|.+||+.||++|||+.+
T Consensus 220 ~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 9999643 2334444444432110 111234568899999999999999999999
Q ss_pred HHHHHHHHHh
Q 048724 361 VVKLLEAVNT 370 (394)
Q Consensus 361 ll~~l~~~~~ 370 (394)
+++.++++..
T Consensus 300 ~l~~l~~il~ 309 (396)
T 4eut_A 300 FFAETSDILH 309 (396)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHhh
Confidence 9999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=355.14 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=207.4
Q ss_pred ccccccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKF 154 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 154 (394)
.+..++|++.+.||+|+||+||+|++ +++.||||+++........ .....+.+|+.+++++ +||||+++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~ 124 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTL 124 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh-----hHHHHHHHHHHHHHHccCCCceeEE
Confidence 45678999999999999999999987 6789999998643210000 0013456799999999 79999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++.....+ |+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 125 ~~~~~~~~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 182 (355)
T 1vzo_A 125 HYAFQTETKL--------------------HLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIY 182 (355)
T ss_dssp EEEEEETTEE--------------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEeeCceE--------------------EEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999766554 8999999999999999654 46999999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCC-CCCccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHHHHHhCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf 311 (394)
|||||+|||++.++.+||+|||+++..... ........||+.|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus 183 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp CCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999754322 122233579999999999986 45789999999999999999999999
Q ss_pred CCCC----hhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHHH
Q 048724 312 PDLS----FTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKLL 365 (394)
Q Consensus 312 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~l 365 (394)
.... ...+...+.. ..+.++..++..+.+||.+||+.||++|| +++++++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 263 TVDGEKNSQAEISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp SCTTSCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ccCCccchHHHHHHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 7543 2333333332 24556778999999999999999999999 999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=364.93 Aligned_cols=274 Identities=14% Similarity=0.166 Sum_probs=199.0
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHH---HHHHhCCCCccee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV---AVWQKLDHPNVTK 153 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~il~~l~h~nIv~ 153 (394)
+|....++|++.+.||+|+||+||+|++ +|+.||||+++........ ..+.+.+|+ .++++++|||||+
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~------~~~~~~~E~~~l~~l~~l~hpniv~ 140 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN------AIKQMKEEVLRLRLLRGIKNQKQAK 140 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT------HHHHHHHHHHGGGGSTTCCSHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH------HHHHHHHHHHHHHhccccCCHHHHH
Confidence 4455568999999999999999999986 6899999999744221111 236788899 5555668999999
Q ss_pred eeeeecCCCccccCCCCC----CCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHH
Q 048724 154 FIGASMGTTNLKIPSQSA----TSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR-----KKLAFKVVIQIALDLARGL 224 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l 224 (394)
+++.+............. .........-...|+||||+ +|+|.+++..... ..+++..++.|+.||+.||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 219 (377)
T 3byv_A 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 219 (377)
T ss_dssp HHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHH
Confidence 995443222110000000 00000000001258999999 6899999976432 1233588889999999999
Q ss_pred HHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-----------CCCccch
Q 048724 225 SYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-----------PYNRKCD 293 (394)
Q Consensus 225 ~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~D 293 (394)
+|||++||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++|
T Consensus 220 ~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 220 ASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp HHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred HHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 999999999999999999999999999999999985322 2334567 999999999877 8999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHH
Q 048724 294 VYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAVN 369 (394)
Q Consensus 294 vwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~~ 369 (394)
||||||++|||++|+.||...........+ ......+++++.+||.+||+.||++|||+.++++ +++.+.
T Consensus 296 vwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 296 AWALGLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999999999999765433322211 1123568999999999999999999999999997 555554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=338.50 Aligned_cols=249 Identities=30% Similarity=0.505 Sum_probs=212.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +++.||||+++........ ...+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-------TSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH-------HHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 47899999999999999999998 6889999999754332111 35678899999999999999999999865
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... |+|+||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 94 ~~~--------------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 151 (287)
T 2wei_A 94 SSF--------------------YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151 (287)
T ss_dssp SEE--------------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CeE--------------------EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhh
Confidence 554 8999999999999988654 469999999999999999999999999999999999
Q ss_pred eeeCCC---CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDAN---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~---~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+++.+ +.+||+|||++...... .......+++.|+|||.+.+. ++.++||||||+++|+|++|..||...+..+
T Consensus 152 Ilv~~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (287)
T 2wei_A 152 ILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (287)
T ss_dssp EEESCSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999754 47999999999754332 222334688999999998765 8999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 319 VSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
....+.........+ ..++.++.++|.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 777776665544433 468999999999999999999999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=351.89 Aligned_cols=257 Identities=18% Similarity=0.221 Sum_probs=211.5
Q ss_pred CcccccccccccceeeeccCCceEEEEEE-----E--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC--
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGA-----Y--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-- 147 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-----~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-- 147 (394)
..++++..++|.+.+.||+|+||+||+|. . +++.||||+++... ...+..|+.+++.++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~l~~~ 124 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------------PWEFYIGTQLMERLKPS 124 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------------HHHHHHHHHHHHHSCGG
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------------hhHHHHHHHHHHHhhhh
Confidence 45677888999999999999999999993 2 68899999997432 245677888888886
Q ss_pred -CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc---ccCCCCHHHHHHHHHHHHHH
Q 048724 148 -HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN---KRKKLAFKVVIQIALDLARG 223 (394)
Q Consensus 148 -h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~ 223 (394)
|+||+++++++...+.. |+||||+++|+|.+++... ....+++..++.|+.||+.|
T Consensus 125 ~~~~iv~~~~~~~~~~~~--------------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~ 184 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGS--------------------VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184 (365)
T ss_dssp GGGGBCCEEEEEECSSCE--------------------EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhheeeecCCCc--------------------EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHH
Confidence 99999999999876655 8999999999999999753 24569999999999999999
Q ss_pred HHHHHhCCCcccCCCCCceeeCC-----------CCcEEEeecccccccc--CCCCCccCCCCCCCcCCccccCCCCCCc
Q 048724 224 LSYLHSKTIVHRDVKTENMLLDA-----------NRTLKIADFGVARVEA--QNPRDMTGETGTLGYMAPEVLDGKPYNR 290 (394)
Q Consensus 224 l~yLH~~~iiH~Dlkp~NIll~~-----------~~~vkl~DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 290 (394)
|+|||++||+||||||+|||++. ++.+||+|||+++... ..........||+.|+|||++.+..++.
T Consensus 185 L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 264 (365)
T 3e7e_A 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY 264 (365)
T ss_dssp HHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST
T ss_pred HHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc
Confidence 99999999999999999999988 8999999999997432 2223344568999999999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCC-CCCcHHHHHHHHHhchhCCCCC-CCHHHHHHHHHHH
Q 048724 291 KCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIP-RCCPSSLASIMRKCWDANPDKR-PVMDEVVKLLEAV 368 (394)
Q Consensus 291 ~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cL~~dP~~R-pt~~~ll~~l~~~ 368 (394)
++|||||||++|||++|+.||........ .....+. ...++.+.+++..||+.+|.+| |+++++.+.|+++
T Consensus 265 ~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 265 QIDYFGVAATVYCMLFGTYMKVKNEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp HHHHHHHHHHHHHHHHSSCCCEEEETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCccccCCCCce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 99999999999999999999854322110 0111111 1247789999999999999999 6899999999988
Q ss_pred Hhcc
Q 048724 369 NTSK 372 (394)
Q Consensus 369 ~~~~ 372 (394)
....
T Consensus 338 l~~~ 341 (365)
T 3e7e_A 338 FQQH 341 (365)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 7543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=348.60 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=207.1
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
..++|++.+.||+|+||+||+|++ +|+.||||++......... ...+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-------CHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-------hHHHHHHHHHHHhccCCCcccHhheeec
Confidence 468999999999999999999998 6889999998654332211 2456789999999999999999999976
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
....+. .....+|+||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 88 ~~~~~~------------~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 153 (351)
T 3mi9_A 88 KASPYN------------RCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAA 153 (351)
T ss_dssp C--------------------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cccccc------------cCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHH
Confidence 543210 113456999999975 787777543 346999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccC----CCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQ----NPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||++.++.+||+|||+++.... .........||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 154 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 154 NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp GEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999975432 1222344678999999999876 568999999999999999999999999888
Q ss_pred hhhHHHHHHhcc--CCCCCCCC----------------------------CcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQN--LRPDIPRC----------------------------CPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~--~~~~~~~~----------------------------~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.......+.... ..+..... .++.+.+||.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 776665554321 11111111 26789999999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=357.01 Aligned_cols=265 Identities=23% Similarity=0.345 Sum_probs=201.4
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.|.+ .++|++.+.||+|+||+||+|.+ +++.||||+++.... .....+.+.+|+.+|++++||||+++++
T Consensus 21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 92 (432)
T 3n9x_A 21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-------DLIDCKRILREITILNRLKSDYIIRLYD 92 (432)
T ss_dssp GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-------SHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-------ChHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence 3443 47899999999999999999988 688999999974321 1122467889999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++...... ....+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus 93 ~~~~~~~~---------------~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrD 154 (432)
T 3n9x_A 93 LIIPDDLL---------------KFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRD 154 (432)
T ss_dssp ECCCSCTT---------------TCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEecCCCC---------------cCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Confidence 98755321 1134599999995 699999854 35699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCC----------------------CCccCCCCCCCcCCcccc-CCCCCCccch
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNP----------------------RDMTGETGTLGYMAPEVL-DGKPYNRKCD 293 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~----------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~D 293 (394)
|||+|||++.++.+||+|||+++...... ...+..+||+.|+|||++ .+..++.++|
T Consensus 155 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~D 234 (432)
T 3n9x_A 155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234 (432)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred CCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccc
Confidence 99999999999999999999998643321 123556899999999986 5677999999
Q ss_pred HHHHHHHHHHHHhC-----------CCCCCCCCh-----------------hhHHHHH----------------------
Q 048724 294 VYSFGICLWEIYCC-----------DMPYPDLSF-----------------TDVSSAV---------------------- 323 (394)
Q Consensus 294 vwslG~~l~elltg-----------~~Pf~~~~~-----------------~~~~~~~---------------------- 323 (394)
||||||++|||++| .++|++.+. .+....+
T Consensus 235 iwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~ 314 (432)
T 3n9x_A 235 IWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314 (432)
T ss_dssp HHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence 99999999999984 444443321 1111111
Q ss_pred -Hhc-cCCCCC-----CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHHH
Q 048724 324 -VRQ-NLRPDI-----PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAVN 369 (394)
Q Consensus 324 -~~~-~~~~~~-----~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~~ 369 (394)
... ...... ...+++++.+||.+||+.||++|||++++++. ++.+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 000 011111 13478999999999999999999999999983 44443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=351.17 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=207.0
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +++.||||+++.... ......+.+|+.++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--------QTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC--------HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC--------cHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 36899999999999999999988 688999999863221 12236678999999999999999999998754
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... .....|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 98 ~~~---------------~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 158 (364)
T 3qyz_A 98 TIE---------------QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 158 (364)
T ss_dssp STT---------------TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred Ccc---------------ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHh
Confidence 321 1234599999996 599999854 359999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||++.++.+||+|||+++....... ......||+.|+|||.+. +..++.++|||||||++|+|++|+.||.+.+..
T Consensus 159 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred EEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 9999999999999999985432211 123458999999999865 455899999999999999999999999988777
Q ss_pred hHHHHHHhccCCC------------------------C-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRP------------------------D-----IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~------------------------~-----~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+....+......+ . ....+++++.+||.+||+.||++|||+.++++.
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp GHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6665553211000 0 113578999999999999999999999999973
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.23 Aligned_cols=262 Identities=21% Similarity=0.380 Sum_probs=213.4
Q ss_pred cccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchH--------HHHHHHHHHHHHHHHHHhCCCCcc
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSA--------EAAAIRASFRQEVAVWQKLDHPNV 151 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~--------~~~~~~~~~~~E~~il~~l~h~nI 151 (394)
..+..++|++.+.||+|+||+||+|.++|+.||||+++.......... ........+.+|+.++++++||||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 345578999999999999999999999999999999874321110000 000011568899999999999999
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHH------HHhcccCCCCHHHHHHHHHHHHHHHH
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF------LIRNKRKKLAFKVVIQIALDLARGLS 225 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qi~~~l~ 225 (394)
+++++++.+.+.. |+||||+++|+|.++ +.......+++..++.++.|++.||.
T Consensus 106 ~~~~~~~~~~~~~--------------------~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~ 165 (348)
T 2pml_X 106 LTCEGIITNYDEV--------------------YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFS 165 (348)
T ss_dssp CCCSEEEESSSEE--------------------EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHH
T ss_pred ceEEEEEeeCCeE--------------------EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHH
Confidence 9999999876554 899999999999998 65443567999999999999999999
Q ss_pred HHHh-CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCc-cchHHHHHHHHH
Q 048724 226 YLHS-KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNR-KCDVYSFGICLW 302 (394)
Q Consensus 226 yLH~-~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~ 302 (394)
|||+ +|++||||||+||+++.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|
T Consensus 166 ~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 243 (348)
T 2pml_X 166 YIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243 (348)
T ss_dssp HHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred HHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence 9999 99999999999999999999999999999864332 33446799999999999877 6666 999999999999
Q ss_pred HHHhCCCCCCCCCh-hhHHHHHHhccCCCCC-----------------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 303 EIYCCDMPYPDLSF-TDVSSAVVRQNLRPDI-----------------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 303 elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+|++|..||..... .+....+.......+. ...++.++.+||.+||+.||.+|||+.++++
T Consensus 244 ~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 244 VMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999999988766 5555544333222221 1568999999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.33 Aligned_cols=256 Identities=26% Similarity=0.357 Sum_probs=206.9
Q ss_pred cccccceeeeccCCceEEEEEEE---CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC---CCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~ 157 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||+++........ ...+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-------CchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 47899999999999999999987 4789999998754322111 12344577666666 89999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...... .....++||||++ |+|.+++.......+++..++.++.||+.||.|||++|++||||
T Consensus 83 ~~~~~~~---------------~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dl 146 (326)
T 1blx_A 83 CTVSRTD---------------RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 146 (326)
T ss_dssp EEEEECS---------------SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred eeecccC---------------CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 8621110 1123489999997 69999998766667999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+||+++.++.+||+|||+++..... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (326)
T 1blx_A 147 KPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225 (326)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CHHHeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999999999999999999999754322 2233467899999999999999999999999999999999999999988877
Q ss_pred hHHHHHHhccCC-------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 318 DVSSAVVRQNLR-------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+....+...... ..+...++..+.+||.+||+.||++|||+.++++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 666555431100 0123457899999999999999999999999995
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=357.27 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=203.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
..+|++.+.||+|+||+||+|++ +|+.||||++..... .+.+|+.+++.++|||||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------------~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------------hHHHHHHHHHHcCCCCccceeeEEecc
Confidence 45799999999999999999998 688999999864321 223699999999999999999998643
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
... .....+++||||+++ +|.+++.. .....+++..++.++.||+.||.|||++||+||||||
T Consensus 120 ~~~--------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 184 (420)
T 1j1b_A 120 GEK--------------KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 184 (420)
T ss_dssp ETT--------------TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG
T ss_pred CCC--------------CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 211 011234799999975 67666653 2345799999999999999999999999999999999
Q ss_pred CceeeCCC-CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 240 ENMLLDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 240 ~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
+|||++.+ +.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..
T Consensus 185 ~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~ 263 (420)
T 1j1b_A 185 QNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263 (420)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhEEEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999854 67899999999864332 223346789999999999764 7999999999999999999999999988766
Q ss_pred hHHHHHHhcc---------------CCCC------------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 048724 318 DVSSAVVRQN---------------LRPD------------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAV 368 (394)
Q Consensus 318 ~~~~~~~~~~---------------~~~~------------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~ 368 (394)
+....+.... .... ++..+++++.+||.+||+.||++|||+.++++ +++.+
T Consensus 264 ~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 264 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 6555543310 0001 22356899999999999999999999999996 44444
Q ss_pred H
Q 048724 369 N 369 (394)
Q Consensus 369 ~ 369 (394)
.
T Consensus 344 ~ 344 (420)
T 1j1b_A 344 R 344 (420)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.67 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=198.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +++.||||+++..... ......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-------hHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 57899999999999999999987 6889999999743211 12235677899999999999999999999765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ......|+||||++ |+|.+++. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 97 ~~~--------------~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 157 (371)
T 2xrw_A 97 KSL--------------EEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157 (371)
T ss_dssp CST--------------TTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ccc--------------ccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 432 11234699999996 57888874 348999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 158 Il~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 236 (371)
T 2xrw_A 158 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236 (371)
T ss_dssp EEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999754332 22334679999999999999999999999999999999999999999887766655
Q ss_pred HHHhccCC--------------------CCC--------------CC------CCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 322 AVVRQNLR--------------------PDI--------------PR------CCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 322 ~~~~~~~~--------------------~~~--------------~~------~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
.+...... +.. +. ..+.++.+||.+||+.||++|||++++
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 316 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence 55332110 000 00 115689999999999999999999999
Q ss_pred HHHH
Q 048724 362 VKLL 365 (394)
Q Consensus 362 l~~l 365 (394)
++.-
T Consensus 317 l~hp 320 (371)
T 2xrw_A 317 LQHP 320 (371)
T ss_dssp HHSH
T ss_pred hCCc
Confidence 9843
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=341.83 Aligned_cols=245 Identities=20% Similarity=0.334 Sum_probs=199.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|.+ +++.||||+++... ...+.+|+.++++++ ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 57899999999999999999987 78899999987322 256788999999996 9999999999876
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... ...++||||+++++|.+++. .+++..++.++.||+.||.|||++|++||||||+
T Consensus 103 ~~~------------------~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 159 (330)
T 3nsz_A 103 PVS------------------RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 159 (330)
T ss_dssp TTT------------------CCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCC------------------CceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 332 23489999999999998873 3899999999999999999999999999999999
Q ss_pred ceeeCCCC-cEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-hh
Q 048724 241 NMLLDANR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FT 317 (394)
Q Consensus 241 NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~-~~ 317 (394)
|||++.++ .+||+|||+++..... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..
T Consensus 160 Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 238 (330)
T 3nsz_A 160 NVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238 (330)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred HEEEcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH
Confidence 99998766 8999999999854432 23344678999999999987 678999999999999999999999995432 22
Q ss_pred hHHHHHH-------------hcc----------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 318 DVSSAVV-------------RQN----------------------LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 318 ~~~~~~~-------------~~~----------------------~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
+....+. ... .....+..+++++.+||.+||+.||++|||+++++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 318 (330)
T 3nsz_A 239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318 (330)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 2211111 000 01111223789999999999999999999999998
Q ss_pred HH
Q 048724 363 KL 364 (394)
Q Consensus 363 ~~ 364 (394)
+.
T Consensus 319 ~h 320 (330)
T 3nsz_A 319 EH 320 (330)
T ss_dssp TS
T ss_pred cC
Confidence 73
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=345.78 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=199.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||.||+|.+ +++.||||+++....... ..........+.+|+.++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG-SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhc-ccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 36899999999999999999988 678999999874332110 011112234678899999999999999999998643
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 88 ~---------------------~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 144 (322)
T 2ycf_A 88 D---------------------YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144 (322)
T ss_dssp S---------------------EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred c---------------------eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 2 3899999999999999854 3569999999999999999999999999999999999
Q ss_pred eeeCCCCc---EEEeeccccccccCCCCCccCCCCCCCcCCcccc---CCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 242 MLLDANRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL---DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 242 Ill~~~~~---vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
||++.++. +||+|||+++..... .......||+.|+|||.+ ....++.++|||||||++|+|++|..||....
T Consensus 145 Il~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 145 VLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp EEESSSSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred EEEecCCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99987654 999999999754322 112234689999999997 35678999999999999999999999997654
Q ss_pred hh-hHHHHHHhccCC--CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 316 FT-DVSSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 316 ~~-~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.. .....+...... +..+..++..+.+||.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 224 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 43 333333333221 1122457899999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=352.44 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=192.6
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.|++. ++|++.+.||+|+||+||+|.+ +|+.||||++...... ......+.+|+.+++.++||||+++++
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~ 95 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-------IIHAKRTYRELRLLKHMKHENVIGLLD 95 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 35443 7899999999999999999987 7899999998643211 122356778999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++....... ....+|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~~~--------------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~D 157 (367)
T 2fst_X 96 VFTPARSLE--------------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157 (367)
T ss_dssp EECSCSSGG--------------GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEecCCccc--------------cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 987543321 113359999999 7899998854 4699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 158 lkp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 158 LKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp CCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCHhhEEECCCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999975432 2334689999999999987 678999999999999999999999999887
Q ss_pred hhhHHHHHHhccCC---------------------CC--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQNLR---------------------PD--------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~---------------------~~--------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+....+...... +. ....+++.+.+||.+||+.||++|||+.+++..
T Consensus 235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 76655544321000 00 012468899999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.32 Aligned_cols=266 Identities=20% Similarity=0.302 Sum_probs=205.3
Q ss_pred ccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccc--hHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVT--SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..-.++|++.+.||+|+||+||+|.+ +|+.||||++......... ........+.+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 34458899999999999999999987 7889999998654322110 11223335778899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...... ....+|+||||++ |+|.+++... ...+++..++.++.||+.||.|||++|++||||
T Consensus 98 ~~~~~~~---------------~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 160 (362)
T 3pg1_A 98 FVHFEEP---------------AMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDL 160 (362)
T ss_dssp EEECCTT---------------TCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEeccCC---------------CcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCC
Confidence 8643321 1234599999997 6888888643 356999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||+|||++.++.+||+|||+++..... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 161 HPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ChHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999743332 22334578999999999877 6789999999999999999999999998877
Q ss_pred hhHHHHHHhccCCC----------------------C--------CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLRP----------------------D--------IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~~----------------------~--------~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....+......+ . .+..+++.+.+||.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 66665553211110 0 123468889999999999999999999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=357.63 Aligned_cols=276 Identities=12% Similarity=0.168 Sum_probs=191.6
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC--CCCcceee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL--DHPNVTKF 154 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~l 154 (394)
.|.....+|++.+.||+|+||+||+|++ +|+.||||+++..... .......+.+|+.+++.+ +||||+++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~~~~l~~~hp~iv~~ 129 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN------SRSELERLHEATFAAARLLGESPEEARD 129 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT------HHHHHHHHHHHHHHHHHHHC--------
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc------cccHHHHHHHHHHHHHHhcccChhhhhh
Confidence 3444456799999999999999999997 6889999999854321 122245677785555444 69998886
Q ss_pred eeeec-------CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHH------HHHHHHHH
Q 048724 155 IGASM-------GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVV------IQIALDLA 221 (394)
Q Consensus 155 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qi~ 221 (394)
+..+. ......+. ...+.........+|+||||++ |+|.+++.... ..+++..+ +.++.||+
T Consensus 130 ~~~~~~p~d~~~~~~~~~~~---~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~ 204 (371)
T 3q60_A 130 RRRLLLPSDAVAVQSQPPFA---QLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLI 204 (371)
T ss_dssp --CBCCCCEEEEETTSCSSS---BCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEEeeehheecCCCCCee---eccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHH
Confidence 64443 21110000 0000000011134699999998 89999997653 23455556 78889999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC--CCCCccchHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGI 299 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~ 299 (394)
.||+|||++||+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||
T Consensus 205 ~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp HHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred HHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 9999999999999999999999999999999999999854322 113467799999999987 77999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHH--H---HH--hccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHH
Q 048724 300 CLWEIYCCDMPYPDLSFTDVSS--A---VV--RQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAV 368 (394)
Q Consensus 300 ~l~elltg~~Pf~~~~~~~~~~--~---~~--~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~ 368 (394)
++|+|++|+.||.......... . .. ......+....+++.+.+||.+||+.||++|||+.++++ +++.+
T Consensus 282 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred HHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9999999999997764321110 0 00 011222223468999999999999999999999999986 44444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=339.44 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=209.2
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC--CCcce
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD--HPNVT 152 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv 152 (394)
..+...+..++|++.+.||+|+||+||+|.+ +++.||||+++..... ......+.+|+.++++++ ||||+
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-------HHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-------ccchHHHHHHHHHHHhccccCCceE
Confidence 3456777788999999999999999999988 6889999999754321 122467889999999996 59999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++++++...... |+||| +.+++|.+++... ..+++..++.++.|++.||.|||++|+
T Consensus 92 ~~~~~~~~~~~~--------------------~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~i 148 (313)
T 3cek_A 92 RLYDYEITDQYI--------------------YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGI 148 (313)
T ss_dssp CEEEEEECSSEE--------------------EEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEeecCCEE--------------------EEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 999999876554 89999 5588999999654 468999999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCC-----------CCCCccchHHHHHH
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDG-----------KPYNRKCDVYSFGI 299 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~ 299 (394)
+||||||+|||++ ++.+||+|||+++....... ......|++.|+|||.+.+ ..++.++||||||+
T Consensus 149 vH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~ 227 (313)
T 3cek_A 149 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227 (313)
T ss_dssp CCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHH
T ss_pred eecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHH
Confidence 9999999999996 48899999999975433221 1223578999999999875 46888999999999
Q ss_pred HHHHHHhCCCCCCCCCh-hhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 300 CLWEIYCCDMPYPDLSF-TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 300 ~l~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
++|+|++|..||..... ...............++..++.++.++|.+||+.||++|||+.++++.-
T Consensus 228 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 228 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 99999999999976543 3334444455556667777899999999999999999999999999854
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.57 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=205.2
Q ss_pred cccccccceeeeccCCceEEEEEEE---CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc------ce
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN------VT 152 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n------Iv 152 (394)
+-.++|++.+.||+|+||+||+|.+ +++.||||+++... .....+.+|+.+++.++|++ ++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----------RYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----------HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----------chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 3457999999999999999999987 57899999986321 12356778999999887664 99
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
++++++.....+ |+||||+ +++|.+++.......+++..++.++.||+.||+|||++|+
T Consensus 81 ~~~~~~~~~~~~--------------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 139 (339)
T 1z57_A 81 QMLEWFEHHGHI--------------------CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139 (339)
T ss_dssp CEEEEEEETTEE--------------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eeecccccCCcE--------------------EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCC
Confidence 999998866554 8999999 8999999987665679999999999999999999999999
Q ss_pred cccCCCCCceeeCC-------------------CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccch
Q 048724 233 VHRDVKTENMLLDA-------------------NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCD 293 (394)
Q Consensus 233 iH~Dlkp~NIll~~-------------------~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 293 (394)
+||||||+|||++. ++.+||+|||+++..... .....||+.|+|||.+.+..++.++|
T Consensus 140 vH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~D 216 (339)
T 1z57_A 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCD 216 (339)
T ss_dssp ECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHH
T ss_pred cCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchh
Confidence 99999999999987 668999999999754322 23457899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCC------------------------------------------CC
Q 048724 294 VYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLR------------------------------------------PD 331 (394)
Q Consensus 294 vwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~------------------------------------------~~ 331 (394)
||||||++|+|++|..||...+..+....+...... ..
T Consensus 217 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (339)
T 1z57_A 217 VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296 (339)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcc
Confidence 999999999999999999887766554433211000 00
Q ss_pred CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 332 IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 332 ~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+..+++++.+||.+||+.||++|||+.++++.
T Consensus 297 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 112246789999999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=346.57 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=206.6
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.|++. ++|.+.+.||+|+||+||+|.+ +|+.||||+++.... .......+.+|+.+++.++||||+++++
T Consensus 37 ~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 108 (371)
T 4exu_A 37 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-------SEIFAKRAYRELLLLKHMQHENVIGLLD 108 (371)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred eeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-------chhHHHHHHHHHHHHHhcCCCCchhhhh
Confidence 45554 7899999999999999999988 689999999974321 1223467789999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++....... ....+|+||||+. ++|.+++ ...+++..++.++.||+.||.|||++||+|||
T Consensus 109 ~~~~~~~~~--------------~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 169 (371)
T 4exu_A 109 VFTPASSLR--------------NFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 169 (371)
T ss_dssp EECSCSSST--------------TCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred heeccCCcc--------------cceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 998655431 1123489999996 6888876 23499999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 170 ikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 170 LKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp CCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999754322 334678999999999987 789999999999999999999999999887
Q ss_pred hhhHHHHHHhccCCC-----------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQNLRP-----------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+....+......+ ..+..+++.+.+||.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 247 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 766665553311000 0123468999999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=352.14 Aligned_cols=259 Identities=21% Similarity=0.324 Sum_probs=203.7
Q ss_pred ccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
...+|++.+.||+|+||+||+|++ .+..||+|.+..... ...+|+.+++.++||||++++++|...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------------~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------------FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------------hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 346899999999999999999998 556699998754321 123699999999999999999999654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI-RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... .....+|+||||++++.+..... ......+++..++.++.||+.||.|||++||+||||||+
T Consensus 105 ~~~--------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (394)
T 4e7w_A 105 GDK--------------KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170 (394)
T ss_dssp SSS--------------SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCC--------------CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 321 01223589999997654433322 122457999999999999999999999999999999999
Q ss_pred ceeeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 241 NMLLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 241 NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|||++ .++.+||+|||+++..... .......+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus 171 Nill~~~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 249 (394)
T 4e7w_A 171 NLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249 (394)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HEEEcCCCCcEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99998 7899999999999864332 223346789999999998764 58999999999999999999999999888766
Q ss_pred HHHHHHhcc---------------CCC------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHHH
Q 048724 319 VSSAVVRQN---------------LRP------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAVN 369 (394)
Q Consensus 319 ~~~~~~~~~---------------~~~------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~~ 369 (394)
....+.... ... .++..+++++.+||.+||+.||++|||+.++++. ++.++
T Consensus 250 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 665554310 000 1223478999999999999999999999999984 54544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=338.92 Aligned_cols=257 Identities=25% Similarity=0.478 Sum_probs=193.7
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
...+|.+..++|++.+.||+|+||+||+|.+ +|+.||||+++.... .....+.+.++..+++.++||||++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~i~~ 88 (318)
T 2dyl_A 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-------KEENKRILMDLDVVLKSHDCPYIVQ 88 (318)
T ss_dssp SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-------HHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCceee
Confidence 3456888899999999999999999999998 688999999974431 1122344555666788889999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-TI 232 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~i 232 (394)
+++++.+.+.. |+||||+ ++.+..+... ....+++..++.++.|++.||.|||++ |+
T Consensus 89 ~~~~~~~~~~~--------------------~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 146 (318)
T 2dyl_A 89 CFGTFITNTDV--------------------FIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGV 146 (318)
T ss_dssp EEEEEECSSEE--------------------EEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred EEEEEecCCcE--------------------EEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 99999876554 8999999 6666655543 346799999999999999999999995 99
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhC
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCC 307 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg 307 (394)
+||||||+||+++.++.+||+|||++...... .......+++.|+|||.+. +..++.++||||||+++|+|++|
T Consensus 147 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (318)
T 2dyl_A 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225 (318)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred EeCCCCHHHEEECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence 99999999999999999999999999754332 2223357899999999995 45688999999999999999999
Q ss_pred CCCCCCC-ChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 308 DMPYPDL-SFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 308 ~~Pf~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..||... ...+....+.... .+..+ ..++.++.++|.+||+.||.+|||+.++++
T Consensus 226 ~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 226 QFPYKNCKTDFEVLTKVLQEE-PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCTTTTCCSHHHHHHHHHHSC-CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCCCccHHHHHHHhccC-CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999874 3344444443332 22233 458999999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=357.33 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=205.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc-ceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN-VTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|++ +++.||||+++..... ..+..|+.+++.++|++ +..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 47899999999999999999997 6889999998754321 34668999999997754 4444444443
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... .++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+
T Consensus 75 ~~~--------------------~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~ 132 (483)
T 3sv0_A 75 GDY--------------------NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (483)
T ss_dssp TTE--------------------EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCE--------------------EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcc
Confidence 332 38999999 99999999653 346999999999999999999999999999999999
Q ss_pred ceee---CCCCcEEEeeccccccccCCCC-------CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 241 NMLL---DANRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 241 NIll---~~~~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
|||| +.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P 212 (483)
T 3sv0_A 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (483)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999 5789999999999986443221 12246799999999999999999999999999999999999999
Q ss_pred CCCCChh---hHHHHHHhccCCC---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 311 YPDLSFT---DVSSAVVRQNLRP---DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 311 f~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
|...... .....+....... .+...++.++.+||..||+.+|++||++.+|++.|+++....
T Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 213 WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp TSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 9875432 2222222221111 122568999999999999999999999999999999996543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=352.16 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=199.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC--------CCcce
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD--------HPNVT 152 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--------h~nIv 152 (394)
-.++|++.+.||+|+||+||+|++ +++.||||+++... .....+.+|+.+++.++ |+||+
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----------HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----------cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 357899999999999999999987 68899999986321 12356778999999985 78899
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK-T 231 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~ 231 (394)
+++++|..... .....|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ |
T Consensus 105 ~~~~~~~~~~~----------------~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g 167 (397)
T 1wak_A 105 QLLDDFKISGV----------------NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR 167 (397)
T ss_dssp CEEEEEEEEET----------------TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeecceeecCC----------------CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999873211 012349999999 67777777665556799999999999999999999998 9
Q ss_pred CcccCCCCCceeeCCCC-------------------------------------------------cEEEeecccccccc
Q 048724 232 IVHRDVKTENMLLDANR-------------------------------------------------TLKIADFGVARVEA 262 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~~-------------------------------------------------~vkl~DFG~a~~~~ 262 (394)
|+||||||+|||++.++ .+||+|||+++...
T Consensus 168 ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~ 247 (397)
T 1wak_A 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247 (397)
T ss_dssp EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT
T ss_pred EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc
Confidence 99999999999998775 79999999998643
Q ss_pred CCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh------hHHHHHHh--cc-------
Q 048724 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT------DVSSAVVR--QN------- 327 (394)
Q Consensus 263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~------~~~~~~~~--~~------- 327 (394)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. +....+.. ..
T Consensus 248 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 324 (397)
T 1wak_A 248 KH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324 (397)
T ss_dssp BC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHH
T ss_pred cc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhh
Confidence 32 33467999999999999999999999999999999999999999765421 11111111 00
Q ss_pred ---C----------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 328 ---L----------------------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 328 ---~----------------------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
. ....+..++..+.+||.+||+.||++|||+.++++.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 001122345678999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=343.89 Aligned_cols=258 Identities=27% Similarity=0.471 Sum_probs=186.0
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHH-HHHhCCCCcce
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA-VWQKLDHPNVT 152 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv 152 (394)
....|.+..++|++.+.||+|+||+||+|.+ +|+.||||+++.... . .. ...+..|+. +++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~---~~-~~~~~~e~~~~~~~~~h~niv 84 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----E---KE-QKQLLMDLDVVMRSSDCPYIV 84 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----H---HH-HHHHHHHHHHHHSSCCCTTBC
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----c---hH-HHHHHHHHHHHHHcCCCCcEe
Confidence 4467899999999999999999999999998 589999999974321 1 11 233444554 67778999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHh
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR---NKRKKLAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
++++++...+.. ++||||+++ +|.+++.. .....+++..++.++.|++.||.|||+
T Consensus 85 ~~~~~~~~~~~~--------------------~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 143 (327)
T 3aln_A 85 QFYGALFREGDC--------------------WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143 (327)
T ss_dssp CEEEEEECSSEE--------------------EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeeeEEEeCCce--------------------EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc
Confidence 999999876554 899999975 88887753 224679999999999999999999999
Q ss_pred C-CCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCcccc----CCCCCCccchHHHHHHHHHHH
Q 048724 230 K-TIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL----DGKPYNRKCDVYSFGICLWEI 304 (394)
Q Consensus 230 ~-~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~el 304 (394)
+ |++||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+ .+..++.++||||||+++|+|
T Consensus 144 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l 222 (327)
T 3aln_A 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222 (327)
T ss_dssp HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHH
T ss_pred cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHH
Confidence 8 99999999999999999999999999997543322 22334799999999999 456789999999999999999
Q ss_pred HhCCCCCCCCChh-hHHHHHHhccCCCCC----CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 305 YCCDMPYPDLSFT-DVSSAVVRQNLRPDI----PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 305 ltg~~Pf~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
++|..||...... +....+ .....+.+ ...+++.+.+||.+||+.||++|||+.++++.
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 223 ATGRFPYPKWNSVFDQLTQV-VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp HHSCCCSSCC-------CCC-CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHCCCCCCCcchHHHHHHHH-hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 9999999865422 111111 11111122 23589999999999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=341.96 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=205.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||+++.... ......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------PLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS--------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc--------chHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 47899999999999999999998 589999999863221 12235677899999999999999999987653
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... .....|+||||+. ++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 82 ~~~---------------~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (353)
T 2b9h_A 82 SFE---------------NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN 142 (353)
T ss_dssp CST---------------TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ccC---------------ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 211 1244699999996 699999865 359999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCC----------CccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPR----------DMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
||++.++.+||+|||+++....... ......||+.|+|||.+. +..++.++|||||||++|+|++|..|
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 222 (353)
T 2b9h_A 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222 (353)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999975432211 122347899999999875 47789999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccCCC------------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 311 YPDLSFTDVSSAVVRQNLRP------------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
|.+.+..+....+......+ .....+++++.+||.+||+.||++|||+.+
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 223 FPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 99887655444332110000 011357899999999999999999999999
Q ss_pred HHH--HHHHH
Q 048724 361 VVK--LLEAV 368 (394)
Q Consensus 361 ll~--~l~~~ 368 (394)
+++ .++.+
T Consensus 303 ll~hp~~~~~ 312 (353)
T 2b9h_A 303 ALEHPYLQTY 312 (353)
T ss_dssp HHTSGGGTTT
T ss_pred HhcCcccccc
Confidence 998 34444
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=335.27 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=199.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++... .....+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----------EKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----------HHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 36799999999999999999997 68899999986321 1236788999999999999999999998765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
.....+ ..........|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 75 ~~~~~~-------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~N 146 (303)
T 1zy4_A 75 RNFVKP-------MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMN 146 (303)
T ss_dssp CCCCC-------------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred cchhhh-------hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHh
Confidence 432110 00111234569999999999999999753 3468899999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCC--------------CCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHh
Q 048724 242 MLLDANRTLKIADFGVARVEAQN--------------PRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ellt 306 (394)
|+++.++.+||+|||++...... ........|++.|+|||.+.+. .++.++||||||+++|+|++
T Consensus 147 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp EEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999999999999999754321 1122345689999999999864 68999999999999999998
Q ss_pred CCCCCCCC-ChhhHHHHHHhc--cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 307 CDMPYPDL-SFTDVSSAVVRQ--NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 307 g~~Pf~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
||... ........+... .....++..++..+.++|.+||+.||++|||+.++++.
T Consensus 227 ---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 227 ---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 55432 222333333222 12334456678899999999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=345.28 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=199.2
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
......++|++.+.||+|+||+||+|++ +|+.||||++....... ..+.+++..++.++||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~l~~l~h~niv~~~~ 86 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----------NRELQIMQDLAVLHHPNIVQLQS 86 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----------CHHHHHHHHHHHHCCTTBCCEEE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----------HHHHHHHHHHHhcCCCCcccHHH
Confidence 3456678999999999999999999998 58899999986433211 23456788888999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHH--hCCC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR--NKRKKLAFKVVIQIALDLARGLSYLH--SKTI 232 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~yLH--~~~i 232 (394)
+|...... ......+++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| ++||
T Consensus 87 ~~~~~~~~-------------~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i 152 (360)
T 3e3p_A 87 YFYTLGER-------------DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV 152 (360)
T ss_dssp EEEEECSS-------------CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC
T ss_pred hhhccccc-------------cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence 98653321 0112235899999976 55554442 23457899999999999999999999 9999
Q ss_pred cccCCCCCceeeCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCC
Q 048724 233 VHRDVKTENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 233 iH~Dlkp~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~P 310 (394)
+||||||+|||++. ++.+||+|||+++..... .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.|
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p 231 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999986 899999999999865432 223346789999999998664 489999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccC------------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHH
Q 048724 311 YPDLSFTDVSSAVVRQNL------------------------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ 360 (394)
|...+.......+..... ....+..+++++.+||.+||+.||++|||+.+
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 998887776665543110 11122336789999999999999999999999
Q ss_pred HHHH--HHHHH
Q 048724 361 VVKL--LEAVN 369 (394)
Q Consensus 361 ll~~--l~~~~ 369 (394)
+++. ++++.
T Consensus 312 ~l~hp~f~~~~ 322 (360)
T 3e3p_A 312 ALCHPYFDELH 322 (360)
T ss_dssp HTTSGGGGGGG
T ss_pred HhcCccccccC
Confidence 9984 55554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=342.84 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=177.2
Q ss_pred ccccccee-eeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 84 LAKLDIRH-EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~-~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
.++|.+.+ .||+|+||+||+|.+ +|+.||||++.... ....+....++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------------KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------------HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 57898855 699999999999998 58999999986321 111223344567799999999999865
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... .....++||||++||+|.+++.......+++..++.++.||+.||.|||++|++||||||+
T Consensus 94 ~~~----------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~ 157 (336)
T 3fhr_A 94 MHH----------------GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157 (336)
T ss_dssp EET----------------TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ccC----------------CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 221 0123489999999999999998766567999999999999999999999999999999999
Q ss_pred ceeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 241 NMLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 241 NIll~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|||++. ++.+||+|||+++..... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 158 NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 158 NLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp GEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred HEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 999976 456999999999754322 233457899999999999888999999999999999999999999766544
Q ss_pred hHHHH----HHhcc--CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 318 DVSSA----VVRQN--LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 318 ~~~~~----~~~~~--~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
..... +.... ........++.++.+||.+||+.||++|||+.++++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 33211 11111 12222356899999999999999999999999999843
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=341.49 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=205.3
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.|++ .++|.+.+.||+|+||+||+|.+ +|+.||||++..... .......+.+|+.+++.++||||+++++
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 90 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-------SEIFAKRAYRELLLLKHMQHENVIGLLD 90 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCCcccHhh
Confidence 3444 37899999999999999999988 689999999864321 1223467789999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
++........ ...+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++|++|||
T Consensus 91 ~~~~~~~~~~--------------~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~d 151 (353)
T 3coi_A 91 VFTPASSLRN--------------FYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 151 (353)
T ss_dssp EECSCSSGGG--------------CCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred eEeccccccc--------------ceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 9986554311 123489999996 68877762 3499999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||+||+++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus 152 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 152 LKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp CCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999754322 234578999999999887 678999999999999999999999998887
Q ss_pred hhhHHHHHHhcc--------------------------CC---CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 316 FTDVSSAVVRQN--------------------------LR---PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 316 ~~~~~~~~~~~~--------------------------~~---~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+....+.... .+ ......+++++.+||.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 666554443210 01 11234578999999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=337.89 Aligned_cols=262 Identities=19% Similarity=0.281 Sum_probs=201.1
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---------PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---------hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 47899999999999999999998 58999999986432 11246678899999999999999999998654
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..... .+..........|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 ~~~~~------~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 150 (320)
T 2i6l_A 81 GSQLT------DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 150 (320)
T ss_dssp SCBCC------C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred ccccc------cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 32210 00111223456799999997 699999843 469999999999999999999999999999999999
Q ss_pred eeeC-CCCcEEEeeccccccccCC---CCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 242 MLLD-ANRTLKIADFGVARVEAQN---PRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 242 Ill~-~~~~vkl~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||++ .++.+||+|||+++..... ........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 151 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp EEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 9997 5679999999999854322 112233467899999998865 6789999999999999999999999998877
Q ss_pred hhHHHHHHhccCC-----------------------C-----CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNLR-----------------------P-----DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~~-----------------------~-----~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+....+...... + .....++.++.+||.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 6655544332100 0 0124579999999999999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=349.03 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=182.3
Q ss_pred ccccc-eeeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 85 AKLDI-RHEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 85 ~~~~~-~~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
+.|++ .++||+|+||+||+|++ +++.||||+++.... ...+.+|+.+|++++||||++++++|.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----------CHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----------CHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 44655 45799999999999986 367899999864321 135678999999999999999999996
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-------RKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
.... ..+|+||||+. |+|.+++.... ...+++..++.|+.||+.||.|||++||
T Consensus 89 ~~~~------------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 149 (405)
T 3rgf_A 89 SHAD------------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV 149 (405)
T ss_dssp ETTT------------------TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cCCC------------------CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4322 23499999995 58888886422 2249999999999999999999999999
Q ss_pred cccCCCCCceee----CCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHH
Q 048724 233 VHRDVKTENMLL----DANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEI 304 (394)
Q Consensus 233 iH~Dlkp~NIll----~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el 304 (394)
+||||||+|||+ +.++.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 150 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred eCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 999999999999 677899999999998644321 22334678999999999987 4589999999999999999
Q ss_pred HhCCCCCCCCChh---------hHHHHHHhc-cCCCC-----------------------------------CCCCCcHH
Q 048724 305 YCCDMPYPDLSFT---------DVSSAVVRQ-NLRPD-----------------------------------IPRCCPSS 339 (394)
Q Consensus 305 ltg~~Pf~~~~~~---------~~~~~~~~~-~~~~~-----------------------------------~~~~~~~~ 339 (394)
++|..||...... +....+... +.... .....+..
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 9999999755431 222222110 00000 01112678
Q ss_pred HHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 340 LASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 340 l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+.+||.+||+.||++|||++++++.
T Consensus 310 ~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC
Confidence 8999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.55 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=200.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CC-eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc------ceee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DG-QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN------VTKF 154 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n------Iv~l 154 (394)
.++|++.+.||+|+||+||+|.+ ++ +.||||+++... .....+.+|+.+++.++|++ ++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----------KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----------cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 57999999999999999999987 34 789999986321 12356778999999997766 8899
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
++++...... |+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|
T Consensus 88 ~~~~~~~~~~--------------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH 146 (355)
T 2eu9_A 88 SDWFNFHGHM--------------------CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTH 146 (355)
T ss_dssp EEEEEETTEE--------------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred eeeeeeCCeE--------------------EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 8888765554 8999999 778888887665567999999999999999999999999999
Q ss_pred cCCCCCceee-------------------CCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHH
Q 048724 235 RDVKTENMLL-------------------DANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVY 295 (394)
Q Consensus 235 ~Dlkp~NIll-------------------~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 295 (394)
|||||+|||+ +.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||
T Consensus 147 ~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 223 (355)
T 2eu9_A 147 TDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVW 223 (355)
T ss_dssp CCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred CCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchH
Confidence 9999999999 56789999999999754322 2346899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCC------------------------------------------CCC
Q 048724 296 SFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRP------------------------------------------DIP 333 (394)
Q Consensus 296 slG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------------------------~~~ 333 (394)
||||++|+|++|..||......+....+....... ...
T Consensus 224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (355)
T 2eu9_A 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303 (355)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccccc
Confidence 99999999999999998877665444332211000 001
Q ss_pred CCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 334 RCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 334 ~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+.++.+||.+||+.||++|||+.++++
T Consensus 304 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 112468899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.44 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=201.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CC-----cceee
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HP-----NVTKF 154 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~-----nIv~l 154 (394)
-.++|++.+.||+|+||+||+|.+ +++.||||+++... .....+..|+.+++.++ |+ +|+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----------AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----------HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 368999999999999999999988 68899999996321 12355667888888884 55 49999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCC
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLH--SKTI 232 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH--~~~i 232 (394)
++++.....+ |+||||++ |+|.+++.......+++..++.++.|++.||.||| +.||
T Consensus 122 ~~~~~~~~~~--------------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~i 180 (382)
T 2vx3_A 122 KRHFMFRNHL--------------------CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSI 180 (382)
T ss_dssp EEEEEETTEE--------------------EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCE
T ss_pred eeeeccCCce--------------------EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCE
Confidence 9998866554 89999995 59999998766567999999999999999999999 5799
Q ss_pred cccCCCCCceeeC--CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCC
Q 048724 233 VHRDVKTENMLLD--ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP 310 (394)
Q Consensus 233 iH~Dlkp~NIll~--~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~P 310 (394)
+||||||+|||++ .++.+||+|||+++..... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 181 vHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 181 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp ECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EcCCCCcccEEEecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999995 4778999999999865332 3346899999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHhccCCCC----------------CCC----------------------------------------
Q 048724 311 YPDLSFTDVSSAVVRQNLRPD----------------IPR---------------------------------------- 334 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~----------------~~~---------------------------------------- 334 (394)
|.+.+..+....+......++ ++.
T Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 337 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337 (382)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccc
Confidence 998887776655543210000 000
Q ss_pred ------CCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 335 ------CCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 335 ------~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..++++.+||.+||+.||++|||+.++++
T Consensus 338 ~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp CTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence 00147899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=345.09 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=201.0
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-----------
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD----------- 147 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~----------- 147 (394)
.+..++|++.+.||+|+||+||+|++ +++.||||+++... .....+.+|+.++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----------cchhhhhHHHHHHHHhhcccccchhccc
Confidence 44568999999999999999999997 78999999986321 11356778999998886
Q ss_pred CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Q 048724 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYL 227 (394)
Q Consensus 148 h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yL 227 (394)
||||+++++++.....- ...+++||||+ +++|.+++.......+++..++.++.||+.||.||
T Consensus 85 ~~~i~~~~~~~~~~~~~----------------~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l 147 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPN----------------GVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 147 (373)
T ss_dssp HTTBCCCCEEEEEEETT----------------EEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHhhccCCC----------------CceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH
Confidence 89999999998754310 11348999999 89999999876666799999999999999999999
Q ss_pred HhC-CCcccCCCCCceeeC------CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHH
Q 048724 228 HSK-TIVHRDVKTENMLLD------ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGIC 300 (394)
Q Consensus 228 H~~-~iiH~Dlkp~NIll~------~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 300 (394)
|++ ||+||||||+|||++ ..+.+||+|||++...... .....+|+.|+|||.+.+..++.++|||||||+
T Consensus 148 H~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 224 (373)
T 1q8y_A 148 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 224 (373)
T ss_dssp HHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred HhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHH
Confidence 998 999999999999994 4458999999999754332 334578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCh------hhHHHHHHhc-c---------------------------------------CCCCCCC
Q 048724 301 LWEIYCCDMPYPDLSF------TDVSSAVVRQ-N---------------------------------------LRPDIPR 334 (394)
Q Consensus 301 l~elltg~~Pf~~~~~------~~~~~~~~~~-~---------------------------------------~~~~~~~ 334 (394)
+|+|++|..||..... .+....+... + ....++.
T Consensus 225 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (373)
T 1q8y_A 225 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304 (373)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCc
Confidence 9999999999976542 1111111110 0 0112333
Q ss_pred CCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 335 CCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 335 ~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.++.++.+||.+||+.||++|||+.++++.
T Consensus 305 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred chHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 456789999999999999999999999983
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.66 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=197.1
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC----CCCcce
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL----DHPNVT 152 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l----~h~nIv 152 (394)
..+.-.++|++.+.||+|+||+||+|.+ +++.||||+++...... .........+.+|+.+++++ +||||+
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG---WSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccc---cccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 3445568899999999999999999988 68899999997543211 11111224456799999998 899999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEec-CCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY-LPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT 231 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ 231 (394)
++++++...+.. ++|+|| +.+++|.+++... ..+++..++.++.||+.||.|||++|
T Consensus 102 ~~~~~~~~~~~~--------------------~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ 159 (312)
T 2iwi_A 102 RLLDWFETQEGF--------------------MLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG 159 (312)
T ss_dssp CEEEEC-----C--------------------EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEecCCeE--------------------EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999998766554 889999 7899999999664 46999999999999999999999999
Q ss_pred CcccCCCCCceeeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCC-ccchHHHHHHHHHHHHhCCC
Q 048724 232 IVHRDVKTENMLLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDM 309 (394)
Q Consensus 232 iiH~Dlkp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~ 309 (394)
++||||||+||+++ .++.+||+|||++...... ......|++.|+|||.+.+..+. .++||||||+++|+|++|+.
T Consensus 160 i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred eeecCCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 99999999999998 7899999999999865432 23345799999999998766654 58999999999999999999
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
||.... .+... ...++..++..+.++|.+||+.||++|||+.++++.
T Consensus 238 pf~~~~------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 238 PFERDQ------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp SCCSHH------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCChH------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 996532 12222 344667789999999999999999999999999973
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.28 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=203.8
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC--CCcceee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD--HPNVTKF 154 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l 154 (394)
+.+.-.++|++.+.||+|+||+||+|++ +++.||||+++.......... .....+.+|+.++++++ |+||+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh---hhhhHHHHHHHHHHhhccCCCCceEE
Confidence 4455578999999999999999999987 788999999975432210000 00134557999999996 5999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG-GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
++++...+.. ++|+|++.+ ++|.+++... ..+++..++.++.||+.||.|||++|++
T Consensus 114 ~~~~~~~~~~--------------------~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iv 171 (320)
T 3a99_A 114 LDWFERPDSF--------------------VLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVL 171 (320)
T ss_dssp EEEEECSSEE--------------------EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEecCCcE--------------------EEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 9999876554 899999976 8999999653 4699999999999999999999999999
Q ss_pred ccCCCCCceeeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCC
Q 048724 234 HRDVKTENMLLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 234 H~Dlkp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf 311 (394)
||||||+|||++ .++.+||+|||+++..... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||
T Consensus 172 H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eCCCCHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 999999999998 7889999999999865432 2334579999999999977665 67899999999999999999999
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.... .+... ....+..+++++.+||.+||+.||++|||+.++++.
T Consensus 250 ~~~~------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 250 EHDE------EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CSHH------HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CChh------hhhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6532 12222 234556789999999999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.14 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=187.6
Q ss_pred cccccccccc-cceeeeccCCceEEEEE-EECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceee
Q 048724 78 EEWEIELAKL-DIRHEIARGTYGTVYRG-AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKF 154 (394)
Q Consensus 78 ~~~~~~~~~~-~~~~~lG~G~fg~Vy~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 154 (394)
++++..+.++ .+.+.||+|+||+||.+ ..+|+.||||++.... ...+.+|+.+++++ +|||||++
T Consensus 7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------------~~~~~~E~~~l~~l~~HpnIv~~ 74 (434)
T 2rio_A 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------------CDIALMEIKLLTESDDHPNVIRY 74 (434)
T ss_dssp -CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------------HHHHHHHHHHHHHHTTSTTBCCE
T ss_pred cchhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------------HHHHHHHHHHHHhccCCCCcCeE
Confidence 3455555555 44678999999999754 4489999999986321 13466899999886 89999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCC-----CCHHHHHHHHHHHHHHHHHHHh
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK-----LAFKVVIQIALDLARGLSYLHS 229 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~-----l~~~~~~~i~~qi~~~l~yLH~ 229 (394)
++++.+...+ |+||||+. |+|.+++....... .++..++.++.||+.||.|||+
T Consensus 75 ~~~~~~~~~~--------------------~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 133 (434)
T 2rio_A 75 YCSETTDRFL--------------------YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133 (434)
T ss_dssp EEEEECSSEE--------------------EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeE--------------------EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH
Confidence 9998866554 89999995 69999997543211 1333467899999999999999
Q ss_pred CCCcccCCCCCceeeCCC-------------CcEEEeeccccccccCCCC----CccCCCCCCCcCCccccCC-------
Q 048724 230 KTIVHRDVKTENMLLDAN-------------RTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLDG------- 285 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~-------------~~vkl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~------- 285 (394)
+||+||||||+|||++.+ +.+||+|||+++....... ......||+.|+|||++.+
T Consensus 134 ~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 213 (434)
T 2rio_A 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213 (434)
T ss_dssp TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCC
T ss_pred CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccc
Confidence 999999999999999654 4899999999986543221 1234579999999999975
Q ss_pred CCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCC-----CCCcHHHHHHHHHhchhCCCCCCCHH
Q 048724 286 KPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIP-----RCCPSSLASIMRKCWDANPDKRPVMD 359 (394)
Q Consensus 286 ~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cL~~dP~~Rpt~~ 359 (394)
..++.++|||||||++|||++ |..||....... ..+.......... ..+++++.+||.+||+.||++|||+.
T Consensus 214 ~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (434)
T 2rio_A 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291 (434)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHH
Confidence 678999999999999999999 899997654433 2333333222211 12468899999999999999999999
Q ss_pred HHHH
Q 048724 360 EVVK 363 (394)
Q Consensus 360 ~ll~ 363 (394)
++++
T Consensus 292 eil~ 295 (434)
T 2rio_A 292 KVLR 295 (434)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=346.00 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=191.3
Q ss_pred cccccccccccceeeeccCCceEE-EEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeee
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTV-YRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFI 155 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~V-y~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 155 (394)
..+.+...+|.+.+.||+|+||+| |++..+|+.||||++..... ..+.+|+.+|+++ +|||||+++
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------------~~~~~E~~~l~~l~~HpnIv~l~ 84 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------------SFADREVQLLRESDEHPNVIRYF 84 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------------EECHHHHHHHHHSCCCTTBCCEE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------------HHHHHHHHHHHhccCCCCcCeEE
Confidence 346667778999999999999985 56666899999999864321 1244799999999 899999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.+.... |+||||+. |+|.+++.... ..+.+..++.++.||+.||.|||++||+||
T Consensus 85 ~~~~~~~~~--------------------~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 142 (432)
T 3p23_A 85 CTEKDRQFQ--------------------YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142 (432)
T ss_dssp EEEEETTEE--------------------EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred EEEecCCEE--------------------EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeC
Confidence 998866554 89999995 69999997543 335555678999999999999999999999
Q ss_pred CCCCCceeeCC-----CCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccC---CCCCCccchHHHHHHHHHHH
Q 048724 236 DVKTENMLLDA-----NRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLD---GKPYNRKCDVYSFGICLWEI 304 (394)
Q Consensus 236 Dlkp~NIll~~-----~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el 304 (394)
||||+|||++. ...+||+|||+++...... .......||+.|+|||++. ...++.++|||||||++|||
T Consensus 143 DlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~el 222 (432)
T 3p23_A 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222 (432)
T ss_dssp CCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHH
Confidence 99999999953 2358899999998644321 2233467999999999997 45678899999999999999
Q ss_pred Hh-CCCCCCCCChhhHHHHHHhccCCCC-CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 305 YC-CDMPYPDLSFTDVSSAVVRQNLRPD-IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 305 lt-g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
++ |..||.................... .+...+..+.+||.+||+.||++|||+.++++
T Consensus 223 lt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 99 8999976544443322111111111 11234567899999999999999999999984
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=321.30 Aligned_cols=230 Identities=22% Similarity=0.402 Sum_probs=181.9
Q ss_pred cccccce-eeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHH-HhCCCCcceeeeeeec
Q 048724 84 LAKLDIR-HEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW-QKLDHPNVTKFIGASM 159 (394)
Q Consensus 84 ~~~~~~~-~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~ 159 (394)
.++|.+. +.||+|+||+||+|.+ +++.||||+++.. ..+.+|+.++ +.++||||+++++++.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 5677777 7899999999999988 6889999998631 3456788887 5569999999999986
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
.... .....|+||||+++|+|.+++.......+++..++.++.|++.||.|||++|++||||||
T Consensus 82 ~~~~----------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 145 (299)
T 3m2w_A 82 NLYA----------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145 (299)
T ss_dssp EEET----------------TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred hhcC----------------CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 5110 012348999999999999999876656799999999999999999999999999999999
Q ss_pred CceeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 240 ENMLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
+|||++. ++.+||+|||++.... +..++.++|||||||++|+|++|..||.....
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred HHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9999987 7889999999986422 23467899999999999999999999976544
Q ss_pred hhHHHHHHhcc--CCCCCC----CCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 317 TDVSSAVVRQN--LRPDIP----RCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 317 ~~~~~~~~~~~--~~~~~~----~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
........... .....+ ..+++++.++|.+||+.||++|||+.++++.-
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 204 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp ----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 33221111110 011122 45799999999999999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=321.87 Aligned_cols=232 Identities=13% Similarity=0.125 Sum_probs=186.9
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
-.++|++.+.||+|+||+||+|.+ +|+.||||+++...... ......+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP------DDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC------HHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 347899999999999999999998 48999999997543211 2234678899999999999999999999986
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.. |+||||++|++|.+++.. . .....+..|+.||+.||.|||++||+||||||+
T Consensus 103 ~~~~--------------------~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~ 158 (286)
T 3uqc_A 103 RAGG--------------------LVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPS 158 (286)
T ss_dssp TTEE--------------------EEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred CCcE--------------------EEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcc
Confidence 6554 899999999999999843 2 456678899999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|||++.++.+||+++| |++ .++.++|||||||++|+|++|+.||...+.....
T Consensus 159 NIll~~~g~~kl~~~~--------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 159 RVRVSIDGDVVLAYPA--------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp GEEEETTSCEEECSCC--------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred cEEEcCCCCEEEEecc--------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 9999999999998543 333 3688999999999999999999999876543211
Q ss_pred H---HHHhccCCC--CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 321 S---AVVRQNLRP--DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 321 ~---~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
. ......... .....+++++.++|.+||+.||++| |+.++++.|+++....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 000111000 1234689999999999999999999 9999999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.83 Aligned_cols=264 Identities=14% Similarity=0.179 Sum_probs=189.5
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC-Ccceeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-PNVTKFIG 156 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~ 156 (394)
+.....+|.+.+.||+|+||+||+|++ +|+.||||+++...... ....+.|.+|+.+++.++| +|......
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~------~~~~~~~~~E~~~~~~l~~~~~~~~~~~ 146 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP------SNAIKQMKEEVLRLRLLRGIKNQKQAKV 146 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc------HHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence 344456788999999999999999998 58999999987332211 1123568899999999977 32221111
Q ss_pred ---------eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh-----cccCCCCHHHHHHHHHHHHH
Q 048724 157 ---------ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR-----NKRKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 157 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~-----~~~~~l~~~~~~~i~~qi~~ 222 (394)
.........+.. .............+++|+++ +++|.+++.. .....+++..++.++.||+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~ 222 (413)
T 3dzo_A 147 HLRFIFPFDLVKDPQKKKMIR---VRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222 (413)
T ss_dssp HTCBCCCCEEEECCC------------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHH
T ss_pred hcccccchhhcccCCCCcccc---ccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHH
Confidence 111100000000 00000000112346777766 7899999852 22445888899999999999
Q ss_pred HHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCcccc----------CCCCCCccc
Q 048724 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL----------DGKPYNRKC 292 (394)
Q Consensus 223 ~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~ 292 (394)
||.|||++||+||||||+|||++.++.+||+|||+++..... .....| +.|+|||.+ .+..++.++
T Consensus 223 aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 223 LLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 999999999999999999999999999999999998754332 334577 999999999 666788999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 293 DVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 293 DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
|||||||++|||++|+.||...........+. .....+|+++.+||.+||+.||++|||+.++++
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999999999998765443322221 112357899999999999999999999777754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=347.90 Aligned_cols=265 Identities=25% Similarity=0.354 Sum_probs=201.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|.+ +|+.||||+++... . ......+.+|+.++++++||||+++++++...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~----~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----S----PKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----C----HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----C----HHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 47899999999999999999987 68899999986421 1 12246788999999999999999999997653
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK-RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... ......|+||||++||+|.+++.... ...+++..++.++.|++.||.|||++|++||||||+
T Consensus 85 ~~~--------------~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~ 150 (676)
T 3qa8_A 85 QKL--------------APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPE 150 (676)
T ss_dssp CCC--------------CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCST
T ss_pred ccc--------------cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 221 12344589999999999999997633 236899999999999999999999999999999999
Q ss_pred ceeeCCCCc---EEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 241 NMLLDANRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 241 NIll~~~~~---vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+++.++. +||+|||++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 151 NILl~~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 151 NIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp TEEEECCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred HeEeecCCCceeEEEcccccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 999987664 999999999865433 2334468999999999999999999999999999999999999999654321
Q ss_pred hHH---------HHHH-----hcc--C------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHH-----HHHHHHHHHh
Q 048724 318 DVS---------SAVV-----RQN--L------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDE-----VVKLLEAVNT 370 (394)
Q Consensus 318 ~~~---------~~~~-----~~~--~------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~-----ll~~l~~~~~ 370 (394)
... .... ... + ....+..++..+.++|.+||..||++|||+.+ ..+.++++..
T Consensus 230 ~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 230 VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 110 0000 000 0 00122335789999999999999999999988 4566666654
Q ss_pred c
Q 048724 371 S 371 (394)
Q Consensus 371 ~ 371 (394)
.
T Consensus 310 ~ 310 (676)
T 3qa8_A 310 L 310 (676)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.36 Aligned_cols=246 Identities=26% Similarity=0.311 Sum_probs=194.7
Q ss_pred cccccccceeeeccCCceEEEEEEE---CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY---DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
+-.++|++.+.||+|+||+||+|.+ +|+.||||++..... ......+.+|+.++++++||||+++++++
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--------AEAQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--------HHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--------HHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 4458999999999999999999987 478999999864221 12245678999999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
...+.. .....|+||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+|||||
T Consensus 149 ~~~~~~---------------~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlk 209 (681)
T 2pzi_A 149 EHTDRH---------------GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209 (681)
T ss_dssp EEECTT---------------SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred eecCCC---------------CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Confidence 865441 01124899999999999987733 69999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|+|||++.+ .+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.......
T Consensus 210 p~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~ 283 (681)
T 2pzi_A 210 PENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283 (681)
T ss_dssp GGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS
T ss_pred hHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc
Confidence 999999875 8999999999864332 345799999999998765 4889999999999999999999886522110
Q ss_pred HHHHHHhccCCCCC-CCCCcHHHHHHHHHhchhCCCCCC-CHHHHHHHHHHHH
Q 048724 319 VSSAVVRQNLRPDI-PRCCPSSLASIMRKCWDANPDKRP-VMDEVVKLLEAVN 369 (394)
Q Consensus 319 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~cL~~dP~~Rp-t~~~ll~~l~~~~ 369 (394)
..... ...+++.+.++|.+||+.||++|| +++++...|..+.
T Consensus 284 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 ---------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00000 012357899999999999999999 5677777776553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.75 Aligned_cols=266 Identities=16% Similarity=0.221 Sum_probs=187.5
Q ss_pred cccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---------CCcce
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---------HPNVT 152 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---------h~nIv 152 (394)
+..++|++.+.||+|+||+||+|+++|+.||||+++......... ......+.+.+|+.+++.++ |||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG-SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTT-BCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCcccccc-ccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 456889999999999999999999999999999998653210000 00011256778999888886 66666
Q ss_pred eeeeeecCCCc--cccCC--------CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHH
Q 048724 153 KFIGASMGTTN--LKIPS--------QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 153 ~l~~~~~~~~~--~~~~~--------~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~ 222 (394)
++.+++..... ..+.. .....+..........|+||||+++|++.+.+.+ ..+++..++.|+.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 66555421100 00000 0000000011124566999999999976665532 46899999999999999
Q ss_pred HHHHHH-hCCCcccCCCCCceeeCCCC--------------------cEEEeeccccccccCCCCCccCCCCCCCcCCcc
Q 048724 223 GLSYLH-SKTIVHRDVKTENMLLDANR--------------------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 281 (394)
Q Consensus 223 ~l~yLH-~~~iiH~Dlkp~NIll~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE 281 (394)
||.||| ++||+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 999999 99999999999999999876 8999999999865432 247999999999
Q ss_pred ccCCCCCCccchHHHHHHH-HHHHHhCCCCCCCCCh-hhHHHHHHhc-cCCCCC----CCCCcHHHHHHHHHhchhCCCC
Q 048724 282 VLDGKPYNRKCDVYSFGIC-LWEIYCCDMPYPDLSF-TDVSSAVVRQ-NLRPDI----PRCCPSSLASIMRKCWDANPDK 354 (394)
Q Consensus 282 ~~~~~~~~~~~DvwslG~~-l~elltg~~Pf~~~~~-~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~cL~~dP~~ 354 (394)
++.+.. +.++|||||+++ .+++++|..||..... ......+... ...... +..+++++.+||.+||+.|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 998776 889999998777 7778899999854221 1122222211 111111 1246889999999999976
Q ss_pred CCCHHHHH
Q 048724 355 RPVMDEVV 362 (394)
Q Consensus 355 Rpt~~~ll 362 (394)
|+++++
T Consensus 324 --sa~e~l 329 (336)
T 2vuw_A 324 --SATDLL 329 (336)
T ss_dssp --SHHHHH
T ss_pred --CHHHHH
Confidence 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=287.93 Aligned_cols=190 Identities=18% Similarity=0.177 Sum_probs=135.1
Q ss_pred eccCCceEEEEEEE--CCeeEEEEEeecccc-cccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCCccccCC
Q 048724 93 IARGTYGTVYRGAY--DGQDVAVKILDWAED-GMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 93 lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~ 168 (394)
.+.|++|.+..++. .|+.||+|++..... ........+...+.|.+|+++|+++ .|+||+++++++.+...+
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~---- 317 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG---- 317 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE----
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE----
Confidence 45666666665443 788999999975432 2334455666678899999999999 799999999999987776
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCC
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR 248 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~ 248 (394)
||||||++|++|.++|.+. +++++. .|+.||+.||+|||++|||||||||+|||++.+|
T Consensus 318 ----------------yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg 376 (569)
T 4azs_A 318 ----------------WLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ 376 (569)
T ss_dssp ----------------EEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS
T ss_pred ----------------EEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC
Confidence 9999999999999999654 457664 4889999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCC
Q 048724 249 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308 (394)
Q Consensus 249 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 308 (394)
.+||+|||+|+............+||+.|+|||++.+. +..++|+||+|++++++.++.
T Consensus 377 ~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 377 HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 99999999998765554445556899999999999865 567899999999988876553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=262.46 Aligned_cols=190 Identities=17% Similarity=0.214 Sum_probs=146.5
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCccccCCC
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQ 169 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 169 (394)
.+.||+|+||+||+|.+.+..+++|....... ...........+.+.+|+.++++++||||+++..++......
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~----- 414 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGY-RDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK----- 414 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTT-SCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT-----
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccc-cchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc-----
Confidence 56899999999999988999999998754221 112223334467789999999999999999555444443333
Q ss_pred CCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCc
Q 048724 170 SATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249 (394)
Q Consensus 170 ~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~ 249 (394)
|+||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .
T Consensus 415 ---------------~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 415 ---------------RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp ---------------EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S
T ss_pred ---------------EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e
Confidence 899999999999999843 5689999999999999999999999999999998 9
Q ss_pred EEEeeccccccccCCCCC-------ccCCCCCCCcCCccccCC--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 250 LKIADFGVARVEAQNPRD-------MTGETGTLGYMAPEVLDG--KPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 250 vkl~DFG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
+||+|||+++........ .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999999999865432111 123579999999999987 568888999999999888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-26 Score=212.91 Aligned_cols=149 Identities=17% Similarity=0.126 Sum_probs=112.7
Q ss_pred ceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccch---------HHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 89 IRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTS---------AEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~---------~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
+.+.||+|+||.||+|.+ +|+.||||+++......... .........+.+|+.++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 459999999999999999 68999999996432111000 000123567889999999998 4 5555544
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.. +. .|+||||++|++|.+ +. . .....++.|++.||.|||++||+|||||
T Consensus 171 ~~-~~--------------------~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlk 220 (282)
T 1zar_A 171 AW-EG--------------------NAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLS 220 (282)
T ss_dssp EE-ET--------------------TEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ec-cc--------------------eEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCC
Confidence 32 22 289999999999987 41 1 2345799999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD 284 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 284 (394)
|+|||++ ++.+||+|||+++. +..++|||.+.
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred HHHEEEE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 9999999 99999999999863 23467888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=177.05 Aligned_cols=143 Identities=18% Similarity=0.179 Sum_probs=106.0
Q ss_pred ccceeeeccCCceEEEEEEE--CCee--EEEEEeecccccccc---------------hHHHHHHHHHHHHHHHHHHhCC
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQD--VAVKILDWAEDGMVT---------------SAEAAAIRASFRQEVAVWQKLD 147 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~--vavK~~~~~~~~~~~---------------~~~~~~~~~~~~~E~~il~~l~ 147 (394)
|.+.+.||+|+||.||+|.+ +|+. ||||+++........ ..........+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999988 8888 999997643211000 0001122356788999999998
Q ss_pred CCcc--eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCC-C----CHHHHHHhcccCCCCHHHHHHHHHHH
Q 048724 148 HPNV--TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG-G----TLKKFLIRNKRKKLAFKVVIQIALDL 220 (394)
Q Consensus 148 h~nI--v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qi 220 (394)
|+++ +.+++. .. .++||||+.+ | +|.++... .++..+..++.|+
T Consensus 129 ~~~i~~p~~~~~----~~--------------------~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi 179 (258)
T 1zth_A 129 EAGVSVPQPYTY----MK--------------------NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDV 179 (258)
T ss_dssp HTTCCCCCEEEE----ET--------------------TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHH
T ss_pred hCCCCCCeEEEc----CC--------------------CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHH
Confidence 8754 333332 11 2899999942 3 77776422 2345678899999
Q ss_pred HHHHHHHH-hCCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 221 ARGLSYLH-SKTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 221 ~~~l~yLH-~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
+.||.||| +.||+||||||+|||++. .++|+|||+|..
T Consensus 180 ~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 180 VENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 99999999 999999999999999988 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3.3e-19 Score=170.18 Aligned_cols=141 Identities=16% Similarity=0.154 Sum_probs=97.4
Q ss_pred ccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccc------------cch-HHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 87 LDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGM------------VTS-AEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~------------~~~-~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
|.+.+.||+|+||.||+|.. +|+.||||+++...... ... ......+.....|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78899999999999999988 78999999986432110 000 11111112223456666666433321
Q ss_pred --eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 048724 153 --KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK 230 (394)
Q Consensus 153 --~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 230 (394)
..++.. ..+|||||++|++|.++. .......++.||+.+|.|||++
T Consensus 177 vp~p~~~~------------------------~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~ 224 (397)
T 4gyi_A 177 VPEPIAQS------------------------RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKH 224 (397)
T ss_dssp CCCEEEEE------------------------TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHT
T ss_pred CCeeeecc------------------------CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHC
Confidence 122111 117999999998885432 1123457889999999999999
Q ss_pred CCcccCCCCCceeeCCCC----------cEEEeeccccc
Q 048724 231 TIVHRDVKTENMLLDANR----------TLKIADFGVAR 259 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~----------~vkl~DFG~a~ 259 (394)
|||||||||.|||+++++ .+.|+||+.+.
T Consensus 225 gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 225 GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 999999999999998776 38999999774
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.7e-13 Score=124.77 Aligned_cols=140 Identities=14% Similarity=0.111 Sum_probs=108.2
Q ss_pred cccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecCCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTT 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 162 (394)
+..|++...++.|+++.||++...++.+++|+........ ...+.+|+.+++.+ .+..+.++++++.+..
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---------TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 4568888889999999999998888899999986422111 13467899999988 4667888888876543
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-------------
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS------------- 229 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------------- 229 (394)
.. |+||||++|.+|.+.+. +......++.+++++|..||+
T Consensus 84 ~~--------------------~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~ 136 (263)
T 3tm0_A 84 WS--------------------NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLD 136 (263)
T ss_dssp EE--------------------EEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHH
T ss_pred ce--------------------EEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHH
Confidence 33 89999999999987531 122234678899999999998
Q ss_pred ----------------------------------------------CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 ----------------------------------------------KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ----------------------------------------------~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 137 SRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=8.6e-12 Score=112.93 Aligned_cols=134 Identities=17% Similarity=0.147 Sum_probs=94.5
Q ss_pred ccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc--ceeeeeeecCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN--VTKFIGASMGT 161 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~ 161 (394)
..+.+....+.|..+.||++.. +|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 4455544445666799999876 46789999975321 134567899998885444 45577776543
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC----------
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT---------- 231 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~---------- 231 (394)
+. .++||||++|.+|. .. ..+ ...++.++++.|..||+..
T Consensus 88 ~~--------------------~~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~ 137 (264)
T 1nd4_A 88 GR--------------------DWLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQA 137 (264)
T ss_dssp SC--------------------EEEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCH
T ss_pred CC--------------------CEEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 33 38999999998884 21 112 2256677778888888643
Q ss_pred ------------------------------------------------CcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 232 ------------------------------------------------IVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 232 ------------------------------------------------iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
++|+|++|.||+++.++.+.|+||+.+..
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 138 KHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 89999999999998776667999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.6e-11 Score=114.65 Aligned_cols=142 Identities=15% Similarity=0.223 Sum_probs=105.0
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEee--cccccccchHHHHHHHHHHHHHHHHHHhCC--CCcceeeeeeecCCCccc
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILD--WAEDGMVTSAEAAAIRASFRQEVAVWQKLD--HPNVTKFIGASMGTTNLK 165 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~ 165 (394)
.+.|+.|.++.||+....+..+++|+.. ..... .....+.+|+.+++.+. +..++++++++.+....
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~- 113 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI- 113 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT-
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc-
Confidence 5578999999999998877889999875 22110 01246678999999996 45578888887654321
Q ss_pred cCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh----------------
Q 048724 166 IPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS---------------- 229 (394)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~---------------- 229 (394)
+..|+||||++|.++.+.. ...++......++.+++..|..||+
T Consensus 114 ----------------g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~ 173 (359)
T 3dxp_A 114 ----------------GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGN 173 (359)
T ss_dssp ----------------SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSC
T ss_pred ----------------CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCC
Confidence 2348999999998874311 1347788888999999999999996
Q ss_pred ------------------------------------------CCCcccCCCCCceeeCCCCc--EEEeecccccc
Q 048724 230 ------------------------------------------KTIVHRDVKTENMLLDANRT--LKIADFGVARV 260 (394)
Q Consensus 230 ------------------------------------------~~iiH~Dlkp~NIll~~~~~--vkl~DFG~a~~ 260 (394)
..++|+|++|.||+++.++. +.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 174 YFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred chHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987653 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=107.17 Aligned_cols=185 Identities=21% Similarity=0.248 Sum_probs=119.1
Q ss_pred eeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCc--ceeeeeeecCCCccccC
Q 048724 91 HEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPN--VTKFIGASMGTTNLKIP 167 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~n--Iv~l~~~~~~~~~~~~~ 167 (394)
+.++.|....||+.. ..+++|+.+.. .....+.+|+.+|+.+ .+.. +.+++.........
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~-----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~--- 88 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS-----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY--- 88 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH-----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC---
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc-----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC---
Confidence 459999999999864 57999986421 1135678899999888 3332 33444433222211
Q ss_pred CCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 048724 168 SQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS------------------ 229 (394)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------------------ 229 (394)
...|+||++++|.+|.+... ..++..+...++.+++..|..||+
T Consensus 89 --------------~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~ 150 (304)
T 3sg8_A 89 --------------QMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKI 150 (304)
T ss_dssp --------------SCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHH
T ss_pred --------------CcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHH
Confidence 11278999999988865332 236777788888888888888885
Q ss_pred ----------------------------------------CCCcccCCCCCceeeCC--CCcEEEeeccccccccCCCCC
Q 048724 230 ----------------------------------------KTIVHRDVKTENMLLDA--NRTLKIADFGVARVEAQNPRD 267 (394)
Q Consensus 230 ----------------------------------------~~iiH~Dlkp~NIll~~--~~~vkl~DFG~a~~~~~~~~~ 267 (394)
..++|+|++|.||+++. ++.+.|+||+.+..... ..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~D 229 (304)
T 3sg8_A 151 NEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DND 229 (304)
T ss_dssp HHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THH
T ss_pred HHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHH
Confidence 13699999999999987 55678999999875321 111
Q ss_pred ccCCCCCCCcCCccccCC-----CCC---------CccchHHHHHHHHHHHHhCCCCC
Q 048724 268 MTGETGTLGYMAPEVLDG-----KPY---------NRKCDVYSFGICLWEIYCCDMPY 311 (394)
Q Consensus 268 ~~~~~gt~~y~aPE~~~~-----~~~---------~~~~DvwslG~~l~elltg~~Pf 311 (394)
.........-..|+.... ... ....+.|+++.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 110000000022222110 000 12358999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=4.4e-07 Score=84.33 Aligned_cols=134 Identities=16% Similarity=0.158 Sum_probs=89.3
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC---cceeeeeeecCCCcccc
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP---NVTKFIGASMGTTNLKI 166 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~l~~~~~~~~~~~~ 166 (394)
...++.|....||+. |..+++|+.+.. .....+.+|+.+|+.+.+. .+.+++.+....
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~~-----------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----- 84 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKSQ-----------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----- 84 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESSH-----------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-----
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCCc-----------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-----
Confidence 345889999999987 678999985311 1135678999999999642 244555544311
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----------------
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK---------------- 230 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------- 230 (394)
....++||+|++|.+|.+... ..++......++.++.+.|..||+.
T Consensus 85 --------------~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~ 146 (306)
T 3tdw_A 85 --------------DGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLK 146 (306)
T ss_dssp --------------TSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHH
T ss_pred --------------CCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHH
Confidence 122389999999988876321 1234444555555555555555531
Q ss_pred --------------------------------------------CCcccCCCCCceeeCC---CCc-EEEeecccccc
Q 048724 231 --------------------------------------------TIVHRDVKTENMLLDA---NRT-LKIADFGVARV 260 (394)
Q Consensus 231 --------------------------------------------~iiH~Dlkp~NIll~~---~~~-vkl~DFG~a~~ 260 (394)
.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 147 NKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 355 48999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=7.1e-07 Score=81.02 Aligned_cols=130 Identities=19% Similarity=0.175 Sum_probs=89.4
Q ss_pred eccCCce-EEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCCCccccCC
Q 048724 93 IARGTYG-TVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTTNLKIPS 168 (394)
Q Consensus 93 lG~G~fg-~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~ 168 (394)
+..|..| .||+... .+..+++|+..... ...+.+|..+|+.+. +--+.++++++.+.+..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~---- 95 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV------------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA---- 95 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHH------------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE----
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCC------------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE----
Confidence 4445544 6898765 45689999875221 245678999998883 32356777776654433
Q ss_pred CCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC------------------
Q 048724 169 QSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK------------------ 230 (394)
Q Consensus 169 ~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------------------ 230 (394)
++|||+++|.++.+..... ......++.++...|.-||+.
T Consensus 96 ----------------~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~ 153 (272)
T 4gkh_A 96 ----------------WLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQA 153 (272)
T ss_dssp ----------------EEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHH
T ss_pred ----------------EEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhH
Confidence 8999999999987765321 112334556666666666642
Q ss_pred ----------------------------------------CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 ----------------------------------------TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 ----------------------------------------~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++|+|++|.||+++.++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 154 QSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999877777999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-06 Score=83.15 Aligned_cols=85 Identities=13% Similarity=0.094 Sum_probs=52.9
Q ss_pred ceeee-ccCCceEEEEEEEC--------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-C--Ccceeeee
Q 048724 89 IRHEI-ARGTYGTVYRGAYD--------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-H--PNVTKFIG 156 (394)
Q Consensus 89 ~~~~l-G~G~fg~Vy~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h--~nIv~l~~ 156 (394)
..+.| +.|....+|+.... +..+++|+........... ...+.+|+.+++.+. + -.+.++++
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~------~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP------TYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS------CCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc------hhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 34567 88999999988764 6789999875432000000 023456888887773 2 34667777
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCH
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL 196 (394)
++.+.... ...|+||||++|.++
T Consensus 98 ~~~~~~~~-----------------g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 98 IETTGDVL-----------------GTPFFLMDYVEGVVP 120 (357)
T ss_dssp EECSSTTT-----------------SSCEEEEECCCCBCC
T ss_pred EccCCCcc-----------------CCceEEEEecCCCCh
Confidence 76543211 223889999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=9.1e-06 Score=76.04 Aligned_cols=30 Identities=27% Similarity=0.426 Sum_probs=27.4
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 679999999999999878889999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=8e-06 Score=78.50 Aligned_cols=31 Identities=23% Similarity=0.359 Sum_probs=26.1
Q ss_pred hCCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 229 SKTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 229 ~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
...++|+|++|.||+++.++ ++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 45799999999999998654 89999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.01 E-value=8.6e-05 Score=64.33 Aligned_cols=138 Identities=12% Similarity=0.092 Sum_probs=93.2
Q ss_pred CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCC
Q 048724 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET 272 (394)
Q Consensus 194 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 272 (394)
-+|.+.|... ..++++.++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|-+.+ ..+. .
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~ 98 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------A 98 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------c
Confidence 4899988764 4689999999999999999877621 1212334557899999999987763 1110 1
Q ss_pred CCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchh--
Q 048724 273 GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA-- 350 (394)
Q Consensus 273 gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~-- 350 (394)
....+.+||... ...+.+.=|||||+++|..+-...| ...+..+|+.+.+||..|..-
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~~ 158 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTVE 158 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhccc
Confidence 123456787763 3446788999999999998854433 223345789999999999866
Q ss_pred -----------------------CCCCCCCHHHHHHHH
Q 048724 351 -----------------------NPDKRPVMDEVVKLL 365 (394)
Q Consensus 351 -----------------------dP~~Rpt~~~ll~~l 365 (394)
.+..|+++++|++.=
T Consensus 159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C 196 (229)
T 2yle_A 159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLC 196 (229)
T ss_dssp --------------------CCSCCCCCCSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCcCCHHHHHHHH
Confidence 246889999988653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.91 E-value=5.4e-05 Score=70.23 Aligned_cols=75 Identities=21% Similarity=0.221 Sum_probs=55.9
Q ss_pred eeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC---CCcceeeeeeecCCCcccc
Q 048724 90 RHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD---HPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~ 166 (394)
.+.|+.|....+|+....+..+++|+..... ...+..|+..|+.|. ...+.+++++......
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~------------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~--- 105 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY------------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH--- 105 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG------------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE---
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc------------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc---
Confidence 4579999999999988878889999875321 256778988888883 3567777777654322
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCH
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTL 196 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL 196 (394)
.++||||++|.++
T Consensus 106 -----------------~~lvme~l~G~~~ 118 (312)
T 3jr1_A 106 -----------------SFLLLEALNKSKN 118 (312)
T ss_dssp -----------------EEEEEECCCCCCC
T ss_pred -----------------eEEEEEeccCCCC
Confidence 3899999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0001 Score=71.25 Aligned_cols=78 Identities=12% Similarity=0.158 Sum_probs=45.9
Q ss_pred HhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCC--CCCCcCCccccCCCC---CCccchHHHHHHHHH
Q 048724 228 HSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKP---YNRKCDVYSFGICLW 302 (394)
Q Consensus 228 H~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ 302 (394)
+...++|+|++|.||+++.++ +.|+||+.+...... .+..... -...|.+|+...... -....++......+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 457899999999999998776 999999988643211 0000000 012345554443111 112344557777777
Q ss_pred HHHhC
Q 048724 303 EIYCC 307 (394)
Q Consensus 303 elltg 307 (394)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00019 Score=65.62 Aligned_cols=78 Identities=19% Similarity=0.185 Sum_probs=53.2
Q ss_pred cccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCC---cceeeeeeecCC
Q 048724 86 KLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP---NVTKFIGASMGT 161 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~l~~~~~~~ 161 (394)
...-...+|.|..+.||+.+. +|+.|.+|+........ ...|..|+..|+.|... -+.+++++..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~-- 84 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---------DGLFRAEALGLDWLGRSFGSPVPQVAGWDD-- 84 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---------TTHHHHHHHHHHHHTCSTTCCSCCEEEEET--
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---------hhHHHHHHHHHHHHHhhCCCCcceEEeccC--
Confidence 344566799999999999988 78999999865332211 13467899999888421 2445554321
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCH
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL 196 (394)
.++||||++++..
T Consensus 85 ----------------------~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 ----------------------RTLAMEWVDERPP 97 (288)
T ss_dssp ----------------------TEEEEECCCCCCC
T ss_pred ----------------------ceEEEEeecccCC
Confidence 1789999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00041 Score=63.74 Aligned_cols=29 Identities=28% Similarity=0.396 Sum_probs=24.5
Q ss_pred CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4799999999999 4566789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00039 Score=64.38 Aligned_cols=146 Identities=16% Similarity=0.192 Sum_probs=77.7
Q ss_pred ceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc--ceeeeeeecCCCcccc
Q 048724 89 IRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN--VTKFIGASMGTTNLKI 166 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~ 166 (394)
-.+.|+.|....+|+...++..+++|+...... ...+..|+.+++.+...+ +.+++... +...+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~-----------~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~- 92 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE-----------KNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLG- 92 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC--------------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCE-
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCCC-----------HHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEE-
Confidence 355688898899999887666899998864210 123456777777763222 23333211 110000
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHH-----------HH---HHhcc-c--CC----CC---HHHHHH-------
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLK-----------KF---LIRNK-R--KK----LA---FKVVIQ------- 215 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~-----------~~---l~~~~-~--~~----l~---~~~~~~------- 215 (394)
...+..+++++|++|..+. +. ++... . .+ .. |.....
T Consensus 93 ------------~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 93 ------------ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp ------------EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ------------EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 0113348899999886431 11 11110 0 00 11 111000
Q ss_pred -----HHHHHHHHHHHHHh-------CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 216 -----IALDLARGLSYLHS-------KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 216 -----i~~qi~~~l~yLH~-------~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
+...+...+..++. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113344555542 368999999999999877656899999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00055 Score=63.78 Aligned_cols=32 Identities=28% Similarity=0.479 Sum_probs=27.6
Q ss_pred hCCCcccCCCCCceeeCCC----CcEEEeecccccc
Q 048724 229 SKTIVHRDVKTENMLLDAN----RTLKIADFGVARV 260 (394)
Q Consensus 229 ~~~iiH~Dlkp~NIll~~~----~~vkl~DFG~a~~ 260 (394)
...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3579999999999999874 6789999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0022 Score=59.46 Aligned_cols=29 Identities=24% Similarity=0.267 Sum_probs=25.3
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999998 4 899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00069 Score=65.72 Aligned_cols=59 Identities=15% Similarity=0.178 Sum_probs=37.8
Q ss_pred eeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc-ceeeeeeec
Q 048724 90 RHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN-VTKFIGASM 159 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~ 159 (394)
.+.|+.|....||+.... +..+++|+..... . ...+..|..+++.+...+ ..++++.+.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~-------~~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-------ESHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-------HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----c-------HHHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 456888989999998863 4689999874210 1 022336888888773223 356666553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00063 Score=64.44 Aligned_cols=28 Identities=21% Similarity=0.466 Sum_probs=24.0
Q ss_pred CCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.++|+|+++.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999998655 8999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0048 Score=60.18 Aligned_cols=59 Identities=12% Similarity=0.043 Sum_probs=38.0
Q ss_pred eeeeccCCceEEEEEEECC--eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcc-eeeeeee
Q 048724 90 RHEIARGTYGTVYRGAYDG--QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNV-TKFIGAS 158 (394)
Q Consensus 90 ~~~lG~G~fg~Vy~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~l~~~~ 158 (394)
.+.|+.|-...+|+....+ ..+++|+.......... ...|..+++.|...++ .++++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id----------R~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN----------REREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC----------HHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC----------HHHHHHHHHHHHhcCCCCCEEEEe
Confidence 4568889899999998865 88999987533221111 1368888888854444 5677665
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0021 Score=61.12 Aligned_cols=141 Identities=17% Similarity=0.257 Sum_probs=80.5
Q ss_pred ccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceee
Q 048724 85 AKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKF 154 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l 154 (394)
+.+++ +.|..|-...+|+.... +..+++|+..... .. ...+.+|..+++.+. +.-..++
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~-------~~~~~rE~~vl~~L~~~gv~P~l 119 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QG-------VDSLVLESVMFAILAERSLGPQL 119 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CC-------HHHHHHHHHHHHHHHHTTSSCCE
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---ch-------HHHHHHHHHHHHHHHhcCCCCeE
Confidence 34443 45777888899998762 3689999853211 01 133457888888773 3334566
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHH--------------HHHHh---cc---cCCCC--HHH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK--------------KFLIR---NK---RKKLA--FKV 212 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~--------------~~l~~---~~---~~~l~--~~~ 212 (394)
++.+.+ .+|+||++|.+|. +.|.+ .. .+... +.+
T Consensus 120 l~~~~~------------------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~ 175 (379)
T 3feg_A 120 YGVFPE------------------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGT 175 (379)
T ss_dssp EEEETT------------------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHH
T ss_pred EEEcCC------------------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHH
Confidence 666542 3699999875542 11111 10 11122 355
Q ss_pred HHHHHHHHHH-------------------HHHHHH----h----CCCcccCCCCCceeeCCC----CcEEEeecccccc
Q 048724 213 VIQIALDLAR-------------------GLSYLH----S----KTIVHRDVKTENMLLDAN----RTLKIADFGVARV 260 (394)
Q Consensus 213 ~~~i~~qi~~-------------------~l~yLH----~----~~iiH~Dlkp~NIll~~~----~~vkl~DFG~a~~ 260 (394)
+.++..++-. .+..|. . ..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 176 i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 176 MERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 5555544422 233332 2 258999999999999876 7899999998863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.028 Score=52.40 Aligned_cols=31 Identities=19% Similarity=0.424 Sum_probs=27.5
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999878899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.069 Score=51.38 Aligned_cols=29 Identities=17% Similarity=0.558 Sum_probs=25.6
Q ss_pred CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4799999999999 7788899999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.93 E-value=0.094 Score=50.03 Aligned_cols=29 Identities=28% Similarity=0.507 Sum_probs=24.9
Q ss_pred CcccCCCCCceee------CCCCcEEEeecccccc
Q 048724 232 IVHRDVKTENMLL------DANRTLKIADFGVARV 260 (394)
Q Consensus 232 iiH~Dlkp~NIll------~~~~~vkl~DFG~a~~ 260 (394)
++|+|+.+.|||+ +++..+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998863
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.16 E-value=0.058 Score=52.60 Aligned_cols=62 Identities=13% Similarity=0.064 Sum_probs=18.3
Q ss_pred cceeeeccCCceEEEEEEECC--eeEEE------EEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 88 DIRHEIARGTYGTVYRGAYDG--QDVAV------KILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~~g--~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
.+.+.|| ||.||+|.+.+ .+||+ |..+... ........|.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-------~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-------VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccc-------ccccccccccccccccccccccccCCCcceEE
Confidence 4555676 99999999854 57888 6554211 11222356778999999999999999987664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 394 | ||||
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-77 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-77 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-68 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-67 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-66 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-62 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-61 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-60 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-17 |
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 2e-77
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 35/294 (11%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
W + + +L + I +G +G V G Y G VAVK + A +F E
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----------NDATAQAFLAE 50
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
+V +L H N+ + +G + + L +V EY+ G+L +
Sbjct: 51 ASVMTQLRHSNLVQLLGVIV--------------EEKGGL-----YIVTEYMAKGSLVDY 91
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
L R L +++ +LD+ + YL VHRD+ N+L+ + K++DFG+ +
Sbjct: 92 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTD 318
+ + + APE L K ++ K DV+SFGI LWEIY +PYP + D
Sbjct: 152 ---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372
V V + + D P CP ++ +M+ CW + RP ++ + LE + T +
Sbjct: 209 VVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 5e-77
Identities = 87/303 (28%), Positives = 148/303 (48%), Gaps = 39/303 (12%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFR 137
++WEI ++ + I G++GTVY+G + G DVAVK+L+ +A +F+
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFK 52
Query: 138 QEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
EV V +K H N+ F+G S +V ++ G +L
Sbjct: 53 NEVGVLRKTRHVNILLFMGYSTAPQ---------------------LAIVTQWCEGSSLY 91
Query: 198 KFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGV 257
L K +I IA A+G+ YLH+K+I+HRD+K+ N+ L + T+KI DFG+
Sbjct: 92 HHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL 150
Query: 258 ARV--EAQNPRDMTGETGTLGYMAPEVL---DGKPYNRKCDVYSFGICLWEIYCCDMPYP 312
A V +G++ +MAPEV+ D PY+ + DVY+FGI L+E+ +PY
Sbjct: 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
Query: 313 DLSFTDVSSAVVRQNLR----PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+++ D +V + + CP ++ +M +C D+RP+ +++ +E +
Sbjct: 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
Query: 369 NTS 371
S
Sbjct: 271 ARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-71
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 35/297 (11%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
+EWE+ L + + G +G V+ G Y VAVK L + + +F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK----------QGSMSPDAF 55
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
E + ++L H + + ++ EY+ G+L
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVT---------------------QEPIYIITEYMENGSL 94
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
FL KL ++ +A +A G++++ + +HRD++ N+L+ + KIADFG
Sbjct: 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 257 VAR-VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MPYPDL 314
+AR +E G + + APE ++ + K DV+SFGI L EI +PYP +
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371
+ +V + R R P CP L +MR CW P+ RP D + +LE T+
Sbjct: 215 TNPEVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 3e-68
Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ + I G+YG + DG+ + K LD + A + EV + ++
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELD-------YGSMTEAEKQMLVSEVNLLRE 59
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L HPN+ ++ + TN + +V+EY GG L + + +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTL------------------YIVMEYCEGGDLASVITKGTK 101
Query: 206 KKLAF--KVVIQIALDLARGLSYLHSK-----TIVHRDVKTENMLLDANRTLKIADFGVA 258
++ + V+++ L L H + T++HRD+K N+ LD + +K+ DFG+A
Sbjct: 102 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
Query: 259 RVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318
R+ + GT YM+PE ++ YN K D++S G L+E+ P+ S +
Sbjct: 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221
Query: 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++ + IP L I+ + + RP ++E+++
Sbjct: 222 LAGKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-67
Identities = 74/299 (24%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 78 EEWEIELAKLDIRH-EIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAI 132
++ ++ L I E+ G +G+V +G Y DVA+K+L + A
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KAD 52
Query: 133 RASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLP 192
+E + +LD+P + + IG +V+E
Sbjct: 53 TEEMMREAQIMHQLDNPYIVRLIGVCQAEA---------------------LMLVMEMAG 91
Query: 193 GGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKI 252
GG L KFL KR+++ V ++ ++ G+ YL K VHRD+ N+LL KI
Sbjct: 92 GGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 150
Query: 253 ADFGVARVEAQNPRDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-D 308
+DFG+++ + T + L + APE ++ + ++ + DV+S+G+ +WE
Sbjct: 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEA 367
PY + +V + + Q R + P CP L ++M CW + RP V + + A
Sbjct: 211 KPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 8e-67
Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 33/294 (11%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRAS 135
++WE+E + ++H++ G YG VY G + VAVK L E
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----------EDTMEVEE 59
Query: 136 FRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195
F +E AV +++ HPN+ + +G ++ E++ G
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPF--------------------YIITEFMTYGN 99
Query: 196 LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADF 255
L +L R++++ V++ +A ++ + YL K +HRD+ N L+ N +K+ADF
Sbjct: 100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 159
Query: 256 GVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
G++R+ + G + + APE L ++ K DV++FG+ LWEI M
Sbjct: 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
++ ++ R + P CP + +MR CW NP RP E+ + E +
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 9e-67
Identities = 74/322 (22%), Positives = 123/322 (38%), Gaps = 60/322 (18%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRG-------AYDGQDVAVKILDWAEDGMVTSAEAA 130
+WE L+ + G +G V VAVK+L D +
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------S 81
Query: 131 AIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
+ R + E+ + +L H N+ +GA + + ++ E
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPI--------------------YLIFE 121
Query: 190 YLPGGTLKKFLIRNKRK---------------------KLAFKVVIQIALDLARGLSYLH 228
Y G L +L + K L F+ ++ A +A+G+ +L
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 229 SKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGK 286
K+ VHRD+ N+L+ + +KI DFG+AR + + + +MAPE L
Sbjct: 182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 287 PYNRKCDVYSFGICLWEIYCCD-MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMR 345
Y K DV+S+GI LWEI+ PYP + +++ + D P + IM+
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ 301
Query: 346 KCWDANPDKRPVMDEVVKLLEA 367
CW + KRP + L
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-66
Identities = 82/297 (27%), Positives = 126/297 (42%), Gaps = 35/297 (11%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
+ WEI L + ++ +G +G V+ G + VA+K L +F
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----------PGTMSPEAF 59
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
QE V +KL H + + +V EY+ G+L
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVS---------------------EEPIYIVTEYMSKGSL 98
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
FL K L ++ +A +A G++Y+ VHRD++ N+L+ N K+ADFG
Sbjct: 99 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158
Query: 257 VAR-VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDL 314
+AR +E G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218
Query: 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371
+V V R R P CP SL +M +CW P++RP + + LE TS
Sbjct: 219 VNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 5e-66
Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 36/287 (12%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
+W +E +I + +G +G VY +A+K+L A+ E A +
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQL 53
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
R+EV + L HPN+ + G T + +++EY P GT+
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRV--------------------YLILEYAPLGTV 93
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ L K K + +LA LSY HSK ++HRD+K EN+LL + LKIADFG
Sbjct: 94 YREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
+ + R GTL Y+ PE+++G+ ++ K D++S G+ +E P+ ++
Sbjct: 152 WSVHAPSSRRTTL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209
Query: 317 TDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ + R + P ++ + NP +RP++ EV++
Sbjct: 210 QETYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-64
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 39/283 (13%)
Query: 92 EIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD 147
E+ G +GTV +G Y + VAVKIL A A++ E V Q+LD
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-------NEANDPALKDELLAEANVMQQLD 66
Query: 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKK 207
+P + + IG + +V+E G L K+L +N+
Sbjct: 67 NPYIVRMIGICEAES---------------------WMLVMEMAELGPLNKYLQQNRH-- 103
Query: 208 LAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD 267
+ K +I++ ++ G+ YL VHRD+ N+LL KI+DFG+++ +
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 268 MTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAV 323
+T + + APE ++ ++ K DV+SFG+ +WE + PY + ++V +A+
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAM 222
Query: 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ + R P CP + +M CW + + RP V L
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 4e-64
Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 38/284 (13%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+I E+ G +G VY+ A K++D ++ + E+ +
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVID---------TKSEEELEDYMVEIDILAS 65
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
DHPN+ K + A NL +++E+ GG + ++ +R
Sbjct: 66 CDHPNIVKLLDAFYYENNL--------------------WILIEFCAGGAVDAVMLELER 105
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
L + + L+YLH I+HRD+K N+L + +K+ADFGV+ +
Sbjct: 106 P-LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164
Query: 266 RDMTGETGTLGYMAPEVL-----DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320
+ GT +MAPEV+ +PY+ K DV+S GI L E+ + P+ +L+ V
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224
Query: 321 SAVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ + P S+ ++KC + N D R ++++
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 9e-64
Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 35/283 (12%)
Query: 87 LDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
L E+ G +G V G + DVA+K++ E + F +E V
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK----------EGSMSEDEFIEEAKVMMN 55
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L H + + G + ++ EY+ G L +L R R
Sbjct: 56 LSHEKLVQLYGVCTKQRPI--------------------FIITEYMANGCLLNYL-REMR 94
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR-VEAQN 264
+ + ++++ D+ + YL SK +HRD+ N L++ +K++DFG++R V
Sbjct: 95 HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154
Query: 265 PRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFTDVSSAV 323
G + + PEVL ++ K D+++FG+ +WEIY MPY + ++ + +
Sbjct: 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214
Query: 324 VRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
Q LR P + +IM CW D+RP ++ +
Sbjct: 215 A-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-63
Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 33/289 (11%)
Query: 82 IELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
I+ ++L EI G +G V+ G + + VA+K + E A F +E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR----------EGAMSEEDFIEEA 51
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
V KL HP + + G + + C+V E++ G L +
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPI--------------------CLVFEFMEHGCLSDY- 90
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+R +R A + ++ + LD+ G++YL ++HRD+ N L+ N+ +K++DFG+ R
Sbjct: 91 LRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150
Query: 261 EAQNPRDMT-GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
+ + G + + +PEV Y+ K DV+SFG+ +WE++ +
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+ R PR + + IM CW P+ RP +++ L +
Sbjct: 211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (516), Expect = 3e-63
Identities = 79/323 (24%), Positives = 133/323 (41%), Gaps = 61/323 (18%)
Query: 76 KTEEWEIELAKLDIRHEIARGTYGTVYRG-------AYDGQDVAVKILDWAEDGMVTSAE 128
K E ++ +I G +G V++ VAVK+L
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--------EEA 55
Query: 129 AAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVV 188
+A ++A F++E A+ + D+PN+ K +G + C++
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM--------------------CLLF 95
Query: 189 EYLPGGTLKKFLIRNKR----------------------KKLAFKVVIQIALDLARGLSY 226
EY+ G L +FL L+ + IA +A G++Y
Sbjct: 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 155
Query: 227 LHSKTIVHRDVKTENMLLDANRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLD 284
L + VHRD+ T N L+ N +KIADFG++R A + + + +M PE +
Sbjct: 156 LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215
Query: 285 GKPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASI 343
Y + DV+++G+ LWEI+ + PY ++ +V V N P CP L ++
Sbjct: 216 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNL 274
Query: 344 MRKCWDANPDKRPVMDEVVKLLE 366
MR CW P RP + ++L+
Sbjct: 275 MRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 5e-63
Identities = 66/277 (23%), Positives = 108/277 (38%), Gaps = 37/277 (13%)
Query: 92 EIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
EI G++G VY + + VA+K + + ++ +EV QKL HP
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMS------YSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N ++ G + +V+EY G L+ +K L
Sbjct: 76 NTIQYRGCYLREHTA--------------------WLVMEYCLGSAS--DLLEVHKKPLQ 113
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMT 269
+ + +GL+YLHS ++HRDVK N+LL +K+ DFG A + A
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN 169
Query: 270 GETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
GT +MAPEV+ Y+ K DV+S GI E+ P +++ + +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 327 NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ + C P RP + ++K
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-62
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 37/294 (12%)
Query: 82 IELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASF 136
I L + ++ G++G V RG +D VAVK L F
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK------PDVLSQPEAMDDF 58
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
+EV LDH N+ + G + + +V E P G+L
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVL---------------------TPPMKMVTELAPLGSL 97
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+R + + + A+ +A G+ YL SK +HRD+ N+LL +KI DFG
Sbjct: 98 LDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156
Query: 257 VARVEAQNPRDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYP 312
+ R QN + + APE L + ++ D + FG+ LWE++ P+
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
L+ + + + ++ R P CP + ++M +CW P+ RP + L
Sbjct: 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-62
Identities = 74/296 (25%), Positives = 133/296 (44%), Gaps = 36/296 (12%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIR 133
++EI+ ++++ I G +G V++G Y VA+K + + ++R
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--------NCTSDSVR 52
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F QE ++ DHP++ K IG +++E
Sbjct: 53 EKFLQEALTMRQFDHPHIVKLIGVIT---------------------ENPVWIIMELCTL 91
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
G L+ F ++ ++ L +I A L+ L+YL SK VHRD+ N+L+ +N +K+
Sbjct: 92 GELRSF-LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 150
Query: 254 DFGVAR-VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYP 312
DFG++R +E + + +MAPE ++ + + DV+ FG+C+WEI +
Sbjct: 151 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210
Query: 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
+ + R +P CP +L S+M KCW +P +RP E+ L +
Sbjct: 211 QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-62
Identities = 78/316 (24%), Positives = 128/316 (40%), Gaps = 55/316 (17%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRG-------AYDGQDVAVKILDWAEDGMVTSAEAA 130
+WE +L + G +G V + VAVK+L +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------L 67
Query: 131 AIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
R + E+ V L +H N+ +GA V+ E
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT--------------------LVITE 107
Query: 190 YLPGGTLKKFLIRNK----------------RKKLAFKVVIQIALDLARGLSYLHSKTIV 233
Y G L FL R + L + ++ + +A+G+++L SK +
Sbjct: 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167
Query: 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLDGKPYNRK 291
HRD+ N+LL R KI DFG+AR + + + +MAPE + Y +
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227
Query: 292 CDVYSFGICLWEIYCCDMP-YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDA 350
DV+S+GI LWE++ YP + ++++ R P P+ + IM+ CWDA
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287
Query: 351 NPDKRPVMDEVVKLLE 366
+P KRP ++V+L+E
Sbjct: 288 DPLKRPTFKQIVQLIE 303
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-61
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 92 EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHP 149
EI RG++ TVY+G +VA L + R F++E + + L HP
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQ-------DRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLA 209
N+ +F + T K + +V E + GTLK +L + K +
Sbjct: 69 NIVRFYDSWESTVKGK----------------KCIVLVTELMTSGTLKTYL--KRFKVMK 110
Query: 210 FKVVIQIALDLARGLSYLHSK--TIVHRDVKTENMLLDA-NRTLKIADFGVARVEAQNPR 266
KV+ + +GL +LH++ I+HRD+K +N+ + ++KI D G+A + +
Sbjct: 111 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRAS 168
Query: 267 DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQ 326
GT +MAPE+ + K Y+ DVY+FG+C+ E+ + PY + V
Sbjct: 169 FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
Query: 327 NLRP-DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++P + + I+ C N D+R + +++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 4e-61
Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 41/298 (13%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRA 134
EI+++ + I I G +G V G VA+K L S R
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK--------SGYTEKQRR 72
Query: 135 SFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG 194
F E ++ + DHPNV G +T + ++ E++ G
Sbjct: 73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPV--------------------MIITEFMENG 112
Query: 195 TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIAD 254
+L F +R + ++ + +A G+ YL VHRD+ N+L+++N K++D
Sbjct: 113 SLDSF-LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSD 171
Query: 255 FGVARVEAQNPRDMT-----GETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-D 308
FG++R + D T G + + APE + + + DV+S+GI +WE+ +
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 309 MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
PY D++ DV +A + Q+ R P CPS+L +M CW + + RP ++V L+
Sbjct: 232 RPYWDMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-61
Identities = 90/311 (28%), Positives = 139/311 (44%), Gaps = 41/311 (13%)
Query: 73 LPRKTEEWEIELAKLDIRHE--IARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVT 125
L + + I + L + I RG +G VY G AVK L+ D
Sbjct: 13 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---- 68
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185
+ F E + + HPNV +G + + +
Sbjct: 69 ----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-------------------SPL 105
Query: 186 VVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD 245
VV+ Y+ G L+ F IRN+ K +I L +A+G+ +L SK VHRD+ N +LD
Sbjct: 106 VVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164
Query: 246 ANRTLKIADFGVARV----EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301
T+K+ADFG+AR E + + TG + +MA E L + + K DV+SFG+ L
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224
Query: 302 WEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDE 360
WE+ PYPD++ D++ ++ Q R P CP L +M KCW + RP E
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283
Query: 361 VVKLLEAVNTS 371
+V + A+ ++
Sbjct: 284 LVSRISAIFST 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-60
Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 47/307 (15%)
Query: 78 EEWEIELAKLDIRHEIARGTYGTVYRG-------AYDGQDVAVKILDWAEDGMVTSAEAA 130
+EWE+ K+ + E+ +G++G VY G VA+K ++ A +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASM 64
Query: 131 AIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEY 190
R F E +V ++ + +V + +G V++E
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT--------------------LVIMEL 104
Query: 191 LPGGTLKKFLIRNKRK--------KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242
+ G LK +L + + +IQ+A ++A G++YL++ VHRD+ N
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164
Query: 243 LLDANRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGIC 300
++ + T+KI DFG+ R E R + +M+PE L + DV+SFG+
Sbjct: 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224
Query: 301 LWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMD 359
LWEI + PY LS V V+ D P CP L +MR CW NP RP
Sbjct: 225 LWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 283
Query: 360 EVVKLLE 366
E++ ++
Sbjct: 284 EIISSIK 290
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-60
Identities = 62/281 (22%), Positives = 117/281 (41%), Gaps = 35/281 (12%)
Query: 86 KLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
K +I +G GTVY GQ+VA++ ++ + + E+ V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVM 71
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
++ +PN+ ++ + + L VV+EYL GG+L +
Sbjct: 72 RENKNPNIVNYLDSYLVGDEL--------------------WVVMEYLAGGSLTDVVTET 111
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
+ + + + + L +LHS ++HRD+K++N+LL + ++K+ DFG
Sbjct: 112 CMDE---GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 264 NPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323
+ GT +MAPEV+ K Y K D++S GI E+ + PY + + +
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
Query: 324 VRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
P + + +C D + +KR E+++
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-59
Identities = 78/318 (24%), Positives = 126/318 (39%), Gaps = 50/318 (15%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRG-------AYDGQDVAVKILDWAEDGMVT 125
LP +WE +L + + RG +G V + VAVK+L
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-------E 53
Query: 126 SAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACC 185
A + RA + + H NV +GA P
Sbjct: 54 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-------------------PGGPLM 94
Query: 186 VVVEYLPGGTLKKFLIRNK--------------RKKLAFKVVIQIALDLARGLSYLHSKT 231
V+VE+ G L +L + + L + +I + +A+G+ +L S+
Sbjct: 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154
Query: 232 IVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLDGKPYN 289
+HRD+ N+LL +KI DFG+AR ++P + L +MAPE + + Y
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 290 RKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCW 348
+ DV+SFG+ LWEI+ PYP + + +++ R P + M CW
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 274
Query: 349 DANPDKRPVMDEVVKLLE 366
P +RP E+V+ L
Sbjct: 275 HGEPSQRPTFSELVEHLG 292
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-59
Identities = 72/282 (25%), Positives = 118/282 (41%), Gaps = 36/282 (12%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D+ + G YG V + VAVKI+D A + ++E+ + +
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKM 59
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+H NV KF G + +EY GG L +
Sbjct: 60 LNHENVVKFYGHRREGNIQ--------------------YLFLEYCSGGELFDRI--EPD 97
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ + L G+ YLH I HRD+K EN+LLD LKI+DFG+A V N
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157
Query: 266 RD--MTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
R+ + GTL Y+APE+L + ++ DV+S GI L + ++P+ S + +
Sbjct: 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
Query: 323 VVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++ + + S+ +++ K NP R + ++ K
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-59
Identities = 85/323 (26%), Positives = 139/323 (43%), Gaps = 57/323 (17%)
Query: 73 LPRKTEEWEIELAKLDIRHEIARGTYGTVYRG---------AYDGQDVAVKILDWAEDGM 123
LP WE+ +L + + G +G V VAVK+L
Sbjct: 2 LPED-PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK------ 54
Query: 124 VTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSR 182
S + E+ + + + H N+ +GA L
Sbjct: 55 --SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL------------------ 94
Query: 183 ACCVVVEYLPGGTLKKFL--------------IRNKRKKLAFKVVIQIALDLARGLSYLH 228
V+VEY G L+++L N ++L+ K ++ A +ARG+ YL
Sbjct: 95 --YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152
Query: 229 SKTIVHRDVKTENMLLDANRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLDGK 286
SK +HRD+ N+L+ + +KIADFG+AR + T + +MAPE L +
Sbjct: 153 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 287 PYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMR 345
Y + DV+SFG+ LWEI+ PYP + ++ ++++ R D P C + L +MR
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMR 271
Query: 346 KCWDANPDKRPVMDEVVKLLEAV 368
CW A P +RP ++V+ L+ +
Sbjct: 272 DCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 8e-59
Identities = 87/323 (26%), Positives = 134/323 (41%), Gaps = 67/323 (20%)
Query: 89 IRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH 148
++ I +G +G V+RG + G++VAVKI E+ E+ L H
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER----------SWFREAEIYQTVMLRH 56
Query: 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKL 208
N+ FI A D+ ++ +V +Y G+L +L R +
Sbjct: 57 ENILGFIAA----------------DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTV 97
Query: 209 AFKVVIQIALDLARGLSYLHS--------KTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+ +I++AL A GL++LH I HRD+K++N+L+ N T IAD G+A
Sbjct: 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157
Query: 261 EAQNPRDM----TGETGTLGYMAPEVLDGK------PYNRKCDVYSFGICLWEIYC---- 306
+ GT YMAPEVLD ++ D+Y+ G+ WEI
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
Query: 307 -----------CDMPYPDLSFTDVSSAVVRQNLRPDIPRC-----CPSSLASIMRKCWDA 350
D+ D S ++ V Q LRP+IP +A IMR+CW A
Sbjct: 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277
Query: 351 NPDKRPVMDEVVKLLEAVNTSKG 373
N R + K L ++ +G
Sbjct: 278 NGAARLTALRIKKTLSQLSQQEG 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 9e-59
Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 46/304 (15%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
++ + + I G +G V + DG + I + + F
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK------RMKEYASKDDHRDFAG 59
Query: 139 EVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLK 197
E+ V KL HPN+ +GA L + +EY P G L
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYL--------------------YLAIEYAPHGNLL 99
Query: 198 KFLIRN--------------KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243
FL ++ L+ + ++ A D+ARG+ YL K +HRD+ N+L
Sbjct: 100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159
Query: 244 LDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303
+ N KIADFG++R + + G + +MA E L+ Y DV+S+G+ LWE
Sbjct: 160 VGENYVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218
Query: 304 IYCCDM-PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362
I PY ++ ++ + Q R + P C + +MR+CW P +RP +++
Sbjct: 219 IVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
Query: 363 KLLE 366
L
Sbjct: 278 VSLN 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 192 bits (488), Expect = 2e-58
Identities = 58/311 (18%), Positives = 119/311 (38%), Gaps = 39/311 (12%)
Query: 59 EKHLSRVWSREREVLPRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKIL 116
+K +W + P + ++ + DI E+ G +G V+R G+ K +
Sbjct: 5 DKFYEDIWKKY-VPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI 62
Query: 117 DWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSH 176
+ + + + E+++ +L HP + A +
Sbjct: 63 N---------TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM------------ 101
Query: 177 NSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236
+++E+L GG L I + K++ VI GL ++H +IVH D
Sbjct: 102 --------VLILEFLSGGELFDR-IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 152
Query: 237 VKTENMLLDANR--TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDV 294
+K EN++ + + ++KI DFG+A + + T T + APE++D +P D+
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPVGFYTDM 211
Query: 295 YSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRP--DIPRCCPSSLASIMRKCWDANP 352
++ G+ + + P+ + V R + D ++ P
Sbjct: 212 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEP 271
Query: 353 DKRPVMDEVVK 363
KR + + ++
Sbjct: 272 RKRLTVHDALE 282
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-58
Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 38/296 (12%)
Query: 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQD------VAVKILDWAEDGMVTSAEAAAIR 133
EI + + + I G +G VY+G VA+K L + R
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--------AGYTEKQR 53
Query: 134 ASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG 193
F E + + H N+ + G + ++ EY+
Sbjct: 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPM--------------------MIITEYMEN 93
Query: 194 GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIA 253
G L KF +R K + + ++ + +A G+ YL + VHRD+ N+L+++N K++
Sbjct: 94 GALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 152
Query: 254 DFGVARVEAQNPRD---MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP 310
DFG++RV +P +G + + APE + + + DV+SFGI +WE+
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212
Query: 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
+ R P CPS++ +M +CW +RP ++V +L+
Sbjct: 213 PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 189 bits (480), Expect = 2e-57
Identities = 57/282 (20%), Positives = 110/282 (39%), Gaps = 37/282 (13%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
DI E+ G +G V+R G + A K + + + + R+E+
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFV---------MTPHESDKETVRKEIQTMSV 79
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L HP + A + ++ E++ GG L + + ++
Sbjct: 80 LRHPTLVNLHDAFEDDNEM--------------------VMIYEFMSGGELFE-KVADEH 118
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR--TLKIADFGVARVEAQ 263
K++ ++ + +GL ++H VH D+K EN++ R LK+ DFG+
Sbjct: 119 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLD 177
Query: 264 NPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAV 323
+ + TGT + APEV +GKP D++S G+ + + P+ + + V
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237
Query: 324 VRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ D +RK A+P+ R + + ++
Sbjct: 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-57
Identities = 63/328 (19%), Positives = 126/328 (38%), Gaps = 77/328 (23%)
Query: 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQ 138
E++ + E+ G G V++ ++ G +A K++ AIR +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIR 53
Query: 139 EVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKK 198
E+ V + + P + F GA + + +E++ GG+L +
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEI--------------------SICMEHMDGGSLDQ 93
Query: 199 FLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT-IVHRDVKTENMLLDANRTLKIADFGV 257
L K ++ +++ ++++ + +GL+YL K I+HRDVK N+L+++ +K+ DFGV
Sbjct: 94 VL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151
Query: 258 ARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPY------ 311
+ + GT YM+PE L G Y+ + D++S G+ L E+ P
Sbjct: 152 SGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 312 ------------------------------------PDLSFTDVSSAVVRQNLRPDIPRC 335
P ++ ++ +V +
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV 269
Query: 336 CPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ KC NP +R + +++
Sbjct: 270 FSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 8e-57
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 43/299 (14%)
Query: 74 PRK--TEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEA 129
PRK E+++ + G++ TV ++ A+KIL+
Sbjct: 2 PRKKRPEDFKFG-------KILGEGSFSTVVLARELATSREYAIKILE------KRHIIK 48
Query: 130 AAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVE 189
+E V +LDHP K L +
Sbjct: 49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL--------------------YFGLS 88
Query: 190 YLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRT 249
Y G L K++ + ++ L YLH K I+HRD+K EN+LL+ +
Sbjct: 89 YAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH 146
Query: 250 LKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC 307
++I DFG A+V + + GT Y++PE+L K + D+++ G ++++
Sbjct: 147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
Query: 308 DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
P+ + + ++ L D P ++ K + KR +E+
Sbjct: 207 LPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 185 bits (470), Expect = 1e-56
Identities = 61/287 (21%), Positives = 119/287 (41%), Gaps = 34/287 (11%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + + RG V R + ++ AVKI+D G ++ E +R + +EV + +K
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 146 L-DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK 204
+ HPN+ + T +V + + G L +L +
Sbjct: 66 VSGHPNIIQLKDTYETNTFF--------------------FLVFDLMKKGELFDYL--TE 103
Query: 205 RKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQN 264
+ L+ K +I L + LH IVHRD+K EN+LLD + +K+ DFG +
Sbjct: 104 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163
Query: 265 PRDMTGETGTLGYMAPEVLDG------KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318
+ + GT Y+APE+++ Y ++ D++S G+ ++ + P+
Sbjct: 164 EK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
Query: 319 VSSAVVRQNLRPDIPRC--CPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ ++ N + P ++ ++ + P KR +E +
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (461), Expect = 2e-55
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 32/289 (11%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
++ + G V+ +DVAVK+L A + FR+E
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLR------ADLARDPSFYLRFRREAQNAAA 63
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+HP + T +V+EY+ G TL+ + +
Sbjct: 64 LNHPAIVAVYDTGEAETPA----------------GPLPYIVMEYVDGVTLRDIV--HTE 105
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ K I++ D + L++ H I+HRDVK N+++ A +K+ DFG+AR A +
Sbjct: 106 GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165
Query: 266 RDMTGET---GTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
+T GT Y++PE G + + DVYS G L+E+ + P+ S V+
Sbjct: 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 225
Query: 323 VVRQNLRPDIPRC--CPSSLASIMRKCWDANPDKRP-VMDEVVKLLEAV 368
VR++ P R + L +++ K NP+ R E+ L V
Sbjct: 226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 5e-55
Identities = 62/283 (21%), Positives = 117/283 (41%), Gaps = 38/283 (13%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D R + G + V + VA+K + S E+AV K
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--------KKALEGKEGSMENEIAVLHK 63
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+ HPN+ +L ++++ + GG L ++ ++
Sbjct: 64 IKHPNIVALDDIYESGGHL--------------------YLIMQLVSGGELFDRIV--EK 101
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLL---DANRTLKIADFGVARVEA 262
+ ++ + + YLH IVHRD+K EN+L D + + I+DFG++++E
Sbjct: 102 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
++ GT GY+APEVL KPY++ D +S G+ + + C P+ D + +
Sbjct: 162 PGSV-LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
Query: 323 VVRQNLRPDIPRC--CPSSLASIMRKCWDANPDKRPVMDEVVK 363
+++ D P S +R + +P+KR ++ ++
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-55
Identities = 62/284 (21%), Positives = 126/284 (44%), Gaps = 32/284 (11%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ G +GTVY+G + +G+ V + + + A + E V
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI----KELREATSPKANKEILDEAYVMAS 67
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+D+P+V + +G + + ++ + +P G L ++ +K
Sbjct: 68 VDNPHVCRLLGICL---------------------TSTVQLITQLMPFGCLLDYVREHKD 106
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV--EAQ 263
+ ++ + +A+G++YL + +VHRD+ N+L+ + +KI DFG+A++ +
Sbjct: 107 NI-GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165
Query: 264 NPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFTDVSSA 322
G + +MA E + + Y + DV+S+G+ +WE+ PY + +++SS
Sbjct: 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS- 224
Query: 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLE 366
++ + R P C + IM KCW + D RP E++
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-54
Identities = 67/271 (24%), Positives = 111/271 (40%), Gaps = 31/271 (11%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + +G++G V+ + Q A+K L + + ++ +
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-----KDVVLMDDDVECTMVEKRVLSLA 59
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+HP +T NL V+EYL GG L +
Sbjct: 60 WEHPFLTHMFCTFQTKENL--------------------FFVMEYLNGGDLMYHI--QSC 97
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
K A ++ GL +LHSK IV+RD+K +N+LLD + +KIADFG+ +
Sbjct: 98 HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157
Query: 266 RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325
GT Y+APE+L G+ YN D +SFG+ L+E+ P+ ++ ++
Sbjct: 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217
Query: 326 QNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
N P PR ++ K + P+KR
Sbjct: 218 DN--PFYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-53
Identities = 45/284 (15%), Positives = 96/284 (33%), Gaps = 38/284 (13%)
Query: 86 KLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
K I ++ RG +G V+R + K + + ++E+++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----------QVLVKKEISIL 55
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
H N+ + L ++ E++ G + + I
Sbjct: 56 NIARHRNILHLHESFESMEEL--------------------VMIFEFISGLDIFER-INT 94
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR--TLKIADFGVARVE 261
+L + ++ + L +LHS I H D++ EN++ R T+KI +FG AR +
Sbjct: 95 SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-Q 153
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ + Y APEV + D++S G ++ + P+ + +
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
Query: 322 AVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++ D + + + R E ++
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-53
Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 43/287 (14%)
Query: 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
+ G G V + + A+K+L R+EV + +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------------ARREVELHWRA 61
Query: 147 -DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
P++ + + L +V+E L GG L +
Sbjct: 62 SQCPHIVRIVDVYENL-----------YAGRKCL-----LIVMECLDGGELFSRIQDRGD 105
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA---NRTLKIADFGVARVEA 262
+ + +I + + YLHS I HRDVK EN+L + N LK+ DFG A+
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
+ T T Y+APEVL + Y++ CD++S G+ ++ + C P+ +S
Sbjct: 166 SHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 323 VVRQNLRPDI------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
+ + + ++R P +R + E +
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-52
Identities = 56/284 (19%), Positives = 112/284 (39%), Gaps = 34/284 (11%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
D E+ G + V + G A K + S+ R +EV++ ++
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKE 69
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
+ HPNV T++ +++E + GG L F ++
Sbjct: 70 IQHPNVITLHEVYENKTDV--------------------ILILELVAGGELFDF--LAEK 107
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLD----ANRTLKIADFGVARVE 261
+ L + + + G+ YLHS I H D+K EN++L +KI DFG+A +
Sbjct: 108 ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-K 166
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ GT ++APE+++ +P + D++S G+ + + P+ + + +
Sbjct: 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 322 AVVRQN--LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
V N + + +R+ +P KR + + ++
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (433), Expect = 3e-50
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ I RG +G VY A G+ A+K LD + + + + R +++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVST 63
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
D P + A L +++ + GG L L ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKL--------------------SFILDLMNGGDLHYHLSQHGV 103
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ A ++ GL ++H++ +V+RD+K N+LLD + ++I+D G+A ++
Sbjct: 104 FSE--ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161
Query: 266 RDMTGETGTLGYMAPEVL-DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324
+ GT GYMAPEVL G Y+ D +S G L+++ P+ D
Sbjct: 162 PHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219
Query: 325 R-QNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
+ ++P L S++ + ++R
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-49
Identities = 57/282 (20%), Positives = 104/282 (36%), Gaps = 40/282 (14%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ + G +G+VY G D VA+K ++ ++ EV + +K
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR---ISDWGELPNGTRVPMEVVLLKK 63
Query: 146 LD--HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
+ V + + + +++E I
Sbjct: 64 VSSGFSGVIRLLDWFERPDSF--------------------VLILERPEPVQDLFDFIT- 102
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANR-TLKIADFGVARVEA 262
+R L ++ + + + H+ ++HRD+K EN+L+D NR LK+ DFG +
Sbjct: 103 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-- 160
Query: 263 QNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
T GT Y PE + Y R V+S GI L+++ C D+P+
Sbjct: 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DE 214
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
++R + + S ++R C P RP +E+
Sbjct: 215 EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 1e-49
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 35/275 (12%)
Query: 84 LAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVA 141
L I + G++G V+ ++G+ A+K+L E
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK------KEIVVRLKQVEHTNDERL 56
Query: 142 VWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
+ + HP + + G + ++++Y+ GG L F +
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQI--------------------FMIMDYIEGGEL--FSL 94
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
K ++ V A ++ L YLHSK I++RD+K EN+LLD N +KI DFG A+
Sbjct: 95 LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-- 152
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
P GT Y+APEV+ KPYN+ D +SFGI ++E+ P+ D +
Sbjct: 153 -YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
Query: 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
++ P + ++ + + +R
Sbjct: 212 KILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 5e-49
Identities = 57/303 (18%), Positives = 104/303 (34%), Gaps = 50/303 (16%)
Query: 89 IRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
+ +I G++G +Y G G++VA+K+ E +++ +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMM 59
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
I + +V+E L L +
Sbjct: 60 QGGVGIPTIRWCGAEGDY-------------------NVMVMELLGPSLE--DLFNFCSR 98
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML---LDANRTLKIADFGVARV--- 260
K + K V+ +A + + Y+HSK +HRDVK +N L + I DFG+A+
Sbjct: 99 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158
Query: 261 ----EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
+ R+ TGT Y + G +R+ D+ S G L +P+ L
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218
Query: 317 TDVSSAVVRQNLR------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370
R + + + + PS A+ + C D +P + +L +
Sbjct: 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 371 SKG 373
+G
Sbjct: 279 RQG 281
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 162 bits (410), Expect = 9e-48
Identities = 50/300 (16%), Positives = 95/300 (31%), Gaps = 52/300 (17%)
Query: 89 IRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
+ I G++G ++ G + Q VA+K D R E ++ L
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----------APQLRDEYRTYKLL 57
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
+ +V++ L G + L+ +
Sbjct: 58 AGCTGIPNVYYFGQEGLH-------------------NVLVIDLL--GPSLEDLLDLCGR 96
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA-----NRTLKIADFGVARV- 260
K + K V A + + +H K++V+RD+K +N L+ + + DFG+ +
Sbjct: 97 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
Query: 261 ------EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314
+ R+ +GT YM+ G+ +R+ D+ + G +P+ L
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
Query: 315 SFTDVSSAVVR------QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368
R ++ P M + D P D + L V
Sbjct: 217 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-47
Identities = 68/277 (24%), Positives = 110/277 (39%), Gaps = 32/277 (11%)
Query: 82 IELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQE 139
+ + D + +GT+G V G+ A+KIL A A E
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTE 55
Query: 140 VAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKF 199
V Q HP +T A L C V+EY GG L
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRL--------------------CFVMEYANGGELFFH 95
Query: 200 LIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVAR 259
L R + + ++ L YLHS+ +V+RD+K EN++LD + +KI DFG+ +
Sbjct: 96 LSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
+ M GT Y+APEVL+ Y R D + G+ ++E+ C +P+ + +
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP 356
++ + PR S++ +P +R
Sbjct: 214 FELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRL 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-45
Identities = 71/307 (23%), Positives = 115/307 (37%), Gaps = 58/307 (18%)
Query: 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVW 143
KLD + G + TVY+ Q VA+K + S I + +E+ +
Sbjct: 2 KLDF---LGEGQFATVYKARDKNTNQIVAIKKIKLGHR----SEAKDGINRTALREIKLL 54
Query: 144 QKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN 203
Q+L HPN+ + A +N+ +V +++ +I++
Sbjct: 55 QELSHPNIIGLLDAFGHKSNI--------------------SLVFDFMETDLE--VIIKD 92
Query: 204 KRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQ 263
L + L +GL YLH I+HRD+K N+LLD N LK+ADFG+A+
Sbjct: 93 NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152
Query: 264 NPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
R T + T Y APE+L G + Y D+++ G L E+ P S D +
Sbjct: 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212
Query: 323 VVRQNLRP--------------------------DIPRCCPSSLASIMRKCWDANPDKRP 356
+ P I L +++ + NP R
Sbjct: 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
Query: 357 VMDEVVK 363
+ +K
Sbjct: 273 TATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-44
Identities = 67/306 (21%), Positives = 117/306 (38%), Gaps = 58/306 (18%)
Query: 88 DIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+I GTYG VY+ G+ VA+K + E + ++ +E+++ ++
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-------LDTETEGVPSTAIREISLLKE 57
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L+HPN+ K + + +V LKKF+ +
Sbjct: 58 LNHPNIVKLLDVIH---------------------TENKLYLVFEFLHQDLKKFMDASAL 96
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
+ ++ L +GL++ HS ++HRD+K +N+L++ +K+ADFG+AR
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 266 RDMTGETGTLGYMAPEVLDGKPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVV 324
R T E TL Y APE+L G Y D++S G E+ +P S D +
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 325 RQNLRPD---------------------------IPRCCPSSLASIMRKCWDANPDKRPV 357
R PD + S++ + +P+KR
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276
Query: 358 MDEVVK 363
+
Sbjct: 277 AKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-44
Identities = 68/307 (22%), Positives = 114/307 (37%), Gaps = 55/307 (17%)
Query: 88 DIRHEIARGTYGTVYRG---AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ 144
+ EI G YG V++ G+ VA+K + + S +EVAV +
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVAVLR 62
Query: 145 KL---DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLI 201
L +HPNV + + +D L +V E++ +L
Sbjct: 63 HLETFEHPNVVRLFDVC----------TVSRTDRETKL-----TLVFEHVDQDLTT-YLD 106
Query: 202 RNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVE 261
+ + + + + L RGL +LHS +VHRD+K +N+L+ ++ +K+ADFG+AR+
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166
Query: 262 AQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
+ + TL Y APEVL Y D++S G E++ + S D
Sbjct: 167 SFQMALTS-VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225
Query: 322 AVVRQNLRPD-------------------------IPRCCPSSLASIMRKCWDANPDKRP 356
++ P ++ KC NP KR
Sbjct: 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
Query: 357 VMDEVVK 363
+
Sbjct: 286 SAYSALS 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 1e-42
Identities = 63/303 (20%), Positives = 116/303 (38%), Gaps = 38/303 (12%)
Query: 59 EKHLSRVWSREREVLPRKTEEWEIELAKLD---IRHEIARGTYGTVYRGAY--DGQDVAV 113
++ + ++ +E +K E A+LD + G++G V + G A+
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 114 KILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATS 173
KILD E + Q ++ P + K + +NL
Sbjct: 72 KILD------KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL--------- 116
Query: 174 DSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233
+V+EY+ GG + L R R + A + YLHS ++
Sbjct: 117 -----------YMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCD 293
+RD+K EN+L+D +++ DFG A+ + G +APE++ K YN+ D
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILSKGYNKAVD 220
Query: 294 VYSFGICLWEIYCCDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPD 353
++ G+ ++E+ P+ + +V + P S L ++R +
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 354 KRP 356
KR
Sbjct: 279 KRF 281
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (373), Expect = 2e-42
Identities = 70/309 (22%), Positives = 117/309 (37%), Gaps = 58/309 (18%)
Query: 84 LAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAV 142
+ K +I GTYG VY+ G+ A+K + E I ++ +E+++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-------LEKEDEGIPSTTIREISI 53
Query: 143 WQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR 202
++L H N+ K L +V E+L L+
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRL--------------------VLVFEHLDQDLK--KLLD 91
Query: 203 NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEA 262
L L L G++Y H + ++HRD+K +N+L++ LKIADFG+AR
Sbjct: 92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151
Query: 263 QNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321
R T E TL Y AP+VL G K Y+ D++S G E+ +P +S D
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211
Query: 322 AVVRQNLRPD---------------------------IPRCCPSSLASIMRKCWDANPDK 354
+ R P+ + S ++ K +P++
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
Query: 355 RPVMDEVVK 363
R + ++
Sbjct: 272 RITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-42
Identities = 64/310 (20%), Positives = 107/310 (34%), Gaps = 62/310 (20%)
Query: 89 IRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
I G YG V + VA+K + E +E+ + +
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--------QTYCQRTLREIKILLRF 63
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
H N+ ++ +V +L G L K L K +
Sbjct: 64 RHENIIGINDIIR----------------APTIEQMKDVYLVTHLMGADLYKLL---KTQ 104
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR 266
L+ + + RGL Y+HS ++HRD+K N+LL+ LKI DFG+ARV +
Sbjct: 105 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164
Query: 267 DMTGET---GTLGYMAPEVL-DGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322
T T Y APE++ + K Y + D++S G L E+ +P + D +
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224
Query: 323 VVRQNLRPD-----------------------------IPRCCPSSLASIMRKCWDANPD 353
++ P + S ++ K NP
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284
Query: 354 KRPVMDEVVK 363
KR +++ +
Sbjct: 285 KRIEVEQALA 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-41
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 58/318 (18%)
Query: 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEV 140
E++K + +I +GT+G V++ + GQ VA+K + E + +E+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-------MENEKEGFPITALREI 60
Query: 141 AVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL 200
+ Q L H NV I T S + + +V ++ L
Sbjct: 61 KILQLLKHENVVNLIEICR------------TKASPYNRCKGSIYLVFDFCEHDLA--GL 106
Query: 201 IRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARV 260
+ N K + ++ L GL Y+H I+HRD+K N+L+ + LK+ADFG+AR
Sbjct: 107 LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166
Query: 261 ----EAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
+ P T TL Y PE+L G + Y D++ G + E++ +
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226
Query: 316 FTDVSSAVVRQNLRPD------------------------------IPRCCPSSLASIMR 345
+ + + ++
Sbjct: 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286
Query: 346 KCWDANPDKRPVMDEVVK 363
K +P +R D+ +
Sbjct: 287 KLLVLDPAQRIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-40
Identities = 61/286 (21%), Positives = 120/286 (41%), Gaps = 38/286 (13%)
Query: 82 IELAKLDIRHEIARGTYGTVYRG-----AYDGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
+ + ++ + G YG V+ G+ A+K+L A T + A
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA-----TIVQKAKTTEHT 75
Query: 137 RQEVAVWQKLDH-PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGT 195
R E V + + P + A T L ++++Y+ GG
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKL--------------------HLILDYINGGE 115
Query: 196 LKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADF 255
L L ++R++ V ++ L +LH I++RD+K EN+LLD+N + + DF
Sbjct: 116 LFTHL--SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 173
Query: 256 GVA-RVEAQNPRDMTGETGTLGYMAPEVLDGKP--YNRKCDVYSFGICLWEIYCCDMPYP 312
G++ A GT+ YMAP+++ G +++ D +S G+ ++E+ P+
Sbjct: 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
Query: 313 DLSFTDVSSAVVRQNLR--PDIPRCCPSSLASIMRKCWDANPDKRP 356
+ + + R+ L+ P P+ + ++++ +P KR
Sbjct: 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-39
Identities = 56/302 (18%), Positives = 99/302 (32%), Gaps = 58/302 (19%)
Query: 93 IARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150
I G++G VY+ G+ VA+K + + +E+ + +KLDH N
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVL-------------QDKRFKNRELQIMRKLDHCN 74
Query: 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFL-IRNKRKKLA 209
+ + S +V++Y+P + ++ L
Sbjct: 75 IVRLRYFFY--------------SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 210 FKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDAN-RTLKIADFGVARVEAQNPRDM 268
V L R L+Y+HS I HRD+K +N+LLD + LK+ DFG A+ + ++
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 269 TGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR--- 325
+ + Y DV+S G L E+ +P S D +++
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240
Query: 326 ------------------------QNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEV 361
P ++ + + P R E
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 362 VK 363
Sbjct: 301 CA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-38
Identities = 62/317 (19%), Positives = 110/317 (34%), Gaps = 61/317 (19%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
WE+ A + G YG V G VA+K L ++
Sbjct: 13 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRA 64
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
+E+ + + + H NV + L + +V+ ++
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTD--------------FYLVMPFMGTDLG 110
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
K K +KL + + + +GL Y+H+ I+HRD+K N+ ++ + LKI DFG
Sbjct: 111 K----LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
+AR Q +MTG T Y APEV L+ Y + D++S G + E+ +
Sbjct: 167 LAR---QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223
Query: 316 FTDVSSAVVRQNLRP-----------------------------DIPRCCPSSLASIMRK 346
D +++ P I +++ K
Sbjct: 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 283
Query: 347 CWDANPDKRPVMDEVVK 363
+ ++R E +
Sbjct: 284 MLVLDAEQRVTAGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-37
Identities = 65/307 (21%), Positives = 118/307 (38%), Gaps = 60/307 (19%)
Query: 88 DIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQK 145
+ +I GTYGTV++ + VA+K + +D + +S +E+ + ++
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLLKE 57
Query: 146 LDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR 205
L H N+ + +V E+ K F N
Sbjct: 58 LKHKNIVRLHDVLHSDKK--------------------LTLVFEFCDQDLKKYFDSCNGD 97
Query: 206 KKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP 265
++V L +GL + HS+ ++HRD+K +N+L++ N LK+A+FG+AR
Sbjct: 98 LDP--EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
Query: 266 RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMP-YPDLSFTDVSSAV 323
R + E TL Y P+VL G K Y+ D++S G E+ P +P D +
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215
Query: 324 VRQNLRP---------------------------DIPRCCPSSLASIMRKCWDANPDKRP 356
R P ++ ++ +++ NP +R
Sbjct: 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
Query: 357 VMDEVVK 363
+E ++
Sbjct: 276 SAEEALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 1e-34
Identities = 57/348 (16%), Positives = 113/348 (32%), Gaps = 83/348 (23%)
Query: 63 SRVWSREREVLPRK---TEEWEIELAKLD---IRHEIARGTYGTVYRG--AYDGQDVAVK 114
+RV++ PR+ E +E D + ++ RG Y V+ + + V VK
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66
Query: 115 ILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMGTTNLKIPSQSATS 173
IL + + ++E+ + + L PN+ +
Sbjct: 67 ILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP------- 107
Query: 174 DSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233
+V E++ K+ + L + ++ + L Y HS I+
Sbjct: 108 -----------ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 234 HRDVKTENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRK 291
HRDVK N+++D +R L++ D+G+A ++ + + PE+L + Y+
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYS 210
Query: 292 CDVYSFGICLWEIYCCDMPYP--------------------------------DLSFTDV 319
D++S G L + P+ D F D+
Sbjct: 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270
Query: 320 SSAVVRQNLR----PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363
R+ + + K + R E ++
Sbjct: 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-34
Identities = 69/317 (21%), Positives = 112/317 (35%), Gaps = 61/317 (19%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
WE+ + + G YG+V G VAVK L ++
Sbjct: 13 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRT 64
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
+E+ + + + H NV + SL +V +L G L
Sbjct: 65 YRELRLLKHMKHENVIGLLDVF---------------TPARSLEEFNDVYLVTHLMGADL 109
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
K +KL V + + RGL Y+HS I+HRD+K N+ ++ + LKI DFG
Sbjct: 110 NNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEV-LDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315
+AR +MTG T Y APE+ L+ YN+ D++S G + E+ +P
Sbjct: 167 LAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223
Query: 316 FTDVSSAVVRQNLRP-----------------------------DIPRCCPSSLASIMRK 346
D ++R P ++ ++ K
Sbjct: 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283
Query: 347 CWDANPDKRPVMDEVVK 363
+ DKR + +
Sbjct: 284 MLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 60/327 (18%), Positives = 118/327 (36%), Gaps = 70/327 (21%)
Query: 79 EWEIELAKLDIRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASF 136
+ + L + I G G V A ++VA+K L +
Sbjct: 12 TFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRA 63
Query: 137 RQEVAVWQKLDHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196
+E+ + + ++H N+ + L+ +V+E +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD--------------VYLVMELMDANLC 109
Query: 197 KKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFG 256
+ + +++++ + + G+ +LHS I+HRD+K N+++ ++ TLKI DFG
Sbjct: 110 QVIQMELDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164
Query: 257 VARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316
+AR + MT T Y APEV+ G Y D++S G + E+ + +P +
Sbjct: 165 LARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 317 TDVSSAVVRQNLRP----------------------------------------DIPRCC 336
D + V+ Q P + +
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283
Query: 337 PSSLASIMRKCWDANPDKRPVMDEVVK 363
S ++ K +P KR +D+ ++
Sbjct: 284 ASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 5e-27
Identities = 62/321 (19%), Positives = 118/321 (36%), Gaps = 36/321 (11%)
Query: 89 IRHEIARGTYGTVYRG--AYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL 146
+ ++ G + TV+ + VA+KI+ + E+ + Q++
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR----------GDKVYTEAAEDEIKLLQRV 66
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
+ + TK + ++ P+ V+V + G L + + + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHF------NHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120
Query: 207 KLAFKVVIQIALDLARGLSYLHSKT-IVHRDVKTENMLLDANRT------LKIADFGVAR 259
+ V QI+ L GL Y+H + I+H D+K EN+L++ + +KIAD G A
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 260 VEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319
++ + T Y +PEVL G P+ D++S ++E+ D +
Sbjct: 181 WYDEHYTNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 320 SSAVVRQNLRPDIPRCCPSSL---ASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGM 376
+ ++ PS L R +++ R + LE V T K
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297
Query: 377 IPEDQA-----HGCLCFIPTR 392
E + L P +
Sbjct: 298 KDEAKEISDFLSPMLQLDPRK 318
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 7e-17
Identities = 29/220 (13%), Positives = 60/220 (27%), Gaps = 51/220 (23%)
Query: 89 IRHEIARGTYGTVYRG-AYDGQDVAVKILDWAEDGMVTSAEAAAIR-ASFRQEVAVWQKL 146
I + G V+ + + VK E F +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 147 DHPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRK 206
+ + K G ++ V++E + L + + N
Sbjct: 64 EFRALQKLQGLAV----------------PKVYAWEGNAVLMELIDAKELYRVRVENPD- 106
Query: 207 KLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR 266
++ + ++ + + IVH D+ N+L+ + I DF + VE
Sbjct: 107 --------EVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS-VEVGEE- 155
Query: 267 DMTGETGTLGYMAPEVLD----------GKPYNRKCDVYS 296
E+L+ + Y + D+ S
Sbjct: 156 -----------GWREILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.75 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-60 Score=441.07 Aligned_cols=263 Identities=29% Similarity=0.622 Sum_probs=229.6
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
...+|++..++|++.+.||+|+||+||+|++ +|+.||||+++..... .+.|.+|+.+|++++|||||+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----------HHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----------HHHHHHHHHHHHhCCCCCEec
Confidence 4567999999999999999999999999998 6889999998743321 256889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
++++|.+.+.+ |+||||+++|+|.+++.......+++..++.|+.||+.||+|||++||+
T Consensus 78 ~~~~~~~~~~~--------------------~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ii 137 (287)
T d1opja_ 78 LLGVCTREPPF--------------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 137 (287)
T ss_dssp EEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCccEeeCCee--------------------EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999876665 8999999999999999877677899999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCCC-CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCC-C
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMP-Y 311 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~P-f 311 (394)
||||||+|||++.++.+||+|||+++....... ......|++.|+|||.+.+..|+.++|||||||++|||++|..| |
T Consensus 138 HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999986543322 23334688999999999999999999999999999999997655 4
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
...+...+. ..+..+.+++.+..+|+++.+||.+||+.||++|||++++++.|+.+.
T Consensus 218 ~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 218 PGIDLSQVY-ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TTCCHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchHHHHH-HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 555555544 455667788888999999999999999999999999999999998875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-60 Score=436.12 Aligned_cols=267 Identities=29% Similarity=0.566 Sum_probs=230.7
Q ss_pred CCCCcccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcce
Q 048724 74 PRKTEEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVT 152 (394)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 152 (394)
|...++|+|..++|++.+.||+|+||+||+|++ +++.||||+++..... .+.|.+|+.++++++|||||
T Consensus 2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----------~~~~~~E~~~l~~l~HpnIv 71 (272)
T d1qpca_ 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLV 71 (272)
T ss_dssp CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----------HHHHHHHHHHHHhCCCCCEe
Confidence 344578999999999999999999999999999 5678999999743321 25688999999999999999
Q ss_pred eeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048724 153 KFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTI 232 (394)
Q Consensus 153 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~i 232 (394)
+++|++.+. . +|+||||+++|+|.+++.......+++..++.|+.||+.||.|||+++|
T Consensus 72 ~~~g~~~~~-~--------------------~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~i 130 (272)
T d1qpca_ 72 RLYAVVTQE-P--------------------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130 (272)
T ss_dssp CEEEEECSS-S--------------------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEeeeccC-C--------------------eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 999987542 2 2899999999999998876555679999999999999999999999999
Q ss_pred cccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC-CCC
Q 048724 233 VHRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMP 310 (394)
Q Consensus 233 iH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~P 310 (394)
+||||||+||||+.++.+||+|||+|+...... .......||+.|+|||.+.+..++.++|||||||++|||+|| .+|
T Consensus 131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 999999999999999999999999998654332 233446789999999999988999999999999999999995 566
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
|...+..+....+ ..+.++..|..+|+++.+|+.+||+.||++|||+++|++.|+++.++.
T Consensus 211 ~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 211 YPGMTNPEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp STTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHH-HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 6666666666555 556677788899999999999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-60 Score=435.33 Aligned_cols=263 Identities=33% Similarity=0.633 Sum_probs=219.2
Q ss_pred ccccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
+|++..++|++.+.||+|+||+||+|++.+ .||||+++...... ...+.|.+|+.+|++++|||||++++++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP-------QQLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT-------THHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH-------HHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 699999999999999999999999998765 59999997543221 1136788999999999999999999987
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVK 238 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlk 238 (394)
.+. . +|+|||||++|+|.+++... ...+++..+..|+.||+.||+|||++||||||||
T Consensus 74 ~~~-~--------------------~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlK 131 (276)
T d1uwha_ 74 TAP-Q--------------------LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131 (276)
T ss_dssp CSS-S--------------------CEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred ecc-E--------------------EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccC
Confidence 532 2 38999999999999999654 3569999999999999999999999999999999
Q ss_pred CCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCC
Q 048724 239 TENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYPD 313 (394)
Q Consensus 239 p~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf~~ 313 (394)
|+|||++.++.+||+|||+|+...... .......||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+
T Consensus 132 p~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp GGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 999999999999999999997643321 23344679999999999964 3589999999999999999999999998
Q ss_pred CChhhHHHHHHhccCC-C---CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 314 LSFTDVSSAVVRQNLR-P---DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 314 ~~~~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
.+...........+.. + ..+..+|+++.+||.+||+.||++|||+++|++.|+.+..+
T Consensus 212 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 212 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 7766555555444433 2 24567899999999999999999999999999999999754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-59 Score=427.01 Aligned_cols=249 Identities=29% Similarity=0.512 Sum_probs=219.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++.+.||+|+||+||+|++ +|+.||+|+++... .........+.+|+.++++++|||||++++++.+.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH------ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 57899999999999999999998 68899999987422 12222356788999999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+|||||++|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 79 ~~~--------------------~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~N 136 (263)
T d2j4za1 79 TRV--------------------YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136 (263)
T ss_dssp SEE--------------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CEE--------------------EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccc
Confidence 665 8999999999999999654 469999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||+|+..... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+...
T Consensus 137 ill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 214 (263)
T d2j4za1 137 LLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214 (263)
T ss_dssp EEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999999754432 2334689999999999999999999999999999999999999999988888877
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+... ...+|..+|+++++||.+||+.||++|||++|+++.
T Consensus 215 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 215 RISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 76554 445777899999999999999999999999999973
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-59 Score=425.00 Aligned_cols=258 Identities=28% Similarity=0.605 Sum_probs=215.7
Q ss_pred cccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
|+.++|++.+.||+|+||+||+|.+ +++.||||+++..... .+.|.+|+.++++++|||||+++|+|..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----------HHHHHHHHHHHHhcCCCCcccccceecc
Confidence 4567899999999999999999999 6788999998743321 2568899999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |+||||+++|+|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+
T Consensus 72 ~~~~--------------------~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~ 130 (263)
T d1sm2a_ 72 QAPI--------------------CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 130 (263)
T ss_dssp SSSC--------------------EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGG
T ss_pred CCce--------------------EEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchh
Confidence 6665 8999999999999998654 356899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~ 318 (394)
|||++.++.+||+|||+++...... .......||+.|+|||.+.+..|+.++|||||||++|||+| |.+||...+..+
T Consensus 131 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 131 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp GEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred heeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999998654332 22334578999999999999999999999999999999999 577777777777
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
+...+ ..+.++..|..+++++.+|+.+||+.||++|||+++|++.|+++..+
T Consensus 211 ~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 211 VVEDI-STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHH-HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH-HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 77665 44567778888999999999999999999999999999999999765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=428.82 Aligned_cols=247 Identities=25% Similarity=0.451 Sum_probs=217.9
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|++ +|+.||||+++...... .+.+.+|+.++++++|||||+++++|.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---------HHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 4799999999999999999987 68999999997544221 256789999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+|||||+||+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 91 ~~--------------------~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 147 (293)
T d1yhwa1 91 EL--------------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (293)
T ss_dssp EE--------------------EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EE--------------------EEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHe
Confidence 65 899999999999998754 3599999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSA 322 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~ 322 (394)
|++.++.+||+|||+++............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....
T Consensus 148 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 227 (293)
T d1yhwa1 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (293)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred EECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 99999999999999998765444445567899999999999999999999999999999999999999998887776666
Q ss_pred HHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 323 VVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 323 ~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+.... .....+..+|+++++||.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 65443 344556778999999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-59 Score=428.71 Aligned_cols=254 Identities=26% Similarity=0.490 Sum_probs=208.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++.... .. ...+.+.+|+.++++++|||||++++++.+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TE----AEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---CH----HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---CH----HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence 47899999999999999999988 688999999975432 11 1246788999999999999999999998754
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ccc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--KRKKLAFKVVIQIALDLARGLSYLHSKT-----IVH 234 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----iiH 234 (394)
.. ..+|+|||||+||+|.+++.+. ....+++..++.++.||+.||+|||++| |+|
T Consensus 76 ~~------------------~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiH 137 (269)
T d2java1 76 TN------------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137 (269)
T ss_dssp ---------------------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-------
T ss_pred CC------------------CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEe
Confidence 33 2248999999999999999753 3457999999999999999999999876 999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||||+|||++.++.+||+|||+++.............||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 138 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp --CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999987655444445578999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+..++...+..... ..++..+|+++.+||.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 218 SQKELAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SHHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 88888877765543 4567789999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=436.33 Aligned_cols=261 Identities=28% Similarity=0.515 Sum_probs=225.3
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC--C-----eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCC
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD--G-----QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHP 149 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~ 149 (394)
..|++..++|++.++||+|+||+||+|++. + ..||+|++..... ......+.+|+.+++++ +||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~Hp 101 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------SSEREALMSELKMMTQLGSHE 101 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCT
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--------HHHHHHHHHHHHHHHHhcCCC
Confidence 359999999999999999999999999872 2 2699998863321 12246788999999998 899
Q ss_pred cceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhccc---------------------CCC
Q 048724 150 NVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKR---------------------KKL 208 (394)
Q Consensus 150 nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~---------------------~~l 208 (394)
|||+++++|.+.+.+ |+|||||++|+|.++|..+.. ..+
T Consensus 102 nIv~l~~~~~~~~~~--------------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 161 (325)
T d1rjba_ 102 NIVNLLGACTLSGPI--------------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161 (325)
T ss_dssp TBCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred cEeEEEEEEeeCCeE--------------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCC
Confidence 999999999877665 899999999999999975432 358
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCC--ccCCCCCCCcCCccccCCC
Q 048724 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLDGK 286 (394)
Q Consensus 209 ~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 286 (394)
++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+........ .....||+.|+|||++.+.
T Consensus 162 ~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 241 (325)
T d1rjba_ 162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC
Confidence 99999999999999999999999999999999999999999999999999864433221 2235679999999999999
Q ss_pred CCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 287 PYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 287 ~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.|+.++|||||||++|||+| |..||.+.+.......++..+.+++.|..+|+++.+||.+||+.||++|||+++|++.|
T Consensus 242 ~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999997 89999988877777788888888889999999999999999999999999999999998
Q ss_pred H
Q 048724 366 E 366 (394)
Q Consensus 366 ~ 366 (394)
.
T Consensus 322 ~ 322 (325)
T d1rjba_ 322 G 322 (325)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-58 Score=421.00 Aligned_cols=258 Identities=30% Similarity=0.631 Sum_probs=223.4
Q ss_pred cccccccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
|++..++|++.+.||+|+||+||+|+++|+.||||+++.... .+.|.+|++++++++|||||+++|+|.
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~-----------~~~~~~E~~~l~~l~HpnIv~~~g~~~ 70 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIV 70 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 999999999999999999999999999999999999974321 256889999999999999999999986
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+.+. .+|+||||+++|+|.+++..+....+++..++.|+.||+.||.|||+++++||||||
T Consensus 71 ~~~~-------------------~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp 131 (262)
T d1byga_ 71 EEKG-------------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131 (262)
T ss_dssp CC---------------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred ecCC-------------------cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccch
Confidence 5322 138999999999999999776556799999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhh
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTD 318 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~ 318 (394)
+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+..++.++|||||||++|||+| |++||...+..+
T Consensus 132 ~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 132 RNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp GGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred HhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999999854322 233578899999999998999999999999999999998 799999888888
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
+...+ ..+.+++++..+++++.+||.+||+.||++|||+.+++++|+++++.
T Consensus 209 ~~~~i-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 209 VVPRV-EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHH-TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH-HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 77665 55678888999999999999999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-58 Score=424.15 Aligned_cols=272 Identities=30% Similarity=0.533 Sum_probs=226.9
Q ss_pred CCCcccccccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 75 RKTEEWEIELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
....+|+|..++|++.+.||+|+||+||+|++ +++.||||+++..... .+.|.+|+.++++++|||||+
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----------~~~~~~E~~~l~~l~h~nIv~ 76 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQ 76 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----------HHHHHHHHHHHHhcccCCEeE
Confidence 34568999999999999999999999999999 5568999999744321 256889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
++|+|.+. .+ ++||||+++|+|..++.......+++.+++.|+.||+.||+|||++||+
T Consensus 77 ~~g~~~~~-~~--------------------~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~iv 135 (285)
T d1fmka3 77 LYAVVSEE-PI--------------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 135 (285)
T ss_dssp EEEEECSS-SC--------------------EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEecC-Ce--------------------EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhee
Confidence 99998542 23 8999999999999998776666799999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhC-CCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCC-DMPY 311 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~Pf 311 (394)
||||||+||||+.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++| .+|+
T Consensus 136 H~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 99999999999999999999999998643322 223346789999999999999999999999999999999996 5555
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhccCCCCCC
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSKGGGMIP 378 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~~~~~~~ 378 (394)
......+....+ ..+.+.+.+..+|.++.+||.+||+.||++|||+++|+++|+.+.++......|
T Consensus 216 ~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 216 PGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp TTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CCCCHHHHHHHH-HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 666666666554 456677788899999999999999999999999999999999988765544443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-58 Score=425.75 Aligned_cols=261 Identities=29% Similarity=0.580 Sum_probs=214.2
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCe---eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQ---DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFI 155 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 155 (394)
++..++|++.+.||+|+||+||+|.+ +++ .||||.+..... ....+.|.+|+.+|++++|||||+++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~ 93 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--------EKQRRDFLSEASIMGQFDHPNVIHLE 93 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--------HHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 46678899999999999999999987 333 588888753221 12246788999999999999999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
|+|.+.+.+ |+|||||++|+|.+++... ...+++.+++.|+.||+.||.|||+++++||
T Consensus 94 g~~~~~~~~--------------------~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHr 152 (299)
T d1jpaa_ 94 GVVTKSTPV--------------------MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 152 (299)
T ss_dssp EEECSSSSC--------------------EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeCCEE--------------------EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccC
Confidence 999876665 8999999999999988653 3569999999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCCCC-----CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQNPR-----DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..
T Consensus 153 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~ 232 (299)
T d1jpaa_ 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232 (299)
T ss_dssp CCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence 9999999999999999999999986443221 1122457899999999999999999999999999999998 899
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
||.+.+..++...+ ..+.+++.+..+|.++.+||.+||+.||++|||+.+|++.|+++..+
T Consensus 233 Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 233 PYWDMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 99998888877665 45566777888999999999999999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=415.37 Aligned_cols=254 Identities=26% Similarity=0.536 Sum_probs=223.5
Q ss_pred ccccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+.++|++.++||+|+||+||+|++ +++.||||+++..... .+.|.+|+.++++++|||||+++|+|.+.
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----------HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----------HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 457899999999999999999999 6779999999854321 25688999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ ++||||+++|+|.+++... ...+++..+++++.|+++||.|||++||+||||||+|
T Consensus 72 ~~~--------------------~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~N 130 (258)
T d1k2pa_ 72 RPI--------------------FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130 (258)
T ss_dssp SSE--------------------EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGG
T ss_pred Cce--------------------EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCccccccccee
Confidence 655 8999999999999987654 3568999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~ 319 (394)
||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..++
T Consensus 131 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 131 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp EEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred EEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH
Confidence 999999999999999997544332 23334678999999999999999999999999999999998 8999999998888
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
...+. .+.+...|..++.++.+||.+||+.||++|||++++++.|.+|
T Consensus 211 ~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 211 AEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHH-hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 87664 5567788889999999999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=421.24 Aligned_cols=262 Identities=27% Similarity=0.518 Sum_probs=223.5
Q ss_pred ccccccccccceee-eccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 79 EWEIELAKLDIRHE-IARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 79 ~~~~~~~~~~~~~~-lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
+|.+..++|.+... ||+|+||+||+|.+ ++..||||+++.... ....+.|.+|+.+|++++|||||+
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~ 73 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KADTEEMMREAQIMHQLDNPYIVR 73 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 35667788888885 99999999999976 345799999974321 112467889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
++|++.+. . +|+||||+++|+|.+++... +..+++..++.|+.||+.||+|||++||+
T Consensus 74 l~g~~~~~-~--------------------~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~ii 131 (285)
T d1u59a_ 74 LIGVCQAE-A--------------------LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFV 131 (285)
T ss_dssp EEEEEESS-S--------------------EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EeeeeccC-e--------------------EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99998642 2 38999999999999998543 35799999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDM 309 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~ 309 (394)
||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||+| |..
T Consensus 132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence 99999999999999999999999998654322 12233568999999999998899999999999999999998 899
Q ss_pred CCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 310 PYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 310 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
||.+.+..++...+ ..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus 212 Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 212 PYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTTTCCTHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99998877777655 45667788889999999999999999999999999999999987653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-58 Score=425.33 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=215.7
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+.|++.+.||+|+||+||+|++ +|+.||||+++...... .+.+.+|+.+|++++|||||++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---------LEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---------GGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4689999999999999999998 68899999997543221 256778999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+|||||+||+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 83 ~~--------------------~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NI 141 (288)
T d2jfla1 83 NL--------------------WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141 (288)
T ss_dssp EE--------------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred eE--------------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhe
Confidence 65 8999999999999988654 35699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-----GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
|++.++.+||+|||+|+.............||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..
T Consensus 142 ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 142 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp EECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred eECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 999999999999999975433323334568999999999984 456899999999999999999999999998888
Q ss_pred hHHHHHHhccC-CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 318 DVSSAVVRQNL-RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 318 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
+....+..... ....+..+|+++.+||.+||+.||++|||++|+++
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 88877766543 23445678999999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=425.42 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=216.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++... .........+.+|+.++++++|||||+++++|.+.
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH------ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 47899999999999999999998 68899999997432 11122246788999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+|||||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|
T Consensus 81 ~~~--------------------~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~N 138 (288)
T d1uu3a_ 81 EKL--------------------YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138 (288)
T ss_dssp SEE--------------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CEE--------------------EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccc
Confidence 665 8999999999999998654 569999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||++.++.+||+|||+|+...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++
T Consensus 139 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 218 (288)
T d1uu3a_ 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218 (288)
T ss_dssp EEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence 999999999999999998654322 223446799999999999999999999999999999999999999999888888
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+.... ..+|..+++++++||.+||+.||++|||++|++..
T Consensus 219 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 219 FQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 87776553 45677899999999999999999999999997654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=422.95 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=208.6
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++.... ....+.+.+|+.+|++++|||||++++++.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--------chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 46899999999999999999998 688999999974321 11235678999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 76 ~~~--------------------~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~N 133 (271)
T d1nvra_ 76 NIQ--------------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 133 (271)
T ss_dssp TEE--------------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred cee--------------------EEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHH
Confidence 665 899999999999999843 4579999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
||++.++.+||+|||+|+...... ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 134 ILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred EEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999999998654322 22345689999999999988776 578999999999999999999997765544
Q ss_pred HHHHHHhc-cCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 319 VSSAVVRQ-NLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 319 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
........ .........+|+++.+||.+||+.||++|||++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 214 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33333332 2233334568999999999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=424.68 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=223.4
Q ss_pred cccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeec
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASM 159 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 159 (394)
|.+++|++++.||+|+||+||+|++ +|+.||||+++.... ........+.+|+.+|++++|||||+++++|.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc------cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 5678999999999999999999998 789999999974321 11122466788999999999999999999999
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+.+.+ |+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 76 ~~~~~--------------------~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP 133 (337)
T d1o6la_ 76 THDRL--------------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp CSSEE--------------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred ccccc--------------------ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCH
Confidence 87766 8999999999999998654 4699999999999999999999999999999999
Q ss_pred CceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 240 ENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 240 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
+|||++.+|.+||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++
T Consensus 134 ~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence 99999999999999999998655444455567899999999999999999999999999999999999999999998888
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
...+.... ..+|..+|+++++||.+||++||++||+ ++++++.
T Consensus 214 ~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 214 FELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 87776654 4577889999999999999999999994 8888873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=416.43 Aligned_cols=248 Identities=29% Similarity=0.538 Sum_probs=210.6
Q ss_pred eeeccCCceEEEEEEE----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 91 HEIARGTYGTVYRGAY----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 91 ~~lG~G~fg~Vy~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
++||+|+||+||+|.+ +++.||||+++... ......+.|.+|+.+|++++|||||+++|+|.+. .
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~--- 81 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-------NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-S--- 81 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-S---
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-C---
Confidence 4799999999999986 24679999986332 1223356789999999999999999999998642 2
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~ 246 (394)
.|+||||+++|+|.+++... ..+++..++.|+.||+.||+|||+++|+||||||+|||++.
T Consensus 82 -----------------~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~ 142 (277)
T d1xbba_ 82 -----------------WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 142 (277)
T ss_dssp -----------------EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred -----------------EEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc
Confidence 28999999999999998653 46999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 048724 247 NRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSA 322 (394)
Q Consensus 247 ~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~ 322 (394)
++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...
T Consensus 143 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~ 222 (277)
T d1xbba_ 143 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222 (277)
T ss_dssp TTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred cCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH
Confidence 99999999999986443222 1223578999999999999999999999999999999998 8999999888877765
Q ss_pred HHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 323 VVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 323 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
+ ..+.+++.|..+|+++.+||.+||+.||++|||+++|++.|+.+.
T Consensus 223 i-~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 223 L-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp H-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred H-HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 5 455677888899999999999999999999999999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=414.63 Aligned_cols=261 Identities=28% Similarity=0.565 Sum_probs=215.1
Q ss_pred ccccccccceeeeccCCceEEEEEEEC--C----eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAYD--G----QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKF 154 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 154 (394)
+|..+.|++.++||+|+||+||+|.+. + ..||||+++.... ......|.+|+.++++++|||||++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~E~~il~~l~H~nIv~~ 74 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--------EKQRVDFLGEAGIMGQFSHHNIIRL 74 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--------hHHHHHHHHHHHHHHhcCCCCEeee
Confidence 466788999999999999999999873 2 3699999864321 1123568899999999999999999
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVH 234 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH 234 (394)
+|++.+...+ ++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+++|+|
T Consensus 75 ~g~~~~~~~~--------------------~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiH 133 (283)
T d1mqba_ 75 EGVISKYKPM--------------------MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133 (283)
T ss_dssp EEEECSSSSE--------------------EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eEEEecCCce--------------------EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccccccc
Confidence 9999876665 8999999999999987654 357999999999999999999999999999
Q ss_pred cCCCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCC-CC
Q 048724 235 RDVKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD-MP 310 (394)
Q Consensus 235 ~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~-~P 310 (394)
|||||+||||+.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 99999999999999999999999986433221 223356899999999999999999999999999999999964 55
Q ss_pred CCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 311 YPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 311 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
|...+..++... +..+.+++.+..++.++.+||.+||+.||++|||+.+|++.|+++...
T Consensus 214 ~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 214 YWELSNHEVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTTCCHHHHHHH-HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cccCCHHHHHHH-HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 555666666544 466677888889999999999999999999999999999999988754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-57 Score=414.64 Aligned_cols=261 Identities=30% Similarity=0.581 Sum_probs=215.4
Q ss_pred ccccccccccceeeeccCCceEEEEEEEC-----CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCccee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAYD-----GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTK 153 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 153 (394)
+|+|..++|++.+.||+|+||+||+|++. +..||||.++.... ...+..|.+|+.++++++|||||+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~ 72 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIVK 72 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 59999999999999999999999999872 24688888753221 223467889999999999999999
Q ss_pred eeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 048724 154 FIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIV 233 (394)
Q Consensus 154 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~ii 233 (394)
+++++.+ +. +|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++++
T Consensus 73 l~~~~~~-~~--------------------~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~ii 130 (273)
T d1mp8a_ 73 LIGVITE-NP--------------------VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFV 130 (273)
T ss_dssp EEEEECS-SS--------------------CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEec-Ce--------------------EEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCee
Confidence 9999853 22 28999999999999987654 45799999999999999999999999999
Q ss_pred ccCCCCCceeeCCCCcEEEeeccccccccCCC-CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 048724 234 HRDVKTENMLLDANRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPY 311 (394)
Q Consensus 234 H~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf 311 (394)
||||||+||+++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+||
T Consensus 131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~ 210 (273)
T d1mp8a_ 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210 (273)
T ss_dssp CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence 99999999999999999999999998644322 23334578999999999999999999999999999999998 89999
Q ss_pred CCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 312 PDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
...+..++...+. .+.+++.+..+|+++.+||.+||+.||++|||+++|++.|+.+..
T Consensus 211 ~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 211 QGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999888887764 455667888899999999999999999999999999999998854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-57 Score=420.54 Aligned_cols=249 Identities=24% Similarity=0.423 Sum_probs=202.4
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+.|++.+.||+|+||+||+|++ +|+.||||+++..... .....+.+|+.+|++++|||||++++++.+.+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--------GKEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5699999999999999999998 6889999999743311 11356778999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+|||||+||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 81 ~~--------------------~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni 138 (307)
T d1a06a_ 81 HL--------------------YLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138 (307)
T ss_dssp EE--------------------EEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred EE--------------------EEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence 65 899999999999999965 45699999999999999999999999999999999999
Q ss_pred eeC---CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLD---ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~---~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|+. .++.+||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....+.
T Consensus 139 l~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 139 LYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp EESSSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 995 4789999999999865433 233446899999999999999999999999999999999999999999988888
Q ss_pred HHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+........ .+..+|+++.+||.+||+.||++|||++|+++.
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 888877655443 345789999999999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-57 Score=421.14 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=214.6
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
..|++++.||+|+||+||+|++ +|+.||||+++..... .....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC------HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence 3589999999999999999987 6889999999754321 1223467889999999999999999999998766
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+|||||++|+|..++.. +.++++..++.|+.||+.||.|||++||+||||||+||
T Consensus 89 ~~--------------------~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 146 (309)
T d1u5ra_ 89 TA--------------------WLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (309)
T ss_dssp EE--------------------EEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred EE--------------------EEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence 65 899999999999766643 35699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC---CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG---KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|++.++.+||+|||+++.... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+....+.
T Consensus 147 Ll~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~ 222 (309)
T d1u5ra_ 147 LLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (309)
T ss_dssp EEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EECCCCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999999999975432 234689999999999864 4689999999999999999999999999888888
Q ss_pred HHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+.........+..+|+++.+||.+||+.||++|||++++++
T Consensus 223 ~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 87777766555556678999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=418.88 Aligned_cols=269 Identities=27% Similarity=0.535 Sum_probs=219.6
Q ss_pred CCcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-C
Q 048724 76 KTEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-D 147 (394)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 147 (394)
...+|++..++|++.+.||+|+||+||+|++ +++.||||+++.... ....+.+.+|..++.++ +
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~~e~~~l~~~~~ 75 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGH 75 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--------HHHHHHHHHHHHHHHHHCC
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--------cHHHHHHHHHHHHHHhhcC
Confidence 3457999999999999999999999999986 236799999863221 11235567777777777 7
Q ss_pred CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHH
Q 048724 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVV 213 (394)
Q Consensus 148 h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~ 213 (394)
|+|||.+++++...+. .+++|||||++|+|.+++.... ...+++..+
T Consensus 76 h~~iv~~~~~~~~~~~-------------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (299)
T d1ywna1 76 HLNVVNLLGACTKPGG-------------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136 (299)
T ss_dssp CTTBCCEEEEECSTTS-------------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHH
T ss_pred CCeEEEeeeeeccCCC-------------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHH
Confidence 8999999998865432 2389999999999999997543 235899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCcc
Q 048724 214 IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRK 291 (394)
Q Consensus 214 ~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 291 (394)
+.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... .......||+.|+|||.+.+..++.+
T Consensus 137 ~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 216 (299)
T d1ywna1 137 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 216 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc
Confidence 9999999999999999999999999999999999999999999998644332 22334579999999999999999999
Q ss_pred chHHHHHHHHHHHHhC-CCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 292 CDVYSFGICLWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 292 ~DvwslG~~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+|||||||++|||++| .+||......+.....+..+.++..+..+++++.++|.+||+.||++|||+++++++|+++..
T Consensus 217 sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999987 578988776666666677777888899999999999999999999999999999999999865
Q ss_pred c
Q 048724 371 S 371 (394)
Q Consensus 371 ~ 371 (394)
+
T Consensus 297 ~ 297 (299)
T d1ywna1 297 A 297 (299)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=420.95 Aligned_cols=257 Identities=24% Similarity=0.473 Sum_probs=211.5
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGAS 158 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 158 (394)
++..++|++.+.||+|+||+||+|++ +|+.||+|+++..... .....+.+|+.+|++++|||||+++++|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--------THHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45678999999999999999999998 6899999999754221 1235778999999999999999999999
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCC
Q 048724 159 MGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS-KTIVHRDV 237 (394)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~iiH~Dl 237 (394)
.+...+ |+||||++||+|.+++.+. +.+++..+..++.||+.||.|||+ +||+||||
T Consensus 74 ~~~~~~--------------------~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDi 131 (322)
T d1s9ja_ 74 YSDGEI--------------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131 (322)
T ss_dssp ECSSEE--------------------EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCC
T ss_pred EECCEE--------------------EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcccc
Confidence 877665 8999999999999999654 469999999999999999999997 59999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+|||++.++.+||+|||+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 132 KP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 132 KPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred CHHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999999999854332 223468999999999999999999999999999999999999999765433
Q ss_pred hHHHHH-----------------------------------------HhccCCCCCC-CCCcHHHHHHHHHhchhCCCCC
Q 048724 318 DVSSAV-----------------------------------------VRQNLRPDIP-RCCPSSLASIMRKCWDANPDKR 355 (394)
Q Consensus 318 ~~~~~~-----------------------------------------~~~~~~~~~~-~~~~~~l~~li~~cL~~dP~~R 355 (394)
...... ......+..+ ..++.++.+||.+||+.||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHC
Confidence 221100 0011111222 2368899999999999999999
Q ss_pred CCHHHHHH--HHHHHH
Q 048724 356 PVMDEVVK--LLEAVN 369 (394)
Q Consensus 356 pt~~~ll~--~l~~~~ 369 (394)
||++|+++ ++++..
T Consensus 290 ~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 290 ADLKQLMVHAFIKRSD 305 (322)
T ss_dssp CCHHHHHTSHHHHHHH
T ss_pred cCHHHHhhCHhhCcCC
Confidence 99999998 466554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-56 Score=408.05 Aligned_cols=249 Identities=29% Similarity=0.517 Sum_probs=205.3
Q ss_pred ccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 87 LDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 87 ~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
|++.++||+|+||+||+|++ +++.||+|+++.... . ....+.|.+|+++|++++|||||+++++|.+...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---T----KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---C----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---C----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc-
Confidence 46777899999999999998 578999999874432 1 1124678899999999999999999999864221
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCce
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKT--IVHRDVKTENM 242 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--iiH~Dlkp~NI 242 (394)
....+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 83 ---------------~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 83 ---------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 145 (270)
T ss_dssp ---------------SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred ---------------cCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhc
Confidence 112348999999999999999654 46999999999999999999999998 99999999999
Q ss_pred eeC-CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLD-ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|++ +++.+||+|||+++..... ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||..........
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~ 222 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred eeeCCCCCEEEeecCcceeccCC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH
Confidence 996 5789999999999854322 2334689999999999876 59999999999999999999999998765544443
Q ss_pred HHHhcc-CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQN-LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~-~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
..+..+ ....++..+++++.+||.+||+.||++|||++|+++
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 333333 333455678999999999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-55 Score=405.03 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=226.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++................+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 78999999998776555555666677788999999999996 9999999999997
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |+||||++||+|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 82 ~~~~--------------------~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 139 (277)
T d1phka_ 82 NTFF--------------------FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 139 (277)
T ss_dssp SSEE--------------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred Ccce--------------------EEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 7666 9999999999999999653 56999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC------CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD------GKPYNRKCDVYSFGICLWEIYCCDMPYPDL 314 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~Pf~~~ 314 (394)
|||++.++.+||+|||+++...... ......||+.|+|||.+. ...++.++||||+||++|+|++|+.||.+.
T Consensus 140 Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 140 NILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 9999999999999999998655432 334468999999999985 345788999999999999999999999999
Q ss_pred ChhhHHHHHHhccCCCCCC--CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 315 SFTDVSSAVVRQNLRPDIP--RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
+..+....+.........+ ..+|+++++||.+||+.||++|||++++++.
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 219 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 9888888887776544333 4689999999999999999999999999763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=409.97 Aligned_cols=259 Identities=28% Similarity=0.524 Sum_probs=215.6
Q ss_pred cccccccceeeeccCCceEEEEEEEC---C--eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAYD---G--QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~~---g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
|..++|++.+.||+|+||+||+|++. + ..||||+++.... ......+.|.+|+.+|++++|||||+++|
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~------~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL------SQPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc------CCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45688999999999999999999872 2 3689998864321 12223467889999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|.+. .+ ++||||+++|+|.+++..+ .+.+++..++.++.||+.||.|||++||+|||
T Consensus 79 ~~~~~-~~--------------------~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrD 136 (273)
T d1u46a_ 79 VVLTP-PM--------------------KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 136 (273)
T ss_dssp EECSS-SC--------------------EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEeec-ch--------------------heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeee
Confidence 99653 32 8999999999999988764 35699999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCC---CccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYP 312 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~ 312 (394)
|||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986543322 1223467889999999999999999999999999999998 899999
Q ss_pred CCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHH
Q 048724 313 DLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAV 368 (394)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~ 368 (394)
+.+..+....+...+.+++.+..+|+++.+||.+||+.||++|||+++|++.|++.
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999888888888888889999999999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-56 Score=421.33 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=217.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|++++|||||+++++|.+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---------SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---------HHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---------hhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 57899999999999999999998 689999999864321 1135688999999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+|||||+||+|.+++.+. ...+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 96 ~~~--------------------~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~N 154 (350)
T d1koaa2 96 NEM--------------------VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154 (350)
T ss_dssp TEE--------------------EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhH
Confidence 665 8999999999999998543 3469999999999999999999999999999999999
Q ss_pred eeeCC--CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDA--NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~--~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||++. ++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.
T Consensus 155 Ill~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 233 (350)
T d1koaa2 155 IMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233 (350)
T ss_dssp EEESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eeeccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 99964 678999999999865433 233346899999999999999999999999999999999999999999988888
Q ss_pred HHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+......... ...+|+++++||.+||+.||++|||++++++.
T Consensus 234 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 8888766554332 24689999999999999999999999999884
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-55 Score=413.09 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=218.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++++.||+|+||+||+|++ +|+.||||+++... .......+.+.+|+.++++++|||||++++++.+.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI------VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH------ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 57899999999999999999998 68999999997432 11122246788999999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+|||||+||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 ~~~--------------------~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~N 134 (316)
T d1fota_ 77 QQI--------------------FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 134 (316)
T ss_dssp SEE--------------------EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred Cee--------------------eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchh
Confidence 665 8999999999999988654 468999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+...
T Consensus 135 ILl~~~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 135 ILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp EEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred eeEcCCCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 99999999999999999865432 334689999999999999999999999999999999999999999999888888
Q ss_pred HHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHHH
Q 048724 322 AVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVKL 364 (394)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~~ 364 (394)
.+.... ..+|..+|+++.++|.+||++||.+|+ |++++++.
T Consensus 212 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 212 KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 877654 456677999999999999999999996 89999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-56 Score=412.96 Aligned_cols=263 Identities=29% Similarity=0.533 Sum_probs=225.2
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n 150 (394)
.+|++..++|++.+.||+|+||+||+|++. ++.||||+++.... ....+.|.+|+.+|++++|||
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~E~~il~~l~h~n 77 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDNPN 77 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHHTCCCTT
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--------hHHHHHHHHHHHHHHhcCCCC
Confidence 457888899999999999999999999873 36899999864321 123467889999999999999
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----------------------cCCC
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----------------------RKKL 208 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----------------------~~~l 208 (394)
|++++++|.....+ +++|||+++|+|.+++.... ...+
T Consensus 78 iv~~~~~~~~~~~~--------------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 137 (301)
T d1lufa_ 78 IVKLLGVCAVGKPM--------------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137 (301)
T ss_dssp BCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHTCC----------------------CCC
T ss_pred cccceeeeccCCce--------------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCC
Confidence 99999999876665 89999999999999996432 2348
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCC
Q 048724 209 AFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGK 286 (394)
Q Consensus 209 ~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 286 (394)
++..++.|+.|++.||+|||++++|||||||+|||++.++.+||+|||+++...... .......+++.|+|||.+.+.
T Consensus 138 ~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 217 (301)
T d1lufa_ 138 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 217 (301)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC
Confidence 899999999999999999999999999999999999999999999999998543221 223346788999999999999
Q ss_pred CCCccchHHHHHHHHHHHHhCC-CCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHH
Q 048724 287 PYNRKCDVYSFGICLWEIYCCD-MPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLL 365 (394)
Q Consensus 287 ~~~~~~DvwslG~~l~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l 365 (394)
.|+.++|||||||++|||++|. +||.+.+..++...+.. +..++.+..+|+++.+||.+||+.||++|||+.+|+++|
T Consensus 218 ~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 218 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999999999999985 68998888888877644 446778888999999999999999999999999999999
Q ss_pred HHHH
Q 048724 366 EAVN 369 (394)
Q Consensus 366 ~~~~ 369 (394)
+++.
T Consensus 297 ~~i~ 300 (301)
T d1lufa_ 297 QRMC 300 (301)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-56 Score=412.35 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=217.3
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|++ +|+.||||+++........ .....+.+.+|+.+|++++|||||+++++|.+..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR---RGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS---SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh---hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5699999999999999999998 6889999999754322111 0111367889999999999999999999998776
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.+ |+|||||+||+|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 87 ~~--------------------~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Ni 144 (293)
T d1jksa_ 87 DV--------------------ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144 (293)
T ss_dssp EE--------------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EE--------------------EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceE
Confidence 65 8999999999999999654 4699999999999999999999999999999999999
Q ss_pred eeCCCC----cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 243 LLDANR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 243 ll~~~~----~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|++.++ .+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 145 ll~~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 145 MLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp EESCSSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEecCCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence 998766 5999999999865433 33445689999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhccCCCC--CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 319 VSSAVVRQNLRPD--IPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 319 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
....+........ .+..+|+++++||.+||+.||++|||++++++
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8877766544332 23568999999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-55 Score=418.98 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=217.3
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++.... . ....+.+|+.+|++++|||||+++++|.+.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----L----DKYTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----H----HHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-----h----HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 46899999999999999999998 689999999874321 1 135677899999999999999999999876
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+|||||+||+|.+++... ..++++.+++.|+.||+.||.|||++||+||||||+|
T Consensus 99 ~~~--------------------~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~N 157 (352)
T d1koba_ 99 YEM--------------------VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157 (352)
T ss_dssp SEE--------------------EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccc
Confidence 665 8999999999999887543 3469999999999999999999999999999999999
Q ss_pred eeeC--CCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLD--ANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~--~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||++ .++.+||+|||+|+..... .......||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+..+.
T Consensus 158 ILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 158 IMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9997 5789999999999865433 233446899999999999999999999999999999999999999999998888
Q ss_pred HHHHHhccCCC--CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNLRP--DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+....... ..+..+|+++.+||.+||+.||++|||++++++
T Consensus 237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 88877765443 234578999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=407.29 Aligned_cols=265 Identities=31% Similarity=0.575 Sum_probs=223.4
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-C
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-D 147 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 147 (394)
++|+|..++|++++.||+|+||.||+|+.. +..||||+++.... ......+.+|...+.++ +
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~e~~~l~~~~~ 77 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--------EKDLSDLISEMEMMKMIGK 77 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--------HHHHHHHHHHHHHHHHHCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--------hHHHHHHHHHHHHHHHhcC
Confidence 459999999999999999999999999862 24799999864321 11235677888888888 8
Q ss_pred CCcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCCHHHH
Q 048724 148 HPNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------------RKKLAFKVV 213 (394)
Q Consensus 148 h~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------------~~~l~~~~~ 213 (394)
|||||+++++|.+...+ ++||||+++|+|.++|.... ...+++.++
T Consensus 78 HpnIv~~~~~~~~~~~~--------------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 137 (299)
T d1fgka_ 78 HKNIINLLGACTQDGPL--------------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137 (299)
T ss_dssp CTTBCCEEEEECSSSSC--------------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHH
T ss_pred CCeEEecccccccCCeE--------------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHH
Confidence 99999999999876655 89999999999999997543 245899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCC--CCccCCCCCCCcCCccccCCCCCCcc
Q 048724 214 IQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLDGKPYNRK 291 (394)
Q Consensus 214 ~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~ 291 (394)
+.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..|+.+
T Consensus 138 ~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k 217 (299)
T d1fgka_ 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch
Confidence 9999999999999999999999999999999999999999999998654332 22334578899999999999999999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 292 CDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 292 ~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+|||||||++|||++ |.+||.+.+..++...+ ..+.+++.+..+++++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 218 ~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 218 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 999999999999998 79999988887776544 5677888899999999999999999999999999999999999865
Q ss_pred c
Q 048724 371 S 371 (394)
Q Consensus 371 ~ 371 (394)
.
T Consensus 297 ~ 297 (299)
T d1fgka_ 297 L 297 (299)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=411.61 Aligned_cols=256 Identities=25% Similarity=0.549 Sum_probs=215.2
Q ss_pred cccccceeeeccCCceEEEEEEE--CCe----eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQ----DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
..+|+++++||+|+||+||+|.+ +|+ .||+|.++.... ....+.|.+|+.++++++|||||+++|+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 79 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLLGI 79 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 46799999999999999999988 444 588888763221 1124678899999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
|.+.. .++++||+.+|+|.+++... ...+++..++.|+.||+.||+|||++||+||||
T Consensus 80 ~~~~~---------------------~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDl 137 (317)
T d1xkka_ 80 CLTST---------------------VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 137 (317)
T ss_dssp EESSS---------------------EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EecCC---------------------eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcc
Confidence 97543 27899999999999988664 467999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCC--ccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYC-CDMPYPDL 314 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~Pf~~~ 314 (394)
||+|||++.++.+||+|||+++........ .....||+.|+|||.+.+..|+.++|||||||++|||+| |.+||.+.
T Consensus 138 Kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp CGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred hhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999865433222 233468999999999999999999999999999999998 79999988
Q ss_pred ChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 315 SFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
+..++...+ ..+.+++.|..+++++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 218 ~~~~~~~~i-~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 218 PASEISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CGGGHHHHH-HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHH-HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 888776554 5566777888899999999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-55 Score=403.72 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=216.1
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|++ +|+.||||+++..... .......|.+|+.+++.++|||||++++++...+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR------DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc------CHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 5799999999999999999997 6899999999753321 1223467889999999999999999999987654
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. ....|+||||++||+|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+||
T Consensus 81 ~~----------------~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NI 142 (277)
T d1o6ya_ 81 PA----------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 142 (277)
T ss_dssp SS----------------SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CC----------------CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccc
Confidence 31 12348999999999999988654 4699999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 243 LLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|++.++.++|+|||.+....... .......||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..+.
T Consensus 143 ll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 222 (277)
T d1o6ya_ 143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222 (277)
T ss_dssp EEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH
Confidence 99999999999999987433221 233446799999999999999999999999999999999999999999888888
Q ss_pred HHHHHhccCCC--CCCCCCcHHHHHHHHHhchhCCCCCC-CHHHHHHHHHHHH
Q 048724 320 SSAVVRQNLRP--DIPRCCPSSLASIMRKCWDANPDKRP-VMDEVVKLLEAVN 369 (394)
Q Consensus 320 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~Rp-t~~~ll~~l~~~~ 369 (394)
...+......+ .....+|+++.++|.+||++||++|| |++++++.|.+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 77777665433 23456899999999999999999999 8999999999886
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=409.54 Aligned_cols=268 Identities=29% Similarity=0.544 Sum_probs=231.6
Q ss_pred CcccccccccccceeeeccCCceEEEEEEE-------CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CC
Q 048724 77 TEEWEIELAKLDIRHEIARGTYGTVYRGAY-------DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DH 148 (394)
Q Consensus 77 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 148 (394)
..+|++..++|++.++||+|+||+||+|++ +++.||||+++.... ......|.+|+.+++++ +|
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~E~~~~~~l~~H 86 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYLGNH 86 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCC
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--------HHHHHHHHHHHHHHHhccCC
Confidence 347999999999999999999999999986 346899999974321 11235788999999999 79
Q ss_pred CcceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc----------------cCCCCHHH
Q 048724 149 PNVTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK----------------RKKLAFKV 212 (394)
Q Consensus 149 ~nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~----------------~~~l~~~~ 212 (394)
||||+++++|.+...+ |+|||||++|+|.+++.... ...+++..
T Consensus 87 pnIv~~~g~~~~~~~~--------------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (311)
T d1t46a_ 87 MNIVNLLGACTIGGPT--------------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146 (311)
T ss_dssp TTBCCEEEEECSSSSC--------------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred CCEEEEEEEEeeCCEE--------------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence 9999999999876665 89999999999999997643 23589999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCc
Q 048724 213 VIQIALDLARGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNR 290 (394)
Q Consensus 213 ~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 290 (394)
+..++.||+.||+|||+++++||||||+||+++.++.+||+|||.++....... ......||+.|+|||.+.+..++.
T Consensus 147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 226 (311)
T d1t46a_ 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC
Confidence 999999999999999999999999999999999999999999999986543322 223457899999999999999999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 291 KCDVYSFGICLWEIYC-CDMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 291 ~~DvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
++|||||||++|||+| |.+||...+..+....++..+.++..+..+|.++.+||.+||+.||++|||+.+|+++|+++.
T Consensus 227 ~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 9999999999999998 677787777777777788888888888899999999999999999999999999999999876
Q ss_pred hcc
Q 048724 370 TSK 372 (394)
Q Consensus 370 ~~~ 372 (394)
...
T Consensus 307 ~~~ 309 (311)
T d1t46a_ 307 SES 309 (311)
T ss_dssp HHT
T ss_pred ccC
Confidence 543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=411.26 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=216.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHH-hCCCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQ-KLDHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~ 160 (394)
+++|++.+.||+|+||+||+|++ +|+.||||+++... .........+..|..++. .++|||||++++++.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~------~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV------VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhh------ccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 36899999999999999999998 78999999997422 111111244556666654 6899999999999998
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |+||||+++|+|.+++..+ ..+++..++.++.||+.||+|||++|++||||||+
T Consensus 75 ~~~~--------------------yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~ 132 (320)
T d1xjda_ 75 KENL--------------------FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 132 (320)
T ss_dssp SSEE--------------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred CCce--------------------eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCccc
Confidence 7766 8999999999999999654 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|||++.++.+||+|||+++.............||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++.
T Consensus 133 NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 133 NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212 (320)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999986555455555678999999999999999999999999999999999999999999988888
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHH-HHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMD-EVVK 363 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~-~ll~ 363 (394)
..+... .+.+|..+|+++.+||.+||+.||++|||+. ++++
T Consensus 213 ~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 213 HSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 777655 4567788999999999999999999999996 6764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-54 Score=412.52 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=218.1
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
.+++|++++.||+|+||+||+|++ +|+.||||+++... .......+.+.+|+.+|+.++|||||++++++.+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH------ccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 368999999999999999999998 68999999986322 1111224568899999999999999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
...+ ++||||+.||+|.+++.+. +.+++..++.|+.||+.||.|||++|||||||||+
T Consensus 113 ~~~~--------------------~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~ 170 (350)
T d1rdqe_ 113 NSNL--------------------YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170 (350)
T ss_dssp SSEE--------------------EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cccc--------------------ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHH
Confidence 6665 8999999999999999654 46999999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|||++.++.+||+|||+|+..... .....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+.....
T Consensus 171 NILl~~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 247 (350)
T d1rdqe_ 171 NLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp GEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred HcccCCCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH
Confidence 999999999999999999865432 33468999999999999999999999999999999999999999998888888
Q ss_pred HHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHH
Q 048724 321 SAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVK 363 (394)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~ 363 (394)
..+.... ...+..+++++.+||++||+.||.+|+ |++++++
T Consensus 248 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 248 EKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 7776654 445677999999999999999999994 8999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-54 Score=411.51 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=208.8
Q ss_pred ccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecC
Q 048724 83 ELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMG 160 (394)
Q Consensus 83 ~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 160 (394)
.+++|++.+.||+|+||+||+|++ +|+.||||+++..... .............++.+++.++|||||+++++|.+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~---~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~ 78 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK---MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc---hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence 468999999999999999999998 6899999998643210 01111111222345777778899999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.+.+ |+|||||+||+|.+++.++ ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 79 ~~~~--------------------~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~ 136 (364)
T d1omwa3 79 PDKL--------------------SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 136 (364)
T ss_dssp SSEE--------------------EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCEE--------------------EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccc
Confidence 7665 8999999999999999654 46899999999999999999999999999999999
Q ss_pred ceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccC-CCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 241 NMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLD-GKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 241 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
|||++.++.+||+|||+|+..... ......||+.|+|||++. +..|+.++|||||||++|||+||+.||......+.
T Consensus 137 NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 214 (364)
T d1omwa3 137 NILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214 (364)
T ss_dssp GEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred eeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999865432 334568999999999996 45789999999999999999999999987655443
Q ss_pred HHHHH-hccCCCCCCCCCcHHHHHHHHHhchhCCCCCCC-----HHHHHHH
Q 048724 320 SSAVV-RQNLRPDIPRCCPSSLASIMRKCWDANPDKRPV-----MDEVVKL 364 (394)
Q Consensus 320 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt-----~~~ll~~ 364 (394)
..... .......++..+|+++.+||.+||+.||++||| ++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 215 HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 32221 223345567789999999999999999999999 7888863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=406.25 Aligned_cols=263 Identities=30% Similarity=0.534 Sum_probs=226.7
Q ss_pred cccccccccccceeeeccCCceEEEEEEEC-------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCc
Q 048724 78 EEWEIELAKLDIRHEIARGTYGTVYRGAYD-------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPN 150 (394)
Q Consensus 78 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~n 150 (394)
++|+|..++|++.+.||+|+||+||+|.+. ++.||||+++.... . .....|.+|+.++++++|||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~----~----~~~~~~~~E~~il~~l~h~n 84 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----M----RERIEFLNEASVMKEFNCHH 84 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC----H----HHHHHHHHHHHHGGGCCCTT
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC----h----HHHHHHHHHHHHHHHcCCCC
Confidence 369999999999999999999999999873 46899999863221 1 12356889999999999999
Q ss_pred ceeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcc--------cCCCCHHHHHHHHHHHHH
Q 048724 151 VTKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNK--------RKKLAFKVVIQIALDLAR 222 (394)
Q Consensus 151 Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~ 222 (394)
||+++++|...... ++||||+++|+|.+++.... ...+++..+..++.|+++
T Consensus 85 Iv~~~~~~~~~~~~--------------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~ 144 (308)
T d1p4oa_ 85 VVRLLGVVSQGQPT--------------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144 (308)
T ss_dssp BCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred EeeeeeEEecCCce--------------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHH
Confidence 99999999876665 89999999999999987532 134789999999999999
Q ss_pred HHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCC--CccCCCCCCCcCCccccCCCCCCccchHHHHHHH
Q 048724 223 GLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGIC 300 (394)
Q Consensus 223 ~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 300 (394)
||.|||+++|+||||||+|||++.++++||+|||+++....... ......+|+.|+|||.+.+..++.++||||||++
T Consensus 145 gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 145 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224 (308)
T ss_dssp HHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHH
Confidence 99999999999999999999999999999999999985433222 2233468999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHH
Q 048724 301 LWEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVN 369 (394)
Q Consensus 301 l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~ 369 (394)
+|||+|| .+||.+.+..+....+.. +.+++.+..+|+.+.++|.+||+.||++|||+++|++.|++..
T Consensus 225 l~El~t~~~~p~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNEQVLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999998 589999988888877654 4467778889999999999999999999999999999998763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=404.72 Aligned_cols=262 Identities=29% Similarity=0.546 Sum_probs=221.0
Q ss_pred ccccccccceeeeccCCceEEEEEEE--CCe--eEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeee
Q 048724 81 EIELAKLDIRHEIARGTYGTVYRGAY--DGQ--DVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFI 155 (394)
Q Consensus 81 ~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 155 (394)
.|+.++|++.++||+|+||+||+|++ +|. .||||.++.... ....+.|.+|+++|+++ +|||||+++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~~HpnIv~~~ 77 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------KDDHRDFAGELEVLCKLGHHPNIINLL 77 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--------hHHHHHHHHHHHHHHhccCCCCEeeEE
Confidence 36779999999999999999999988 454 477777653221 11246788999999999 799999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhc--------------ccCCCCHHHHHHHHHHHH
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRN--------------KRKKLAFKVVIQIALDLA 221 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~ 221 (394)
|+|.+.+.+ |+||||+++|+|.++|..+ ....+++..++.++.||+
T Consensus 78 ~~~~~~~~~--------------------~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia 137 (309)
T d1fvra_ 78 GACEHRGYL--------------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137 (309)
T ss_dssp EEEEETTEE--------------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHH
T ss_pred EEEecCCee--------------------EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHH
Confidence 999876665 8999999999999999653 235799999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHH
Q 048724 222 RGLSYLHSKTIVHRDVKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICL 301 (394)
Q Consensus 222 ~~l~yLH~~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l 301 (394)
.||.|||+++++||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++
T Consensus 138 ~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 138 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 99999999999999999999999999999999999997543322 22345789999999999999999999999999999
Q ss_pred HHHHhC-CCCCCCCChhhHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhcc
Q 048724 302 WEIYCC-DMPYPDLSFTDVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTSK 372 (394)
Q Consensus 302 ~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~~ 372 (394)
|||++| .+||.+.+..++...+ ..+.+++.+..+++++.+||.+||+.||++|||+++|++.|+++....
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHG-GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHhcCCCCCCCCCHHHHHHHH-HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 999997 4678888888877665 445677888889999999999999999999999999999999997543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=406.31 Aligned_cols=249 Identities=17% Similarity=0.274 Sum_probs=215.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|++.+.||+|+||+||+|.+ +|+.||||+++... .. ...+.+|+.+|++++|||||+++++|.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD----QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH----HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------cc----HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 47899999999999999999998 68899999997432 11 24577899999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
+.+ |+|||||+||+|.+++... ...+++.+++.|+.||+.||+|||++||+||||||+|
T Consensus 74 ~~~--------------------~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~N 132 (321)
T d1tkia_ 74 EEL--------------------VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132 (321)
T ss_dssp TEE--------------------EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CEE--------------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccc
Confidence 665 9999999999999999543 3469999999999999999999999999999999999
Q ss_pred eeeCC--CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhH
Q 048724 242 MLLDA--NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDV 319 (394)
Q Consensus 242 Ill~~--~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~ 319 (394)
||++. .+.+||+|||+++..... .......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||...+..+.
T Consensus 133 Ill~~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~ 211 (321)
T d1tkia_ 133 IIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211 (321)
T ss_dssp EEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred eeecCCCceEEEEcccchhhccccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99975 458999999999865432 223345789999999999999999999999999999999999999999998888
Q ss_pred HHHHHhccCCCCC--CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 320 SSAVVRQNLRPDI--PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 320 ~~~~~~~~~~~~~--~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...+.......+. ...+|+++++||.+||..||++|||++++++.
T Consensus 212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 8888776544322 24689999999999999999999999999983
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=400.38 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=203.5
Q ss_pred ceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcccc
Q 048724 89 IRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNLKI 166 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 166 (394)
.+++||+|+||+||+|++ +|+.||||+++..... .........+.+|+.++++++|||||+++++|.+.+.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~-- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS----EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI-- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC--
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh----hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce--
Confidence 457899999999999988 6889999998744321 11222345688999999999999999999999877665
Q ss_pred CCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCceeeCC
Q 048724 167 PSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENMLLDA 246 (394)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIll~~ 246 (394)
|+||||+.++++..++ ..+..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 ------------------~ivmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~ 135 (299)
T d1ua2a_ 76 ------------------SLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 135 (299)
T ss_dssp ------------------EEEEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred ------------------eehhhhhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC
Confidence 8999999888776554 33456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHh
Q 048724 247 NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSSAVVR 325 (394)
Q Consensus 247 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~ 325 (394)
++.+||+|||+++.............||+.|+|||.+.+ ..|+.++|||||||++|||++|.+||.+.+..+....+..
T Consensus 136 ~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 136 NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215 (299)
T ss_dssp TCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence 999999999999866555444555689999999999864 5689999999999999999999999999888777766543
Q ss_pred ccCCC---------------------C-----CCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 326 QNLRP---------------------D-----IPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 326 ~~~~~---------------------~-----~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
....+ . ....+++++.+||.+||+.||++|||++|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 216 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 21000 0 012467899999999999999999999999873
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-54 Score=404.75 Aligned_cols=250 Identities=23% Similarity=0.401 Sum_probs=202.4
Q ss_pred ccccccee-eeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeec
Q 048724 84 LAKLDIRH-EIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASM 159 (394)
Q Consensus 84 ~~~~~~~~-~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 159 (394)
.++|++.+ .||+|+||+||+|++ +|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 57898875 599999999999998 6889999998631 3456799887655 8999999999986
Q ss_pred CCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 160 GTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
+... ....+|+|||||+||+|.++|.++....+++.+++.|+.||+.||.|||++||+||||||
T Consensus 76 ~~~~----------------~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp 139 (335)
T d2ozaa1 76 NLYA----------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 139 (335)
T ss_dssp EEET----------------TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred eccc----------------CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccc
Confidence 5211 012349999999999999999765556799999999999999999999999999999999
Q ss_pred CceeeCC---CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 240 ENMLLDA---NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 240 ~NIll~~---~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
+|||++. .+.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.
T Consensus 140 ~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 140 ENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred cccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 9999975 567999999999865433 334456899999999999999999999999999999999999999987665
Q ss_pred hhHHHHHHhccC--CCCCC----CCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNL--RPDIP----RCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~--~~~~~----~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
......+..... ...++ ..+|+++.+||.+||+.||++|||+.++++.
T Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp C--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 544433322211 11222 2478999999999999999999999999884
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=394.43 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=209.9
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|+++++||+|+||+||+|++ +|+.||||+++.... .......+.+|+.+|++++|||||+++++|.+.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~ 73 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 73 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc
Confidence 36899999999999999999998 689999999964321 112236788899999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
..+ |+||||+.+ ++.+++.......+++..+..++.||+.||+|||++|||||||||+|
T Consensus 74 ~~~--------------------~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN 132 (298)
T d1gz8a_ 74 NKL--------------------YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132 (298)
T ss_dssp TEE--------------------EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred cce--------------------eEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence 665 899999965 56666665556779999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC-CCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
||++.++.+||+|||+|+.............||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 133 Il~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 133 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212 (298)
T ss_dssp EEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence 9999999999999999987655555556678999999999887655 578999999999999999999999988877766
Q ss_pred HHHHhccCC----------------CCC-----------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 321 SAVVRQNLR----------------PDI-----------PRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 321 ~~~~~~~~~----------------~~~-----------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
..+...... ... ...++.++.+||.+||+.||++|||++|+++.
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 555331100 000 12467899999999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=391.51 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=208.5
Q ss_pred ceeeeccCCceEEEEEEEC---C--eeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 89 IRHEIARGTYGTVYRGAYD---G--QDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 89 ~~~~lG~G~fg~Vy~~~~~---g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+.++||+|+||+||+|++. + ..||||+++.... ....+.|.+|+++|++++|||||+++|++...+.
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC--------HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 3678999999999999872 2 2689999863221 1224678999999999999999999999864332
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcee
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENML 243 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NIl 243 (394)
..++|||||++|+|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||
T Consensus 103 -------------------~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NIL 162 (311)
T d1r0pa_ 103 -------------------SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 162 (311)
T ss_dssp -------------------EEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred -------------------ceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEe
Confidence 238999999999999988653 456788999999999999999999999999999999999
Q ss_pred eCCCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-Chhh
Q 048724 244 LDANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFTD 318 (394)
Q Consensus 244 l~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~-~~~~ 318 (394)
+++++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||+||..||... +..+
T Consensus 163 l~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~ 242 (311)
T d1r0pa_ 163 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242 (311)
T ss_dssp ECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------
T ss_pred ECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999998543321 1222356899999999999999999999999999999999987776544 3334
Q ss_pred HHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHhc
Q 048724 319 VSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNTS 371 (394)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~~ 371 (394)
.... +..+.++..|..+++++.+||.+||+.||++|||+.||++.|+.+...
T Consensus 243 ~~~~-i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 243 ITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH-HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 4443 345567778888999999999999999999999999999999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-52 Score=384.91 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=204.8
Q ss_pred cccccceeeeccCCceEEEEEEE-CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
+++|+++++||+|+||+||+|++ +|+.||||+++...... .....+.+|+.+|++++|||||+++++|.+.+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-------GIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-------HHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 36899999999999999999998 68999999996543211 11356888999999999999999999999776
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
.. |+++||+.++.+..+.. ..+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus 74 ~~--------------------~i~~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NI 131 (286)
T d1ob3a_ 74 RL--------------------VLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (286)
T ss_dssp CE--------------------EEEEECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ce--------------------eEEEEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCcee
Confidence 66 89999997766665543 346799999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 243 LLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
|++.++.+||+|||.+..............+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+...
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred eEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999999999865544444455678999999999875 457899999999999999999999999888777665
Q ss_pred HHHhccCC---------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 322 AVVRQNLR---------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 322 ~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
.+...... ......+++++.+||++||+.||++|||++|+++
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 54321100 0123456889999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=385.51 Aligned_cols=245 Identities=22% Similarity=0.379 Sum_probs=201.8
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC--CCcceeeeeeecC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD--HPNVTKFIGASMG 160 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~ 160 (394)
++|++.+.||+|+||+||+|++ +|+.||||+++........... ....+.+|+.++++++ |||||+++++|.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~---~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP---NGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT---TCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh---HHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 5799999999999999999998 6899999999754321110000 0123557999999996 8999999999987
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPG-GTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKT 239 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp 239 (394)
.+.. |+||||+.+ +++.+++..+ ..+++..++.++.||+.||+|||++||+||||||
T Consensus 81 ~~~~--------------------~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp 138 (273)
T d1xwsa_ 81 PDSF--------------------VLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 138 (273)
T ss_dssp SSEE--------------------EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CCeE--------------------EEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcc
Confidence 7665 899999976 6888888653 4699999999999999999999999999999999
Q ss_pred CceeeCC-CCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCC-CccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 240 ENMLLDA-NRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 240 ~NIll~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
+|||++. ++.+||+|||+++..... ..+...||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+
T Consensus 139 ~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-- 214 (273)
T d1xwsa_ 139 ENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-- 214 (273)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred cceEEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--
Confidence 9999985 479999999999864332 3345689999999999987665 578999999999999999999997532
Q ss_pred hHHHHHHhccCCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 318 DVSSAVVRQNLRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
.+... ...++..+|+++++||.+||+.||++|||++|+++.
T Consensus 215 ----~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 ----EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 23333 334667799999999999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=382.83 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=207.4
Q ss_pred cccccceeeeccCCceEEEEEEE--C-CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC---CCCcceeeeee
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--D-GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL---DHPNVTKFIGA 157 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~ 157 (394)
.++|++++.||+|+||+||+|++ + ++.||||+++........ ...+.+|+.+|+.+ +||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-------HHHHHHHHHHHHHHhhcCCCCcceeeee
Confidence 36899999999999999999987 3 567999998754322111 12344577766655 89999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
|...... ....++++|||++++.+... .......+++..++.++.|++.||+|||++||+||||
T Consensus 79 ~~~~~~~---------------~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDi 142 (305)
T d1blxa_ 79 CTVSRTD---------------RETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 142 (305)
T ss_dssp EEEEECS---------------SEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred ecccccc---------------cCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCC
Confidence 8643211 11335899999988766544 3445567999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFT 317 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~ 317 (394)
||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 143 Kp~NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~ 221 (305)
T d1blxa_ 143 KPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 221 (305)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CccEEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999999998754332 3344578999999999999999999999999999999999999999998887
Q ss_pred hHHHHHHhccC-------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--HHHH
Q 048724 318 DVSSAVVRQNL-------------------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL--LEAV 368 (394)
Q Consensus 318 ~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~ 368 (394)
+....+..... ...++..+++.+.+||.+||+.||++|||++|+++. ++++
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 77666543210 001234578999999999999999999999999873 4444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=387.13 Aligned_cols=258 Identities=32% Similarity=0.479 Sum_probs=203.6
Q ss_pred ccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCcc
Q 048724 85 AKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTNL 164 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 164 (394)
++|.+.+.||+|+||+||+|+++|+.||||+++... .. ...+..|+..+.+++|||||++++++.+....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~------~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ER----SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG------HH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc------hh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence 578889999999999999999999999999986322 11 12223455666678999999999999865431
Q ss_pred ccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccC
Q 048724 165 KIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS--------KTIVHRD 236 (394)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~--------~~iiH~D 236 (394)
...+|+||||+++|+|.+++++. .+++..++.++.|++.||.|||+ +||+|||
T Consensus 73 ----------------~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrD 133 (303)
T d1vjya_ 73 ----------------WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp ----------------SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred ----------------ceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccc
Confidence 12358999999999999999653 59999999999999999999996 5999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCC----CccCCCCCCCcCCccccCCCC------CCccchHHHHHHHHHHHHh
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLDGKP------YNRKCDVYSFGICLWEIYC 306 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~ellt 306 (394)
|||+||||+.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||+|
T Consensus 134 lKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t 213 (303)
T d1vjya_ 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh
Confidence 999999999999999999999986543221 223467999999999987643 5678999999999999999
Q ss_pred CCCCCCC---------------CChhhHHHHHHhccCCCCCCCCC-----cHHHHHHHHHhchhCCCCCCCHHHHHHHHH
Q 048724 307 CDMPYPD---------------LSFTDVSSAVVRQNLRPDIPRCC-----PSSLASIMRKCWDANPDKRPVMDEVVKLLE 366 (394)
Q Consensus 307 g~~Pf~~---------------~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~ 366 (394)
|..||.. ...............++.++... +..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 9877632 12233333444455566555432 346899999999999999999999999999
Q ss_pred HHHhc
Q 048724 367 AVNTS 371 (394)
Q Consensus 367 ~~~~~ 371 (394)
++...
T Consensus 294 ~i~~~ 298 (303)
T d1vjya_ 294 QLSQQ 298 (303)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=381.62 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=207.7
Q ss_pred ccccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeee
Q 048724 79 EWEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIG 156 (394)
Q Consensus 79 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 156 (394)
.|++ .++|++++.||+|+||+||+|++ +|+.||||+++.... . ....+.+.+|+.+|++++|||||++++
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~----~~~~~~~~~Ei~il~~l~hpniv~l~~ 84 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---S----ELFAKRAYRELRLLKHMRHENVIGLLD 84 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS---S----HHHHHHHHHHHHHHHHCCBTTBCCCSE
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc---C----hHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 3666 57999999999999999999998 689999999974321 1 122467789999999999999999999
Q ss_pred eecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 048724 157 ASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRD 236 (394)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~D 236 (394)
+|...+... ....+|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||++||+|||
T Consensus 85 ~~~~~~~~~--------------~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrD 146 (346)
T d1cm8a_ 85 VFTPDETLD--------------DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 146 (346)
T ss_dssp EECSCSSTT--------------TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EeccCcccc--------------ccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence 998765431 123459999999 6788887643 4599999999999999999999999999999
Q ss_pred CCCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 048724 237 VKTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLS 315 (394)
Q Consensus 237 lkp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~ 315 (394)
|||+|||++.++.+||+|||+++.... ..+...||+.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 147 iKp~NIL~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 147 LKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCcchhhcccccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 999999999999999999999986433 3345689999999999865 457899999999999999999999998877
Q ss_pred hhhHHHHHHhccCC-----------------------------CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH--
Q 048724 316 FTDVSSAVVRQNLR-----------------------------PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL-- 364 (394)
Q Consensus 316 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~-- 364 (394)
..+........... ......+++++.+||.+||..||++|||++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 66554433221100 01224578999999999999999999999999984
Q ss_pred HHHHH
Q 048724 365 LEAVN 369 (394)
Q Consensus 365 l~~~~ 369 (394)
++.+.
T Consensus 304 f~~~~ 308 (346)
T d1cm8a_ 304 FESLH 308 (346)
T ss_dssp GTTTC
T ss_pred hCcCC
Confidence 55554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=381.45 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=203.3
Q ss_pred cccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCCc
Q 048724 86 KLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTTN 163 (394)
Q Consensus 86 ~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 163 (394)
+|+..++||+|+||+||+|++ +|+.||||+++.... .+.+|+.+|++++|||||+++++|.....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 688999999999999999998 689999999975432 22369999999999999999999864322
Q ss_pred cccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 164 LKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIR-NKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. .....+|+|||||+++.+..+... .....+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 88 ~--------------~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NI 153 (350)
T d1q5ka_ 88 K--------------KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153 (350)
T ss_dssp C--------------CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred c--------------CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceE
Confidence 1 112345899999976544433321 2345799999999999999999999999999999999999
Q ss_pred eeCCCC-cEEEeeccccccccCCCCCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 048724 243 LLDANR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVS 320 (394)
Q Consensus 243 ll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~ 320 (394)
|++.++ .+||+|||+++..... .......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...+..+..
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l 232 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred EEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence 998765 8999999999865433 23344689999999998865 57899999999999999999999999988877666
Q ss_pred HHHHhcc---------------CCC------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HHHHHH
Q 048724 321 SAVVRQN---------------LRP------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LLEAVN 369 (394)
Q Consensus 321 ~~~~~~~---------------~~~------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l~~~~ 369 (394)
..+.... ... .....+++++.+||.+||+.||++|||+.|+++ +++++.
T Consensus 233 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 5543210 000 112346899999999999999999999999997 466664
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=379.66 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=200.5
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++++.||+|+||+||+|++ +|+.||||+++.... ....+.+.+|+.+|++++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--------QTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--------HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--------hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 4699999999999999999988 689999999964321 122356788999999999999999999987654
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
... ... +++++|+.+|+|.+++..+ .+++..++.++.||+.||+|||++|||||||||+||
T Consensus 80 ~~~---------------~~~-~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NI 140 (345)
T d1pmea_ 80 IEQ---------------MKD-VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 140 (345)
T ss_dssp TTT---------------CCC-EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ccc---------------cce-EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceE
Confidence 321 122 4455667799999999543 599999999999999999999999999999999999
Q ss_pred eeCCCCcEEEeeccccccccCCC---CCccCCCCCCCcCCccccCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 243 LLDANRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLDG-KPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 243 ll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|++.++.+||+|||+++...... .......||+.|+|||.+.. ..++.++||||+||++|+|++|+.||...+..+
T Consensus 141 Ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 141 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp EECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 99999999999999997543221 22344679999999999854 567899999999999999999999998877655
Q ss_pred HHHHHHhccCCC-----------------------------CCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 319 VSSAVVRQNLRP-----------------------------DIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 319 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
...........+ .....+++++.+||.+||+.||++|||++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 554432211000 0123467899999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=371.69 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=201.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|+++++||+|+||+||+|++ +|+.||||+++....... ....+.+|+.+|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-------FPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS-------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH-------HHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 58999999999999999999998 689999999865432211 125577899999999999999999999765
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
...+. .....+|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 82 ~~~~~------------~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~N 147 (318)
T d3blha1 82 ASPYN------------RCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147 (318)
T ss_dssp ---------------------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ccccc------------ccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchh
Confidence 44321 1234569999999877665443 344579999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCC----CCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 242 MLLDANRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||++.++.+||+|||+++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 148 ILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 999999999999999997543221 122335799999999998764 689999999999999999999999988877
Q ss_pred hhHHHHHHhccC--CCCCCC----------------------------CCcHHHHHHHHHhchhCCCCCCCHHHHHHH
Q 048724 317 TDVSSAVVRQNL--RPDIPR----------------------------CCPSSLASIMRKCWDANPDKRPVMDEVVKL 364 (394)
Q Consensus 317 ~~~~~~~~~~~~--~~~~~~----------------------------~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~ 364 (394)
......+..... ...... ..++++.+||.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 666655433211 111000 125678899999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=369.99 Aligned_cols=254 Identities=22% Similarity=0.353 Sum_probs=199.3
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCCC
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGTT 162 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 162 (394)
++|++.+.||+|+||+||+|++ +|+.||||+++..... ..+..|+++++.++|+|++..+..+....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----------CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----------HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 4699999999999999999998 6899999998753321 34668999999998777666555543322
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCce
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTENM 242 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~NI 242 (394)
. ..++||||+ +++|.+.+... ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus 76 ~-------------------~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NI 134 (299)
T d1ckia_ 76 D-------------------YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134 (299)
T ss_dssp T-------------------EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred C-------------------EEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhc
Confidence 2 238899999 66777766543 45699999999999999999999999999999999999
Q ss_pred eeCC---CCcEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 243 LLDA---NRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 243 ll~~---~~~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
|++. +..+||+|||+|+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 135 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp EECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 9864 4579999999998644321 12234579999999999999999999999999999999999999998
Q ss_pred CCChhhHHHHHH---hccCC---CCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 313 DLSFTDVSSAVV---RQNLR---PDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 313 ~~~~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
..........+. ..... ......+|+++.++|.+||+.||++||+++++.+.|+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp CCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 765444332221 11111 12345689999999999999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=366.65 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=207.5
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
+++|+++++||+|+||+||+|++ +|+.||||+++...... .....+.+|+.+|+.++||||++++++|.+.
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 73 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-------THHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-------HHHHHHHHHHHHHHhcCcCCEEeeccccccc
Confidence 36899999999999999999998 68899999997543221 1246788999999999999999999999877
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... ++|++++.+++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|
T Consensus 74 ~~~--------------------~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~N 131 (292)
T d1unla_ 74 KKL--------------------TLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp SEE--------------------EEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cce--------------------eEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcc
Confidence 765 889999999999887754 3568999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCC-CCccchHHHHHHHHHHHHhCCCCC-CCCChhhH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKP-YNRKCDVYSFGICLWEIYCCDMPY-PDLSFTDV 319 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~Pf-~~~~~~~~ 319 (394)
||++.++.+||+|||.++.............+++.|+|||.+.+.. ++.++|||||||++|||++|+.|| ...+..+.
T Consensus 132 Ili~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~ 211 (292)
T d1unla_ 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp EEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred cccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH
Confidence 9999999999999999987655554555567888999999987654 689999999999999999999886 44444444
Q ss_pred HHHHHhccC---------------------------CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHH
Q 048724 320 SSAVVRQNL---------------------------RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVK 363 (394)
Q Consensus 320 ~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~ 363 (394)
...+..... .......+++.+.+||.+||+.||++|||++|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 443322100 01122346789999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=377.12 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=208.5
Q ss_pred cccccccceeeeccCCceEEEEEEE-----CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC-Ccceeee
Q 048724 82 IELAKLDIRHEIARGTYGTVYRGAY-----DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-PNVTKFI 155 (394)
Q Consensus 82 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~ 155 (394)
+.+++|++++.||+|+||+||+|.. +|+.||||+++........ ...+.+.+|+.++++++| |||++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~-----~~~~~~~~E~~il~~l~h~pnIv~~~ 95 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTLH 95 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch-----HHHHHHHHHHHHHHhccCCCeEEEee
Confidence 5679999999999999999999976 4789999998643211000 002456789999999966 8999999
Q ss_pred eeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 048724 156 GASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHR 235 (394)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~ 235 (394)
+++.+...+ +++|||+.+|+|.+++.... .+++..+..++.||+.||+|||++|++||
T Consensus 96 ~~~~~~~~~--------------------~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHr 153 (322)
T d1vzoa_ 96 YAFQTETKL--------------------HLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYR 153 (322)
T ss_dssp EEEEETTEE--------------------EEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eeeccCCce--------------------eeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEec
Confidence 999877665 89999999999999996653 57899999999999999999999999999
Q ss_pred CCCCCceeeCCCCcEEEeeccccccccCC-CCCccCCCCCCCcCCccccCCC--CCCccchHHHHHHHHHHHHhCCCCCC
Q 048724 236 DVKTENMLLDANRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLDGK--PYNRKCDVYSFGICLWEIYCCDMPYP 312 (394)
Q Consensus 236 Dlkp~NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~Pf~ 312 (394)
||||+|||++.++.+||+|||+++..... ........|++.|++||.+.+. .++.++|||||||+||+|++|+.||.
T Consensus 154 DiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999754322 2223446799999999999764 47789999999999999999999997
Q ss_pred CCChhhHHHHHHhc--cCCCCCCCCCcHHHHHHHHHhchhCCCCCC-----CHHHHHH
Q 048724 313 DLSFTDVSSAVVRQ--NLRPDIPRCCPSSLASIMRKCWDANPDKRP-----VMDEVVK 363 (394)
Q Consensus 313 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cL~~dP~~Rp-----t~~~ll~ 363 (394)
.....+....+... ...+.++..+++++.+||.+||+.||++|| |++|+++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 76555444333332 234566778999999999999999999999 5899986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-48 Score=363.65 Aligned_cols=254 Identities=20% Similarity=0.319 Sum_probs=207.8
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCC-CcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDH-PNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~ 160 (394)
.++|++.+.||+|+||+||+|++ +|+.||||+++..... ..+.+|+++++.+.| +|++.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----------HHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 46899999999999999999998 6899999998644321 345678899999965 899999999876
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
.... |+||||+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+
T Consensus 73 ~~~~--------------------~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~ 130 (293)
T d1csna_ 73 GLHN--------------------VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130 (293)
T ss_dssp TTEE--------------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred CCcc--------------------EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCcc
Confidence 5554 8999999 78999988654 356999999999999999999999999999999999
Q ss_pred ceeeCC-----CCcEEEeeccccccccCCC-------CCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCC
Q 048724 241 NMLLDA-----NRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCD 308 (394)
Q Consensus 241 NIll~~-----~~~vkl~DFG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 308 (394)
|||++. ++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 131 Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~ 210 (293)
T d1csna_ 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210 (293)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCC
Confidence 999964 5789999999998643221 1233457999999999999999999999999999999999999
Q ss_pred CCCCCCChhh---HHHHHHhccC---CCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHHHHHHHHHh
Q 048724 309 MPYPDLSFTD---VSSAVVRQNL---RPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVVKLLEAVNT 370 (394)
Q Consensus 309 ~Pf~~~~~~~---~~~~~~~~~~---~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~~l~~~~~ 370 (394)
.||.+..... ....+..... ...+...+|+++.+++..||..+|++||+++.+.+.|+++..
T Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 211 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 9997654332 2222222111 112335689999999999999999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-49 Score=370.15 Aligned_cols=244 Identities=20% Similarity=0.335 Sum_probs=197.4
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceeeeeeecC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKFIGASMG 160 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 160 (394)
.++|+++++||+|+||+||+|++ +|+.||||+++... .+.+.+|+.+|+++ .||||++++++|..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 47899999999999999999998 68999999987432 25677899999999 49999999999875
Q ss_pred CCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 048724 161 TTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTE 240 (394)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~ 240 (394)
... ..+++|||||++++|..+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 102 ~~~------------------~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~ 158 (328)
T d3bqca1 102 PVS------------------RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 158 (328)
T ss_dssp TTT------------------CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCC------------------CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhccccccccccc
Confidence 433 2348999999999997653 35999999999999999999999999999999999
Q ss_pred ceeeCCC-CcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCChhh
Q 048724 241 NMLLDAN-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFTD 318 (394)
Q Consensus 241 NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~ 318 (394)
|||++.+ +.+||+|||+|+..... .......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||.......
T Consensus 159 NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 159 NVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp GEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ceEEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 9999865 46999999999865433 334456899999999998765 57999999999999999999999997654321
Q ss_pred -HHHHHHh-------------cc----------------------CCCCCCCCCcHHHHHHHHHhchhCCCCCCCHHHHH
Q 048724 319 -VSSAVVR-------------QN----------------------LRPDIPRCCPSSLASIMRKCWDANPDKRPVMDEVV 362 (394)
Q Consensus 319 -~~~~~~~-------------~~----------------------~~~~~~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll 362 (394)
....+.. .. ........+++++.+||++||+.||++|||++|++
T Consensus 238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1111100 00 00111234688999999999999999999999998
Q ss_pred H
Q 048724 363 K 363 (394)
Q Consensus 363 ~ 363 (394)
+
T Consensus 318 ~ 318 (328)
T d3bqca1 318 E 318 (328)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=374.62 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=207.4
Q ss_pred cccccccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 80 WEIELAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 80 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
|++ .++|++++.||+|+||+||+|++ +|+.||||+++..... . .....+.+|+.+|++++|||||+++++
T Consensus 14 ~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~----~~~~~~~~Ei~il~~l~h~~iv~~~~~ 85 (348)
T d2gfsa1 14 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS---I----IHAKRTYRELRLLKHMKHENVIGLLDV 85 (348)
T ss_dssp EEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS---H----HHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred ccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC---h----HHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 655 47899999999999999999987 6899999999743321 1 113567789999999999999999999
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
+...... .....+++++|+.||+|.+++.. ..+++..++.++.||+.||+|||++||+||||
T Consensus 86 ~~~~~~~---------------~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDi 147 (348)
T d2gfsa1 86 FTPARSL---------------EEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 147 (348)
T ss_dssp ECSCSST---------------TTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred Eeecccc---------------ccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCccccc
Confidence 8754432 12223566778889999999843 45999999999999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGK-PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 316 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~Pf~~~~~ 316 (394)
||+|||++.++.+|++|||++.... .......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus 148 Kp~NILi~~~~~~kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 148 KPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp CGGGEEECTTCCEEECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCccccccccccccccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999997433 223446789999999987665 568899999999999999999999998877
Q ss_pred hhHHHHHHhccCCC---------------------CC--------CCCCcHHHHHHHHHhchhCCCCCCCHHHHHH--HH
Q 048724 317 TDVSSAVVRQNLRP---------------------DI--------PRCCPSSLASIMRKCWDANPDKRPVMDEVVK--LL 365 (394)
Q Consensus 317 ~~~~~~~~~~~~~~---------------------~~--------~~~~~~~l~~li~~cL~~dP~~Rpt~~~ll~--~l 365 (394)
......+......+ .. ...+++++.+||.+||+.||++|||++|+++ ++
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 66665554321111 00 1347889999999999999999999999998 45
Q ss_pred HHHH
Q 048724 366 EAVN 369 (394)
Q Consensus 366 ~~~~ 369 (394)
+++.
T Consensus 305 ~~~~ 308 (348)
T d2gfsa1 305 AQYH 308 (348)
T ss_dssp TTTC
T ss_pred CCCC
Confidence 5543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=371.17 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=194.7
Q ss_pred cccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCCCCcceeeeeeecCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGASMGT 161 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 161 (394)
.++|+++++||+|+||+||+|.+ +|+.||||+++.... . ......+.+|+.++++++|||||+++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~----~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~ 88 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---N----QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---S----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---C----HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence 36799999999999999999998 689999999974331 1 11235678999999999999999999999754
Q ss_pred CccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 048724 162 TNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDVKTEN 241 (394)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dlkp~N 241 (394)
... .....+|+|||||.++.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~~~--------------~~~~~~~iv~Ey~~~~l~-~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~N 149 (355)
T d2b1pa1 89 KTL--------------EEFQDVYLVMELMDANLC-QVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_dssp CST--------------TTCCEEEEEEECCSEEHH-HHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ccc--------------ccCceeEEEEeccchHHH-Hhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccc
Confidence 332 123456999999976544 444 2358999999999999999999999999999999999
Q ss_pred eeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 048724 242 MLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFTDVSS 321 (394)
Q Consensus 242 Ill~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~Pf~~~~~~~~~~ 321 (394)
||++.++.+|++|||+++..... .......+|+.|+|||.+.+..++.++||||+||++|+|++|++||.+.+......
T Consensus 150 il~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~ 228 (355)
T d2b1pa1 150 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_dssp EEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cccccccceeeechhhhhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH
Confidence 99999999999999998854432 33344679999999999999999999999999999999999999998877665554
Q ss_pred HHHhccCC--------------------CCC--------------C------CCCcHHHHHHHHHhchhCCCCCCCHHHH
Q 048724 322 AVVRQNLR--------------------PDI--------------P------RCCPSSLASIMRKCWDANPDKRPVMDEV 361 (394)
Q Consensus 322 ~~~~~~~~--------------------~~~--------------~------~~~~~~l~~li~~cL~~dP~~Rpt~~~l 361 (394)
.+...... ... + ...++++.+||++||..||++|||++|+
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 43321100 000 0 1135678999999999999999999999
Q ss_pred HHH
Q 048724 362 VKL 364 (394)
Q Consensus 362 l~~ 364 (394)
|+.
T Consensus 309 L~H 311 (355)
T d2b1pa1 309 LQH 311 (355)
T ss_dssp HTS
T ss_pred hcC
Confidence 974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-42 Score=331.18 Aligned_cols=267 Identities=21% Similarity=0.321 Sum_probs=194.3
Q ss_pred ccccceeeeccCCceEEEEEEE--CCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-----------CCcc
Q 048724 85 AKLDIRHEIARGTYGTVYRGAY--DGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-----------HPNV 151 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----------h~nI 151 (394)
++|+++++||+|+||+||+|++ +|+.||||+++... .....+.+|+.+++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----------cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 4699999999999999999988 78999999997321 11245667888888775 5789
Q ss_pred eeeeeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-
Q 048724 152 TKFIGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGG-TLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHS- 229 (394)
Q Consensus 152 v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~- 229 (394)
+++++++....... .+++++++..+ .............+++..++.++.||+.||+|||+
T Consensus 83 v~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~ 144 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNG------------------VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR 144 (362)
T ss_dssp CCCCEEEEEEETTE------------------EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEeeeccccc------------------eeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh
Confidence 99998886443321 24555555444 44445555556789999999999999999999997
Q ss_pred CCCcccCCCCCceeeCCCC------cEEEeeccccccccCCCCCccCCCCCCCcCCccccCCCCCCccchHHHHHHHHHH
Q 048724 230 KTIVHRDVKTENMLLDANR------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWE 303 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~------~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e 303 (394)
.||+||||||+|||++.++ .++++|||.+..... ......||+.|+|||.+.+..++.++||||+||++++
T Consensus 145 ~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 221 (362)
T d1q8ya_ 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221 (362)
T ss_dssp TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred cCcccccCChhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHH
Confidence 8999999999999997654 399999999975432 2334689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChh------hHHHHHHh--c------------------------cC--------------CCCCCCCCc
Q 048724 304 IYCCDMPYPDLSFT------DVSSAVVR--Q------------------------NL--------------RPDIPRCCP 337 (394)
Q Consensus 304 lltg~~Pf~~~~~~------~~~~~~~~--~------------------------~~--------------~~~~~~~~~ 337 (394)
|++|+.||...... +....... + .. ....+...+
T Consensus 222 l~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (362)
T d1q8ya_ 222 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301 (362)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHH
T ss_pred HHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccC
Confidence 99999999654321 11111100 0 00 001112246
Q ss_pred HHHHHHHHHhchhCCCCCCCHHHHHHH--HHHHHhccCCCCCCCCCCC
Q 048724 338 SSLASIMRKCWDANPDKRPVMDEVVKL--LEAVNTSKGGGMIPEDQAH 383 (394)
Q Consensus 338 ~~l~~li~~cL~~dP~~Rpt~~~ll~~--l~~~~~~~~~~~~~~~~~~ 383 (394)
+++.+||.+||..||.+|||++|+|+. +++... ......|....+
T Consensus 302 ~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~-~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG-MEEIRVPDRELY 348 (362)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT-CTTCCCTTSCTT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC-cccCCCCCcccC
Confidence 789999999999999999999999984 554432 233334444444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.1e-27 Score=201.37 Aligned_cols=171 Identities=16% Similarity=0.135 Sum_probs=121.2
Q ss_pred cceeeeccCCceEEEEEEE-CCeeEEEEEeecccccc---------cchHHHHHHHHHHHHHHHHHHhCCCCcceeeeee
Q 048724 88 DIRHEIARGTYGTVYRGAY-DGQDVAVKILDWAEDGM---------VTSAEAAAIRASFRQEVAVWQKLDHPNVTKFIGA 157 (394)
Q Consensus 88 ~~~~~lG~G~fg~Vy~~~~-~g~~vavK~~~~~~~~~---------~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~ 157 (394)
.+.++||+|+||+||+|++ +|+.||||+++...... ...............|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999987 78999999986432110 0000112223455678999999999999988765
Q ss_pred ecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 048724 158 SMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSKTIVHRDV 237 (394)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~iiH~Dl 237 (394)
.. .+++|||+++..+. .++...+..++.|++.+|.|||++||+||||
T Consensus 83 ~~------------------------~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDi 129 (191)
T d1zara2 83 EG------------------------NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDL 129 (191)
T ss_dssp ET------------------------TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cC------------------------CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccC
Confidence 32 17899999876542 2445556789999999999999999999999
Q ss_pred CCCceeeCCCCcEEEeeccccccccCCCCCccCCCCCCCcCCc------cccCCCCCCccchHHHHHHHH
Q 048724 238 KTENMLLDANRTLKIADFGVARVEAQNPRDMTGETGTLGYMAP------EVLDGKPYNRKCDVYSFGICL 301 (394)
Q Consensus 238 kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~~l 301 (394)
||+|||+++++ ++|+|||.|.....+... .|... +.+ .+.|+.++|+||+.--+
T Consensus 130 KP~NILv~~~~-~~liDFG~a~~~~~~~~~--------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 130 SQYNVLVSEEG-IWIIDFPQSVEVGEEGWR--------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp STTSEEEETTE-EEECCCTTCEETTSTTHH--------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ChhheeeeCCC-EEEEECCCcccCCCCCcH--------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999998654 899999998643322110 11111 111 25678889999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=6.9e-08 Score=85.15 Aligned_cols=141 Identities=14% Similarity=0.117 Sum_probs=91.6
Q ss_pred cccccceeeeccCCceEEEEEEECCeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhCC-CCcceeeeeeecCCC
Q 048724 84 LAKLDIRHEIARGTYGTVYRGAYDGQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKLD-HPNVTKFIGASMGTT 162 (394)
Q Consensus 84 ~~~~~~~~~lG~G~fg~Vy~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~ 162 (394)
++.|++.+..+-++.+.||+...+++.+.||+......... ..+.+|..++..+. +--+.+++.+..+.+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~---------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---------YDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST---------TCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch---------hhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 35566666655555679999887888899998764432211 23556888877773 323556666655443
Q ss_pred ccccCCCCCCCCCCCCCCCCceEEEEecCCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC------------
Q 048724 163 NLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTLKKFLIRNKRKKLAFKVVIQIALDLARGLSYLHSK------------ 230 (394)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------------ 230 (394)
. .++||++++|.++.+.... ......++.++.+.+..||+.
T Consensus 84 ~--------------------~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~ 136 (263)
T d1j7la_ 84 W--------------------SNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLD 136 (263)
T ss_dssp E--------------------EEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHH
T ss_pred c--------------------eEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchh
Confidence 3 3899999999888654311 111223344455555555531
Q ss_pred -----------------------------------------------CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 -----------------------------------------------TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 -----------------------------------------------~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++|+|+.|.||++++++.+-|.||+.+..
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 137 SRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 158999999999999776667999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=3.1e-06 Score=73.77 Aligned_cols=28 Identities=21% Similarity=0.332 Sum_probs=24.9
Q ss_pred CcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 232 IVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 232 iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 6999999999999887667799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.66 E-value=0.00012 Score=67.92 Aligned_cols=29 Identities=24% Similarity=0.358 Sum_probs=25.3
Q ss_pred CCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 231 TIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 231 ~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++|+|++|.|||+++++ ++|+||.++..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998765 89999988864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.47 E-value=0.00017 Score=64.97 Aligned_cols=29 Identities=24% Similarity=0.240 Sum_probs=23.8
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeecccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVARV 260 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~~ 260 (394)
.++||+|+.|.|||+++ + ..+.||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999974 3 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.01 E-value=0.0014 Score=58.30 Aligned_cols=30 Identities=20% Similarity=0.335 Sum_probs=26.9
Q ss_pred CCCcccCCCCCceeeCCCCcEEEeeccccc
Q 048724 230 KTIVHRDVKTENMLLDANRTLKIADFGVAR 259 (394)
Q Consensus 230 ~~iiH~Dlkp~NIll~~~~~vkl~DFG~a~ 259 (394)
.|+||+|+.++||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.75 E-value=0.002 Score=59.29 Aligned_cols=76 Identities=20% Similarity=0.304 Sum_probs=47.6
Q ss_pred ccccceeeeccCCceEEEEEEEC---------CeeEEEEEeecccccccchHHHHHHHHHHHHHHHHHHhC-CCCcceee
Q 048724 85 AKLDIRHEIARGTYGTVYRGAYD---------GQDVAVKILDWAEDGMVTSAEAAAIRASFRQEVAVWQKL-DHPNVTKF 154 (394)
Q Consensus 85 ~~~~~~~~lG~G~fg~Vy~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 154 (394)
+++++ +.|+.|-.-.+|+.... .+.|.+++.- ... .. ....+|..+++.+ .+.-..++
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~---~~-------idr~~E~~i~~~ls~~gl~Pkl 110 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE---TE-------SHLVAESVIFTLLSERHLGPKL 110 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC---CH-------HHHHHHHHHHHHHHHTTSSSCE
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc---hh-------hHHHHHHHHHHHHHhCCCCCeE
Confidence 34444 46888888999998762 2457777653 111 11 1234688888877 34444578
Q ss_pred eeeecCCCccccCCCCCCCCCCCCCCCCceEEEEecCCCCCH
Q 048724 155 IGASMGTTNLKIPSQSATSDSHNSLPSRACCVVVEYLPGGTL 196 (394)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~e~~~ggsL 196 (394)
+++|.+ .+|+||++|.+|
T Consensus 111 l~~~~~------------------------g~I~efi~g~~l 128 (395)
T d1nw1a_ 111 YGIFSG------------------------GRLEEYIPSRPL 128 (395)
T ss_dssp EEEETT------------------------EEEECCCCEEEC
T ss_pred EEEcCC------------------------ceEEEEeccccC
Confidence 887643 679999987544
|